{
    "5e2900368b3851296d000001_001": [
        {
            "text": "",
            "probability": 0.9912810719958098,
            "start_logit": 3.1748158931732178,
            "end_logit": 3.6177706718444824
        },
        {
            "text": "potent and prolonged LH suppression",
            "probability": 0.0023397253687540095,
            "start_logit": -0.1255396604537964,
            "end_logit": 0.8691616654396057
        },
        {
            "text": "prolonged LH suppression",
            "probability": 0.0008959663736183429,
            "start_logit": -1.085425615310669,
            "end_logit": 0.8691616654396057
        },
        {
            "text": "potent and prolonged LH suppression after a single dose was orally administered in castrated monkeys compared to a known antagonist",
            "probability": 0.0007762780377610506,
            "start_logit": -0.1255396604537964,
            "end_logit": -0.23411642014980316
        },
        {
            "text": "12c as a highly potent GnRH antagonist with moderate CYP inhibition. Compound 12c showed potent and prolonged LH suppression",
            "probability": 0.0007485202069550699,
            "start_logit": -1.2652302980422974,
            "end_logit": 0.8691616654396057
        },
        {
            "text": "showed potent and prolonged LH suppression",
            "probability": 0.0005804022001903302,
            "start_logit": -1.5196071863174438,
            "end_logit": 0.8691616654396057
        },
        {
            "text": "12c showed potent and prolonged LH suppression",
            "probability": 0.000549106127829753,
            "start_logit": -1.5750367641448975,
            "end_logit": 0.8691616654396057
        },
        {
            "text": "Compound 12c showed potent and prolonged LH suppression",
            "probability": 0.00044014071670962296,
            "start_logit": -1.7962340116500854,
            "end_logit": 0.8691616654396057
        },
        {
            "text": "potent and prolonged LH suppression after a single dose was orally administered in castrated monkeys",
            "probability": 0.00035251855018613457,
            "start_logit": -0.1255396604537964,
            "end_logit": -1.0235239267349243
        },
        {
            "text": "prolonged LH suppression after a single dose was orally administered in castrated monkeys compared to a known antagonist",
            "probability": 0.00029726523792094505,
            "start_logit": -1.085425615310669,
            "end_logit": -0.23411642014980316
        },
        {
            "text": "compound 12c as a highly potent GnRH antagonist with moderate CYP inhibition. Compound 12c showed potent and prolonged LH suppression",
            "probability": 0.0002752405173608456,
            "start_logit": -2.265683174133301,
            "end_logit": 0.8691616654396057
        },
        {
            "text": "LH suppression",
            "probability": 0.00024976250727070683,
            "start_logit": -2.3628180027008057,
            "end_logit": 0.8691616654396057
        },
        {
            "text": "showed potent and prolonged LH suppression after a single dose was orally administered in castrated monkeys compared to a known antagonist",
            "probability": 0.00019256682305234923,
            "start_logit": -1.5196071863174438,
            "end_logit": -0.23411642014980316
        },
        {
            "text": "12c showed potent and prolonged LH suppression after a single dose was orally administered in castrated monkeys compared to a known antagonist",
            "probability": 0.0001821833592637618,
            "start_logit": -1.5750367641448975,
            "end_logit": -0.23411642014980316
        },
        {
            "text": "potent and prolonged LH suppression after a single dose was orally administered in castrated monkeys compared",
            "probability": 0.00016740971303962806,
            "start_logit": -0.1255396604537964,
            "end_logit": -1.7681829929351807
        },
        {
            "text": "suppression",
            "probability": 0.00016108349449061056,
            "start_logit": -2.801405668258667,
            "end_logit": 0.8691616654396057
        },
        {
            "text": "Compound 12c showed potent and prolonged LH suppression after a single dose was orally administered in castrated monkeys compared to a known antagonist",
            "probability": 0.0001460306309744555,
            "start_logit": -1.7962340116500854,
            "end_logit": -0.23411642014980316
        },
        {
            "text": "prolonged LH suppression after a single dose was orally administered in castrated monkeys",
            "probability": 0.00013499223937195066,
            "start_logit": -1.085425615310669,
            "end_logit": -1.0235239267349243
        },
        {
            "text": "12c",
            "probability": 0.00011592951518771129,
            "start_logit": -1.2652302980422974,
            "end_logit": -0.995954155921936
        },
        {
            "text": "potent",
            "probability": 0.00011380638425309756,
            "start_logit": -0.1255396604537964,
            "end_logit": -2.1541285514831543
        }
    ],
    "5e2900368b3851296d000001_002": [
        {
            "text": "orally active, non-peptide, competitive gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.23296424852671183,
            "start_logit": 1.0897103548049927,
            "end_logit": 0.6662139892578125
        },
        {
            "text": "orally active",
            "probability": 0.1497312061103169,
            "start_logit": 1.0897103548049927,
            "end_logit": 0.2241707146167755
        },
        {
            "text": "Elagolix population pharmacokinetics were best described by a two-compartment model with a lag time in absorption",
            "probability": 0.07759490031276929,
            "start_logit": -0.3182086944580078,
            "end_logit": 0.974749743938446
        },
        {
            "text": "a two-compartment model with a lag time in absorption",
            "probability": 0.0775256507978021,
            "start_logit": -0.3191015422344208,
            "end_logit": 0.974749743938446
        },
        {
            "text": "two-compartment model with a lag time in absorption",
            "probability": 0.07265087880984612,
            "start_logit": -0.38404491543769836,
            "end_logit": 0.974749743938446
        },
        {
            "text": "non-peptide, competitive gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.058794340640110965,
            "start_logit": -0.2871290445327759,
            "end_logit": 0.6662139892578125
        },
        {
            "text": "competitive gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.04154710336464394,
            "start_logit": -0.6343468427658081,
            "end_logit": 0.6662139892578125
        },
        {
            "text": "lag time in absorption",
            "probability": 0.027979535128360027,
            "start_logit": -1.3382370471954346,
            "end_logit": 0.974749743938446
        },
        {
            "text": "orally active, non-peptide, competitive gonadotropin-releasing hormone",
            "probability": 0.0275570262824992,
            "start_logit": 1.0897103548049927,
            "end_logit": -1.4684134721755981
        },
        {
            "text": "novel, orally active, non-peptide, competitive gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.025042856786094227,
            "start_logit": -1.140586018562317,
            "end_logit": 0.6662139892578125
        },
        {
            "text": "orally active, non-peptide, competitive gonadotropin-releasing hormone (GnRH) receptor antagonist in development",
            "probability": 0.024125372339271606,
            "start_logit": 1.0897103548049927,
            "end_logit": -1.6014069318771362
        },
        {
            "text": "a lag time in absorption",
            "probability": 0.023363849332048964,
            "start_logit": -1.518520474433899,
            "end_logit": 0.974749743938446
        },
        {
            "text": "oral",
            "probability": 0.02206289871139751,
            "start_logit": 1.0897103548049927,
            "end_logit": -1.690773606300354
        },
        {
            "text": "gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.021482563653594234,
            "start_logit": -1.2939330339431763,
            "end_logit": 0.6662139892578125
        },
        {
            "text": "Elagolix is a novel, orally active",
            "probability": 0.019685438004172013,
            "start_logit": -0.9392521977424622,
            "end_logit": 0.2241707146167755
        },
        {
            "text": "Elagolix population pharmacokinetics were best described by a two-compartment model",
            "probability": 0.018587385474452323,
            "start_logit": -0.3182086944580078,
            "end_logit": -0.45426881313323975
        },
        {
            "text": "a two-compartment model",
            "probability": 0.018570797175177175,
            "start_logit": -0.3191015422344208,
            "end_logit": -0.45426881313323975
        },
        {
            "text": "two-compartment model",
            "probability": 0.017403075254342523,
            "start_logit": -0.38404491543769836,
            "end_logit": -0.45426881313323975
        },
        {
            "text": "novel, orally active",
            "probability": 0.01609559052405365,
            "start_logit": -1.140586018562317,
            "end_logit": 0.2241707146167755
        },
        {
            "text": "a novel, orally active, non-peptide, competitive gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.016040971861952618,
            "start_logit": -1.5860284566879272,
            "end_logit": 0.6662139892578125
        },
        {
            "text": "",
            "probability": 0.011194310910383035,
            "start_logit": -0.8385547995567322,
            "end_logit": -0.44100016355514526
        }
    ],
    "5e2900368b3851296d000001_003": [
        {
            "text": "oral, nonpeptide gonadotropin-releasing hormone antagonist",
            "probability": 0.17390614501309945,
            "start_logit": -0.07444309443235397,
            "end_logit": 1.5154320001602173
        },
        {
            "text": "evaluate the efficacy and safety of elagolix, an oral, nonpeptide gonadotropin-releasing hormone antagonist",
            "probability": 0.15679827400615706,
            "start_logit": -0.17799875140190125,
            "end_logit": 1.5154320001602173
        },
        {
            "text": "an oral, nonpeptide gonadotropin-releasing hormone antagonist",
            "probability": 0.1350674071307889,
            "start_logit": -0.32718488574028015,
            "end_logit": 1.5154320001602173
        },
        {
            "text": "nonpeptide gonadotropin-releasing hormone antagonist",
            "probability": 0.13259452415915926,
            "start_logit": -0.34566307067871094,
            "end_logit": 1.5154320001602173
        },
        {
            "text": "gonadotropin-releasing hormone antagonist",
            "probability": 0.09461185742806029,
            "start_logit": -0.6831760406494141,
            "end_logit": 1.5154320001602173
        },
        {
            "text": "To evaluate the efficacy and safety of elagolix, an oral, nonpeptide gonadotropin-releasing hormone antagonist",
            "probability": 0.05677639918859434,
            "start_logit": -1.193838119506836,
            "end_logit": 1.5154320001602173
        },
        {
            "text": "efficacy and safety of elagolix, an oral, nonpeptide gonadotropin-releasing hormone antagonist",
            "probability": 0.04440747698471802,
            "start_logit": -1.4395509958267212,
            "end_logit": 1.5154320001602173
        },
        {
            "text": "",
            "probability": 0.0333221783795846,
            "start_logit": -0.31470903754234314,
            "end_logit": 0.10340537875890732
        },
        {
            "text": "the efficacy and safety of elagolix, an oral, nonpeptide gonadotropin-releasing hormone antagonist",
            "probability": 0.027674397383878457,
            "start_logit": -1.912451148033142,
            "end_logit": 1.5154320001602173
        },
        {
            "text": "elagolix, an oral, nonpeptide gonadotropin-releasing hormone antagonist",
            "probability": 0.02551736189698452,
            "start_logit": -1.993599772453308,
            "end_logit": 1.5154320001602173
        },
        {
            "text": "oral, nonpeptide gonadotropin-releasing hormone antagonist, over 12 months in women with endometriosis-associated pain",
            "probability": 0.01646698477980283,
            "start_logit": -0.07444309443235397,
            "end_logit": -0.8417263031005859
        },
        {
            "text": "safety of elagolix, an oral, nonpeptide gonadotropin-releasing hormone antagonist",
            "probability": 0.014370286271023302,
            "start_logit": -2.567796230316162,
            "end_logit": 1.5154320001602173
        },
        {
            "text": "evaluate the efficacy and safety",
            "probability": 0.013633479984642052,
            "start_logit": -0.17799875140190125,
            "end_logit": -0.926999568939209
        },
        {
            "text": "an oral, nonpeptide gonadotropin-releasing hormone antagonist, over 12 months in women with endometriosis-associated pain",
            "probability": 0.012789386696499996,
            "start_logit": -0.32718488574028015,
            "end_logit": -0.8417263031005859
        },
        {
            "text": "nonpeptide gonadotropin-releasing hormone antagonist, over 12 months in women with endometriosis-associated pain",
            "probability": 0.012555232082509837,
            "start_logit": -0.34566307067871094,
            "end_logit": -0.8417263031005859
        },
        {
            "text": "provided sustained reductions in dysmenorrhea, nonmenstrual pelvic pain, and dyspareunia",
            "probability": 0.011287152191797382,
            "start_logit": -0.7399538159370422,
            "end_logit": -0.5539079308509827
        },
        {
            "text": "reductions in dysmenorrhea, nonmenstrual pelvic pain, and dyspareunia",
            "probability": 0.010764203362750765,
            "start_logit": -0.787392795085907,
            "end_logit": -0.5539079308509827
        },
        {
            "text": "oral",
            "probability": 0.00972775938582441,
            "start_logit": -0.07444309443235397,
            "end_logit": -1.3681001663208008
        },
        {
            "text": "gonadotropin-releasing hormone antagonist, over 12 months in women with endometriosis-associated pain",
            "probability": 0.008958694450615244,
            "start_logit": -0.6831760406494141,
            "end_logit": -0.8417263031005859
        },
        {
            "text": "evaluate the efficacy and safety of elagolix, an oral",
            "probability": 0.008770799223509724,
            "start_logit": -0.17799875140190125,
            "end_logit": -1.3681001663208008
        }
    ],
    "5e2900368b3851296d000001_004": [
        {
            "text": "a new oral GnRH antagonist",
            "probability": 0.2834954723756403,
            "start_logit": 0.8156974911689758,
            "end_logit": 2.0558536052703857
        },
        {
            "text": "oral GnRH antagonist",
            "probability": 0.22973987308254476,
            "start_logit": 0.6054490208625793,
            "end_logit": 2.0558536052703857
        },
        {
            "text": "GnRH antagonist",
            "probability": 0.11810274026028801,
            "start_logit": -0.05994373559951782,
            "end_logit": 2.0558536052703857
        },
        {
            "text": "new oral GnRH antagonist",
            "probability": 0.09746265144066153,
            "start_logit": -0.2520294189453125,
            "end_logit": 2.0558536052703857
        },
        {
            "text": "",
            "probability": 0.09099740930551538,
            "start_logit": 0.77950519323349,
            "end_logit": 0.955680787563324
        },
        {
            "text": "elagolix, a new oral GnRH antagonist",
            "probability": 0.0816394535977325,
            "start_logit": -0.42918601632118225,
            "end_logit": 2.0558536052703857
        },
        {
            "text": "a new oral",
            "probability": 0.021661188345911443,
            "start_logit": 0.8156974911689758,
            "end_logit": -0.5158204436302185
        },
        {
            "text": "antagonist",
            "probability": 0.018126298153711716,
            "start_logit": -1.934134840965271,
            "end_logit": 2.0558536052703857
        },
        {
            "text": "oral",
            "probability": 0.01755385586833238,
            "start_logit": 0.6054490208625793,
            "end_logit": -0.5158204436302185
        },
        {
            "text": "new oral",
            "probability": 0.007446880304143757,
            "start_logit": -0.2520294189453125,
            "end_logit": -0.5158204436302185
        },
        {
            "text": "Promising preliminary data have emerged from multicenter Phase III trials on elagolix, a new oral GnRH antagonist",
            "probability": 0.006992459565345365,
            "start_logit": -2.8866662979125977,
            "end_logit": 2.0558536052703857
        },
        {
            "text": "elagolix",
            "probability": 0.006934360566690977,
            "start_logit": -0.42918601632118225,
            "end_logit": -0.4099701941013336
        },
        {
            "text": "elagolix, a new oral",
            "probability": 0.006237868866189815,
            "start_logit": -0.42918601632118225,
            "end_logit": -0.5158204436302185
        },
        {
            "text": "Phase III trials on elagolix, a new oral GnRH antagonist",
            "probability": 0.0037963912038656194,
            "start_logit": -3.4974477291107178,
            "end_logit": 2.0558536052703857
        },
        {
            "text": "a new",
            "probability": 0.002208763031860456,
            "start_logit": 0.8156974911689758,
            "end_logit": -2.798909902572632
        },
        {
            "text": "a new oral GnRH antagonist but non-inferiority RCT data are required to compare elagolix",
            "probability": 0.0019217990636874968,
            "start_logit": 0.8156974911689758,
            "end_logit": -2.9380807876586914
        },
        {
            "text": "a new oral GnRH",
            "probability": 0.0018363687043719673,
            "start_logit": 0.8156974911689758,
            "end_logit": -2.9835524559020996
        },
        {
            "text": "oral GnRH antagonist but non-inferiority RCT data are required to compare elagolix",
            "probability": 0.0015573930309430103,
            "start_logit": 0.6054490208625793,
            "end_logit": -2.9380807876586914
        },
        {
            "text": "oral GnRH",
            "probability": 0.0014881617316136867,
            "start_logit": 0.6054490208625793,
            "end_logit": -2.9835524559020996
        },
        {
            "text": "GnRH antagonist but non-inferiority RCT data are required to compare elagolix",
            "probability": 0.0008006115009498535,
            "start_logit": -0.05994373559951782,
            "end_logit": -2.9380807876586914
        }
    ],
    "5e2900368b3851296d000001_005": [
        {
            "text": "orally bioavailable, second-generation, non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.34438290935193533,
            "start_logit": -0.03493073955178261,
            "end_logit": -0.08369306474924088
        },
        {
            "text": "",
            "probability": 0.11876269177954867,
            "start_logit": -0.6879364252090454,
            "end_logit": -0.49531421065330505
        },
        {
            "text": "This article",
            "probability": 0.08527994301927962,
            "start_logit": -0.38874974846839905,
            "end_logit": -1.125688910484314
        },
        {
            "text": "non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.06512301224587295,
            "start_logit": -1.7004069089889526,
            "end_logit": -0.08369306474924088
        },
        {
            "text": "orally bioavailable, second-generation, non-peptide gonadotropin-releasing hormone",
            "probability": 0.05012791041359061,
            "start_logit": -0.03493073955178261,
            "end_logit": -2.010869264602661
        },
        {
            "text": "GnRH) receptor antagonist",
            "probability": 0.03404241288110442,
            "start_logit": -2.3490777015686035,
            "end_logit": -0.08369306474924088
        },
        {
            "text": "second-generation, non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.031310716232628155,
            "start_logit": -2.4327244758605957,
            "end_logit": -0.08369306474924088
        },
        {
            "text": "orally bioavailable",
            "probability": 0.030284403221597977,
            "start_logit": -0.03493073955178261,
            "end_logit": -2.5148143768310547
        },
        {
            "text": "gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.029520075128266952,
            "start_logit": -2.49161434173584,
            "end_logit": -0.08369306474924088
        },
        {
            "text": "orally bioavailable, second-generation",
            "probability": 0.025501112331085554,
            "start_logit": -0.03493073955178261,
            "end_logit": -2.68672513961792
        },
        {
            "text": "bioavailable, second-generation, non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.023258203908817297,
            "start_logit": -2.730026960372925,
            "end_logit": -0.08369306474924088
        },
        {
            "text": "This",
            "probability": 0.02147181400857037,
            "start_logit": -0.38874974846839905,
            "end_logit": -2.504887104034424
        },
        {
            "text": "oral",
            "probability": 0.021345100627740875,
            "start_logit": -0.03493073955178261,
            "end_logit": -2.8646249771118164
        },
        {
            "text": "article",
            "probability": 0.019791652695976877,
            "start_logit": -1.8494287729263306,
            "end_logit": -1.125688910484314
        },
        {
            "text": "summarizes the milestones",
            "probability": 0.01950337788649916,
            "start_logit": -0.151555135846138,
            "end_logit": -2.8382351398468018
        },
        {
            "text": "orally bioavailable, second-generation, non-peptide gonadotropin-releasing hormone (GnRH) receptor",
            "probability": 0.018423660159781717,
            "start_logit": -0.03493073955178261,
            "end_logit": -3.0118114948272705
        },
        {
            "text": "summarizes the milestones in the development of elagolix",
            "probability": 0.017801885063525993,
            "start_logit": -0.151555135846138,
            "end_logit": -2.929518461227417
        },
        {
            "text": "This article summarizes the milestones",
            "probability": 0.01538500083264239,
            "start_logit": -0.38874974846839905,
            "end_logit": -2.8382351398468018
        },
        {
            "text": "summarizes",
            "probability": 0.014641319158016173,
            "start_logit": -0.151555135846138,
            "end_logit": -3.1249752044677734
        },
        {
            "text": "This article summarizes the milestones in the development of elagolix",
            "probability": 0.014042799053518882,
            "start_logit": -0.38874974846839905,
            "end_logit": -2.929518461227417
        }
    ],
    "5e2900368b3851296d000001_006": [
        {
            "text": "oral gonadotropin-releasing hormone receptor antagonist",
            "probability": 0.3725670516918007,
            "start_logit": 0.38770902156829834,
            "end_logit": 2.0198216438293457
        },
        {
            "text": "an oral gonadotropin-releasing hormone receptor antagonist",
            "probability": 0.227436555499555,
            "start_logit": -0.10583668202161789,
            "end_logit": 2.0198216438293457
        },
        {
            "text": "gonadotropin-releasing hormone receptor antagonist",
            "probability": 0.17195476963548476,
            "start_logit": -0.3854765295982361,
            "end_logit": 2.0198216438293457
        },
        {
            "text": "evaluate elagolix, an oral gonadotropin-releasing hormone receptor antagonist",
            "probability": 0.052995237134633444,
            "start_logit": -1.5625059604644775,
            "end_logit": 2.0198216438293457
        },
        {
            "text": "elagolix, an oral gonadotropin-releasing hormone receptor antagonist",
            "probability": 0.04324002725715178,
            "start_logit": -1.7659413814544678,
            "end_logit": 2.0198216438293457
        },
        {
            "text": "To evaluate elagolix, an oral gonadotropin-releasing hormone receptor antagonist",
            "probability": 0.01971416912795911,
            "start_logit": -2.55137038230896,
            "end_logit": 2.0198216438293457
        },
        {
            "text": "antagonist",
            "probability": 0.01367754768040964,
            "start_logit": -2.91695237159729,
            "end_logit": 2.0198216438293457
        },
        {
            "text": "oral gonadotropin-releasing hormone receptor antagonist, alone or with add-back therapy",
            "probability": 0.011275266821353937,
            "start_logit": 0.38770902156829834,
            "end_logit": -1.477983832359314
        },
        {
            "text": "oral gonadotropin-releasing hormone receptor antagonist,",
            "probability": 0.010624580396378796,
            "start_logit": 0.38770902156829834,
            "end_logit": -1.53742516040802
        },
        {
            "text": "oral gonadotropin-releasing hormone receptor",
            "probability": 0.00993774667297444,
            "start_logit": 0.38770902156829834,
            "end_logit": -1.6042550802230835
        },
        {
            "text": "Elagolix with and without add-back",
            "probability": 0.009285511025793915,
            "start_logit": -0.9053183197975159,
            "end_logit": -0.3791128098964691
        },
        {
            "text": "",
            "probability": 0.009209260778426686,
            "start_logit": -0.8591597676277161,
            "end_logit": -0.4335170090198517
        },
        {
            "text": "Elagolix with and without add-back significantly reduced menstrual blood loss in women with uterine leiomyomas",
            "probability": 0.007227058408931046,
            "start_logit": -0.9053183197975159,
            "end_logit": -0.6297359466552734
        },
        {
            "text": "an oral gonadotropin-releasing hormone receptor antagonist, alone or with add-back therapy",
            "probability": 0.006883077385781595,
            "start_logit": -0.10583668202161789,
            "end_logit": -1.477983832359314
        },
        {
            "text": "oral",
            "probability": 0.006535047257027789,
            "start_logit": 0.38770902156829834,
            "end_logit": -2.0234158039093018
        },
        {
            "text": "an oral gonadotropin-releasing hormone receptor antagonist,",
            "probability": 0.006485860620276823,
            "start_logit": -0.10583668202161789,
            "end_logit": -1.53742516040802
        },
        {
            "text": "an oral gonadotropin-releasing hormone receptor",
            "probability": 0.0060665774454961305,
            "start_logit": -0.10583668202161789,
            "end_logit": -1.6042550802230835
        },
        {
            "text": "gonadotropin-releasing hormone receptor antagonist, alone or with add-back therapy",
            "probability": 0.005203991872175555,
            "start_logit": -0.3854765295982361,
            "end_logit": -1.477983832359314
        },
        {
            "text": "gonadotropin-releasing hormone receptor antagonist,",
            "probability": 0.004903673758151625,
            "start_logit": -0.3854765295982361,
            "end_logit": -1.53742516040802
        },
        {
            "text": "oral gonadotropin-releasing hormone receptor antagonist, alone or with add-back therapy,",
            "probability": 0.004776989530237596,
            "start_logit": 0.38770902156829834,
            "end_logit": -2.336784839630127
        }
    ],
    "5c7006037c78d6947100005d_001": [
        {
            "text": "8 for central nervous system and vascular",
            "probability": 0.24851870414756563,
            "start_logit": 5.080143928527832,
            "end_logit": 4.146080017089844
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.23757779944081303,
            "start_logit": 5.080143928527832,
            "end_logit": 4.101057052612305
        },
        {
            "text": "central nervous system and vascular",
            "probability": 0.15594304603625866,
            "start_logit": 4.614116668701172,
            "end_logit": 4.146080017089844
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.14907773578842173,
            "start_logit": 4.614116668701172,
            "end_logit": 4.101057052612305
        },
        {
            "text": "8",
            "probability": 0.05524220560901602,
            "start_logit": 5.080143928527832,
            "end_logit": 2.642289161682129
        },
        {
            "text": "8 for central nervous system and vascular,",
            "probability": 0.026627875592011074,
            "start_logit": 5.080143928527832,
            "end_logit": 1.9125205278396606
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal,",
            "probability": 0.021431564164798505,
            "start_logit": 5.080143928527832,
            "end_logit": 1.6954267024993896
        },
        {
            "text": "central nervous system and vascular,",
            "probability": 0.016708730409390502,
            "start_logit": 4.614116668701172,
            "end_logit": 1.9125205278396606
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal,",
            "probability": 0.013448096024175824,
            "start_logit": 4.614116668701172,
            "end_logit": 1.6954267024993896
        },
        {
            "text": "8 for central nervous system",
            "probability": 0.011575209437032635,
            "start_logit": 5.080143928527832,
            "end_logit": 1.0794275999069214
        },
        {
            "text": "",
            "probability": 0.010368533111203766,
            "start_logit": 2.8603780269622803,
            "end_logit": 3.189103364944458
        },
        {
            "text": "8 for central nervous system and vascular, 4",
            "probability": 0.009194707354217138,
            "start_logit": 5.080143928527832,
            "end_logit": 0.8491899371147156
        },
        {
            "text": "central nervous system",
            "probability": 0.007263330236289571,
            "start_logit": 4.614116668701172,
            "end_logit": 1.0794275999069214
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal, 2 for serosal, dermal",
            "probability": 0.006210422311320862,
            "start_logit": 5.080143928527832,
            "end_logit": 0.4567908048629761
        },
        {
            "text": "central nervous system and vascular, 4",
            "probability": 0.005769588559327174,
            "start_logit": 4.614116668701172,
            "end_logit": 0.8491899371147156
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal, 2",
            "probability": 0.005641938379927039,
            "start_logit": 5.080143928527832,
            "end_logit": 0.36078959703445435
        },
        {
            "text": "as follows: 8 for central nervous system and vascular",
            "probability": 0.0055040388929843975,
            "start_logit": 1.2701079845428467,
            "end_logit": 4.146080017089844
        },
        {
            "text": "as follows: 8 for central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.005261726487417349,
            "start_logit": 1.2701079845428467,
            "end_logit": 4.101057052612305
        },
        {
            "text": "4 for renal and musculoskeletal",
            "probability": 0.004737769012885434,
            "start_logit": 1.1652151346206665,
            "end_logit": 4.101057052612305
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal, 2 for serosal, dermal",
            "probability": 0.0038969790049438575,
            "start_logit": 4.614116668701172,
            "end_logit": 0.4567908048629761
        }
    ],
    "5c7006037c78d6947100005d_002": [
        {
            "text": "8 for central nervous system and vascular",
            "probability": 0.24851870414756563,
            "start_logit": 5.080143928527832,
            "end_logit": 4.146080017089844
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.23757779944081303,
            "start_logit": 5.080143928527832,
            "end_logit": 4.101057052612305
        },
        {
            "text": "central nervous system and vascular",
            "probability": 0.15594304603625866,
            "start_logit": 4.614116668701172,
            "end_logit": 4.146080017089844
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.14907773578842173,
            "start_logit": 4.614116668701172,
            "end_logit": 4.101057052612305
        },
        {
            "text": "8",
            "probability": 0.05524220560901602,
            "start_logit": 5.080143928527832,
            "end_logit": 2.642289161682129
        },
        {
            "text": "8 for central nervous system and vascular,",
            "probability": 0.026627875592011074,
            "start_logit": 5.080143928527832,
            "end_logit": 1.9125205278396606
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal,",
            "probability": 0.021431564164798505,
            "start_logit": 5.080143928527832,
            "end_logit": 1.6954267024993896
        },
        {
            "text": "central nervous system and vascular,",
            "probability": 0.016708730409390502,
            "start_logit": 4.614116668701172,
            "end_logit": 1.9125205278396606
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal,",
            "probability": 0.013448096024175824,
            "start_logit": 4.614116668701172,
            "end_logit": 1.6954267024993896
        },
        {
            "text": "8 for central nervous system",
            "probability": 0.011575209437032635,
            "start_logit": 5.080143928527832,
            "end_logit": 1.0794275999069214
        },
        {
            "text": "",
            "probability": 0.010368533111203766,
            "start_logit": 2.8603780269622803,
            "end_logit": 3.189103364944458
        },
        {
            "text": "8 for central nervous system and vascular, 4",
            "probability": 0.009194707354217138,
            "start_logit": 5.080143928527832,
            "end_logit": 0.8491899371147156
        },
        {
            "text": "central nervous system",
            "probability": 0.007263330236289571,
            "start_logit": 4.614116668701172,
            "end_logit": 1.0794275999069214
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal, 2 for serosal, dermal",
            "probability": 0.006210422311320862,
            "start_logit": 5.080143928527832,
            "end_logit": 0.4567908048629761
        },
        {
            "text": "central nervous system and vascular, 4",
            "probability": 0.005769588559327174,
            "start_logit": 4.614116668701172,
            "end_logit": 0.8491899371147156
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal, 2",
            "probability": 0.005641938379927039,
            "start_logit": 5.080143928527832,
            "end_logit": 0.36078959703445435
        },
        {
            "text": "as follows: 8 for central nervous system and vascular",
            "probability": 0.0055040388929843975,
            "start_logit": 1.2701079845428467,
            "end_logit": 4.146080017089844
        },
        {
            "text": "as follows: 8 for central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.005261726487417349,
            "start_logit": 1.2701079845428467,
            "end_logit": 4.101057052612305
        },
        {
            "text": "4 for renal and musculoskeletal",
            "probability": 0.004737769012885434,
            "start_logit": 1.1652151346206665,
            "end_logit": 4.101057052612305
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal, 2 for serosal, dermal",
            "probability": 0.0038969790049438575,
            "start_logit": 4.614116668701172,
            "end_logit": 0.4567908048629761
        }
    ],
    "5c7006037c78d6947100005d_003": [
        {
            "text": "8 for central nervous system and vascular",
            "probability": 0.24851870414756563,
            "start_logit": 5.080143928527832,
            "end_logit": 4.146080017089844
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.23757779944081303,
            "start_logit": 5.080143928527832,
            "end_logit": 4.101057052612305
        },
        {
            "text": "central nervous system and vascular",
            "probability": 0.15594304603625866,
            "start_logit": 4.614116668701172,
            "end_logit": 4.146080017089844
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.14907773578842173,
            "start_logit": 4.614116668701172,
            "end_logit": 4.101057052612305
        },
        {
            "text": "8",
            "probability": 0.05524220560901602,
            "start_logit": 5.080143928527832,
            "end_logit": 2.642289161682129
        },
        {
            "text": "8 for central nervous system and vascular,",
            "probability": 0.026627875592011074,
            "start_logit": 5.080143928527832,
            "end_logit": 1.9125205278396606
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal,",
            "probability": 0.021431564164798505,
            "start_logit": 5.080143928527832,
            "end_logit": 1.6954267024993896
        },
        {
            "text": "central nervous system and vascular,",
            "probability": 0.016708730409390502,
            "start_logit": 4.614116668701172,
            "end_logit": 1.9125205278396606
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal,",
            "probability": 0.013448096024175824,
            "start_logit": 4.614116668701172,
            "end_logit": 1.6954267024993896
        },
        {
            "text": "8 for central nervous system",
            "probability": 0.011575209437032635,
            "start_logit": 5.080143928527832,
            "end_logit": 1.0794275999069214
        },
        {
            "text": "",
            "probability": 0.010368533111203766,
            "start_logit": 2.8603780269622803,
            "end_logit": 3.189103364944458
        },
        {
            "text": "8 for central nervous system and vascular, 4",
            "probability": 0.009194707354217138,
            "start_logit": 5.080143928527832,
            "end_logit": 0.8491899371147156
        },
        {
            "text": "central nervous system",
            "probability": 0.007263330236289571,
            "start_logit": 4.614116668701172,
            "end_logit": 1.0794275999069214
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal, 2 for serosal, dermal",
            "probability": 0.006210422311320862,
            "start_logit": 5.080143928527832,
            "end_logit": 0.4567908048629761
        },
        {
            "text": "central nervous system and vascular, 4",
            "probability": 0.005769588559327174,
            "start_logit": 4.614116668701172,
            "end_logit": 0.8491899371147156
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal, 2",
            "probability": 0.005641938379927039,
            "start_logit": 5.080143928527832,
            "end_logit": 0.36078959703445435
        },
        {
            "text": "as follows: 8 for central nervous system and vascular",
            "probability": 0.0055040388929843975,
            "start_logit": 1.2701079845428467,
            "end_logit": 4.146080017089844
        },
        {
            "text": "as follows: 8 for central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.005261726487417349,
            "start_logit": 1.2701079845428467,
            "end_logit": 4.101057052612305
        },
        {
            "text": "4 for renal and musculoskeletal",
            "probability": 0.004737769012885434,
            "start_logit": 1.1652151346206665,
            "end_logit": 4.101057052612305
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal, 2 for serosal, dermal",
            "probability": 0.0038969790049438575,
            "start_logit": 4.614116668701172,
            "end_logit": 0.4567908048629761
        }
    ],
    "5c7006037c78d6947100005d_004": [
        {
            "text": "renal, immunological and hematologic active descriptors",
            "probability": 0.6355243926979529,
            "start_logit": 6.3065972328186035,
            "end_logit": 6.1751179695129395
        },
        {
            "text": "renal, immunological and hematologic",
            "probability": 0.17253050706289008,
            "start_logit": 6.3065972328186035,
            "end_logit": 4.871241569519043
        },
        {
            "text": "renal, immunological and hematologic active descriptors were identified",
            "probability": 0.05109667880556485,
            "start_logit": 6.3065972328186035,
            "end_logit": 3.6543869972229004
        },
        {
            "text": "Patients with SLEDAI-2K renal, immunological and hematologic active descriptors",
            "probability": 0.048531368358459705,
            "start_logit": 3.7343571186065674,
            "end_logit": 6.1751179695129395
        },
        {
            "text": "SLEDAI-2K renal, immunological and hematologic active descriptors",
            "probability": 0.019052485047875434,
            "start_logit": 2.799344301223755,
            "end_logit": 6.1751179695129395
        },
        {
            "text": "",
            "probability": 0.016288440496601955,
            "start_logit": 4.288827896118164,
            "end_logit": 4.528892517089844
        },
        {
            "text": "Patients with SLEDAI-2K renal, immunological and hematologic",
            "probability": 0.0131751694939591,
            "start_logit": 3.7343571186065674,
            "end_logit": 4.871241569519043
        },
        {
            "text": "active descriptors",
            "probability": 0.008423602424658762,
            "start_logit": 1.9831843376159668,
            "end_logit": 6.1751179695129395
        },
        {
            "text": "renal, immunological",
            "probability": 0.006084424324418734,
            "start_logit": 6.3065972328186035,
            "end_logit": 1.5263996124267578
        },
        {
            "text": "SLEDAI-2K renal, immunological and hematologic",
            "probability": 0.00517231902329257,
            "start_logit": 2.799344301223755,
            "end_logit": 4.871241569519043
        },
        {
            "text": "renal, immunological and hematologic active",
            "probability": 0.004295484433667213,
            "start_logit": 6.3065972328186035,
            "end_logit": 1.1782318353652954
        },
        {
            "text": "Patients with SLEDAI-2K renal, immunological and hematologic active descriptors were identified",
            "probability": 0.0039019615446693715,
            "start_logit": 3.7343571186065674,
            "end_logit": 3.6543869972229004
        },
        {
            "text": "renal, immunological and hematologic active descriptors were identified. The percentage of descriptors with partial and complete recovery",
            "probability": 0.0028381757286110153,
            "start_logit": 6.3065972328186035,
            "end_logit": 0.7638289928436279
        },
        {
            "text": "immunological and hematologic active descriptors",
            "probability": 0.002802273570224838,
            "start_logit": 0.8825778365135193,
            "end_logit": 6.1751179695129395
        },
        {
            "text": "renal, immunological and hematologic active descriptors were identified.",
            "probability": 0.0026010527600645273,
            "start_logit": 6.3065972328186035,
            "end_logit": 0.6765837669372559
        },
        {
            "text": "Patients with SLEDAI-2K",
            "probability": 0.001977865799853355,
            "start_logit": 3.7343571186065674,
            "end_logit": 2.974925994873047
        },
        {
            "text": "renal",
            "probability": 0.0017168333576844017,
            "start_logit": 6.3065972328186035,
            "end_logit": 0.26114901900291443
        },
        {
            "text": "SLEDAI-2K renal, immunological and hematologic active descriptors were identified",
            "probability": 0.0015318353160392447,
            "start_logit": 2.799344301223755,
            "end_logit": 3.6543869972229004
        },
        {
            "text": "hematologic active descriptors",
            "probability": 0.001512292236068748,
            "start_logit": 0.26577329635620117,
            "end_logit": 6.1751179695129395
        },
        {
            "text": "with SLEDAI-2K renal, immunological and hematologic active descriptors",
            "probability": 0.0009428375174432204,
            "start_logit": -0.20671455562114716,
            "end_logit": 6.1751179695129395
        }
    ],
    "5c7006037c78d6947100005d_005": [
        {
            "text": "variability",
            "probability": 0.36408283590405277,
            "start_logit": 2.588893175125122,
            "end_logit": 3.3735973834991455
        },
        {
            "text": "the variability",
            "probability": 0.3323777545792898,
            "start_logit": 2.497783899307251,
            "end_logit": 3.3735973834991455
        },
        {
            "text": "",
            "probability": 0.06095712993946381,
            "start_logit": 1.8510433435440063,
            "end_logit": 2.3242366313934326
        },
        {
            "text": "2K",
            "probability": 0.03831172535022527,
            "start_logit": 1.2656971216201782,
            "end_logit": 2.4451680183410645
        },
        {
            "text": "AMS, independent of variability",
            "probability": 0.026434825046387778,
            "start_logit": 0.8704997301101685,
            "end_logit": 2.4692916870117188
        },
        {
            "text": "AMS, independent of variability of the SLEDAI-2K",
            "probability": 0.02580475049621213,
            "start_logit": 0.8704997301101685,
            "end_logit": 2.4451680183410645
        },
        {
            "text": "SLEDAI-2K",
            "probability": 0.023447749839830258,
            "start_logit": 1.7464964389801025,
            "end_logit": 1.4733872413635254
        },
        {
            "text": "variability of the SLEDAI-2K",
            "probability": 0.018754475438414603,
            "start_logit": 0.5513735413551331,
            "end_logit": 2.4451680183410645
        },
        {
            "text": "variability of the Systemic Lupus Erythematosus Disease Activity Index 2000",
            "probability": 0.018088593410092217,
            "start_logit": 2.588893175125122,
            "end_logit": 0.3714975118637085
        },
        {
            "text": "the variability of the Systemic Lupus Erythematosus Disease Activity Index 2000",
            "probability": 0.016513401534612872,
            "start_logit": 2.497783899307251,
            "end_logit": 0.3714975118637085
        },
        {
            "text": "Six different approaches to measure variability",
            "probability": 0.014865229625183298,
            "start_logit": 1.1299829483032227,
            "end_logit": 1.6341511011123657
        },
        {
            "text": "SLEDAI-2K at presentation",
            "probability": 0.011709820729293679,
            "start_logit": 1.7464964389801025,
            "end_logit": 0.7790405750274658
        },
        {
            "text": "variability of the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K)",
            "probability": 0.008787943196476957,
            "start_logit": 2.588893175125122,
            "end_logit": -0.3504033386707306
        },
        {
            "text": "independent of variability",
            "probability": 0.008222515731349658,
            "start_logit": -0.2973063290119171,
            "end_logit": 2.4692916870117188
        },
        {
            "text": "independent of variability of the SLEDAI-2K",
            "probability": 0.008026531914863222,
            "start_logit": -0.2973063290119171,
            "end_logit": 2.4451680183410645
        },
        {
            "text": "the variability of the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K)",
            "probability": 0.008022671048917863,
            "start_logit": 2.497783899307251,
            "end_logit": -0.3504033386707306
        },
        {
            "text": "2K at presentation",
            "probability": 0.004768310158269595,
            "start_logit": 0.8480605483055115,
            "end_logit": 0.7790405750274658
        },
        {
            "text": "variability of the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K",
            "probability": 0.0039374989319597474,
            "start_logit": 2.588893175125122,
            "end_logit": -1.153238296508789
        },
        {
            "text": "the variability of the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K",
            "probability": 0.0035946134357402832,
            "start_logit": 2.497783899307251,
            "end_logit": -1.153238296508789
        },
        {
            "text": "Multivariate analysis revealed that AMS, independent of variability",
            "probability": 0.003291623689363945,
            "start_logit": -1.2128015756607056,
            "end_logit": 2.4692916870117188
        }
    ],
    "5e2894109499698331000002_002": [
        {
            "text": "CNEFinder",
            "probability": 0.9737091542054644,
            "start_logit": 5.832803726196289,
            "end_logit": 7.100942134857178
        },
        {
            "text": "CNEFinder; a tool for identifying CNEs between two given DNA sequences with user-defined criteria",
            "probability": 0.013338434485233695,
            "start_logit": 5.832803726196289,
            "end_logit": 2.810479164123535
        },
        {
            "text": "CNEFinder; a tool for identifying CNEs between two given DNA sequences",
            "probability": 0.004289923842566288,
            "start_logit": 5.832803726196289,
            "end_logit": 1.6760984659194946
        },
        {
            "text": "",
            "probability": 0.0030932445603662393,
            "start_logit": 3.0953025817871094,
            "end_logit": 4.086551189422607
        },
        {
            "text": "CNEFinder;",
            "probability": 0.002815355095994384,
            "start_logit": -0.013220525346696377,
            "end_logit": 7.100942134857178
        },
        {
            "text": "presenting CNEFinder",
            "probability": 0.0013326182670682616,
            "start_logit": -0.7611632943153381,
            "end_logit": 7.100942134857178
        },
        {
            "text": "CNEFinder; a tool for identifying CNEs between two given DNA sequences with user-defined criteria.",
            "probability": 0.000404754076404922,
            "start_logit": 5.832803726196289,
            "end_logit": -0.6846461296081543
        },
        {
            "text": "We fill this gap by presenting CNEFinder",
            "probability": 0.00034716960621494726,
            "start_logit": -2.106250762939453,
            "end_logit": 7.100942134857178
        },
        {
            "text": "CNEFinder; a tool",
            "probability": 0.00017594599124811026,
            "start_logit": 5.832803726196289,
            "end_logit": -1.5177487134933472
        },
        {
            "text": "by presenting CNEFinder",
            "probability": 0.0001333855129757276,
            "start_logit": -3.0628206729888916,
            "end_logit": 7.100942134857178
        },
        {
            "text": "C",
            "probability": 0.0001325274477341576,
            "start_logit": 5.832803726196289,
            "end_logit": -1.8011360168457031
        },
        {
            "text": "CNEFinder; a tool for identifying CNEs between two given DNA",
            "probability": 5.826648032513854e-05,
            "start_logit": 5.832803726196289,
            "end_logit": -2.622898817062378
        },
        {
            "text": "a tool for identifying CNEs between two given DNA sequences with user-defined criteria",
            "probability": 5.412898887327166e-05,
            "start_logit": 0.3257686495780945,
            "end_logit": 2.810479164123535
        },
        {
            "text": "user-defined criteria. The results presented here show the tool's ability of identifying CNEs accurately and efficiently. CNEFinder",
            "probability": 2.3870104803508964e-05,
            "start_logit": -0.8792508840560913,
            "end_logit": 3.1967556476593018
        },
        {
            "text": "identifying CNEs between two given DNA sequences with user-defined criteria",
            "probability": 1.906279341657659e-05,
            "start_logit": -0.7178627848625183,
            "end_logit": 2.810479164123535
        },
        {
            "text": "presenting CNEFinder; a tool for identifying CNEs between two given DNA sequences with user-defined criteria",
            "probability": 1.825498032173673e-05,
            "start_logit": -0.7611632943153381,
            "end_logit": 2.810479164123535
        },
        {
            "text": "a tool for identifying CNEs between two given DNA sequences",
            "probability": 1.7409032536653417e-05,
            "start_logit": 0.3257686495780945,
            "end_logit": 1.6760984659194946
        },
        {
            "text": "user-defined criteria",
            "probability": 1.6221708035055596e-05,
            "start_logit": -0.8792508840560913,
            "end_logit": 2.810479164123535
        },
        {
            "text": "tool for identifying CNEs between two given DNA sequences with user-defined criteria",
            "probability": 1.2109524680032892e-05,
            "start_logit": -1.1716089248657227,
            "end_logit": 2.810479164123535
        },
        {
            "text": "CNEFinder is based on a k-mer technique for computing maximal exact matches",
            "probability": 8.163295736869999e-06,
            "start_logit": 2.114598035812378,
            "end_logit": -0.8700721263885498
        }
    ],
    "5e29f666aa19d74431000001_001": [
        {
            "text": "PP2A",
            "probability": 0.9929679298146394,
            "start_logit": 6.385335922241211,
            "end_logit": 7.142111778259277
        },
        {
            "text": "Protein phosphatase 2A",
            "probability": 0.002393361176006737,
            "start_logit": 2.3393356800079346,
            "end_logit": 5.160112380981445
        },
        {
            "text": "PP",
            "probability": 0.0010855838128459798,
            "start_logit": 6.385335922241211,
            "end_logit": 0.3235313296318054
        },
        {
            "text": "PP2",
            "probability": 0.0010204250031756533,
            "start_logit": 6.385335922241211,
            "end_logit": 0.26163262128829956
        },
        {
            "text": "2A",
            "probability": 0.0007669450323803815,
            "start_logit": 1.2012968063354492,
            "end_logit": 5.160112380981445
        },
        {
            "text": "Protein phosphatase 2A (PP2A",
            "probability": 0.0003847159224112775,
            "start_logit": 2.3393356800079346,
            "end_logit": 3.3321635723114014
        },
        {
            "text": "",
            "probability": 0.0003334428395990804,
            "start_logit": 2.3895952701568604,
            "end_logit": 3.1388702392578125
        },
        {
            "text": "PP2A inhibition",
            "probability": 0.00024355843289195568,
            "start_logit": 6.385335922241211,
            "end_logit": -1.1709849834442139
        },
        {
            "text": "Pharmacologic PP2A",
            "probability": 0.0002329310692133198,
            "start_logit": -1.9723751544952393,
            "end_logit": 7.142111778259277
        },
        {
            "text": "phosphatase 2A",
            "probability": 0.0001652827244572517,
            "start_logit": -0.33346083760261536,
            "end_logit": 5.160112380981445
        },
        {
            "text": "2A (PP2A",
            "probability": 0.0001232810026872998,
            "start_logit": 1.2012968063354492,
            "end_logit": 3.3321635723114014
        },
        {
            "text": "PP2A inhibition with LB-100 prior to RT",
            "probability": 5.66238596663509e-05,
            "start_logit": 6.385335922241211,
            "end_logit": -2.629911422729492
        },
        {
            "text": "PP2A against AAM",
            "probability": 4.564840717420003e-05,
            "start_logit": 2.988586902618408,
            "end_logit": 0.5513758659362793
        },
        {
            "text": "Protein phosphatase 2A (PP2A)",
            "probability": 4.332208964021489e-05,
            "start_logit": 2.3393356800079346,
            "end_logit": 1.1483210325241089
        },
        {
            "text": "PP2A inhibition with LB-100 prior to RT enhanced the radiosensitivity of meningioma cells and reduced survival fraction",
            "probability": 3.5245545547633475e-05,
            "start_logit": 6.385335922241211,
            "end_logit": -3.1040027141571045
        },
        {
            "text": "PP2A inhibition with LB-100",
            "probability": 2.7767412360131376e-05,
            "start_logit": 6.385335922241211,
            "end_logit": -3.3424787521362305
        },
        {
            "text": "phosphatase 2A (PP2A",
            "probability": 2.6568031785454857e-05,
            "start_logit": -0.33346083760261536,
            "end_logit": 3.3321635723114014
        },
        {
            "text": "PP2A)",
            "probability": 2.38013133814884e-05,
            "start_logit": 1.740413784980774,
            "end_logit": 1.1483210325241089
        },
        {
            "text": "2A (PP2A)",
            "probability": 1.3882426845970897e-05,
            "start_logit": 1.2012968063354492,
            "end_logit": 1.1483210325241089
        },
        {
            "text": "STAT3",
            "probability": 9.68408328958419e-06,
            "start_logit": 0.5606856942176819,
            "end_logit": 1.4287919998168945
        }
    ],
    "5e29f666aa19d74431000001_003": [
        {
            "text": "PP2A",
            "probability": 0.9929679298146394,
            "start_logit": 6.385335922241211,
            "end_logit": 7.142111778259277
        },
        {
            "text": "Protein phosphatase 2A",
            "probability": 0.002393361176006737,
            "start_logit": 2.3393356800079346,
            "end_logit": 5.160112380981445
        },
        {
            "text": "PP",
            "probability": 0.0010855838128459798,
            "start_logit": 6.385335922241211,
            "end_logit": 0.3235313296318054
        },
        {
            "text": "PP2",
            "probability": 0.0010204250031756533,
            "start_logit": 6.385335922241211,
            "end_logit": 0.26163262128829956
        },
        {
            "text": "2A",
            "probability": 0.0007669450323803815,
            "start_logit": 1.2012968063354492,
            "end_logit": 5.160112380981445
        },
        {
            "text": "Protein phosphatase 2A (PP2A",
            "probability": 0.0003847159224112775,
            "start_logit": 2.3393356800079346,
            "end_logit": 3.3321635723114014
        },
        {
            "text": "",
            "probability": 0.0003334428395990804,
            "start_logit": 2.3895952701568604,
            "end_logit": 3.1388702392578125
        },
        {
            "text": "PP2A inhibition",
            "probability": 0.00024355843289195568,
            "start_logit": 6.385335922241211,
            "end_logit": -1.1709849834442139
        },
        {
            "text": "Pharmacologic PP2A",
            "probability": 0.0002329310692133198,
            "start_logit": -1.9723751544952393,
            "end_logit": 7.142111778259277
        },
        {
            "text": "phosphatase 2A",
            "probability": 0.0001652827244572517,
            "start_logit": -0.33346083760261536,
            "end_logit": 5.160112380981445
        },
        {
            "text": "2A (PP2A",
            "probability": 0.0001232810026872998,
            "start_logit": 1.2012968063354492,
            "end_logit": 3.3321635723114014
        },
        {
            "text": "PP2A inhibition with LB-100 prior to RT",
            "probability": 5.66238596663509e-05,
            "start_logit": 6.385335922241211,
            "end_logit": -2.629911422729492
        },
        {
            "text": "PP2A against AAM",
            "probability": 4.564840717420003e-05,
            "start_logit": 2.988586902618408,
            "end_logit": 0.5513758659362793
        },
        {
            "text": "Protein phosphatase 2A (PP2A)",
            "probability": 4.332208964021489e-05,
            "start_logit": 2.3393356800079346,
            "end_logit": 1.1483210325241089
        },
        {
            "text": "PP2A inhibition with LB-100 prior to RT enhanced the radiosensitivity of meningioma cells and reduced survival fraction",
            "probability": 3.5245545547633475e-05,
            "start_logit": 6.385335922241211,
            "end_logit": -3.1040027141571045
        },
        {
            "text": "PP2A inhibition with LB-100",
            "probability": 2.7767412360131376e-05,
            "start_logit": 6.385335922241211,
            "end_logit": -3.3424787521362305
        },
        {
            "text": "phosphatase 2A (PP2A",
            "probability": 2.6568031785454857e-05,
            "start_logit": -0.33346083760261536,
            "end_logit": 3.3321635723114014
        },
        {
            "text": "PP2A)",
            "probability": 2.38013133814884e-05,
            "start_logit": 1.740413784980774,
            "end_logit": 1.1483210325241089
        },
        {
            "text": "2A (PP2A)",
            "probability": 1.3882426845970897e-05,
            "start_logit": 1.2012968063354492,
            "end_logit": 1.1483210325241089
        },
        {
            "text": "STAT3",
            "probability": 9.68408328958419e-06,
            "start_logit": 0.5606856942176819,
            "end_logit": 1.4287919998168945
        }
    ],
    "5e46da9c3f5415952900000a_001": [
        {
            "text": "damage recognition step of NER",
            "probability": 0.583694941896749,
            "start_logit": 6.003612041473389,
            "end_logit": 5.024774074554443
        },
        {
            "text": "damage recognition",
            "probability": 0.20959250066329027,
            "start_logit": 6.003612041473389,
            "end_logit": 4.000560760498047
        },
        {
            "text": "damage",
            "probability": 0.06263692804361566,
            "start_logit": 6.003612041473389,
            "end_logit": 2.792750597000122
        },
        {
            "text": "the damage recognition step of NER",
            "probability": 0.048214882081719986,
            "start_logit": 3.509901285171509,
            "end_logit": 5.024774074554443
        },
        {
            "text": "damage recognition step",
            "probability": 0.026809982271687977,
            "start_logit": 6.003612041473389,
            "end_logit": 1.9441698789596558
        },
        {
            "text": "damage recognition step of NER.",
            "probability": 0.02113762265110739,
            "start_logit": 6.003612041473389,
            "end_logit": 1.70645010471344
        },
        {
            "text": "the damage recognition",
            "probability": 0.0173129437645203,
            "start_logit": 3.509901285171509,
            "end_logit": 4.000560760498047
        },
        {
            "text": "NER",
            "probability": 0.012562103578636987,
            "start_logit": 2.1649181842803955,
            "end_logit": 5.024774074554443
        },
        {
            "text": "the damage",
            "probability": 0.005173990526233357,
            "start_logit": 3.509901285171509,
            "end_logit": 2.792750597000122
        },
        {
            "text": "involved in the damage recognition step of NER",
            "probability": 0.0031546345363964233,
            "start_logit": 0.7831062078475952,
            "end_logit": 5.024774074554443
        },
        {
            "text": "the damage recognition step",
            "probability": 0.002214581695092189,
            "start_logit": 3.509901285171509,
            "end_logit": 1.9441698789596558
        },
        {
            "text": "the damage recognition step of NER.",
            "probability": 0.0017460284653131627,
            "start_logit": 3.509901285171509,
            "end_logit": 1.70645010471344
        },
        {
            "text": "",
            "probability": 0.0014558220063585286,
            "start_logit": 2.5845587253570557,
            "end_logit": 2.450019598007202
        },
        {
            "text": "involved in the damage recognition",
            "probability": 0.0011327624992149834,
            "start_logit": 0.7831062078475952,
            "end_logit": 4.000560760498047
        },
        {
            "text": "monoubiquitinated histone H2A",
            "probability": 0.0008094943266542328,
            "start_logit": 1.9923300743103027,
            "end_logit": 2.455332040786743
        },
        {
            "text": "loss of monoubiquitinated histone H2A",
            "probability": 0.0007104378242341573,
            "start_logit": 1.8618017435073853,
            "end_logit": 2.455332040786743
        },
        {
            "text": "in the damage recognition step of NER",
            "probability": 0.0006231415785653428,
            "start_logit": -0.8387479782104492,
            "end_logit": 5.024774074554443
        },
        {
            "text": "NER.",
            "probability": 0.00045491743390218566,
            "start_logit": 2.1649181842803955,
            "end_logit": 1.70645010471344
        },
        {
            "text": "involved in the damage",
            "probability": 0.00033852720364179704,
            "start_logit": 0.7831062078475952,
            "end_logit": 2.792750597000122
        },
        {
            "text": "in the damage recognition",
            "probability": 0.0002237569530658765,
            "start_logit": -0.8387479782104492,
            "end_logit": 4.000560760498047
        }
    ],
    "5e46da9c3f5415952900000a_002": [
        {
            "text": "p127 subunit of UV-DDB binds in vivo to p300, a histone acetyltransferase",
            "probability": 0.14185036541669566,
            "start_logit": 0.3479539752006531,
            "end_logit": 2.2829763889312744
        },
        {
            "text": "p300, a histone acetyltransferase",
            "probability": 0.1325228094939798,
            "start_logit": 0.2799360156059265,
            "end_logit": 2.2829763889312744
        },
        {
            "text": "binds in vivo to p300, a histone acetyltransferase",
            "probability": 0.09563282648162552,
            "start_logit": -0.04630262777209282,
            "end_logit": 2.2829763889312744
        },
        {
            "text": "",
            "probability": 0.09528348869399247,
            "start_logit": 0.7738243937492371,
            "end_logit": 1.459189772605896
        },
        {
            "text": "the p127 subunit of UV-DDB binds in vivo to p300",
            "probability": 0.08464831973826654,
            "start_logit": 1.0083869695663452,
            "end_logit": 1.1062759160995483
        },
        {
            "text": "histone acetyltransferase",
            "probability": 0.08360707998867516,
            "start_logit": -0.18069055676460266,
            "end_logit": 2.2829763889312744
        },
        {
            "text": "the p127 subunit",
            "probability": 0.06477476941183383,
            "start_logit": 1.0083869695663452,
            "end_logit": 0.8386868238449097
        },
        {
            "text": "a histone acetyltransferase",
            "probability": 0.06273805841908298,
            "start_logit": -0.4678505063056946,
            "end_logit": 2.2829763889312744
        },
        {
            "text": "p127 subunit of UV-DDB binds in vivo to p300",
            "probability": 0.04373165735787735,
            "start_logit": 0.3479539752006531,
            "end_logit": 1.1062759160995483
        },
        {
            "text": "p300",
            "probability": 0.04085602514924407,
            "start_logit": 0.2799360156059265,
            "end_logit": 1.1062759160995483
        },
        {
            "text": "p127 subunit",
            "probability": 0.033464432963496424,
            "start_logit": 0.3479539752006531,
            "end_logit": 0.8386868238449097
        },
        {
            "text": "binds in vivo to p300",
            "probability": 0.029483054115330098,
            "start_logit": -0.04630262777209282,
            "end_logit": 1.1062759160995483
        },
        {
            "text": "the p127",
            "probability": 0.021303475381834146,
            "start_logit": 1.0083869695663452,
            "end_logit": -0.27335911989212036
        },
        {
            "text": "genomic nucleotide excision repair",
            "probability": 0.015179066342142769,
            "start_logit": -0.8528739213943481,
            "end_logit": 1.2489488124847412
        },
        {
            "text": "global genomic nucleotide excision repair",
            "probability": 0.01222374516067201,
            "start_logit": -1.069410800933838,
            "end_logit": 1.2489488124847412
        },
        {
            "text": "p127",
            "probability": 0.011005963128517792,
            "start_logit": 0.3479539752006531,
            "end_logit": -0.27335911989212036
        },
        {
            "text": "chromatin remodeling",
            "probability": 0.009029055486760232,
            "start_logit": -0.5766620635986328,
            "end_logit": 0.4532674551010132
        },
        {
            "text": "proteasomal degradation of p48 and chromatin remodeling",
            "probability": 0.008861273418768714,
            "start_logit": -0.5954193472862244,
            "end_logit": 0.4532674551010132
        },
        {
            "text": "p127 and p48",
            "probability": 0.007284203390654682,
            "start_logit": -1.1048637628555298,
            "end_logit": 0.766729474067688
        },
        {
            "text": "proteasomal degradation",
            "probability": 0.006520330460550172,
            "start_logit": -0.5954193472862244,
            "end_logit": 0.1465020328760147
        }
    ],
    "5e46da9c3f5415952900000a_003": [
        {
            "text": "p127 subunit of UV-DDB binds in vivo to p300, a histone acetyltransferase",
            "probability": 0.14185036541669566,
            "start_logit": 0.3479539752006531,
            "end_logit": 2.2829763889312744
        },
        {
            "text": "p300, a histone acetyltransferase",
            "probability": 0.1325228094939798,
            "start_logit": 0.2799360156059265,
            "end_logit": 2.2829763889312744
        },
        {
            "text": "binds in vivo to p300, a histone acetyltransferase",
            "probability": 0.09563282648162552,
            "start_logit": -0.04630262777209282,
            "end_logit": 2.2829763889312744
        },
        {
            "text": "",
            "probability": 0.09528348869399247,
            "start_logit": 0.7738243937492371,
            "end_logit": 1.459189772605896
        },
        {
            "text": "the p127 subunit of UV-DDB binds in vivo to p300",
            "probability": 0.08464831973826654,
            "start_logit": 1.0083869695663452,
            "end_logit": 1.1062759160995483
        },
        {
            "text": "histone acetyltransferase",
            "probability": 0.08360707998867516,
            "start_logit": -0.18069055676460266,
            "end_logit": 2.2829763889312744
        },
        {
            "text": "the p127 subunit",
            "probability": 0.06477476941183383,
            "start_logit": 1.0083869695663452,
            "end_logit": 0.8386868238449097
        },
        {
            "text": "a histone acetyltransferase",
            "probability": 0.06273805841908298,
            "start_logit": -0.4678505063056946,
            "end_logit": 2.2829763889312744
        },
        {
            "text": "p127 subunit of UV-DDB binds in vivo to p300",
            "probability": 0.04373165735787735,
            "start_logit": 0.3479539752006531,
            "end_logit": 1.1062759160995483
        },
        {
            "text": "p300",
            "probability": 0.04085602514924407,
            "start_logit": 0.2799360156059265,
            "end_logit": 1.1062759160995483
        },
        {
            "text": "p127 subunit",
            "probability": 0.033464432963496424,
            "start_logit": 0.3479539752006531,
            "end_logit": 0.8386868238449097
        },
        {
            "text": "binds in vivo to p300",
            "probability": 0.029483054115330098,
            "start_logit": -0.04630262777209282,
            "end_logit": 1.1062759160995483
        },
        {
            "text": "the p127",
            "probability": 0.021303475381834146,
            "start_logit": 1.0083869695663452,
            "end_logit": -0.27335911989212036
        },
        {
            "text": "genomic nucleotide excision repair",
            "probability": 0.015179066342142769,
            "start_logit": -0.8528739213943481,
            "end_logit": 1.2489488124847412
        },
        {
            "text": "global genomic nucleotide excision repair",
            "probability": 0.01222374516067201,
            "start_logit": -1.069410800933838,
            "end_logit": 1.2489488124847412
        },
        {
            "text": "p127",
            "probability": 0.011005963128517792,
            "start_logit": 0.3479539752006531,
            "end_logit": -0.27335911989212036
        },
        {
            "text": "chromatin remodeling",
            "probability": 0.009029055486760232,
            "start_logit": -0.5766620635986328,
            "end_logit": 0.4532674551010132
        },
        {
            "text": "proteasomal degradation of p48 and chromatin remodeling",
            "probability": 0.008861273418768714,
            "start_logit": -0.5954193472862244,
            "end_logit": 0.4532674551010132
        },
        {
            "text": "p127 and p48",
            "probability": 0.007284203390654682,
            "start_logit": -1.1048637628555298,
            "end_logit": 0.766729474067688
        },
        {
            "text": "proteasomal degradation",
            "probability": 0.006520330460550172,
            "start_logit": -0.5954193472862244,
            "end_logit": 0.1465020328760147
        }
    ],
    "5e46da9c3f5415952900000a_004": [
        {
            "text": "",
            "probability": 0.31585014577822784,
            "start_logit": 2.5327537059783936,
            "end_logit": 2.722344398498535
        },
        {
            "text": "removal of photoproducts from the non-transcribed regions of the genome",
            "probability": 0.12531283728778417,
            "start_logit": 1.5961281061172485,
            "end_logit": 2.734515428543091
        },
        {
            "text": "photoproducts from the non-transcribed regions of the genome",
            "probability": 0.11067690930887873,
            "start_logit": 1.4719300270080566,
            "end_logit": 2.734515428543091
        },
        {
            "text": "specifically involved in the removal of photoproducts from the non-transcribed regions of the genome",
            "probability": 0.07633948617535495,
            "start_logit": 1.1005051136016846,
            "end_logit": 2.734515428543091
        },
        {
            "text": "binds to UV-damaged DNA",
            "probability": 0.040866285721231035,
            "start_logit": 0.9937476515769958,
            "end_logit": 2.216387987136841
        },
        {
            "text": "removal of photoproducts",
            "probability": 0.040536181655651086,
            "start_logit": 1.5961281061172485,
            "end_logit": 1.605897068977356
        },
        {
            "text": "involved in the removal of photoproducts from the non-transcribed regions of the genome",
            "probability": 0.03692021763543042,
            "start_logit": 0.3740741014480591,
            "end_logit": 2.734515428543091
        },
        {
            "text": "photoproducts",
            "probability": 0.03580175341914532,
            "start_logit": 1.4719300270080566,
            "end_logit": 1.605897068977356
        },
        {
            "text": "the removal of photoproducts from the non-transcribed regions of the genome",
            "probability": 0.03515735299448022,
            "start_logit": 0.3251485824584961,
            "end_logit": 2.734515428543091
        },
        {
            "text": "p48 protein",
            "probability": 0.031946129421132674,
            "start_logit": 1.3095722198486328,
            "end_logit": 1.6543090343475342
        },
        {
            "text": "is specifically involved in the removal of photoproducts from the non-transcribed regions of the genome",
            "probability": 0.026461113128124637,
            "start_logit": 0.04099102318286896,
            "end_logit": 2.734515428543091
        },
        {
            "text": "specifically involved in the removal of photoproducts",
            "probability": 0.024694287880471722,
            "start_logit": 1.1005051136016846,
            "end_logit": 1.605897068977356
        },
        {
            "text": "binds to UV-damaged DNA (UV-DDB) and is specifically involved in the removal of photoproducts",
            "probability": 0.022193833831619415,
            "start_logit": 0.9937476515769958,
            "end_logit": 1.605897068977356
        },
        {
            "text": "p48",
            "probability": 0.017714271167026105,
            "start_logit": 1.3095722198486328,
            "end_logit": 1.0646286010742188
        },
        {
            "text": "UV-damaged DNA",
            "probability": 0.012804002837653206,
            "start_logit": -0.16679991781711578,
            "end_logit": 2.216387987136841
        },
        {
            "text": "involved in the removal of photoproducts",
            "probability": 0.011942947596015158,
            "start_logit": 0.3740741014480591,
            "end_logit": 1.605897068977356
        },
        {
            "text": "the removal of photoproducts",
            "probability": 0.011372696352275682,
            "start_logit": 0.3251485824584961,
            "end_logit": 1.605897068977356
        },
        {
            "text": "is specifically involved in the removal of photoproducts",
            "probability": 0.008559637717794753,
            "start_logit": 0.04099102318286896,
            "end_logit": 1.605897068977356
        },
        {
            "text": "and is specifically involved in the removal of photoproducts from the non-transcribed regions of the genome",
            "probability": 0.007486014226306134,
            "start_logit": -1.2216486930847168,
            "end_logit": 2.734515428543091
        },
        {
            "text": "removal of photoproducts from the non-transcribed regions",
            "probability": 0.007363895865396808,
            "start_logit": 1.5961281061172485,
            "end_logit": -0.09970875829458237
        }
    ],
    "5e2902688b3851296d000005_001": [
        {
            "text": "IGF1R",
            "probability": 0.40274971839117746,
            "start_logit": 3.6843514442443848,
            "end_logit": 4.027690410614014
        },
        {
            "text": "insulin-like growth factorI receptor",
            "probability": 0.15422827016497273,
            "start_logit": 3.3880746364593506,
            "end_logit": 3.3640856742858887
        },
        {
            "text": "",
            "probability": 0.12559463496230241,
            "start_logit": 3.081477642059326,
            "end_logit": 3.465308427810669
        },
        {
            "text": "insulin-like growth factorI",
            "probability": 0.1171838820798882,
            "start_logit": 3.3880746364593506,
            "end_logit": 3.0893962383270264
        },
        {
            "text": "insulin-like growth factorI receptor (IGF1R",
            "probability": 0.051108137800992534,
            "start_logit": 3.3880746364593506,
            "end_logit": 2.2595956325531006
        },
        {
            "text": "IGF1R in active TAO. A recently completed therapeutic trial of teprotumumab, a human IGF1R",
            "probability": 0.04797319474708447,
            "start_logit": 2.1259021759033203,
            "end_logit": 3.4584667682647705
        },
        {
            "text": "IGF1R. These findings underpin the rationale for therapeutically targeting IGF1R",
            "probability": 0.04396424466213228,
            "start_logit": 3.6843514442443848,
            "end_logit": 1.8127517700195312
        },
        {
            "text": "insulin-like growth factorI receptor (IGF1R)",
            "probability": 0.010699178318977218,
            "start_logit": 3.3880746364593506,
            "end_logit": 0.6958188414573669
        },
        {
            "text": "the insulin-like growth factorI receptor",
            "probability": 0.0106560408048783,
            "start_logit": 0.7157678008079529,
            "end_logit": 3.3640856742858887
        },
        {
            "text": "the insulin-like growth factorI",
            "probability": 0.00809654564485244,
            "start_logit": 0.7157678008079529,
            "end_logit": 3.0893962383270264
        },
        {
            "text": "activity of IGF1R",
            "probability": 0.00652885413123841,
            "start_logit": -0.43773242831230164,
            "end_logit": 4.027690410614014
        },
        {
            "text": "the insulin-like growth factorI receptor (IGF1R",
            "probability": 0.003531196980204527,
            "start_logit": 0.7157678008079529,
            "end_logit": 2.2595956325531006
        },
        {
            "text": "inhibiting the activity of IGF1R",
            "probability": 0.003230863337465272,
            "start_logit": -1.1412144899368286,
            "end_logit": 4.027690410614014
        },
        {
            "text": "insulin",
            "probability": 0.0028092441503055365,
            "start_logit": 3.3880746364593506,
            "end_logit": -0.6414326429367065
        },
        {
            "text": "IGF1R) may also participate in the pathogenesis of TAO. Activating antibodies against IGF1R",
            "probability": 0.002346957011317177,
            "start_logit": 1.7486974000930786,
            "end_logit": 0.8181487321853638
        },
        {
            "text": "either receptor can be attenuated by inhibiting the activity of IGF1R",
            "probability": 0.0022376284392512684,
            "start_logit": -1.508547306060791,
            "end_logit": 4.027690410614014
        },
        {
            "text": "IGF1R)",
            "probability": 0.0020767199658368696,
            "start_logit": 1.7486974000930786,
            "end_logit": 0.6958188414573669
        },
        {
            "text": "IGF1R. These findings underpin the rationale for therapeutically targeting IGF1R in active TAO",
            "probability": 0.0018940976569049727,
            "start_logit": 3.6843514442443848,
            "end_logit": -1.331882357597351
        },
        {
            "text": "IGF1R.",
            "probability": 0.0016388414763591186,
            "start_logit": -1.8199743032455444,
            "end_logit": 4.027690410614014
        },
        {
            "text": "signaling initiated from either receptor can be attenuated by inhibiting the activity of IGF1R",
            "probability": 0.001451749273858686,
            "start_logit": -1.9411946535110474,
            "end_logit": 4.027690410614014
        }
    ],
    "5e2902688b3851296d000005_002": [
        {
            "text": "",
            "probability": 0.46067449970471797,
            "start_logit": 3.6415674686431885,
            "end_logit": 3.7009294033050537
        },
        {
            "text": "insulin-like growth factor-I receptor",
            "probability": 0.2292727406739551,
            "start_logit": 3.2505998611450195,
            "end_logit": 3.394117593765259
        },
        {
            "text": "insulin-like growth factor-I",
            "probability": 0.09787565958106906,
            "start_logit": 3.2505998611450195,
            "end_logit": 2.542903184890747
        },
        {
            "text": "insulin-like growth factor-I receptor (IGF-IR",
            "probability": 0.08017701758495817,
            "start_logit": 3.2505998611450195,
            "end_logit": 2.34344220161438
        },
        {
            "text": "the insulin-like growth factor-I receptor",
            "probability": 0.027487163987958814,
            "start_logit": 1.1294066905975342,
            "end_logit": 3.394117593765259
        },
        {
            "text": "IGF-IR",
            "probability": 0.01982959822334011,
            "start_logit": 1.8535386323928833,
            "end_logit": 2.34344220161438
        },
        {
            "text": "thyrotropin receptor, the proposed role for which is supported by substantial evidence. Considerations of any involvement of the insulin-like growth factor-I",
            "probability": 0.019807742094282973,
            "start_logit": 1.6529748439788818,
            "end_logit": 2.542903184890747
        },
        {
            "text": "insulin-like growth factor-I receptor (IGF-IR)",
            "probability": 0.01636694294040348,
            "start_logit": 3.2505998611450195,
            "end_logit": 0.7544689178466797
        },
        {
            "text": "the insulin-like growth factor-I",
            "probability": 0.011734165594331786,
            "start_logit": 1.1294066905975342,
            "end_logit": 2.542903184890747
        },
        {
            "text": "the insulin-like growth factor-I receptor (IGF-IR",
            "probability": 0.009612302029211772,
            "start_logit": 1.1294066905975342,
            "end_logit": 2.34344220161438
        },
        {
            "text": "thyrotropin",
            "probability": 0.009580891154204086,
            "start_logit": 1.6529748439788818,
            "end_logit": 1.8166009187698364
        },
        {
            "text": "thyrotropin receptor",
            "probability": 0.004374387534080027,
            "start_logit": 1.6529748439788818,
            "end_logit": 1.0325968265533447
        },
        {
            "text": "IGF-IR)",
            "probability": 0.004047916877285068,
            "start_logit": 1.8535386323928833,
            "end_logit": 0.7544689178466797
        },
        {
            "text": "insulin",
            "probability": 0.0020431914908261967,
            "start_logit": 3.2505998611450195,
            "end_logit": -1.3262816667556763
        },
        {
            "text": "the insulin-like growth factor-I receptor (IGF-IR)",
            "probability": 0.0019622081685855683,
            "start_logit": 1.1294066905975342,
            "end_logit": 0.7544689178466797
        },
        {
            "text": "inhibitory human anti-IGF-IR",
            "probability": 0.0015201476750651213,
            "start_logit": -0.8178480863571167,
            "end_logit": 2.446460723876953
        },
        {
            "text": "I receptor",
            "probability": 0.0012270395097665958,
            "start_logit": -1.9797080755233765,
            "end_logit": 3.394117593765259
        },
        {
            "text": "anti-IGF-IR",
            "probability": 0.0010187694070971805,
            "start_logit": -1.2180601358413696,
            "end_logit": 2.446460723876953
        },
        {
            "text": "human anti-IGF-IR",
            "probability": 0.0007640870869920264,
            "start_logit": -1.505729079246521,
            "end_logit": 2.446460723876953
        },
        {
            "text": "an inhibitory human anti-IGF-IR",
            "probability": 0.0006235286818686962,
            "start_logit": -1.7090160846710205,
            "end_logit": 2.446460723876953
        }
    ],
    "5e2902688b3851296d000005_003": [
        {
            "text": "IGF-1",
            "probability": 0.6996857849411313,
            "start_logit": 7.41261100769043,
            "end_logit": 7.598017692565918
        },
        {
            "text": "IGF-1 receptor",
            "probability": 0.2832789871130605,
            "start_logit": 7.41261100769043,
            "end_logit": 6.69381856918335
        },
        {
            "text": "1",
            "probability": 0.005981854830753493,
            "start_logit": 2.650710344314575,
            "end_logit": 7.598017692565918
        },
        {
            "text": "IGF",
            "probability": 0.004039448696423779,
            "start_logit": 7.41261100769043,
            "end_logit": 2.4434945583343506
        },
        {
            "text": "1 receptor",
            "probability": 0.002421849655922034,
            "start_logit": 2.650710344314575,
            "end_logit": 6.69381856918335
        },
        {
            "text": "",
            "probability": 0.001739344974691793,
            "start_logit": 4.556014060974121,
            "end_logit": 4.457491874694824
        },
        {
            "text": "IGF-",
            "probability": 0.0010367798909934238,
            "start_logit": 7.41261100769043,
            "end_logit": 1.0835059881210327
        },
        {
            "text": "I",
            "probability": 0.0005523458328288551,
            "start_logit": 7.41261100769043,
            "end_logit": 0.45380541682243347
        },
        {
            "text": "IGF-1 receptor inhibiting antibody",
            "probability": 0.00042261097081044155,
            "start_logit": 7.41261100769043,
            "end_logit": 0.186083123087883
        },
        {
            "text": "receptor",
            "probability": 0.00029824970916240946,
            "start_logit": 0.5563545823097229,
            "end_logit": 6.69381856918335
        },
        {
            "text": "IG",
            "probability": 0.000296275926107878,
            "start_logit": 7.41261100769043,
            "end_logit": -0.16907773911952972
        },
        {
            "text": "-1",
            "probability": 5.647538437643952e-05,
            "start_logit": -2.0119707584381104,
            "end_logit": 7.598017692565918
        },
        {
            "text": "IGF-1 receptor inhibiting antibody, teprotumumab",
            "probability": 4.304940408731095e-05,
            "start_logit": 7.41261100769043,
            "end_logit": -2.098020553588867
        },
        {
            "text": "the IGF-1",
            "probability": 3.309732050168203e-05,
            "start_logit": -2.546323299407959,
            "end_logit": 7.598017692565918
        },
        {
            "text": "It could be attenuated by dexamethasone and the IGF-1",
            "probability": 3.079059703386581e-05,
            "start_logit": -2.6185662746429443,
            "end_logit": 7.598017692565918
        },
        {
            "text": "attenuated by dexamethasone and the IGF-1",
            "probability": 2.4432040555230055e-05,
            "start_logit": -2.8498802185058594,
            "end_logit": 7.598017692565918
        },
        {
            "text": "-1 receptor",
            "probability": 2.2864963141025623e-05,
            "start_logit": -2.0119707584381104,
            "end_logit": 6.69381856918335
        },
        {
            "text": "the IGF-1 receptor",
            "probability": 1.3399979861905666e-05,
            "start_logit": -2.546323299407959,
            "end_logit": 6.69381856918335
        },
        {
            "text": "It could be attenuated by dexamethasone and the IGF-1 receptor",
            "probability": 1.2466065951438147e-05,
            "start_logit": -2.6185662746429443,
            "end_logit": 6.69381856918335
        },
        {
            "text": "attenuated by dexamethasone and the IGF-1 receptor",
            "probability": 9.891702605010187e-06,
            "start_logit": -2.8498802185058594,
            "end_logit": 6.69381856918335
        }
    ],
    "5e2902688b3851296d000005_005": [
        {
            "text": "IGF-1",
            "probability": 0.6450025125022675,
            "start_logit": 7.568892955780029,
            "end_logit": 8.633843421936035
        },
        {
            "text": "IGF-1 receptor",
            "probability": 0.33132849588757296,
            "start_logit": 7.568892955780029,
            "end_logit": 7.9676995277404785
        },
        {
            "text": "1",
            "probability": 0.008915926986819898,
            "start_logit": 3.287477970123291,
            "end_logit": 8.633843421936035
        },
        {
            "text": "1 receptor",
            "probability": 0.00457998321049342,
            "start_logit": 3.287477970123291,
            "end_logit": 7.9676995277404785
        },
        {
            "text": "IGF",
            "probability": 0.0030395777613489213,
            "start_logit": 7.568892955780029,
            "end_logit": 3.2763078212738037
        },
        {
            "text": "",
            "probability": 0.0022657376429236977,
            "start_logit": 5.268502235412598,
            "end_logit": 5.2828803062438965
        },
        {
            "text": "IGF-1 receptor antibody",
            "probability": 0.0009128667583311662,
            "start_logit": 7.568892955780029,
            "end_logit": 2.0734238624572754
        },
        {
            "text": "IGF-",
            "probability": 0.0007028648845083559,
            "start_logit": 7.568892955780029,
            "end_logit": 1.8119986057281494
        },
        {
            "text": "interleukin-6 receptor antibodies were effective. Results of randomised controlled trials investigating the efficacy of the IGF-1",
            "probability": 0.0006937981821194207,
            "start_logit": 0.7340645790100098,
            "end_logit": 8.633843421936035
        },
        {
            "text": "the IGF-1",
            "probability": 0.0005972681000557576,
            "start_logit": 0.5842495560646057,
            "end_logit": 8.633843421936035
        },
        {
            "text": "receptor",
            "probability": 0.00038576895205206477,
            "start_logit": 0.8132659792900085,
            "end_logit": 7.9676995277404785
        },
        {
            "text": "interleukin-6 receptor antibodies were effective. Results of randomised controlled trials investigating the efficacy of the IGF-1 receptor",
            "probability": 0.0003563941282017129,
            "start_logit": 0.7340645790100098,
            "end_logit": 7.9676995277404785
        },
        {
            "text": "the IGF-1 receptor",
            "probability": 0.00030680801608878525,
            "start_logit": 0.5842495560646057,
            "end_logit": 7.9676995277404785
        },
        {
            "text": "IG",
            "probability": 0.00018115940568756077,
            "start_logit": 7.568892955780029,
            "end_logit": 0.45621126890182495
        },
        {
            "text": "IGF-1 receptor antibody teprotumumab and the interleukin-6",
            "probability": 0.00015900312732212025,
            "start_logit": 7.568892955780029,
            "end_logit": 0.32575780153274536
        },
        {
            "text": "I",
            "probability": 0.00014489350258229053,
            "start_logit": 7.568892955780029,
            "end_logit": 0.23283293843269348
        },
        {
            "text": "6 receptor antibodies were effective. Results of randomised controlled trials investigating the efficacy of the IGF-1",
            "probability": 0.00013654442737821623,
            "start_logit": -0.891466498374939,
            "end_logit": 8.633843421936035
        },
        {
            "text": "IGF-1 receptor antibody teprotumumab",
            "probability": 0.00011211334700644599,
            "start_logit": 7.568892955780029,
            "end_logit": -0.023655682802200317
        },
        {
            "text": "thyroid-stimulating-hormone receptors",
            "probability": 0.00010814227256382719,
            "start_logit": 4.045129299163818,
            "end_logit": 3.464045286178589
        },
        {
            "text": "6 receptor antibodies were effective. Results of randomised controlled trials investigating the efficacy of the IGF-1 receptor",
            "probability": 7.014090467577097e-05,
            "start_logit": -0.891466498374939,
            "end_logit": 7.9676995277404785
        }
    ],
    "5e2902688b3851296d000005_007": [
        {
            "text": "insulin-like growth factor I",
            "probability": 0.49328139426734613,
            "start_logit": 6.136023998260498,
            "end_logit": 5.650084018707275
        },
        {
            "text": "insulin-like growth factor I receptor",
            "probability": 0.38458124170557123,
            "start_logit": 6.136023998260498,
            "end_logit": 5.401159286499023
        },
        {
            "text": "insulin-like growth factor I receptor (IGF-IR",
            "probability": 0.07736965200557286,
            "start_logit": 6.136023998260498,
            "end_logit": 3.7975988388061523
        },
        {
            "text": "the insulin-like growth factor I",
            "probability": 0.012951434114376026,
            "start_logit": 2.4961507320404053,
            "end_logit": 5.650084018707275
        },
        {
            "text": "the insulin-like growth factor I receptor",
            "probability": 0.010097438645486628,
            "start_logit": 2.4961507320404053,
            "end_logit": 5.401159286499023
        },
        {
            "text": "insulin-like growth factor I receptor (IGF-IR)",
            "probability": 0.00450541238665813,
            "start_logit": 6.136023998260498,
            "end_logit": 0.9542836546897888
        },
        {
            "text": "IGF-IR",
            "probability": 0.004250519532241421,
            "start_logit": 3.2344706058502197,
            "end_logit": 3.7975988388061523
        },
        {
            "text": "insulin-like growth factor",
            "probability": 0.003299465020329133,
            "start_logit": 6.136023998260498,
            "end_logit": 0.6427645683288574
        },
        {
            "text": "insulin",
            "probability": 0.0025671585441697235,
            "start_logit": 6.136023998260498,
            "end_logit": 0.39180389046669006
        },
        {
            "text": "the insulin-like growth factor I receptor (IGF-IR",
            "probability": 0.0020313921466482334,
            "start_logit": 2.4961507320404053,
            "end_logit": 3.7975988388061523
        },
        {
            "text": "I",
            "probability": 0.0015438276867498968,
            "start_logit": 0.36920905113220215,
            "end_logit": 5.650084018707275
        },
        {
            "text": "I receptor",
            "probability": 0.0012036277379396348,
            "start_logit": 0.36920905113220215,
            "end_logit": 5.401159286499023
        },
        {
            "text": "",
            "probability": 0.00047235717942193767,
            "start_logit": 2.4648196697235107,
            "end_logit": 2.3701887130737305
        },
        {
            "text": "insulin-like growth factor I receptor (IGF",
            "probability": 0.0003172690323061673,
            "start_logit": 6.136023998260498,
            "end_logit": -1.6990009546279907
        },
        {
            "text": "Inhibition of the insulin-like growth factor I",
            "probability": 0.00031205881746761615,
            "start_logit": -1.2296193838119507,
            "end_logit": 5.650084018707275
        },
        {
            "text": "insulin-like growth",
            "probability": 0.00024841587631655967,
            "start_logit": 6.136023998260498,
            "end_logit": -1.943646788597107
        },
        {
            "text": "IGF-IR)",
            "probability": 0.0002475175065917764,
            "start_logit": 3.2344706058502197,
            "end_logit": 0.9542836546897888
        },
        {
            "text": "Inhibition of the insulin-like growth factor I receptor",
            "probability": 0.00024329311606231907,
            "start_logit": -1.2296193838119507,
            "end_logit": 5.401159286499023
        },
        {
            "text": "I receptor (IGF-IR",
            "probability": 0.00024214456954699498,
            "start_logit": 0.36920905113220215,
            "end_logit": 3.7975988388061523
        },
        {
            "text": "receptor",
            "probability": 0.0002343801091975956,
            "start_logit": -1.2669421434402466,
            "end_logit": 5.401159286499023
        }
    ],
    "5c700c607c78d6947100005e_001": [
        {
            "text": "",
            "probability": 0.6503433883239789,
            "start_logit": 2.374763011932373,
            "end_logit": 2.6752922534942627
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE) severity index",
            "probability": 0.11779375756262392,
            "start_logit": 1.8498636484146118,
            "end_logit": 1.4916263818740845
        },
        {
            "text": "simple systemic lupus erythematosus (SLE) severity index",
            "probability": 0.08946969958866863,
            "start_logit": 1.5748283863067627,
            "end_logit": 1.4916263818740845
        },
        {
            "text": "simple systemic lupus erythematosus (SLE) severity index that requires knowledge of only American College of Rheumatology",
            "probability": 0.03775542899001202,
            "start_logit": 1.5748283863067627,
            "end_logit": 0.6288556456565857
        },
        {
            "text": "American College of Rheumatology (ACR) criteria and subcriteria",
            "probability": 0.016261939512695497,
            "start_logit": -0.017077680677175522,
            "end_logit": 1.3784598112106323
        },
        {
            "text": "a simple",
            "probability": 0.015643519760924623,
            "start_logit": 1.8498636484146118,
            "end_logit": -0.5272521376609802
        },
        {
            "text": "simple",
            "probability": 0.011881962529085906,
            "start_logit": 1.5748283863067627,
            "end_logit": -0.5272521376609802
        },
        {
            "text": "develop a simple systemic lupus erythematosus (SLE) severity index",
            "probability": 0.008407463542116387,
            "start_logit": -0.7899518013000488,
            "end_logit": 1.4916263818740845
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE)",
            "probability": 0.007980604520678482,
            "start_logit": 1.8498636484146118,
            "end_logit": -1.2002947330474854
        },
        {
            "text": "American College of Rheumatology",
            "probability": 0.007684637550788198,
            "start_logit": -0.017077680677175522,
            "end_logit": 0.6288556456565857
        },
        {
            "text": "simple systemic lupus erythematosus (SLE)",
            "probability": 0.006061630970736895,
            "start_logit": 1.5748283863067627,
            "end_logit": -1.2002947330474854
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE",
            "probability": 0.0054829704030090135,
            "start_logit": 1.8498636484146118,
            "end_logit": -1.5756618976593018
        },
        {
            "text": "simple systemic lupus erythematosus (SLE",
            "probability": 0.004164564616677385,
            "start_logit": 1.5748283863067627,
            "end_logit": -1.5756618976593018
        },
        {
            "text": "a simple systemic lupus erythematosus",
            "probability": 0.003994229504480221,
            "start_logit": 1.8498636484146118,
            "end_logit": -1.892458200454712
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE) severity",
            "probability": 0.0038763283125514375,
            "start_logit": 1.8498636484146118,
            "end_logit": -1.9224205017089844
        },
        {
            "text": "simple systemic lupus erythematosus",
            "probability": 0.0030337984053531337,
            "start_logit": 1.5748283863067627,
            "end_logit": -1.892458200454712
        },
        {
            "text": "simple systemic lupus erythematosus (SLE) severity",
            "probability": 0.0029442471044923376,
            "start_logit": 1.5748283863067627,
            "end_logit": -1.9224205017089844
        },
        {
            "text": "ACR) criteria and subcriteria",
            "probability": 0.0025012480931561323,
            "start_logit": -1.8891152143478394,
            "end_logit": 1.3784598112106323
        },
        {
            "text": "systemic lupus erythematosus (SLE) severity index",
            "probability": 0.0024330881729459778,
            "start_logit": -2.0299103260040283,
            "end_logit": 1.4916263818740845
        },
        {
            "text": "requires knowledge of only American College of Rheumatology (ACR) criteria and subcriteria",
            "probability": 0.0022854925350253297,
            "start_logit": -1.9793235063552856,
            "end_logit": 1.3784598112106323
        }
    ],
    "5c700c607c78d6947100005e_002": [
        {
            "text": "",
            "probability": 0.6503433883239789,
            "start_logit": 2.374763011932373,
            "end_logit": 2.6752922534942627
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE) severity index",
            "probability": 0.11779375756262392,
            "start_logit": 1.8498636484146118,
            "end_logit": 1.4916263818740845
        },
        {
            "text": "simple systemic lupus erythematosus (SLE) severity index",
            "probability": 0.08946969958866863,
            "start_logit": 1.5748283863067627,
            "end_logit": 1.4916263818740845
        },
        {
            "text": "simple systemic lupus erythematosus (SLE) severity index that requires knowledge of only American College of Rheumatology",
            "probability": 0.03775542899001202,
            "start_logit": 1.5748283863067627,
            "end_logit": 0.6288556456565857
        },
        {
            "text": "American College of Rheumatology (ACR) criteria and subcriteria",
            "probability": 0.016261939512695497,
            "start_logit": -0.017077680677175522,
            "end_logit": 1.3784598112106323
        },
        {
            "text": "a simple",
            "probability": 0.015643519760924623,
            "start_logit": 1.8498636484146118,
            "end_logit": -0.5272521376609802
        },
        {
            "text": "simple",
            "probability": 0.011881962529085906,
            "start_logit": 1.5748283863067627,
            "end_logit": -0.5272521376609802
        },
        {
            "text": "develop a simple systemic lupus erythematosus (SLE) severity index",
            "probability": 0.008407463542116387,
            "start_logit": -0.7899518013000488,
            "end_logit": 1.4916263818740845
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE)",
            "probability": 0.007980604520678482,
            "start_logit": 1.8498636484146118,
            "end_logit": -1.2002947330474854
        },
        {
            "text": "American College of Rheumatology",
            "probability": 0.007684637550788198,
            "start_logit": -0.017077680677175522,
            "end_logit": 0.6288556456565857
        },
        {
            "text": "simple systemic lupus erythematosus (SLE)",
            "probability": 0.006061630970736895,
            "start_logit": 1.5748283863067627,
            "end_logit": -1.2002947330474854
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE",
            "probability": 0.0054829704030090135,
            "start_logit": 1.8498636484146118,
            "end_logit": -1.5756618976593018
        },
        {
            "text": "simple systemic lupus erythematosus (SLE",
            "probability": 0.004164564616677385,
            "start_logit": 1.5748283863067627,
            "end_logit": -1.5756618976593018
        },
        {
            "text": "a simple systemic lupus erythematosus",
            "probability": 0.003994229504480221,
            "start_logit": 1.8498636484146118,
            "end_logit": -1.892458200454712
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE) severity",
            "probability": 0.0038763283125514375,
            "start_logit": 1.8498636484146118,
            "end_logit": -1.9224205017089844
        },
        {
            "text": "simple systemic lupus erythematosus",
            "probability": 0.0030337984053531337,
            "start_logit": 1.5748283863067627,
            "end_logit": -1.892458200454712
        },
        {
            "text": "simple systemic lupus erythematosus (SLE) severity",
            "probability": 0.0029442471044923376,
            "start_logit": 1.5748283863067627,
            "end_logit": -1.9224205017089844
        },
        {
            "text": "ACR) criteria and subcriteria",
            "probability": 0.0025012480931561323,
            "start_logit": -1.8891152143478394,
            "end_logit": 1.3784598112106323
        },
        {
            "text": "systemic lupus erythematosus (SLE) severity index",
            "probability": 0.0024330881729459778,
            "start_logit": -2.0299103260040283,
            "end_logit": 1.4916263818740845
        },
        {
            "text": "requires knowledge of only American College of Rheumatology (ACR) criteria and subcriteria",
            "probability": 0.0022854925350253297,
            "start_logit": -1.9793235063552856,
            "end_logit": 1.3784598112106323
        }
    ],
    "5c700c607c78d6947100005e_003": [
        {
            "text": "",
            "probability": 0.6503433883239789,
            "start_logit": 2.374763011932373,
            "end_logit": 2.6752922534942627
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE) severity index",
            "probability": 0.11779375756262392,
            "start_logit": 1.8498636484146118,
            "end_logit": 1.4916263818740845
        },
        {
            "text": "simple systemic lupus erythematosus (SLE) severity index",
            "probability": 0.08946969958866863,
            "start_logit": 1.5748283863067627,
            "end_logit": 1.4916263818740845
        },
        {
            "text": "simple systemic lupus erythematosus (SLE) severity index that requires knowledge of only American College of Rheumatology",
            "probability": 0.03775542899001202,
            "start_logit": 1.5748283863067627,
            "end_logit": 0.6288556456565857
        },
        {
            "text": "American College of Rheumatology (ACR) criteria and subcriteria",
            "probability": 0.016261939512695497,
            "start_logit": -0.017077680677175522,
            "end_logit": 1.3784598112106323
        },
        {
            "text": "a simple",
            "probability": 0.015643519760924623,
            "start_logit": 1.8498636484146118,
            "end_logit": -0.5272521376609802
        },
        {
            "text": "simple",
            "probability": 0.011881962529085906,
            "start_logit": 1.5748283863067627,
            "end_logit": -0.5272521376609802
        },
        {
            "text": "develop a simple systemic lupus erythematosus (SLE) severity index",
            "probability": 0.008407463542116387,
            "start_logit": -0.7899518013000488,
            "end_logit": 1.4916263818740845
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE)",
            "probability": 0.007980604520678482,
            "start_logit": 1.8498636484146118,
            "end_logit": -1.2002947330474854
        },
        {
            "text": "American College of Rheumatology",
            "probability": 0.007684637550788198,
            "start_logit": -0.017077680677175522,
            "end_logit": 0.6288556456565857
        },
        {
            "text": "simple systemic lupus erythematosus (SLE)",
            "probability": 0.006061630970736895,
            "start_logit": 1.5748283863067627,
            "end_logit": -1.2002947330474854
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE",
            "probability": 0.0054829704030090135,
            "start_logit": 1.8498636484146118,
            "end_logit": -1.5756618976593018
        },
        {
            "text": "simple systemic lupus erythematosus (SLE",
            "probability": 0.004164564616677385,
            "start_logit": 1.5748283863067627,
            "end_logit": -1.5756618976593018
        },
        {
            "text": "a simple systemic lupus erythematosus",
            "probability": 0.003994229504480221,
            "start_logit": 1.8498636484146118,
            "end_logit": -1.892458200454712
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE) severity",
            "probability": 0.0038763283125514375,
            "start_logit": 1.8498636484146118,
            "end_logit": -1.9224205017089844
        },
        {
            "text": "simple systemic lupus erythematosus",
            "probability": 0.0030337984053531337,
            "start_logit": 1.5748283863067627,
            "end_logit": -1.892458200454712
        },
        {
            "text": "simple systemic lupus erythematosus (SLE) severity",
            "probability": 0.0029442471044923376,
            "start_logit": 1.5748283863067627,
            "end_logit": -1.9224205017089844
        },
        {
            "text": "ACR) criteria and subcriteria",
            "probability": 0.0025012480931561323,
            "start_logit": -1.8891152143478394,
            "end_logit": 1.3784598112106323
        },
        {
            "text": "systemic lupus erythematosus (SLE) severity index",
            "probability": 0.0024330881729459778,
            "start_logit": -2.0299103260040283,
            "end_logit": 1.4916263818740845
        },
        {
            "text": "requires knowledge of only American College of Rheumatology (ACR) criteria and subcriteria",
            "probability": 0.0022854925350253297,
            "start_logit": -1.9793235063552856,
            "end_logit": 1.3784598112106323
        }
    ],
    "5c700c607c78d6947100005e_004": [
        {
            "text": "",
            "probability": 0.6503433883239789,
            "start_logit": 2.374763011932373,
            "end_logit": 2.6752922534942627
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE) severity index",
            "probability": 0.11779375756262392,
            "start_logit": 1.8498636484146118,
            "end_logit": 1.4916263818740845
        },
        {
            "text": "simple systemic lupus erythematosus (SLE) severity index",
            "probability": 0.08946969958866863,
            "start_logit": 1.5748283863067627,
            "end_logit": 1.4916263818740845
        },
        {
            "text": "simple systemic lupus erythematosus (SLE) severity index that requires knowledge of only American College of Rheumatology",
            "probability": 0.03775542899001202,
            "start_logit": 1.5748283863067627,
            "end_logit": 0.6288556456565857
        },
        {
            "text": "American College of Rheumatology (ACR) criteria and subcriteria",
            "probability": 0.016261939512695497,
            "start_logit": -0.017077680677175522,
            "end_logit": 1.3784598112106323
        },
        {
            "text": "a simple",
            "probability": 0.015643519760924623,
            "start_logit": 1.8498636484146118,
            "end_logit": -0.5272521376609802
        },
        {
            "text": "simple",
            "probability": 0.011881962529085906,
            "start_logit": 1.5748283863067627,
            "end_logit": -0.5272521376609802
        },
        {
            "text": "develop a simple systemic lupus erythematosus (SLE) severity index",
            "probability": 0.008407463542116387,
            "start_logit": -0.7899518013000488,
            "end_logit": 1.4916263818740845
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE)",
            "probability": 0.007980604520678482,
            "start_logit": 1.8498636484146118,
            "end_logit": -1.2002947330474854
        },
        {
            "text": "American College of Rheumatology",
            "probability": 0.007684637550788198,
            "start_logit": -0.017077680677175522,
            "end_logit": 0.6288556456565857
        },
        {
            "text": "simple systemic lupus erythematosus (SLE)",
            "probability": 0.006061630970736895,
            "start_logit": 1.5748283863067627,
            "end_logit": -1.2002947330474854
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE",
            "probability": 0.0054829704030090135,
            "start_logit": 1.8498636484146118,
            "end_logit": -1.5756618976593018
        },
        {
            "text": "simple systemic lupus erythematosus (SLE",
            "probability": 0.004164564616677385,
            "start_logit": 1.5748283863067627,
            "end_logit": -1.5756618976593018
        },
        {
            "text": "a simple systemic lupus erythematosus",
            "probability": 0.003994229504480221,
            "start_logit": 1.8498636484146118,
            "end_logit": -1.892458200454712
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE) severity",
            "probability": 0.0038763283125514375,
            "start_logit": 1.8498636484146118,
            "end_logit": -1.9224205017089844
        },
        {
            "text": "simple systemic lupus erythematosus",
            "probability": 0.0030337984053531337,
            "start_logit": 1.5748283863067627,
            "end_logit": -1.892458200454712
        },
        {
            "text": "simple systemic lupus erythematosus (SLE) severity",
            "probability": 0.0029442471044923376,
            "start_logit": 1.5748283863067627,
            "end_logit": -1.9224205017089844
        },
        {
            "text": "ACR) criteria and subcriteria",
            "probability": 0.0025012480931561323,
            "start_logit": -1.8891152143478394,
            "end_logit": 1.3784598112106323
        },
        {
            "text": "systemic lupus erythematosus (SLE) severity index",
            "probability": 0.0024330881729459778,
            "start_logit": -2.0299103260040283,
            "end_logit": 1.4916263818740845
        },
        {
            "text": "requires knowledge of only American College of Rheumatology (ACR) criteria and subcriteria",
            "probability": 0.0022854925350253297,
            "start_logit": -1.9793235063552856,
            "end_logit": 1.3784598112106323
        }
    ],
    "5e2b0d167d50947c2f000002_002": [
        {
            "text": "acromelic frontonasal dysostosis",
            "probability": 0.7399074849177679,
            "start_logit": 3.962073802947998,
            "end_logit": 4.9590325355529785
        },
        {
            "text": "acromelic frontonasal dysostosis (AFND)",
            "probability": 0.1431363316896643,
            "start_logit": 3.962073802947998,
            "end_logit": 3.316304922103882
        },
        {
            "text": "",
            "probability": 0.036874370409428286,
            "start_logit": 2.563605308532715,
            "end_logit": 3.358492612838745
        },
        {
            "text": "an autosomal-dominant severe frontonasal and limb malformation syndrome",
            "probability": 0.017447500485951367,
            "start_logit": 1.6342966556549072,
            "end_logit": 3.5394809246063232
        },
        {
            "text": "frontonasal dysostosis",
            "probability": 0.008783824345585394,
            "start_logit": -0.4715394675731659,
            "end_logit": 4.9590325355529785
        },
        {
            "text": "severe frontonasal and limb malformation syndrome",
            "probability": 0.008364340221231064,
            "start_logit": 0.8990777134895325,
            "end_logit": 3.5394809246063232
        },
        {
            "text": "acromelic frontonasal dysostosis (AFND),",
            "probability": 0.008126214245929193,
            "start_logit": 3.962073802947998,
            "end_logit": 0.4476025402545929
        },
        {
            "text": "autosomal-dominant severe frontonasal and limb malformation syndrome",
            "probability": 0.0042997454474660015,
            "start_logit": 0.23365607857704163,
            "end_logit": 3.5394809246063232
        },
        {
            "text": "severe-profound intellectual disability and additional central and peripheral nervous system symptoms but an absence of frontonasal or limb malformations",
            "probability": 0.004137348017316109,
            "start_logit": 1.4050546884536743,
            "end_logit": 2.3295814990997314
        },
        {
            "text": "AFND), an autosomal-dominant severe frontonasal and limb malformation syndrome",
            "probability": 0.00386880391137635,
            "start_logit": 0.12804564833641052,
            "end_logit": 3.5394809246063232
        },
        {
            "text": "acromelic frontonasal dysostosis (AFND",
            "probability": 0.0037823426992502976,
            "start_logit": 3.962073802947998,
            "end_logit": -0.3171490430831909
        },
        {
            "text": "an autosomal-dominant severe frontonasal and limb malformation syndrome, associated with neurocognitive and motor delay",
            "probability": 0.0031205604681181277,
            "start_logit": 1.6342966556549072,
            "end_logit": 1.8182971477508545
        },
        {
            "text": "AFND)",
            "probability": 0.0030949426929035586,
            "start_logit": 0.12804564833641052,
            "end_logit": 3.316304922103882
        },
        {
            "text": "cause acromelic frontonasal dysostosis",
            "probability": 0.002987409368948942,
            "start_logit": -1.5500447750091553,
            "end_logit": 4.9590325355529785
        },
        {
            "text": "dysostosis",
            "probability": 0.0027135373592549897,
            "start_logit": -1.6461982727050781,
            "end_logit": 4.9590325355529785
        },
        {
            "text": "severe-profound intellectual disability",
            "probability": 0.002381689205612547,
            "start_logit": 1.4050546884536743,
            "end_logit": 1.7773364782333374
        },
        {
            "text": "frontonasal dysostosis (AFND), an autosomal-dominant severe frontonasal and limb malformation syndrome",
            "probability": 0.0021241256874968933,
            "start_logit": -0.4715394675731659,
            "end_logit": 3.5394809246063232
        },
        {
            "text": "frontonasal dysostosis (AFND)",
            "probability": 0.0016992454065702445,
            "start_logit": -0.4715394675731659,
            "end_logit": 3.316304922103882
        },
        {
            "text": "frontonasal and limb malformation syndrome",
            "probability": 0.001654185213549925,
            "start_logit": -0.7215911746025085,
            "end_logit": 3.5394809246063232
        },
        {
            "text": "severe frontonasal and limb malformation syndrome, associated with neurocognitive and motor delay",
            "probability": 0.0014959982065786918,
            "start_logit": 0.8990777134895325,
            "end_logit": 1.8182971477508545
        }
    ],
    "5e2b0d167d50947c2f000002_003": [
        {
            "text": "acromelic frontonasal dysostosis",
            "probability": 0.7399074849177679,
            "start_logit": 3.962073802947998,
            "end_logit": 4.9590325355529785
        },
        {
            "text": "acromelic frontonasal dysostosis (AFND)",
            "probability": 0.1431363316896643,
            "start_logit": 3.962073802947998,
            "end_logit": 3.316304922103882
        },
        {
            "text": "",
            "probability": 0.036874370409428286,
            "start_logit": 2.563605308532715,
            "end_logit": 3.358492612838745
        },
        {
            "text": "an autosomal-dominant severe frontonasal and limb malformation syndrome",
            "probability": 0.017447500485951367,
            "start_logit": 1.6342966556549072,
            "end_logit": 3.5394809246063232
        },
        {
            "text": "frontonasal dysostosis",
            "probability": 0.008783824345585394,
            "start_logit": -0.4715394675731659,
            "end_logit": 4.9590325355529785
        },
        {
            "text": "severe frontonasal and limb malformation syndrome",
            "probability": 0.008364340221231064,
            "start_logit": 0.8990777134895325,
            "end_logit": 3.5394809246063232
        },
        {
            "text": "acromelic frontonasal dysostosis (AFND),",
            "probability": 0.008126214245929193,
            "start_logit": 3.962073802947998,
            "end_logit": 0.4476025402545929
        },
        {
            "text": "autosomal-dominant severe frontonasal and limb malformation syndrome",
            "probability": 0.0042997454474660015,
            "start_logit": 0.23365607857704163,
            "end_logit": 3.5394809246063232
        },
        {
            "text": "severe-profound intellectual disability and additional central and peripheral nervous system symptoms but an absence of frontonasal or limb malformations",
            "probability": 0.004137348017316109,
            "start_logit": 1.4050546884536743,
            "end_logit": 2.3295814990997314
        },
        {
            "text": "AFND), an autosomal-dominant severe frontonasal and limb malformation syndrome",
            "probability": 0.00386880391137635,
            "start_logit": 0.12804564833641052,
            "end_logit": 3.5394809246063232
        },
        {
            "text": "acromelic frontonasal dysostosis (AFND",
            "probability": 0.0037823426992502976,
            "start_logit": 3.962073802947998,
            "end_logit": -0.3171490430831909
        },
        {
            "text": "an autosomal-dominant severe frontonasal and limb malformation syndrome, associated with neurocognitive and motor delay",
            "probability": 0.0031205604681181277,
            "start_logit": 1.6342966556549072,
            "end_logit": 1.8182971477508545
        },
        {
            "text": "AFND)",
            "probability": 0.0030949426929035586,
            "start_logit": 0.12804564833641052,
            "end_logit": 3.316304922103882
        },
        {
            "text": "cause acromelic frontonasal dysostosis",
            "probability": 0.002987409368948942,
            "start_logit": -1.5500447750091553,
            "end_logit": 4.9590325355529785
        },
        {
            "text": "dysostosis",
            "probability": 0.0027135373592549897,
            "start_logit": -1.6461982727050781,
            "end_logit": 4.9590325355529785
        },
        {
            "text": "severe-profound intellectual disability",
            "probability": 0.002381689205612547,
            "start_logit": 1.4050546884536743,
            "end_logit": 1.7773364782333374
        },
        {
            "text": "frontonasal dysostosis (AFND), an autosomal-dominant severe frontonasal and limb malformation syndrome",
            "probability": 0.0021241256874968933,
            "start_logit": -0.4715394675731659,
            "end_logit": 3.5394809246063232
        },
        {
            "text": "frontonasal dysostosis (AFND)",
            "probability": 0.0016992454065702445,
            "start_logit": -0.4715394675731659,
            "end_logit": 3.316304922103882
        },
        {
            "text": "frontonasal and limb malformation syndrome",
            "probability": 0.001654185213549925,
            "start_logit": -0.7215911746025085,
            "end_logit": 3.5394809246063232
        },
        {
            "text": "severe frontonasal and limb malformation syndrome, associated with neurocognitive and motor delay",
            "probability": 0.0014959982065786918,
            "start_logit": 0.8990777134895325,
            "end_logit": 1.8182971477508545
        }
    ],
    "5e2b0d167d50947c2f000002_005": [
        {
            "text": "",
            "probability": 0.9996540861765144,
            "start_logit": 3.812502384185791,
            "end_logit": 4.2361884117126465
        },
        {
            "text": "disruption of Hedgehog signaling",
            "probability": 5.7913115914260794e-05,
            "start_logit": -1.309808611869812,
            "end_logit": -0.3977212905883789
        },
        {
            "text": "craniofacial, brain and limb malformations",
            "probability": 4.72223616257003e-05,
            "start_logit": -1.9658371210098267,
            "end_logit": 0.05423087626695633
        },
        {
            "text": "craniofacial, brain and limb malformations through the disruption of Hedgehog signaling",
            "probability": 3.0051584152173872e-05,
            "start_logit": -1.9658371210098267,
            "end_logit": -0.3977212905883789
        },
        {
            "text": "through the disruption of Hedgehog signaling",
            "probability": 2.886022778886844e-05,
            "start_logit": -2.0062880516052246,
            "end_logit": -0.3977212905883789
        },
        {
            "text": "Hedgehog signaling",
            "probability": 2.549107106975476e-05,
            "start_logit": -2.1304242610931396,
            "end_logit": -0.3977212905883789
        },
        {
            "text": "disruption of Hedgehog signaling.",
            "probability": 2.1462174621003105e-05,
            "start_logit": -1.309808611869812,
            "end_logit": -1.3903731107711792
        },
        {
            "text": "the disruption of Hedgehog signaling",
            "probability": 1.5094194315611526e-05,
            "start_logit": -2.654442310333252,
            "end_logit": -0.3977212905883789
        },
        {
            "text": "lead to the craniofacial, brain and limb malformations",
            "probability": 1.4649249133808023e-05,
            "start_logit": -3.1363155841827393,
            "end_logit": 0.05423087626695633
        },
        {
            "text": "may lead to the craniofacial, brain and limb malformations",
            "probability": 1.3796479575582083e-05,
            "start_logit": -3.196291208267212,
            "end_logit": 0.05423087626695633
        },
        {
            "text": "malformations",
            "probability": 1.2337016354162005e-05,
            "start_logit": -3.308100461959839,
            "end_logit": 0.05423087626695633
        },
        {
            "text": "craniofacial, brain and limb malformations through the disruption of Hedgehog signaling.",
            "probability": 1.1136895960952851e-05,
            "start_logit": -1.9658371210098267,
            "end_logit": -1.3903731107711792
        },
        {
            "text": "through the disruption of Hedgehog signaling.",
            "probability": 1.0695388058961201e-05,
            "start_logit": -2.0062880516052246,
            "end_logit": -1.3903731107711792
        },
        {
            "text": "disruption of Hedgehog",
            "probability": 1.0672109169315823e-05,
            "start_logit": -1.309808611869812,
            "end_logit": -2.089031457901001
        },
        {
            "text": "Hedgehog signaling.",
            "probability": 9.446803369817616e-06,
            "start_logit": -2.1304242610931396,
            "end_logit": -1.3903731107711792
        },
        {
            "text": "lead to the craniofacial, brain and limb malformations through the disruption of Hedgehog signaling",
            "probability": 9.32255668617809e-06,
            "start_logit": -3.1363155841827393,
            "end_logit": -0.3977212905883789
        },
        {
            "text": "may lead to the craniofacial, brain and limb malformations through the disruption of Hedgehog signaling",
            "probability": 8.779867264065586e-06,
            "start_logit": -3.196291208267212,
            "end_logit": -0.3977212905883789
        },
        {
            "text": "malformations through the disruption of Hedgehog signaling",
            "probability": 7.851087332152177e-06,
            "start_logit": -3.308100461959839,
            "end_logit": -0.3977212905883789
        },
        {
            "text": "the disruption of Hedgehog signaling.",
            "probability": 5.59379734712625e-06,
            "start_logit": -2.654442310333252,
            "end_logit": -1.3903731107711792
        },
        {
            "text": "craniofacial, brain and limb malformations through the disruption of Hedgehog",
            "probability": 5.537843746098745e-06,
            "start_logit": -1.9658371210098267,
            "end_logit": -2.089031457901001
        }
    ],
    "5e29f6e0aa19d74431000002_002": [
        {
            "text": "",
            "probability": 0.9263892601748804,
            "start_logit": 4.884548664093018,
            "end_logit": 5.353157043457031
        },
        {
            "text": "chordoma",
            "probability": 0.0651806175238651,
            "start_logit": 3.2741150856018066,
            "end_logit": 4.309458255767822
        },
        {
            "text": "therapeutic potential of LB100 in chordoma",
            "probability": 0.002917764557420725,
            "start_logit": 0.16777069866657257,
            "end_logit": 4.309458255767822
        },
        {
            "text": "chordoma.Methods: Three patient-derived chordoma",
            "probability": 0.002396014118794062,
            "start_logit": 3.2741150856018066,
            "end_logit": 1.0061026811599731
        },
        {
            "text": "Standard therapy for chordoma",
            "probability": 0.0006893945093076759,
            "start_logit": -1.2510123252868652,
            "end_logit": 4.285481929779053
        },
        {
            "text": "chordoma.",
            "probability": 0.0004087156741007517,
            "start_logit": 3.2741150856018066,
            "end_logit": -0.7624394297599792
        },
        {
            "text": "potential of LB100 in chordoma",
            "probability": 0.0003344747906194462,
            "start_logit": -1.9982408285140991,
            "end_logit": 4.309458255767822
        },
        {
            "text": "LB100 in chordoma",
            "probability": 0.00028566807941412284,
            "start_logit": -2.1559717655181885,
            "end_logit": 4.309458255767822
        },
        {
            "text": "chordoma.Methods:",
            "probability": 0.0002512768152189852,
            "start_logit": -2.2842471599578857,
            "end_logit": 4.309458255767822
        },
        {
            "text": "chord",
            "probability": 0.00023152356125066142,
            "start_logit": 3.2793362140655518,
            "end_logit": -1.3359986543655396
        },
        {
            "text": "in chordoma",
            "probability": 0.0002228930695296635,
            "start_logit": -2.4041101932525635,
            "end_logit": 4.309458255767822
        },
        {
            "text": "the therapeutic potential of LB100 in chordoma",
            "probability": 0.00021382240832829965,
            "start_logit": -2.4456565380096436,
            "end_logit": 4.309458255767822
        },
        {
            "text": "chordoma consists of surgical resection followed by high-dose irradiation",
            "probability": 0.00016261426992140803,
            "start_logit": 3.2793362140655518,
            "end_logit": -1.6892993450164795
        },
        {
            "text": "chordoma consists of surgical resection followed by high-dose irradiation.",
            "probability": 0.00012372960075078822,
            "start_logit": 3.2793362140655518,
            "end_logit": -1.962581753730774
        },
        {
            "text": "therapeutic potential of LB100 in chordoma.Methods: Three patient-derived chordoma",
            "probability": 0.00010725588895099517,
            "start_logit": 0.16777069866657257,
            "end_logit": 1.0061026811599731
        },
        {
            "text": "therapeutic potential",
            "probability": 3.1451393136668376e-05,
            "start_logit": 0.16777069866657257,
            "end_logit": -0.22067150473594666
        },
        {
            "text": "therapeutic potential of LB100 in chordoma.",
            "probability": 1.829587004935724e-05,
            "start_logit": 0.16777069866657257,
            "end_logit": -0.7624394297599792
        },
        {
            "text": "chordoma cell lines were used: U-CH1, JHC7, and UM-Chor1. Cell proliferation",
            "probability": 1.2431484042585146e-05,
            "start_logit": 0.3074527680873871,
            "end_logit": -1.2885645627975464
        },
        {
            "text": "potential of LB100 in chordoma.Methods: Three patient-derived chordoma",
            "probability": 1.2295163058426924e-05,
            "start_logit": -1.9982408285140991,
            "end_logit": 1.0061026811599731
        },
        {
            "text": "LB100 in chordoma.Methods: Three patient-derived chordoma",
            "probability": 1.0501047359890586e-05,
            "start_logit": -2.1559717655181885,
            "end_logit": 1.0061026811599731
        }
    ],
    "5e29f6e0aa19d74431000002_003": [
        {
            "text": "",
            "probability": 0.9263892601748804,
            "start_logit": 4.884548664093018,
            "end_logit": 5.353157043457031
        },
        {
            "text": "chordoma",
            "probability": 0.0651806175238651,
            "start_logit": 3.2741150856018066,
            "end_logit": 4.309458255767822
        },
        {
            "text": "therapeutic potential of LB100 in chordoma",
            "probability": 0.002917764557420725,
            "start_logit": 0.16777069866657257,
            "end_logit": 4.309458255767822
        },
        {
            "text": "chordoma.Methods: Three patient-derived chordoma",
            "probability": 0.002396014118794062,
            "start_logit": 3.2741150856018066,
            "end_logit": 1.0061026811599731
        },
        {
            "text": "Standard therapy for chordoma",
            "probability": 0.0006893945093076759,
            "start_logit": -1.2510123252868652,
            "end_logit": 4.285481929779053
        },
        {
            "text": "chordoma.",
            "probability": 0.0004087156741007517,
            "start_logit": 3.2741150856018066,
            "end_logit": -0.7624394297599792
        },
        {
            "text": "potential of LB100 in chordoma",
            "probability": 0.0003344747906194462,
            "start_logit": -1.9982408285140991,
            "end_logit": 4.309458255767822
        },
        {
            "text": "LB100 in chordoma",
            "probability": 0.00028566807941412284,
            "start_logit": -2.1559717655181885,
            "end_logit": 4.309458255767822
        },
        {
            "text": "chordoma.Methods:",
            "probability": 0.0002512768152189852,
            "start_logit": -2.2842471599578857,
            "end_logit": 4.309458255767822
        },
        {
            "text": "chord",
            "probability": 0.00023152356125066142,
            "start_logit": 3.2793362140655518,
            "end_logit": -1.3359986543655396
        },
        {
            "text": "in chordoma",
            "probability": 0.0002228930695296635,
            "start_logit": -2.4041101932525635,
            "end_logit": 4.309458255767822
        },
        {
            "text": "the therapeutic potential of LB100 in chordoma",
            "probability": 0.00021382240832829965,
            "start_logit": -2.4456565380096436,
            "end_logit": 4.309458255767822
        },
        {
            "text": "chordoma consists of surgical resection followed by high-dose irradiation",
            "probability": 0.00016261426992140803,
            "start_logit": 3.2793362140655518,
            "end_logit": -1.6892993450164795
        },
        {
            "text": "chordoma consists of surgical resection followed by high-dose irradiation.",
            "probability": 0.00012372960075078822,
            "start_logit": 3.2793362140655518,
            "end_logit": -1.962581753730774
        },
        {
            "text": "therapeutic potential of LB100 in chordoma.Methods: Three patient-derived chordoma",
            "probability": 0.00010725588895099517,
            "start_logit": 0.16777069866657257,
            "end_logit": 1.0061026811599731
        },
        {
            "text": "therapeutic potential",
            "probability": 3.1451393136668376e-05,
            "start_logit": 0.16777069866657257,
            "end_logit": -0.22067150473594666
        },
        {
            "text": "therapeutic potential of LB100 in chordoma.",
            "probability": 1.829587004935724e-05,
            "start_logit": 0.16777069866657257,
            "end_logit": -0.7624394297599792
        },
        {
            "text": "chordoma cell lines were used: U-CH1, JHC7, and UM-Chor1. Cell proliferation",
            "probability": 1.2431484042585146e-05,
            "start_logit": 0.3074527680873871,
            "end_logit": -1.2885645627975464
        },
        {
            "text": "potential of LB100 in chordoma.Methods: Three patient-derived chordoma",
            "probability": 1.2295163058426924e-05,
            "start_logit": -1.9982408285140991,
            "end_logit": 1.0061026811599731
        },
        {
            "text": "LB100 in chordoma.Methods: Three patient-derived chordoma",
            "probability": 1.0501047359890586e-05,
            "start_logit": -2.1559717655181885,
            "end_logit": 1.0061026811599731
        }
    ],
    "5e29f6e0aa19d74431000002_004": [
        {
            "text": "",
            "probability": 0.9263892601748804,
            "start_logit": 4.884548664093018,
            "end_logit": 5.353157043457031
        },
        {
            "text": "chordoma",
            "probability": 0.0651806175238651,
            "start_logit": 3.2741150856018066,
            "end_logit": 4.309458255767822
        },
        {
            "text": "therapeutic potential of LB100 in chordoma",
            "probability": 0.002917764557420725,
            "start_logit": 0.16777069866657257,
            "end_logit": 4.309458255767822
        },
        {
            "text": "chordoma.Methods: Three patient-derived chordoma",
            "probability": 0.002396014118794062,
            "start_logit": 3.2741150856018066,
            "end_logit": 1.0061026811599731
        },
        {
            "text": "Standard therapy for chordoma",
            "probability": 0.0006893945093076759,
            "start_logit": -1.2510123252868652,
            "end_logit": 4.285481929779053
        },
        {
            "text": "chordoma.",
            "probability": 0.0004087156741007517,
            "start_logit": 3.2741150856018066,
            "end_logit": -0.7624394297599792
        },
        {
            "text": "potential of LB100 in chordoma",
            "probability": 0.0003344747906194462,
            "start_logit": -1.9982408285140991,
            "end_logit": 4.309458255767822
        },
        {
            "text": "LB100 in chordoma",
            "probability": 0.00028566807941412284,
            "start_logit": -2.1559717655181885,
            "end_logit": 4.309458255767822
        },
        {
            "text": "chordoma.Methods:",
            "probability": 0.0002512768152189852,
            "start_logit": -2.2842471599578857,
            "end_logit": 4.309458255767822
        },
        {
            "text": "chord",
            "probability": 0.00023152356125066142,
            "start_logit": 3.2793362140655518,
            "end_logit": -1.3359986543655396
        },
        {
            "text": "in chordoma",
            "probability": 0.0002228930695296635,
            "start_logit": -2.4041101932525635,
            "end_logit": 4.309458255767822
        },
        {
            "text": "the therapeutic potential of LB100 in chordoma",
            "probability": 0.00021382240832829965,
            "start_logit": -2.4456565380096436,
            "end_logit": 4.309458255767822
        },
        {
            "text": "chordoma consists of surgical resection followed by high-dose irradiation",
            "probability": 0.00016261426992140803,
            "start_logit": 3.2793362140655518,
            "end_logit": -1.6892993450164795
        },
        {
            "text": "chordoma consists of surgical resection followed by high-dose irradiation.",
            "probability": 0.00012372960075078822,
            "start_logit": 3.2793362140655518,
            "end_logit": -1.962581753730774
        },
        {
            "text": "therapeutic potential of LB100 in chordoma.Methods: Three patient-derived chordoma",
            "probability": 0.00010725588895099517,
            "start_logit": 0.16777069866657257,
            "end_logit": 1.0061026811599731
        },
        {
            "text": "therapeutic potential",
            "probability": 3.1451393136668376e-05,
            "start_logit": 0.16777069866657257,
            "end_logit": -0.22067150473594666
        },
        {
            "text": "therapeutic potential of LB100 in chordoma.",
            "probability": 1.829587004935724e-05,
            "start_logit": 0.16777069866657257,
            "end_logit": -0.7624394297599792
        },
        {
            "text": "chordoma cell lines were used: U-CH1, JHC7, and UM-Chor1. Cell proliferation",
            "probability": 1.2431484042585146e-05,
            "start_logit": 0.3074527680873871,
            "end_logit": -1.2885645627975464
        },
        {
            "text": "potential of LB100 in chordoma.Methods: Three patient-derived chordoma",
            "probability": 1.2295163058426924e-05,
            "start_logit": -1.9982408285140991,
            "end_logit": 1.0061026811599731
        },
        {
            "text": "LB100 in chordoma.Methods: Three patient-derived chordoma",
            "probability": 1.0501047359890586e-05,
            "start_logit": -2.1559717655181885,
            "end_logit": 1.0061026811599731
        }
    ],
    "5e29f6e0aa19d74431000002_006": [
        {
            "text": "",
            "probability": 0.49848425471378277,
            "start_logit": 3.5500402450561523,
            "end_logit": 4.6229987144470215
        },
        {
            "text": "medulloblastoma",
            "probability": 0.436716092124394,
            "start_logit": 2.8295791149139404,
            "end_logit": 5.2111711502075195
        },
        {
            "text": "medulloblastoma (MB)",
            "probability": 0.019873635840808576,
            "start_logit": 2.8295791149139404,
            "end_logit": 2.121281862258911
        },
        {
            "text": "cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma",
            "probability": 0.015036418505812705,
            "start_logit": -0.5392290353775024,
            "end_logit": 5.2111711502075195
        },
        {
            "text": "treatment of various cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma",
            "probability": 0.010749880423527862,
            "start_logit": -0.8748095631599426,
            "end_logit": 5.2111711502075195
        },
        {
            "text": "medulloblastoma (MB",
            "probability": 0.00707885988035208,
            "start_logit": 2.8295791149139404,
            "end_logit": 1.0890007019042969
        },
        {
            "text": "various cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma",
            "probability": 0.006900669284124963,
            "start_logit": -1.318085789680481,
            "end_logit": 5.2111711502075195
        },
        {
            "text": "We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma",
            "probability": 0.002281641671538295,
            "start_logit": -2.424808979034424,
            "end_logit": 5.2111711502075195
        },
        {
            "text": "MB)",
            "probability": 0.000980108048030075,
            "start_logit": -0.17990736663341522,
            "end_logit": 2.121281862258911
        },
        {
            "text": "medulloblast",
            "probability": 0.00035100328869132384,
            "start_logit": 2.8295791149139404,
            "end_logit": -1.9150718450546265
        },
        {
            "text": "MB",
            "probability": 0.0003491081146492421,
            "start_logit": -0.17990736663341522,
            "end_logit": 1.0890007019042969
        },
        {
            "text": "cancers",
            "probability": 0.00028937426639359795,
            "start_logit": -0.5392290353775024,
            "end_logit": 1.2606616020202637
        },
        {
            "text": "cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma (MB",
            "probability": 0.00024372974026948063,
            "start_logit": -0.5392290353775024,
            "end_logit": 1.0890007019042969
        },
        {
            "text": "treatment of various cancers",
            "probability": 0.00020688029933289904,
            "start_logit": -0.8748095631599426,
            "end_logit": 1.2606616020202637
        },
        {
            "text": "various cancers",
            "probability": 0.0001328026425273115,
            "start_logit": -1.318085789680481,
            "end_logit": 1.2606616020202637
        },
        {
            "text": "We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma (MB)",
            "probability": 0.0001038306499739651,
            "start_logit": -2.424808979034424,
            "end_logit": 2.121281862258911
        },
        {
            "text": "MB cells. By itself, LB100 inhibited proliferation and induced significant apoptosis in a range of pediatric MB",
            "probability": 8.125038205575305e-05,
            "start_logit": -0.6135938167572021,
            "end_logit": 0.06484101712703705
        },
        {
            "text": "chemo- and radio-sensitizer for treatment of various cancers",
            "probability": 5.4864660629540576e-05,
            "start_logit": -2.202080488204956,
            "end_logit": 1.2606616020202637
        },
        {
            "text": "cancer",
            "probability": 4.415465791456448e-05,
            "start_logit": -0.5392290353775024,
            "end_logit": -0.6193608641624451
        },
        {
            "text": "has been shown in pre-clinical studies to be an effective chemo- and radio-sensitizer for treatment of various cancers",
            "probability": 4.1440805191341035e-05,
            "start_logit": -2.4826838970184326,
            "end_logit": 1.2606616020202637
        }
    ],
    "5e29f6e0aa19d74431000002_007": [
        {
            "text": "",
            "probability": 0.49848425471378277,
            "start_logit": 3.5500402450561523,
            "end_logit": 4.6229987144470215
        },
        {
            "text": "medulloblastoma",
            "probability": 0.436716092124394,
            "start_logit": 2.8295791149139404,
            "end_logit": 5.2111711502075195
        },
        {
            "text": "medulloblastoma (MB)",
            "probability": 0.019873635840808576,
            "start_logit": 2.8295791149139404,
            "end_logit": 2.121281862258911
        },
        {
            "text": "cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma",
            "probability": 0.015036418505812705,
            "start_logit": -0.5392290353775024,
            "end_logit": 5.2111711502075195
        },
        {
            "text": "treatment of various cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma",
            "probability": 0.010749880423527862,
            "start_logit": -0.8748095631599426,
            "end_logit": 5.2111711502075195
        },
        {
            "text": "medulloblastoma (MB",
            "probability": 0.00707885988035208,
            "start_logit": 2.8295791149139404,
            "end_logit": 1.0890007019042969
        },
        {
            "text": "various cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma",
            "probability": 0.006900669284124963,
            "start_logit": -1.318085789680481,
            "end_logit": 5.2111711502075195
        },
        {
            "text": "We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma",
            "probability": 0.002281641671538295,
            "start_logit": -2.424808979034424,
            "end_logit": 5.2111711502075195
        },
        {
            "text": "MB)",
            "probability": 0.000980108048030075,
            "start_logit": -0.17990736663341522,
            "end_logit": 2.121281862258911
        },
        {
            "text": "medulloblast",
            "probability": 0.00035100328869132384,
            "start_logit": 2.8295791149139404,
            "end_logit": -1.9150718450546265
        },
        {
            "text": "MB",
            "probability": 0.0003491081146492421,
            "start_logit": -0.17990736663341522,
            "end_logit": 1.0890007019042969
        },
        {
            "text": "cancers",
            "probability": 0.00028937426639359795,
            "start_logit": -0.5392290353775024,
            "end_logit": 1.2606616020202637
        },
        {
            "text": "cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma (MB",
            "probability": 0.00024372974026948063,
            "start_logit": -0.5392290353775024,
            "end_logit": 1.0890007019042969
        },
        {
            "text": "treatment of various cancers",
            "probability": 0.00020688029933289904,
            "start_logit": -0.8748095631599426,
            "end_logit": 1.2606616020202637
        },
        {
            "text": "various cancers",
            "probability": 0.0001328026425273115,
            "start_logit": -1.318085789680481,
            "end_logit": 1.2606616020202637
        },
        {
            "text": "We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma (MB)",
            "probability": 0.0001038306499739651,
            "start_logit": -2.424808979034424,
            "end_logit": 2.121281862258911
        },
        {
            "text": "MB cells. By itself, LB100 inhibited proliferation and induced significant apoptosis in a range of pediatric MB",
            "probability": 8.125038205575305e-05,
            "start_logit": -0.6135938167572021,
            "end_logit": 0.06484101712703705
        },
        {
            "text": "chemo- and radio-sensitizer for treatment of various cancers",
            "probability": 5.4864660629540576e-05,
            "start_logit": -2.202080488204956,
            "end_logit": 1.2606616020202637
        },
        {
            "text": "cancer",
            "probability": 4.415465791456448e-05,
            "start_logit": -0.5392290353775024,
            "end_logit": -0.6193608641624451
        },
        {
            "text": "has been shown in pre-clinical studies to be an effective chemo- and radio-sensitizer for treatment of various cancers",
            "probability": 4.1440805191341035e-05,
            "start_logit": -2.4826838970184326,
            "end_logit": 1.2606616020202637
        }
    ],
    "5e29f6e0aa19d74431000002_009": [
        {
            "text": "progressive solid tumors",
            "probability": 0.6685889421842194,
            "start_logit": 4.32982063293457,
            "end_logit": 6.356358528137207
        },
        {
            "text": "adult patients with progressive solid tumors",
            "probability": 0.2032951136693785,
            "start_logit": 3.139309883117676,
            "end_logit": 6.356358528137207
        },
        {
            "text": "solid tumors",
            "probability": 0.04129231749423942,
            "start_logit": 1.5453276634216309,
            "end_logit": 6.356358528137207
        },
        {
            "text": "",
            "probability": 0.031780830762594615,
            "start_logit": 3.3266983032226562,
            "end_logit": 4.313174724578857
        },
        {
            "text": "patients with progressive solid tumors",
            "probability": 0.009527073302959271,
            "start_logit": 0.07878876477479935,
            "end_logit": 6.356358528137207
        },
        {
            "text": "tumors",
            "probability": 0.0094222908162822,
            "start_logit": 0.06772944331169128,
            "end_logit": 6.356358528137207
        },
        {
            "text": "in adult patients with progressive solid tumors",
            "probability": 0.008044309181115449,
            "start_logit": -0.09038389474153519,
            "end_logit": 6.356358528137207
        },
        {
            "text": "progressive",
            "probability": 0.006300232058047285,
            "start_logit": 4.32982063293457,
            "end_logit": 1.6917755603790283
        },
        {
            "text": "first-in-class small-molecule inhibitor of protein phosphatase 2A (PP2A) in adult patients with progressive solid tumors",
            "probability": 0.00577708207365293,
            "start_logit": -0.42145007848739624,
            "end_logit": 6.356358528137207
        },
        {
            "text": "with progressive solid tumors",
            "probability": 0.003858678370548145,
            "start_logit": -0.8250240683555603,
            "end_logit": 6.356358528137207
        },
        {
            "text": "protein phosphatase 2A (PP2A) in adult patients with progressive solid tumors",
            "probability": 0.00212258272791171,
            "start_logit": -1.422715187072754,
            "end_logit": 6.356358528137207
        },
        {
            "text": "adult patients with progressive",
            "probability": 0.00191568587449249,
            "start_logit": 3.139309883117676,
            "end_logit": 1.6917755603790283
        },
        {
            "text": "inhibitor of protein phosphatase 2A (PP2A) in adult patients with progressive solid tumors",
            "probability": 0.0018621101685757447,
            "start_logit": -1.5536384582519531,
            "end_logit": 6.356358528137207
        },
        {
            "text": "a first-in-class small-molecule inhibitor of protein phosphatase 2A (PP2A) in adult patients with progressive solid tumors",
            "probability": 0.0014544908181833203,
            "start_logit": -1.8006929159164429,
            "end_logit": 6.356358528137207
        },
        {
            "text": "small-molecule inhibitor of protein phosphatase 2A (PP2A) in adult patients with progressive solid tumors",
            "probability": 0.0014309799646289667,
            "start_logit": -1.8169893026351929,
            "end_logit": 6.356358528137207
        },
        {
            "text": "adult",
            "probability": 0.0011691975223136189,
            "start_logit": 3.139309883117676,
            "end_logit": 1.1980174779891968
        },
        {
            "text": "adult patients",
            "probability": 0.0009356490065711478,
            "start_logit": 3.139309883117676,
            "end_logit": 0.975184977054596
        },
        {
            "text": "progressive solid",
            "probability": 0.0007791113367396781,
            "start_logit": 4.32982063293457,
            "end_logit": -0.39841222763061523
        },
        {
            "text": "adult patients with progressive solid",
            "probability": 0.0002369012075583393,
            "start_logit": 3.139309883117676,
            "end_logit": -0.39841222763061523
        },
        {
            "text": "progressive solid tumors.",
            "probability": 0.0002064214599877825,
            "start_logit": 4.32982063293457,
            "end_logit": -1.7266461849212646
        }
    ],
    "5e29f6e0aa19d74431000002_010": [
        {
            "text": "progressive solid tumors",
            "probability": 0.6685889421842194,
            "start_logit": 4.32982063293457,
            "end_logit": 6.356358528137207
        },
        {
            "text": "adult patients with progressive solid tumors",
            "probability": 0.2032951136693785,
            "start_logit": 3.139309883117676,
            "end_logit": 6.356358528137207
        },
        {
            "text": "solid tumors",
            "probability": 0.04129231749423942,
            "start_logit": 1.5453276634216309,
            "end_logit": 6.356358528137207
        },
        {
            "text": "",
            "probability": 0.031780830762594615,
            "start_logit": 3.3266983032226562,
            "end_logit": 4.313174724578857
        },
        {
            "text": "patients with progressive solid tumors",
            "probability": 0.009527073302959271,
            "start_logit": 0.07878876477479935,
            "end_logit": 6.356358528137207
        },
        {
            "text": "tumors",
            "probability": 0.0094222908162822,
            "start_logit": 0.06772944331169128,
            "end_logit": 6.356358528137207
        },
        {
            "text": "in adult patients with progressive solid tumors",
            "probability": 0.008044309181115449,
            "start_logit": -0.09038389474153519,
            "end_logit": 6.356358528137207
        },
        {
            "text": "progressive",
            "probability": 0.006300232058047285,
            "start_logit": 4.32982063293457,
            "end_logit": 1.6917755603790283
        },
        {
            "text": "first-in-class small-molecule inhibitor of protein phosphatase 2A (PP2A) in adult patients with progressive solid tumors",
            "probability": 0.00577708207365293,
            "start_logit": -0.42145007848739624,
            "end_logit": 6.356358528137207
        },
        {
            "text": "with progressive solid tumors",
            "probability": 0.003858678370548145,
            "start_logit": -0.8250240683555603,
            "end_logit": 6.356358528137207
        },
        {
            "text": "protein phosphatase 2A (PP2A) in adult patients with progressive solid tumors",
            "probability": 0.00212258272791171,
            "start_logit": -1.422715187072754,
            "end_logit": 6.356358528137207
        },
        {
            "text": "adult patients with progressive",
            "probability": 0.00191568587449249,
            "start_logit": 3.139309883117676,
            "end_logit": 1.6917755603790283
        },
        {
            "text": "inhibitor of protein phosphatase 2A (PP2A) in adult patients with progressive solid tumors",
            "probability": 0.0018621101685757447,
            "start_logit": -1.5536384582519531,
            "end_logit": 6.356358528137207
        },
        {
            "text": "a first-in-class small-molecule inhibitor of protein phosphatase 2A (PP2A) in adult patients with progressive solid tumors",
            "probability": 0.0014544908181833203,
            "start_logit": -1.8006929159164429,
            "end_logit": 6.356358528137207
        },
        {
            "text": "small-molecule inhibitor of protein phosphatase 2A (PP2A) in adult patients with progressive solid tumors",
            "probability": 0.0014309799646289667,
            "start_logit": -1.8169893026351929,
            "end_logit": 6.356358528137207
        },
        {
            "text": "adult",
            "probability": 0.0011691975223136189,
            "start_logit": 3.139309883117676,
            "end_logit": 1.1980174779891968
        },
        {
            "text": "adult patients",
            "probability": 0.0009356490065711478,
            "start_logit": 3.139309883117676,
            "end_logit": 0.975184977054596
        },
        {
            "text": "progressive solid",
            "probability": 0.0007791113367396781,
            "start_logit": 4.32982063293457,
            "end_logit": -0.39841222763061523
        },
        {
            "text": "adult patients with progressive solid",
            "probability": 0.0002369012075583393,
            "start_logit": 3.139309883117676,
            "end_logit": -0.39841222763061523
        },
        {
            "text": "progressive solid tumors.",
            "probability": 0.0002064214599877825,
            "start_logit": 4.32982063293457,
            "end_logit": -1.7266461849212646
        }
    ],
    "5e46e74e3f5415952900000b_001": [
        {
            "text": "Pathogenic variants",
            "probability": 0.7827913634797989,
            "start_logit": 4.294295787811279,
            "end_logit": 4.724583148956299
        },
        {
            "text": "",
            "probability": 0.10659823911876988,
            "start_logit": 3.37829852104187,
            "end_logit": 3.6467812061309814
        },
        {
            "text": "variants",
            "probability": 0.06753527327863355,
            "start_logit": 1.844079613685608,
            "end_logit": 4.724583148956299
        },
        {
            "text": "Pathogenic variants in this gene",
            "probability": 0.015965281622569234,
            "start_logit": 4.294295787811279,
            "end_logit": 0.832133412361145
        },
        {
            "text": "accelerated aging",
            "probability": 0.010932585228116555,
            "start_logit": 2.1036574840545654,
            "end_logit": 2.6441030502319336
        },
        {
            "text": "Pathogenic",
            "probability": 0.007737799582659401,
            "start_logit": 4.294295787811279,
            "end_logit": 0.10783430188894272
        },
        {
            "text": "ERCC4 is also FANCQ, illustrating a critical role in interstrand crosslink repair. Pathogenic variants",
            "probability": 0.002276078357743495,
            "start_logit": -1.5461164712905884,
            "end_logit": 4.724583148956299
        },
        {
            "text": "variants in this gene",
            "probability": 0.0013774036194746345,
            "start_logit": 1.844079613685608,
            "end_logit": 0.832133412361145
        },
        {
            "text": "accelerated aging, we were unable to provide biological evidence supporting the pathogenic roles of the associated ERCC4 variants",
            "probability": 0.0013114397538847855,
            "start_logit": 2.1036574840545654,
            "end_logit": 0.5234808325767517
        },
        {
            "text": "FANCQ, illustrating a critical role in interstrand crosslink repair. Pathogenic variants",
            "probability": 0.0007867160739216059,
            "start_logit": -2.6084582805633545,
            "end_logit": 4.724583148956299
        },
        {
            "text": "Pathogenic variants in",
            "probability": 0.0005453454721247261,
            "start_logit": 4.294295787811279,
            "end_logit": -2.544618844985962
        },
        {
            "text": "Pathogenic variants in this gene cause xeroderma pigmentosum, XFE progeroid syndrome",
            "probability": 0.0004533926722133028,
            "start_logit": 4.294295787811279,
            "end_logit": -2.7292797565460205
        },
        {
            "text": "Pathogenic variants in genes",
            "probability": 0.0003304890768369738,
            "start_logit": 1.0628844499588013,
            "end_logit": 0.18594661355018616
        },
        {
            "text": "accelerated aging, we were unable to provide biological evidence supporting the pathogenic roles of the associated ERCC4 variants. Precise genetic",
            "probability": 0.0002589910337610816,
            "start_logit": 2.1036574840545654,
            "end_logit": -1.0986065864562988
        },
        {
            "text": "aging",
            "probability": 0.00024749176920112675,
            "start_logit": -1.6844682693481445,
            "end_logit": 2.6441030502319336
        },
        {
            "text": "a variant of CS",
            "probability": 0.00022324455546648037,
            "start_logit": 0.1937721222639084,
            "end_logit": 0.662753164768219
        },
        {
            "text": "accelerated aging, we were unable to provide biological evidence supporting the pathogenic roles of the associated ERCC4",
            "probability": 0.00017264576422383143,
            "start_logit": 2.1036574840545654,
            "end_logit": -1.5041581392288208
        },
        {
            "text": "gene",
            "probability": 0.00015871156618260212,
            "start_logit": -0.316787451505661,
            "end_logit": 0.832133412361145
        },
        {
            "text": "variants in genes",
            "probability": 0.00015354507300723412,
            "start_logit": 0.29630500078201294,
            "end_logit": 0.18594661355018616
        },
        {
            "text": "a variant of CS. The second case was heterozygous for two variants in cis",
            "probability": 0.00014396290141034773,
            "start_logit": 0.1937721222639084,
            "end_logit": 0.22404097020626068
        }
    ],
    "5e46e74e3f5415952900000b_002": [
        {
            "text": "complementation group F",
            "probability": 0.7444116417341464,
            "start_logit": 5.978619575500488,
            "end_logit": 7.138463497161865
        },
        {
            "text": "",
            "probability": 0.07160763101003574,
            "start_logit": 5.041550159454346,
            "end_logit": 5.734140396118164
        },
        {
            "text": "complementation group F (XP-F",
            "probability": 0.06387518594121613,
            "start_logit": 5.978619575500488,
            "end_logit": 4.68280029296875
        },
        {
            "text": "ERCC4 mutations have been known to cause xeroderma pigmentosum complementation group F",
            "probability": 0.045616734211412824,
            "start_logit": 3.186300039291382,
            "end_logit": 7.138463497161865
        },
        {
            "text": "complementation group F (XP-F)",
            "probability": 0.030831089387232526,
            "start_logit": 5.978619575500488,
            "end_logit": 3.954392910003662
        },
        {
            "text": "F",
            "probability": 0.012017163381231877,
            "start_logit": 1.8523613214492798,
            "end_logit": 7.138463497161865
        },
        {
            "text": "complementation group F (XP-F), Cockayne syndrome, and Fanconi anemia phenotypes",
            "probability": 0.00583853501420687,
            "start_logit": 5.978619575500488,
            "end_logit": 2.290349245071411
        },
        {
            "text": "ERCC4 mutations",
            "probability": 0.00418335084903857,
            "start_logit": 3.186300039291382,
            "end_logit": 4.749301433563232
        },
        {
            "text": "ERCC4 mutations have been known to cause xeroderma pigmentosum complementation group F (XP-F",
            "probability": 0.003914201788941976,
            "start_logit": 3.186300039291382,
            "end_logit": 4.68280029296875
        },
        {
            "text": "biallelic mutations in ERCC4. ERCC4 mutations have been known to cause xeroderma pigmentosum complementation group F",
            "probability": 0.0035355187528584675,
            "start_logit": 0.6288854479789734,
            "end_logit": 7.138463497161865
        },
        {
            "text": "mutations have been known to cause xeroderma pigmentosum complementation group F",
            "probability": 0.003443460121251127,
            "start_logit": 0.6025022268295288,
            "end_logit": 7.138463497161865
        },
        {
            "text": "ERCC4 mutations have been known to cause xeroderma pigmentosum complementation group F (XP-F)",
            "probability": 0.0018892955606516061,
            "start_logit": 3.186300039291382,
            "end_logit": 3.954392910003662
        },
        {
            "text": "ERCC4. ERCC4 mutations have been known to cause xeroderma pigmentosum complementation group F",
            "probability": 0.0016656282082178255,
            "start_logit": -0.12377223372459412,
            "end_logit": 7.138463497161865
        },
        {
            "text": "group F",
            "probability": 0.0014805764259535209,
            "start_logit": -0.24154309928417206,
            "end_logit": 7.138463497161865
        },
        {
            "text": "ERCC4",
            "probability": 0.001234867605264634,
            "start_logit": 3.186300039291382,
            "end_logit": 3.5291526317596436
        },
        {
            "text": "complementation group F (XP-F), Cockayne syndrome, and Fanconi anemia phenotypes.",
            "probability": 0.0012236879708489422,
            "start_logit": 5.978619575500488,
            "end_logit": 0.7277385592460632
        },
        {
            "text": "XP-F",
            "probability": 0.0010758219633964729,
            "start_logit": 1.8947736024856567,
            "end_logit": 4.68280029296875
        },
        {
            "text": "F (XP-F",
            "probability": 0.001031147959580533,
            "start_logit": 1.8523613214492798,
            "end_logit": 4.68280029296875
        },
        {
            "text": "complementation group",
            "probability": 0.0006051874912079485,
            "start_logit": 5.978619575500488,
            "end_logit": 0.023652367293834686
        },
        {
            "text": "XP-F)",
            "probability": 0.0005192746233059833,
            "start_logit": 1.8947736024856567,
            "end_logit": 3.954392910003662
        }
    ],
    "5e46e74e3f5415952900000b_003": [
        {
            "text": "mutations",
            "probability": 0.3167375943844734,
            "start_logit": 4.306739330291748,
            "end_logit": 3.465982437133789
        },
        {
            "text": "mutations in XPA",
            "probability": 0.13449647358125824,
            "start_logit": 4.306739330291748,
            "end_logit": 2.6094467639923096
        },
        {
            "text": "Xeroderma pigmentosum group A (XPA) protein is known to be involved in damage recognition step. Any mutations",
            "probability": 0.12744552241502685,
            "start_logit": 3.3963546752929688,
            "end_logit": 3.465982437133789
        },
        {
            "text": "Any mutations",
            "probability": 0.09835342233084755,
            "start_logit": 3.137233018875122,
            "end_logit": 3.465982437133789
        },
        {
            "text": "Xeroderma pigmentosum group A",
            "probability": 0.07264815011495297,
            "start_logit": 3.3963546752929688,
            "end_logit": 2.903921365737915
        },
        {
            "text": "Xeroderma pigmentosum group A (XPA) protein is known to be involved in damage recognition step. Any mutations in XPA",
            "probability": 0.05411726818173552,
            "start_logit": 3.3963546752929688,
            "end_logit": 2.6094467639923096
        },
        {
            "text": "Any mutations in XPA",
            "probability": 0.04176387237471431,
            "start_logit": 3.137233018875122,
            "end_logit": 2.6094467639923096
        },
        {
            "text": "damage recognition step. Any mutations",
            "probability": 0.029839274761955584,
            "start_logit": 1.9444911479949951,
            "end_logit": 3.465982437133789
        },
        {
            "text": "XPA) protein is known to be involved in damage recognition step. Any mutations",
            "probability": 0.01825880510311423,
            "start_logit": 1.4533131122589111,
            "end_logit": 3.465982437133789
        },
        {
            "text": "Xeroderma pigmentosum group A (XPA) protein is known to be involved in damage recognition step",
            "probability": 0.01728254991500753,
            "start_logit": 3.3963546752929688,
            "end_logit": 1.467990756034851
        },
        {
            "text": "",
            "probability": 0.01368277942888909,
            "start_logit": 2.4128353595733643,
            "end_logit": 2.2179508209228516
        },
        {
            "text": "Xeroderma pigmentosum group A (XPA",
            "probability": 0.013623528997121695,
            "start_logit": 3.3963546752929688,
            "end_logit": 1.2300918102264404
        },
        {
            "text": "damage recognition step. Any mutations in XPA",
            "probability": 0.012670669036002495,
            "start_logit": 1.9444911479949951,
            "end_logit": 2.6094467639923096
        },
        {
            "text": "Xeroderma pigmentosum group A (XPA) protein",
            "probability": 0.012279412081266875,
            "start_logit": 3.3963546752929688,
            "end_logit": 1.1262174844741821
        },
        {
            "text": "mutations in XPA cause classical Xeroderma pigmentosum disease",
            "probability": 0.009157042120542512,
            "start_logit": 4.306739330291748,
            "end_logit": -0.07756800204515457
        },
        {
            "text": "XPA) protein is known to be involved in damage recognition step. Any mutations in XPA",
            "probability": 0.007753247299073152,
            "start_logit": 1.4533131122589111,
            "end_logit": 2.6094467639923096
        },
        {
            "text": "Xeroderma pigmentosum group A (XPA)",
            "probability": 0.007406627964824408,
            "start_logit": 3.3963546752929688,
            "end_logit": 0.6206687092781067
        },
        {
            "text": "mutations in XPA cause classical Xeroderma pigmentosum disease.",
            "probability": 0.004236909160990794,
            "start_logit": 4.306739330291748,
            "end_logit": -0.8482571840286255
        },
        {
            "text": "XPA",
            "probability": 0.004200425689645509,
            "start_logit": 0.840387225151062,
            "end_logit": 2.6094467639923096
        },
        {
            "text": "damage recognition step",
            "probability": 0.004046425058557544,
            "start_logit": 1.9444911479949951,
            "end_logit": 1.467990756034851
        }
    ],
    "5e46e74e3f5415952900000b_004": [
        {
            "text": "NER-defective",
            "probability": 0.7740711725131084,
            "start_logit": 4.392745494842529,
            "end_logit": 5.220686435699463
        },
        {
            "text": "NER-defective xeroderma pigmentosum (XP), in which bulky DNA lesions are not efficiently removed",
            "probability": 0.12913621558535082,
            "start_logit": 4.392745494842529,
            "end_logit": 3.4298903942108154
        },
        {
            "text": "",
            "probability": 0.038545396517234716,
            "start_logit": 3.2491111755371094,
            "end_logit": 3.3644936084747314
        },
        {
            "text": "bulky DNA lesions are not efficiently removed",
            "probability": 0.02403334426755112,
            "start_logit": 2.711319923400879,
            "end_logit": 3.4298903942108154
        },
        {
            "text": "chemicals",
            "probability": 0.008932961482366839,
            "start_logit": 3.34474778175354,
            "end_logit": 1.8067682981491089
        },
        {
            "text": "chemicals with the potential to cause cancer and neurological diseases. With further validation, the assay might be also applicable to XP diagnosis",
            "probability": 0.004602033914133379,
            "start_logit": 3.34474778175354,
            "end_logit": 1.1435186862945557
        },
        {
            "text": "NER-defective xeroderma pigmentosum (XP), in which bulky DNA lesions",
            "probability": 0.0035099908475266705,
            "start_logit": 4.392745494842529,
            "end_logit": -0.1753639578819275
        },
        {
            "text": "defective",
            "probability": 0.002457436137612951,
            "start_logit": -1.3597997426986694,
            "end_logit": 5.220686435699463
        },
        {
            "text": "NER",
            "probability": 0.002182149837584204,
            "start_logit": 4.392745494842529,
            "end_logit": -0.6506668329238892
        },
        {
            "text": "in which bulky DNA lesions are not efficiently removed",
            "probability": 0.0019441576062208166,
            "start_logit": 0.19670648872852325,
            "end_logit": 3.4298903942108154
        },
        {
            "text": "NER-defective xeroderma pigmentosum (XP",
            "probability": 0.0018849049218293006,
            "start_logit": 4.392745494842529,
            "end_logit": -0.7971000075340271
        },
        {
            "text": "chemicals with the potential to cause cancer and neurological diseases",
            "probability": 0.001491827355361496,
            "start_logit": 3.34474778175354,
            "end_logit": 0.017022106796503067
        },
        {
            "text": "which bulky DNA lesions are not efficiently removed",
            "probability": 0.0014849504387173867,
            "start_logit": -0.07274089008569717,
            "end_logit": 3.4298903942108154
        },
        {
            "text": "NER-defective xeroderma pigmentosum (XP), in which bulky DNA lesions are not efficiently removed,",
            "probability": 0.0012474639522208782,
            "start_logit": 4.392745494842529,
            "end_logit": -1.2098647356033325
        },
        {
            "text": "chemicals with the potential to cause cancer and neurological diseases. With further validation, the assay might be also applicable to XP diagnosis.",
            "probability": 0.0010423599755574043,
            "start_logit": 3.34474778175354,
            "end_logit": -0.34149232506752014
        },
        {
            "text": "chemicals with the potential to cause cancer",
            "probability": 0.000915678226386743,
            "start_logit": 3.34474778175354,
            "end_logit": -0.47106993198394775
        },
        {
            "text": "Individuals with NER-defective",
            "probability": 0.0008651021646217661,
            "start_logit": -2.4038259983062744,
            "end_logit": 5.220686435699463
        },
        {
            "text": "bulky DNA lesions",
            "probability": 0.0006532390470960296,
            "start_logit": 2.711319923400879,
            "end_logit": -0.1753639578819275
        },
        {
            "text": "NER-defective xeroderma pigmentosum (XP), in which bulky DNA",
            "probability": 0.0005012342849181843,
            "start_logit": 4.392745494842529,
            "end_logit": -2.12165904045105
        },
        {
            "text": "NER-defective xeroderma pigmentosum (XP)",
            "probability": 0.0004983809246011058,
            "start_logit": 4.392745494842529,
            "end_logit": -2.1273679733276367
        }
    ],
    "5e46e74e3f5415952900000b_005": [
        {
            "text": "",
            "probability": 0.9217097849095385,
            "start_logit": 5.455158710479736,
            "end_logit": 5.663834095001221
        },
        {
            "text": "mutations in the ERCC1 or ERCC4 genes",
            "probability": 0.0385553166762628,
            "start_logit": 4.7347493171691895,
            "end_logit": 3.2101070880889893
        },
        {
            "text": "mutations",
            "probability": 0.035566547898128326,
            "start_logit": 4.7347493171691895,
            "end_logit": 3.1294186115264893
        },
        {
            "text": "mutations in the ERCC1 or ERCC4",
            "probability": 0.0013533657424025076,
            "start_logit": 4.7347493171691895,
            "end_logit": -0.13939228653907776
        },
        {
            "text": "mutations in the ERCC1 or ERCC4 genes cause a remarkable array of rare inherited human disorders",
            "probability": 0.0007897408489642677,
            "start_logit": 4.7347493171691895,
            "end_logit": -0.6780373454093933
        },
        {
            "text": "ERCC1 or ERCC4 genes",
            "probability": 0.0006382390498563036,
            "start_logit": 0.6336129307746887,
            "end_logit": 3.2101070880889893
        },
        {
            "text": "mutations in the ERCC1 or ERCC4 genes cause a remarkable array of rare inherited human disorders. These include specific forms",
            "probability": 0.0002268491359131345,
            "start_logit": 4.7347493171691895,
            "end_logit": -1.9254570007324219
        },
        {
            "text": "mutations in the ERCC1 or ERCC4 genes cause a remarkable array of rare inherited human disorders.",
            "probability": 0.0001795063109896035,
            "start_logit": 4.7347493171691895,
            "end_logit": -2.159531831741333
        },
        {
            "text": "mutations in the ERCC1 or ERCC4 genes cause a remarkable array of rare inherited",
            "probability": 0.00016049917737753956,
            "start_logit": 4.7347493171691895,
            "end_logit": -2.271453380584717
        },
        {
            "text": "mutations in",
            "probability": 0.0001445745021870629,
            "start_logit": 4.7347493171691895,
            "end_logit": -2.3759472370147705
        },
        {
            "text": "genes",
            "probability": 0.00012071843730265327,
            "start_logit": -1.0316390991210938,
            "end_logit": 3.2101070880889893
        },
        {
            "text": "in the ERCC1 or ERCC4 genes",
            "probability": 0.00010389767639260719,
            "start_logit": -1.181693434715271,
            "end_logit": 3.2101070880889893
        },
        {
            "text": "mutations in the ERCC1 or ERCC4 genes cause a remarkable array of rare",
            "probability": 9.278826630890014e-05,
            "start_logit": 4.7347493171691895,
            "end_logit": -2.8194220066070557
        },
        {
            "text": "Complete deletion of either ERCC1 or ERCC4 is not compatible with viability in mice or humans. However, mutations",
            "probability": 8.977632253570797e-05,
            "start_logit": -1.247090220451355,
            "end_logit": 3.1294186115264893
        },
        {
            "text": "mutations in the ERCC1",
            "probability": 7.851761518457922e-05,
            "start_logit": 4.7347493171691895,
            "end_logit": -2.986419200897217
        },
        {
            "text": "the ERCC1 or ERCC4 genes",
            "probability": 5.410160342960116e-05,
            "start_logit": -1.8342361450195312,
            "end_logit": 3.2101070880889893
        },
        {
            "text": ", mutations in the ERCC1 or ERCC4 genes",
            "probability": 4.0481690890578554e-05,
            "start_logit": -2.1242501735687256,
            "end_logit": 3.2101070880889893
        },
        {
            "text": ", mutations",
            "probability": 3.734359155045974e-05,
            "start_logit": -2.1242501735687256,
            "end_logit": 3.1294186115264893
        },
        {
            "text": "deletion of either ERCC1 or ERCC4 is not compatible with viability in mice or humans. However, mutations",
            "probability": 2.9085520514534554e-05,
            "start_logit": -2.374171018600464,
            "end_logit": 3.1294186115264893
        },
        {
            "text": "ERCC4 genes",
            "probability": 2.886502426982467e-05,
            "start_logit": -2.4624693393707275,
            "end_logit": 3.2101070880889893
        }
    ],
    "5e2902e48b3851296d000006_001": [
        {
            "text": "",
            "probability": 0.9616269527340523,
            "start_logit": 3.37007999420166,
            "end_logit": 3.572671413421631
        },
        {
            "text": "Lupus Low Disease Activity State (LLDAS) definition as an endpoint in an systemic lupus erythematosus",
            "probability": 0.010349689289279762,
            "start_logit": 1.212243676185608,
            "end_logit": 1.1988376379013062
        },
        {
            "text": "systemic lupus erythematosus",
            "probability": 0.009992490550273353,
            "start_logit": 1.1771210432052612,
            "end_logit": 1.1988376379013062
        },
        {
            "text": "Lupus",
            "probability": 0.0038136722569107697,
            "start_logit": 1.212243676185608,
            "end_logit": 0.20047371089458466
        },
        {
            "text": "LLDAS",
            "probability": 0.001650595483720045,
            "start_logit": 0.24018245935440063,
            "end_logit": 0.33507847785949707
        },
        {
            "text": "LLDAS attainment represents a clinically meaningful SLE outcome measure, and anifrolumab is associated with more patients who met LLDAS",
            "probability": 0.0015503041523648286,
            "start_logit": 0.1774974763393402,
            "end_logit": 0.33507847785949707
        },
        {
            "text": "LLDAS criteria versus placebo. These data support LLDAS",
            "probability": 0.0014116932149877352,
            "start_logit": 0.24018245935440063,
            "end_logit": 0.17873220145702362
        },
        {
            "text": "lupus erythematosus",
            "probability": 0.0011069411887900064,
            "start_logit": -1.0231122970581055,
            "end_logit": 1.1988376379013062
        },
        {
            "text": "Lupus Low Disease Activity State (LLDAS) definition as an endpoint in an systemic lupus",
            "probability": 0.0010194208329343069,
            "start_logit": 1.212243676185608,
            "end_logit": -1.1188842058181763
        },
        {
            "text": "systemic lupus",
            "probability": 0.0009842375703393445,
            "start_logit": 1.1771210432052612,
            "end_logit": -1.1188842058181763
        },
        {
            "text": "LLDAS criteria versus placebo",
            "probability": 0.0008606797537388573,
            "start_logit": 0.24018245935440063,
            "end_logit": -0.3160904347896576
        },
        {
            "text": "Lupus Low Disease Activity State",
            "probability": 0.0008492146234324483,
            "start_logit": 1.212243676185608,
            "end_logit": -1.3015621900558472
        },
        {
            "text": "SLE outcome measure, and anifrolumab is associated with more patients who met LLDAS",
            "probability": 0.0008128950538567059,
            "start_logit": -0.4681069254875183,
            "end_logit": 0.33507847785949707
        },
        {
            "text": "SLE outcome measure, and anifrolumab is associated with more patients who met LLDAS criteria versus placebo. These data support LLDAS",
            "probability": 0.0006952390475710503,
            "start_logit": -0.4681069254875183,
            "end_logit": 0.17873220145702362
        },
        {
            "text": "Lupus Low Disease Activity State (LLDAS) definition as an endpoint in an systemic",
            "probability": 0.0006723576985656075,
            "start_logit": 1.212243676185608,
            "end_logit": -1.5350836515426636
        },
        {
            "text": "systemic",
            "probability": 0.0006491526229951118,
            "start_logit": 1.1771210432052612,
            "end_logit": -1.5350836515426636
        },
        {
            "text": "systemic lupus erythematosus (SLE)",
            "probability": 0.0005993580366184071,
            "start_logit": 1.1771210432052612,
            "end_logit": -1.6148923635482788
        },
        {
            "text": "LLDAS attainment represents a clinically meaningful SLE",
            "probability": 0.0004813636616525177,
            "start_logit": 0.1774974763393402,
            "end_logit": -0.8345049023628235
        },
        {
            "text": "LLDAS criteria versus placebo. These data support LLDAS as an SLE RCT",
            "probability": 0.00044986955791992037,
            "start_logit": 0.24018245935440063,
            "end_logit": -0.9648552536964417
        },
        {
            "text": "SLE outcome measure, and anifrolumab is associated with more patients who met LLDAS criteria versus placebo",
            "probability": 0.0004238726699967089,
            "start_logit": -0.4681069254875183,
            "end_logit": -0.3160904347896576
        }
    ],
    "5e2902e48b3851296d000006_002": [
        {
            "text": "",
            "probability": 0.9616269527340523,
            "start_logit": 3.37007999420166,
            "end_logit": 3.572671413421631
        },
        {
            "text": "Lupus Low Disease Activity State (LLDAS) definition as an endpoint in an systemic lupus erythematosus",
            "probability": 0.010349689289279762,
            "start_logit": 1.212243676185608,
            "end_logit": 1.1988376379013062
        },
        {
            "text": "systemic lupus erythematosus",
            "probability": 0.009992490550273353,
            "start_logit": 1.1771210432052612,
            "end_logit": 1.1988376379013062
        },
        {
            "text": "Lupus",
            "probability": 0.0038136722569107697,
            "start_logit": 1.212243676185608,
            "end_logit": 0.20047371089458466
        },
        {
            "text": "LLDAS",
            "probability": 0.001650595483720045,
            "start_logit": 0.24018245935440063,
            "end_logit": 0.33507847785949707
        },
        {
            "text": "LLDAS attainment represents a clinically meaningful SLE outcome measure, and anifrolumab is associated with more patients who met LLDAS",
            "probability": 0.0015503041523648286,
            "start_logit": 0.1774974763393402,
            "end_logit": 0.33507847785949707
        },
        {
            "text": "LLDAS criteria versus placebo. These data support LLDAS",
            "probability": 0.0014116932149877352,
            "start_logit": 0.24018245935440063,
            "end_logit": 0.17873220145702362
        },
        {
            "text": "lupus erythematosus",
            "probability": 0.0011069411887900064,
            "start_logit": -1.0231122970581055,
            "end_logit": 1.1988376379013062
        },
        {
            "text": "Lupus Low Disease Activity State (LLDAS) definition as an endpoint in an systemic lupus",
            "probability": 0.0010194208329343069,
            "start_logit": 1.212243676185608,
            "end_logit": -1.1188842058181763
        },
        {
            "text": "systemic lupus",
            "probability": 0.0009842375703393445,
            "start_logit": 1.1771210432052612,
            "end_logit": -1.1188842058181763
        },
        {
            "text": "LLDAS criteria versus placebo",
            "probability": 0.0008606797537388573,
            "start_logit": 0.24018245935440063,
            "end_logit": -0.3160904347896576
        },
        {
            "text": "Lupus Low Disease Activity State",
            "probability": 0.0008492146234324483,
            "start_logit": 1.212243676185608,
            "end_logit": -1.3015621900558472
        },
        {
            "text": "SLE outcome measure, and anifrolumab is associated with more patients who met LLDAS",
            "probability": 0.0008128950538567059,
            "start_logit": -0.4681069254875183,
            "end_logit": 0.33507847785949707
        },
        {
            "text": "SLE outcome measure, and anifrolumab is associated with more patients who met LLDAS criteria versus placebo. These data support LLDAS",
            "probability": 0.0006952390475710503,
            "start_logit": -0.4681069254875183,
            "end_logit": 0.17873220145702362
        },
        {
            "text": "Lupus Low Disease Activity State (LLDAS) definition as an endpoint in an systemic",
            "probability": 0.0006723576985656075,
            "start_logit": 1.212243676185608,
            "end_logit": -1.5350836515426636
        },
        {
            "text": "systemic",
            "probability": 0.0006491526229951118,
            "start_logit": 1.1771210432052612,
            "end_logit": -1.5350836515426636
        },
        {
            "text": "systemic lupus erythematosus (SLE)",
            "probability": 0.0005993580366184071,
            "start_logit": 1.1771210432052612,
            "end_logit": -1.6148923635482788
        },
        {
            "text": "LLDAS attainment represents a clinically meaningful SLE",
            "probability": 0.0004813636616525177,
            "start_logit": 0.1774974763393402,
            "end_logit": -0.8345049023628235
        },
        {
            "text": "LLDAS criteria versus placebo. These data support LLDAS as an SLE RCT",
            "probability": 0.00044986955791992037,
            "start_logit": 0.24018245935440063,
            "end_logit": -0.9648552536964417
        },
        {
            "text": "SLE outcome measure, and anifrolumab is associated with more patients who met LLDAS criteria versus placebo",
            "probability": 0.0004238726699967089,
            "start_logit": -0.4681069254875183,
            "end_logit": -0.3160904347896576
        }
    ],
    "5e2902e48b3851296d000006_003": [
        {
            "text": "",
            "probability": 0.9271430672827394,
            "start_logit": 3.9691033363342285,
            "end_logit": 4.01197624206543
        },
        {
            "text": "Systemic Lupus Erythematosus",
            "probability": 0.03644758239807836,
            "start_logit": 2.4297876358032227,
            "end_logit": 2.315059185028076
        },
        {
            "text": "SLE",
            "probability": 0.007700980116329278,
            "start_logit": 1.6397792100906372,
            "end_logit": 1.5505400896072388
        },
        {
            "text": "Lupus Erythematosus",
            "probability": 0.005717477752395571,
            "start_logit": 0.5774402618408203,
            "end_logit": 2.315059185028076
        },
        {
            "text": "SLE disease activity",
            "probability": 0.004573912288901661,
            "start_logit": 1.6397792100906372,
            "end_logit": 1.0295614004135132
        },
        {
            "text": "moderate to severe SLE",
            "probability": 0.00410835172463132,
            "start_logit": 1.0114535093307495,
            "end_logit": 1.5505400896072388
        },
        {
            "text": "moderate to severe SLE disease activity",
            "probability": 0.002440110240068831,
            "start_logit": 1.0114535093307495,
            "end_logit": 1.0295614004135132
        },
        {
            "text": "Systemic Lupus",
            "probability": 0.00222881633449641,
            "start_logit": 2.4297876358032227,
            "end_logit": -0.47934529185295105
        },
        {
            "text": "SLE disease",
            "probability": 0.001995849575765726,
            "start_logit": 1.6397792100906372,
            "end_logit": 0.20026229321956635
        },
        {
            "text": "Systemic Lupus Erythematosus (SLE",
            "probability": 0.0013529236999719064,
            "start_logit": 2.4297876358032227,
            "end_logit": -0.978547990322113
        },
        {
            "text": "moderate to severe SLE disease",
            "probability": 0.0010647543459195719,
            "start_logit": 1.0114535093307495,
            "end_logit": 0.20026229321956635
        },
        {
            "text": "Systemic",
            "probability": 0.0010434199173168354,
            "start_logit": 2.4297876358032227,
            "end_logit": -1.2383122444152832
        },
        {
            "text": "moderate to severe",
            "probability": 0.0008877072977612158,
            "start_logit": 1.0114535093307495,
            "end_logit": 0.018404971808195114
        },
        {
            "text": "Erythematosus",
            "probability": 0.0006008365588481644,
            "start_logit": -1.6755198240280151,
            "end_logit": 2.315059185028076
        },
        {
            "text": "SLE) Responder Index (SRI(4)) response (Week 52) for 736 patients with moderate to severe SLE",
            "probability": 0.0005991048673897732,
            "start_logit": -0.9138870239257812,
            "end_logit": 1.5505400896072388
        },
        {
            "text": "Systemic Lupus Erythemato",
            "probability": 0.0004779304942629819,
            "start_logit": 2.4297876358032227,
            "end_logit": -2.019105911254883
        },
        {
            "text": "Systemic Lupus Er",
            "probability": 0.00045066916793431343,
            "start_logit": 2.4297876358032227,
            "end_logit": -2.0778377056121826
        },
        {
            "text": "SLE disease activity (study entry)",
            "probability": 0.00041461665424884626,
            "start_logit": 1.6397792100906372,
            "end_logit": -1.3712084293365479
        },
        {
            "text": "Systemic Lupus Erythematosus (SLE)",
            "probability": 0.0003960575480304032,
            "start_logit": 2.4297876358032227,
            "end_logit": -2.2070116996765137
        },
        {
            "text": "SLE) Responder Index (SRI(4)) response (Week 52) for 736 patients with moderate to severe SLE disease activity",
            "probability": 0.00035583173490922384,
            "start_logit": -0.9138870239257812,
            "end_logit": 1.0295614004135132
        }
    ],
    "5e2902e48b3851296d000006_004": [
        {
            "text": "SLE",
            "probability": 0.9902199001261321,
            "start_logit": 6.962309837341309,
            "end_logit": 7.272584915161133
        },
        {
            "text": "SLE,",
            "probability": 0.005093833909786449,
            "start_logit": 6.962309837341309,
            "end_logit": 2.0026886463165283
        },
        {
            "text": "S",
            "probability": 0.0033234790089507276,
            "start_logit": 6.962309837341309,
            "end_logit": 1.5756700038909912
        },
        {
            "text": "SLE, in healthy volunteers",
            "probability": 0.0004488448896218865,
            "start_logit": 6.962309837341309,
            "end_logit": -0.42642003297805786
        },
        {
            "text": "in development for SLE",
            "probability": 0.00017830467612157825,
            "start_logit": -1.6598787307739258,
            "end_logit": 7.272584915161133
        },
        {
            "text": "intravenous anifrolumab, an anti-type I interferon receptor monoclonal antibody in development for SLE",
            "probability": 0.00013109416768288605,
            "start_logit": -1.967456579208374,
            "end_logit": 7.272584915161133
        },
        {
            "text": "anti-type I interferon receptor monoclonal antibody in development for SLE",
            "probability": 0.00011692494166772335,
            "start_logit": -2.0818402767181396,
            "end_logit": 7.272584915161133
        },
        {
            "text": "for SLE",
            "probability": 9.672559894982793e-05,
            "start_logit": -2.2714943885803223,
            "end_logit": 7.272584915161133
        },
        {
            "text": "",
            "probability": 9.250648944325978e-05,
            "start_logit": 2.337740659713745,
            "end_logit": 2.61875057220459
        },
        {
            "text": "anifrolumab, an anti-type I interferon receptor monoclonal antibody in development for SLE",
            "probability": 8.705445108018069e-05,
            "start_logit": -2.3768386840820312,
            "end_logit": 7.272584915161133
        },
        {
            "text": "an anti-type I interferon receptor monoclonal antibody in development for SLE",
            "probability": 8.426802862191356e-05,
            "start_logit": -2.409369945526123,
            "end_logit": 7.272584915161133
        },
        {
            "text": "interferon receptor monoclonal antibody in development for SLE",
            "probability": 4.204049381680571e-05,
            "start_logit": -3.104739189147949,
            "end_logit": 7.272584915161133
        },
        {
            "text": "SLE, in healthy volunteers.Methods: In this Phase I randomised, placebo-controlled study, 30 adults",
            "probability": 3.156521834615469e-05,
            "start_logit": 6.962309837341309,
            "end_logit": -3.0810415744781494
        },
        {
            "text": "SLE, in healthy volunteers.",
            "probability": 2.5907962530179968e-05,
            "start_logit": 6.962309837341309,
            "end_logit": -3.2785470485687256
        },
        {
            "text": "SLE, in healthy volunteers.Methods: In this Phase I randomised, placebo-controlled study, 30",
            "probability": 2.4487497769113354e-05,
            "start_logit": 6.962309837341309,
            "end_logit": -3.334934711456299
        },
        {
            "text": "in development for SLE,",
            "probability": 9.172249571897049e-07,
            "start_logit": -1.6598787307739258,
            "end_logit": 2.0026886463165283
        },
        {
            "text": "anti-type I interferon receptor monoclonal antibody in development for SLE,",
            "probability": 6.014787550633814e-07,
            "start_logit": -2.0818402767181396,
            "end_logit": 2.0026886463165283
        },
        {
            "text": "in development for S",
            "probability": 5.984446971953809e-07,
            "start_logit": -1.6598787307739258,
            "end_logit": 1.5756700038909912
        },
        {
            "text": "for SLE,",
            "probability": 4.975704243191622e-07,
            "start_logit": -2.2714943885803223,
            "end_logit": 2.0026886463165283
        },
        {
            "text": "anifrolumab, an anti-type I interferon receptor monoclonal antibody in development for SLE,",
            "probability": 4.4782064554912035e-07,
            "start_logit": -2.3768386840820312,
            "end_logit": 2.0026886463165283
        }
    ],
    "5e2902e48b3851296d000006_006": [
        {
            "text": "SLE",
            "probability": 0.78987801405231,
            "start_logit": 6.174683094024658,
            "end_logit": 6.650187969207764
        },
        {
            "text": "patients with SLE",
            "probability": 0.09442032698045494,
            "start_logit": 4.05056095123291,
            "end_logit": 6.650187969207764
        },
        {
            "text": "SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling.",
            "probability": 0.045500745139985796,
            "start_logit": 6.174683094024658,
            "end_logit": 3.7960381507873535
        },
        {
            "text": "SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling",
            "probability": 0.04325764367687886,
            "start_logit": 6.174683094024658,
            "end_logit": 3.7454833984375
        },
        {
            "text": "patients with SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling.",
            "probability": 0.005439061674765502,
            "start_logit": 4.05056095123291,
            "end_logit": 3.7960381507873535
        },
        {
            "text": "patients with SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling",
            "probability": 0.005170926127467095,
            "start_logit": 4.05056095123291,
            "end_logit": 3.7454833984375
        },
        {
            "text": "a promising therapeutic for patients with SLE",
            "probability": 0.0038992142472524145,
            "start_logit": 0.8635796308517456,
            "end_logit": 6.650187969207764
        },
        {
            "text": "is a promising therapeutic for patients with SLE",
            "probability": 0.0023691731072821667,
            "start_logit": 0.3653455674648285,
            "end_logit": 6.650187969207764
        },
        {
            "text": "for patients with SLE",
            "probability": 0.0014892423665687562,
            "start_logit": -0.09892791509628296,
            "end_logit": 6.650187969207764
        },
        {
            "text": "S",
            "probability": 0.0013984206383872277,
            "start_logit": 5.938536167144775,
            "end_logit": 0.5497998595237732
        },
        {
            "text": "promising therapeutic for patients with SLE",
            "probability": 0.0013221051531046239,
            "start_logit": -0.21797014772891998,
            "end_logit": 6.650187969207764
        },
        {
            "text": "therapeutic for patients with SLE",
            "probability": 0.0012626085662503497,
            "start_logit": -0.2640155553817749,
            "end_logit": 6.650187969207764
        },
        {
            "text": "with SLE",
            "probability": 0.0011555722972321123,
            "start_logit": -0.35259971022605896,
            "end_logit": 6.650187969207764
        },
        {
            "text": "SLE and other diseases",
            "probability": 0.0011235315791140422,
            "start_logit": 6.174683094024658,
            "end_logit": 0.09478636831045151
        },
        {
            "text": "SLE.",
            "probability": 0.0007291229228146549,
            "start_logit": 5.938536167144775,
            "end_logit": -0.10145656764507294
        },
        {
            "text": "",
            "probability": 0.00046649700479964664,
            "start_logit": 2.5333268642425537,
            "end_logit": 2.8571619987487793
        },
        {
            "text": "SLE.Methods:",
            "probability": 0.00046455135969723094,
            "start_logit": -1.0187933444976807,
            "end_logit": 6.405102729797363
        },
        {
            "text": "a promising therapeutic for patients with SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling.",
            "probability": 0.00022461335871374715,
            "start_logit": 0.8635796308517456,
            "end_logit": 3.7960381507873535
        },
        {
            "text": "SLE and other diseases that exhibit chronic dysfunctional type I IFN",
            "probability": 0.00021508940584699234,
            "start_logit": 6.174683094024658,
            "end_logit": -1.55839204788208
        },
        {
            "text": "a promising therapeutic for patients with SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling",
            "probability": 0.0002135403410738358,
            "start_logit": 0.8635796308517456,
            "end_logit": 3.7454833984375
        }
    ],
    "5e2902e48b3851296d000006_007": [
        {
            "text": "SLE",
            "probability": 0.78987801405231,
            "start_logit": 6.174683094024658,
            "end_logit": 6.650187969207764
        },
        {
            "text": "patients with SLE",
            "probability": 0.09442032698045494,
            "start_logit": 4.05056095123291,
            "end_logit": 6.650187969207764
        },
        {
            "text": "SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling.",
            "probability": 0.045500745139985796,
            "start_logit": 6.174683094024658,
            "end_logit": 3.7960381507873535
        },
        {
            "text": "SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling",
            "probability": 0.04325764367687886,
            "start_logit": 6.174683094024658,
            "end_logit": 3.7454833984375
        },
        {
            "text": "patients with SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling.",
            "probability": 0.005439061674765502,
            "start_logit": 4.05056095123291,
            "end_logit": 3.7960381507873535
        },
        {
            "text": "patients with SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling",
            "probability": 0.005170926127467095,
            "start_logit": 4.05056095123291,
            "end_logit": 3.7454833984375
        },
        {
            "text": "a promising therapeutic for patients with SLE",
            "probability": 0.0038992142472524145,
            "start_logit": 0.8635796308517456,
            "end_logit": 6.650187969207764
        },
        {
            "text": "is a promising therapeutic for patients with SLE",
            "probability": 0.0023691731072821667,
            "start_logit": 0.3653455674648285,
            "end_logit": 6.650187969207764
        },
        {
            "text": "for patients with SLE",
            "probability": 0.0014892423665687562,
            "start_logit": -0.09892791509628296,
            "end_logit": 6.650187969207764
        },
        {
            "text": "S",
            "probability": 0.0013984206383872277,
            "start_logit": 5.938536167144775,
            "end_logit": 0.5497998595237732
        },
        {
            "text": "promising therapeutic for patients with SLE",
            "probability": 0.0013221051531046239,
            "start_logit": -0.21797014772891998,
            "end_logit": 6.650187969207764
        },
        {
            "text": "therapeutic for patients with SLE",
            "probability": 0.0012626085662503497,
            "start_logit": -0.2640155553817749,
            "end_logit": 6.650187969207764
        },
        {
            "text": "with SLE",
            "probability": 0.0011555722972321123,
            "start_logit": -0.35259971022605896,
            "end_logit": 6.650187969207764
        },
        {
            "text": "SLE and other diseases",
            "probability": 0.0011235315791140422,
            "start_logit": 6.174683094024658,
            "end_logit": 0.09478636831045151
        },
        {
            "text": "SLE.",
            "probability": 0.0007291229228146549,
            "start_logit": 5.938536167144775,
            "end_logit": -0.10145656764507294
        },
        {
            "text": "",
            "probability": 0.00046649700479964664,
            "start_logit": 2.5333268642425537,
            "end_logit": 2.8571619987487793
        },
        {
            "text": "SLE.Methods:",
            "probability": 0.00046455135969723094,
            "start_logit": -1.0187933444976807,
            "end_logit": 6.405102729797363
        },
        {
            "text": "a promising therapeutic for patients with SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling.",
            "probability": 0.00022461335871374715,
            "start_logit": 0.8635796308517456,
            "end_logit": 3.7960381507873535
        },
        {
            "text": "SLE and other diseases that exhibit chronic dysfunctional type I IFN",
            "probability": 0.00021508940584699234,
            "start_logit": 6.174683094024658,
            "end_logit": -1.55839204788208
        },
        {
            "text": "a promising therapeutic for patients with SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling",
            "probability": 0.0002135403410738358,
            "start_logit": 0.8635796308517456,
            "end_logit": 3.7454833984375
        }
    ],
    "5e2902e48b3851296d000006_008": [
        {
            "text": "",
            "probability": 0.9794727065044543,
            "start_logit": 3.4764533042907715,
            "end_logit": 3.8419666290283203
        },
        {
            "text": "Systemic lupus erythematosus",
            "probability": 0.01532894677622814,
            "start_logit": 1.3781260251998901,
            "end_logit": 1.7830225229263306
        },
        {
            "text": "Systemic lupus erythematosus (SLE)",
            "probability": 0.001221834292510982,
            "start_logit": 1.3781260251998901,
            "end_logit": -0.7463672161102295
        },
        {
            "text": "Systemic lupus erythematosus (SLE",
            "probability": 0.0010313051348431919,
            "start_logit": 1.3781260251998901,
            "end_logit": -0.9158953428268433
        },
        {
            "text": "lupus erythematosus",
            "probability": 0.0005443478367794293,
            "start_logit": -1.9597837924957275,
            "end_logit": 1.7830225229263306
        },
        {
            "text": "Systemic lupus",
            "probability": 0.000532840097949491,
            "start_logit": 1.3781260251998901,
            "end_logit": -1.5762543678283691
        },
        {
            "text": "erythematosus",
            "probability": 0.00022149978657355613,
            "start_logit": -2.858950614929199,
            "end_logit": 1.7830225229263306
        },
        {
            "text": "Systemic lupus erythematosus (SLE) is an autoimmune disease",
            "probability": 0.000186001057687156,
            "start_logit": 1.3781260251998901,
            "end_logit": -2.628723382949829
        },
        {
            "text": "Systemic lupus er",
            "probability": 0.00017513479954086317,
            "start_logit": 1.3781260251998901,
            "end_logit": -2.68891978263855
        },
        {
            "text": "Systemic",
            "probability": 0.00015180493370317878,
            "start_logit": 1.3781260251998901,
            "end_logit": -2.8318793773651123
        },
        {
            "text": "the most promising is anifrolumab, a monoclonal antibody targeting the type 1 IFN receptor",
            "probability": 0.0001471885070926079,
            "start_logit": -2.039714813232422,
            "end_logit": 0.5550792217254639
        },
        {
            "text": "type 1 IFN receptor",
            "probability": 0.00014641025558813182,
            "start_logit": -2.045016288757324,
            "end_logit": 0.5550792217254639
        },
        {
            "text": "a monoclonal antibody targeting the type 1 IFN receptor",
            "probability": 0.00013907417994978605,
            "start_logit": -2.096421480178833,
            "end_logit": 0.5550792217254639
        },
        {
            "text": "monoclonal antibody targeting the type 1 IFN receptor",
            "probability": 0.00013209343633951572,
            "start_logit": -2.1479194164276123,
            "end_logit": 0.5550792217254639
        },
        {
            "text": "the type 1 IFN receptor",
            "probability": 0.00012855851426947667,
            "start_logit": -2.1750447750091553,
            "end_logit": 0.5550792217254639
        },
        {
            "text": "Systemic lupus erythematosus (SLE) is an autoimmune",
            "probability": 0.0001026783555040616,
            "start_logit": 1.3781260251998901,
            "end_logit": -3.222874402999878
        },
        {
            "text": "SLE)",
            "probability": 9.914611764257151e-05,
            "start_logit": -1.133387804031372,
            "end_logit": -0.7463672161102295
        },
        {
            "text": "SLE",
            "probability": 8.368557082680845e-05,
            "start_logit": -1.133387804031372,
            "end_logit": -0.9158953428268433
        },
        {
            "text": "targeting the type 1 IFN receptor",
            "probability": 8.240632778496409e-05,
            "start_logit": -2.6197667121887207,
            "end_logit": 0.5550792217254639
        },
        {
            "text": "IFN receptor",
            "probability": 7.233751473193189e-05,
            "start_logit": -2.7500860691070557,
            "end_logit": 0.5550792217254639
        }
    ],
    "5e2902e48b3851296d000006_009": [
        {
            "text": "moderate-to-severe SLE",
            "probability": 0.6474595203840037,
            "start_logit": 5.694167613983154,
            "end_logit": 7.231107711791992
        },
        {
            "text": "SLE",
            "probability": 0.20096046030230919,
            "start_logit": 4.524219512939453,
            "end_logit": 7.231107711791992
        },
        {
            "text": "systemic lupus erythematosus",
            "probability": 0.048822216214481455,
            "start_logit": 4.969362735748291,
            "end_logit": 5.371041774749756
        },
        {
            "text": "patients with moderate-to-severe SLE",
            "probability": 0.031327449145440806,
            "start_logit": 2.6656060218811035,
            "end_logit": 7.231107711791992
        },
        {
            "text": "moderate-to-severe systemic lupus erythematosus",
            "probability": 0.029118774810184423,
            "start_logit": 4.4525604248046875,
            "end_logit": 5.371041774749756
        },
        {
            "text": "systemic lupus erythematosus (SLE)",
            "probability": 0.00954201196846093,
            "start_logit": 4.969362735748291,
            "end_logit": 3.738560676574707
        },
        {
            "text": "moderate-to-severe systemic lupus erythematosus (SLE)",
            "probability": 0.005691091459778575,
            "start_logit": 4.4525604248046875,
            "end_logit": 3.738560676574707
        },
        {
            "text": "reduced disease activity compared with placebo across multiple clinical end points in the patients with moderate-to-severe SLE",
            "probability": 0.004322909959243358,
            "start_logit": 0.6850401163101196,
            "end_logit": 7.231107711791992
        },
        {
            "text": "moderate-to-severe SLE.",
            "probability": 0.00396489649509209,
            "start_logit": 5.694167613983154,
            "end_logit": 2.135531187057495
        },
        {
            "text": "the patients with moderate-to-severe SLE",
            "probability": 0.0025396274298882414,
            "start_logit": 0.1531287282705307,
            "end_logit": 7.231107711791992
        },
        {
            "text": "moderate-to-severe",
            "probability": 0.0022959767636489487,
            "start_logit": 5.694167613983154,
            "end_logit": 1.589209794998169
        },
        {
            "text": "substantially reduced disease activity compared with placebo across multiple clinical end points in the patients with moderate-to-severe SLE",
            "probability": 0.002064088212433256,
            "start_logit": -0.054200075566768646,
            "end_logit": 7.231107711791992
        },
        {
            "text": "disease activity compared with placebo across multiple clinical end points in the patients with moderate-to-severe SLE",
            "probability": 0.0019338261138181789,
            "start_logit": -0.11938817799091339,
            "end_logit": 7.231107711791992
        },
        {
            "text": "adults with moderate-to-severe systemic lupus erythematosus",
            "probability": 0.001896240241529027,
            "start_logit": 1.7210503816604614,
            "end_logit": 5.371041774749756
        },
        {
            "text": "lupus erythematosus",
            "probability": 0.0016165541382729056,
            "start_logit": 1.561474084854126,
            "end_logit": 5.371041774749756
        },
        {
            "text": "systemic lupus erythematosus (SLE",
            "probability": 0.001363042918121362,
            "start_logit": 4.969362735748291,
            "end_logit": 1.7925759553909302
        },
        {
            "text": "Anifrolumab substantially reduced disease activity compared with placebo across multiple clinical end points in the patients with moderate-to-severe SLE",
            "probability": 0.0013407328876915486,
            "start_logit": -0.485672265291214,
            "end_logit": 7.231107711791992
        },
        {
            "text": "severe SLE",
            "probability": 0.001325844222710526,
            "start_logit": -0.4968392550945282,
            "end_logit": 7.231107711791992
        },
        {
            "text": "SLE.",
            "probability": 0.0012306366647171234,
            "start_logit": 4.524219512939453,
            "end_logit": 2.135531187057495
        },
        {
            "text": "moderate-to-severe S",
            "probability": 0.001165639340042238,
            "start_logit": 5.694167613983154,
            "end_logit": 0.9113211631774902
        },
        {
            "text": "",
            "probability": 1.8460328132265452e-05,
            "start_logit": 1.1528756618499756,
            "end_logit": 1.3072121143341064
        }
    ],
    "5e2902e48b3851296d000006_010": [
        {
            "text": "moderate-to-severe SLE",
            "probability": 0.6474595203840037,
            "start_logit": 5.694167613983154,
            "end_logit": 7.231107711791992
        },
        {
            "text": "SLE",
            "probability": 0.20096046030230919,
            "start_logit": 4.524219512939453,
            "end_logit": 7.231107711791992
        },
        {
            "text": "systemic lupus erythematosus",
            "probability": 0.048822216214481455,
            "start_logit": 4.969362735748291,
            "end_logit": 5.371041774749756
        },
        {
            "text": "patients with moderate-to-severe SLE",
            "probability": 0.031327449145440806,
            "start_logit": 2.6656060218811035,
            "end_logit": 7.231107711791992
        },
        {
            "text": "moderate-to-severe systemic lupus erythematosus",
            "probability": 0.029118774810184423,
            "start_logit": 4.4525604248046875,
            "end_logit": 5.371041774749756
        },
        {
            "text": "systemic lupus erythematosus (SLE)",
            "probability": 0.00954201196846093,
            "start_logit": 4.969362735748291,
            "end_logit": 3.738560676574707
        },
        {
            "text": "moderate-to-severe systemic lupus erythematosus (SLE)",
            "probability": 0.005691091459778575,
            "start_logit": 4.4525604248046875,
            "end_logit": 3.738560676574707
        },
        {
            "text": "reduced disease activity compared with placebo across multiple clinical end points in the patients with moderate-to-severe SLE",
            "probability": 0.004322909959243358,
            "start_logit": 0.6850401163101196,
            "end_logit": 7.231107711791992
        },
        {
            "text": "moderate-to-severe SLE.",
            "probability": 0.00396489649509209,
            "start_logit": 5.694167613983154,
            "end_logit": 2.135531187057495
        },
        {
            "text": "the patients with moderate-to-severe SLE",
            "probability": 0.0025396274298882414,
            "start_logit": 0.1531287282705307,
            "end_logit": 7.231107711791992
        },
        {
            "text": "moderate-to-severe",
            "probability": 0.0022959767636489487,
            "start_logit": 5.694167613983154,
            "end_logit": 1.589209794998169
        },
        {
            "text": "substantially reduced disease activity compared with placebo across multiple clinical end points in the patients with moderate-to-severe SLE",
            "probability": 0.002064088212433256,
            "start_logit": -0.054200075566768646,
            "end_logit": 7.231107711791992
        },
        {
            "text": "disease activity compared with placebo across multiple clinical end points in the patients with moderate-to-severe SLE",
            "probability": 0.0019338261138181789,
            "start_logit": -0.11938817799091339,
            "end_logit": 7.231107711791992
        },
        {
            "text": "adults with moderate-to-severe systemic lupus erythematosus",
            "probability": 0.001896240241529027,
            "start_logit": 1.7210503816604614,
            "end_logit": 5.371041774749756
        },
        {
            "text": "lupus erythematosus",
            "probability": 0.0016165541382729056,
            "start_logit": 1.561474084854126,
            "end_logit": 5.371041774749756
        },
        {
            "text": "systemic lupus erythematosus (SLE",
            "probability": 0.001363042918121362,
            "start_logit": 4.969362735748291,
            "end_logit": 1.7925759553909302
        },
        {
            "text": "Anifrolumab substantially reduced disease activity compared with placebo across multiple clinical end points in the patients with moderate-to-severe SLE",
            "probability": 0.0013407328876915486,
            "start_logit": -0.485672265291214,
            "end_logit": 7.231107711791992
        },
        {
            "text": "severe SLE",
            "probability": 0.001325844222710526,
            "start_logit": -0.4968392550945282,
            "end_logit": 7.231107711791992
        },
        {
            "text": "SLE.",
            "probability": 0.0012306366647171234,
            "start_logit": 4.524219512939453,
            "end_logit": 2.135531187057495
        },
        {
            "text": "moderate-to-severe S",
            "probability": 0.001165639340042238,
            "start_logit": 5.694167613983154,
            "end_logit": 0.9113211631774902
        },
        {
            "text": "",
            "probability": 1.8460328132265452e-05,
            "start_logit": 1.1528756618499756,
            "end_logit": 1.3072121143341064
        }
    ],
    "5c7019557c78d6947100005f_002": [
        {
            "text": "",
            "probability": 0.2989373272190712,
            "start_logit": 0.9955861568450928,
            "end_logit": 1.4317413568496704
        },
        {
            "text": "activation",
            "probability": 0.23695501244148132,
            "start_logit": 0.9837297797203064,
            "end_logit": 1.2112340927124023
        },
        {
            "text": "activation of the IFN signature",
            "probability": 0.12806876192905364,
            "start_logit": 0.9837297797203064,
            "end_logit": 0.5959311127662659
        },
        {
            "text": "In SLE post-transplant, recurrent disease activity and induction of IRF7 protein expression correlated with activation",
            "probability": 0.06578385431271426,
            "start_logit": -0.2977660894393921,
            "end_logit": 1.2112340927124023
        },
        {
            "text": "SLE post-transplant, recurrent disease activity and induction of IRF7 protein expression correlated with activation",
            "probability": 0.03881130922292319,
            "start_logit": -0.82542884349823,
            "end_logit": 1.2112340927124023
        },
        {
            "text": "In SLE post-transplant, recurrent disease activity and induction of IRF7 protein expression correlated with activation of the IFN signature",
            "probability": 0.03555466790908744,
            "start_logit": -0.2977660894393921,
            "end_logit": 0.5959311127662659
        },
        {
            "text": "induction of IRF7 protein expression correlated with activation",
            "probability": 0.02097785859355065,
            "start_logit": -1.4406729936599731,
            "end_logit": 1.2112340927124023
        },
        {
            "text": "SLE post-transplant, recurrent disease activity and induction of IRF7 protein expression correlated with activation of the IFN signature",
            "probability": 0.020976624506953444,
            "start_logit": -0.82542884349823,
            "end_logit": 0.5959311127662659
        },
        {
            "text": "correlated with activation",
            "probability": 0.01962147705427756,
            "start_logit": -1.507515788078308,
            "end_logit": 1.2112340927124023
        },
        {
            "text": "IRF7 protein expression correlated with activation",
            "probability": 0.017481761539137584,
            "start_logit": -1.622982382774353,
            "end_logit": 1.2112340927124023
        },
        {
            "text": "activation of the IFN signature.",
            "probability": 0.0167884744439019,
            "start_logit": 0.9837297797203064,
            "end_logit": -1.435943603515625
        },
        {
            "text": "In SLE post-transplant",
            "probability": 0.013777150337142937,
            "start_logit": -0.2977660894393921,
            "end_logit": -0.35212889313697815
        },
        {
            "text": "recurrent disease activity and induction of IRF7 protein expression correlated with activation",
            "probability": 0.013257064751258128,
            "start_logit": -1.899609923362732,
            "end_logit": 1.2112340927124023
        },
        {
            "text": "post-transplant, recurrent disease activity and induction of IRF7 protein expression correlated with activation",
            "probability": 0.01222674344743174,
            "start_logit": -1.9805148839950562,
            "end_logit": 1.2112340927124023
        },
        {
            "text": "induction of IRF7 protein expression correlated with activation of the IFN signature",
            "probability": 0.011338052528693727,
            "start_logit": -1.4406729936599731,
            "end_logit": 0.5959311127662659
        },
        {
            "text": "activation of the IFN signature. This unique trend in regulation of IRF warrants further mechanistic investigation and confirmation with increased numbers",
            "probability": 0.010957723884959225,
            "start_logit": 0.9837297797203064,
            "end_logit": -1.8625916242599487
        },
        {
            "text": "correlated with activation of the IFN signature",
            "probability": 0.010604959345104593,
            "start_logit": -1.507515788078308,
            "end_logit": 0.5959311127662659
        },
        {
            "text": "This unique trend in regulation of IRF warrants further mechanistic investigation and confirmation with increased numbers of SLE patients.",
            "probability": 0.010304409710825128,
            "start_logit": -0.45783504843711853,
            "end_logit": -0.48249945044517517
        },
        {
            "text": "IRF7 protein expression correlated with activation of the IFN signature",
            "probability": 0.009448492072769345,
            "start_logit": -1.622982382774353,
            "end_logit": 0.5959311127662659
        },
        {
            "text": "SLE post-transplant",
            "probability": 0.008128274749663156,
            "start_logit": -0.82542884349823,
            "end_logit": -0.35212889313697815
        }
    ],
    "5c7019557c78d6947100005f_004": [
        {
            "text": "Ifit3 and Isg15",
            "probability": 0.24805210907782982,
            "start_logit": 0.7290852069854736,
            "end_logit": 0.46786922216415405
        },
        {
            "text": "",
            "probability": 0.19755247838738937,
            "start_logit": 0.319192498922348,
            "end_logit": 0.6501273512840271
        },
        {
            "text": "Ifit3",
            "probability": 0.1407168316790662,
            "start_logit": 0.7290852069854736,
            "end_logit": -0.09902003407478333
        },
        {
            "text": "Ifit3 and Isg15 in CD4+ from SLE-prone mice following TOFA and DEXA treatment, and IFIT3",
            "probability": 0.07831143870214906,
            "start_logit": 0.7290852069854736,
            "end_logit": -0.6850759387016296
        },
        {
            "text": "genes Ifit3 and Isg15",
            "probability": 0.06158220801850253,
            "start_logit": -0.6641806364059448,
            "end_logit": 0.46786922216415405
        },
        {
            "text": "genes Ifit3",
            "probability": 0.03493480959456746,
            "start_logit": -0.6641806364059448,
            "end_logit": -0.09902003407478333
        },
        {
            "text": "decreased expression of several IFN-signature genes Ifit3 and Isg15",
            "probability": 0.025287511715806555,
            "start_logit": -1.5542429685592651,
            "end_logit": 0.46786922216415405
        },
        {
            "text": "Ifit3 and Isg15 in CD4+",
            "probability": 0.02480572020434959,
            "start_logit": 0.7290852069854736,
            "end_logit": -1.8346953392028809
        },
        {
            "text": "IFIT3",
            "probability": 0.02299861687858248,
            "start_logit": -0.4961743950843811,
            "end_logit": -0.6850759387016296
        },
        {
            "text": "genes",
            "probability": 0.02285426476584926,
            "start_logit": -0.6641806364059448,
            "end_logit": -0.5233660340309143
        },
        {
            "text": "Isg15",
            "probability": 0.02035851005197481,
            "start_logit": -1.7710546255111694,
            "end_logit": 0.46786922216415405
        },
        {
            "text": "IFN-signature genes Ifit3 and Isg15",
            "probability": 0.020280877972699334,
            "start_logit": -1.7748751640319824,
            "end_logit": 0.46786922216415405
        },
        {
            "text": "Ifit3 and Isg15 in CD4+ from SLE-prone mice",
            "probability": 0.015704037740644643,
            "start_logit": 0.7290852069854736,
            "end_logit": -2.291851758956909
        },
        {
            "text": "Modulation of type I IFN signalling via JAK-STAT inhibition",
            "probability": 0.014727752098085438,
            "start_logit": -0.9839067459106445,
            "end_logit": -0.6430440545082092
        },
        {
            "text": "signature genes Ifit3 and Isg15",
            "probability": 0.014504567749683285,
            "start_logit": -2.1100900173187256,
            "end_logit": 0.46786922216415405
        },
        {
            "text": "decreased expression of several IFN-signature genes Ifit3",
            "probability": 0.014345286330861533,
            "start_logit": -1.5542429685592651,
            "end_logit": -0.09902003407478333
        },
        {
            "text": "Ifit3 and Isg15 in CD4+ from SLE-prone mice following TOFA and DEXA treatment",
            "probability": 0.01236733451735568,
            "start_logit": 0.7290852069854736,
            "end_logit": -2.5307109355926514
        },
        {
            "text": "IFN-signature genes Ifit3",
            "probability": 0.011505086179664675,
            "start_logit": -1.7748751640319824,
            "end_logit": -0.09902003407478333
        },
        {
            "text": "We also detected decreased expression of several IFN-signature genes Ifit3 and Isg15",
            "probability": 0.009725908017611133,
            "start_logit": -2.5097603797912598,
            "end_logit": 0.46786922216415405
        },
        {
            "text": "decreased expression of several IFN-signature genes",
            "probability": 0.009384650317327341,
            "start_logit": -1.5542429685592651,
            "end_logit": -0.5233660340309143
        }
    ],
    "5c7019557c78d6947100005f_005": [
        {
            "text": "Estrogens",
            "probability": 0.16396050931522094,
            "start_logit": 0.9297678470611572,
            "end_logit": 1.1259784698486328
        },
        {
            "text": "Estrogens are necessary but not sufficient",
            "probability": 0.09188812848457538,
            "start_logit": 0.9297678470611572,
            "end_logit": 0.5469247102737427
        },
        {
            "text": "IFN signature found in SLE patients",
            "probability": 0.08958359281337805,
            "start_logit": 0.3005078136920929,
            "end_logit": 1.1507850885391235
        },
        {
            "text": "resembling the IFN signature found in SLE patients",
            "probability": 0.08432794993444785,
            "start_logit": 0.24004898965358734,
            "end_logit": 1.1507850885391235
        },
        {
            "text": "female lupus-prone mice constitutively overexpress IFN-responsive genes",
            "probability": 0.0739647351217557,
            "start_logit": 0.03132154792547226,
            "end_logit": 1.2283875942230225
        },
        {
            "text": "female TCSle cDCs do",
            "probability": 0.05440726405561017,
            "start_logit": -0.3433017432689667,
            "end_logit": 1.2959201335906982
        },
        {
            "text": "female TCSle cDCs do. Estrogens",
            "probability": 0.04590417225051289,
            "start_logit": -0.3433017432689667,
            "end_logit": 1.1259784698486328
        },
        {
            "text": "that DCs from female lupus-prone mice constitutively overexpress IFN-responsive genes",
            "probability": 0.044404251255943473,
            "start_logit": -0.4789316654205322,
            "end_logit": 1.2283875942230225
        },
        {
            "text": "Estrogens are necessary but not sufficient to express this IFN signature",
            "probability": 0.043672895137388215,
            "start_logit": 0.9297678470611572,
            "end_logit": -0.19691947102546692
        },
        {
            "text": "female TCSle cDCs",
            "probability": 0.03746110145466388,
            "start_logit": -0.3433017432689667,
            "end_logit": 0.9227255582809448
        },
        {
            "text": "Type I",
            "probability": 0.03745258073028309,
            "start_logit": 1.0113096237182617,
            "end_logit": -0.43211328983306885
        },
        {
            "text": "",
            "probability": 0.029958905415079704,
            "start_logit": -0.0487467423081398,
            "end_logit": 0.4046940803527832
        },
        {
            "text": "female TCSle cDCs do.",
            "probability": 0.02807426710608149,
            "start_logit": -0.3433017432689667,
            "end_logit": 0.6342758536338806
        },
        {
            "text": "DCs from female lupus-prone mice constitutively overexpress IFN-responsive genes",
            "probability": 0.027556647146855285,
            "start_logit": -0.956023097038269,
            "end_logit": 1.2283875942230225
        },
        {
            "text": "constitutively overexpress IFN-responsive genes",
            "probability": 0.02603970449478499,
            "start_logit": -1.0126444101333618,
            "end_logit": 1.2283875942230225
        },
        {
            "text": "female TCSle cDCs do. Estrogens are necessary but not sufficient",
            "probability": 0.02572600253164519,
            "start_logit": -0.3433017432689667,
            "end_logit": 0.5469247102737427
        },
        {
            "text": "resembling",
            "probability": 0.024355975770525475,
            "start_logit": 0.24004898965358734,
            "end_logit": -0.09115104377269745
        },
        {
            "text": "constitutively overexpress IFN-responsive genes resembling the IFN signature found in SLE patients",
            "probability": 0.024095376207165304,
            "start_logit": -1.0126444101333618,
            "end_logit": 1.1507850885391235
        },
        {
            "text": "Type I interferons",
            "probability": 0.02369996838267606,
            "start_logit": 1.0113096237182617,
            "end_logit": -0.8897151947021484
        },
        {
            "text": "IFN signature",
            "probability": 0.02346597239140716,
            "start_logit": 0.3005078136920929,
            "end_logit": -0.18883571028709412
        }
    ],
    "5c7019557c78d6947100005f_008": [
        {
            "text": "positive",
            "probability": 0.18717735352041953,
            "start_logit": 3.2465713024139404,
            "end_logit": 3.0928452014923096
        },
        {
            "text": "The IFN-I signature was positive",
            "probability": 0.1504008702529894,
            "start_logit": 3.0278189182281494,
            "end_logit": 3.0928452014923096
        },
        {
            "text": "positive in 57%",
            "probability": 0.13458521451823835,
            "start_logit": 3.2465713024139404,
            "end_logit": 2.762986183166504
        },
        {
            "text": "The IFN-I signature was positive in 57%",
            "probability": 0.10814200011926176,
            "start_logit": 3.0278189182281494,
            "end_logit": 2.762986183166504
        },
        {
            "text": "IFN-I signature was positive",
            "probability": 0.0831693665729594,
            "start_logit": 2.435393810272217,
            "end_logit": 3.0928452014923096
        },
        {
            "text": "57%",
            "probability": 0.06180150987838861,
            "start_logit": 2.46830153465271,
            "end_logit": 2.762986183166504
        },
        {
            "text": "IFN-I signature was positive in 57%",
            "probability": 0.0598008617551409,
            "start_logit": 2.435393810272217,
            "end_logit": 2.762986183166504
        },
        {
            "text": "positive in 57% of cSLE patients and 15% of the HCs",
            "probability": 0.028321057288295957,
            "start_logit": 3.2465713024139404,
            "end_logit": 1.2043942213058472
        },
        {
            "text": "positive in 57% of cSLE patients and 15% of the HCs.",
            "probability": 0.027118416228981514,
            "start_logit": 3.2465713024139404,
            "end_logit": 1.1610016822814941
        },
        {
            "text": "The IFN-I signature was positive in 57% of cSLE patients and 15% of the HCs",
            "probability": 0.022756554585968123,
            "start_logit": 3.0278189182281494,
            "end_logit": 1.2043942213058472
        },
        {
            "text": "positive in 57% of cSLE patients",
            "probability": 0.022255214466779197,
            "start_logit": 3.2465713024139404,
            "end_logit": 0.9633649587631226
        },
        {
            "text": "The IFN-I signature was positive in 57% of cSLE patients and 15% of the HCs.",
            "probability": 0.02179020765071702,
            "start_logit": 3.0278189182281494,
            "end_logit": 1.1610016822814941
        },
        {
            "text": "The IFN-I signature was positive in 57% of cSLE patients",
            "probability": 0.017882524571036625,
            "start_logit": 3.0278189182281494,
            "end_logit": 0.9633649587631226
        },
        {
            "text": "57% of cSLE patients and 15% of the HCs",
            "probability": 0.013005025165909605,
            "start_logit": 2.46830153465271,
            "end_logit": 1.2043942213058472
        },
        {
            "text": "IFN-I signature was positive in 57% of cSLE patients and 15% of the HCs",
            "probability": 0.012584024461522852,
            "start_logit": 2.435393810272217,
            "end_logit": 1.2043942213058472
        },
        {
            "text": "57% of cSLE patients and 15% of the HCs.",
            "probability": 0.01245277257580577,
            "start_logit": 2.46830153465271,
            "end_logit": 1.1610016822814941
        },
        {
            "text": "IFN-I signature was positive in 57% of cSLE patients and 15% of the HCs.",
            "probability": 0.012049649478456841,
            "start_logit": 2.435393810272217,
            "end_logit": 1.1610016822814941
        },
        {
            "text": "57% of cSLE patients",
            "probability": 0.010219591072003851,
            "start_logit": 2.46830153465271,
            "end_logit": 0.9633649587631226
        },
        {
            "text": "IFN-I signature was positive in 57% of cSLE patients",
            "probability": 0.009888760874832352,
            "start_logit": 2.435393810272217,
            "end_logit": 0.9633649587631226
        },
        {
            "text": "The IFN-I signature",
            "probability": 0.00419403585449793,
            "start_logit": 3.0278189182281494,
            "end_logit": -0.4867955148220062
        },
        {
            "text": "",
            "probability": 0.0004049891077945136,
            "start_logit": -0.008985450491309166,
            "end_logit": 0.21245026588439941
        }
    ],
    "5c7019557c78d6947100005f_009": [
        {
            "text": "positive",
            "probability": 0.18717735352041953,
            "start_logit": 3.2465713024139404,
            "end_logit": 3.0928452014923096
        },
        {
            "text": "The IFN-I signature was positive",
            "probability": 0.1504008702529894,
            "start_logit": 3.0278189182281494,
            "end_logit": 3.0928452014923096
        },
        {
            "text": "positive in 57%",
            "probability": 0.13458521451823835,
            "start_logit": 3.2465713024139404,
            "end_logit": 2.762986183166504
        },
        {
            "text": "The IFN-I signature was positive in 57%",
            "probability": 0.10814200011926176,
            "start_logit": 3.0278189182281494,
            "end_logit": 2.762986183166504
        },
        {
            "text": "IFN-I signature was positive",
            "probability": 0.0831693665729594,
            "start_logit": 2.435393810272217,
            "end_logit": 3.0928452014923096
        },
        {
            "text": "57%",
            "probability": 0.06180150987838861,
            "start_logit": 2.46830153465271,
            "end_logit": 2.762986183166504
        },
        {
            "text": "IFN-I signature was positive in 57%",
            "probability": 0.0598008617551409,
            "start_logit": 2.435393810272217,
            "end_logit": 2.762986183166504
        },
        {
            "text": "positive in 57% of cSLE patients and 15% of the HCs",
            "probability": 0.028321057288295957,
            "start_logit": 3.2465713024139404,
            "end_logit": 1.2043942213058472
        },
        {
            "text": "positive in 57% of cSLE patients and 15% of the HCs.",
            "probability": 0.027118416228981514,
            "start_logit": 3.2465713024139404,
            "end_logit": 1.1610016822814941
        },
        {
            "text": "The IFN-I signature was positive in 57% of cSLE patients and 15% of the HCs",
            "probability": 0.022756554585968123,
            "start_logit": 3.0278189182281494,
            "end_logit": 1.2043942213058472
        },
        {
            "text": "positive in 57% of cSLE patients",
            "probability": 0.022255214466779197,
            "start_logit": 3.2465713024139404,
            "end_logit": 0.9633649587631226
        },
        {
            "text": "The IFN-I signature was positive in 57% of cSLE patients and 15% of the HCs.",
            "probability": 0.02179020765071702,
            "start_logit": 3.0278189182281494,
            "end_logit": 1.1610016822814941
        },
        {
            "text": "The IFN-I signature was positive in 57% of cSLE patients",
            "probability": 0.017882524571036625,
            "start_logit": 3.0278189182281494,
            "end_logit": 0.9633649587631226
        },
        {
            "text": "57% of cSLE patients and 15% of the HCs",
            "probability": 0.013005025165909605,
            "start_logit": 2.46830153465271,
            "end_logit": 1.2043942213058472
        },
        {
            "text": "IFN-I signature was positive in 57% of cSLE patients and 15% of the HCs",
            "probability": 0.012584024461522852,
            "start_logit": 2.435393810272217,
            "end_logit": 1.2043942213058472
        },
        {
            "text": "57% of cSLE patients and 15% of the HCs.",
            "probability": 0.01245277257580577,
            "start_logit": 2.46830153465271,
            "end_logit": 1.1610016822814941
        },
        {
            "text": "IFN-I signature was positive in 57% of cSLE patients and 15% of the HCs.",
            "probability": 0.012049649478456841,
            "start_logit": 2.435393810272217,
            "end_logit": 1.1610016822814941
        },
        {
            "text": "57% of cSLE patients",
            "probability": 0.010219591072003851,
            "start_logit": 2.46830153465271,
            "end_logit": 0.9633649587631226
        },
        {
            "text": "IFN-I signature was positive in 57% of cSLE patients",
            "probability": 0.009888760874832352,
            "start_logit": 2.435393810272217,
            "end_logit": 0.9633649587631226
        },
        {
            "text": "The IFN-I signature",
            "probability": 0.00419403585449793,
            "start_logit": 3.0278189182281494,
            "end_logit": -0.4867955148220062
        },
        {
            "text": "",
            "probability": 0.0004049891077945136,
            "start_logit": -0.008985450491309166,
            "end_logit": 0.21245026588439941
        }
    ],
    "5e2b253ffbd6abf43b000006_002": [
        {
            "text": "AZD5153 induced apoptosis activation and cell cycle arrest in prostate cancer cells",
            "probability": 0.28117133954286894,
            "start_logit": 2.0798451900482178,
            "end_logit": 1.8795897960662842
        },
        {
            "text": "AZD5153 induced apoptosis activation and cell cycle arrest in prostate cancer cells.",
            "probability": 0.20708411260719134,
            "start_logit": 2.0798451900482178,
            "end_logit": 1.573750615119934
        },
        {
            "text": "AZD5153 induced apoptosis activation and cell cycle arrest",
            "probability": 0.18609426151851563,
            "start_logit": 2.0798451900482178,
            "end_logit": 1.466878890991211
        },
        {
            "text": "induced apoptosis activation and cell cycle arrest in prostate cancer cells",
            "probability": 0.038539917631041774,
            "start_logit": 0.09257548302412033,
            "end_logit": 1.8795897960662842
        },
        {
            "text": "apoptosis activation and cell cycle arrest in prostate cancer cells",
            "probability": 0.03380238923570373,
            "start_logit": -0.038587555289268494,
            "end_logit": 1.8795897960662842
        },
        {
            "text": "AZD5153 induced apoptosis activation",
            "probability": 0.028959592520074236,
            "start_logit": 2.0798451900482178,
            "end_logit": -0.39347293972969055
        },
        {
            "text": "induced apoptosis activation and cell cycle arrest in prostate cancer cells.",
            "probability": 0.02838484411517236,
            "start_logit": 0.09257548302412033,
            "end_logit": 1.573750615119934
        },
        {
            "text": "AZD5153",
            "probability": 0.026397387078448405,
            "start_logit": 2.0798451900482178,
            "end_logit": -0.4861094057559967
        },
        {
            "text": "induced apoptosis activation and cell cycle arrest",
            "probability": 0.02550778298454437,
            "start_logit": 0.09257548302412033,
            "end_logit": 1.466878890991211
        },
        {
            "text": "apoptosis activation and cell cycle arrest in prostate cancer cells.",
            "probability": 0.024895630508639847,
            "start_logit": -0.038587555289268494,
            "end_logit": 1.573750615119934
        },
        {
            "text": "apoptosis activation and cell cycle arrest",
            "probability": 0.022372232790890952,
            "start_logit": -0.038587555289268494,
            "end_logit": 1.466878890991211
        },
        {
            "text": "AZD5153 induced apoptosis",
            "probability": 0.02093845726289603,
            "start_logit": 2.0798451900482178,
            "end_logit": -0.7177869081497192
        },
        {
            "text": "AZD5153 inhibited proliferation and survival of established and primary prostate cancer cells.",
            "probability": 0.01735532053181605,
            "start_logit": 0.3040671944618225,
            "end_logit": 0.870302677154541
        },
        {
            "text": "AZD5153 induced apoptosis activation and cell cycle arrest in prostate cancer cells. AZD5153",
            "probability": 0.012520159573890265,
            "start_logit": 2.0798451900482178,
            "end_logit": -1.2320343255996704
        },
        {
            "text": "inhibited proliferation and survival of established and primary prostate cancer cells. AZD5153 induced apoptosis activation and cell cycle arrest",
            "probability": 0.009561523828972825,
            "start_logit": -0.8886610269546509,
            "end_logit": 1.466878890991211
        },
        {
            "text": "AZD5153 induced apoptosis activation and cell cycle arrest in prostate cancer",
            "probability": 0.009415772034954474,
            "start_logit": 2.0798451900482178,
            "end_logit": -1.5169882774353027
        },
        {
            "text": "cell cycle arrest in prostate cancer cells",
            "probability": 0.008572438540356275,
            "start_logit": -1.410566806793213,
            "end_logit": 1.8795897960662842
        },
        {
            "text": "",
            "probability": 0.006439494129526937,
            "start_logit": -0.06556664407253265,
            "end_logit": 0.24848738312721252
        },
        {
            "text": "cell cycle arrest in prostate cancer cells.",
            "probability": 0.0063136443098913584,
            "start_logit": -1.410566806793213,
            "end_logit": 1.573750615119934
        },
        {
            "text": "cell cycle arrest",
            "probability": 0.005673699254604282,
            "start_logit": -1.410566806793213,
            "end_logit": 1.466878890991211
        }
    ],
    "5e29f959aa19d74431000004_002": [
        {
            "text": "by modulation of the DDR pathway and cell-cycle checkpoint abrogation",
            "probability": 0.16432832343562664,
            "start_logit": 0.8591218590736389,
            "end_logit": 0.5586309432983398
        },
        {
            "text": "by modulation of the DDR pathway and cell-cycle checkpoint abrogation.",
            "probability": 0.10041274076348942,
            "start_logit": 0.8591218590736389,
            "end_logit": 0.06605364382266998
        },
        {
            "text": "cell death",
            "probability": 0.08928273665615022,
            "start_logit": -0.4809577465057373,
            "end_logit": 1.2886523008346558
        },
        {
            "text": "by modulation of the DDR pathway",
            "probability": 0.08704612485239768,
            "start_logit": 0.8591218590736389,
            "end_logit": -0.07679730653762817
        },
        {
            "text": "in vitro and in vivo by modulation of the DDR pathway and cell-cycle checkpoint abrogation",
            "probability": 0.0775444081215922,
            "start_logit": 0.10810624063014984,
            "end_logit": 0.5586309432983398
        },
        {
            "text": "modulation of the DDR pathway and cell-cycle checkpoint abrogation",
            "probability": 0.05352570304763114,
            "start_logit": -0.26258257031440735,
            "end_logit": 0.5586309432983398
        },
        {
            "text": "LB100 sensitized ovarian carcinoma lines to cisplatin-mediated cell death",
            "probability": 0.048572614941058,
            "start_logit": -0.720563530921936,
            "end_logit": 0.9195098280906677
        },
        {
            "text": "in vitro and in vivo by modulation of the DDR pathway and cell-cycle checkpoint abrogation.",
            "probability": 0.04738347223156509,
            "start_logit": 0.10810624063014984,
            "end_logit": 0.06605364382266998
        },
        {
            "text": "in vitro and in vivo by modulation of the DDR pathway",
            "probability": 0.04107593925280685,
            "start_logit": 0.10810624063014984,
            "end_logit": -0.07679730653762817
        },
        {
            "text": "modulation of the DDR pathway and cell-cycle checkpoint abrogation.",
            "probability": 0.03270685437505088,
            "start_logit": -0.26258257031440735,
            "end_logit": 0.06605364382266998
        },
        {
            "text": "Sensitization via LB100 was mediated by abrogation of cell-cycle arrest",
            "probability": 0.032028976647226655,
            "start_logit": -0.44866839051246643,
            "end_logit": 0.23119580745697021
        },
        {
            "text": "Sensitization via LB100 was mediated by abrogation of cell-cycle arrest induced by cisplatin",
            "probability": 0.031914551552306464,
            "start_logit": -0.44866839051246643,
            "end_logit": 0.22761686146259308
        },
        {
            "text": "cell death. Sensitization via LB100 was mediated by abrogation of cell-cycle arrest",
            "probability": 0.03101130009619287,
            "start_logit": -0.4809577465057373,
            "end_logit": 0.23119580745697021
        },
        {
            "text": "cell death. Sensitization via LB100 was mediated by abrogation of cell-cycle arrest induced by cisplatin",
            "probability": 0.030900510700821646,
            "start_logit": -0.4809577465057373,
            "end_logit": 0.22761686146259308
        },
        {
            "text": "modulation of the DDR pathway",
            "probability": 0.02835302480355216,
            "start_logit": -0.26258257031440735,
            "end_logit": -0.07679730653762817
        },
        {
            "text": "in vivo by modulation of the DDR pathway and cell-cycle checkpoint abrogation",
            "probability": 0.025055724679558064,
            "start_logit": -1.0216422080993652,
            "end_logit": 0.5586309432983398
        },
        {
            "text": "in vitro and in vivo",
            "probability": 0.02372494137272544,
            "start_logit": 0.10810624063014984,
            "end_logit": -0.6256929636001587
        },
        {
            "text": "sensitized ovarian carcinoma lines to cisplatin-mediated cell death",
            "probability": 0.020609641822751008,
            "start_logit": -1.577864408493042,
            "end_logit": 0.9195098280906677
        },
        {
            "text": "cisplatin-mediated cell death",
            "probability": 0.01681194401570155,
            "start_logit": -1.7815338373184204,
            "end_logit": 0.9195098280906677
        },
        {
            "text": "in vivo by modulation of the DDR pathway and cell-cycle checkpoint abrogation.",
            "probability": 0.015310288173635524,
            "start_logit": -1.0216422080993652,
            "end_logit": 0.06605364382266998
        },
        {
            "text": "",
            "probability": 0.002400178458160551,
            "start_logit": -1.5645228624343872,
            "end_logit": -1.2440476417541504
        }
    ],
    "5e29f959aa19d74431000004_003": [
        {
            "text": "by modulation of the DDR pathway and cell-cycle checkpoint abrogation",
            "probability": 0.16432832343562664,
            "start_logit": 0.8591218590736389,
            "end_logit": 0.5586309432983398
        },
        {
            "text": "by modulation of the DDR pathway and cell-cycle checkpoint abrogation.",
            "probability": 0.10041274076348942,
            "start_logit": 0.8591218590736389,
            "end_logit": 0.06605364382266998
        },
        {
            "text": "cell death",
            "probability": 0.08928273665615022,
            "start_logit": -0.4809577465057373,
            "end_logit": 1.2886523008346558
        },
        {
            "text": "by modulation of the DDR pathway",
            "probability": 0.08704612485239768,
            "start_logit": 0.8591218590736389,
            "end_logit": -0.07679730653762817
        },
        {
            "text": "in vitro and in vivo by modulation of the DDR pathway and cell-cycle checkpoint abrogation",
            "probability": 0.0775444081215922,
            "start_logit": 0.10810624063014984,
            "end_logit": 0.5586309432983398
        },
        {
            "text": "modulation of the DDR pathway and cell-cycle checkpoint abrogation",
            "probability": 0.05352570304763114,
            "start_logit": -0.26258257031440735,
            "end_logit": 0.5586309432983398
        },
        {
            "text": "LB100 sensitized ovarian carcinoma lines to cisplatin-mediated cell death",
            "probability": 0.048572614941058,
            "start_logit": -0.720563530921936,
            "end_logit": 0.9195098280906677
        },
        {
            "text": "in vitro and in vivo by modulation of the DDR pathway and cell-cycle checkpoint abrogation.",
            "probability": 0.04738347223156509,
            "start_logit": 0.10810624063014984,
            "end_logit": 0.06605364382266998
        },
        {
            "text": "in vitro and in vivo by modulation of the DDR pathway",
            "probability": 0.04107593925280685,
            "start_logit": 0.10810624063014984,
            "end_logit": -0.07679730653762817
        },
        {
            "text": "modulation of the DDR pathway and cell-cycle checkpoint abrogation.",
            "probability": 0.03270685437505088,
            "start_logit": -0.26258257031440735,
            "end_logit": 0.06605364382266998
        },
        {
            "text": "Sensitization via LB100 was mediated by abrogation of cell-cycle arrest",
            "probability": 0.032028976647226655,
            "start_logit": -0.44866839051246643,
            "end_logit": 0.23119580745697021
        },
        {
            "text": "Sensitization via LB100 was mediated by abrogation of cell-cycle arrest induced by cisplatin",
            "probability": 0.031914551552306464,
            "start_logit": -0.44866839051246643,
            "end_logit": 0.22761686146259308
        },
        {
            "text": "cell death. Sensitization via LB100 was mediated by abrogation of cell-cycle arrest",
            "probability": 0.03101130009619287,
            "start_logit": -0.4809577465057373,
            "end_logit": 0.23119580745697021
        },
        {
            "text": "cell death. Sensitization via LB100 was mediated by abrogation of cell-cycle arrest induced by cisplatin",
            "probability": 0.030900510700821646,
            "start_logit": -0.4809577465057373,
            "end_logit": 0.22761686146259308
        },
        {
            "text": "modulation of the DDR pathway",
            "probability": 0.02835302480355216,
            "start_logit": -0.26258257031440735,
            "end_logit": -0.07679730653762817
        },
        {
            "text": "in vivo by modulation of the DDR pathway and cell-cycle checkpoint abrogation",
            "probability": 0.025055724679558064,
            "start_logit": -1.0216422080993652,
            "end_logit": 0.5586309432983398
        },
        {
            "text": "in vitro and in vivo",
            "probability": 0.02372494137272544,
            "start_logit": 0.10810624063014984,
            "end_logit": -0.6256929636001587
        },
        {
            "text": "sensitized ovarian carcinoma lines to cisplatin-mediated cell death",
            "probability": 0.020609641822751008,
            "start_logit": -1.577864408493042,
            "end_logit": 0.9195098280906677
        },
        {
            "text": "cisplatin-mediated cell death",
            "probability": 0.01681194401570155,
            "start_logit": -1.7815338373184204,
            "end_logit": 0.9195098280906677
        },
        {
            "text": "in vivo by modulation of the DDR pathway and cell-cycle checkpoint abrogation.",
            "probability": 0.015310288173635524,
            "start_logit": -1.0216422080993652,
            "end_logit": 0.06605364382266998
        },
        {
            "text": "",
            "probability": 0.002400178458160551,
            "start_logit": -1.5645228624343872,
            "end_logit": -1.2440476417541504
        }
    ],
    "5e46e8c13f5415952900000c_001": [
        {
            "text": "different",
            "probability": 0.19763927885372187,
            "start_logit": 0.33029764890670776,
            "end_logit": -1.212988018989563
        },
        {
            "text": "different UV-induced DNA lesions reported in the literature",
            "probability": 0.17764655576449917,
            "start_logit": 0.33029764890670776,
            "end_logit": -1.3196356296539307
        },
        {
            "text": "",
            "probability": 0.11407361856669268,
            "start_logit": -0.9275788068771362,
            "end_logit": -0.5047110915184021
        },
        {
            "text": "different UV-induced DNA lesions",
            "probability": 0.09713918896684963,
            "start_logit": 0.33029764890670776,
            "end_logit": -1.9232866764068604
        },
        {
            "text": "different UV-induced DNA lesions reported in the literature.",
            "probability": 0.05599408708581239,
            "start_logit": 0.33029764890670776,
            "end_logit": -2.4741854667663574
        },
        {
            "text": "different UV-induced DNA lesions reported in the literature. Additional information on mutagenesis, repair and photoprotection",
            "probability": 0.05131516527919199,
            "start_logit": 0.33029764890670776,
            "end_logit": -2.5614452362060547
        },
        {
            "text": "quantitative formation of the different",
            "probability": 0.04507437306381861,
            "start_logit": -1.1478320360183716,
            "end_logit": -1.212988018989563
        },
        {
            "text": "quantitative formation of the different UV-induced DNA lesions reported in the literature",
            "probability": 0.04051475584444889,
            "start_logit": -1.1478320360183716,
            "end_logit": -1.3196356296539307
        },
        {
            "text": "the quantitative formation of the different",
            "probability": 0.027600395419804698,
            "start_logit": -1.6383157968521118,
            "end_logit": -1.212988018989563
        },
        {
            "text": "the quantitative formation of the different UV-induced DNA lesions reported in the literature",
            "probability": 0.024808404546423635,
            "start_logit": -1.6383157968521118,
            "end_logit": -1.3196356296539307
        },
        {
            "text": "quantitative formation of the different UV-induced DNA lesions",
            "probability": 0.02215393654542319,
            "start_logit": -1.1478320360183716,
            "end_logit": -1.9232866764068604
        },
        {
            "text": "quantitative formation",
            "probability": 0.020711352531390545,
            "start_logit": -1.1478320360183716,
            "end_logit": -1.9906198978424072
        },
        {
            "text": "discussing the quantitative formation of the different",
            "probability": 0.020615666501855194,
            "start_logit": -1.930094599723816,
            "end_logit": -1.212988018989563
        },
        {
            "text": "discussing the quantitative formation of the different UV-induced DNA lesions reported in the literature",
            "probability": 0.018530234324294938,
            "start_logit": -1.930094599723816,
            "end_logit": -1.3196356296539307
        },
        {
            "text": "quantitative",
            "probability": 0.018251337352074872,
            "start_logit": -1.1478320360183716,
            "end_logit": -2.117063522338867
        },
        {
            "text": "cyclobutane pyrimidine dimers",
            "probability": 0.01721058228820804,
            "start_logit": -0.943550705909729,
            "end_logit": -2.380058765411377
        },
        {
            "text": "the quantitative formation of the different UV-induced DNA lesions",
            "probability": 0.01356552220689147,
            "start_logit": -1.6383157968521118,
            "end_logit": -1.9232866764068604
        },
        {
            "text": "quantitative formation of the different UV-induced DNA lesions reported in the literature.",
            "probability": 0.012770226572936753,
            "start_logit": -1.1478320360183716,
            "end_logit": -2.4741854667663574
        },
        {
            "text": "the quantitative formation",
            "probability": 0.012682184591585835,
            "start_logit": -1.6383157968521118,
            "end_logit": -1.9906198978424072
        },
        {
            "text": "quantitative formation of the different UV-induced DNA lesions reported in the literature. Additional information on mutagenesis, repair and photoprotection",
            "probability": 0.011703133694075682,
            "start_logit": -1.1478320360183716,
            "end_logit": -2.5614452362060547
        }
    ],
    "5e46e8c13f5415952900000c_002": [
        {
            "text": "different",
            "probability": 0.19763927885372187,
            "start_logit": 0.33029764890670776,
            "end_logit": -1.212988018989563
        },
        {
            "text": "different UV-induced DNA lesions reported in the literature",
            "probability": 0.17764655576449917,
            "start_logit": 0.33029764890670776,
            "end_logit": -1.3196356296539307
        },
        {
            "text": "",
            "probability": 0.11407361856669268,
            "start_logit": -0.9275788068771362,
            "end_logit": -0.5047110915184021
        },
        {
            "text": "different UV-induced DNA lesions",
            "probability": 0.09713918896684963,
            "start_logit": 0.33029764890670776,
            "end_logit": -1.9232866764068604
        },
        {
            "text": "different UV-induced DNA lesions reported in the literature.",
            "probability": 0.05599408708581239,
            "start_logit": 0.33029764890670776,
            "end_logit": -2.4741854667663574
        },
        {
            "text": "different UV-induced DNA lesions reported in the literature. Additional information on mutagenesis, repair and photoprotection",
            "probability": 0.05131516527919199,
            "start_logit": 0.33029764890670776,
            "end_logit": -2.5614452362060547
        },
        {
            "text": "quantitative formation of the different",
            "probability": 0.04507437306381861,
            "start_logit": -1.1478320360183716,
            "end_logit": -1.212988018989563
        },
        {
            "text": "quantitative formation of the different UV-induced DNA lesions reported in the literature",
            "probability": 0.04051475584444889,
            "start_logit": -1.1478320360183716,
            "end_logit": -1.3196356296539307
        },
        {
            "text": "the quantitative formation of the different",
            "probability": 0.027600395419804698,
            "start_logit": -1.6383157968521118,
            "end_logit": -1.212988018989563
        },
        {
            "text": "the quantitative formation of the different UV-induced DNA lesions reported in the literature",
            "probability": 0.024808404546423635,
            "start_logit": -1.6383157968521118,
            "end_logit": -1.3196356296539307
        },
        {
            "text": "quantitative formation of the different UV-induced DNA lesions",
            "probability": 0.02215393654542319,
            "start_logit": -1.1478320360183716,
            "end_logit": -1.9232866764068604
        },
        {
            "text": "quantitative formation",
            "probability": 0.020711352531390545,
            "start_logit": -1.1478320360183716,
            "end_logit": -1.9906198978424072
        },
        {
            "text": "discussing the quantitative formation of the different",
            "probability": 0.020615666501855194,
            "start_logit": -1.930094599723816,
            "end_logit": -1.212988018989563
        },
        {
            "text": "discussing the quantitative formation of the different UV-induced DNA lesions reported in the literature",
            "probability": 0.018530234324294938,
            "start_logit": -1.930094599723816,
            "end_logit": -1.3196356296539307
        },
        {
            "text": "quantitative",
            "probability": 0.018251337352074872,
            "start_logit": -1.1478320360183716,
            "end_logit": -2.117063522338867
        },
        {
            "text": "cyclobutane pyrimidine dimers",
            "probability": 0.01721058228820804,
            "start_logit": -0.943550705909729,
            "end_logit": -2.380058765411377
        },
        {
            "text": "the quantitative formation of the different UV-induced DNA lesions",
            "probability": 0.01356552220689147,
            "start_logit": -1.6383157968521118,
            "end_logit": -1.9232866764068604
        },
        {
            "text": "quantitative formation of the different UV-induced DNA lesions reported in the literature.",
            "probability": 0.012770226572936753,
            "start_logit": -1.1478320360183716,
            "end_logit": -2.4741854667663574
        },
        {
            "text": "the quantitative formation",
            "probability": 0.012682184591585835,
            "start_logit": -1.6383157968521118,
            "end_logit": -1.9906198978424072
        },
        {
            "text": "quantitative formation of the different UV-induced DNA lesions reported in the literature. Additional information on mutagenesis, repair and photoprotection",
            "probability": 0.011703133694075682,
            "start_logit": -1.1478320360183716,
            "end_logit": -2.5614452362060547
        }
    ],
    "5e46e8c13f5415952900000c_003": [
        {
            "text": "cyclobutane pyrimidine dimer (CPD) and a (6-4) photoproduct",
            "probability": 0.3281954559412991,
            "start_logit": 3.5636117458343506,
            "end_logit": 1.7803637981414795
        },
        {
            "text": "deoxyribonucleic acid",
            "probability": 0.28463173699346056,
            "start_logit": 2.6291019916534424,
            "end_logit": 2.572460412979126
        },
        {
            "text": "cyclobutane pyrimidine dimer",
            "probability": 0.09278241956285603,
            "start_logit": 3.5636117458343506,
            "end_logit": 0.5170116424560547
        },
        {
            "text": "cyclobutane pyrimidine dimer (CPD)",
            "probability": 0.08094010954121987,
            "start_logit": 3.5636117458343506,
            "end_logit": 0.38046395778656006
        },
        {
            "text": "CPD) and a (6-4) photoproduct ((6-4)pp)",
            "probability": 0.06253183767092296,
            "start_logit": -0.23507025837898254,
            "end_logit": 3.921112298965454
        },
        {
            "text": "deoxyribonucleic acid (DNA) lesions such as a cyclobutane pyrimidine dimer",
            "probability": 0.03644292810468245,
            "start_logit": 2.6291019916534424,
            "end_logit": 0.5170116424560547
        },
        {
            "text": "cyclobutane pyrimidine dimer (CPD",
            "probability": 0.03228036220725077,
            "start_logit": 3.5636117458343506,
            "end_logit": -0.5387864708900452
        },
        {
            "text": "a cyclobutane pyrimidine dimer",
            "probability": 0.014989893301745034,
            "start_logit": 1.7407307624816895,
            "end_logit": 0.5170116424560547
        },
        {
            "text": "a cyclobutane pyrimidine dimer (CPD)",
            "probability": 0.013076654085664307,
            "start_logit": 1.7407307624816895,
            "end_logit": 0.38046395778656006
        },
        {
            "text": "(6-4) photoproduct ((6-4)pp)",
            "probability": 0.008423564993811486,
            "start_logit": -2.239712953567505,
            "end_logit": 3.921112298965454
        },
        {
            "text": "(6-4)pp)",
            "probability": 0.007490028819964148,
            "start_logit": -2.357173442840576,
            "end_logit": 3.921112298965454
        },
        {
            "text": "CPD) and a (6-4) photoproduct",
            "probability": 0.00735166875500218,
            "start_logit": -0.23507025837898254,
            "end_logit": 1.7803637981414795
        },
        {
            "text": "",
            "probability": 0.005707344694388784,
            "start_logit": 0.5200164914131165,
            "end_logit": 0.7721036076545715
        },
        {
            "text": "a cyclobutane pyrimidine dimer (CPD",
            "probability": 0.005215203348955186,
            "start_logit": 1.7407307624816895,
            "end_logit": -0.5387864708900452
        },
        {
            "text": "6-4) photoproduct ((6-4)pp)",
            "probability": 0.004260712409624036,
            "start_logit": -2.92130970954895,
            "end_logit": 3.921112298965454
        },
        {
            "text": "deoxyribonucleic acid (DNA)",
            "probability": 0.004136254126992763,
            "start_logit": 2.6291019916534424,
            "end_logit": -1.6589452028274536
        },
        {
            "text": "a (6-4) photoproduct ((6-4)pp)",
            "probability": 0.0040743664085886614,
            "start_logit": -2.9660308361053467,
            "end_logit": 3.921112298965454
        },
        {
            "text": "dimer (CPD) and a (6-4) photoproduct ((6-4)pp)",
            "probability": 0.002702340274985352,
            "start_logit": -3.3766279220581055,
            "end_logit": 3.921112298965454
        },
        {
            "text": "6-4)pp)",
            "probability": 0.0024632041051320286,
            "start_logit": -3.469283103942871,
            "end_logit": 3.921112298965454
        },
        {
            "text": "deoxyribonucleic acid (DNA) lesions",
            "probability": 0.002303914653454111,
            "start_logit": 2.6291019916534424,
            "end_logit": -2.244126081466675
        }
    ],
    "5e46e8c13f5415952900000c_004": [
        {
            "text": "bulky",
            "probability": 0.6177602392473289,
            "start_logit": 4.178768157958984,
            "end_logit": 3.8978610038757324
        },
        {
            "text": "bulky DNA lesions",
            "probability": 0.23717275260435863,
            "start_logit": 4.178768157958984,
            "end_logit": 2.940549373626709
        },
        {
            "text": "bulky DNA lesions such as those generated by UV light: cyclobutane pyrimidine dimers",
            "probability": 0.04108672417243131,
            "start_logit": 4.178768157958984,
            "end_logit": 1.1874456405639648
        },
        {
            "text": "cyclobutane pyrimidine dimers",
            "probability": 0.037755956783957684,
            "start_logit": 4.094226360321045,
            "end_logit": 1.1874456405639648
        },
        {
            "text": "cyclobutane pyrimidine dimers (CPDs)",
            "probability": 0.01518265256524558,
            "start_logit": 4.094226360321045,
            "end_logit": 0.2764558792114258
        },
        {
            "text": "cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone",
            "probability": 0.008576749205619716,
            "start_logit": 4.094226360321045,
            "end_logit": -0.2946426570415497
        },
        {
            "text": "bulky DNA",
            "probability": 0.007567127917593324,
            "start_logit": 4.178768157958984,
            "end_logit": -0.5044258236885071
        },
        {
            "text": "bulky DNA lesions such",
            "probability": 0.005609645518085555,
            "start_logit": 4.178768157958984,
            "end_logit": -0.8037518858909607
        },
        {
            "text": "",
            "probability": 0.005474376646590748,
            "start_logit": 1.4001535177230835,
            "end_logit": 1.9504536390304565
        },
        {
            "text": "CPDs) and pyrimidine-pyrimidone photoproducts (6-4 PPs)",
            "probability": 0.004621117668967331,
            "start_logit": -0.6110981702804565,
            "end_logit": 3.7922635078430176
        },
        {
            "text": "cyclobutane pyrimidine dimers (CPDs",
            "probability": 0.0029938121172163085,
            "start_logit": 4.094226360321045,
            "end_logit": -1.3471500873565674
        },
        {
            "text": "NER), the system responsible for removing bulky",
            "probability": 0.0026730057193828606,
            "start_logit": -1.2641286849975586,
            "end_logit": 3.8978610038757324
        },
        {
            "text": "CPDs) and pyrimidine-pyrimidone photoproducts",
            "probability": 0.0025224575613324307,
            "start_logit": -0.6110981702804565,
            "end_logit": 3.1868605613708496
        },
        {
            "text": "pyrimidine-pyrimidone photoproducts (6-4 PPs)",
            "probability": 0.002464238155449016,
            "start_logit": -1.2398520708084106,
            "end_logit": 3.7922635078430176
        },
        {
            "text": "bulky DNA lesions such as",
            "probability": 0.002026140630123795,
            "start_logit": 4.178768157958984,
            "end_logit": -1.8221065998077393
        },
        {
            "text": "nucleotide excision repair (NER), the system responsible for removing bulky",
            "probability": 0.0016700390230409278,
            "start_logit": -1.7344852685928345,
            "end_logit": 3.8978610038757324
        },
        {
            "text": "removing bulky",
            "probability": 0.0015536351784779326,
            "start_logit": -1.8067348003387451,
            "end_logit": 3.8978610038757324
        },
        {
            "text": "pyrimidine-pyrimidone photoproducts",
            "probability": 0.0013451153191529337,
            "start_logit": -1.2398520708084106,
            "end_logit": 3.1868605613708496
        },
        {
            "text": "NER), the system responsible for removing bulky DNA lesions",
            "probability": 0.0010262300548278091,
            "start_logit": -1.2641286849975586,
            "end_logit": 2.940549373626709
        },
        {
            "text": "bulk",
            "probability": 0.0009179839108174247,
            "start_logit": 4.178768157958984,
            "end_logit": -2.6138148307800293
        }
    ],
    "5e2903978b3851296d000007_001": [
        {
            "text": "",
            "probability": 0.9398573620658593,
            "start_logit": 0.2731036841869354,
            "end_logit": 0.5707479119300842
        },
        {
            "text": "A method for the detection of Sotatercept (ACE-011, ACVR2A-Fc) in human serum",
            "probability": 0.008039468035132315,
            "start_logit": -1.5061864852905273,
            "end_logit": -2.4113271236419678
        },
        {
            "text": "erythropoiesis stimulating fusion protein",
            "probability": 0.007462565906239558,
            "start_logit": -1.721257209777832,
            "end_logit": -2.2707200050354004
        },
        {
            "text": "erythropoiesis stimulating",
            "probability": 0.00539799559087207,
            "start_logit": -1.721257209777832,
            "end_logit": -2.5945916175842285
        },
        {
            "text": "A method for the detection of Sotatercept",
            "probability": 0.004672990540291912,
            "start_logit": -1.5061864852905273,
            "end_logit": -2.953890800476074
        },
        {
            "text": "erythropoiesis",
            "probability": 0.004075925730164823,
            "start_logit": -1.721257209777832,
            "end_logit": -2.875521421432495
        },
        {
            "text": "erythropoiesis stimulating fusion protein.",
            "probability": 0.003912472511940451,
            "start_logit": -1.721257209777832,
            "end_logit": -2.916449785232544
        },
        {
            "text": "detection of Sotatercept (ACE-011, ACVR2A-Fc) in human serum is presented",
            "probability": 0.0029782459322836917,
            "start_logit": -2.8692166805267334,
            "end_logit": -2.041325330734253
        },
        {
            "text": "The adapted protocol allows the detection of 0.1\u00a0ng/mL Sotatercept in just 50\u00a0\u03bcL human serum.",
            "probability": 0.002682629909599288,
            "start_logit": -1.9101892709732056,
            "end_logit": -3.1048896312713623
        },
        {
            "text": "Sotatercept (ACE-011, ACVR2A-Fc) in human serum is presented",
            "probability": 0.0024758374730484796,
            "start_logit": -3.0539724826812744,
            "end_logit": -2.041325330734253
        },
        {
            "text": "method for the detection of Sotatercept (ACE-011, ACVR2A-Fc) in human serum is presented",
            "probability": 0.0024348841693774765,
            "start_logit": -3.0706520080566406,
            "end_logit": -2.041325330734253
        },
        {
            "text": "immunoprecipitation followed by SAR-PAGE and Western single blotting",
            "probability": 0.002118010588607163,
            "start_logit": -2.7997238636016846,
            "end_logit": -2.4516754150390625
        },
        {
            "text": "detection of Sotatercept (ACE-011, ACVR2A-Fc) in human serum",
            "probability": 0.0020571730221847113,
            "start_logit": -2.8692166805267334,
            "end_logit": -2.4113271236419678
        },
        {
            "text": "immunoprecipitation followed by SAR-PAGE and Western single blotting.",
            "probability": 0.001937054475744834,
            "start_logit": -2.7997238636016846,
            "end_logit": -2.5409841537475586
        },
        {
            "text": "presented",
            "probability": 0.0019064613406163246,
            "start_logit": -3.3153023719787598,
            "end_logit": -2.041325330734253
        },
        {
            "text": "Sotatercept (ACE-011, ACVR2A-Fc) in human serum",
            "probability": 0.001710142873581921,
            "start_logit": -3.0539724826812744,
            "end_logit": -2.4113271236419678
        },
        {
            "text": "method for the detection of Sotatercept (ACE-011, ACVR2A-Fc) in human serum",
            "probability": 0.0016818550715008063,
            "start_logit": -3.0706520080566406,
            "end_logit": -2.4113271236419678
        },
        {
            "text": "detection of Sotatercept (ACE-011, ACVR2A-Fc) in human serum is presented.",
            "probability": 0.0016440410531014537,
            "start_logit": -2.8692166805267334,
            "end_logit": -2.635502576828003
        },
        {
            "text": "ACE-536, ACVR2B-Fc), another erythropoiesis stimulating fusion protein",
            "probability": 0.0015218080853272834,
            "start_logit": -3.3112573623657227,
            "end_logit": -2.2707200050354004
        },
        {
            "text": "IPG-IEF/2D-PAGE generated discrete isoforms.",
            "probability": 0.0014330756245262552,
            "start_logit": -3.0329530239105225,
            "end_logit": -2.609100580215454
        }
    ],
    "5e2903978b3851296d000007_002": [
        {
            "text": "",
            "probability": 0.9799390815188801,
            "start_logit": 1.4996485710144043,
            "end_logit": 1.950392723083496
        },
        {
            "text": "a modified ActRIIB-Fc",
            "probability": 0.0036928203204268243,
            "start_logit": -1.2724196910858154,
            "end_logit": -0.8586389422416687
        },
        {
            "text": "a modified ActRIIB-Fc) in particular are now in phase 2/3 of clinical trials against anemia",
            "probability": 0.0034231801073365343,
            "start_logit": -1.2724196910858154,
            "end_logit": -0.9344594478607178
        },
        {
            "text": "ActRIIB-Fc",
            "probability": 0.0014708495135095432,
            "start_logit": -2.192970037460327,
            "end_logit": -0.8586389422416687
        },
        {
            "text": "ActRIIB-Fc) in particular are now in phase 2/3 of clinical trials against anemia",
            "probability": 0.0013634518765184688,
            "start_logit": -2.192970037460327,
            "end_logit": -0.9344594478607178
        },
        {
            "text": "against anemia",
            "probability": 0.0011538283076443655,
            "start_logit": -2.3599042892456055,
            "end_logit": -0.9344594478607178
        },
        {
            "text": "this method is specific, sensitive, and easy to perform.",
            "probability": 0.001044618841529712,
            "start_logit": -1.5814570188522339,
            "end_logit": -1.8123400211334229
        },
        {
            "text": "Sotatercept (ActRIIA-Fc) and Luspatercept (a modified ActRIIB-Fc",
            "probability": 0.0010428661460665388,
            "start_logit": -2.536837339401245,
            "end_logit": -0.8586389422416687
        },
        {
            "text": "modified ActRIIB-Fc",
            "probability": 0.0008143197481066094,
            "start_logit": -2.784212350845337,
            "end_logit": -0.8586389422416687
        },
        {
            "text": "ActRIIA-Fc) and Luspatercept (a modified ActRIIB-Fc",
            "probability": 0.0007712052594753309,
            "start_logit": -2.838610887527466,
            "end_logit": -0.8586389422416687
        },
        {
            "text": "modified ActRIIB-Fc) in particular are now in phase 2/3 of clinical trials against anemia",
            "probability": 0.0007548602208752062,
            "start_logit": -2.784212350845337,
            "end_logit": -0.9344594478607178
        },
        {
            "text": "(a modified ActRIIB-Fc",
            "probability": 0.0007106027625135839,
            "start_logit": -2.9204518795013428,
            "end_logit": -0.8586389422416687
        },
        {
            "text": "(a modified ActRIIB-Fc) in particular are now in phase 2/3 of clinical trials against anemia",
            "probability": 0.0006587163820019631,
            "start_logit": -2.9204518795013428,
            "end_logit": -0.9344594478607178
        },
        {
            "text": "Luspatercept (a modified ActRIIB-Fc",
            "probability": 0.0006003786006013173,
            "start_logit": -3.0890049934387207,
            "end_logit": -0.8586389422416687
        },
        {
            "text": "anemia",
            "probability": 0.0005896513459054996,
            "start_logit": -3.0312135219573975,
            "end_logit": -0.9344594478607178
        },
        {
            "text": "Luspatercept (a modified ActRIIB-Fc) in particular are now in phase 2/3 of clinical trials against anemia",
            "probability": 0.0005565405040371502,
            "start_logit": -3.0890049934387207,
            "end_logit": -0.9344594478607178
        },
        {
            "text": "a modified ActRIIB-Fc)",
            "probability": 0.00041345337677651536,
            "start_logit": -1.2724196910858154,
            "end_logit": -3.0482399463653564
        },
        {
            "text": "this method is specific, sensitive, and easy to perform. It could easily be adopted by anti-doping laboratories.",
            "probability": 0.0004001922067871509,
            "start_logit": -1.5814570188522339,
            "end_logit": -2.7718024253845215
        },
        {
            "text": "this method is specific, sensitive, and easy to perform",
            "probability": 0.0003042796454758382,
            "start_logit": -1.5814570188522339,
            "end_logit": -3.04580020904541
        },
        {
            "text": "Starting from a few hundred microliters of serum or plasma, this method is specific, sensitive, and easy to perform.",
            "probability": 0.00029510331553204457,
            "start_logit": -2.845538854598999,
            "end_logit": -1.8123400211334229
        }
    ],
    "5e2903978b3851296d000007_003": [
        {
            "text": "",
            "probability": 0.37903547992971437,
            "start_logit": 0.6596691608428955,
            "end_logit": 0.9842053651809692
        },
        {
            "text": "The mechanism of the action of the novel drugs is incompletely understood",
            "probability": 0.32456954621976325,
            "start_logit": 0.14258413016796112,
            "end_logit": 1.3461604118347168
        },
        {
            "text": "incompletely understood",
            "probability": 0.10122645253935404,
            "start_logit": -1.0225555896759033,
            "end_logit": 1.3461604118347168
        },
        {
            "text": "mechanism of the action of the novel drugs is incompletely understood",
            "probability": 0.054080007180646754,
            "start_logit": -1.6494511365890503,
            "end_logit": 1.3461604118347168
        },
        {
            "text": "inactivation of soluble proteins of the transforming growth factor-\u00df (TGF\u00df) family",
            "probability": 0.029408326707417564,
            "start_logit": -0.5277642607688904,
            "end_logit": -0.38471317291259766
        },
        {
            "text": "action of the novel drugs is incompletely understood",
            "probability": 0.02463628927566367,
            "start_logit": -2.435695171356201,
            "end_logit": 1.3461604118347168
        },
        {
            "text": "it seems to be based on the inactivation of soluble proteins of the transforming growth factor-\u00df (TGF\u00df) family",
            "probability": 0.02151810130061064,
            "start_logit": -0.8401476144790649,
            "end_logit": -0.38471317291259766
        },
        {
            "text": "the novel drugs is incompletely understood",
            "probability": 0.012674227062644327,
            "start_logit": -3.1003451347351074,
            "end_logit": 1.3461604118347168
        },
        {
            "text": "The mechanism of the action of the novel drugs is incompletely understood,",
            "probability": 0.010538255120624507,
            "start_logit": 0.14258413016796112,
            "end_logit": -2.081327438354492
        },
        {
            "text": "is incompletely understood",
            "probability": 0.008996544157070041,
            "start_logit": -3.443075180053711,
            "end_logit": 1.3461604118347168
        },
        {
            "text": "based on the inactivation of soluble proteins of the transforming growth factor-\u00df (TGF\u00df) family",
            "probability": 0.006698611645384375,
            "start_logit": -2.0071418285369873,
            "end_logit": -0.38471317291259766
        },
        {
            "text": "the inactivation of soluble proteins of the transforming growth factor-\u00df (TGF\u00df) family",
            "probability": 0.004608762317268759,
            "start_logit": -2.381082773208618,
            "end_logit": -0.38471317291259766
        },
        {
            "text": "Sotatercept",
            "probability": 0.003493377495881308,
            "start_logit": -1.0586813688278198,
            "end_logit": -1.984204888343811
        },
        {
            "text": "incompletely understood,",
            "probability": 0.003286661346512202,
            "start_logit": -1.0225555896759033,
            "end_logit": -2.081327438354492
        },
        {
            "text": "but it seems to be based on the inactivation of soluble proteins of the transforming growth factor-\u00df (TGF\u00df) family",
            "probability": 0.003278794800816145,
            "start_logit": -2.7215662002563477,
            "end_logit": -0.38471317291259766
        },
        {
            "text": "inactivation of soluble proteins of the transforming growth factor-\u00df (TGF\u00df) family. This review",
            "probability": 0.0030254115656033476,
            "start_logit": -0.5277642607688904,
            "end_logit": -2.6589438915252686
        },
        {
            "text": "inactivation of soluble proteins of the transforming growth factor-\u00df",
            "probability": 0.002540244486349373,
            "start_logit": -0.5277642607688904,
            "end_logit": -2.833730697631836
        },
        {
            "text": "inactivation of soluble proteins of the transforming growth factor-\u00df (TGF\u00df) family.",
            "probability": 0.0023125108935507658,
            "start_logit": -0.5277642607688904,
            "end_logit": -2.927657127380371
        },
        {
            "text": "it seems to be based on the inactivation of soluble proteins of the transforming growth factor-\u00df (TGF\u00df) family. This review",
            "probability": 0.0022136965898257523,
            "start_logit": -0.8401476144790649,
            "end_logit": -2.6589438915252686
        },
        {
            "text": "it seems to be based on the inactivation of soluble proteins of the transforming growth factor-\u00df",
            "probability": 0.001858699365299027,
            "start_logit": -0.8401476144790649,
            "end_logit": -2.833730697631836
        }
    ],
    "5e2903978b3851296d000007_004": [
        {
            "text": "",
            "probability": 0.9999965719849667,
            "start_logit": 3.8760392665863037,
            "end_logit": 4.225973606109619
        },
        {
            "text": "activin receptor type II-Fc fusion proteins",
            "probability": 3.3861378982544723e-07,
            "start_logit": -3.189847946166992,
            "end_logit": -3.606541395187378
        },
        {
            "text": "Methods of identification of ActRII-Fc in blood by SAR/SDS-PAGE have been described",
            "probability": 3.1140184919629764e-07,
            "start_logit": -2.980985641479492,
            "end_logit": -3.899179697036743
        },
        {
            "text": "Methods of identification of ActRII-Fc in blood by SAR/SDS-PAGE have been described, but not by IEF",
            "probability": 2.83898057352741e-07,
            "start_logit": -2.980985641479492,
            "end_logit": -3.9916486740112305
        },
        {
            "text": "Methods of identification of ActRII-Fc in blood by SAR/SDS-PAGE have been described, but not by IEF.",
            "probability": 2.728946701640473e-07,
            "start_logit": -2.980985641479492,
            "end_logit": -4.031177997589111
        },
        {
            "text": "distinctive profiles for all the ESAs were obtained by IEF.",
            "probability": 2.4609921828515214e-07,
            "start_logit": -3.56398606300354,
            "end_logit": -3.5515286922454834
        },
        {
            "text": "distinctive profiles for all the ESAs were obtained by IEF",
            "probability": 2.3697377696800015e-07,
            "start_logit": -3.56398606300354,
            "end_logit": -3.5893139839172363
        },
        {
            "text": "Methods of identification of ActRII-Fc in blood by SAR/SDS-PAGE",
            "probability": 2.1366997937251512e-07,
            "start_logit": -2.980985641479492,
            "end_logit": -4.27583122253418
        },
        {
            "text": "Iso-electric focusing",
            "probability": 1.8538555158618812e-07,
            "start_logit": -3.521651029586792,
            "end_logit": -3.8771607875823975
        },
        {
            "text": "activin receptor type II-Fc fusion proteins (ActRII-Fc)",
            "probability": 1.8148174065245216e-07,
            "start_logit": -3.189847946166992,
            "end_logit": -4.230246543884277
        },
        {
            "text": "activin receptor type II-Fc fusion proteins (ActRII-Fc",
            "probability": 1.711181663011666e-07,
            "start_logit": -3.189847946166992,
            "end_logit": -4.2890472412109375
        },
        {
            "text": "luspatercept and sotatercept, both activin receptor type II-Fc fusion proteins",
            "probability": 1.5741778409277655e-07,
            "start_logit": -3.9558048248291016,
            "end_logit": -3.606541395187378
        },
        {
            "text": "both activin receptor type II-Fc fusion proteins",
            "probability": 1.4872999004466913e-07,
            "start_logit": -4.012575626373291,
            "end_logit": -3.606541395187378
        },
        {
            "text": "sotatercept, both activin receptor type II-Fc fusion proteins",
            "probability": 1.2364674728080585e-07,
            "start_logit": -4.197279453277588,
            "end_logit": -3.606541395187378
        },
        {
            "text": "luspatercept",
            "probability": 1.0776502874769354e-07,
            "start_logit": -3.9558048248291016,
            "end_logit": -3.9854915142059326
        },
        {
            "text": "luspatercept and sotatercept",
            "probability": 1.0160775251578178e-07,
            "start_logit": -3.9558048248291016,
            "end_logit": -4.04432487487793
        },
        {
            "text": "IEF.",
            "probability": 9.566802233768248e-08,
            "start_logit": -4.50883674621582,
            "end_logit": -3.5515286922454834
        },
        {
            "text": "IEF",
            "probability": 9.212062007507571e-08,
            "start_logit": -4.50883674621582,
            "end_logit": -3.5893139839172363
        },
        {
            "text": "sotatercept",
            "probability": 7.980971253975386e-08,
            "start_logit": -4.197279453277588,
            "end_logit": -4.04432487487793
        },
        {
            "text": "both activin receptor type II-Fc fusion proteins (ActRII-Fc)",
            "probability": 7.971257607211591e-08,
            "start_logit": -4.012575626373291,
            "end_logit": -4.230246543884277
        }
    ],
    "5e2903978b3851296d000007_005": [
        {
            "text": "",
            "probability": 0.9946954544137087,
            "start_logit": 2.2574586868286133,
            "end_logit": 2.47228741645813
        },
        {
            "text": "activin inhibitors such as Luspatercept have shown to be effective in patients' refractory to ESAs",
            "probability": 0.001079084359982415,
            "start_logit": -1.0355557203292847,
            "end_logit": -1.0610219240188599
        },
        {
            "text": "activin inhibitors",
            "probability": 0.0008287760586273809,
            "start_logit": -1.0355557203292847,
            "end_logit": -1.3249400854110718
        },
        {
            "text": "effective in patients' refractory to ESAs",
            "probability": 0.00046904398074488313,
            "start_logit": -1.8687273263931274,
            "end_logit": -1.0610219240188599
        },
        {
            "text": "shown to be effective in patients' refractory to ESAs",
            "probability": 0.00046809847197187615,
            "start_logit": -1.8707451820373535,
            "end_logit": -1.0610219240188599
        },
        {
            "text": "Recently, activin inhibitors such as Luspatercept have shown to be effective in patients' refractory to ESAs",
            "probability": 0.0003740114860499327,
            "start_logit": -2.095137357711792,
            "end_logit": -1.0610219240188599
        },
        {
            "text": "activin inhibitors such as Luspatercept have shown to be effective",
            "probability": 0.00031222847697106313,
            "start_logit": -1.0355557203292847,
            "end_logit": -2.301154851913452
        },
        {
            "text": "This review",
            "probability": 0.00028957042250943576,
            "start_logit": -2.007110357284546,
            "end_logit": -1.4049369096755981
        },
        {
            "text": "Recently, activin inhibitors",
            "probability": 0.0002872544323549312,
            "start_logit": -2.095137357711792,
            "end_logit": -1.3249400854110718
        },
        {
            "text": "have shown to be effective in patients' refractory to ESAs",
            "probability": 0.00019916712500043886,
            "start_logit": -2.7252795696258545,
            "end_logit": -1.0610219240188599
        },
        {
            "text": "effective",
            "probability": 0.00013571588392107366,
            "start_logit": -1.8687273263931274,
            "end_logit": -2.301154851913452
        },
        {
            "text": "shown to be effective",
            "probability": 0.00013544230497293327,
            "start_logit": -1.8707451820373535,
            "end_logit": -2.301154851913452
        },
        {
            "text": "review",
            "probability": 0.00012050743752331845,
            "start_logit": -2.8837974071502686,
            "end_logit": -1.4049369096755981
        },
        {
            "text": "patients' refractory to ESAs",
            "probability": 0.00011448121050408282,
            "start_logit": -3.279013156890869,
            "end_logit": -1.0610219240188599
        },
        {
            "text": "Recently, activin inhibitors such as Luspatercept have shown to be effective",
            "probability": 0.00010821863515931001,
            "start_logit": -2.095137357711792,
            "end_logit": -2.301154851913452
        },
        {
            "text": "activin inhibitors such as Luspatercept have shown to be effective in patients' refractory",
            "probability": 8.428916760477079e-05,
            "start_logit": -1.0355557203292847,
            "end_logit": -3.6106367111206055
        },
        {
            "text": "activin inhibitors such as Luspatercept have shown to be effective in patients' refractory to ESAs and",
            "probability": 8.316087516649221e-05,
            "start_logit": -1.0355557203292847,
            "end_logit": -3.624113082885742
        },
        {
            "text": "ESAs",
            "probability": 7.848973660582938e-05,
            "start_logit": -3.6564559936523438,
            "end_logit": -1.0610219240188599
        },
        {
            "text": "activin",
            "probability": 7.001599036337651e-05,
            "start_logit": -1.0355557203292847,
            "end_logit": -3.79616641998291
        },
        {
            "text": "inhibitors such as Luspatercept have shown to be effective in patients' refractory to ESAs",
            "probability": 6.698953025751058e-05,
            "start_logit": -3.814887523651123,
            "end_logit": -1.0610219240188599
        }
    ],
    "5e2903978b3851296d000007_007": [
        {
            "text": "",
            "probability": 0.9269073444181843,
            "start_logit": 1.878339171409607,
            "end_logit": 2.3731982707977295
        },
        {
            "text": "inhibit negative regulators of late-stage erythropoiesis",
            "probability": 0.051096587184791806,
            "start_logit": 0.6328660249710083,
            "end_logit": 0.7205355167388916
        },
        {
            "text": "they were found to inhibit negative regulators of late-stage erythropoiesis",
            "probability": 0.005364912800450738,
            "start_logit": -1.6209715604782104,
            "end_logit": 0.7205355167388916
        },
        {
            "text": "negative regulators of late-stage erythropoiesis",
            "probability": 0.005021680426467845,
            "start_logit": -1.687087059020996,
            "end_logit": 0.7205355167388916
        },
        {
            "text": "to inhibit negative regulators of late-stage erythropoiesis",
            "probability": 0.003574920888909596,
            "start_logit": -2.0269086360931396,
            "end_logit": 0.7205355167388916
        },
        {
            "text": "inhibit negative regulators of late-stage erythropoiesis.",
            "probability": 0.002187756242623639,
            "start_logit": 0.6328660249710083,
            "end_logit": -2.4303057193756104
        },
        {
            "text": "inhibit negative regulators",
            "probability": 0.0017118117919159644,
            "start_logit": 0.6328660249710083,
            "end_logit": -2.6756298542022705
        },
        {
            "text": "inhibit",
            "probability": 0.0012692569778554013,
            "start_logit": 0.6328660249710083,
            "end_logit": -2.974750518798828
        },
        {
            "text": "found to inhibit negative regulators of late-stage erythropoiesis",
            "probability": 0.0008034004382874198,
            "start_logit": -3.5197536945343018,
            "end_logit": 0.7205355167388916
        },
        {
            "text": "inhibit negative regulators of late-stage erythropoiesis. Within this study",
            "probability": 0.0004493943297652807,
            "start_logit": 0.6328660249710083,
            "end_logit": -4.013036727905273
        },
        {
            "text": "modified ActRIIB-Fc",
            "probability": 0.00025874129309516456,
            "start_logit": -2.3143818378448486,
            "end_logit": -1.6178609132766724
        },
        {
            "text": "they were found to inhibit negative regulators of late-stage erythropoiesis.",
            "probability": 0.00022970460684331112,
            "start_logit": -1.6209715604782104,
            "end_logit": -2.4303057193756104
        },
        {
            "text": "negative regulators of late-stage erythropoiesis.",
            "probability": 0.00021500873750597305,
            "start_logit": -1.687087059020996,
            "end_logit": -2.4303057193756104
        },
        {
            "text": "they were found to inhibit negative regulators",
            "probability": 0.00017973257120283521,
            "start_logit": -1.6209715604782104,
            "end_logit": -2.6756298542022705
        },
        {
            "text": "negative regulators",
            "probability": 0.0001682337753434104,
            "start_logit": -1.687087059020996,
            "end_logit": -2.6756298542022705
        },
        {
            "text": "to inhibit negative regulators of late-stage erythropoiesis.",
            "probability": 0.00015306414620829014,
            "start_logit": -2.0269086360931396,
            "end_logit": -2.4303057193756104
        },
        {
            "text": "they were found to inhibit",
            "probability": 0.0001332662978631301,
            "start_logit": -1.6209715604782104,
            "end_logit": -2.974750518798828
        },
        {
            "text": "to inhibit negative regulators",
            "probability": 0.0001197651755227903,
            "start_logit": -2.0269086360931396,
            "end_logit": -2.6756298542022705
        },
        {
            "text": "to inhibit",
            "probability": 8.880227689414178e-05,
            "start_logit": -2.0269086360931396,
            "end_logit": -2.974750518798828
        },
        {
            "text": "modified ActRIIB-Fc), have the potential for being misused as doping agents in sports as they were found to inhibit",
            "probability": 6.661562026882996e-05,
            "start_logit": -2.3143818378448486,
            "end_logit": -2.974750518798828
        }
    ],
    "5e2903978b3851296d000007_008": [
        {
            "text": "",
            "probability": 0.32425279931941364,
            "start_logit": 0.49602511525154114,
            "end_logit": 1.0945806503295898
        },
        {
            "text": "modifies transforming growth factor-\u03b2 signaling",
            "probability": 0.12581281373242395,
            "start_logit": -0.2890017032623291,
            "end_logit": 0.9328792095184326
        },
        {
            "text": "an activin-receptor trap that modifies transforming growth factor-\u03b2 signaling",
            "probability": 0.08686586478197364,
            "start_logit": -0.6594317555427551,
            "end_logit": 0.9328792095184326
        },
        {
            "text": "activin-receptor trap that modifies transforming growth factor-\u03b2 signaling",
            "probability": 0.0836590497206306,
            "start_logit": -0.6970472931861877,
            "end_logit": 0.9328792095184326
        },
        {
            "text": "An example is luspatercept, an activin-receptor trap that modifies transforming growth factor-\u03b2 signaling",
            "probability": 0.052876903473558536,
            "start_logit": -1.1558302640914917,
            "end_logit": 0.9328792095184326
        },
        {
            "text": "modifies transforming growth factor-\u03b2 signaling, thereby increasing the efficiency of erythropoiesis",
            "probability": 0.03879034443485091,
            "start_logit": -0.2890017032623291,
            "end_logit": -0.2437446266412735
        },
        {
            "text": "modifies transforming growth factor-\u03b2",
            "probability": 0.03332862207169583,
            "start_logit": -0.2890017032623291,
            "end_logit": -0.39549943804740906
        },
        {
            "text": "an activin-receptor trap",
            "probability": 0.027123757992969875,
            "start_logit": -0.6594317555427551,
            "end_logit": -0.23107591271400452
        },
        {
            "text": "an activin-receptor trap that modifies transforming growth factor-\u03b2 signaling, thereby increasing the efficiency of erythropoiesis",
            "probability": 0.026782302331225544,
            "start_logit": -0.6594317555427551,
            "end_logit": -0.2437446266412735
        },
        {
            "text": "transforming growth factor-\u03b2 signaling",
            "probability": 0.0264985125858329,
            "start_logit": -1.8467082977294922,
            "end_logit": 0.9328792095184326
        },
        {
            "text": "activin-receptor trap",
            "probability": 0.026122433987615244,
            "start_logit": -0.6970472931861877,
            "end_logit": -0.23107591271400452
        },
        {
            "text": "activin-receptor trap that modifies transforming growth factor-\u03b2 signaling, thereby increasing the efficiency of erythropoiesis",
            "probability": 0.025793583797094972,
            "start_logit": -0.6970472931861877,
            "end_logit": -0.2437446266412735
        },
        {
            "text": "an activin-receptor trap that modifies transforming growth factor-\u03b2",
            "probability": 0.023011325256636517,
            "start_logit": -0.6594317555427551,
            "end_logit": -0.39549943804740906
        },
        {
            "text": "activin-receptor trap that modifies transforming growth factor-\u03b2",
            "probability": 0.02216181935924333,
            "start_logit": -0.6970472931861877,
            "end_logit": -0.39549943804740906
        },
        {
            "text": "An example is luspatercept, an activin-receptor trap",
            "probability": 0.01651074719435774,
            "start_logit": -1.1558302640914917,
            "end_logit": -0.23107591271400452
        },
        {
            "text": "An example is luspatercept, an activin-receptor trap that modifies transforming growth factor-\u03b2",
            "probability": 0.014007431198064028,
            "start_logit": -1.1558302640914917,
            "end_logit": -0.39549943804740906
        },
        {
            "text": "increasing the efficiency of erythropoiesis",
            "probability": 0.013823926471279285,
            "start_logit": -1.3207721710205078,
            "end_logit": -0.2437446266412735
        },
        {
            "text": "modifies transforming growth factor-\u03b2 signaling,",
            "probability": 0.012946198355405471,
            "start_logit": -0.2890017032623291,
            "end_logit": -1.341113805770874
        },
        {
            "text": "luspatercept, an activin-receptor trap that modifies transforming growth factor-\u03b2 signaling",
            "probability": 0.010693025146085928,
            "start_logit": -2.7542052268981934,
            "end_logit": 0.9328792095184326
        },
        {
            "text": "an activin-receptor trap that modifies transforming growth factor-\u03b2 signaling,",
            "probability": 0.00893853878964189,
            "start_logit": -0.6594317555427551,
            "end_logit": -1.341113805770874
        }
    ],
    "5e2903978b3851296d000007_009": [
        {
            "text": "",
            "probability": 0.2624268361424948,
            "start_logit": 0.08605662733316422,
            "end_logit": 0.30599719285964966
        },
        {
            "text": "well tolerated and effective for the treatment of anaemia in lower-risk myelodysplastic syndromes",
            "probability": 0.11831932858999192,
            "start_logit": -0.2579473555088043,
            "end_logit": -0.14658400416374207
        },
        {
            "text": "assess the safety and efficacy of luspatercept in patients with anaemia due to lower-risk myelodysplastic syndromes",
            "probability": 0.09977361139772968,
            "start_logit": -0.5021477937698364,
            "end_logit": -0.07286697626113892
        },
        {
            "text": "safety and efficacy of luspatercept in patients with anaemia due to lower-risk myelodysplastic syndromes",
            "probability": 0.07049843480554076,
            "start_logit": -0.849461019039154,
            "end_logit": -0.07286697626113892
        },
        {
            "text": "well tolerated and effective for the treatment of anaemia",
            "probability": 0.047082250703164644,
            "start_logit": -0.2579473555088043,
            "end_logit": -1.0680750608444214
        },
        {
            "text": "We aimed to assess the safety and efficacy",
            "probability": 0.043553467862877594,
            "start_logit": -0.3292819857597351,
            "end_logit": -1.0746471881866455
        },
        {
            "text": "Luspatercept was well tolerated and effective for the treatment of anaemia in lower-risk myelodysplastic syndromes",
            "probability": 0.04089293332268602,
            "start_logit": -1.320377230644226,
            "end_logit": -0.14658400416374207
        },
        {
            "text": "assess the safety and efficacy",
            "probability": 0.036639376457351415,
            "start_logit": -0.5021477937698364,
            "end_logit": -1.0746471881866455
        },
        {
            "text": "assess the safety and efficacy of luspatercept in patients with anaemia due to lower-risk myelodysplastic syndromes.",
            "probability": 0.02915260049448092,
            "start_logit": -0.5021477937698364,
            "end_logit": -1.3032265901565552
        },
        {
            "text": "We aimed to assess the safety and efficacy of luspatercept in patients with anaemia",
            "probability": 0.02901250464835892,
            "start_logit": -0.3292819857597351,
            "end_logit": -1.4809095859527588
        },
        {
            "text": "the safety and efficacy of luspatercept in patients with anaemia due to lower-risk myelodysplastic syndromes",
            "probability": 0.02686426287635218,
            "start_logit": -1.814254641532898,
            "end_logit": -0.07286697626113892
        },
        {
            "text": "safety and efficacy",
            "probability": 0.025888796208824304,
            "start_logit": -0.849461019039154,
            "end_logit": -1.0746471881866455
        },
        {
            "text": "patients with anaemia due to lower-risk myelodysplastic syndromes",
            "probability": 0.025624309452368817,
            "start_logit": -1.8615100383758545,
            "end_logit": -0.07286697626113892
        },
        {
            "text": "assess the safety and efficacy of luspatercept in patients with anaemia",
            "probability": 0.0244067839357499,
            "start_logit": -0.5021477937698364,
            "end_logit": -1.4809095859527588
        },
        {
            "text": "to assess the safety and efficacy of luspatercept in patients with anaemia due to lower-risk myelodysplastic syndromes",
            "probability": 0.02226410755536904,
            "start_logit": -2.002075672149658,
            "end_logit": -0.07286697626113892
        },
        {
            "text": "safety and efficacy of luspatercept in patients with anaemia due to lower-risk myelodysplastic syndromes.",
            "probability": 0.020598760299247867,
            "start_logit": -0.849461019039154,
            "end_logit": -1.3032265901565552
        },
        {
            "text": "anaemia due to lower-risk myelodysplastic syndromes",
            "probability": 0.020166005472750922,
            "start_logit": -2.101053237915039,
            "end_logit": -0.07286697626113892
        },
        {
            "text": "well tolerated and effective",
            "probability": 0.019364821607311775,
            "start_logit": -0.2579473555088043,
            "end_logit": -1.9565130472183228
        },
        {
            "text": "treatment of anaemia in lower-risk myelodysplastic syndromes",
            "probability": 0.019106052194177048,
            "start_logit": -2.081329345703125,
            "end_logit": -0.14658400416374207
        },
        {
            "text": "was well tolerated and effective for the treatment of anaemia in lower-risk myelodysplastic syndromes",
            "probability": 0.018364755973171592,
            "start_logit": -2.120901107788086,
            "end_logit": -0.14658400416374207
        }
    ],
    "5c701f4f7c78d69471000060_001": [
        {
            "text": "chronic myeloid leukemia",
            "probability": 0.563431814131645,
            "start_logit": 4.414157867431641,
            "end_logit": 5.191971302032471
        },
        {
            "text": "",
            "probability": 0.3883351366654885,
            "start_logit": 4.316092014312744,
            "end_logit": 4.9178595542907715
        },
        {
            "text": "Patients with chronic myeloid leukemia",
            "probability": 0.01859367963313566,
            "start_logit": 1.0029332637786865,
            "end_logit": 5.191971302032471
        },
        {
            "text": "myeloid leukemia",
            "probability": 0.008979788124914043,
            "start_logit": 0.275087833404541,
            "end_logit": 5.191971302032471
        },
        {
            "text": "leukemia",
            "probability": 0.005513848472800438,
            "start_logit": -0.2126256227493286,
            "end_logit": 5.191971302032471
        },
        {
            "text": "chronic myeloid leuke",
            "probability": 0.00450252236696454,
            "start_logit": 4.414157867431641,
            "end_logit": 0.36256274580955505
        },
        {
            "text": "chronic myeloid",
            "probability": 0.0023546058769920368,
            "start_logit": 4.414157867431641,
            "end_logit": -0.2857016623020172
        },
        {
            "text": "leukemia,",
            "probability": 0.00215166607843143,
            "start_logit": -1.1536459922790527,
            "end_logit": 5.191971302032471
        },
        {
            "text": "with chronic myeloid leukemia",
            "probability": 0.0020128027936001046,
            "start_logit": -1.220360279083252,
            "end_logit": 5.191971302032471
        },
        {
            "text": "chronic",
            "probability": 0.0012028476707510892,
            "start_logit": 4.414157867431641,
            "end_logit": -0.9573832154273987
        },
        {
            "text": "myeloid leukemia,",
            "probability": 0.0010170773394870241,
            "start_logit": -1.9029552936553955,
            "end_logit": 5.191971302032471
        },
        {
            "text": "chronic myeloid le",
            "probability": 0.0006414267747977473,
            "start_logit": 4.414157867431641,
            "end_logit": -1.5861352682113647
        },
        {
            "text": "chronic myeloid leukemia, treated with imatinib",
            "probability": 0.0004443800945204642,
            "start_logit": 4.414157867431641,
            "end_logit": -1.9531500339508057
        },
        {
            "text": "chronic myeloid leukemia,",
            "probability": 0.0002268822017543036,
            "start_logit": 4.414157867431641,
            "end_logit": -2.625399351119995
        },
        {
            "text": "chronic myelo",
            "probability": 0.00020971420266847887,
            "start_logit": 4.414157867431641,
            "end_logit": -2.704084634780884
        },
        {
            "text": "Patients with chronic myeloid leuke",
            "probability": 0.00014858667248208605,
            "start_logit": 1.0029332637786865,
            "end_logit": 0.36256274580955505
        },
        {
            "text": "Patients with chronic myeloid",
            "probability": 7.770378995471323e-05,
            "start_logit": 1.0029332637786865,
            "end_logit": -0.2857016623020172
        },
        {
            "text": "myeloid leuke",
            "probability": 7.175969810178527e-05,
            "start_logit": 0.275087833404541,
            "end_logit": 0.36256274580955505
        },
        {
            "text": "leuke",
            "probability": 4.406252088391414e-05,
            "start_logit": -0.2126256227493286,
            "end_logit": 0.36256274580955505
        },
        {
            "text": "Patients with chronic",
            "probability": 3.969489062643445e-05,
            "start_logit": 1.0029332637786865,
            "end_logit": -0.9573832154273987
        }
    ],
    "5c701f4f7c78d69471000060_002": [
        {
            "text": "chronic myeloid leukemia",
            "probability": 0.563431814131645,
            "start_logit": 4.414157867431641,
            "end_logit": 5.191971302032471
        },
        {
            "text": "",
            "probability": 0.3883351366654885,
            "start_logit": 4.316092014312744,
            "end_logit": 4.9178595542907715
        },
        {
            "text": "Patients with chronic myeloid leukemia",
            "probability": 0.01859367963313566,
            "start_logit": 1.0029332637786865,
            "end_logit": 5.191971302032471
        },
        {
            "text": "myeloid leukemia",
            "probability": 0.008979788124914043,
            "start_logit": 0.275087833404541,
            "end_logit": 5.191971302032471
        },
        {
            "text": "leukemia",
            "probability": 0.005513848472800438,
            "start_logit": -0.2126256227493286,
            "end_logit": 5.191971302032471
        },
        {
            "text": "chronic myeloid leuke",
            "probability": 0.00450252236696454,
            "start_logit": 4.414157867431641,
            "end_logit": 0.36256274580955505
        },
        {
            "text": "chronic myeloid",
            "probability": 0.0023546058769920368,
            "start_logit": 4.414157867431641,
            "end_logit": -0.2857016623020172
        },
        {
            "text": "leukemia,",
            "probability": 0.00215166607843143,
            "start_logit": -1.1536459922790527,
            "end_logit": 5.191971302032471
        },
        {
            "text": "with chronic myeloid leukemia",
            "probability": 0.0020128027936001046,
            "start_logit": -1.220360279083252,
            "end_logit": 5.191971302032471
        },
        {
            "text": "chronic",
            "probability": 0.0012028476707510892,
            "start_logit": 4.414157867431641,
            "end_logit": -0.9573832154273987
        },
        {
            "text": "myeloid leukemia,",
            "probability": 0.0010170773394870241,
            "start_logit": -1.9029552936553955,
            "end_logit": 5.191971302032471
        },
        {
            "text": "chronic myeloid le",
            "probability": 0.0006414267747977473,
            "start_logit": 4.414157867431641,
            "end_logit": -1.5861352682113647
        },
        {
            "text": "chronic myeloid leukemia, treated with imatinib",
            "probability": 0.0004443800945204642,
            "start_logit": 4.414157867431641,
            "end_logit": -1.9531500339508057
        },
        {
            "text": "chronic myeloid leukemia,",
            "probability": 0.0002268822017543036,
            "start_logit": 4.414157867431641,
            "end_logit": -2.625399351119995
        },
        {
            "text": "chronic myelo",
            "probability": 0.00020971420266847887,
            "start_logit": 4.414157867431641,
            "end_logit": -2.704084634780884
        },
        {
            "text": "Patients with chronic myeloid leuke",
            "probability": 0.00014858667248208605,
            "start_logit": 1.0029332637786865,
            "end_logit": 0.36256274580955505
        },
        {
            "text": "Patients with chronic myeloid",
            "probability": 7.770378995471323e-05,
            "start_logit": 1.0029332637786865,
            "end_logit": -0.2857016623020172
        },
        {
            "text": "myeloid leuke",
            "probability": 7.175969810178527e-05,
            "start_logit": 0.275087833404541,
            "end_logit": 0.36256274580955505
        },
        {
            "text": "leuke",
            "probability": 4.406252088391414e-05,
            "start_logit": -0.2126256227493286,
            "end_logit": 0.36256274580955505
        },
        {
            "text": "Patients with chronic",
            "probability": 3.969489062643445e-05,
            "start_logit": 1.0029332637786865,
            "end_logit": -0.9573832154273987
        }
    ],
    "5c701f4f7c78d69471000060_004": [
        {
            "text": "Sclerotic chronic graft-versus-host disease",
            "probability": 0.43017631276234325,
            "start_logit": 3.6323025226593018,
            "end_logit": 4.853033065795898
        },
        {
            "text": "chronic graft-versus-host disease",
            "probability": 0.23264710436970534,
            "start_logit": 3.017630100250244,
            "end_logit": 4.853033065795898
        },
        {
            "text": "Sclerotic chronic graft-versus-host disease (scGVHD",
            "probability": 0.051043342331588866,
            "start_logit": 3.6323025226593018,
            "end_logit": 2.721513032913208
        },
        {
            "text": "",
            "probability": 0.04940689440956918,
            "start_logit": 3.0560295581817627,
            "end_logit": 3.2652008533477783
        },
        {
            "text": "Sclerotic chronic graft-versus-host disease (scGVHD)",
            "probability": 0.04777356633130353,
            "start_logit": 3.6323025226593018,
            "end_logit": 2.6553103923797607
        },
        {
            "text": "scGVHD",
            "probability": 0.04508581891577215,
            "start_logit": 2.862738609313965,
            "end_logit": 3.366969585418701
        },
        {
            "text": "chronic graft-versus-host disease (scGVHD",
            "probability": 0.02760515964847257,
            "start_logit": 3.017630100250244,
            "end_logit": 2.721513032913208
        },
        {
            "text": "Sclerotic chronic graft-versus-host",
            "probability": 0.025939511418761944,
            "start_logit": 3.6323025226593018,
            "end_logit": 2.044605255126953
        },
        {
            "text": "chronic graft-versus-host disease (scGVHD)",
            "probability": 0.02583680584600693,
            "start_logit": 3.017630100250244,
            "end_logit": 2.6553103923797607
        },
        {
            "text": "chronic graft-versus-host",
            "probability": 0.014028555365097135,
            "start_logit": 3.017630100250244,
            "end_logit": 2.044605255126953
        },
        {
            "text": "graft-versus-host disease",
            "probability": 0.01050018478900269,
            "start_logit": -0.08049977570772171,
            "end_logit": 4.853033065795898
        },
        {
            "text": "scGVHD)",
            "probability": 0.010329105677344762,
            "start_logit": 2.1007957458496094,
            "end_logit": 2.6553103923797607
        },
        {
            "text": "Sclerotic",
            "probability": 0.007556754526943026,
            "start_logit": 3.6323025226593018,
            "end_logit": 0.8112797141075134
        },
        {
            "text": "chronic graft-versus-host disease (scGVHD) is a severe form of this disease that resembles systemic sclerosis",
            "probability": 0.00617435564327703,
            "start_logit": 3.017630100250244,
            "end_logit": 1.2239148616790771
        },
        {
            "text": "scGVHD patients refractory to corticosteroids and resistant or intolerant to imatinib",
            "probability": 0.004352276105522459,
            "start_logit": 2.862738609313965,
            "end_logit": 1.029100775718689
        },
        {
            "text": "scGVHD patients",
            "probability": 0.00303145680705021,
            "start_logit": 2.862738609313965,
            "end_logit": 0.6674451231956482
        },
        {
            "text": "chronic myeloid leukemia",
            "probability": 0.0028674870076386243,
            "start_logit": 1.6438734531402588,
            "end_logit": 1.8307030200958252
        },
        {
            "text": "scGVHD) is a severe form of this disease that resembles systemic sclerosis",
            "probability": 0.0024684000146548662,
            "start_logit": 2.1007957458496094,
            "end_logit": 1.2239148616790771
        },
        {
            "text": "host disease",
            "probability": 0.0016191298713537606,
            "start_logit": -1.950003743171692,
            "end_logit": 4.853033065795898
        },
        {
            "text": "disease",
            "probability": 0.0015577781585915632,
            "start_logit": -1.988632082939148,
            "end_logit": 4.853033065795898
        }
    ],
    "5c701f4f7c78d69471000060_005": [
        {
            "text": "myeloproliferative diseases",
            "probability": 0.6251132275232656,
            "start_logit": 5.894245147705078,
            "end_logit": 6.030724048614502
        },
        {
            "text": "myeloproliferative",
            "probability": 0.14586959705383365,
            "start_logit": 5.894245147705078,
            "end_logit": 4.575504302978516
        },
        {
            "text": "myeloproliferative diseases (MPDs)",
            "probability": 0.13468409460173025,
            "start_logit": 5.894245147705078,
            "end_logit": 4.495723247528076
        },
        {
            "text": "myeloproliferative diseases (MPDs",
            "probability": 0.03867895594369185,
            "start_logit": 5.894245147705078,
            "end_logit": 3.248086929321289
        },
        {
            "text": "myeloproliferative diseases (MPDs) involving c-Cbl mutations",
            "probability": 0.030783560624104044,
            "start_logit": 5.894245147705078,
            "end_logit": 3.0197720527648926
        },
        {
            "text": "MPDs)",
            "probability": 0.009504805428670358,
            "start_logit": 3.2431106567382812,
            "end_logit": 4.495723247528076
        },
        {
            "text": "",
            "probability": 0.003331344986871491,
            "start_logit": 3.149033784866333,
            "end_logit": 3.5413787364959717
        },
        {
            "text": "MPDs",
            "probability": 0.0027296166746045825,
            "start_logit": 3.2431106567382812,
            "end_logit": 3.248086929321289
        },
        {
            "text": "MPDs) involving c-Cbl mutations",
            "probability": 0.002172429899751714,
            "start_logit": 3.2431106567382812,
            "end_logit": 3.0197720527648926
        },
        {
            "text": "leukemia",
            "probability": 0.001656378732026628,
            "start_logit": 3.203488349914551,
            "end_logit": 2.788181781768799
        },
        {
            "text": "myeloproliferative diseases (MPDs) involving c-Cbl",
            "probability": 0.00146772171143954,
            "start_logit": 5.894245147705078,
            "end_logit": -0.023497406393289566
        },
        {
            "text": "leukemia patients with c-Cbl mutations",
            "probability": 0.0012492737478210936,
            "start_logit": 3.203488349914551,
            "end_logit": 2.506110429763794
        },
        {
            "text": "myeloproliferative diseases (MPDs) involving c-Cbl mutations.",
            "probability": 0.0009709852792342353,
            "start_logit": 5.894245147705078,
            "end_logit": -0.4366527199745178
        },
        {
            "text": "diseases",
            "probability": 0.000521729653660596,
            "start_logit": -1.1942933797836304,
            "end_logit": 6.030724048614502
        },
        {
            "text": "my",
            "probability": 0.0003595835500506902,
            "start_logit": 5.894245147705078,
            "end_logit": -1.4300174713134766
        },
        {
            "text": "myeloprolifer",
            "probability": 0.00028507318416855774,
            "start_logit": 5.894245147705078,
            "end_logit": -1.6622180938720703
        },
        {
            "text": "multi-kinase inhibitor dasatinib would provide an effective therapy for myeloproliferative diseases",
            "probability": 0.0001856989007960554,
            "start_logit": -2.227316379547119,
            "end_logit": 6.030724048614502
        },
        {
            "text": "for myeloproliferative diseases",
            "probability": 0.00015327339103619222,
            "start_logit": -2.419219732284546,
            "end_logit": 6.030724048614502
        },
        {
            "text": "hematopoietic disorder",
            "probability": 0.00014621373434021818,
            "start_logit": 1.684848666191101,
            "end_logit": 1.8795019388198853
        },
        {
            "text": "the multi-kinase inhibitor dasatinib would provide an effective therapy for myeloproliferative diseases",
            "probability": 0.00013643537890293896,
            "start_logit": -2.5355918407440186,
            "end_logit": 6.030724048614502
        }
    ],
    "5c701f4f7c78d69471000060_006": [
        {
            "text": "myeloproliferative diseases",
            "probability": 0.6251132275232656,
            "start_logit": 5.894245147705078,
            "end_logit": 6.030724048614502
        },
        {
            "text": "myeloproliferative",
            "probability": 0.14586959705383365,
            "start_logit": 5.894245147705078,
            "end_logit": 4.575504302978516
        },
        {
            "text": "myeloproliferative diseases (MPDs)",
            "probability": 0.13468409460173025,
            "start_logit": 5.894245147705078,
            "end_logit": 4.495723247528076
        },
        {
            "text": "myeloproliferative diseases (MPDs",
            "probability": 0.03867895594369185,
            "start_logit": 5.894245147705078,
            "end_logit": 3.248086929321289
        },
        {
            "text": "myeloproliferative diseases (MPDs) involving c-Cbl mutations",
            "probability": 0.030783560624104044,
            "start_logit": 5.894245147705078,
            "end_logit": 3.0197720527648926
        },
        {
            "text": "MPDs)",
            "probability": 0.009504805428670358,
            "start_logit": 3.2431106567382812,
            "end_logit": 4.495723247528076
        },
        {
            "text": "",
            "probability": 0.003331344986871491,
            "start_logit": 3.149033784866333,
            "end_logit": 3.5413787364959717
        },
        {
            "text": "MPDs",
            "probability": 0.0027296166746045825,
            "start_logit": 3.2431106567382812,
            "end_logit": 3.248086929321289
        },
        {
            "text": "MPDs) involving c-Cbl mutations",
            "probability": 0.002172429899751714,
            "start_logit": 3.2431106567382812,
            "end_logit": 3.0197720527648926
        },
        {
            "text": "leukemia",
            "probability": 0.001656378732026628,
            "start_logit": 3.203488349914551,
            "end_logit": 2.788181781768799
        },
        {
            "text": "myeloproliferative diseases (MPDs) involving c-Cbl",
            "probability": 0.00146772171143954,
            "start_logit": 5.894245147705078,
            "end_logit": -0.023497406393289566
        },
        {
            "text": "leukemia patients with c-Cbl mutations",
            "probability": 0.0012492737478210936,
            "start_logit": 3.203488349914551,
            "end_logit": 2.506110429763794
        },
        {
            "text": "myeloproliferative diseases (MPDs) involving c-Cbl mutations.",
            "probability": 0.0009709852792342353,
            "start_logit": 5.894245147705078,
            "end_logit": -0.4366527199745178
        },
        {
            "text": "diseases",
            "probability": 0.000521729653660596,
            "start_logit": -1.1942933797836304,
            "end_logit": 6.030724048614502
        },
        {
            "text": "my",
            "probability": 0.0003595835500506902,
            "start_logit": 5.894245147705078,
            "end_logit": -1.4300174713134766
        },
        {
            "text": "myeloprolifer",
            "probability": 0.00028507318416855774,
            "start_logit": 5.894245147705078,
            "end_logit": -1.6622180938720703
        },
        {
            "text": "multi-kinase inhibitor dasatinib would provide an effective therapy for myeloproliferative diseases",
            "probability": 0.0001856989007960554,
            "start_logit": -2.227316379547119,
            "end_logit": 6.030724048614502
        },
        {
            "text": "for myeloproliferative diseases",
            "probability": 0.00015327339103619222,
            "start_logit": -2.419219732284546,
            "end_logit": 6.030724048614502
        },
        {
            "text": "hematopoietic disorder",
            "probability": 0.00014621373434021818,
            "start_logit": 1.684848666191101,
            "end_logit": 1.8795019388198853
        },
        {
            "text": "the multi-kinase inhibitor dasatinib would provide an effective therapy for myeloproliferative diseases",
            "probability": 0.00013643537890293896,
            "start_logit": -2.5355918407440186,
            "end_logit": 6.030724048614502
        }
    ],
    "5c701f4f7c78d69471000060_007": [
        {
            "text": "acute lymphoblastic leukemia",
            "probability": 0.4530855923562942,
            "start_logit": 2.82906174659729,
            "end_logit": 3.828958749771118
        },
        {
            "text": "",
            "probability": 0.2893080295517115,
            "start_logit": 2.9368484020233154,
            "end_logit": 3.2725830078125
        },
        {
            "text": "Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia",
            "probability": 0.07816654255997595,
            "start_logit": 1.0718224048614502,
            "end_logit": 3.828958749771118
        },
        {
            "text": "leukemia",
            "probability": 0.03498913490941095,
            "start_logit": 0.26801827549934387,
            "end_logit": 3.828958749771118
        },
        {
            "text": "lymphoblastic leukemia",
            "probability": 0.02674651231469039,
            "start_logit": -0.0006152225541882217,
            "end_logit": 3.828958749771118
        },
        {
            "text": "Ph+ all and mrd elevation but hematologic remission during imatinib chemotherapy",
            "probability": 0.0226380324648422,
            "start_logit": 1.4986116886138916,
            "end_logit": 2.162959098815918
        },
        {
            "text": "acute lymphoblastic leukemia (all)",
            "probability": 0.01930243586219925,
            "start_logit": 2.82906174659729,
            "end_logit": 0.6731089949607849
        },
        {
            "text": "Ph+ all and mrd elevation",
            "probability": 0.0105975851100166,
            "start_logit": 1.4986116886138916,
            "end_logit": 1.4039539098739624
        },
        {
            "text": "Ph+ all and mrd elevation but hematologic remission",
            "probability": 0.010483900702621023,
            "start_logit": 1.4986116886138916,
            "end_logit": 1.393168568611145
        },
        {
            "text": "Ph+) acute lymphoblastic leukemia",
            "probability": 0.008191793806134726,
            "start_logit": -1.1838864088058472,
            "end_logit": 3.828958749771118
        },
        {
            "text": "hematologic remission during imatinib chemotherapy",
            "probability": 0.006582034463900697,
            "start_logit": 0.26332423090934753,
            "end_logit": 2.162959098815918
        },
        {
            "text": "acute lymphoblastic",
            "probability": 0.0061045520416490515,
            "start_logit": 2.82906174659729,
            "end_logit": -0.47808757424354553
        },
        {
            "text": "patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia",
            "probability": 0.0056537520752694,
            "start_logit": -1.5546998977661133,
            "end_logit": 3.828958749771118
        },
        {
            "text": "acute lymphoblastic leukemia (all",
            "probability": 0.00543392720182092,
            "start_logit": 2.82906174659729,
            "end_logit": -0.5944601893424988
        },
        {
            "text": "acute",
            "probability": 0.005013733679295578,
            "start_logit": 2.82906174659729,
            "end_logit": -0.6749414205551147
        },
        {
            "text": "patients with Ph+ all and mrd elevation but hematologic remission during imatinib chemotherapy",
            "probability": 0.003972346604684681,
            "start_logit": -0.2416626513004303,
            "end_logit": 2.162959098815918
        },
        {
            "text": "mrd elevation but hematologic remission during imatinib chemotherapy",
            "probability": 0.003695171423746021,
            "start_logit": -0.3139927089214325,
            "end_logit": 2.162959098815918
        },
        {
            "text": "Ph+ all",
            "probability": 0.0036566510144533946,
            "start_logit": 1.4986116886138916,
            "end_logit": 0.3398754596710205
        },
        {
            "text": "Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (all)",
            "probability": 0.0033300654441188243,
            "start_logit": 1.0718224048614502,
            "end_logit": 0.6731089949607849
        },
        {
            "text": "hematologic remission",
            "probability": 0.003048206413164772,
            "start_logit": 0.26332423090934753,
            "end_logit": 1.393168568611145
        }
    ],
    "5c701f4f7c78d69471000060_009": [
        {
            "text": "Ph-positive ALL",
            "probability": 0.7059620373966617,
            "start_logit": 7.26523494720459,
            "end_logit": 8.093955993652344
        },
        {
            "text": "adults with Ph-positive ALL",
            "probability": 0.1697729730329014,
            "start_logit": 5.84013557434082,
            "end_logit": 8.093955993652344
        },
        {
            "text": "Ph-positive",
            "probability": 0.08409069720111226,
            "start_logit": 7.26523494720459,
            "end_logit": 5.966290473937988
        },
        {
            "text": "adults with Ph-positive",
            "probability": 0.020222514684909054,
            "start_logit": 5.84013557434082,
            "end_logit": 5.966290473937988
        },
        {
            "text": "ALL",
            "probability": 0.0064450442541676084,
            "start_logit": 2.5689849853515625,
            "end_logit": 8.093955993652344
        },
        {
            "text": "Ph-positive ALL.",
            "probability": 0.0034475619352923627,
            "start_logit": 7.26523494720459,
            "end_logit": 2.772061824798584
        },
        {
            "text": "positive ALL",
            "probability": 0.0027953619166276394,
            "start_logit": 1.7336350679397583,
            "end_logit": 8.093955993652344
        },
        {
            "text": "with Ph-positive ALL",
            "probability": 0.0020143164855729177,
            "start_logit": 1.4059534072875977,
            "end_logit": 8.093955993652344
        },
        {
            "text": "adults with Ph-positive ALL.",
            "probability": 0.000829085430185506,
            "start_logit": 5.84013557434082,
            "end_logit": 2.772061824798584
        },
        {
            "text": "adults",
            "probability": 0.0007440376641614455,
            "start_logit": 5.84013557434082,
            "end_logit": 2.663830280303955
        },
        {
            "text": "acute lymphoblastic leukemia",
            "probability": 0.0007316838152667196,
            "start_logit": 3.703573703765869,
            "end_logit": 4.78364896774292
        },
        {
            "text": "in adults with Ph-positive ALL",
            "probability": 0.0005912407383795724,
            "start_logit": 0.18014147877693176,
            "end_logit": 8.093955993652344
        },
        {
            "text": "Ph",
            "probability": 0.0003983892554743538,
            "start_logit": 7.26523494720459,
            "end_logit": 0.6140688061714172
        },
        {
            "text": "This dasatinib-based protocol was effective for achieving a good quality molecular response and durable DFS in adults with Ph-positive ALL",
            "probability": 0.0003346645965401611,
            "start_logit": -0.38895297050476074,
            "end_logit": 8.093955993652344
        },
        {
            "text": "positive",
            "probability": 0.0003329696499906542,
            "start_logit": 1.7336350679397583,
            "end_logit": 5.966290473937988
        },
        {
            "text": "effective for achieving a good quality molecular response and durable DFS in adults with Ph-positive ALL",
            "probability": 0.00029596392700020544,
            "start_logit": -0.5118442177772522,
            "end_logit": 8.093955993652344
        },
        {
            "text": "with Ph-positive",
            "probability": 0.00023993539125723216,
            "start_logit": 1.4059534072875977,
            "end_logit": 5.966290473937988
        },
        {
            "text": "achieving a good quality molecular response and durable DFS in adults with Ph-positive ALL",
            "probability": 0.00022344447194676373,
            "start_logit": -0.792918860912323,
            "end_logit": 8.093955993652344
        },
        {
            "text": "P",
            "probability": 0.00021865132022643504,
            "start_logit": 7.26523494720459,
            "end_logit": 0.01411756593734026
        },
        {
            "text": "molecular response and durable DFS in adults with Ph-positive ALL",
            "probability": 0.00019980961870248962,
            "start_logit": -0.9047167897224426,
            "end_logit": 8.093955993652344
        },
        {
            "text": "",
            "probability": 0.00010961721362363995,
            "start_logit": 3.1995410919189453,
            "end_logit": 3.3893275260925293
        }
    ],
    "5c701f4f7c78d69471000060_010": [
        {
            "text": "Ph-positive ALL",
            "probability": 0.7059620373966617,
            "start_logit": 7.26523494720459,
            "end_logit": 8.093955993652344
        },
        {
            "text": "adults with Ph-positive ALL",
            "probability": 0.1697729730329014,
            "start_logit": 5.84013557434082,
            "end_logit": 8.093955993652344
        },
        {
            "text": "Ph-positive",
            "probability": 0.08409069720111226,
            "start_logit": 7.26523494720459,
            "end_logit": 5.966290473937988
        },
        {
            "text": "adults with Ph-positive",
            "probability": 0.020222514684909054,
            "start_logit": 5.84013557434082,
            "end_logit": 5.966290473937988
        },
        {
            "text": "ALL",
            "probability": 0.0064450442541676084,
            "start_logit": 2.5689849853515625,
            "end_logit": 8.093955993652344
        },
        {
            "text": "Ph-positive ALL.",
            "probability": 0.0034475619352923627,
            "start_logit": 7.26523494720459,
            "end_logit": 2.772061824798584
        },
        {
            "text": "positive ALL",
            "probability": 0.0027953619166276394,
            "start_logit": 1.7336350679397583,
            "end_logit": 8.093955993652344
        },
        {
            "text": "with Ph-positive ALL",
            "probability": 0.0020143164855729177,
            "start_logit": 1.4059534072875977,
            "end_logit": 8.093955993652344
        },
        {
            "text": "adults with Ph-positive ALL.",
            "probability": 0.000829085430185506,
            "start_logit": 5.84013557434082,
            "end_logit": 2.772061824798584
        },
        {
            "text": "adults",
            "probability": 0.0007440376641614455,
            "start_logit": 5.84013557434082,
            "end_logit": 2.663830280303955
        },
        {
            "text": "acute lymphoblastic leukemia",
            "probability": 0.0007316838152667196,
            "start_logit": 3.703573703765869,
            "end_logit": 4.78364896774292
        },
        {
            "text": "in adults with Ph-positive ALL",
            "probability": 0.0005912407383795724,
            "start_logit": 0.18014147877693176,
            "end_logit": 8.093955993652344
        },
        {
            "text": "Ph",
            "probability": 0.0003983892554743538,
            "start_logit": 7.26523494720459,
            "end_logit": 0.6140688061714172
        },
        {
            "text": "This dasatinib-based protocol was effective for achieving a good quality molecular response and durable DFS in adults with Ph-positive ALL",
            "probability": 0.0003346645965401611,
            "start_logit": -0.38895297050476074,
            "end_logit": 8.093955993652344
        },
        {
            "text": "positive",
            "probability": 0.0003329696499906542,
            "start_logit": 1.7336350679397583,
            "end_logit": 5.966290473937988
        },
        {
            "text": "effective for achieving a good quality molecular response and durable DFS in adults with Ph-positive ALL",
            "probability": 0.00029596392700020544,
            "start_logit": -0.5118442177772522,
            "end_logit": 8.093955993652344
        },
        {
            "text": "with Ph-positive",
            "probability": 0.00023993539125723216,
            "start_logit": 1.4059534072875977,
            "end_logit": 5.966290473937988
        },
        {
            "text": "achieving a good quality molecular response and durable DFS in adults with Ph-positive ALL",
            "probability": 0.00022344447194676373,
            "start_logit": -0.792918860912323,
            "end_logit": 8.093955993652344
        },
        {
            "text": "P",
            "probability": 0.00021865132022643504,
            "start_logit": 7.26523494720459,
            "end_logit": 0.01411756593734026
        },
        {
            "text": "molecular response and durable DFS in adults with Ph-positive ALL",
            "probability": 0.00019980961870248962,
            "start_logit": -0.9047167897224426,
            "end_logit": 8.093955993652344
        },
        {
            "text": "",
            "probability": 0.00010961721362363995,
            "start_logit": 3.1995410919189453,
            "end_logit": 3.3893275260925293
        }
    ],
    "5c701f4f7c78d69471000060_012": [
        {
            "text": "chronic myeloid leukemia",
            "probability": 0.9671926743130709,
            "start_logit": 7.169256210327148,
            "end_logit": 7.768360137939453
        },
        {
            "text": "myeloid leukemia",
            "probability": 0.009209258443788343,
            "start_logit": 2.5150678157806396,
            "end_logit": 7.768360137939453
        },
        {
            "text": "chronic myeloid leukemia (CML",
            "probability": 0.007170061044169536,
            "start_logit": 7.169256210327148,
            "end_logit": 2.8638765811920166
        },
        {
            "text": "leukemia",
            "probability": 0.005875514595166679,
            "start_logit": 2.0656521320343018,
            "end_logit": 7.768360137939453
        },
        {
            "text": "chronic myeloid leukemia (CML)",
            "probability": 0.0039239714361209025,
            "start_logit": 7.169256210327148,
            "end_logit": 2.2610666751861572
        },
        {
            "text": "chronic myeloid leuke",
            "probability": 0.0020209020904107763,
            "start_logit": 7.169256210327148,
            "end_logit": 1.5975064039230347
        },
        {
            "text": "chronic",
            "probability": 0.0018839079501728308,
            "start_logit": 7.169256210327148,
            "end_logit": 1.5273107290267944
        },
        {
            "text": "chronic myeloid",
            "probability": 0.0010943794825886554,
            "start_logit": 7.169256210327148,
            "end_logit": 0.9841499328613281
        },
        {
            "text": "TFR) of chronic myeloid leukemia",
            "probability": 0.0004292027416296449,
            "start_logit": -0.5509673953056335,
            "end_logit": 7.768360137939453
        },
        {
            "text": "treatment-free remission (TFR) of chronic myeloid leukemia",
            "probability": 0.00034007473179069005,
            "start_logit": -0.7837314009666443,
            "end_logit": 7.768360137939453
        },
        {
            "text": "chronic myeloid leukemia (CML) after dasatinib",
            "probability": 0.000190092010663808,
            "start_logit": 7.169256210327148,
            "end_logit": -0.7662846446037292
        },
        {
            "text": "",
            "probability": 0.0001573962448026703,
            "start_logit": 2.7689647674560547,
            "end_logit": 3.445265054702759
        },
        {
            "text": "chronic myeloid le",
            "probability": 0.00015270906648670986,
            "start_logit": 7.169256210327148,
            "end_logit": -0.9852582812309265
        },
        {
            "text": "chronic myelo",
            "probability": 8.297169974563156e-05,
            "start_logit": 7.169256210327148,
            "end_logit": -1.5952932834625244
        },
        {
            "text": "myeloid leukemia (CML",
            "probability": 6.827072512764152e-05,
            "start_logit": 2.5150678157806396,
            "end_logit": 2.8638765811920166
        },
        {
            "text": "CML",
            "probability": 4.693698781333397e-05,
            "start_logit": 2.140392780303955,
            "end_logit": 2.8638765811920166
        },
        {
            "text": "chronic myeloid leukemia (CML) after dasatinib (Das) treatment",
            "probability": 4.453124555446835e-05,
            "start_logit": 7.169256210327148,
            "end_logit": -2.217601776123047
        },
        {
            "text": "leukemia (CML",
            "probability": 4.3556779773145584e-05,
            "start_logit": 2.0656521320343018,
            "end_logit": 2.8638765811920166
        },
        {
            "text": "myeloid leukemia (CML)",
            "probability": 3.73626352235827e-05,
            "start_logit": 2.5150678157806396,
            "end_logit": 2.2610666751861572
        },
        {
            "text": "chronic myeloid leukemia (",
            "probability": 3.6225775900174486e-05,
            "start_logit": 7.169256210327148,
            "end_logit": -2.4240219593048096
        }
    ],
    "5c701f4f7c78d69471000060_014": [
        {
            "text": "chronic myeloid leukemia",
            "probability": 0.3957880502051781,
            "start_logit": 3.7762579917907715,
            "end_logit": 4.418678283691406
        },
        {
            "text": "",
            "probability": 0.20998721017876223,
            "start_logit": 3.45564866065979,
            "end_logit": 4.10545539855957
        },
        {
            "text": "mixed connective tissue disease",
            "probability": 0.18445131286221902,
            "start_logit": 3.3692843914031982,
            "end_logit": 4.062158584594727
        },
        {
            "text": "chronic phase chronic myeloid leukemia",
            "probability": 0.1453269852906235,
            "start_logit": 2.7743654251098633,
            "end_logit": 4.418678283691406
        },
        {
            "text": "leukemia",
            "probability": 0.015530892768526212,
            "start_logit": 0.5382102727890015,
            "end_logit": 4.418678283691406
        },
        {
            "text": "mixed connective tissue",
            "probability": 0.013333578474788247,
            "start_logit": 3.3692843914031982,
            "end_logit": 1.43505859375
        },
        {
            "text": "mixed connective tissue disease (MCTD)",
            "probability": 0.008285739785372925,
            "start_logit": 3.3692843914031982,
            "end_logit": 0.9593089818954468
        },
        {
            "text": "myeloid leukemia",
            "probability": 0.007026157200324727,
            "start_logit": -0.2549809217453003,
            "end_logit": 4.418678283691406
        },
        {
            "text": "mixed connective tissue disease (MCTD",
            "probability": 0.005479466787483911,
            "start_logit": 3.3692843914031982,
            "end_logit": 0.5457808375358582
        },
        {
            "text": "chronic myeloid leuke",
            "probability": 0.002319117610699813,
            "start_logit": 3.7762579917907715,
            "end_logit": -0.7210137844085693
        },
        {
            "text": "connective tissue disease",
            "probability": 0.001986795129288982,
            "start_logit": -1.1615782976150513,
            "end_logit": 4.062158584594727
        },
        {
            "text": "leukemia.",
            "probability": 0.001854117355529997,
            "start_logit": -1.587212085723877,
            "end_logit": 4.418678283691406
        },
        {
            "text": "chronic",
            "probability": 0.0017133932536513572,
            "start_logit": 3.7762579917907715,
            "end_logit": -1.0237247943878174
        },
        {
            "text": "chronic myeloid",
            "probability": 0.001374782927446392,
            "start_logit": 3.7762579917907715,
            "end_logit": -1.243904709815979
        },
        {
            "text": "chronic myeloid leukemia.",
            "probability": 0.0013490000636214045,
            "start_logit": 3.7762579917907715,
            "end_logit": -1.2628369331359863
        },
        {
            "text": "myeloid leukemia.",
            "probability": 0.0011015904938912714,
            "start_logit": -2.107865810394287,
            "end_logit": 4.418678283691406
        },
        {
            "text": "chronic phase",
            "probability": 0.0008746637338008337,
            "start_logit": 2.7743654251098633,
            "end_logit": -0.6942237615585327
        },
        {
            "text": "chronic phase chronic myeloid leuke",
            "probability": 0.0008515425635581462,
            "start_logit": 2.7743654251098633,
            "end_logit": -0.7210137844085693
        },
        {
            "text": "with chronic phase chronic myeloid leukemia",
            "probability": 0.0006943082143586446,
            "start_logit": -2.569460153579712,
            "end_logit": 4.418678283691406
        },
        {
            "text": "phase chronic myeloid leukemia",
            "probability": 0.0006712951008742621,
            "start_logit": -2.6031672954559326,
            "end_logit": 4.418678283691406
        }
    ],
    "5e2b3784fbd6abf43b000009_001": [
        {
            "text": "",
            "probability": 0.9998380917417895,
            "start_logit": 3.886145830154419,
            "end_logit": 4.503702163696289
        },
        {
            "text": "late embryonic and postnatal mouse development",
            "probability": 2.9167403697223315e-05,
            "start_logit": -1.3951970338821411,
            "end_logit": -0.6572518348693848
        },
        {
            "text": "late embryonic and postnatal mouse development. Here, we describe a previously unknown role",
            "probability": 1.8011735687187674e-05,
            "start_logit": -1.3951970338821411,
            "end_logit": -1.139280080795288
        },
        {
            "text": "late embryonic and postnatal mouse development.",
            "probability": 1.6225044688613973e-05,
            "start_logit": -1.3951970338821411,
            "end_logit": -1.243747591972351
        },
        {
            "text": "postnatal mouse development",
            "probability": 1.1901345269014507e-05,
            "start_logit": -2.291597366333008,
            "end_logit": -0.6572518348693848
        },
        {
            "text": "implicated in late embryonic and postnatal mouse development",
            "probability": 1.0498271300816204e-05,
            "start_logit": -2.4170382022857666,
            "end_logit": -0.6572518348693848
        },
        {
            "text": "late embryonic and postnatal mouse development. Here, we describe a previously unknown role of GRG5 in early developmental stages",
            "probability": 8.257976664376086e-06,
            "start_logit": -1.3951970338821411,
            "end_logit": -1.9191240072250366
        },
        {
            "text": "late embryonic and postnatal",
            "probability": 7.614147041969571e-06,
            "start_logit": -1.3951970338821411,
            "end_logit": -2.000295639038086
        },
        {
            "text": "postnatal mouse development. Here, we describe a previously unknown role",
            "probability": 7.34943320744924e-06,
            "start_logit": -2.291597366333008,
            "end_logit": -1.139280080795288
        },
        {
            "text": "postnatal mouse development.",
            "probability": 6.6203992939819865e-06,
            "start_logit": -2.291597366333008,
            "end_logit": -1.243747591972351
        },
        {
            "text": "implicated in late embryonic and postnatal mouse development. Here, we describe a previously unknown role",
            "probability": 6.482993474687999e-06,
            "start_logit": -2.4170382022857666,
            "end_logit": -1.139280080795288
        },
        {
            "text": "late embryonic and postnatal mouse development. Here, we describe a previously unknown",
            "probability": 5.8726417317071135e-06,
            "start_logit": -1.3951970338821411,
            "end_logit": -2.2599990367889404
        },
        {
            "text": "implicated in late embryonic and postnatal mouse development.",
            "probability": 5.839906862370202e-06,
            "start_logit": -2.4170382022857666,
            "end_logit": -1.243747591972351
        },
        {
            "text": "has been implicated in late embryonic and postnatal mouse development",
            "probability": 5.521841430500234e-06,
            "start_logit": -3.059537410736084,
            "end_logit": -0.6572518348693848
        },
        {
            "text": "late",
            "probability": 5.070231684405098e-06,
            "start_logit": -1.3951970338821411,
            "end_logit": -2.406917095184326
        },
        {
            "text": "in late embryonic and postnatal mouse development",
            "probability": 3.874684747223904e-06,
            "start_logit": -3.4137845039367676,
            "end_logit": -0.6572518348693848
        },
        {
            "text": "late embryonic and postnatal mouse development. Here, we describe a previously unknown role of GRG5 in early",
            "probability": 3.458552339040069e-06,
            "start_logit": -1.3951970338821411,
            "end_logit": -2.7894535064697266
        },
        {
            "text": "has been implicated in late embryonic and postnatal mouse development. Here, we describe a previously unknown role",
            "probability": 3.4099006337749808e-06,
            "start_logit": -3.059537410736084,
            "end_logit": -1.139280080795288
        },
        {
            "text": "postnatal mouse development. Here, we describe a previously unknown role of GRG5 in early developmental stages",
            "probability": 3.3695502186764985e-06,
            "start_logit": -2.291597366333008,
            "end_logit": -1.9191240072250366
        },
        {
            "text": "role",
            "probability": 3.3621982373990326e-06,
            "start_logit": -3.0736255645751953,
            "end_logit": -1.139280080795288
        }
    ],
    "5e29fb27aa19d74431000005_001": [
        {
            "text": "induced constitutive hyperphosphorylation",
            "probability": 0.5104925484730871,
            "start_logit": 4.879667282104492,
            "end_logit": 7.281749725341797
        },
        {
            "text": "constitutive hyperphosphorylation",
            "probability": 0.41342760063900913,
            "start_logit": 4.668773651123047,
            "end_logit": 7.281749725341797
        },
        {
            "text": "hyperphosphorylation",
            "probability": 0.049533269533898985,
            "start_logit": 2.546935796737671,
            "end_logit": 7.281749725341797
        },
        {
            "text": "LB100 also induced constitutive hyperphosphorylation",
            "probability": 0.012146273694455818,
            "start_logit": 1.1413136720657349,
            "end_logit": 7.281749725341797
        },
        {
            "text": "induced constitutive hyperphosphory",
            "probability": 0.0022805356735151067,
            "start_logit": 4.879667282104492,
            "end_logit": 1.870784044265747
        },
        {
            "text": "induced constitutive hyperphosphorylation of DDR proteins",
            "probability": 0.0019513725721784362,
            "start_logit": 4.879667282104492,
            "end_logit": 1.7149066925048828
        },
        {
            "text": "constitutive hyperphosphory",
            "probability": 0.0018469150911077854,
            "start_logit": 4.668773651123047,
            "end_logit": 1.870784044265747
        },
        {
            "text": "constitutive hyperphosphorylation of DDR proteins",
            "probability": 0.0015803389939413267,
            "start_logit": 4.668773651123047,
            "end_logit": 1.7149066925048828
        },
        {
            "text": "also induced constitutive hyperphosphorylation",
            "probability": 0.0014300694910521496,
            "start_logit": -0.9979857206344604,
            "end_logit": 7.281749725341797
        },
        {
            "text": "induced constitutive hyperphosphorylation of",
            "probability": 0.0010399993989785297,
            "start_logit": 4.879667282104492,
            "end_logit": 1.085593819618225
        },
        {
            "text": "constitutive hyperphosphorylation of",
            "probability": 0.0008422541278452619,
            "start_logit": 4.668773651123047,
            "end_logit": 1.085593819618225
        },
        {
            "text": "induced constitutive",
            "probability": 0.0006190030047827635,
            "start_logit": 4.879667282104492,
            "end_logit": 0.5667285323143005
        },
        {
            "text": "induced constitutive hyperphosph",
            "probability": 0.0005952825950394702,
            "start_logit": 4.879667282104492,
            "end_logit": 0.5276546478271484
        },
        {
            "text": "constitutive",
            "probability": 0.0005013059011754929,
            "start_logit": 4.668773651123047,
            "end_logit": 0.5667285323143005
        },
        {
            "text": "constitutive hyperphosph",
            "probability": 0.0004820956852464335,
            "start_logit": 4.668773651123047,
            "end_logit": 0.5276546478271484
        },
        {
            "text": "modulation",
            "probability": 0.00027836790174517334,
            "start_logit": 1.640971064567566,
            "end_logit": 3.006258249282837
        },
        {
            "text": "by modulation",
            "probability": 0.0002729375405889332,
            "start_logit": 1.6212704181671143,
            "end_logit": 3.006258249282837
        },
        {
            "text": "induced constitutive hyper",
            "probability": 0.00023534584602475248,
            "start_logit": 4.879667282104492,
            "end_logit": -0.4003254771232605
        },
        {
            "text": "hyperphosphory",
            "probability": 0.00022128116959938536,
            "start_logit": 2.546935796737671,
            "end_logit": 1.870784044265747
        },
        {
            "text": "induced constitutive hyperphos",
            "probability": 0.00021436988663696722,
            "start_logit": 4.879667282104492,
            "end_logit": -0.49367862939834595
        },
        {
            "text": "",
            "probability": 8.832780090998767e-06,
            "start_logit": 0.31517037749290466,
            "end_logit": 0.8815851211547852
        }
    ],
    "5e480909d14c9f295d000003_001": [
        {
            "text": "",
            "probability": 0.4696360937363425,
            "start_logit": 2.30288028717041,
            "end_logit": 2.627042770385742
        },
        {
            "text": "excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.10814957355328433,
            "start_logit": 1.4197518825531006,
            "end_logit": 2.0417282581329346
        },
        {
            "text": "excess cardiovascular disease or cancer mortality",
            "probability": 0.09683063051614052,
            "start_logit": 1.4197518825531006,
            "end_logit": 1.9311764240264893
        },
        {
            "text": "cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.08666079415724005,
            "start_logit": 1.1982382535934448,
            "end_logit": 2.0417282581329346
        },
        {
            "text": "cardiovascular disease or cancer mortality",
            "probability": 0.07759086849418452,
            "start_logit": 1.1982382535934448,
            "end_logit": 1.9311764240264893
        },
        {
            "text": "excess cardiovascular disease",
            "probability": 0.034956909578098584,
            "start_logit": 1.4197518825531006,
            "end_logit": 0.9123291969299316
        },
        {
            "text": "cardiovascular disease",
            "probability": 0.028011146468629386,
            "start_logit": 1.1982382535934448,
            "end_logit": 0.9123291969299316
        },
        {
            "text": "early NASA astronauts",
            "probability": 0.025934581795251946,
            "start_logit": -0.008186044171452522,
            "end_logit": 2.0417282581329346
        },
        {
            "text": "cancer mortality in early NASA astronauts",
            "probability": 0.007860323764658604,
            "start_logit": -1.2019355297088623,
            "end_logit": 2.0417282581329346
        },
        {
            "text": "mortality in early NASA astronauts",
            "probability": 0.007856166353708038,
            "start_logit": -1.2024645805358887,
            "end_logit": 2.0417282581329346
        },
        {
            "text": "evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.007470198828237114,
            "start_logit": -1.2528417110443115,
            "end_logit": 2.0417282581329346
        },
        {
            "text": "cancer mortality",
            "probability": 0.007037661649381344,
            "start_logit": -1.2019355297088623,
            "end_logit": 1.9311764240264893
        },
        {
            "text": "mortality",
            "probability": 0.007033939353394114,
            "start_logit": -1.2024645805358887,
            "end_logit": 1.9311764240264893
        },
        {
            "text": "evidence for excess cardiovascular disease or cancer mortality",
            "probability": 0.0066883672200773745,
            "start_logit": -1.2528417110443115,
            "end_logit": 1.9311764240264893
        },
        {
            "text": "excess cardiovascular disease or cancer mortality in early NASA",
            "probability": 0.006096520362094095,
            "start_logit": 1.4197518825531006,
            "end_logit": -0.834068775177002
        },
        {
            "text": "cardiovascular disease or cancer mortality in early NASA",
            "probability": 0.0048851722555758,
            "start_logit": 1.1982382535934448,
            "end_logit": -0.834068775177002
        },
        {
            "text": "whether there is evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.00472663594970237,
            "start_logit": -1.7105495929718018,
            "end_logit": 2.0417282581329346
        },
        {
            "text": "there is evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.0044015693566809315,
            "start_logit": -1.7818021774291992,
            "end_logit": 2.0417282581329346
        },
        {
            "text": "whether there is evidence for excess cardiovascular disease or cancer mortality",
            "probability": 0.00423194585232868,
            "start_logit": -1.7105495929718018,
            "end_logit": 1.9311764240264893
        },
        {
            "text": "there is evidence for excess cardiovascular disease or cancer mortality",
            "probability": 0.003940900754989565,
            "start_logit": -1.7818021774291992,
            "end_logit": 1.9311764240264893
        }
    ],
    "5e480909d14c9f295d000003_002": [
        {
            "text": "",
            "probability": 0.4696360937363425,
            "start_logit": 2.30288028717041,
            "end_logit": 2.627042770385742
        },
        {
            "text": "excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.10814957355328433,
            "start_logit": 1.4197518825531006,
            "end_logit": 2.0417282581329346
        },
        {
            "text": "excess cardiovascular disease or cancer mortality",
            "probability": 0.09683063051614052,
            "start_logit": 1.4197518825531006,
            "end_logit": 1.9311764240264893
        },
        {
            "text": "cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.08666079415724005,
            "start_logit": 1.1982382535934448,
            "end_logit": 2.0417282581329346
        },
        {
            "text": "cardiovascular disease or cancer mortality",
            "probability": 0.07759086849418452,
            "start_logit": 1.1982382535934448,
            "end_logit": 1.9311764240264893
        },
        {
            "text": "excess cardiovascular disease",
            "probability": 0.034956909578098584,
            "start_logit": 1.4197518825531006,
            "end_logit": 0.9123291969299316
        },
        {
            "text": "cardiovascular disease",
            "probability": 0.028011146468629386,
            "start_logit": 1.1982382535934448,
            "end_logit": 0.9123291969299316
        },
        {
            "text": "early NASA astronauts",
            "probability": 0.025934581795251946,
            "start_logit": -0.008186044171452522,
            "end_logit": 2.0417282581329346
        },
        {
            "text": "cancer mortality in early NASA astronauts",
            "probability": 0.007860323764658604,
            "start_logit": -1.2019355297088623,
            "end_logit": 2.0417282581329346
        },
        {
            "text": "mortality in early NASA astronauts",
            "probability": 0.007856166353708038,
            "start_logit": -1.2024645805358887,
            "end_logit": 2.0417282581329346
        },
        {
            "text": "evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.007470198828237114,
            "start_logit": -1.2528417110443115,
            "end_logit": 2.0417282581329346
        },
        {
            "text": "cancer mortality",
            "probability": 0.007037661649381344,
            "start_logit": -1.2019355297088623,
            "end_logit": 1.9311764240264893
        },
        {
            "text": "mortality",
            "probability": 0.007033939353394114,
            "start_logit": -1.2024645805358887,
            "end_logit": 1.9311764240264893
        },
        {
            "text": "evidence for excess cardiovascular disease or cancer mortality",
            "probability": 0.0066883672200773745,
            "start_logit": -1.2528417110443115,
            "end_logit": 1.9311764240264893
        },
        {
            "text": "excess cardiovascular disease or cancer mortality in early NASA",
            "probability": 0.006096520362094095,
            "start_logit": 1.4197518825531006,
            "end_logit": -0.834068775177002
        },
        {
            "text": "cardiovascular disease or cancer mortality in early NASA",
            "probability": 0.0048851722555758,
            "start_logit": 1.1982382535934448,
            "end_logit": -0.834068775177002
        },
        {
            "text": "whether there is evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.00472663594970237,
            "start_logit": -1.7105495929718018,
            "end_logit": 2.0417282581329346
        },
        {
            "text": "there is evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.0044015693566809315,
            "start_logit": -1.7818021774291992,
            "end_logit": 2.0417282581329346
        },
        {
            "text": "whether there is evidence for excess cardiovascular disease or cancer mortality",
            "probability": 0.00423194585232868,
            "start_logit": -1.7105495929718018,
            "end_logit": 1.9311764240264893
        },
        {
            "text": "there is evidence for excess cardiovascular disease or cancer mortality",
            "probability": 0.003940900754989565,
            "start_logit": -1.7818021774291992,
            "end_logit": 1.9311764240264893
        }
    ],
    "5e480909d14c9f295d000003_003": [
        {
            "text": "",
            "probability": 0.9990914843103044,
            "start_logit": 2.7733724117279053,
            "end_logit": 3.3377482891082764
        },
        {
            "text": "long-duration astronauts",
            "probability": 0.0001651122074748225,
            "start_logit": -1.5414880514144897,
            "end_logit": -1.0553675889968872
        },
        {
            "text": "long-duration astronauts remains limited.",
            "probability": 0.00011655452197939948,
            "start_logit": -1.5414880514144897,
            "end_logit": -1.403633713722229
        },
        {
            "text": "long-duration astronauts remains limited",
            "probability": 0.00011359805024484804,
            "start_logit": -1.5414880514144897,
            "end_logit": -1.4293265342712402
        },
        {
            "text": "long-duration",
            "probability": 0.00011218587747988163,
            "start_logit": -1.5414880514144897,
            "end_logit": -1.4418357610702515
        },
        {
            "text": "long-duration astronauts remains limited. There is a disparity between research results and observed empirical effects seen in human astronaut crews",
            "probability": 7.114986861656948e-05,
            "start_logit": -1.5414880514144897,
            "end_logit": -1.8972043991088867
        },
        {
            "text": "There is a disparity between research results and observed empirical effects seen in human astronaut crews",
            "probability": 6.917063393813368e-05,
            "start_logit": -1.5697001218795776,
            "end_logit": -1.8972043991088867
        },
        {
            "text": "long-duration astronauts remains limited. There is a disparity between research results and observed empirical effects",
            "probability": 3.317707211554634e-05,
            "start_logit": -1.5414880514144897,
            "end_logit": -2.6601338386535645
        },
        {
            "text": "There is a disparity between research results and observed empirical effects",
            "probability": 3.225415809002749e-05,
            "start_logit": -1.5697001218795776,
            "end_logit": -2.6601338386535645
        },
        {
            "text": "limited.",
            "probability": 2.774732056827494e-05,
            "start_logit": -2.976707935333252,
            "end_logit": -1.403633713722229
        },
        {
            "text": "limited",
            "probability": 2.7043494002162458e-05,
            "start_logit": -2.976707935333252,
            "end_logit": -1.4293265342712402
        },
        {
            "text": "risk it poses to long-duration astronauts",
            "probability": 2.1623307933843673e-05,
            "start_logit": -3.5743415355682373,
            "end_logit": -1.0553675889968872
        },
        {
            "text": "long-duration astronauts remains limited. There is a disparity between research results and observed empirical effects seen in human astronaut crews,",
            "probability": 1.7315782670435724e-05,
            "start_logit": -1.5414880514144897,
            "end_logit": -3.3103744983673096
        },
        {
            "text": "limited. There is a disparity between research results and observed empirical effects seen in human astronaut crews",
            "probability": 1.6938152028486143e-05,
            "start_logit": -2.976707935333252,
            "end_logit": -1.8972043991088867
        },
        {
            "text": "There is a disparity between research results and observed empirical effects seen in human astronaut crews,",
            "probability": 1.6834095237809845e-05,
            "start_logit": -1.5697001218795776,
            "end_logit": -3.3103744983673096
        },
        {
            "text": "risk it poses to long-duration astronauts remains limited.",
            "probability": 1.526413072895787e-05,
            "start_logit": -3.5743415355682373,
            "end_logit": -1.403633713722229
        },
        {
            "text": "risk it poses to long-duration astronauts remains limited",
            "probability": 1.4876947372308368e-05,
            "start_logit": -3.5743415355682373,
            "end_logit": -1.4293265342712402
        },
        {
            "text": "risk it poses to long-duration",
            "probability": 1.4692007403182752e-05,
            "start_logit": -3.5743415355682373,
            "end_logit": -1.4418357610702515
        },
        {
            "text": "astronauts",
            "probability": 1.1508443586352504e-05,
            "start_logit": -4.2050323486328125,
            "end_logit": -1.0553675889968872
        },
        {
            "text": "space radiation environment and the risk it poses to long-duration astronauts",
            "probability": 1.1469618224842743e-05,
            "start_logit": -4.208411693572998,
            "end_logit": -1.0553675889968872
        }
    ],
    "5e2905da8b3851296d000009_001": [
        {
            "text": "",
            "probability": 0.7045284996108802,
            "start_logit": 1.172037959098816,
            "end_logit": 1.588883876800537
        },
        {
            "text": "an APOC3 antisense oligonucleotide",
            "probability": 0.051711252136684774,
            "start_logit": 0.061055801808834076,
            "end_logit": 0.08801265060901642
        },
        {
            "text": "inhibits TRL catabolism",
            "probability": 0.03594288119583913,
            "start_logit": -1.2449792623519897,
            "end_logit": 1.0303033590316772
        },
        {
            "text": "APOC3 antisense oligonucleotide",
            "probability": 0.03370373753411372,
            "start_logit": -0.36701086163520813,
            "end_logit": 0.08801265060901642
        },
        {
            "text": "apoC-III inhibits TRL catabolism",
            "probability": 0.03295078861442342,
            "start_logit": -1.331895112991333,
            "end_logit": 1.0303033590316772
        },
        {
            "text": "unique mechanisms by which apoC-III inhibits TRL catabolism",
            "probability": 0.028230282862966485,
            "start_logit": -1.4865150451660156,
            "end_logit": 1.0303033590316772
        },
        {
            "text": "Clinical trials with Volanesorsen, an APOC3 antisense oligonucleotide",
            "probability": 0.01782890036144889,
            "start_logit": -1.0037988424301147,
            "end_logit": 0.08801265060901642
        },
        {
            "text": "an APOC3 antisense oligonucleotide, report very promising lipid-lowering outcomes.",
            "probability": 0.011418280968213994,
            "start_logit": 0.061055801808834076,
            "end_logit": -1.4224470853805542
        },
        {
            "text": "antisense oligonucleotide",
            "probability": 0.010807925045130671,
            "start_logit": -1.5043399333953857,
            "end_logit": 0.08801265060901642
        },
        {
            "text": "an APOC3 antisense oligonucleotide, report very promising lipid-lowering outcomes",
            "probability": 0.010051409422186687,
            "start_logit": 0.061055801808834076,
            "end_logit": -1.5499498844146729
        },
        {
            "text": "an APOC3 antisense oligonucleotide, report very promising lipid-lowering",
            "probability": 0.009742370273012203,
            "start_logit": 0.061055801808834076,
            "end_logit": -1.5811783075332642
        },
        {
            "text": "APOC3 antisense oligonucleotide, report very promising lipid-lowering outcomes.",
            "probability": 0.007442069741924498,
            "start_logit": -0.36701086163520813,
            "end_logit": -1.4224470853805542
        },
        {
            "text": "an APOC3 antisense oligonucleotide,",
            "probability": 0.006875123216430791,
            "start_logit": 0.061055801808834076,
            "end_logit": -1.9297531843185425
        },
        {
            "text": "TRL catabolism",
            "probability": 0.006640848799315747,
            "start_logit": -2.9336705207824707,
            "end_logit": 1.0303033590316772
        },
        {
            "text": "APOC3 antisense oligonucleotide, report very promising lipid-lowering outcomes",
            "probability": 0.006551186656974583,
            "start_logit": -0.36701086163520813,
            "end_logit": -1.5499498844146729
        },
        {
            "text": "APOC3 antisense oligonucleotide, report very promising lipid-lowering",
            "probability": 0.006349764839842572,
            "start_logit": -0.36701086163520813,
            "end_logit": -1.5811783075332642
        },
        {
            "text": "APOC3 missense variants revealed unique mechanisms by which apoC-III inhibits TRL catabolism",
            "probability": 0.005959974352290118,
            "start_logit": -3.041844129562378,
            "end_logit": 1.0303033590316772
        },
        {
            "text": "by which apoC-III inhibits TRL catabolism",
            "probability": 0.005424764693073298,
            "start_logit": -3.1359357833862305,
            "end_logit": 1.0303033590316772
        },
        {
            "text": "APOC3 antisense oligonucleotide,",
            "probability": 0.004480985062763374,
            "start_logit": -0.36701086163520813,
            "end_logit": -1.9297531843185425
        },
        {
            "text": "Clinical trials with Volanesorsen, an APOC3 antisense oligonucleotide, report very promising lipid-lowering",
            "probability": 0.003358954612484691,
            "start_logit": -1.0037988424301147,
            "end_logit": -1.5811783075332642
        }
    ],
    "5e2905da8b3851296d000009_003": [
        {
            "text": "modulation of multiple symptom domains",
            "probability": 0.3830162225435262,
            "start_logit": 1.9984110593795776,
            "end_logit": 2.6116108894348145
        },
        {
            "text": "through modulation of multiple symptom domains",
            "probability": 0.220520651725447,
            "start_logit": 1.4463250637054443,
            "end_logit": 2.6116108894348145
        },
        {
            "text": "modulation of multiple symptom domains.",
            "probability": 0.10300456196139222,
            "start_logit": 1.9984110593795776,
            "end_logit": 1.2983068227767944
        },
        {
            "text": "through modulation of multiple symptom domains.",
            "probability": 0.0593046241842644,
            "start_logit": 1.4463250637054443,
            "end_logit": 1.2983068227767944
        },
        {
            "text": "reduce disease burden in patients with FCS through modulation of multiple symptom domains",
            "probability": 0.03743104622969502,
            "start_logit": -0.327165812253952,
            "end_logit": 2.6116108894348145
        },
        {
            "text": "the potential to reduce disease burden in patients with FCS through modulation of multiple symptom domains",
            "probability": 0.031064120720784044,
            "start_logit": -0.5136128067970276,
            "end_logit": 2.6116108894348145
        },
        {
            "text": "has the potential to reduce disease burden in patients with FCS through modulation of multiple symptom domains",
            "probability": 0.023907407295702555,
            "start_logit": -0.775477945804596,
            "end_logit": 2.6116108894348145
        },
        {
            "text": "Treatment with volanesorsen has the potential to reduce disease burden in patients with FCS through modulation of multiple symptom domains",
            "probability": 0.021974473922830372,
            "start_logit": -0.8597847819328308,
            "end_logit": 2.6116108894348145
        },
        {
            "text": "potential to reduce disease burden in patients with FCS through modulation of multiple symptom domains",
            "probability": 0.020660348381050346,
            "start_logit": -0.9214499592781067,
            "end_logit": 2.6116108894348145
        },
        {
            "text": "to reduce disease burden in patients with FCS through modulation of multiple symptom domains",
            "probability": 0.019800082166360675,
            "start_logit": -0.9639801979064941,
            "end_logit": 2.6116108894348145
        },
        {
            "text": "modulation",
            "probability": 0.016119503182559218,
            "start_logit": 1.9984110593795776,
            "end_logit": -0.5564365386962891
        },
        {
            "text": "reduce disease burden in patients with FCS through modulation of multiple symptom domains.",
            "probability": 0.010066332164842465,
            "start_logit": -0.327165812253952,
            "end_logit": 1.2983068227767944
        },
        {
            "text": "through modulation",
            "probability": 0.009280764463976248,
            "start_logit": 1.4463250637054443,
            "end_logit": -0.5564365386962891
        },
        {
            "text": "the potential to reduce disease burden in patients with FCS through modulation of multiple symptom domains.",
            "probability": 0.00835407473425371,
            "start_logit": -0.5136128067970276,
            "end_logit": 1.2983068227767944
        },
        {
            "text": "has the potential to reduce disease burden in patients with FCS through modulation of multiple symptom domains.",
            "probability": 0.006429419620331058,
            "start_logit": -0.775477945804596,
            "end_logit": 1.2983068227767944
        },
        {
            "text": "modulation of multiple symptom",
            "probability": 0.005957713863603409,
            "start_logit": 1.9984110593795776,
            "end_logit": -1.5517796277999878
        },
        {
            "text": "Treatment with volanesorsen has the potential to reduce disease burden in patients with FCS through modulation of multiple symptom domains.",
            "probability": 0.0059095958017703985,
            "start_logit": -0.8597847819328308,
            "end_logit": 1.2983068227767944
        },
        {
            "text": "potential to reduce disease burden in patients with FCS through modulation of multiple symptom domains.",
            "probability": 0.005556187988141965,
            "start_logit": -0.9214499592781067,
            "end_logit": 1.2983068227767944
        },
        {
            "text": "to reduce disease burden in patients with FCS through modulation of multiple symptom domains.",
            "probability": 0.005324836574288405,
            "start_logit": -0.9639801979064941,
            "end_logit": 1.2983068227767944
        },
        {
            "text": "through modulation of multiple symptom",
            "probability": 0.0034301391603491515,
            "start_logit": 1.4463250637054443,
            "end_logit": -1.5517796277999878
        },
        {
            "text": "",
            "probability": 0.0028878933148309433,
            "start_logit": -0.2625538408756256,
            "end_logit": -0.014974275603890419
        }
    ],
    "5e2905da8b3851296d000009_004": [
        {
            "text": "",
            "probability": 0.8479517057371936,
            "start_logit": 1.2880146503448486,
            "end_logit": 1.695047378540039
        },
        {
            "text": "apo C-III antisense oligonucleotide drug",
            "probability": 0.04315131439945023,
            "start_logit": -0.04581156745553017,
            "end_logit": 0.05076279118657112
        },
        {
            "text": "reducing levels of apo C-III mRNA.",
            "probability": 0.013191482937394125,
            "start_logit": -0.3754459619522095,
            "end_logit": -0.804744303226471
        },
        {
            "text": "reducing levels of apo C-III mRNA",
            "probability": 0.013117241956937432,
            "start_logit": -0.3754459619522095,
            "end_logit": -0.8103881478309631
        },
        {
            "text": "antisense oligonucleotide drug",
            "probability": 0.010802584386468814,
            "start_logit": -1.4307390451431274,
            "end_logit": 0.05076279118657112
        },
        {
            "text": "New apo C-III antisense oligonucleotide drug",
            "probability": 0.009496119140939866,
            "start_logit": -1.5596412420272827,
            "end_logit": 0.05076279118657112
        },
        {
            "text": "showed to be promising in decreasing elevated TGs by reducing levels of apo C-III mRNA.",
            "probability": 0.00795064737829855,
            "start_logit": -0.8817639946937561,
            "end_logit": -0.804744303226471
        },
        {
            "text": "showed to be promising in decreasing elevated TGs by reducing levels of apo C-III mRNA",
            "probability": 0.00790590154802066,
            "start_logit": -0.8817639946937561,
            "end_logit": -0.8103881478309631
        },
        {
            "text": "decreasing elevated TGs by reducing levels of apo C-III mRNA.",
            "probability": 0.007417678217231786,
            "start_logit": -0.9511512517929077,
            "end_logit": -0.804744303226471
        },
        {
            "text": "decreasing elevated TGs by reducing levels of apo C-III mRNA",
            "probability": 0.007375931909695848,
            "start_logit": -0.9511512517929077,
            "end_logit": -0.8103881478309631
        },
        {
            "text": "apo C-III antisense oligonucleotide",
            "probability": 0.006841046116378407,
            "start_logit": -0.04581156745553017,
            "end_logit": -1.7910094261169434
        },
        {
            "text": "apo C-III",
            "probability": 0.005158823836268567,
            "start_logit": -0.04581156745553017,
            "end_logit": -2.0732414722442627
        },
        {
            "text": "apo C-III antisense oligonucleotide drug (Volanesorsen) showed to be promising",
            "probability": 0.003543724780603075,
            "start_logit": -0.04581156745553017,
            "end_logit": -2.4487717151641846
        },
        {
            "text": "prevention of cardiovascular disease New apo C-III antisense oligonucleotide drug",
            "probability": 0.002818180065321503,
            "start_logit": -2.774433135986328,
            "end_logit": 0.05076279118657112
        },
        {
            "text": "apo C-III antisense",
            "probability": 0.002749685276407813,
            "start_logit": -0.04581156745553017,
            "end_logit": -2.7024636268615723
        },
        {
            "text": "promising in decreasing elevated TGs by reducing levels of apo C-III mRNA.",
            "probability": 0.002443867658352325,
            "start_logit": -2.0614354610443115,
            "end_logit": -0.804744303226471
        },
        {
            "text": "promising in decreasing elevated TGs by reducing levels of apo C-III mRNA",
            "probability": 0.0024301136981703234,
            "start_logit": -2.0614354610443115,
            "end_logit": -0.8103881478309631
        },
        {
            "text": "in decreasing elevated TGs by reducing levels of apo C-III mRNA.",
            "probability": 0.001976236127711705,
            "start_logit": -2.2738232612609863,
            "end_logit": -0.804744303226471
        },
        {
            "text": "in decreasing elevated TGs by reducing levels of apo C-III mRNA",
            "probability": 0.001965113973482983,
            "start_logit": -2.2738232612609863,
            "end_logit": -0.8103881478309631
        },
        {
            "text": "antisense oligonucleotide",
            "probability": 0.0017126008556727535,
            "start_logit": -1.4307390451431274,
            "end_logit": -1.7910094261169434
        }
    ],
    "5e2905da8b3851296d000009_005": [
        {
            "text": "inhibits the production of the Apo C-III",
            "probability": 0.3980348645940436,
            "start_logit": 1.7572605609893799,
            "end_logit": 1.4000784158706665
        },
        {
            "text": "inhibits lipoprotein lipase (LPL) and hepatic lipase activity",
            "probability": 0.10755270620252481,
            "start_logit": 1.2206063270568848,
            "end_logit": 0.6281740665435791
        },
        {
            "text": "inhibits the production of the Apo C-III which is crucial in regulating TGs metabolism",
            "probability": 0.09541245482015503,
            "start_logit": 1.7572605609893799,
            "end_logit": -0.02825206145644188
        },
        {
            "text": "antisense oligonucleotid that inhibits the production of the Apo C-III",
            "probability": 0.07593994032252319,
            "start_logit": 0.10066372901201248,
            "end_logit": 1.4000784158706665
        },
        {
            "text": "an antisense oligonucleotid that inhibits the production of the Apo C-III",
            "probability": 0.06415258847241845,
            "start_logit": -0.06801459938287735,
            "end_logit": 1.4000784158706665
        },
        {
            "text": "is an antisense oligonucleotid that inhibits the production of the Apo C-III",
            "probability": 0.04347800642101656,
            "start_logit": -0.45702382922172546,
            "end_logit": 1.4000784158706665
        },
        {
            "text": "it inhibits lipoprotein lipase (LPL) and hepatic lipase activity",
            "probability": 0.03743978817854664,
            "start_logit": 0.16535930335521698,
            "end_logit": 0.6281740665435791
        },
        {
            "text": "inhibits lipoprotein lipase",
            "probability": 0.026324885941115112,
            "start_logit": 1.2206063270568848,
            "end_logit": -0.7792922258377075
        },
        {
            "text": "",
            "probability": 0.025001934644361377,
            "start_logit": -0.009801847860217094,
            "end_logit": 0.39955443143844604
        },
        {
            "text": "inhibits lipoprotein lipase (LPL)",
            "probability": 0.02207944813848451,
            "start_logit": 1.2206063270568848,
            "end_logit": -0.9551597237586975
        },
        {
            "text": "Apo C-III",
            "probability": 0.015130747388341909,
            "start_logit": -1.5125501155853271,
            "end_logit": 1.4000784158706665
        },
        {
            "text": "antisense oligonucleotid",
            "probability": 0.014849069400230848,
            "start_logit": 0.10066372901201248,
            "end_logit": -0.23192715644836426
        },
        {
            "text": "an antisense oligonucleotid",
            "probability": 0.012544205781379252,
            "start_logit": -0.06801459938287735,
            "end_logit": -0.23192715644836426
        },
        {
            "text": "that inhibits the production of the Apo C-III",
            "probability": 0.012169059179353103,
            "start_logit": -1.7303824424743652,
            "end_logit": 1.4000784158706665
        },
        {
            "text": "inhibits lipoprotein lipase (LPL) and hepatic lipase activity but also hepatic uptake",
            "probability": 0.009676771293654218,
            "start_logit": 1.2206063270568848,
            "end_logit": -1.780078649520874
        },
        {
            "text": "it inhibits lipoprotein lipase",
            "probability": 0.009163861963676124,
            "start_logit": 0.16535930335521698,
            "end_logit": -0.7792922258377075
        },
        {
            "text": "is an antisense oligonucleotid",
            "probability": 0.008501559679760178,
            "start_logit": -0.45702382922172546,
            "end_logit": -0.23192715644836426
        },
        {
            "text": "inhibits the production",
            "probability": 0.008016797544712264,
            "start_logit": 1.7572605609893799,
            "end_logit": -2.5049221515655518
        },
        {
            "text": "it inhibits lipoprotein lipase (LPL)",
            "probability": 0.007685997782775088,
            "start_logit": 0.16535930335521698,
            "end_logit": -0.9551597237586975
        },
        {
            "text": "inhibits the production of the Apo C-III which is crucial in regulating TGs metabolism because it inhibits",
            "probability": 0.006845312250927488,
            "start_logit": 1.7572605609893799,
            "end_logit": -2.6628971099853516
        }
    ],
    "5e2905da8b3851296d000009_006": [
        {
            "text": "",
            "probability": 0.31748560793329833,
            "start_logit": 1.2971289157867432,
            "end_logit": 1.896101713180542
        },
        {
            "text": "targets apolipoprotein C-III",
            "probability": 0.31243967642317166,
            "start_logit": 0.6906046271324158,
            "end_logit": 2.486604928970337
        },
        {
            "text": "apolipoprotein C-III",
            "probability": 0.28193281637088924,
            "start_logit": 0.5878620147705078,
            "end_logit": 2.486604928970337
        },
        {
            "text": "which targets apolipoprotein C-III",
            "probability": 0.049263229007688966,
            "start_logit": -1.1566288471221924,
            "end_logit": 2.486604928970337
        },
        {
            "text": "(which targets apolipoprotein C-III",
            "probability": 0.008519385744868989,
            "start_logit": -2.9114625453948975,
            "end_logit": 2.486604928970337
        },
        {
            "text": "targets apolipoprotein C-III)",
            "probability": 0.0053270634020774615,
            "start_logit": 0.6906046271324158,
            "end_logit": -1.5850063562393188
        },
        {
            "text": "apolipoprotein C-III)",
            "probability": 0.004806924668235269,
            "start_logit": 0.5878620147705078,
            "end_logit": -1.5850063562393188
        },
        {
            "text": "Some new drugs are on the horizon, such as volanesorsen (which targets apolipoprotein C-III",
            "probability": 0.00398227628483984,
            "start_logit": -3.6719532012939453,
            "end_logit": 2.486604928970337
        },
        {
            "text": "new drugs are on the horizon, such as volanesorsen (which targets apolipoprotein C-III",
            "probability": 0.0035414032096893686,
            "start_logit": -3.7892837524414062,
            "end_logit": 2.486604928970337
        },
        {
            "text": "C-III",
            "probability": 0.0030030786869100117,
            "start_logit": -3.9541687965393066,
            "end_logit": 2.486604928970337
        },
        {
            "text": "drugs are on the horizon, such as volanesorsen (which targets apolipoprotein C-III",
            "probability": 0.0018642610027603743,
            "start_logit": -4.430942058563232,
            "end_logit": 2.486604928970337
        },
        {
            "text": "targets apolipoprotein C",
            "probability": 0.0017930114553896996,
            "start_logit": 0.6906046271324158,
            "end_logit": -2.673909902572632
        },
        {
            "text": "apolipoprotein C",
            "probability": 0.0016179403819334983,
            "start_logit": 0.5878620147705078,
            "end_logit": -2.673909902572632
        },
        {
            "text": "targets apolipoprotein C-III), pemafibrate, and others.",
            "probability": 0.0008639945747944311,
            "start_logit": 0.6906046271324158,
            "end_logit": -3.4039952754974365
        },
        {
            "text": "which targets apolipoprotein C-III)",
            "probability": 0.0008399328386180534,
            "start_logit": -1.1566288471221924,
            "end_logit": -1.5850063562393188
        },
        {
            "text": "apolipoprotein C-III), pemafibrate, and others.",
            "probability": 0.0007796334530542916,
            "start_logit": 0.5878620147705078,
            "end_logit": -3.4039952754974365
        },
        {
            "text": "targets",
            "probability": 0.0006273647883015497,
            "start_logit": 0.6906046271324158,
            "end_logit": -3.7240335941314697
        },
        {
            "text": "targets apolipoprotein C-III), pemafibrate",
            "probability": 0.0005412703826703559,
            "start_logit": 0.6906046271324158,
            "end_logit": -3.871642827987671
        },
        {
            "text": "apolipoprotein C-III), pemafibrate",
            "probability": 0.0004884203093262608,
            "start_logit": 0.5878620147705078,
            "end_logit": -3.871642827987671
        },
        {
            "text": "which targets apolipoprotein C",
            "probability": 0.00028270908148246197,
            "start_logit": -1.1566288471221924,
            "end_logit": -2.673909902572632
        }
    ],
    "5c70273c7c78d69471000061_001": [
        {
            "text": "renal, peripheral vascular, and musculoskeletal",
            "probability": 0.6087588598682012,
            "start_logit": 5.7897114753723145,
            "end_logit": 5.868765354156494
        },
        {
            "text": "",
            "probability": 0.1498713893172537,
            "start_logit": 4.989162921905518,
            "end_logit": 5.267669200897217
        },
        {
            "text": "oral damage",
            "probability": 0.1286725969850727,
            "start_logit": 4.670907974243164,
            "end_logit": 5.433417797088623
        },
        {
            "text": "renal, peripheral vascular, and musculoskeletal damage",
            "probability": 0.038346697523190115,
            "start_logit": 5.7897114753723145,
            "end_logit": 3.1040115356445312
        },
        {
            "text": "oral",
            "probability": 0.023869794591418796,
            "start_logit": 4.670907974243164,
            "end_logit": 3.748760461807251
        },
        {
            "text": "peripheral vascular, and musculoskeletal",
            "probability": 0.015719569352921098,
            "start_logit": 2.133195638656616,
            "end_logit": 5.868765354156494
        },
        {
            "text": "musculoskeletal",
            "probability": 0.012530398444621393,
            "start_logit": 1.9064468145370483,
            "end_logit": 5.868765354156494
        },
        {
            "text": "renal, peripheral vascular",
            "probability": 0.010074512706888425,
            "start_logit": 5.7897114753723145,
            "end_logit": 1.7673518657684326
        },
        {
            "text": "renal",
            "probability": 0.0028515776426838043,
            "start_logit": 5.7897114753723145,
            "end_logit": 0.5052155256271362
        },
        {
            "text": "the greatest renal, peripheral vascular, and musculoskeletal",
            "probability": 0.0017616351556505247,
            "start_logit": -0.05546830967068672,
            "end_logit": 5.868765354156494
        },
        {
            "text": "renal, peripheral vascular, and musculoskeletal damage (24, 19, 38% of patients, respectively)",
            "probability": 0.0016762595917621998,
            "start_logit": 5.7897114753723145,
            "end_logit": -0.02609199658036232
        },
        {
            "text": "peripheral vascular, and musculoskeletal damage",
            "probability": 0.000990200900405428,
            "start_logit": 2.133195638656616,
            "end_logit": 3.1040115356445312
        },
        {
            "text": "greatest renal, peripheral vascular, and musculoskeletal",
            "probability": 0.0009539685932389932,
            "start_logit": -0.6688352823257446,
            "end_logit": 5.868765354156494
        },
        {
            "text": "musculoskeletal damage",
            "probability": 0.0007893099068898619,
            "start_logit": 1.9064468145370483,
            "end_logit": 3.1040115356445312
        },
        {
            "text": "The patients with SLE and SS had the greatest renal, peripheral vascular, and musculoskeletal",
            "probability": 0.0007562493263866986,
            "start_logit": -0.901094913482666,
            "end_logit": 5.868765354156494
        },
        {
            "text": "End organ damage is uncommon in primary SS (with the exception of oral damage",
            "probability": 0.0005572028969685218,
            "start_logit": -0.7711890339851379,
            "end_logit": 5.433417797088623
        },
        {
            "text": "patients with SLE and SS had the greatest renal, peripheral vascular, and musculoskeletal",
            "probability": 0.0004784262472236565,
            "start_logit": -1.358963966369629,
            "end_logit": 5.868765354156494
        },
        {
            "text": "re",
            "probability": 0.0004541811192153485,
            "start_logit": 5.7897114753723145,
            "end_logit": -1.331916093826294
        },
        {
            "text": "vascular, and musculoskeletal",
            "probability": 0.0004468569562443971,
            "start_logit": -1.42722749710083,
            "end_logit": 5.868765354156494
        },
        {
            "text": "renal, peripheral vascular, and musculoskeletal damage (24, 19, 38% of patients",
            "probability": 0.00044031287376304477,
            "start_logit": 5.7897114753723145,
            "end_logit": -1.3629266023635864
        }
    ],
    "5c70273c7c78d69471000061_002": [
        {
            "text": "cardiovascular system",
            "probability": 0.7462434213040936,
            "start_logit": 5.771082878112793,
            "end_logit": 6.673086166381836
        },
        {
            "text": "the cardiovascular system",
            "probability": 0.19542061125126028,
            "start_logit": 4.431185245513916,
            "end_logit": 6.673086166381836
        },
        {
            "text": "cardiovascular",
            "probability": 0.020079338490219468,
            "start_logit": 5.771082878112793,
            "end_logit": 3.057725667953491
        },
        {
            "text": "",
            "probability": 0.01014217979862707,
            "start_logit": 3.9331107139587402,
            "end_logit": 4.212709426879883
        },
        {
            "text": "neuropsychiatric and renal systems",
            "probability": 0.009924492210038797,
            "start_logit": 3.432666063308716,
            "end_logit": 4.6914567947387695
        },
        {
            "text": "the cardiovascular",
            "probability": 0.005258226055008201,
            "start_logit": 4.431185245513916,
            "end_logit": 3.057725667953491
        },
        {
            "text": "in the cardiovascular system",
            "probability": 0.003553172002915435,
            "start_logit": 0.4238717555999756,
            "end_logit": 6.673086166381836
        },
        {
            "text": "neuropsychiatric and renal",
            "probability": 0.0026515762224001067,
            "start_logit": 3.432666063308716,
            "end_logit": 3.371605396270752
        },
        {
            "text": "the neuropsychiatric and renal systems",
            "probability": 0.0018585989707998586,
            "start_logit": 1.7574833631515503,
            "end_logit": 4.6914567947387695
        },
        {
            "text": "the prevalence of damage occurring in the cardiovascular system",
            "probability": 0.0009074680350071673,
            "start_logit": -0.9410659074783325,
            "end_logit": 6.673086166381836
        },
        {
            "text": "damage occurring in the cardiovascular system",
            "probability": 0.0006333886049569691,
            "start_logit": -1.3006401062011719,
            "end_logit": 6.673086166381836
        },
        {
            "text": "cardiovascular system in patients with SLE",
            "probability": 0.0005043570701062394,
            "start_logit": 5.771082878112793,
            "end_logit": -0.6264364719390869
        },
        {
            "text": "cardiovascular system in patients with SLE has increased over the past four decades.",
            "probability": 0.0004973924646022441,
            "start_logit": 5.771082878112793,
            "end_logit": -0.640341579914093
        },
        {
            "text": "the neuropsychiatric and renal",
            "probability": 0.0004965711830541052,
            "start_logit": 1.7574833631515503,
            "end_logit": 3.371605396270752
        },
        {
            "text": "card",
            "probability": 0.0004658562432831695,
            "start_logit": 5.771082878112793,
            "end_logit": -0.7058438658714294
        },
        {
            "text": "system",
            "probability": 0.000398435210238832,
            "start_logit": -1.7641793489456177,
            "end_logit": 6.673086166381836
        },
        {
            "text": "prevalence of damage occurring in the cardiovascular system",
            "probability": 0.00032917071495838557,
            "start_logit": -1.9551477432250977,
            "end_logit": 6.673086166381836
        },
        {
            "text": "lupus-related organ damage involving the neuropsychiatric and renal systems",
            "probability": 0.00029327690206201187,
            "start_logit": -0.08897765725851059,
            "end_logit": 4.6914567947387695
        },
        {
            "text": "cardiovascular system in",
            "probability": 0.00020019807147346222,
            "start_logit": 5.771082878112793,
            "end_logit": -1.550413727760315
        },
        {
            "text": "cardiovascular system in patients with SLE has increased over the past four decades",
            "probability": 0.00014226919489444077,
            "start_logit": 5.771082878112793,
            "end_logit": -1.8919999599456787
        }
    ],
    "5c70273c7c78d69471000061_003": [
        {
            "text": "cardiovascular system",
            "probability": 0.7462434213040936,
            "start_logit": 5.771082878112793,
            "end_logit": 6.673086166381836
        },
        {
            "text": "the cardiovascular system",
            "probability": 0.19542061125126028,
            "start_logit": 4.431185245513916,
            "end_logit": 6.673086166381836
        },
        {
            "text": "cardiovascular",
            "probability": 0.020079338490219468,
            "start_logit": 5.771082878112793,
            "end_logit": 3.057725667953491
        },
        {
            "text": "",
            "probability": 0.01014217979862707,
            "start_logit": 3.9331107139587402,
            "end_logit": 4.212709426879883
        },
        {
            "text": "neuropsychiatric and renal systems",
            "probability": 0.009924492210038797,
            "start_logit": 3.432666063308716,
            "end_logit": 4.6914567947387695
        },
        {
            "text": "the cardiovascular",
            "probability": 0.005258226055008201,
            "start_logit": 4.431185245513916,
            "end_logit": 3.057725667953491
        },
        {
            "text": "in the cardiovascular system",
            "probability": 0.003553172002915435,
            "start_logit": 0.4238717555999756,
            "end_logit": 6.673086166381836
        },
        {
            "text": "neuropsychiatric and renal",
            "probability": 0.0026515762224001067,
            "start_logit": 3.432666063308716,
            "end_logit": 3.371605396270752
        },
        {
            "text": "the neuropsychiatric and renal systems",
            "probability": 0.0018585989707998586,
            "start_logit": 1.7574833631515503,
            "end_logit": 4.6914567947387695
        },
        {
            "text": "the prevalence of damage occurring in the cardiovascular system",
            "probability": 0.0009074680350071673,
            "start_logit": -0.9410659074783325,
            "end_logit": 6.673086166381836
        },
        {
            "text": "damage occurring in the cardiovascular system",
            "probability": 0.0006333886049569691,
            "start_logit": -1.3006401062011719,
            "end_logit": 6.673086166381836
        },
        {
            "text": "cardiovascular system in patients with SLE",
            "probability": 0.0005043570701062394,
            "start_logit": 5.771082878112793,
            "end_logit": -0.6264364719390869
        },
        {
            "text": "cardiovascular system in patients with SLE has increased over the past four decades.",
            "probability": 0.0004973924646022441,
            "start_logit": 5.771082878112793,
            "end_logit": -0.640341579914093
        },
        {
            "text": "the neuropsychiatric and renal",
            "probability": 0.0004965711830541052,
            "start_logit": 1.7574833631515503,
            "end_logit": 3.371605396270752
        },
        {
            "text": "card",
            "probability": 0.0004658562432831695,
            "start_logit": 5.771082878112793,
            "end_logit": -0.7058438658714294
        },
        {
            "text": "system",
            "probability": 0.000398435210238832,
            "start_logit": -1.7641793489456177,
            "end_logit": 6.673086166381836
        },
        {
            "text": "prevalence of damage occurring in the cardiovascular system",
            "probability": 0.00032917071495838557,
            "start_logit": -1.9551477432250977,
            "end_logit": 6.673086166381836
        },
        {
            "text": "lupus-related organ damage involving the neuropsychiatric and renal systems",
            "probability": 0.00029327690206201187,
            "start_logit": -0.08897765725851059,
            "end_logit": 4.6914567947387695
        },
        {
            "text": "cardiovascular system in",
            "probability": 0.00020019807147346222,
            "start_logit": 5.771082878112793,
            "end_logit": -1.550413727760315
        },
        {
            "text": "cardiovascular system in patients with SLE has increased over the past four decades",
            "probability": 0.00014226919489444077,
            "start_logit": 5.771082878112793,
            "end_logit": -1.8919999599456787
        }
    ],
    "5c70273c7c78d69471000061_004": [
        {
            "text": "cardiovascular system",
            "probability": 0.7462434213040936,
            "start_logit": 5.771082878112793,
            "end_logit": 6.673086166381836
        },
        {
            "text": "the cardiovascular system",
            "probability": 0.19542061125126028,
            "start_logit": 4.431185245513916,
            "end_logit": 6.673086166381836
        },
        {
            "text": "cardiovascular",
            "probability": 0.020079338490219468,
            "start_logit": 5.771082878112793,
            "end_logit": 3.057725667953491
        },
        {
            "text": "",
            "probability": 0.01014217979862707,
            "start_logit": 3.9331107139587402,
            "end_logit": 4.212709426879883
        },
        {
            "text": "neuropsychiatric and renal systems",
            "probability": 0.009924492210038797,
            "start_logit": 3.432666063308716,
            "end_logit": 4.6914567947387695
        },
        {
            "text": "the cardiovascular",
            "probability": 0.005258226055008201,
            "start_logit": 4.431185245513916,
            "end_logit": 3.057725667953491
        },
        {
            "text": "in the cardiovascular system",
            "probability": 0.003553172002915435,
            "start_logit": 0.4238717555999756,
            "end_logit": 6.673086166381836
        },
        {
            "text": "neuropsychiatric and renal",
            "probability": 0.0026515762224001067,
            "start_logit": 3.432666063308716,
            "end_logit": 3.371605396270752
        },
        {
            "text": "the neuropsychiatric and renal systems",
            "probability": 0.0018585989707998586,
            "start_logit": 1.7574833631515503,
            "end_logit": 4.6914567947387695
        },
        {
            "text": "the prevalence of damage occurring in the cardiovascular system",
            "probability": 0.0009074680350071673,
            "start_logit": -0.9410659074783325,
            "end_logit": 6.673086166381836
        },
        {
            "text": "damage occurring in the cardiovascular system",
            "probability": 0.0006333886049569691,
            "start_logit": -1.3006401062011719,
            "end_logit": 6.673086166381836
        },
        {
            "text": "cardiovascular system in patients with SLE",
            "probability": 0.0005043570701062394,
            "start_logit": 5.771082878112793,
            "end_logit": -0.6264364719390869
        },
        {
            "text": "cardiovascular system in patients with SLE has increased over the past four decades.",
            "probability": 0.0004973924646022441,
            "start_logit": 5.771082878112793,
            "end_logit": -0.640341579914093
        },
        {
            "text": "the neuropsychiatric and renal",
            "probability": 0.0004965711830541052,
            "start_logit": 1.7574833631515503,
            "end_logit": 3.371605396270752
        },
        {
            "text": "card",
            "probability": 0.0004658562432831695,
            "start_logit": 5.771082878112793,
            "end_logit": -0.7058438658714294
        },
        {
            "text": "system",
            "probability": 0.000398435210238832,
            "start_logit": -1.7641793489456177,
            "end_logit": 6.673086166381836
        },
        {
            "text": "prevalence of damage occurring in the cardiovascular system",
            "probability": 0.00032917071495838557,
            "start_logit": -1.9551477432250977,
            "end_logit": 6.673086166381836
        },
        {
            "text": "lupus-related organ damage involving the neuropsychiatric and renal systems",
            "probability": 0.00029327690206201187,
            "start_logit": -0.08897765725851059,
            "end_logit": 4.6914567947387695
        },
        {
            "text": "cardiovascular system in",
            "probability": 0.00020019807147346222,
            "start_logit": 5.771082878112793,
            "end_logit": -1.550413727760315
        },
        {
            "text": "cardiovascular system in patients with SLE has increased over the past four decades",
            "probability": 0.00014226919489444077,
            "start_logit": 5.771082878112793,
            "end_logit": -1.8919999599456787
        }
    ],
    "5c70273c7c78d69471000061_005": [
        {
            "text": "",
            "probability": 0.9885913068571415,
            "start_logit": 3.088411569595337,
            "end_logit": 3.2844860553741455
        },
        {
            "text": "(SDI\u2009=\u20091: 235",
            "probability": 0.0031485290078672734,
            "start_logit": 0.4124566614627838,
            "end_logit": 0.21109531819820404
        },
        {
            "text": "(SDI\u2009=\u20091: 235 (23.5%);",
            "probability": 0.002451165657362299,
            "start_logit": 0.4124566614627838,
            "end_logit": -0.039276354014873505
        },
        {
            "text": "411 (41.2%) patients had organ damage (SDI\u2009=\u20091: 235",
            "probability": 0.0011357750387454345,
            "start_logit": -0.6071634292602539,
            "end_logit": 0.21109531819820404
        },
        {
            "text": "411 (41.2%) patients had organ damage (SDI\u2009=\u20091: 235 (23.5%);",
            "probability": 0.0008842137907911254,
            "start_logit": -0.6071634292602539,
            "end_logit": -0.039276354014873505
        },
        {
            "text": "(SDI\u2009=\u20091:",
            "probability": 0.0005838583532033343,
            "start_logit": 0.4124566614627838,
            "end_logit": -1.473936915397644
        },
        {
            "text": "235",
            "probability": 0.0004907704521687534,
            "start_logit": -1.446257472038269,
            "end_logit": 0.21109531819820404
        },
        {
            "text": "(SDI\u2009=\u20091: 235 (23.5%); SDI\u2009\u2265\u20092: 176 (17.6%))",
            "probability": 0.000421901538741065,
            "start_logit": 0.4124566614627838,
            "end_logit": -1.798823356628418
        },
        {
            "text": "235 (23.5%)",
            "probability": 0.0003820703811203146,
            "start_logit": -1.446257472038269,
            "end_logit": -0.039276354014873505
        },
        {
            "text": "(SDI\u2009=\u20091: 235 (23.5%); SDI\u2009\u2265\u20092:",
            "probability": 0.0003698570689490363,
            "start_logit": 0.4124566614627838,
            "end_logit": -1.9304786920547485
        },
        {
            "text": "411",
            "probability": 0.0003193647431987634,
            "start_logit": -0.6071634292602539,
            "end_logit": -1.0576413869857788
        },
        {
            "text": "411 (41.2%) patients had organ damage (SDI\u2009=\u20091:",
            "probability": 0.0002106163678576205,
            "start_logit": -0.6071634292602539,
            "end_logit": -1.473936915397644
        },
        {
            "text": "(SDI\u2009=\u20091: 235 (23.5%); SDI\u2009\u2265\u20092: 176 (17.6%)) prior to belimumab.",
            "probability": 0.0001898340410631514,
            "start_logit": -0.6116589903831482,
            "end_logit": -1.5733294486999512
        },
        {
            "text": "(SDI\u2009=\u20091: 235 (23.5%); SDI\u2009\u2265\u20092: 176",
            "probability": 0.00018800765438580858,
            "start_logit": 0.4124566614627838,
            "end_logit": -2.6071126461029053
        },
        {
            "text": "411 (41.2%) patients had organ damage (SDI\u2009=\u20091: 235 (23.5%); SDI\u2009\u2265\u20092:",
            "probability": 0.0001334192652398052,
            "start_logit": -0.6071634292602539,
            "end_logit": -1.9304786920547485
        },
        {
            "text": "SDI\u2009\u2265\u20092: 176 (17.6%)) prior to belimumab.",
            "probability": 0.00011405033477595588,
            "start_logit": -1.1211693286895752,
            "end_logit": -1.5733294486999512
        },
        {
            "text": "411 (41.2%",
            "probability": 0.00011279637208033176,
            "start_logit": -0.6071634292602539,
            "end_logit": -2.098391056060791
        },
        {
            "text": "(41.2%) patients had organ damage (SDI\u2009=\u20091: 235",
            "probability": 9.903977935816532e-05,
            "start_logit": -3.0467123985290527,
            "end_logit": 0.21109531819820404
        },
        {
            "text": "SDI\u2009\u2265\u20092: 176 (17.6%))",
            "probability": 9.102607247013953e-05,
            "start_logit": -1.1211693286895752,
            "end_logit": -1.798823356628418
        },
        {
            "text": "235 (23.5%); SDI\u2009\u2265\u20092: 176 (17.6%)) prior to belimumab.",
            "probability": 8.239722348037145e-05,
            "start_logit": -1.446257472038269,
            "end_logit": -1.5733294486999512
        }
    ],
    "5e2d7fabfbd6abf43b00000c_002": [
        {
            "text": "suffices",
            "probability": 0.44819759584069246,
            "start_logit": 5.253620147705078,
            "end_logit": 6.850234508514404
        },
        {
            "text": "Knocking down HMGB2 suffices",
            "probability": 0.38326885677895856,
            "start_logit": 5.097122669219971,
            "end_logit": 6.850234508514404
        },
        {
            "text": "suffices for senescence-induced CTCF clustering",
            "probability": 0.027500541564050057,
            "start_logit": 5.253620147705078,
            "end_logit": 4.059206008911133
        },
        {
            "text": "Knocking down HMGB2 suffices for senescence-induced CTCF clustering",
            "probability": 0.02351663914279914,
            "start_logit": 5.097122669219971,
            "end_logit": 4.059206008911133
        },
        {
            "text": "suffices for senescence-induced CTCF clustering and for loop reshuffling",
            "probability": 0.01758150621433877,
            "start_logit": 5.253620147705078,
            "end_logit": 3.6118478775024414
        },
        {
            "text": "suffices for senescence-induced",
            "probability": 0.015183801974586162,
            "start_logit": 5.253620147705078,
            "end_logit": 3.4652295112609863
        },
        {
            "text": "Knocking down HMGB2 suffices for senescence-induced CTCF clustering and for loop reshuffling",
            "probability": 0.015034538002334332,
            "start_logit": 5.097122669219971,
            "end_logit": 3.6118478775024414
        },
        {
            "text": "Knocking down HMGB2 suffices for senescence-induced",
            "probability": 0.01298418036679119,
            "start_logit": 5.097122669219971,
            "end_logit": 3.4652295112609863
        },
        {
            "text": "suffices for senescence-induced CTCF clustering and for loop reshuffling,",
            "probability": 0.011276156393460201,
            "start_logit": 5.253620147705078,
            "end_logit": 3.1676907539367676
        },
        {
            "text": "Knocking down HMGB2 suffices for senescence-induced CTCF clustering and for loop reshuffling,",
            "probability": 0.009642621044576905,
            "start_logit": 5.097122669219971,
            "end_logit": 3.1676907539367676
        },
        {
            "text": "suffices for senescence",
            "probability": 0.006950681589486893,
            "start_logit": 5.253620147705078,
            "end_logit": 2.683840036392212
        },
        {
            "text": "Knocking down HMGB2 suffices for senescence",
            "probability": 0.005943761883952813,
            "start_logit": 5.097122669219971,
            "end_logit": 2.683840036392212
        },
        {
            "text": "senescence-induced CTCF clustering",
            "probability": 0.004969126735067384,
            "start_logit": 3.542658567428589,
            "end_logit": 4.059206008911133
        },
        {
            "text": "Knocking down",
            "probability": 0.0033027977440388727,
            "start_logit": 5.097122669219971,
            "end_logit": 2.0962677001953125
        },
        {
            "text": "senescence-induced CTCF clustering and for loop reshuffling",
            "probability": 0.0031768368040661146,
            "start_logit": 3.542658567428589,
            "end_logit": 3.6118478775024414
        },
        {
            "text": "senescence-induced",
            "probability": 0.002743590927333481,
            "start_logit": 3.542658567428589,
            "end_logit": 3.4652295112609863
        },
        {
            "text": "suffices for",
            "probability": 0.002346161321859854,
            "start_logit": 5.253620147705078,
            "end_logit": 1.5977808237075806
        },
        {
            "text": "senescence-induced CTCF clustering and for loop reshuffling,",
            "probability": 0.002037510791307197,
            "start_logit": 3.542658567428589,
            "end_logit": 3.1676907539367676
        },
        {
            "text": "Knocking down HMGB2 suffices for",
            "probability": 0.0020062815508003133,
            "start_logit": 5.097122669219971,
            "end_logit": 1.5977808237075806
        },
        {
            "text": "rescues these effects",
            "probability": 0.0013078627063978034,
            "start_logit": 2.4591758251190186,
            "end_logit": 3.8078389167785645
        },
        {
            "text": "",
            "probability": 0.001028950623101112,
            "start_logit": 2.6375820636749268,
            "end_logit": 3.389577865600586
        }
    ],
    "5e29fc57aa19d74431000006_001": [
        {
            "text": "modulation of the DDR pathway and cell-cycle checkpoint abrogation",
            "probability": 0.4704561911382076,
            "start_logit": 2.2152292728424072,
            "end_logit": 4.249988555908203
        },
        {
            "text": "by modulation of the DDR pathway and cell-cycle checkpoint abrogation",
            "probability": 0.1288149845957356,
            "start_logit": 0.919903576374054,
            "end_logit": 4.249988555908203
        },
        {
            "text": "sensitized ovarian carcinoma lines to cisplatin-mediated cell death",
            "probability": 0.12729886356665168,
            "start_logit": 1.5793923139572144,
            "end_logit": 3.578660249710083
        },
        {
            "text": "modulation of the DDR pathway and cell-cycle checkpoint abrogation.",
            "probability": 0.07259591409734296,
            "start_logit": 2.2152292728424072,
            "end_logit": 2.3811943531036377
        },
        {
            "text": "cell-cycle checkpoint abrogation",
            "probability": 0.03567329431327929,
            "start_logit": -0.36407122015953064,
            "end_logit": 4.249988555908203
        },
        {
            "text": "modulation of the DDR pathway",
            "probability": 0.03141985120919262,
            "start_logit": 2.2152292728424072,
            "end_logit": 1.543725609779358
        },
        {
            "text": "LB100 sensitized ovarian carcinoma lines to cisplatin-mediated cell death",
            "probability": 0.0233689011421451,
            "start_logit": -0.1157391369342804,
            "end_logit": 3.578660249710083
        },
        {
            "text": "in vitro and in vivo by modulation of the DDR pathway and cell-cycle checkpoint abrogation",
            "probability": 0.02039491245392235,
            "start_logit": -0.9231880903244019,
            "end_logit": 4.249988555908203
        },
        {
            "text": "by modulation of the DDR pathway and cell-cycle checkpoint abrogation.",
            "probability": 0.019877390780080884,
            "start_logit": 0.919903576374054,
            "end_logit": 2.3811943531036377
        },
        {
            "text": "modulation",
            "probability": 0.011686626105170978,
            "start_logit": 2.2152292728424072,
            "end_logit": 0.5547308325767517
        },
        {
            "text": "sensitized",
            "probability": 0.010913494960121157,
            "start_logit": 1.5793923139572144,
            "end_logit": 1.1221227645874023
        },
        {
            "text": "by modulation of the DDR pathway",
            "probability": 0.00860302771172045,
            "start_logit": 0.919903576374054,
            "end_logit": 1.543725609779358
        },
        {
            "text": "cisplatin-mediated cell death. Sensitization via LB100 was mediated by abrogation of cell-cycle arrest",
            "probability": 0.007515333126115301,
            "start_logit": -1.3485907316207886,
            "end_logit": 3.677051067352295
        },
        {
            "text": "cisplatin-mediated cell death",
            "probability": 0.006811106119476901,
            "start_logit": -1.3485907316207886,
            "end_logit": 3.578660249710083
        },
        {
            "text": "cell-cycle checkpoint abrogation.",
            "probability": 0.005504732339201507,
            "start_logit": -0.36407122015953064,
            "end_logit": 2.3811943531036377
        },
        {
            "text": "sensitized ovarian carcinoma lines",
            "probability": 0.00387949623600894,
            "start_logit": 1.5793923139572144,
            "end_logit": 0.08782798051834106
        },
        {
            "text": "abrogation of cell-cycle arrest",
            "probability": 0.0037881465489508328,
            "start_logit": 0.23291921615600586,
            "end_logit": 1.4104726314544678
        },
        {
            "text": "by modulation",
            "probability": 0.0031998995657206066,
            "start_logit": 0.919903576374054,
            "end_logit": 0.5547308325767517
        },
        {
            "text": "in vitro and in vivo by modulation of the DDR pathway and cell-cycle checkpoint abrogation.",
            "probability": 0.0031471311046958237,
            "start_logit": -0.9231880903244019,
            "end_logit": 2.3811943531036377
        },
        {
            "text": "sensitized ovarian carcinoma lines to cisplatin-mediated cell death.",
            "probability": 0.0028118884969740706,
            "start_logit": 1.5793923139572144,
            "end_logit": -0.23402100801467896
        },
        {
            "text": "",
            "probability": 0.0022388143892853357,
            "start_logit": 0.11731944233179092,
            "end_logit": 1.000141978263855
        }
    ],
    "5e29fc57aa19d74431000006_002": [
        {
            "text": "modulation of the DDR pathway and cell-cycle checkpoint abrogation",
            "probability": 0.4704561911382076,
            "start_logit": 2.2152292728424072,
            "end_logit": 4.249988555908203
        },
        {
            "text": "by modulation of the DDR pathway and cell-cycle checkpoint abrogation",
            "probability": 0.1288149845957356,
            "start_logit": 0.919903576374054,
            "end_logit": 4.249988555908203
        },
        {
            "text": "sensitized ovarian carcinoma lines to cisplatin-mediated cell death",
            "probability": 0.12729886356665168,
            "start_logit": 1.5793923139572144,
            "end_logit": 3.578660249710083
        },
        {
            "text": "modulation of the DDR pathway and cell-cycle checkpoint abrogation.",
            "probability": 0.07259591409734296,
            "start_logit": 2.2152292728424072,
            "end_logit": 2.3811943531036377
        },
        {
            "text": "cell-cycle checkpoint abrogation",
            "probability": 0.03567329431327929,
            "start_logit": -0.36407122015953064,
            "end_logit": 4.249988555908203
        },
        {
            "text": "modulation of the DDR pathway",
            "probability": 0.03141985120919262,
            "start_logit": 2.2152292728424072,
            "end_logit": 1.543725609779358
        },
        {
            "text": "LB100 sensitized ovarian carcinoma lines to cisplatin-mediated cell death",
            "probability": 0.0233689011421451,
            "start_logit": -0.1157391369342804,
            "end_logit": 3.578660249710083
        },
        {
            "text": "in vitro and in vivo by modulation of the DDR pathway and cell-cycle checkpoint abrogation",
            "probability": 0.02039491245392235,
            "start_logit": -0.9231880903244019,
            "end_logit": 4.249988555908203
        },
        {
            "text": "by modulation of the DDR pathway and cell-cycle checkpoint abrogation.",
            "probability": 0.019877390780080884,
            "start_logit": 0.919903576374054,
            "end_logit": 2.3811943531036377
        },
        {
            "text": "modulation",
            "probability": 0.011686626105170978,
            "start_logit": 2.2152292728424072,
            "end_logit": 0.5547308325767517
        },
        {
            "text": "sensitized",
            "probability": 0.010913494960121157,
            "start_logit": 1.5793923139572144,
            "end_logit": 1.1221227645874023
        },
        {
            "text": "by modulation of the DDR pathway",
            "probability": 0.00860302771172045,
            "start_logit": 0.919903576374054,
            "end_logit": 1.543725609779358
        },
        {
            "text": "cisplatin-mediated cell death. Sensitization via LB100 was mediated by abrogation of cell-cycle arrest",
            "probability": 0.007515333126115301,
            "start_logit": -1.3485907316207886,
            "end_logit": 3.677051067352295
        },
        {
            "text": "cisplatin-mediated cell death",
            "probability": 0.006811106119476901,
            "start_logit": -1.3485907316207886,
            "end_logit": 3.578660249710083
        },
        {
            "text": "cell-cycle checkpoint abrogation.",
            "probability": 0.005504732339201507,
            "start_logit": -0.36407122015953064,
            "end_logit": 2.3811943531036377
        },
        {
            "text": "sensitized ovarian carcinoma lines",
            "probability": 0.00387949623600894,
            "start_logit": 1.5793923139572144,
            "end_logit": 0.08782798051834106
        },
        {
            "text": "abrogation of cell-cycle arrest",
            "probability": 0.0037881465489508328,
            "start_logit": 0.23291921615600586,
            "end_logit": 1.4104726314544678
        },
        {
            "text": "by modulation",
            "probability": 0.0031998995657206066,
            "start_logit": 0.919903576374054,
            "end_logit": 0.5547308325767517
        },
        {
            "text": "in vitro and in vivo by modulation of the DDR pathway and cell-cycle checkpoint abrogation.",
            "probability": 0.0031471311046958237,
            "start_logit": -0.9231880903244019,
            "end_logit": 2.3811943531036377
        },
        {
            "text": "sensitized ovarian carcinoma lines to cisplatin-mediated cell death.",
            "probability": 0.0028118884969740706,
            "start_logit": 1.5793923139572144,
            "end_logit": -0.23402100801467896
        },
        {
            "text": "",
            "probability": 0.0022388143892853357,
            "start_logit": 0.11731944233179092,
            "end_logit": 1.000141978263855
        }
    ],
    "5e480ccfd14c9f295d000005_001": [
        {
            "text": "The specific phosphorylation of histone H2AX on serine residue 139",
            "probability": 0.20825439827934325,
            "start_logit": 0.036187440156936646,
            "end_logit": -0.3389211595058441
        },
        {
            "text": "The specific phosphorylation of histone H2AX on serine residue 139, described as \u03b3-H2AX, is an excellent",
            "probability": 0.1010299732113426,
            "start_logit": 0.036187440156936646,
            "end_logit": -1.062264323234558
        },
        {
            "text": "",
            "probability": 0.10017755274034755,
            "start_logit": -0.7339888215065002,
            "end_logit": -0.30056115984916687
        },
        {
            "text": "do not fully co-localize on the units of higher order chromatin structure.",
            "probability": 0.07039860195884758,
            "start_logit": -1.4318183660507202,
            "end_logit": 0.04449765011668205
        },
        {
            "text": "excellent indicator",
            "probability": 0.07011314077438828,
            "start_logit": -0.6243569850921631,
            "end_logit": -0.7670269012451172
        },
        {
            "text": "excellent",
            "probability": 0.052189055702500056,
            "start_logit": -0.6243569850921631,
            "end_logit": -1.062264323234558
        },
        {
            "text": "The specific phosphorylation of histone H2AX on serine residue 139, described as \u03b3-H2AX",
            "probability": 0.049397077005792246,
            "start_logit": 0.036187440156936646,
            "end_logit": -1.7777903079986572
        },
        {
            "text": "excellent indicator or marker of DNA double-strand breaks (DSBs).",
            "probability": 0.04733529722438477,
            "start_logit": -0.6243569850921631,
            "end_logit": -1.1598808765411377
        },
        {
            "text": "not fully co-localize on the units of higher order chromatin structure.",
            "probability": 0.03619381235293899,
            "start_logit": -2.0971035957336426,
            "end_logit": 0.04449765011668205
        },
        {
            "text": "do not fully co-localize on the units of higher order chromatin structure",
            "probability": 0.03500947879755752,
            "start_logit": -1.4318183660507202,
            "end_logit": -0.6540569067001343
        },
        {
            "text": "an excellent indicator",
            "probability": 0.027647843657016218,
            "start_logit": -1.5549194812774658,
            "end_logit": -0.7670269012451172
        },
        {
            "text": "phosphorylation of histone H2AX on serine residue 139",
            "probability": 0.026109731936545685,
            "start_logit": -2.040264844894409,
            "end_logit": -0.3389211595058441
        },
        {
            "text": "The specific phosphorylation of histone H2AX on serine residue 139,",
            "probability": 0.024474498843909495,
            "start_logit": 0.036187440156936646,
            "end_logit": -2.4800498485565186
        },
        {
            "text": "specific phosphorylation of histone H2AX on serine residue 139",
            "probability": 0.023772291606735805,
            "start_logit": -2.134052276611328,
            "end_logit": -0.3389211595058441
        },
        {
            "text": "excellent indicator or marker of DNA double-strand breaks (DSBs)",
            "probability": 0.023732259276131436,
            "start_logit": -0.6243569850921631,
            "end_logit": -1.8503018617630005
        },
        {
            "text": "excellent indicator or marker of DNA double-strand breaks",
            "probability": 0.023319769899897102,
            "start_logit": -0.6243569850921631,
            "end_logit": -1.8678356409072876
        },
        {
            "text": "The specific phosphorylation of histone H2AX",
            "probability": 0.023055564323745475,
            "start_logit": 0.036187440156936646,
            "end_logit": -2.5397744178771973
        },
        {
            "text": "an excellent",
            "probability": 0.020579806249346,
            "start_logit": -1.5549194812774658,
            "end_logit": -1.062264323234558
        },
        {
            "text": "an excellent indicator or marker of DNA double-strand breaks (DSBs).",
            "probability": 0.018665814748328135,
            "start_logit": -1.5549194812774658,
            "end_logit": -1.1598808765411377
        },
        {
            "text": "excellent indicator or marker of DNA double-strand breaks (DSBs). The yield of \u03b3-H2AX",
            "probability": 0.018544031410901943,
            "start_logit": -0.6243569850921631,
            "end_logit": -2.096989154815674
        }
    ],
    "5e480ccfd14c9f295d000005_002": [
        {
            "text": "",
            "probability": 0.5642616589640628,
            "start_logit": 0.18112225830554962,
            "end_logit": 0.6632703542709351
        },
        {
            "text": "DNA double-strand break marker gamma-H2AX",
            "probability": 0.06993942417210984,
            "start_logit": -1.2773807048797607,
            "end_logit": 0.03388473764061928
        },
        {
            "text": "gamma-H2AX",
            "probability": 0.06915153973034191,
            "start_logit": -1.2887098789215088,
            "end_logit": 0.03388473764061928
        },
        {
            "text": "DNA double-strand break",
            "probability": 0.06222629862530498,
            "start_logit": -1.2773807048797607,
            "end_logit": -0.08296704292297363
        },
        {
            "text": "DNA double-strand break marker",
            "probability": 0.037807317792677396,
            "start_logit": -1.2773807048797607,
            "end_logit": -0.5812420845031738
        },
        {
            "text": "the DNA double-strand break marker gamma-H2AX",
            "probability": 0.03661833957503606,
            "start_logit": -1.924461007118225,
            "end_logit": 0.03388473764061928
        },
        {
            "text": "the DNA double-strand break",
            "probability": 0.032579961309828424,
            "start_logit": -1.924461007118225,
            "end_logit": -0.08296704292297363
        },
        {
            "text": "the DNA double-strand break marker",
            "probability": 0.019794861306645498,
            "start_logit": -1.924461007118225,
            "end_logit": -0.5812420845031738
        },
        {
            "text": "marker gamma-H2AX",
            "probability": 0.01544146386025051,
            "start_logit": -2.7879538536071777,
            "end_logit": 0.03388473764061928
        },
        {
            "text": "expression of the DNA double-strand break marker gamma-H2AX",
            "probability": 0.013955103430677884,
            "start_logit": -2.889164924621582,
            "end_logit": 0.03388473764061928
        },
        {
            "text": "expression of the DNA double-strand break",
            "probability": 0.012416093551005628,
            "start_logit": -2.889164924621582,
            "end_logit": -0.08296704292297363
        },
        {
            "text": "double-strand break marker gamma-H2AX",
            "probability": 0.011481492465607507,
            "start_logit": -3.0842738151550293,
            "end_logit": 0.03388473764061928
        },
        {
            "text": "double-strand break",
            "probability": 0.010215279683614948,
            "start_logit": -3.0842738151550293,
            "end_logit": -0.08296704292297363
        },
        {
            "text": "marker",
            "probability": 0.00834722816579093,
            "start_logit": -2.7879538536071777,
            "end_logit": -0.5812420845031738
        },
        {
            "text": "expression of the DNA double-strand break marker",
            "probability": 0.007543742838587991,
            "start_logit": -2.889164924621582,
            "end_logit": -0.5812420845031738
        },
        {
            "text": "NUCKS1 expression and expression of the DNA double-strand break marker gamma-H2AX",
            "probability": 0.007433411292596605,
            "start_logit": -3.5190253257751465,
            "end_logit": 0.03388473764061928
        },
        {
            "text": "NUCKS1 expression and expression of the DNA double-strand break",
            "probability": 0.006613632816872489,
            "start_logit": -3.5190253257751465,
            "end_logit": -0.08296704292297363
        },
        {
            "text": "double-strand break marker",
            "probability": 0.006206577184754069,
            "start_logit": -3.0842738151550293,
            "end_logit": -0.5812420845031738
        },
        {
            "text": "NUCKS1 expression and expression of the DNA double-strand break marker",
            "probability": 0.004018296495139685,
            "start_logit": -3.5190253257751465,
            "end_logit": -0.5812420845031738
        },
        {
            "text": "peroxidase immunohistochemistry",
            "probability": 0.003948276739095164,
            "start_logit": -2.6982340812683105,
            "end_logit": -1.419612169265747
        }
    ],
    "5e480ccfd14c9f295d000005_003": [
        {
            "text": "",
            "probability": 0.9898106157495153,
            "start_logit": 2.8727314472198486,
            "end_logit": 3.406581163406372
        },
        {
            "text": "pH2AX, a marker of the DNA double-strand break",
            "probability": 0.0013809109438434014,
            "start_logit": -0.15971405804157257,
            "end_logit": -0.13574357330799103
        },
        {
            "text": "pH2AX, a marker of the DNA double-strand break (DSB",
            "probability": 0.0011948090692591041,
            "start_logit": -0.15971405804157257,
            "end_logit": -0.2805005609989166
        },
        {
            "text": "pH2AX",
            "probability": 0.0009813433529189597,
            "start_logit": -0.15971405804157257,
            "end_logit": -0.4773198366165161
        },
        {
            "text": "pH2AX, a marker of the DNA double-strand break (DSB)",
            "probability": 0.0009362062500444859,
            "start_logit": -0.15971405804157257,
            "end_logit": -0.5244064331054688
        },
        {
            "text": "Mice treated with nonregenerating APAP600 dose showed prolonged expression",
            "probability": 0.0008237161879461269,
            "start_logit": -0.678193986415863,
            "end_logit": -0.13393627107143402
        },
        {
            "text": "pH2AX, a marker of the DNA double-strand break (DSB), compared with APAP300",
            "probability": 0.000770839053722182,
            "start_logit": -0.15971405804157257,
            "end_logit": -0.7187626361846924
        },
        {
            "text": "Mice treated with nonregenerating APAP600 dose showed prolonged expression of pH2AX",
            "probability": 0.0005843163158525491,
            "start_logit": -0.678193986415863,
            "end_logit": -0.4773198366165161
        },
        {
            "text": "prolonged expression",
            "probability": 0.00044750247971075816,
            "start_logit": -1.2883379459381104,
            "end_logit": -0.13393627107143402
        },
        {
            "text": "prolonged expression of pH2AX, a marker of the DNA double-strand break",
            "probability": 0.0004466944378861556,
            "start_logit": -1.2883379459381104,
            "end_logit": -0.13574357330799103
        },
        {
            "text": "prolonged expression of pH2AX, a marker of the DNA double-strand break (DSB",
            "probability": 0.0003864945585039123,
            "start_logit": -1.2883379459381104,
            "end_logit": -0.2805005609989166
        },
        {
            "text": "prolonged expression of pH2AX",
            "probability": 0.00031744307578980346,
            "start_logit": -1.2883379459381104,
            "end_logit": -0.4773198366165161
        },
        {
            "text": "prolonged expression of pH2AX, a marker of the DNA double-strand break (DSB)",
            "probability": 0.00030284221185559085,
            "start_logit": -1.2883379459381104,
            "end_logit": -0.5244064331054688
        },
        {
            "text": "DNA double-strand break",
            "probability": 0.00029280440305957896,
            "start_logit": -1.7107079029083252,
            "end_logit": -0.13574357330799103
        },
        {
            "text": "pH2AX, a marker of the DNA double-strand break (DSB), compared with APAP300.",
            "probability": 0.0002788479916010612,
            "start_logit": -0.15971405804157257,
            "end_logit": -1.7355754375457764
        },
        {
            "text": "DNA double-strand break (DSB",
            "probability": 0.0002533438943722764,
            "start_logit": -1.7107079029083252,
            "end_logit": -0.2805005609989166
        },
        {
            "text": "marker of the DNA double-strand break",
            "probability": 0.00020322933210167583,
            "start_logit": -2.0758776664733887,
            "end_logit": -0.13574357330799103
        },
        {
            "text": "DSB",
            "probability": 0.00020049072991699612,
            "start_logit": -1.9446877241134644,
            "end_logit": -0.2805005609989166
        },
        {
            "text": "DNA double-strand break (DSB)",
            "probability": 0.00019851049295182435,
            "start_logit": -1.7107079029083252,
            "end_logit": -0.5244064331054688
        },
        {
            "text": "pH2AX, a marker of the DNA",
            "probability": 0.00018903946914792166,
            "start_logit": -0.15971405804157257,
            "end_logit": -2.124286413192749
        }
    ],
    "5e2906948b3851296d00000a_001": [
        {
            "text": "",
            "probability": 0.5879267916994478,
            "start_logit": 2.305311679840088,
            "end_logit": 2.866328001022339
        },
        {
            "text": "maintenance therapy after partial or complete remission in recurrent ovarian cancer",
            "probability": 0.06831507107139001,
            "start_logit": 0.139371857047081,
            "end_logit": 2.879795789718628
        },
        {
            "text": "have been approved by the US FDA for maintenance therapy after partial or complete remission in recurrent ovarian cancer",
            "probability": 0.06169749673748392,
            "start_logit": 0.03748481348156929,
            "end_logit": 2.879795789718628
        },
        {
            "text": "Niraparib and olaparib have been approved by the US FDA for maintenance therapy after partial or complete remission",
            "probability": 0.05669359377406391,
            "start_logit": 1.8357027769088745,
            "end_logit": 0.9969956874847412
        },
        {
            "text": "approved by the US FDA for maintenance therapy after partial or complete remission in recurrent ovarian cancer",
            "probability": 0.05661799403987684,
            "start_logit": -0.04843169450759888,
            "end_logit": 2.879795789718628
        },
        {
            "text": "Niraparib and olaparib have been approved by the US FDA for maintenance therapy",
            "probability": 0.0408818318349947,
            "start_logit": 1.8357027769088745,
            "end_logit": 0.6700202226638794
        },
        {
            "text": "for maintenance therapy after partial or complete remission in recurrent ovarian cancer",
            "probability": 0.022869982878225014,
            "start_logit": -0.9549332857131958,
            "end_logit": 2.879795789718628
        },
        {
            "text": "partial or complete remission in recurrent ovarian cancer",
            "probability": 0.012667478585395915,
            "start_logit": -1.5457205772399902,
            "end_logit": 2.879795789718628
        },
        {
            "text": "been approved by the US FDA for maintenance therapy after partial or complete remission in recurrent ovarian cancer",
            "probability": 0.01128454178600133,
            "start_logit": -1.6613247394561768,
            "end_logit": 2.879795789718628
        },
        {
            "text": "maintenance therapy after partial or complete remission",
            "probability": 0.010395055910637973,
            "start_logit": 0.139371857047081,
            "end_logit": 0.9969956874847412
        },
        {
            "text": "have been approved by the US FDA for maintenance therapy after partial or complete remission",
            "probability": 0.009388103065315302,
            "start_logit": 0.03748481348156929,
            "end_logit": 0.9969956874847412
        },
        {
            "text": "approved by the US FDA for maintenance therapy after partial or complete remission",
            "probability": 0.008615188484216739,
            "start_logit": -0.04843169450759888,
            "end_logit": 0.9969956874847412
        },
        {
            "text": "maintenance therapy",
            "probability": 0.007495889735755001,
            "start_logit": 0.139371857047081,
            "end_logit": 0.6700202226638794
        },
        {
            "text": "after partial or complete remission in recurrent ovarian cancer",
            "probability": 0.007467973807913659,
            "start_logit": -2.0741348266601562,
            "end_logit": 2.879795789718628
        },
        {
            "text": "Niraparib",
            "probability": 0.006786652304161271,
            "start_logit": 1.8357027769088745,
            "end_logit": -1.125707745552063
        },
        {
            "text": "have been approved by the US FDA for maintenance therapy",
            "probability": 0.006769774593851905,
            "start_logit": 0.03748481348156929,
            "end_logit": 0.6700202226638794
        },
        {
            "text": "Niraparib and olaparib have been approved by the US FDA for maintenance therapy after partial or complete remission in recurrent",
            "probability": 0.006590002596879178,
            "start_logit": 1.8357027769088745,
            "end_logit": -1.1551117897033691
        },
        {
            "text": "approved by the US FDA for maintenance therapy",
            "probability": 0.006212424780163744,
            "start_logit": -0.04843169450759888,
            "end_logit": 0.6700202226638794
        },
        {
            "text": "Niraparib and olaparib",
            "probability": 0.005897205411844321,
            "start_logit": 1.8357027769088745,
            "end_logit": -1.2661869525909424
        },
        {
            "text": "recurrent ovarian cancer",
            "probability": 0.005426946902381314,
            "start_logit": -2.3933818340301514,
            "end_logit": 2.879795789718628
        }
    ],
    "5e2906948b3851296d00000a_002": [
        {
            "text": "maintenance monotherapy",
            "probability": 0.42701010066442047,
            "start_logit": 1.7098991870880127,
            "end_logit": 3.8476548194885254
        },
        {
            "text": "as maintenance monotherapy",
            "probability": 0.18398016002614456,
            "start_logit": 0.8679194450378418,
            "end_logit": 3.8476548194885254
        },
        {
            "text": "niraparib and olaparib as maintenance monotherapy",
            "probability": 0.09774728773121232,
            "start_logit": 0.23547697067260742,
            "end_logit": 3.8476548194885254
        },
        {
            "text": "monotherapy",
            "probability": 0.08027894717364385,
            "start_logit": 0.0385989286005497,
            "end_logit": 3.8476548194885254
        },
        {
            "text": "",
            "probability": 0.06306683211159408,
            "start_logit": 1.5003533363342285,
            "end_logit": 2.144587993621826
        },
        {
            "text": "approvals of niraparib and olaparib as maintenance monotherapy",
            "probability": 0.03975625011203241,
            "start_logit": -0.6641414165496826,
            "end_logit": 3.8476548194885254
        },
        {
            "text": "The recent United States Food and Drug Administration approvals of niraparib and olaparib as maintenance monotherapy",
            "probability": 0.02169406403671038,
            "start_logit": -1.2698698043823242,
            "end_logit": 3.8476548194885254
        },
        {
            "text": "recent United States Food and Drug Administration approvals of niraparib and olaparib as maintenance monotherapy",
            "probability": 0.01853789253271253,
            "start_logit": -1.4270915985107422,
            "end_logit": 3.8476548194885254
        },
        {
            "text": "maintenance monotherapy for platinum-sensitive, high-grade ovarian cancers independent of BRCA status",
            "probability": 0.015458137246701207,
            "start_logit": 1.7098991870880127,
            "end_logit": 0.5289826989173889
        },
        {
            "text": "olaparib as maintenance monotherapy",
            "probability": 0.007943856101459427,
            "start_logit": -2.2745096683502197,
            "end_logit": 3.8476548194885254
        },
        {
            "text": "maintenance monotherapy for platinum-sensitive",
            "probability": 0.006764037009357298,
            "start_logit": 1.7098991870880127,
            "end_logit": -0.29753294587135315
        },
        {
            "text": "as maintenance monotherapy for platinum-sensitive, high-grade ovarian cancers independent of BRCA status",
            "probability": 0.006660241900435125,
            "start_logit": 0.8679194450378418,
            "end_logit": 0.5289826989173889
        },
        {
            "text": "and olaparib as maintenance monotherapy",
            "probability": 0.005885217408431779,
            "start_logit": -2.574464797973633,
            "end_logit": 3.8476548194885254
        },
        {
            "text": "maintenance monotherapy for platinum-sensitive, high-grade ovarian cancers",
            "probability": 0.005438335673809812,
            "start_logit": 1.7098991870880127,
            "end_logit": -0.5156797766685486
        },
        {
            "text": "maintenance monotherapy for platinum-sensitive, high-grade",
            "probability": 0.005192471841405492,
            "start_logit": 1.7098991870880127,
            "end_logit": -0.561942994594574
        },
        {
            "text": "maintenance",
            "probability": 0.004035665163341421,
            "start_logit": 1.7098991870880127,
            "end_logit": -0.8139817118644714
        },
        {
            "text": "as maintenance monotherapy for platinum-sensitive",
            "probability": 0.002914330619973577,
            "start_logit": 0.8679194450378418,
            "end_logit": -0.29753294587135315
        },
        {
            "text": "monotherapy for platinum-sensitive, high-grade ovarian cancers independent of BRCA status",
            "probability": 0.0029061677498961854,
            "start_logit": 0.0385989286005497,
            "end_logit": 0.5289826989173889
        },
        {
            "text": "platinum-sensitive, high-grade ovarian cancers independent of BRCA status",
            "probability": 0.0023868615706316536,
            "start_logit": -0.15825700759887695,
            "end_logit": 0.5289826989173889
        },
        {
            "text": "as maintenance monotherapy for platinum-sensitive, high-grade ovarian cancers",
            "probability": 0.002343143326086637,
            "start_logit": 0.8679194450378418,
            "end_logit": -0.5156797766685486
        }
    ],
    "5e2906948b3851296d00000a_003": [
        {
            "text": "maintenance treatment of adult patients with recurrent ovarian cancer in complete or partial response to platinum-based chemotherapy",
            "probability": 0.16924341126076134,
            "start_logit": 1.674843430519104,
            "end_logit": 2.9974677562713623
        },
        {
            "text": "Niraparib is a highly selective inhibitor of PARP-1 and PARP-2 approved in the United States for maintenance treatment",
            "probability": 0.11229158003905314,
            "start_logit": 1.9070982933044434,
            "end_logit": 2.354973793029785
        },
        {
            "text": "approved in the United States for maintenance treatment of adult patients with recurrent ovarian cancer in complete or partial response to platinum-based chemotherapy",
            "probability": 0.11178208267347403,
            "start_logit": 1.260056734085083,
            "end_logit": 2.9974677562713623
        },
        {
            "text": "maintenance treatment",
            "probability": 0.08901848268216116,
            "start_logit": 1.674843430519104,
            "end_logit": 2.354973793029785
        },
        {
            "text": "complete or partial response to platinum-based chemotherapy",
            "probability": 0.06358980165963661,
            "start_logit": 0.6959585547447205,
            "end_logit": 2.9974677562713623
        },
        {
            "text": "approved in the United States for maintenance treatment",
            "probability": 0.058795029694320475,
            "start_logit": 1.260056734085083,
            "end_logit": 2.354973793029785
        },
        {
            "text": "for maintenance treatment of adult patients with recurrent ovarian cancer in complete or partial response to platinum-based chemotherapy",
            "probability": 0.05320317607478618,
            "start_logit": 0.5176235437393188,
            "end_logit": 2.9974677562713623
        },
        {
            "text": "highly selective inhibitor of PARP-1 and PARP-2 approved in the United States for maintenance treatment",
            "probability": 0.045044777235262394,
            "start_logit": 0.9936564564704895,
            "end_logit": 2.354973793029785
        },
        {
            "text": "in complete or partial response to platinum-based chemotherapy",
            "probability": 0.044065525521862686,
            "start_logit": 0.3291831910610199,
            "end_logit": 2.9974677562713623
        },
        {
            "text": "Niraparib is a highly selective inhibitor of PARP-1 and PARP-2 approved",
            "probability": 0.0322128666158718,
            "start_logit": 1.9070982933044434,
            "end_logit": 1.1062408685684204
        },
        {
            "text": "maintenance treatment of adult patients with recurrent ovarian cancer in complete or partial response",
            "probability": 0.03190457267920094,
            "start_logit": 1.674843430519104,
            "end_logit": 1.3288791179656982
        },
        {
            "text": "for maintenance treatment",
            "probability": 0.027983754125306796,
            "start_logit": 0.5176235437393188,
            "end_logit": 2.354973793029785
        },
        {
            "text": "a highly selective inhibitor of PARP-1 and PARP-2 approved in the United States for maintenance treatment",
            "probability": 0.022597061081495808,
            "start_logit": 0.3038192689418793,
            "end_logit": 2.354973793029785
        },
        {
            "text": "Niraparib is a highly selective inhibitor of PARP-1 and PARP-2 approved in the United States for maintenance treatment of adult patients",
            "probability": 0.022580416289572972,
            "start_logit": 1.9070982933044434,
            "end_logit": 0.7509579062461853
        },
        {
            "text": "approved in the United States for maintenance treatment of adult patients with recurrent ovarian cancer in complete or partial response",
            "probability": 0.021072368810821477,
            "start_logit": 1.260056734085083,
            "end_logit": 1.3288791179656982
        },
        {
            "text": "Niraparib is a highly selective inhibitor of PARP-1 and PARP-2",
            "probability": 0.01994514403826725,
            "start_logit": 1.9070982933044434,
            "end_logit": 0.6268606185913086
        },
        {
            "text": "Niraparib is a highly selective inhibitor of PARP-1 and PARP-2 approved in the United States for maintenance",
            "probability": 0.019052553116880165,
            "start_logit": 1.9070982933044434,
            "end_logit": 0.5810760259628296
        },
        {
            "text": "maintenance treatment of adult patients",
            "probability": 0.01790049080910849,
            "start_logit": 1.674843430519104,
            "end_logit": 0.7509579062461853
        },
        {
            "text": "Niraparib was safe and well-tolerated.",
            "probability": 0.017206852222053117,
            "start_logit": 1.0346876382827759,
            "end_logit": 1.351593255996704
        },
        {
            "text": "approved",
            "probability": 0.016866415527866652,
            "start_logit": 1.260056734085083,
            "end_logit": 1.1062408685684204
        },
        {
            "text": "",
            "probability": 0.0036436378422365838,
            "start_logit": 0.1638125479221344,
            "end_logit": 0.6701432466506958
        }
    ],
    "5e2906948b3851296d00000a_004": [
        {
            "text": "",
            "probability": 0.9992849041997416,
            "start_logit": 2.580206871032715,
            "end_logit": 3.065237522125244
        },
        {
            "text": "approved by the Food and Drug Administration for the treatment of ovarian cancer",
            "probability": 0.00010966616992908428,
            "start_logit": -2.0301477909088135,
            "end_logit": -1.441762089729309
        },
        {
            "text": "approved by the Food and Drug Administration for the treatment of ovarian cancer.",
            "probability": 7.189756506333028e-05,
            "start_logit": -2.0301477909088135,
            "end_logit": -1.86396062374115
        },
        {
            "text": "treatment of ovarian cancer",
            "probability": 6.254232861241665e-05,
            "start_logit": -2.591745138168335,
            "end_logit": -1.441762089729309
        },
        {
            "text": "approved by the Food and Drug Administration for the treatment",
            "probability": 5.11465578301782e-05,
            "start_logit": -2.0301477909088135,
            "end_logit": -2.204507827758789
        },
        {
            "text": "treatment of ovarian cancer.",
            "probability": 4.100299247736258e-05,
            "start_logit": -2.591745138168335,
            "end_logit": -1.86396062374115
        },
        {
            "text": "Niraparib) have recently been approved by the Food and Drug Administration for the treatment of ovarian cancer",
            "probability": 3.893300763301833e-05,
            "start_logit": -3.065746307373047,
            "end_logit": -1.441762089729309
        },
        {
            "text": "approved for the treatment of fallopian tube cancer and primary peritoneal cancer.",
            "probability": 3.8692961842038235e-05,
            "start_logit": -3.2742807865142822,
            "end_logit": -1.2394123077392578
        },
        {
            "text": "treatment of fallopian tube cancer and primary peritoneal cancer.",
            "probability": 3.518826078704943e-05,
            "start_logit": -3.3692259788513184,
            "end_logit": -1.2394123077392578
        },
        {
            "text": "approved",
            "probability": 3.337423112123772e-05,
            "start_logit": -2.0301477909088135,
            "end_logit": -2.6314189434051514
        },
        {
            "text": "treatment",
            "probability": 2.916874756615919e-05,
            "start_logit": -2.591745138168335,
            "end_logit": -2.204507827758789
        },
        {
            "text": "recently been approved by the Food and Drug Administration for the treatment of ovarian cancer",
            "probability": 2.7166947511177314e-05,
            "start_logit": -3.4255876541137695,
            "end_logit": -1.441762089729309
        },
        {
            "text": "Niraparib) have recently been approved by the Food and Drug Administration for the treatment of ovarian cancer.",
            "probability": 2.5524630350600986e-05,
            "start_logit": -3.065746307373047,
            "end_logit": -1.86396062374115
        },
        {
            "text": "have also been approved for the treatment of fallopian tube cancer and primary peritoneal cancer.",
            "probability": 2.5125513851317617e-05,
            "start_logit": -3.7060546875,
            "end_logit": -1.2394123077392578
        },
        {
            "text": "both Olaparib and Niraparib have also been approved for the treatment of fallopian tube cancer and primary peritoneal cancer",
            "probability": 2.3807995857775716e-05,
            "start_logit": -2.3348467350006104,
            "end_logit": -2.664482593536377
        },
        {
            "text": "ovarian cancer",
            "probability": 2.3097674787510844e-05,
            "start_logit": -3.5878567695617676,
            "end_logit": -1.441762089729309
        },
        {
            "text": "the treatment of ovarian cancer",
            "probability": 2.1011727446528165e-05,
            "start_logit": -3.6825079917907715,
            "end_logit": -1.441762089729309
        },
        {
            "text": "in 2017, both Olaparib and Niraparib",
            "probability": 1.9989774149651106e-05,
            "start_logit": -2.056717872619629,
            "end_logit": -3.1174120903015137
        },
        {
            "text": "PARP1 inhibitors (Olaparib, Rucaparib, and Niraparib) have recently been approved",
            "probability": 1.960097776376152e-05,
            "start_logit": -2.562352418899536,
            "end_logit": -2.6314189434051514
        },
        {
            "text": "Niraparib) have recently been approved by the Food and Drug Administration for the treatment",
            "probability": 1.8157735678127635e-05,
            "start_logit": -3.065746307373047,
            "end_logit": -2.204507827758789
        }
    ],
    "5e2906948b3851296d00000a_005": [
        {
            "text": "maintenance treatment of women with recurrent ovarian cancer who are in complete or partial response to platinum-based chemotherapy",
            "probability": 0.18549028981564084,
            "start_logit": 0.9982597827911377,
            "end_logit": 2.792473077774048
        },
        {
            "text": "Niraparib testing is ongoing in newly diagnosed ovarian cancer patients as maintenance therapy",
            "probability": 0.11728082713597734,
            "start_logit": 1.570245623588562,
            "end_logit": 1.7620559930801392
        },
        {
            "text": "maintenance treatment",
            "probability": 0.09816881703044761,
            "start_logit": 0.9982597827911377,
            "end_logit": 2.1561591625213623
        },
        {
            "text": "the maintenance treatment of women with recurrent ovarian cancer who are in complete or partial response to platinum-based chemotherapy",
            "probability": 0.08458176006712502,
            "start_logit": 0.2129758894443512,
            "end_logit": 2.792473077774048
        },
        {
            "text": "Niraparib testing is ongoing in newly diagnosed ovarian cancer patients as maintenance therapy following completion of platinum-based chemotherapy",
            "probability": 0.07869638573339131,
            "start_logit": 1.570245623588562,
            "end_logit": 1.363081932067871
        },
        {
            "text": "the maintenance treatment",
            "probability": 0.044764021536628534,
            "start_logit": 0.2129758894443512,
            "end_logit": 2.1561591625213623
        },
        {
            "text": "for the maintenance treatment of women with recurrent ovarian cancer who are in complete or partial response to platinum-based chemotherapy",
            "probability": 0.04356541761530307,
            "start_logit": -0.45047909021377563,
            "end_logit": 2.792473077774048
        },
        {
            "text": "women with recurrent ovarian cancer who are in complete or partial response to platinum-based chemotherapy",
            "probability": 0.04215347290720949,
            "start_logit": -0.48342567682266235,
            "end_logit": 2.792473077774048
        },
        {
            "text": "as maintenance therapy",
            "probability": 0.04065876211301407,
            "start_logit": 0.5108886957168579,
            "end_logit": 1.7620559930801392
        },
        {
            "text": "maintenance therapy",
            "probability": 0.038061390699878926,
            "start_logit": 0.44487473368644714,
            "end_logit": 1.7620559930801392
        },
        {
            "text": "recurrent ovarian cancer who are in complete or partial response to platinum-based chemotherapy",
            "probability": 0.030747735178849493,
            "start_logit": -0.7989264130592346,
            "end_logit": 2.792473077774048
        },
        {
            "text": "in complete or partial response to platinum-based chemotherapy",
            "probability": 0.0285761167504199,
            "start_logit": -0.8721714615821838,
            "end_logit": 2.792473077774048
        },
        {
            "text": "as maintenance therapy following completion of platinum-based chemotherapy",
            "probability": 0.02728235897397082,
            "start_logit": 0.5108886957168579,
            "end_logit": 1.363081932067871
        },
        {
            "text": "maintenance therapy following completion of platinum-based chemotherapy",
            "probability": 0.025539501700428763,
            "start_logit": 0.44487473368644714,
            "end_logit": 1.363081932067871
        },
        {
            "text": "for the maintenance treatment",
            "probability": 0.023056546598651667,
            "start_logit": -0.45047909021377563,
            "end_logit": 2.1561591625213623
        },
        {
            "text": "complete or partial response to platinum-based chemotherapy",
            "probability": 0.0221993698136983,
            "start_logit": -1.1246788501739502,
            "end_logit": 2.792473077774048
        },
        {
            "text": "maintenance treatment of women with recurrent ovarian cancer who are in complete or partial response",
            "probability": 0.018024933247195115,
            "start_logit": 0.9982597827911377,
            "end_logit": 0.46122652292251587
        },
        {
            "text": "maintenance treatment of women with recurrent ovarian cancer",
            "probability": 0.017289274066168762,
            "start_logit": 0.9982597827911377,
            "end_logit": 0.4195568561553955
        },
        {
            "text": "testing is ongoing in newly diagnosed ovarian cancer patients as maintenance therapy",
            "probability": 0.016404428771070373,
            "start_logit": -0.3967743217945099,
            "end_logit": 1.7620559930801392
        },
        {
            "text": "ongoing in newly diagnosed ovarian cancer patients as maintenance therapy",
            "probability": 0.013647103204484513,
            "start_logit": -0.5807983875274658,
            "end_logit": 1.7620559930801392
        },
        {
            "text": "",
            "probability": 0.003811487040445922,
            "start_logit": -0.2534015476703644,
            "end_logit": 0.15915128588676453
        }
    ],
    "5c72768a7c78d6947100006c_002": [
        {
            "text": "",
            "probability": 0.9995214356414115,
            "start_logit": 4.140665054321289,
            "end_logit": 4.918307304382324
        },
        {
            "text": "Rett syndrome",
            "probability": 0.00012285796724745,
            "start_logit": -1.14543879032135,
            "end_logit": 1.2004082202911377
        },
        {
            "text": "borderline mental impairment without any features of Rett syndrome",
            "probability": 7.949547558131784e-05,
            "start_logit": -1.2469192743301392,
            "end_logit": 0.8665598630905151
        },
        {
            "text": "without any features of Rett syndrome",
            "probability": 3.716785576938352e-05,
            "start_logit": -2.3410234451293945,
            "end_logit": 1.2004082202911377
        },
        {
            "text": "borderline mental impairment without any features of Rett syndrome. The second one, the c.679C>G substitution",
            "probability": 3.613223481770294e-05,
            "start_logit": -1.2469192743301392,
            "end_logit": 0.07804515212774277
        },
        {
            "text": "random X-inactivation, presenting with borderline mental impairment without any features of Rett syndrome",
            "probability": 3.496291412941208e-05,
            "start_logit": -2.068331480026245,
            "end_logit": 0.8665598630905151
        },
        {
            "text": "random X-inactivation",
            "probability": 2.1716668098964793e-05,
            "start_logit": -2.068331480026245,
            "end_logit": 0.3903520405292511
        },
        {
            "text": "borderline mental impairment",
            "probability": 1.8352279539938106e-05,
            "start_logit": -1.2469192743301392,
            "end_logit": -0.59938645362854
        },
        {
            "text": "MECP2",
            "probability": 1.807928702488034e-05,
            "start_logit": -1.4119831323623657,
            "end_logit": -0.44930946826934814
        },
        {
            "text": "Rett syndrome. The second one, the c.679C>G substitution",
            "probability": 1.6587171990311955e-05,
            "start_logit": -1.14543879032135,
            "end_logit": -0.8019911050796509
        },
        {
            "text": "borderline mental impairment without any features of Rett syndrome.",
            "probability": 1.4078669118861306e-05,
            "start_logit": -1.2469192743301392,
            "end_logit": -0.8644794225692749
        },
        {
            "text": "Rett syndrome.",
            "probability": 1.140415174957964e-05,
            "start_logit": -1.14543879032135,
            "end_logit": -1.1766432523727417
        },
        {
            "text": "double nucleotide substitution c.1162_1163delinsTA leading to a premature stop codon",
            "probability": 1.1387316821609408e-05,
            "start_logit": -0.9859383702278137,
            "end_logit": -1.3376209735870361
        },
        {
            "text": "double nucleotide substitution",
            "probability": 9.271293650768118e-06,
            "start_logit": -0.9859383702278137,
            "end_logit": -1.5431982278823853
        },
        {
            "text": "moderately biased",
            "probability": 8.834678926435252e-06,
            "start_logit": -2.065018892288208,
            "end_logit": -0.5123558640480042
        },
        {
            "text": "The second one, the c.679C>G substitution",
            "probability": 8.528489162472164e-06,
            "start_logit": -1.810656189918518,
            "end_logit": -0.8019911050796509
        },
        {
            "text": "random X-inactivation, presenting with borderline mental impairment",
            "probability": 8.071518145425318e-06,
            "start_logit": -2.068331480026245,
            "end_logit": -0.59938645362854
        },
        {
            "text": "borderline mental impairment without any features of Rett syndrome. The second one",
            "probability": 7.562327757400807e-06,
            "start_logit": -1.2469192743301392,
            "end_logit": -1.4859611988067627
        },
        {
            "text": "double nucleotide substitution c.1162_1163delinsTA",
            "probability": 7.04963808022216e-06,
            "start_logit": -0.9859383702278137,
            "end_logit": -1.8171448707580566
        },
        {
            "text": "the double nucleotide substitution c.1162_1163delinsTA leading to a premature stop codon",
            "probability": 7.024420976291988e-06,
            "start_logit": -1.4690457582473755,
            "end_logit": -1.3376209735870361
        }
    ],
    "5c72768a7c78d6947100006c_003": [
        {
            "text": "",
            "probability": 0.9995214356414115,
            "start_logit": 4.140665054321289,
            "end_logit": 4.918307304382324
        },
        {
            "text": "Rett syndrome",
            "probability": 0.00012285796724745,
            "start_logit": -1.14543879032135,
            "end_logit": 1.2004082202911377
        },
        {
            "text": "borderline mental impairment without any features of Rett syndrome",
            "probability": 7.949547558131784e-05,
            "start_logit": -1.2469192743301392,
            "end_logit": 0.8665598630905151
        },
        {
            "text": "without any features of Rett syndrome",
            "probability": 3.716785576938352e-05,
            "start_logit": -2.3410234451293945,
            "end_logit": 1.2004082202911377
        },
        {
            "text": "borderline mental impairment without any features of Rett syndrome. The second one, the c.679C>G substitution",
            "probability": 3.613223481770294e-05,
            "start_logit": -1.2469192743301392,
            "end_logit": 0.07804515212774277
        },
        {
            "text": "random X-inactivation, presenting with borderline mental impairment without any features of Rett syndrome",
            "probability": 3.496291412941208e-05,
            "start_logit": -2.068331480026245,
            "end_logit": 0.8665598630905151
        },
        {
            "text": "random X-inactivation",
            "probability": 2.1716668098964793e-05,
            "start_logit": -2.068331480026245,
            "end_logit": 0.3903520405292511
        },
        {
            "text": "borderline mental impairment",
            "probability": 1.8352279539938106e-05,
            "start_logit": -1.2469192743301392,
            "end_logit": -0.59938645362854
        },
        {
            "text": "MECP2",
            "probability": 1.807928702488034e-05,
            "start_logit": -1.4119831323623657,
            "end_logit": -0.44930946826934814
        },
        {
            "text": "Rett syndrome. The second one, the c.679C>G substitution",
            "probability": 1.6587171990311955e-05,
            "start_logit": -1.14543879032135,
            "end_logit": -0.8019911050796509
        },
        {
            "text": "borderline mental impairment without any features of Rett syndrome.",
            "probability": 1.4078669118861306e-05,
            "start_logit": -1.2469192743301392,
            "end_logit": -0.8644794225692749
        },
        {
            "text": "Rett syndrome.",
            "probability": 1.140415174957964e-05,
            "start_logit": -1.14543879032135,
            "end_logit": -1.1766432523727417
        },
        {
            "text": "double nucleotide substitution c.1162_1163delinsTA leading to a premature stop codon",
            "probability": 1.1387316821609408e-05,
            "start_logit": -0.9859383702278137,
            "end_logit": -1.3376209735870361
        },
        {
            "text": "double nucleotide substitution",
            "probability": 9.271293650768118e-06,
            "start_logit": -0.9859383702278137,
            "end_logit": -1.5431982278823853
        },
        {
            "text": "moderately biased",
            "probability": 8.834678926435252e-06,
            "start_logit": -2.065018892288208,
            "end_logit": -0.5123558640480042
        },
        {
            "text": "The second one, the c.679C>G substitution",
            "probability": 8.528489162472164e-06,
            "start_logit": -1.810656189918518,
            "end_logit": -0.8019911050796509
        },
        {
            "text": "random X-inactivation, presenting with borderline mental impairment",
            "probability": 8.071518145425318e-06,
            "start_logit": -2.068331480026245,
            "end_logit": -0.59938645362854
        },
        {
            "text": "borderline mental impairment without any features of Rett syndrome. The second one",
            "probability": 7.562327757400807e-06,
            "start_logit": -1.2469192743301392,
            "end_logit": -1.4859611988067627
        },
        {
            "text": "double nucleotide substitution c.1162_1163delinsTA",
            "probability": 7.04963808022216e-06,
            "start_logit": -0.9859383702278137,
            "end_logit": -1.8171448707580566
        },
        {
            "text": "the double nucleotide substitution c.1162_1163delinsTA leading to a premature stop codon",
            "probability": 7.024420976291988e-06,
            "start_logit": -1.4690457582473755,
            "end_logit": -1.3376209735870361
        }
    ],
    "5c72768a7c78d6947100006c_005": [
        {
            "text": "There is an excess of escaping genes associated with mental retardation",
            "probability": 0.27082493837568805,
            "start_logit": 3.843327522277832,
            "end_logit": 3.3341174125671387
        },
        {
            "text": "There is an excess of escaping genes",
            "probability": 0.19237711770061883,
            "start_logit": 3.843327522277832,
            "end_logit": 2.9921023845672607
        },
        {
            "text": "There is an excess",
            "probability": 0.08374600835281945,
            "start_logit": 3.843327522277832,
            "end_logit": 2.160433292388916
        },
        {
            "text": "an excess of escaping genes associated with mental retardation",
            "probability": 0.06701071909702001,
            "start_logit": 2.4467074871063232,
            "end_logit": 3.3341174125671387
        },
        {
            "text": "an excess of escaping genes",
            "probability": 0.047600228665233515,
            "start_logit": 2.4467074871063232,
            "end_logit": 2.9921023845672607
        },
        {
            "text": "",
            "probability": 0.04549683216765469,
            "start_logit": 2.657550811767578,
            "end_logit": 2.7360641956329346
        },
        {
            "text": "escaping genes associated with mental retardation",
            "probability": 0.041290765663586915,
            "start_logit": 1.9624937772750854,
            "end_logit": 3.3341174125671387
        },
        {
            "text": "excess of escaping genes associated with mental retardation",
            "probability": 0.03432496556132425,
            "start_logit": 1.7777278423309326,
            "end_logit": 3.3341174125671387
        },
        {
            "text": "mental retardation",
            "probability": 0.029692827298818496,
            "start_logit": 1.6327604055404663,
            "end_logit": 3.3341174125671387
        },
        {
            "text": "escaping genes",
            "probability": 0.029330380479930016,
            "start_logit": 1.9624937772750854,
            "end_logit": 2.9921023845672607
        },
        {
            "text": "excess of escaping genes",
            "probability": 0.02438231124306736,
            "start_logit": 1.7777278423309326,
            "end_logit": 2.9921023845672607
        },
        {
            "text": "There is an excess of escaping genes associated with mental retardation,",
            "probability": 0.022729437136577952,
            "start_logit": 3.843327522277832,
            "end_logit": 0.8563056588172913
        },
        {
            "text": "There is an excess of escaping genes associated",
            "probability": 0.021452505572930606,
            "start_logit": 3.843327522277832,
            "end_logit": 0.7984862327575684
        },
        {
            "text": "an excess",
            "probability": 0.02072143088035225,
            "start_logit": 2.4467074871063232,
            "end_logit": 2.160433292388916
        },
        {
            "text": "There is an excess of escaping",
            "probability": 0.017801310101509295,
            "start_logit": 3.843327522277832,
            "end_logit": 0.6119168400764465
        },
        {
            "text": "genes that escape X-inactivation are under stronger purifying selection than others",
            "probability": 0.013694392000779066,
            "start_logit": 1.5645593404769897,
            "end_logit": 2.62839937210083
        },
        {
            "text": "genes that escape X-inactivation are under stronger purifying selection than others.",
            "probability": 0.012099743099886153,
            "start_logit": 1.5645593404769897,
            "end_logit": 2.5045971870422363
        },
        {
            "text": "excess",
            "probability": 0.010614158614231043,
            "start_logit": 1.7777278423309326,
            "end_logit": 2.160433292388916
        },
        {
            "text": "genes that escape X-inactivation are under stronger purifying selection",
            "probability": 0.007967883044391957,
            "start_logit": 1.5645593404769897,
            "end_logit": 2.08683180809021
        },
        {
            "text": "stronger purifying selection than others",
            "probability": 0.006842044943580168,
            "start_logit": 0.870659589767456,
            "end_logit": 2.62839937210083
        }
    ],
    "5e2d80cafbd6abf43b00000d_001": [
        {
            "text": "a complete pipeline for NOE-driven structure determination of medium- to larger-sized proteins",
            "probability": 0.4016199288143722,
            "start_logit": 4.6735520362854,
            "end_logit": 4.663981914520264
        },
        {
            "text": "a complete pipeline for NOE-driven structure determination",
            "probability": 0.11657910999599948,
            "start_logit": 4.6735520362854,
            "end_logit": 3.4270458221435547
        },
        {
            "text": "autoNOE-Rosetta",
            "probability": 0.07271490417420372,
            "start_logit": 2.7605674266815186,
            "end_logit": 4.868006706237793
        },
        {
            "text": "complete pipeline for NOE-driven structure determination of medium- to larger-sized proteins",
            "probability": 0.0662661676583032,
            "start_logit": 2.87172532081604,
            "end_logit": 4.663981914520264
        },
        {
            "text": "autoNOE-Rosetta, a complete pipeline for NOE-driven structure determination of medium- to larger-sized proteins",
            "probability": 0.05929479814044417,
            "start_logit": 2.7605674266815186,
            "end_logit": 4.663981914520264
        },
        {
            "text": "a complete pipeline",
            "probability": 0.052158762978295685,
            "start_logit": 4.6735520362854,
            "end_logit": 2.622767925262451
        },
        {
            "text": "analyzes two 4D spectra recorded using a single, fully protonated protein sample in an iterative ansatz",
            "probability": 0.040362904857876636,
            "start_logit": 3.6002614498138428,
            "end_logit": 3.4396774768829346
        },
        {
            "text": "pipeline for NOE-driven structure determination of medium- to larger-sized proteins",
            "probability": 0.03764854740620084,
            "start_logit": 2.306340217590332,
            "end_logit": 4.663981914520264
        },
        {
            "text": "4D-CHAINS/autoNOE-Rosetta",
            "probability": 0.02674068323324061,
            "start_logit": 1.760207176208496,
            "end_logit": 4.868006706237793
        },
        {
            "text": "4D-CHAINS/autoNOE-Rosetta, a complete pipeline for NOE-driven structure determination of medium- to larger-sized proteins",
            "probability": 0.021805480354535927,
            "start_logit": 1.760207176208496,
            "end_logit": 4.663981914520264
        },
        {
            "text": "complete pipeline for NOE-driven structure determination",
            "probability": 0.019235227871426834,
            "start_logit": 2.87172532081604,
            "end_logit": 3.4270458221435547
        },
        {
            "text": "autoNOE-Rosetta, a complete pipeline for NOE-driven structure determination",
            "probability": 0.017211632936174302,
            "start_logit": 2.7605674266815186,
            "end_logit": 3.4270458221435547
        },
        {
            "text": "structure determination of medium- to larger-sized proteins",
            "probability": 0.013957839292544164,
            "start_logit": 1.314087152481079,
            "end_logit": 4.663981914520264
        },
        {
            "text": "pipeline for NOE-driven structure determination",
            "probability": 0.01092832759124782,
            "start_logit": 2.306340217590332,
            "end_logit": 3.4270458221435547
        },
        {
            "text": "complete pipeline",
            "probability": 0.008606050358539261,
            "start_logit": 2.87172532081604,
            "end_logit": 2.622767925262451
        },
        {
            "text": "analyzes two 4D spectra recorded using a single, fully protonated protein sample",
            "probability": 0.008504422142383117,
            "start_logit": 3.6002614498138428,
            "end_logit": 1.882352590560913
        },
        {
            "text": "autoNOE-Rosetta, a complete pipeline",
            "probability": 0.007700671954161853,
            "start_logit": 2.7605674266815186,
            "end_logit": 2.622767925262451
        },
        {
            "text": "4D-CHAINS/autoNOE-Rosetta, a complete pipeline for NOE-driven structure determination",
            "probability": 0.006329525280957824,
            "start_logit": 1.760207176208496,
            "end_logit": 3.4270458221435547
        },
        {
            "text": "NOE-driven structure determination of medium- to larger-sized proteins",
            "probability": 0.006243690807231308,
            "start_logit": 0.5096173286437988,
            "end_logit": 4.663981914520264
        },
        {
            "text": "for NOE-driven structure determination of medium- to larger-sized proteins",
            "probability": 0.005463267072651157,
            "start_logit": 0.3760928213596344,
            "end_logit": 4.663981914520264
        },
        {
            "text": "",
            "probability": 0.000628057079210252,
            "start_logit": 0.997329831123352,
            "end_logit": 1.8795737028121948
        }
    ],
    "5e29fe76aa19d74431000007_001": [
        {
            "text": "",
            "probability": 0.1621370921413142,
            "start_logit": 0.16893446445465088,
            "end_logit": 0.5710998177528381
        },
        {
            "text": "support its continued development alone and in combination with other therapies",
            "probability": 0.10629788829998352,
            "start_logit": -0.16356992721557617,
            "end_logit": 0.48140740394592285
        },
        {
            "text": "alone and in combination with other therapies",
            "probability": 0.09749535804411634,
            "start_logit": -0.25001057982444763,
            "end_logit": 0.48140740394592285
        },
        {
            "text": "The safety, tolerability, preliminary evidence of antitumor activity, and novel mechanism of action",
            "probability": 0.0712988418515787,
            "start_logit": 0.4874292314052582,
            "end_logit": -0.5689570903778076
        },
        {
            "text": "The safety, tolerability, preliminary evidence of antitumor activity",
            "probability": 0.06743507599597909,
            "start_logit": 0.4874292314052582,
            "end_logit": -0.6246718764305115
        },
        {
            "text": "continued development alone and in combination with other therapies",
            "probability": 0.06473272988354795,
            "start_logit": -0.6595484018325806,
            "end_logit": 0.48140740394592285
        },
        {
            "text": "The safety",
            "probability": 0.05473570609123997,
            "start_logit": 0.4874292314052582,
            "end_logit": -0.8333209156990051
        },
        {
            "text": "its continued development alone and in combination with other therapies",
            "probability": 0.050912064716909906,
            "start_logit": -0.8997154235839844,
            "end_logit": 0.48140740394592285
        },
        {
            "text": "3 + 3 dose escalation design",
            "probability": 0.044084564271681934,
            "start_logit": -1.2375372648239136,
            "end_logit": 0.6752390265464783
        },
        {
            "text": "LB-100 was administered intravenously daily for 3 days in 21-day cycles in a 3 + 3 dose escalation design",
            "probability": 0.03399007151782607,
            "start_logit": -1.497578501701355,
            "end_logit": 0.6752390265464783
        },
        {
            "text": "The safety, tolerability",
            "probability": 0.03148084088979566,
            "start_logit": 0.4874292314052582,
            "end_logit": -1.3864580392837524
        },
        {
            "text": "The safety, tolerability, preliminary evidence of antitumor activity, and novel mechanism of action of LB-100 support its continued development alone",
            "probability": 0.030597072282155642,
            "start_logit": 0.4874292314052582,
            "end_logit": -1.4149328470230103
        },
        {
            "text": "The recommended phase II dose of LB-100 is 2.33 mg/m2 daily for 3 days every 3 weeks.Conclusions: The safety",
            "probability": 0.02657923814667812,
            "start_logit": -0.23495663702487946,
            "end_logit": -0.8333209156990051
        },
        {
            "text": "safety, tolerability, preliminary evidence of antitumor activity, and novel mechanism of action",
            "probability": 0.026150730171821693,
            "start_logit": -0.5155737400054932,
            "end_logit": -0.5689570903778076
        },
        {
            "text": "safety, tolerability, preliminary evidence of antitumor activity",
            "probability": 0.024733592169114492,
            "start_logit": -0.5155737400054932,
            "end_logit": -0.6246718764305115
        },
        {
            "text": "novel mechanism of action of LB-100 support its continued development alone and in combination with other therapies",
            "probability": 0.023854635333063846,
            "start_logit": -1.6578367948532104,
            "end_logit": 0.48140740394592285
        },
        {
            "text": "in a 3 + 3 dose escalation design",
            "probability": 0.02187535509481184,
            "start_logit": -1.938286304473877,
            "end_logit": 0.6752390265464783
        },
        {
            "text": "The recommended phase II dose of LB-100 is 2.33 mg/m2 daily for 3 days every 3 weeks",
            "probability": 0.02064602621595103,
            "start_logit": -0.23495663702487946,
            "end_logit": -1.0859284400939941
        },
        {
            "text": "development alone and in combination with other therapies",
            "probability": 0.020582568726168635,
            "start_logit": -1.805370807647705,
            "end_logit": 0.48140740394592285
        },
        {
            "text": "antitumor activity, and novel mechanism of action of LB-100 support its continued development alone and in combination with other therapies",
            "probability": 0.020380548156261228,
            "start_logit": -1.8152344226837158,
            "end_logit": 0.48140740394592285
        }
    ],
    "5e480da0d14c9f295d000006_001": [
        {
            "text": "",
            "probability": 0.8314615288827213,
            "start_logit": 3.512944459915161,
            "end_logit": 4.235997200012207
        },
        {
            "text": "stereotactic radiosurgery",
            "probability": 0.06943206440527712,
            "start_logit": 2.2317440509796143,
            "end_logit": 3.0343613624572754
        },
        {
            "text": "Stereotactic radiosurgery",
            "probability": 0.059346580019499884,
            "start_logit": 2.2644388675689697,
            "end_logit": 2.844712257385254
        },
        {
            "text": "stereotactic radiosurgery is a\u00a0new treatment option for uveal melanoma.OBJECTIVE:",
            "probability": 0.00806084314686969,
            "start_logit": 2.2317440509796143,
            "end_logit": 0.8810307383537292
        },
        {
            "text": "CyberKnife\u00ae stereotactic radiosurgery",
            "probability": 0.005742513787600127,
            "start_logit": -0.26070767641067505,
            "end_logit": 3.0343613624572754
        },
        {
            "text": "radiosurgery",
            "probability": 0.00510173422156182,
            "start_logit": -0.3790242075920105,
            "end_logit": 3.0343613624572754
        },
        {
            "text": "Stereotactic radiosurgery using CyberKnife\u00ae seems to be an efficient and safe therapeutic option",
            "probability": 0.00320334832950217,
            "start_logit": 2.2644388675689697,
            "end_logit": -0.07448562234640121
        },
        {
            "text": "Stereotactic radiosurgery using CyberKnife\u00ae seems to be an efficient and safe therapeutic option for malignant melanomas",
            "probability": 0.0027174468477810815,
            "start_logit": 2.2644388675689697,
            "end_logit": -0.23898945748806
        },
        {
            "text": "stereotactic radiosurgery is a\u00a0new treatment option",
            "probability": 0.002626538718734577,
            "start_logit": 2.2317440509796143,
            "end_logit": -0.24032051861286163
        },
        {
            "text": "robot-assisted CyberKnife\u00ae therapy, as well as the pros and cons in the treatment of uveal melanoma",
            "probability": 0.002105563689175823,
            "start_logit": 0.3571593761444092,
            "end_logit": 1.4131804704666138
        },
        {
            "text": "treatment of uveal melanoma",
            "probability": 0.0016996836766271929,
            "start_logit": 0.14301832020282745,
            "end_logit": 1.4131804704666138
        },
        {
            "text": "stereotactic radiosurgery is a\u00a0new treatment option for uveal melanoma.OBJECTIVE: This review outlines the technique of robot-assisted",
            "probability": 0.0013851381063410392,
            "start_logit": 2.2317440509796143,
            "end_logit": -0.8801875710487366
        },
        {
            "text": "CyberKnife\u00ae therapy for choroidal and ciliary body melanomas",
            "probability": 0.0012717301967501444,
            "start_logit": -0.24847044050693512,
            "end_logit": 1.5146054029464722
        },
        {
            "text": "choroidal and ciliary body melanomas",
            "probability": 0.0009679552323077387,
            "start_logit": -0.5214182138442993,
            "end_logit": 1.5146054029464722
        },
        {
            "text": "the treatment of uveal melanoma",
            "probability": 0.0009195311995492636,
            "start_logit": -0.4713151454925537,
            "end_logit": 1.4131804704666138
        },
        {
            "text": "stereotactic radiosurgery is a\u00a0new treatment",
            "probability": 0.0008713063647875548,
            "start_logit": 2.2317440509796143,
            "end_logit": -1.3437490463256836
        },
        {
            "text": "robot-assisted CyberKnife\u00ae therapy",
            "probability": 0.0008471679853751038,
            "start_logit": 0.3571593761444092,
            "end_logit": 0.5027409791946411
        },
        {
            "text": "therapy for choroidal and ciliary body melanomas",
            "probability": 0.0007932142731181702,
            "start_logit": -0.7205106616020203,
            "end_logit": 1.5146054029464722
        },
        {
            "text": "Stereotactic",
            "probability": 0.000779423222383344,
            "start_logit": 2.2644388675689697,
            "end_logit": -1.4878833293914795
        },
        {
            "text": "CyberKnife\u00ae stereotactic radiosurgery is a\u00a0new treatment option for uveal melanoma.OBJECTIVE:",
            "probability": 0.0006666876940369786,
            "start_logit": -0.26070767641067505,
            "end_logit": 0.8810307383537292
        }
    ],
    "5e480da0d14c9f295d000006_002": [
        {
            "text": "",
            "probability": 0.9454147345432803,
            "start_logit": 3.7879085540771484,
            "end_logit": 4.781759738922119
        },
        {
            "text": "radiosurgery",
            "probability": 0.039698989082076905,
            "start_logit": 1.8148635625839233,
            "end_logit": 3.5845067501068115
        },
        {
            "text": "CyberKnife radiosurgery",
            "probability": 0.00887655230003343,
            "start_logit": 0.31695106625556946,
            "end_logit": 3.5845067501068115
        },
        {
            "text": "Three or 4 sessions of CyberKnife radiosurgery",
            "probability": 0.002868996735874075,
            "start_logit": -0.8124997615814209,
            "end_logit": 3.5845067501068115
        },
        {
            "text": "giant CSH (tumor volume > 40 cm3, > 4 cm in diameter) treated using CyberKnife radiosurgery",
            "probability": 0.0009827522564753775,
            "start_logit": -0.4559531509876251,
            "end_logit": 2.156599521636963
        },
        {
            "text": "treated using CyberKnife radiosurgery",
            "probability": 0.0005565809942575194,
            "start_logit": -1.0244975090026855,
            "end_logit": 2.156599521636963
        },
        {
            "text": "radiosurgery were used with a prescription dose based on the intent to cover the entire tumor with a higher dose",
            "probability": 0.0005007678437084619,
            "start_logit": 1.8148635625839233,
            "end_logit": -0.7884316444396973
        },
        {
            "text": "radiosurgery were used with a prescription dose based on the intent to cover the entire tumor",
            "probability": 0.00033376436452483557,
            "start_logit": 1.8148635625839233,
            "end_logit": -1.194139003753662
        },
        {
            "text": "radiosurgery were used with a prescription dose based on the intent to cover the entire tumor with a higher dose while ensuring dose limitation to the visual pathways",
            "probability": 0.0002103702928442084,
            "start_logit": 1.8148635625839233,
            "end_logit": -1.6557049751281738
        },
        {
            "text": "radiosurger",
            "probability": 0.00012913528033255887,
            "start_logit": 1.8148635625839233,
            "end_logit": -2.1437137126922607
        },
        {
            "text": "CyberKnife radiosurgery were used with a prescription dose based on the intent to cover the entire tumor with a higher dose",
            "probability": 0.00011196990295301941,
            "start_logit": 0.31695106625556946,
            "end_logit": -0.7884316444396973
        },
        {
            "text": "CyberKnife radiosurgery were used with a prescription dose based on the intent to cover the entire tumor",
            "probability": 7.462852092950898e-05,
            "start_logit": 0.31695106625556946,
            "end_logit": -1.194139003753662
        },
        {
            "text": "giant CSH",
            "probability": 4.5395178025167885e-05,
            "start_logit": -0.4559531509876251,
            "end_logit": -0.9183516502380371
        },
        {
            "text": "a prescription dose based on the intent to cover the entire tumor with a higher dose while ensuring dose limitation to the visual pathways and brainstem",
            "probability": 4.069825087681796e-05,
            "start_logit": -2.1959004402160645,
            "end_logit": 0.7123748660087585
        },
        {
            "text": "with a prescription dose based on the intent to cover the entire tumor with a higher dose while ensuring dose limitation to the visual pathways and brainstem",
            "probability": 3.538225003642971e-05,
            "start_logit": -2.3358752727508545,
            "end_logit": 0.7123748660087585
        },
        {
            "text": "31 patients with a giant CSH",
            "probability": 2.9226991205733256e-05,
            "start_logit": -0.8962664008140564,
            "end_logit": -0.9183516502380371
        },
        {
            "text": "CyberKnife radiosurger",
            "probability": 2.887418788628429e-05,
            "start_logit": 0.31695106625556946,
            "end_logit": -2.1437137126922607
        },
        {
            "text": "Three or 4 sessions of CyberKnife radiosurgery were used with a prescription dose based on the intent to cover the entire tumor",
            "probability": 2.4120736938491878e-05,
            "start_logit": -0.8124997615814209,
            "end_logit": -1.194139003753662
        },
        {
            "text": "giant CSH (tumor volume > 40 cm3, > 4 cm in diameter",
            "probability": 2.0200732580535e-05,
            "start_logit": -0.4559531509876251,
            "end_logit": -1.7280386686325073
        },
        {
            "text": "Resection",
            "probability": 1.685955516057448e-05,
            "start_logit": -1.584326148033142,
            "end_logit": -0.7804669737815857
        }
    ],
    "5e480da0d14c9f295d000006_003": [
        {
            "text": "treating head and neck paragangliomas",
            "probability": 0.37043682427966657,
            "start_logit": 3.0784337520599365,
            "end_logit": 4.084355354309082
        },
        {
            "text": "robotic stereotactic radiotherapy system",
            "probability": 0.11881140406986619,
            "start_logit": 2.57149338722229,
            "end_logit": 3.4541501998901367
        },
        {
            "text": "head and neck paragangliomas",
            "probability": 0.08600924839206997,
            "start_logit": 1.6182056665420532,
            "end_logit": 4.084355354309082
        },
        {
            "text": "stereotactic radiotherapy system",
            "probability": 0.07163249403378545,
            "start_logit": 2.065504789352417,
            "end_logit": 3.4541501998901367
        },
        {
            "text": "robotic stereotactic radiotherapy",
            "probability": 0.07067082644480256,
            "start_logit": 2.57149338722229,
            "end_logit": 2.934645652770996
        },
        {
            "text": "safe and efficient system treating head and neck paragangliomas",
            "probability": 0.04556460667944131,
            "start_logit": 0.9828820824623108,
            "end_logit": 4.084355354309082
        },
        {
            "text": "stereotactic radiotherapy",
            "probability": 0.042608094679978205,
            "start_logit": 2.065504789352417,
            "end_logit": 2.934645652770996
        },
        {
            "text": "",
            "probability": 0.0413085748326352,
            "start_logit": 2.350679397583008,
            "end_logit": 2.618496894836426
        },
        {
            "text": "a robotic stereotactic radiotherapy system",
            "probability": 0.035091569560831676,
            "start_logit": 1.3519169092178345,
            "end_logit": 3.4541501998901367
        },
        {
            "text": "a robotic stereotactic radiotherapy",
            "probability": 0.020872998190063767,
            "start_logit": 1.3519169092178345,
            "end_logit": 2.934645652770996
        },
        {
            "text": "seems to be a safe and efficient system treating head and neck paragangliomas",
            "probability": 0.01712689252945752,
            "start_logit": 0.004400727339088917,
            "end_logit": 4.084355354309082
        },
        {
            "text": "radiotherapy system",
            "probability": 0.014014794522140548,
            "start_logit": 0.43406951427459717,
            "end_logit": 3.4541501998901367
        },
        {
            "text": "a safe and efficient system treating head and neck paragangliomas",
            "probability": 0.01176538062340534,
            "start_logit": -0.37108778953552246,
            "end_logit": 4.084355354309082
        },
        {
            "text": "robotic",
            "probability": 0.010986445498241348,
            "start_logit": 2.57149338722229,
            "end_logit": 1.073275089263916
        },
        {
            "text": "efficient system treating head and neck paragangliomas",
            "probability": 0.009166433938827127,
            "start_logit": -0.6207008361816406,
            "end_logit": 4.084355354309082
        },
        {
            "text": "CyberKnife\u00ae is a robotic stereotactic radiotherapy system",
            "probability": 0.008955551410582406,
            "start_logit": -0.013770399615168571,
            "end_logit": 3.4541501998901367
        },
        {
            "text": "radiotherapy",
            "probability": 0.00833621249649861,
            "start_logit": 0.43406951427459717,
            "end_logit": 2.934645652770996
        },
        {
            "text": "treating head and neck paragangliomas.",
            "probability": 0.005962841336979478,
            "start_logit": 3.0784337520599365,
            "end_logit": -0.04478045925498009
        },
        {
            "text": "treating",
            "probability": 0.005351908575517235,
            "start_logit": 3.0784337520599365,
            "end_logit": -0.15287432074546814
        },
        {
            "text": "CyberKnife\u00ae is a robotic stereotactic radiotherapy",
            "probability": 0.005326897905209554,
            "start_logit": -0.013770399615168571,
            "end_logit": 2.934645652770996
        }
    ],
    "5e480da0d14c9f295d000006_004": [
        {
            "text": "treating head and neck paragangliomas",
            "probability": 0.37043682427966657,
            "start_logit": 3.0784337520599365,
            "end_logit": 4.084355354309082
        },
        {
            "text": "robotic stereotactic radiotherapy system",
            "probability": 0.11881140406986619,
            "start_logit": 2.57149338722229,
            "end_logit": 3.4541501998901367
        },
        {
            "text": "head and neck paragangliomas",
            "probability": 0.08600924839206997,
            "start_logit": 1.6182056665420532,
            "end_logit": 4.084355354309082
        },
        {
            "text": "stereotactic radiotherapy system",
            "probability": 0.07163249403378545,
            "start_logit": 2.065504789352417,
            "end_logit": 3.4541501998901367
        },
        {
            "text": "robotic stereotactic radiotherapy",
            "probability": 0.07067082644480256,
            "start_logit": 2.57149338722229,
            "end_logit": 2.934645652770996
        },
        {
            "text": "safe and efficient system treating head and neck paragangliomas",
            "probability": 0.04556460667944131,
            "start_logit": 0.9828820824623108,
            "end_logit": 4.084355354309082
        },
        {
            "text": "stereotactic radiotherapy",
            "probability": 0.042608094679978205,
            "start_logit": 2.065504789352417,
            "end_logit": 2.934645652770996
        },
        {
            "text": "",
            "probability": 0.0413085748326352,
            "start_logit": 2.350679397583008,
            "end_logit": 2.618496894836426
        },
        {
            "text": "a robotic stereotactic radiotherapy system",
            "probability": 0.035091569560831676,
            "start_logit": 1.3519169092178345,
            "end_logit": 3.4541501998901367
        },
        {
            "text": "a robotic stereotactic radiotherapy",
            "probability": 0.020872998190063767,
            "start_logit": 1.3519169092178345,
            "end_logit": 2.934645652770996
        },
        {
            "text": "seems to be a safe and efficient system treating head and neck paragangliomas",
            "probability": 0.01712689252945752,
            "start_logit": 0.004400727339088917,
            "end_logit": 4.084355354309082
        },
        {
            "text": "radiotherapy system",
            "probability": 0.014014794522140548,
            "start_logit": 0.43406951427459717,
            "end_logit": 3.4541501998901367
        },
        {
            "text": "a safe and efficient system treating head and neck paragangliomas",
            "probability": 0.01176538062340534,
            "start_logit": -0.37108778953552246,
            "end_logit": 4.084355354309082
        },
        {
            "text": "robotic",
            "probability": 0.010986445498241348,
            "start_logit": 2.57149338722229,
            "end_logit": 1.073275089263916
        },
        {
            "text": "efficient system treating head and neck paragangliomas",
            "probability": 0.009166433938827127,
            "start_logit": -0.6207008361816406,
            "end_logit": 4.084355354309082
        },
        {
            "text": "CyberKnife\u00ae is a robotic stereotactic radiotherapy system",
            "probability": 0.008955551410582406,
            "start_logit": -0.013770399615168571,
            "end_logit": 3.4541501998901367
        },
        {
            "text": "radiotherapy",
            "probability": 0.00833621249649861,
            "start_logit": 0.43406951427459717,
            "end_logit": 2.934645652770996
        },
        {
            "text": "treating head and neck paragangliomas.",
            "probability": 0.005962841336979478,
            "start_logit": 3.0784337520599365,
            "end_logit": -0.04478045925498009
        },
        {
            "text": "treating",
            "probability": 0.005351908575517235,
            "start_logit": 3.0784337520599365,
            "end_logit": -0.15287432074546814
        },
        {
            "text": "CyberKnife\u00ae is a robotic stereotactic radiotherapy",
            "probability": 0.005326897905209554,
            "start_logit": -0.013770399615168571,
            "end_logit": 2.934645652770996
        }
    ],
    "5e290a268b3851296d00000d_001": [
        {
            "text": "",
            "probability": 0.9999936434510602,
            "start_logit": 5.020928859710693,
            "end_logit": 5.8248677253723145
        },
        {
            "text": "We discuss",
            "probability": 1.0071262193517615e-06,
            "start_logit": -1.1687182188034058,
            "end_logit": -1.7938884496688843
        },
        {
            "text": "discuss",
            "probability": 5.654499128627927e-07,
            "start_logit": -1.7459527254104614,
            "end_logit": -1.7938884496688843
        },
        {
            "text": "poor prognoses",
            "probability": 4.925810527970253e-07,
            "start_logit": -2.643239974975586,
            "end_logit": -1.0345638990402222
        },
        {
            "text": "We discuss the approved indications, current research, and areas of future exploration",
            "probability": 4.6053868034754984e-07,
            "start_logit": -1.1687182188034058,
            "end_logit": -2.576347827911377
        },
        {
            "text": "Palbociclib is also food and drug administration-approved for use in combination with fulvestrant",
            "probability": 4.48778044585116e-07,
            "start_logit": -1.6984044313430786,
            "end_logit": -2.0725300312042236
        },
        {
            "text": "monotherapy",
            "probability": 3.9923630428909235e-07,
            "start_logit": -2.608686923980713,
            "end_logit": -1.2792224884033203
        },
        {
            "text": "palbociclib, ribociclib, abemaciclib, and trilaciclib.",
            "probability": 3.385056843158071e-07,
            "start_logit": -3.285435914993286,
            "end_logit": -0.7674860954284668
        },
        {
            "text": "We",
            "probability": 3.170159388733882e-07,
            "start_logit": -1.1687182188034058,
            "end_logit": -2.9497926235198975
        },
        {
            "text": "treatment of various malignancies, including those with such poor prognoses",
            "probability": 2.9995107928107383e-07,
            "start_logit": -3.13927960395813,
            "end_logit": -1.0345638990402222
        },
        {
            "text": "We discuss the approved indications, current research, and areas of future exploration for palbociclib",
            "probability": 2.8112122715429597e-07,
            "start_logit": -1.1687182188034058,
            "end_logit": -3.0699586868286133
        },
        {
            "text": "discuss the approved indications, current research, and areas of future exploration",
            "probability": 2.5856893770483097e-07,
            "start_logit": -1.7459527254104614,
            "end_logit": -2.576347827911377
        },
        {
            "text": "poor prognoses as glioblastoma multiforme, mantle cell lymphoma, and metastatic melanoma. We discuss",
            "probability": 2.3051927249877496e-07,
            "start_logit": -2.643239974975586,
            "end_logit": -1.7938884496688843
        },
        {
            "text": "combination with fulvestrant",
            "probability": 2.093956318741222e-07,
            "start_logit": -2.460707426071167,
            "end_logit": -2.0725300312042236
        },
        {
            "text": "combination with fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer",
            "probability": 1.9656089346837342e-07,
            "start_logit": -2.460707426071167,
            "end_logit": -2.1357831954956055
        },
        {
            "text": "trilaciclib.",
            "probability": 1.9397098215109802e-07,
            "start_logit": -3.842268228530884,
            "end_logit": -0.7674860954284668
        },
        {
            "text": "palbociclib, ribociclib, abemaciclib, and trilaciclib",
            "probability": 1.8532355983299913e-07,
            "start_logit": -3.285435914993286,
            "end_logit": -1.369923710823059
        },
        {
            "text": "ribociclib, abemaciclib, and trilaciclib.",
            "probability": 1.644185964057526e-07,
            "start_logit": -4.007561206817627,
            "end_logit": -0.7674860954284668
        },
        {
            "text": "discuss the approved indications, current research, and areas of future exploration for palbociclib",
            "probability": 1.5783520510526757e-07,
            "start_logit": -1.7459527254104614,
            "end_logit": -3.0699586868286133
        },
        {
            "text": "glioblastoma multiforme, mantle cell lymphoma, and metastatic melanoma. We discuss",
            "probability": 1.4965171689857556e-07,
            "start_logit": -3.075263738632202,
            "end_logit": -1.7938884496688843
        }
    ],
    "5e290a268b3851296d00000d_002": [
        {
            "text": "not an effective treatment",
            "probability": 0.2249949543910629,
            "start_logit": 3.7062604427337646,
            "end_logit": 3.6835036277770996
        },
        {
            "text": "not an effective treatment for recurrent glioblastoma",
            "probability": 0.1395005459212583,
            "start_logit": 3.7062604427337646,
            "end_logit": 3.2054941654205322
        },
        {
            "text": "palbociclib monotherapy was not an effective treatment",
            "probability": 0.11138034005431081,
            "start_logit": 3.0031332969665527,
            "end_logit": 3.6835036277770996
        },
        {
            "text": "palbociclib monotherapy",
            "probability": 0.11059420079706783,
            "start_logit": 3.0031332969665527,
            "end_logit": 3.6764204502105713
        },
        {
            "text": "not an effective",
            "probability": 0.0989713721164394,
            "start_logit": 3.7062604427337646,
            "end_logit": 2.8622562885284424
        },
        {
            "text": "palbociclib monotherapy was not an effective treatment for recurrent glioblastoma",
            "probability": 0.06905762969006794,
            "start_logit": 3.0031332969665527,
            "end_logit": 3.2054941654205322
        },
        {
            "text": "palbociclib monotherapy was not an effective",
            "probability": 0.048994276835252544,
            "start_logit": 3.0031332969665527,
            "end_logit": 2.8622562885284424
        },
        {
            "text": "not",
            "probability": 0.02820784053818074,
            "start_logit": 3.7062604427337646,
            "end_logit": 1.6070256233215332
        },
        {
            "text": "was not an effective treatment",
            "probability": 0.023647902291086185,
            "start_logit": 1.4534568786621094,
            "end_logit": 3.6835036277770996
        },
        {
            "text": "not an effective treatment for recurrent glioblastoma.",
            "probability": 0.016547528403510182,
            "start_logit": 3.7062604427337646,
            "end_logit": 1.0736624002456665
        },
        {
            "text": "not an effective treatment for recurrent",
            "probability": 0.016536026115780467,
            "start_logit": 3.7062604427337646,
            "end_logit": 1.0729670524597168
        },
        {
            "text": "was not an effective treatment for recurrent glioblastoma",
            "probability": 0.014662085593996477,
            "start_logit": 1.4534568786621094,
            "end_logit": 3.2054941654205322
        },
        {
            "text": "not an effective treatment for recurrent glioblastoma. However, these were heavily pretreated patients",
            "probability": 0.014049611726338191,
            "start_logit": 3.7062604427337646,
            "end_logit": 0.9100204110145569
        },
        {
            "text": "palbociclib monotherapy was not",
            "probability": 0.013963863677936509,
            "start_logit": 3.0031332969665527,
            "end_logit": 1.6070256233215332
        },
        {
            "text": "monotherapy was not an effective treatment",
            "probability": 0.01337946378588834,
            "start_logit": 0.883903443813324,
            "end_logit": 3.6835036277770996
        },
        {
            "text": "monotherapy",
            "probability": 0.013285029510343672,
            "start_logit": 0.883903443813324,
            "end_logit": 3.6764204502105713
        },
        {
            "text": "despite adequate tissue PK, palbociclib monotherapy was not an effective treatment",
            "probability": 0.011044281187261454,
            "start_logit": 0.6920952200889587,
            "end_logit": 3.6835036277770996
        },
        {
            "text": "despite adequate tissue PK, palbociclib monotherapy",
            "probability": 0.010966328983083385,
            "start_logit": 0.6920952200889587,
            "end_logit": 3.6764204502105713
        },
        {
            "text": "was not an effective",
            "probability": 0.010402301437197283,
            "start_logit": 1.4534568786621094,
            "end_logit": 2.8622562885284424
        },
        {
            "text": "In this trial, despite adequate tissue PK, palbociclib monotherapy was not an effective treatment",
            "probability": 0.009323898601865234,
            "start_logit": 0.5227633118629456,
            "end_logit": 3.6835036277770996
        },
        {
            "text": "",
            "probability": 0.0004905183420723161,
            "start_logit": 0.4341404438018799,
            "end_logit": 0.8272530436515808
        }
    ],
    "5c72c9207c78d6947100007b_001": [
        {
            "text": "",
            "probability": 0.5096597559568717,
            "start_logit": 5.32606840133667,
            "end_logit": 5.962323188781738
        },
        {
            "text": "reversible jump Markov Chain Monte Carlo (RJMCMC) method",
            "probability": 0.16119834605407748,
            "start_logit": 4.8283185958862305,
            "end_logit": 5.30896520614624
        },
        {
            "text": "reversible jump Markov Chain Monte Carlo (RJMCMC)",
            "probability": 0.13637998785660735,
            "start_logit": 4.8283185958862305,
            "end_logit": 5.141774654388428
        },
        {
            "text": "reversible jump Markov Chain Monte Carlo",
            "probability": 0.05438766105601739,
            "start_logit": 4.8283185958862305,
            "end_logit": 4.222466945648193
        },
        {
            "text": "a reversible jump Markov Chain Monte Carlo (RJMCMC) method",
            "probability": 0.03782424256104099,
            "start_logit": 3.3786332607269287,
            "end_logit": 5.30896520614624
        },
        {
            "text": "a reversible jump Markov Chain Monte Carlo (RJMCMC)",
            "probability": 0.03200076097201159,
            "start_logit": 3.3786332607269287,
            "end_logit": 5.141774654388428
        },
        {
            "text": "RJMCMC) method",
            "probability": 0.016588359351502473,
            "start_logit": 2.554384231567383,
            "end_logit": 5.30896520614624
        },
        {
            "text": "RJMCMC)",
            "probability": 0.014034388703715373,
            "start_logit": 2.554384231567383,
            "end_logit": 5.141774654388428
        },
        {
            "text": "a reversible jump Markov Chain Monte Carlo",
            "probability": 0.012761744363185718,
            "start_logit": 3.3786332607269287,
            "end_logit": 4.222466945648193
        },
        {
            "text": "reversible jump Markov Chain Monte Carlo (RJMCMC",
            "probability": 0.007813448232243121,
            "start_logit": 4.8283185958862305,
            "end_logit": 2.2821760177612305
        },
        {
            "text": "jump Markov Chain Monte Carlo (RJMCMC) method",
            "probability": 0.003684874909407236,
            "start_logit": 1.049919605255127,
            "end_logit": 5.30896520614624
        },
        {
            "text": "jump Markov Chain Monte Carlo (RJMCMC)",
            "probability": 0.0031175456057687275,
            "start_logit": 1.049919605255127,
            "end_logit": 5.141774654388428
        },
        {
            "text": "Markov Chain Monte Carlo (RJMCMC) method",
            "probability": 0.0021360571275913626,
            "start_logit": 0.5046446919441223,
            "end_logit": 5.30896520614624
        },
        {
            "text": "a reversible jump Markov Chain Monte Carlo (RJMCMC",
            "probability": 0.0018333796121912823,
            "start_logit": 3.3786332607269287,
            "end_logit": 2.2821760177612305
        },
        {
            "text": "Markov Chain Monte Carlo (RJMCMC)",
            "probability": 0.0018071863158211404,
            "start_logit": 0.5046446919441223,
            "end_logit": 5.141774654388428
        },
        {
            "text": "jump Markov Chain Monte Carlo",
            "probability": 0.0012432616866889627,
            "start_logit": 1.049919605255127,
            "end_logit": 4.222466945648193
        },
        {
            "text": "reversible jump Markov Chain Monte Carlo (RJMCMC) method can be used to obtain a posteriori distribution",
            "probability": 0.001101322444652244,
            "start_logit": 4.8283185958862305,
            "end_logit": 0.3228413164615631
        },
        {
            "text": "reversible jump Markov Chain",
            "probability": 0.0008779243009564925,
            "start_logit": 4.8283185958862305,
            "end_logit": 0.0961347296833992
        },
        {
            "text": "RJMCMC",
            "probability": 0.0008040546954950108,
            "start_logit": 2.554384231567383,
            "end_logit": 2.2821760177612305
        },
        {
            "text": "reversible jump Markov Chain Monte Carlo (RJMCMC) method can be used",
            "probability": 0.0007456981941544446,
            "start_logit": 4.8283185958862305,
            "end_logit": -0.06710468977689743
        }
    ],
    "5c72c9207c78d6947100007b_002": [
        {
            "text": "",
            "probability": 0.9683544650612398,
            "start_logit": 5.703531742095947,
            "end_logit": 6.22739315032959
        },
        {
            "text": "Markov models",
            "probability": 0.009705201076957078,
            "start_logit": 3.30889892578125,
            "end_logit": 4.019089698791504
        },
        {
            "text": "higher-order Markov-model-based segmentation procedures",
            "probability": 0.004994405269292253,
            "start_logit": 3.745741367340088,
            "end_logit": 2.9179036617279053
        },
        {
            "text": "Higher-order Markov models",
            "probability": 0.003335241304773995,
            "start_logit": 2.4883079528808594,
            "end_logit": 3.771563768386841
        },
        {
            "text": "higher-order Markov-model",
            "probability": 0.002834213599362695,
            "start_logit": 3.745741367340088,
            "end_logit": 2.3513498306274414
        },
        {
            "text": "Markov models for segmentation of symbolic sequences, extending a segmentation procedure based on the Jensen-Shannon divergence",
            "probability": 0.002136033749378898,
            "start_logit": 3.30889892578125,
            "end_logit": 2.505378484725952
        },
        {
            "text": "higher-order Markov-model-based",
            "probability": 0.002119816803195797,
            "start_logit": 3.745741367340088,
            "end_logit": 2.060914993286133
        },
        {
            "text": "We introduce Markov models",
            "probability": 0.0017514251403350624,
            "start_logit": 1.5966668128967285,
            "end_logit": 4.019089698791504
        },
        {
            "text": "Markov models for segmentation of symbolic sequences",
            "probability": 0.0011740926655855644,
            "start_logit": 3.30889892578125,
            "end_logit": 1.9069234132766724
        },
        {
            "text": "Markov-model-based segmentation procedures",
            "probability": 0.0006636172901362549,
            "start_logit": 1.7273733615875244,
            "end_logit": 2.9179036617279053
        },
        {
            "text": "higher-order",
            "probability": 0.0004653712492271587,
            "start_logit": 3.745741367340088,
            "end_logit": 0.544665515422821
        },
        {
            "text": "higher-order Markov-model-based segmentation",
            "probability": 0.00038895917803164956,
            "start_logit": 3.745741367340088,
            "end_logit": 0.36530444025993347
        },
        {
            "text": "We introduce Markov models for segmentation of symbolic sequences, extending a segmentation procedure based on the Jensen-Shannon divergence",
            "probability": 0.0003854740545405921,
            "start_logit": 1.5966668128967285,
            "end_logit": 2.505378484725952
        },
        {
            "text": "Markov-model",
            "probability": 0.0003765880113975856,
            "start_logit": 1.7273733615875244,
            "end_logit": 2.3513498306274414
        },
        {
            "text": "Markov-model-based",
            "probability": 0.000281664584003901,
            "start_logit": 1.7273733615875244,
            "end_logit": 2.060914993286133
        },
        {
            "text": "Jensen-Shannon divergence that has been introduced earlier. Higher-order Markov models",
            "probability": 0.00027390272297952024,
            "start_logit": -0.01121934037655592,
            "end_logit": 3.771563768386841
        },
        {
            "text": "Higher-order Markov models are more sensitive to the details of local patterns and in application to genome analysis",
            "probability": 0.0002404618057034494,
            "start_logit": 2.4883079528808594,
            "end_logit": 1.141824722290039
        },
        {
            "text": "We introduce Markov models for segmentation of symbolic sequences",
            "probability": 0.00021187973286528733,
            "start_logit": 1.5966668128967285,
            "end_logit": 1.9069234132766724
        },
        {
            "text": "introduce Markov models",
            "probability": 0.00017528469728460484,
            "start_logit": -0.705106794834137,
            "end_logit": 4.019089698791504
        },
        {
            "text": "higher-order Markov-model-based segmentation procedures in detecting compositional inhomogeneity in chimeric DNA sequences",
            "probability": 0.00013190200370898352,
            "start_logit": 3.745741367340088,
            "end_logit": -0.7161107063293457
        }
    ],
    "5c72c9207c78d6947100007b_003": [
        {
            "text": "",
            "probability": 0.7748568117700653,
            "start_logit": 4.153157711029053,
            "end_logit": 4.736632823944092
        },
        {
            "text": "combinatorial",
            "probability": 0.09745261005581296,
            "start_logit": 2.911766767501831,
            "end_logit": 3.9047117233276367
        },
        {
            "text": "combinatorial genome segmentation solely using information on combinations of epigenetic marks",
            "probability": 0.08100110737524029,
            "start_logit": 2.911766767501831,
            "end_logit": 3.719808340072632
        },
        {
            "text": "combinations of epigenetic marks",
            "probability": 0.01051433573570477,
            "start_logit": 0.8700435757637024,
            "end_logit": 3.719808340072632
        },
        {
            "text": "information on combinations of epigenetic marks",
            "probability": 0.009423668442243129,
            "start_logit": 0.7605283856391907,
            "end_logit": 3.719808340072632
        },
        {
            "text": "using information on combinations of epigenetic marks",
            "probability": 0.005548558045968797,
            "start_logit": 0.23084202408790588,
            "end_logit": 3.719808340072632
        },
        {
            "text": "a combinatorial",
            "probability": 0.0041464434147519495,
            "start_logit": -0.2453484833240509,
            "end_logit": 3.9047117233276367
        },
        {
            "text": "combinatorial genome segmentation",
            "probability": 0.0036856907770178343,
            "start_logit": 2.911766767501831,
            "end_logit": 0.629803478717804
        },
        {
            "text": "a combinatorial genome segmentation solely using information on combinations of epigenetic marks",
            "probability": 0.0034464598543981887,
            "start_logit": -0.2453484833240509,
            "end_logit": 3.719808340072632
        },
        {
            "text": "epigenetic marks",
            "probability": 0.003331502729328196,
            "start_logit": -0.27927258610725403,
            "end_logit": 3.719808340072632
        },
        {
            "text": "solely using information on combinations of epigenetic marks",
            "probability": 0.0013248749405787002,
            "start_logit": -1.2013779878616333,
            "end_logit": 3.719808340072632
        },
        {
            "text": "Our method is based on a combinatorial",
            "probability": 0.0011357195434163261,
            "start_logit": -1.5403330326080322,
            "end_logit": 3.9047117233276367
        },
        {
            "text": "based on a combinatorial",
            "probability": 0.0009743431997861638,
            "start_logit": -1.6935911178588867,
            "end_logit": 3.9047117233276367
        },
        {
            "text": "Our method is based on a combinatorial genome segmentation solely using information on combinations of epigenetic marks",
            "probability": 0.0009439925788723121,
            "start_logit": -1.5403330326080322,
            "end_logit": 3.719808340072632
        },
        {
            "text": "based on a combinatorial genome segmentation solely using information on combinations of epigenetic marks",
            "probability": 0.0008098590494499183,
            "start_logit": -1.6935911178588867,
            "end_logit": 3.719808340072632
        },
        {
            "text": "combinatorial genome segmentation solely using information on combinations of epigenetic marks.",
            "probability": 0.00045090976160343585,
            "start_logit": 2.911766767501831,
            "end_logit": -1.4711425304412842
        },
        {
            "text": "genome segmentation solely using information on combinations of epigenetic marks",
            "probability": 0.0002851594282988413,
            "start_logit": -2.73740291595459,
            "end_logit": 3.719808340072632
        },
        {
            "text": "compression, clustering",
            "probability": 0.0002269954632409667,
            "start_logit": 1.0293329954147339,
            "end_logit": -0.2750459611415863
        },
        {
            "text": "segmentation solely using information on combinations of epigenetic marks",
            "probability": 0.00022511541955154155,
            "start_logit": -2.9738380908966064,
            "end_logit": 3.719808340072632
        },
        {
            "text": "combinatorial genome",
            "probability": 0.00021584241467050873,
            "start_logit": 2.911766767501831,
            "end_logit": -2.2078611850738525
        }
    ],
    "5e2deb35fbd6abf43b00001c_002": [
        {
            "text": "SLIC-CAGE",
            "probability": 0.6742726661235136,
            "start_logit": 4.880030155181885,
            "end_logit": 5.0567169189453125
        },
        {
            "text": "",
            "probability": 0.22241546816410135,
            "start_logit": 4.378017902374268,
            "end_logit": 4.449641704559326
        },
        {
            "text": "SLIC-CAGE, a Super-Low Input Carrier-CAGE",
            "probability": 0.05573153219799244,
            "start_logit": 4.880030155181885,
            "end_logit": 2.5636284351348877
        },
        {
            "text": "SLIC-CAGE, a Super-Low Input Carrier-CAGE approach",
            "probability": 0.019869292602320187,
            "start_logit": 4.880030155181885,
            "end_logit": 1.5322577953338623
        },
        {
            "text": "SLIC-CAGE,",
            "probability": 0.013001848068876345,
            "start_logit": 4.880030155181885,
            "end_logit": 1.1081738471984863
        },
        {
            "text": "SLIC-CAGE, a Super-Low Input Carrier-CAGE approach to capture 5' ends of RNA polymerase II transcripts",
            "probability": 0.0032037804768497253,
            "start_logit": 4.880030155181885,
            "end_logit": -0.29258614778518677
        },
        {
            "text": "Super-Low Input Carrier-CAGE",
            "probability": 0.0019743066666130676,
            "start_logit": 1.5397013425827026,
            "end_logit": 2.5636284351348877
        },
        {
            "text": "SLIC",
            "probability": 0.0010429963781463279,
            "start_logit": 4.880030155181885,
            "end_logit": -1.4148199558258057
        },
        {
            "text": "SLIC-CAGE, a Super-Low Input Carrier-CAGE approach to capture 5' ends",
            "probability": 0.001008725718638531,
            "start_logit": 4.880030155181885,
            "end_logit": -1.4482297897338867
        },
        {
            "text": "CAGE",
            "probability": 0.0009893264053459996,
            "start_logit": -1.644335389137268,
            "end_logit": 5.0567169189453125
        },
        {
            "text": "SLIC-CAGE, a Super-Low Input Carrier-CAGE approach to capture 5' ends of RNA polymerase II",
            "probability": 0.0009511908178046392,
            "start_logit": 4.880030155181885,
            "end_logit": -1.506958246231079
        },
        {
            "text": "a Super-Low Input Carrier-CAGE",
            "probability": 0.0008407881729928553,
            "start_logit": 0.6860685348510742,
            "end_logit": 2.5636284351348877
        },
        {
            "text": "Here, we present SLIC-CAGE",
            "probability": 0.0007326413139183588,
            "start_logit": -1.944703459739685,
            "end_logit": 5.0567169189453125
        },
        {
            "text": "S",
            "probability": 0.0007065171503357442,
            "start_logit": 4.880030155181885,
            "end_logit": -1.8043254613876343
        },
        {
            "text": "Super-Low Input Carrier-CAGE approach",
            "probability": 0.0007038758006200936,
            "start_logit": 1.5397013425827026,
            "end_logit": 1.5322577953338623
        },
        {
            "text": "SLIC-",
            "probability": 0.0006541299095134409,
            "start_logit": 4.880030155181885,
            "end_logit": -1.8813669681549072
        },
        {
            "text": "we present SLIC-CAGE",
            "probability": 0.0006044644919697133,
            "start_logit": -2.137016773223877,
            "end_logit": 5.0567169189453125
        },
        {
            "text": "present SLIC-CAGE",
            "probability": 0.0005664147927272052,
            "start_logit": -2.202033042907715,
            "end_logit": 5.0567169189453125
        },
        {
            "text": "Carrier-CAGE",
            "probability": 0.00043027865692395705,
            "start_logit": 0.01616181991994381,
            "end_logit": 2.5636284351348877
        },
        {
            "text": "a Super-Low Input Carrier-CAGE approach",
            "probability": 0.0002997560907964239,
            "start_logit": 0.6860685348510742,
            "end_logit": 1.5322577953338623
        }
    ],
    "5e2a046caa19d74431000008_002": [
        {
            "text": "miR-181b-1",
            "probability": 0.779361965612806,
            "start_logit": 2.99497127532959,
            "end_logit": 4.235965728759766
        },
        {
            "text": "",
            "probability": 0.12514466032247645,
            "start_logit": 2.46128511428833,
            "end_logit": 2.9406466484069824
        },
        {
            "text": "miR-181b-1,",
            "probability": 0.02479036954930802,
            "start_logit": 2.99497127532959,
            "end_logit": 0.7879453897476196
        },
        {
            "text": "upregulates miR-181b-1",
            "probability": 0.0212049852460348,
            "start_logit": -0.6092680096626282,
            "end_logit": 4.235965728759766
        },
        {
            "text": "profoundly upregulates miR-181b-1",
            "probability": 0.014305137475234537,
            "start_logit": -1.0028855800628662,
            "end_logit": 4.235965728759766
        },
        {
            "text": "181b-1",
            "probability": 0.008322076616991848,
            "start_logit": -1.5445924997329712,
            "end_logit": 4.235965728759766
        },
        {
            "text": "miR-181b",
            "probability": 0.008239712404889389,
            "start_logit": 2.99497127532959,
            "end_logit": -0.3135444223880768
        },
        {
            "text": "LB100 profoundly upregulates miR-181b-1",
            "probability": 0.007054217279999788,
            "start_logit": -1.70987868309021,
            "end_logit": 4.235965728759766
        },
        {
            "text": "1",
            "probability": 0.003970039436038706,
            "start_logit": -2.2847282886505127,
            "end_logit": 4.235965728759766
        },
        {
            "text": "miR-181b-1, which we show directly binds to the 3' untranslated region of Bcl-2",
            "probability": 0.0017439751567575616,
            "start_logit": 2.99497127532959,
            "end_logit": -1.8663427829742432
        },
        {
            "text": "miR-181b-1, which we show directly binds to the 3' untranslated region of Bcl-2 mRNA",
            "probability": 0.0016232443159394738,
            "start_logit": 2.99497127532959,
            "end_logit": -1.9380830526351929
        },
        {
            "text": "miR-181b-",
            "probability": 0.0010562630812078028,
            "start_logit": 2.99497127532959,
            "end_logit": -2.3677725791931152
        },
        {
            "text": "upregulates miR-181b-1,",
            "probability": 0.0008147411587370802,
            "start_logit": -3.868389129638672,
            "end_logit": 4.235965728759766
        },
        {
            "text": "miR-181b-1, which",
            "probability": 0.000662907547134008,
            "start_logit": 2.99497127532959,
            "end_logit": -2.833629608154297
        },
        {
            "text": "profoundly upregulates miR-181b-1,",
            "probability": 0.00045502559800423013,
            "start_logit": -1.0028855800628662,
            "end_logit": 0.7879453897476196
        },
        {
            "text": "miR-181b-1, which we show directly binds to the 3' untranslated region",
            "probability": 0.0003861550922876935,
            "start_logit": 2.99497127532959,
            "end_logit": -3.37402606010437
        },
        {
            "text": "181b-1,",
            "probability": 0.0002647131421029319,
            "start_logit": -1.5445924997329712,
            "end_logit": 0.7879453897476196
        },
        {
            "text": "LB100 profoundly upregulates miR-181b-1,",
            "probability": 0.0002243843823130438,
            "start_logit": -1.70987868309021,
            "end_logit": 0.7879453897476196
        },
        {
            "text": "upregulates miR-181b",
            "probability": 0.00022418720400329796,
            "start_logit": -0.6092680096626282,
            "end_logit": -0.3135444223880768
        },
        {
            "text": "profoundly upregulates miR-181b",
            "probability": 0.00015123937773337155,
            "start_logit": -1.0028855800628662,
            "end_logit": -0.3135444223880768
        }
    ],
    "5e48136dd14c9f295d000008_001": [
        {
            "text": "hemopoietic stem cells",
            "probability": 0.7938302628671353,
            "start_logit": 6.770477294921875,
            "end_logit": 7.632927417755127
        },
        {
            "text": "hemopoietic stem cells, the possible target cells",
            "probability": 0.10790279939956433,
            "start_logit": 6.770477294921875,
            "end_logit": 5.637288570404053
        },
        {
            "text": "hemopoietic stem",
            "probability": 0.061516586374899325,
            "start_logit": 6.770477294921875,
            "end_logit": 5.075364589691162
        },
        {
            "text": "Number of hemopoietic stem cells",
            "probability": 0.013288504170782013,
            "start_logit": 2.680506944656372,
            "end_logit": 7.632927417755127
        },
        {
            "text": "stem cells",
            "probability": 0.005436756331700202,
            "start_logit": 1.7867902517318726,
            "end_logit": 7.632927417755127
        },
        {
            "text": "hemopoietic stem cells, the possible target cells for radiation-induced leukemias,",
            "probability": 0.0032931356785892447,
            "start_logit": 6.770477294921875,
            "end_logit": 2.147897958755493
        },
        {
            "text": "hemopoietic stem cells,",
            "probability": 0.003182076327507428,
            "start_logit": 6.770477294921875,
            "end_logit": 2.1135916709899902
        },
        {
            "text": "Number of hemopoietic stem cells, the possible target cells",
            "probability": 0.0018062637152196277,
            "start_logit": 2.680506944656372,
            "end_logit": 5.637288570404053
        },
        {
            "text": "hemopoietic stem cells, the possible target cells for radiation-induced leukemias",
            "probability": 0.0016003277296505179,
            "start_logit": 6.770477294921875,
            "end_logit": 1.4262661933898926
        },
        {
            "text": "target cells",
            "probability": 0.0014749044819912039,
            "start_logit": 2.477839708328247,
            "end_logit": 5.637288570404053
        },
        {
            "text": "hemopoietic",
            "probability": 0.0011231820690905453,
            "start_logit": 6.770477294921875,
            "end_logit": 1.0722235441207886
        },
        {
            "text": "Number of hemopoietic stem",
            "probability": 0.0010297710390413041,
            "start_logit": 2.680506944656372,
            "end_logit": 5.075364589691162
        },
        {
            "text": "hemopoietic stem cells, the possible target",
            "probability": 0.0009705005456635568,
            "start_logit": 6.770477294921875,
            "end_logit": 0.9261144399642944
        },
        {
            "text": "the possible target cells",
            "probability": 0.0007609497444717329,
            "start_logit": 1.8160585165023804,
            "end_logit": 5.637288570404053
        },
        {
            "text": "stem cells, the possible target cells",
            "probability": 0.0007390008359280015,
            "start_logit": 1.7867902517318726,
            "end_logit": 5.637288570404053
        },
        {
            "text": "possible target cells",
            "probability": 0.0005447846926751231,
            "start_logit": 1.481881856918335,
            "end_logit": 5.637288570404053
        },
        {
            "text": "cells",
            "probability": 0.0004312362609636967,
            "start_logit": -0.7474915385246277,
            "end_logit": 7.632927417755127
        },
        {
            "text": "stem",
            "probability": 0.0004213125980739964,
            "start_logit": 1.7867902517318726,
            "end_logit": 5.075364589691162
        },
        {
            "text": "of hemopoietic stem cells",
            "probability": 0.0002800214408125173,
            "start_logit": -1.17928147315979,
            "end_logit": 7.632927417755127
        },
        {
            "text": "hem",
            "probability": 0.00022449665210855598,
            "start_logit": 6.770477294921875,
            "end_logit": -0.5378367304801941
        },
        {
            "text": "",
            "probability": 0.00014312704413164455,
            "start_logit": 2.7055821418762207,
            "end_logit": 3.076930284500122
        }
    ],
    "5e48136dd14c9f295d000008_002": [
        {
            "text": "hematopoietic system",
            "probability": 0.4627961097824692,
            "start_logit": 3.4180796146392822,
            "end_logit": 4.232840538024902
        },
        {
            "text": "",
            "probability": 0.19564532548489458,
            "start_logit": 3.345784902572632,
            "end_logit": 3.4441521167755127
        },
        {
            "text": "hematopoietic system: long-range migration through the blood stream of hematopoietic stem cells",
            "probability": 0.08724958586895482,
            "start_logit": 3.4180796146392822,
            "end_logit": 2.564326763153076
        },
        {
            "text": "the hematopoietic system",
            "probability": 0.07841378929431532,
            "start_logit": 1.642792820930481,
            "end_logit": 4.232840538024902
        },
        {
            "text": "cellular initiation, inactivation, and proliferation--a repopulation mechanism specific to the hematopoietic system",
            "probability": 0.06729746603615469,
            "start_logit": 1.4899156093597412,
            "end_logit": 4.232840538024902
        },
        {
            "text": "hematopoietic",
            "probability": 0.020766257071499643,
            "start_logit": 3.4180796146392822,
            "end_logit": 1.1288833618164062
        },
        {
            "text": "hematopoietic stem cells",
            "probability": 0.015738851772427526,
            "start_logit": 1.7054390907287598,
            "end_logit": 2.564326763153076
        },
        {
            "text": "the hematopoietic system: long-range migration through the blood stream of hematopoietic stem cells",
            "probability": 0.014783120466505815,
            "start_logit": 1.642792820930481,
            "end_logit": 2.564326763153076
        },
        {
            "text": "hematopoietic system: long-range migration through the blood stream of hematopoietic stem cells (HSCs)",
            "probability": 0.01201875803811242,
            "start_logit": 3.4180796146392822,
            "end_logit": 0.5820225477218628
        },
        {
            "text": "a repopulation mechanism specific to the hematopoietic system",
            "probability": 0.008372766118254967,
            "start_logit": -0.5942226648330688,
            "end_logit": 4.232840538024902
        },
        {
            "text": "initiation, inactivation, and proliferation--a repopulation mechanism specific to the hematopoietic system",
            "probability": 0.006631903208601284,
            "start_logit": -0.8273151516914368,
            "end_logit": 4.232840538024902
        },
        {
            "text": "cellular initiation, inactivation, and proliferation",
            "probability": 0.005098574611235778,
            "start_logit": 1.4899156093597412,
            "end_logit": 1.6526789665222168
        },
        {
            "text": "repopulation mechanism specific to the hematopoietic system",
            "probability": 0.0037995020794430352,
            "start_logit": -1.3843369483947754,
            "end_logit": 4.232840538024902
        },
        {
            "text": "hematopoietic system: long-range migration through the blood stream of hematopoietic stem",
            "probability": 0.0036839507899307945,
            "start_logit": 3.4180796146392822,
            "end_logit": -0.6004602909088135
        },
        {
            "text": "hematopoietic system: long-range migration through the blood stream of hematopoietic stem cells (HSCs",
            "probability": 0.003657529659925918,
            "start_logit": 3.4180796146392822,
            "end_logit": -0.6076580882072449
        },
        {
            "text": "the hematopoietic",
            "probability": 0.003518527645363195,
            "start_logit": 1.642792820930481,
            "end_logit": 1.1288833618164062
        },
        {
            "text": "proliferation--a repopulation mechanism specific to the hematopoietic system",
            "probability": 0.003144622791377035,
            "start_logit": -1.5735130310058594,
            "end_logit": 4.232840538024902
        },
        {
            "text": "cellular initiation, inactivation, and proliferation--a repopulation mechanism specific to the hematopoietic",
            "probability": 0.0030197239138941494,
            "start_logit": 1.4899156093597412,
            "end_logit": 1.1288833618164062
        },
        {
            "text": "specific to the hematopoietic system",
            "probability": 0.0021955855201383255,
            "start_logit": -1.9327582120895386,
            "end_logit": 4.232840538024902
        },
        {
            "text": "hematopoietic stem cells (HSCs)",
            "probability": 0.0021680498465016873,
            "start_logit": 1.7054390907287598,
            "end_logit": 0.5820225477218628
        }
    ],
    "5e48136dd14c9f295d000008_003": [
        {
            "text": "hematopoietic system",
            "probability": 0.4627961097824692,
            "start_logit": 3.4180796146392822,
            "end_logit": 4.232840538024902
        },
        {
            "text": "",
            "probability": 0.19564532548489458,
            "start_logit": 3.345784902572632,
            "end_logit": 3.4441521167755127
        },
        {
            "text": "hematopoietic system: long-range migration through the blood stream of hematopoietic stem cells",
            "probability": 0.08724958586895482,
            "start_logit": 3.4180796146392822,
            "end_logit": 2.564326763153076
        },
        {
            "text": "the hematopoietic system",
            "probability": 0.07841378929431532,
            "start_logit": 1.642792820930481,
            "end_logit": 4.232840538024902
        },
        {
            "text": "cellular initiation, inactivation, and proliferation--a repopulation mechanism specific to the hematopoietic system",
            "probability": 0.06729746603615469,
            "start_logit": 1.4899156093597412,
            "end_logit": 4.232840538024902
        },
        {
            "text": "hematopoietic",
            "probability": 0.020766257071499643,
            "start_logit": 3.4180796146392822,
            "end_logit": 1.1288833618164062
        },
        {
            "text": "hematopoietic stem cells",
            "probability": 0.015738851772427526,
            "start_logit": 1.7054390907287598,
            "end_logit": 2.564326763153076
        },
        {
            "text": "the hematopoietic system: long-range migration through the blood stream of hematopoietic stem cells",
            "probability": 0.014783120466505815,
            "start_logit": 1.642792820930481,
            "end_logit": 2.564326763153076
        },
        {
            "text": "hematopoietic system: long-range migration through the blood stream of hematopoietic stem cells (HSCs)",
            "probability": 0.01201875803811242,
            "start_logit": 3.4180796146392822,
            "end_logit": 0.5820225477218628
        },
        {
            "text": "a repopulation mechanism specific to the hematopoietic system",
            "probability": 0.008372766118254967,
            "start_logit": -0.5942226648330688,
            "end_logit": 4.232840538024902
        },
        {
            "text": "initiation, inactivation, and proliferation--a repopulation mechanism specific to the hematopoietic system",
            "probability": 0.006631903208601284,
            "start_logit": -0.8273151516914368,
            "end_logit": 4.232840538024902
        },
        {
            "text": "cellular initiation, inactivation, and proliferation",
            "probability": 0.005098574611235778,
            "start_logit": 1.4899156093597412,
            "end_logit": 1.6526789665222168
        },
        {
            "text": "repopulation mechanism specific to the hematopoietic system",
            "probability": 0.0037995020794430352,
            "start_logit": -1.3843369483947754,
            "end_logit": 4.232840538024902
        },
        {
            "text": "hematopoietic system: long-range migration through the blood stream of hematopoietic stem",
            "probability": 0.0036839507899307945,
            "start_logit": 3.4180796146392822,
            "end_logit": -0.6004602909088135
        },
        {
            "text": "hematopoietic system: long-range migration through the blood stream of hematopoietic stem cells (HSCs",
            "probability": 0.003657529659925918,
            "start_logit": 3.4180796146392822,
            "end_logit": -0.6076580882072449
        },
        {
            "text": "the hematopoietic",
            "probability": 0.003518527645363195,
            "start_logit": 1.642792820930481,
            "end_logit": 1.1288833618164062
        },
        {
            "text": "proliferation--a repopulation mechanism specific to the hematopoietic system",
            "probability": 0.003144622791377035,
            "start_logit": -1.5735130310058594,
            "end_logit": 4.232840538024902
        },
        {
            "text": "cellular initiation, inactivation, and proliferation--a repopulation mechanism specific to the hematopoietic",
            "probability": 0.0030197239138941494,
            "start_logit": 1.4899156093597412,
            "end_logit": 1.1288833618164062
        },
        {
            "text": "specific to the hematopoietic system",
            "probability": 0.0021955855201383255,
            "start_logit": -1.9327582120895386,
            "end_logit": 4.232840538024902
        },
        {
            "text": "hematopoietic stem cells (HSCs)",
            "probability": 0.0021680498465016873,
            "start_logit": 1.7054390907287598,
            "end_logit": 0.5820225477218628
        }
    ],
    "5e2ad60e76af173751000003_001": [
        {
            "text": "a heterogeneous clinical condition defined by the presence of the vermiform appendix within an inguinal hernia sac",
            "probability": 0.4276273408228053,
            "start_logit": 5.286718845367432,
            "end_logit": 5.654460906982422
        },
        {
            "text": "a heterogeneous clinical condition",
            "probability": 0.13224215563565977,
            "start_logit": 5.286718845367432,
            "end_logit": 4.480843544006348
        },
        {
            "text": "heterogeneous clinical condition defined by the presence of the vermiform appendix within an inguinal hernia sac",
            "probability": 0.12234920634552478,
            "start_logit": 4.035346031188965,
            "end_logit": 5.654460906982422
        },
        {
            "text": "the presence of the vermiform appendix within an inguinal hernia sac",
            "probability": 0.0645954675904867,
            "start_logit": 3.396610975265503,
            "end_logit": 5.654460906982422
        },
        {
            "text": "a heterogeneous clinical condition defined by the presence of the vermiform appendix",
            "probability": 0.042424154365985095,
            "start_logit": 5.286718845367432,
            "end_logit": 3.3439266681671143
        },
        {
            "text": "heterogeneous clinical condition",
            "probability": 0.037836034422664956,
            "start_logit": 4.035346031188965,
            "end_logit": 4.480843544006348
        },
        {
            "text": "presence of the vermiform appendix within an inguinal hernia sac",
            "probability": 0.03506195950641947,
            "start_logit": 2.78558349609375,
            "end_logit": 5.654460906982422
        },
        {
            "text": "rare",
            "probability": 0.01888019918165615,
            "start_logit": 3.8092072010040283,
            "end_logit": 4.011834144592285
        },
        {
            "text": "containing acute appendicitis and a perforated cecum",
            "probability": 0.01600537627124124,
            "start_logit": 2.809692859649658,
            "end_logit": 4.8461594581604
        },
        {
            "text": "is a heterogeneous clinical condition defined by the presence of the vermiform appendix within an inguinal hernia sac",
            "probability": 0.0150358477466074,
            "start_logit": 1.9389039278030396,
            "end_logit": 5.654460906982422
        },
        {
            "text": "clinical condition defined by the presence of the vermiform appendix within an inguinal hernia sac",
            "probability": 0.013362596009842107,
            "start_logit": 1.8209261894226074,
            "end_logit": 5.654460906982422
        },
        {
            "text": "defined by the presence of the vermiform appendix within an inguinal hernia sac",
            "probability": 0.013151029957081799,
            "start_logit": 1.8049668073654175,
            "end_logit": 5.654460906982422
        },
        {
            "text": "heterogeneous clinical condition defined by the presence of the vermiform appendix",
            "probability": 0.0121380489997928,
            "start_logit": 4.035346031188965,
            "end_logit": 3.3439266681671143
        },
        {
            "text": "vermiform appendix within an inguinal hernia sac",
            "probability": 0.009655965212808806,
            "start_logit": 1.4960426092147827,
            "end_logit": 5.654460906982422
        },
        {
            "text": "acute appendicitis and a perforated cecum",
            "probability": 0.009197092028364329,
            "start_logit": 2.255655527114868,
            "end_logit": 4.8461594581604
        },
        {
            "text": "An Amyand's hernia is a heterogeneous clinical condition",
            "probability": 0.0075706876871681926,
            "start_logit": 2.426367998123169,
            "end_logit": 4.480843544006348
        },
        {
            "text": "a heterogeneous",
            "probability": 0.006477348905222733,
            "start_logit": 5.286718845367432,
            "end_logit": 1.4645200967788696
        },
        {
            "text": "the presence of the vermiform appendix",
            "probability": 0.006408402426114589,
            "start_logit": 3.396610975265503,
            "end_logit": 3.3439266681671143
        },
        {
            "text": "inguinal hernia sac",
            "probability": 0.004727229322916355,
            "start_logit": 0.7818059921264648,
            "end_logit": 5.654460906982422
        },
        {
            "text": "the vermiform appendix within an inguinal hernia sac",
            "probability": 0.004695513674286329,
            "start_logit": 0.7750742435455322,
            "end_logit": 5.654460906982422
        },
        {
            "text": "",
            "probability": 0.0005583438873511288,
            "start_logit": 1.8178797960281372,
            "end_logit": 2.4822676181793213
        }
    ],
    "5e2ad60e76af173751000003_002": [
        {
            "text": "a rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.5733997302818522,
            "start_logit": 6.72330379486084,
            "end_logit": 7.902400016784668
        },
        {
            "text": "rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.24953520155047546,
            "start_logit": 5.891320705413818,
            "end_logit": 7.902400016784668
        },
        {
            "text": "a rare disease",
            "probability": 0.03414761198809046,
            "start_logit": 6.72330379486084,
            "end_logit": 5.081509590148926
        },
        {
            "text": "the appendix is found within an inguinal hernia sac",
            "probability": 0.02400934270766802,
            "start_logit": 3.550163745880127,
            "end_logit": 7.902400016784668
        },
        {
            "text": "where the appendix is found within an inguinal hernia sac",
            "probability": 0.022081106867762858,
            "start_logit": 3.4664430618286133,
            "end_logit": 7.902400016784668
        },
        {
            "text": "appendix is found within an inguinal hernia sac",
            "probability": 0.019589861128766387,
            "start_logit": 3.3467328548431396,
            "end_logit": 7.902400016784668
        },
        {
            "text": "rare disease",
            "probability": 0.014860542811429485,
            "start_logit": 5.891320705413818,
            "end_logit": 5.081509590148926
        },
        {
            "text": "An Amyand hernia is a rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.013995219724884095,
            "start_logit": 3.010436534881592,
            "end_logit": 7.902400016784668
        },
        {
            "text": "is a rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.012999519539138837,
            "start_logit": 2.9366331100463867,
            "end_logit": 7.902400016784668
        },
        {
            "text": "disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.007484313939701543,
            "start_logit": 2.3845300674438477,
            "end_logit": 7.902400016784668
        },
        {
            "text": "inguinal hernia sac",
            "probability": 0.004712886465485348,
            "start_logit": 1.9220212697982788,
            "end_logit": 7.902400016784668
        },
        {
            "text": "a rare",
            "probability": 0.004374881832971494,
            "start_logit": 6.72330379486084,
            "end_logit": 3.0266964435577393
        },
        {
            "text": "a rare disease where the appendix",
            "probability": 0.0037087230315745365,
            "start_logit": 6.72330379486084,
            "end_logit": 2.861504554748535
        },
        {
            "text": "type 2",
            "probability": 0.0034286508519890033,
            "start_logit": 4.962486743927002,
            "end_logit": 4.5438008308410645
        },
        {
            "text": "type 2 Amyand's hernia",
            "probability": 0.003328614703015204,
            "start_logit": 4.962486743927002,
            "end_logit": 4.514190196990967
        },
        {
            "text": "Amyand hernia is a rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.0030270696699803,
            "start_logit": 1.4793157577514648,
            "end_logit": 7.902400016784668
        },
        {
            "text": "rare",
            "probability": 0.0019038847810644087,
            "start_logit": 5.891320705413818,
            "end_logit": 3.0266964435577393
        },
        {
            "text": "rare disease where the appendix",
            "probability": 0.0016139821843375091,
            "start_logit": 5.891320705413818,
            "end_logit": 2.861504554748535
        },
        {
            "text": "a rare disease where the appendix is found within an inguinal hernia sac.",
            "probability": 0.0009607030817069187,
            "start_logit": 6.72330379486084,
            "end_logit": 1.510727047920227
        },
        {
            "text": "An Amyand hernia is a rare disease",
            "probability": 0.0008334558033686218,
            "start_logit": 3.010436534881592,
            "end_logit": 5.081509590148926
        },
        {
            "text": "",
            "probability": 4.697054737393855e-06,
            "start_logit": 1.4475375413894653,
            "end_logit": 1.4657635688781738
        }
    ],
    "5e2ad60e76af173751000003_003": [
        {
            "text": "a rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.5733997302818522,
            "start_logit": 6.72330379486084,
            "end_logit": 7.902400016784668
        },
        {
            "text": "rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.24953520155047546,
            "start_logit": 5.891320705413818,
            "end_logit": 7.902400016784668
        },
        {
            "text": "a rare disease",
            "probability": 0.03414761198809046,
            "start_logit": 6.72330379486084,
            "end_logit": 5.081509590148926
        },
        {
            "text": "the appendix is found within an inguinal hernia sac",
            "probability": 0.02400934270766802,
            "start_logit": 3.550163745880127,
            "end_logit": 7.902400016784668
        },
        {
            "text": "where the appendix is found within an inguinal hernia sac",
            "probability": 0.022081106867762858,
            "start_logit": 3.4664430618286133,
            "end_logit": 7.902400016784668
        },
        {
            "text": "appendix is found within an inguinal hernia sac",
            "probability": 0.019589861128766387,
            "start_logit": 3.3467328548431396,
            "end_logit": 7.902400016784668
        },
        {
            "text": "rare disease",
            "probability": 0.014860542811429485,
            "start_logit": 5.891320705413818,
            "end_logit": 5.081509590148926
        },
        {
            "text": "An Amyand hernia is a rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.013995219724884095,
            "start_logit": 3.010436534881592,
            "end_logit": 7.902400016784668
        },
        {
            "text": "is a rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.012999519539138837,
            "start_logit": 2.9366331100463867,
            "end_logit": 7.902400016784668
        },
        {
            "text": "disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.007484313939701543,
            "start_logit": 2.3845300674438477,
            "end_logit": 7.902400016784668
        },
        {
            "text": "inguinal hernia sac",
            "probability": 0.004712886465485348,
            "start_logit": 1.9220212697982788,
            "end_logit": 7.902400016784668
        },
        {
            "text": "a rare",
            "probability": 0.004374881832971494,
            "start_logit": 6.72330379486084,
            "end_logit": 3.0266964435577393
        },
        {
            "text": "a rare disease where the appendix",
            "probability": 0.0037087230315745365,
            "start_logit": 6.72330379486084,
            "end_logit": 2.861504554748535
        },
        {
            "text": "type 2",
            "probability": 0.0034286508519890033,
            "start_logit": 4.962486743927002,
            "end_logit": 4.5438008308410645
        },
        {
            "text": "type 2 Amyand's hernia",
            "probability": 0.003328614703015204,
            "start_logit": 4.962486743927002,
            "end_logit": 4.514190196990967
        },
        {
            "text": "Amyand hernia is a rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.0030270696699803,
            "start_logit": 1.4793157577514648,
            "end_logit": 7.902400016784668
        },
        {
            "text": "rare",
            "probability": 0.0019038847810644087,
            "start_logit": 5.891320705413818,
            "end_logit": 3.0266964435577393
        },
        {
            "text": "rare disease where the appendix",
            "probability": 0.0016139821843375091,
            "start_logit": 5.891320705413818,
            "end_logit": 2.861504554748535
        },
        {
            "text": "a rare disease where the appendix is found within an inguinal hernia sac.",
            "probability": 0.0009607030817069187,
            "start_logit": 6.72330379486084,
            "end_logit": 1.510727047920227
        },
        {
            "text": "An Amyand hernia is a rare disease",
            "probability": 0.0008334558033686218,
            "start_logit": 3.010436534881592,
            "end_logit": 5.081509590148926
        },
        {
            "text": "",
            "probability": 4.697054737393855e-06,
            "start_logit": 1.4475375413894653,
            "end_logit": 1.4657635688781738
        }
    ],
    "5e2ad60e76af173751000003_004": [
        {
            "text": "the incarceration of the vermiform appendix in the hernia sac",
            "probability": 0.7509979382435356,
            "start_logit": 7.433103561401367,
            "end_logit": 7.761094093322754
        },
        {
            "text": "incarceration of the vermiform appendix in the hernia sac",
            "probability": 0.18655730809377435,
            "start_logit": 6.040439128875732,
            "end_logit": 7.761094093322754
        },
        {
            "text": "the incarceration of the vermiform appendix",
            "probability": 0.03144816333406306,
            "start_logit": 7.433103561401367,
            "end_logit": 4.588031768798828
        },
        {
            "text": "incarceration of the vermiform appendix",
            "probability": 0.007812118246047185,
            "start_logit": 6.040439128875732,
            "end_logit": 4.588031768798828
        },
        {
            "text": "as the incarceration of the vermiform appendix in the hernia sac",
            "probability": 0.005631654422683217,
            "start_logit": 2.5401039123535156,
            "end_logit": 7.761094093322754
        },
        {
            "text": "the incarceration of the vermiform appendix in the hernia sac.",
            "probability": 0.004002458098983122,
            "start_logit": 7.433103561401367,
            "end_logit": 2.526599884033203
        },
        {
            "text": "hernia sac",
            "probability": 0.0034614784946986757,
            "start_logit": 2.053396463394165,
            "end_logit": 7.761094093322754
        },
        {
            "text": "defined as the incarceration of the vermiform appendix in the hernia sac",
            "probability": 0.0020907622836104298,
            "start_logit": 1.549229383468628,
            "end_logit": 7.761094093322754
        },
        {
            "text": "Claudius Amyand's hernia is defined as the incarceration of the vermiform appendix",
            "probability": 0.0015202016012197184,
            "start_logit": 4.403605937957764,
            "end_logit": 4.588031768798828
        },
        {
            "text": "vermiform appendix in the hernia sac",
            "probability": 0.00150897774601055,
            "start_logit": 1.2231330871582031,
            "end_logit": 7.761094093322754
        },
        {
            "text": "the incarceration",
            "probability": 0.0010060622592697153,
            "start_logit": 7.433103561401367,
            "end_logit": 1.1457351446151733
        },
        {
            "text": "incarceration of the vermiform appendix in the hernia sac.",
            "probability": 0.0009942607971079127,
            "start_logit": 6.040439128875732,
            "end_logit": 2.526599884033203
        },
        {
            "text": "Claudius Amyand's hernia",
            "probability": 0.0006031667040430146,
            "start_logit": 4.403605937957764,
            "end_logit": 3.6636271476745605
        },
        {
            "text": "is defined as the incarceration of the vermiform appendix in the hernia sac",
            "probability": 0.0005424811063259265,
            "start_logit": 0.20009863376617432,
            "end_logit": 7.761094093322754
        },
        {
            "text": "the",
            "probability": 0.00034988079774407474,
            "start_logit": 7.433103561401367,
            "end_logit": 0.08952842652797699
        },
        {
            "text": "the hernia sac",
            "probability": 0.0003255133099049581,
            "start_logit": -0.3106512725353241,
            "end_logit": 7.761094093322754
        },
        {
            "text": "the incarceration of the vermiform appendix in the hernia",
            "probability": 0.00028563883540027435,
            "start_logit": 7.433103561401367,
            "end_logit": -0.11333589255809784
        },
        {
            "text": "the vermiform appendix in the hernia sac",
            "probability": 0.00027319740629970783,
            "start_logit": -0.4858599901199341,
            "end_logit": 7.761094093322754
        },
        {
            "text": "incarceration",
            "probability": 0.0002499184848670449,
            "start_logit": 6.040439128875732,
            "end_logit": 1.1457351446151733
        },
        {
            "text": "as the incarceration of the vermiform appendix",
            "probability": 0.00023582646383791842,
            "start_logit": 2.5401039123535156,
            "end_logit": 4.588031768798828
        },
        {
            "text": "",
            "probability": 0.00010299327057330766,
            "start_logit": 2.9315690994262695,
            "end_logit": 3.368134021759033
        }
    ],
    "5e2ad60e76af173751000003_006": [
        {
            "text": "inguinal hernia containing the appendix",
            "probability": 0.42518386908212397,
            "start_logit": 7.222558975219727,
            "end_logit": 8.722204208374023
        },
        {
            "text": "an inguinal hernia containing the appendix",
            "probability": 0.3376204397319377,
            "start_logit": 6.991959571838379,
            "end_logit": 8.722204208374023
        },
        {
            "text": "appendix",
            "probability": 0.08510305364127176,
            "start_logit": 5.613900184631348,
            "end_logit": 8.722204208374023
        },
        {
            "text": "inguinal hernia",
            "probability": 0.06526549321252258,
            "start_logit": 7.222558975219727,
            "end_logit": 6.848145961761475
        },
        {
            "text": "an inguinal hernia",
            "probability": 0.051824554316470615,
            "start_logit": 6.991959571838379,
            "end_logit": 6.848145961761475
        },
        {
            "text": "the appendix",
            "probability": 0.0144019607682559,
            "start_logit": 3.8374016284942627,
            "end_logit": 8.722204208374023
        },
        {
            "text": "containing the appendix",
            "probability": 0.014391004583276665,
            "start_logit": 3.8366405963897705,
            "end_logit": 8.722204208374023
        },
        {
            "text": "hernia containing the appendix",
            "probability": 0.0017568221951658675,
            "start_logit": 1.733543872833252,
            "end_logit": 8.722204208374023
        },
        {
            "text": "inguinal hernia containing the appendix, an Amyand hernia",
            "probability": 0.0007295296277768378,
            "start_logit": 7.222558975219727,
            "end_logit": 2.3543272018432617
        },
        {
            "text": "De Garengeot hernia, is distinctly different than an inguinal hernia containing the appendix",
            "probability": 0.0006864526985774322,
            "start_logit": 0.7938193082809448,
            "end_logit": 8.722204208374023
        },
        {
            "text": "an inguinal hernia containing the appendix, an Amyand hernia",
            "probability": 0.0005792884717362582,
            "start_logit": 6.991959571838379,
            "end_logit": 2.3543272018432617
        },
        {
            "text": "hernia containing the appendix,",
            "probability": 0.0005077549616988611,
            "start_logit": 0.4922809600830078,
            "end_logit": 8.722204208374023
        },
        {
            "text": "inguinal hernia containing the appendix,",
            "probability": 0.00033161737095633215,
            "start_logit": 7.222558975219727,
            "end_logit": 1.5659090280532837
        },
        {
            "text": "appendix,",
            "probability": 0.00030784030398727614,
            "start_logit": -0.00813685730099678,
            "end_logit": 8.722204208374023
        },
        {
            "text": "hernia",
            "probability": 0.0002696712537607123,
            "start_logit": 1.733543872833252,
            "end_logit": 6.848145961761475
        },
        {
            "text": "an inguinal hernia containing the appendix,",
            "probability": 0.00026332326023262374,
            "start_logit": 6.991959571838379,
            "end_logit": 1.5659090280532837
        },
        {
            "text": "a De Garengeot hernia, is distinctly different than an inguinal hernia containing the appendix",
            "probability": 0.0001974499226072981,
            "start_logit": -0.4522330164909363,
            "end_logit": 8.722204208374023
        },
        {
            "text": "inguinal",
            "probability": 0.00019652977736358434,
            "start_logit": 7.222558975219727,
            "end_logit": 1.0427411794662476
        },
        {
            "text": "an inguinal",
            "probability": 0.00015605594350781267,
            "start_logit": 6.991959571838379,
            "end_logit": 1.0427411794662476
        },
        {
            "text": "appendix, an Amyand hernia",
            "probability": 0.00014601964834559032,
            "start_logit": 5.613900184631348,
            "end_logit": 2.3543272018432617
        },
        {
            "text": "",
            "probability": 8.126922842416599e-05,
            "start_logit": 3.322014331817627,
            "end_logit": 4.060239315032959
        }
    ],
    "5c74266a7c78d694710000a2_001": [
        {
            "text": "",
            "probability": 0.4842435617181822,
            "start_logit": 3.544766664505005,
            "end_logit": 4.26157283782959
        },
        {
            "text": "trafficked through nuclear speckles. Although ALREX-promoting elements enhance nuclear speckle localization",
            "probability": 0.21798760049072768,
            "start_logit": 3.3868985176086426,
            "end_logit": 3.621291160583496
        },
        {
            "text": "trafficked",
            "probability": 0.2143957287593245,
            "start_logit": 3.3868985176086426,
            "end_logit": 3.6046764850616455
        },
        {
            "text": "mRNAs containing ALREX-promoting elements are trafficked",
            "probability": 0.03054437845048031,
            "start_logit": 1.4382556676864624,
            "end_logit": 3.6046764850616455
        },
        {
            "text": "ALREX-promoting elements are trafficked through nuclear speckles. Although ALREX-promoting elements enhance nuclear speckle localization",
            "probability": 0.01007226553308798,
            "start_logit": 0.3122459948062897,
            "end_logit": 3.621291160583496
        },
        {
            "text": "ALREX-promoting elements are trafficked",
            "probability": 0.009906300653626753,
            "start_logit": 0.3122459948062897,
            "end_logit": 3.6046764850616455
        },
        {
            "text": "enhance nuclear speckle localization",
            "probability": 0.009533870756329714,
            "start_logit": 0.2573111355304718,
            "end_logit": 3.621291160583496
        },
        {
            "text": "that mRNAs containing ALREX-promoting elements are trafficked",
            "probability": 0.0034673910316222363,
            "start_logit": -0.737522542476654,
            "end_logit": 3.6046764850616455
        },
        {
            "text": "ALREX-promoting elements enhance nuclear speckle localization",
            "probability": 0.003410262682365545,
            "start_logit": -0.7707503437995911,
            "end_logit": 3.621291160583496
        },
        {
            "text": "trafficked through nuclear speckles",
            "probability": 0.0028551185298530545,
            "start_logit": 3.3868985176086426,
            "end_logit": -0.7140336632728577
        },
        {
            "text": "mRNAs containing ALREX-promoting elements",
            "probability": 0.002637864414381852,
            "start_logit": 1.4382556676864624,
            "end_logit": 1.1554654836654663
        },
        {
            "text": "alternative mRNA nuclear export (ALREX) pathway. Here we demonstrate that mRNAs containing ALREX-promoting elements are trafficked",
            "probability": 0.0016289830973162927,
            "start_logit": -1.492969036102295,
            "end_logit": 3.6046764850616455
        },
        {
            "text": "localization",
            "probability": 0.0015575486909282124,
            "start_logit": -1.5544264316558838,
            "end_logit": 3.621291160583496
        },
        {
            "text": "demonstrate that mRNAs containing ALREX-promoting elements are trafficked",
            "probability": 0.001353391630586648,
            "start_logit": -1.6783112287521362,
            "end_logit": 3.6046764850616455
        },
        {
            "text": "nuclear speckle localization",
            "probability": 0.0012151578118212878,
            "start_logit": -1.8026657104492188,
            "end_logit": 3.621291160583496
        },
        {
            "text": "trafficked through nuclear speckles.",
            "probability": 0.001103095937296616,
            "start_logit": 3.3868985176086426,
            "end_logit": -1.665026307106018
        },
        {
            "text": "mRNA nuclear export (ALREX) pathway. Here we demonstrate that mRNAs containing ALREX-promoting elements are trafficked",
            "probability": 0.0010812873527186852,
            "start_logit": -1.9027726650238037,
            "end_logit": 3.6046764850616455
        },
        {
            "text": "mRNAs",
            "probability": 0.0010767550078228652,
            "start_logit": 1.4382556676864624,
            "end_logit": 0.25944772362709045
        },
        {
            "text": "trafficked through nuclear speckles. Although ALREX-promoting elements enhance nuclear speckle localization, additional features within the mRNA",
            "probability": 0.0010739124974111832,
            "start_logit": 3.3868985176086426,
            "end_logit": -1.6918385028839111
        },
        {
            "text": "ALREX-promoting elements",
            "probability": 0.0008555249541166806,
            "start_logit": 0.3122459948062897,
            "end_logit": 1.1554654836654663
        }
    ],
    "5c74266a7c78d694710000a2_002": [
        {
            "text": "",
            "probability": 0.4842435617181822,
            "start_logit": 3.544766664505005,
            "end_logit": 4.26157283782959
        },
        {
            "text": "trafficked through nuclear speckles. Although ALREX-promoting elements enhance nuclear speckle localization",
            "probability": 0.21798760049072768,
            "start_logit": 3.3868985176086426,
            "end_logit": 3.621291160583496
        },
        {
            "text": "trafficked",
            "probability": 0.2143957287593245,
            "start_logit": 3.3868985176086426,
            "end_logit": 3.6046764850616455
        },
        {
            "text": "mRNAs containing ALREX-promoting elements are trafficked",
            "probability": 0.03054437845048031,
            "start_logit": 1.4382556676864624,
            "end_logit": 3.6046764850616455
        },
        {
            "text": "ALREX-promoting elements are trafficked through nuclear speckles. Although ALREX-promoting elements enhance nuclear speckle localization",
            "probability": 0.01007226553308798,
            "start_logit": 0.3122459948062897,
            "end_logit": 3.621291160583496
        },
        {
            "text": "ALREX-promoting elements are trafficked",
            "probability": 0.009906300653626753,
            "start_logit": 0.3122459948062897,
            "end_logit": 3.6046764850616455
        },
        {
            "text": "enhance nuclear speckle localization",
            "probability": 0.009533870756329714,
            "start_logit": 0.2573111355304718,
            "end_logit": 3.621291160583496
        },
        {
            "text": "that mRNAs containing ALREX-promoting elements are trafficked",
            "probability": 0.0034673910316222363,
            "start_logit": -0.737522542476654,
            "end_logit": 3.6046764850616455
        },
        {
            "text": "ALREX-promoting elements enhance nuclear speckle localization",
            "probability": 0.003410262682365545,
            "start_logit": -0.7707503437995911,
            "end_logit": 3.621291160583496
        },
        {
            "text": "trafficked through nuclear speckles",
            "probability": 0.0028551185298530545,
            "start_logit": 3.3868985176086426,
            "end_logit": -0.7140336632728577
        },
        {
            "text": "mRNAs containing ALREX-promoting elements",
            "probability": 0.002637864414381852,
            "start_logit": 1.4382556676864624,
            "end_logit": 1.1554654836654663
        },
        {
            "text": "alternative mRNA nuclear export (ALREX) pathway. Here we demonstrate that mRNAs containing ALREX-promoting elements are trafficked",
            "probability": 0.0016289830973162927,
            "start_logit": -1.492969036102295,
            "end_logit": 3.6046764850616455
        },
        {
            "text": "localization",
            "probability": 0.0015575486909282124,
            "start_logit": -1.5544264316558838,
            "end_logit": 3.621291160583496
        },
        {
            "text": "demonstrate that mRNAs containing ALREX-promoting elements are trafficked",
            "probability": 0.001353391630586648,
            "start_logit": -1.6783112287521362,
            "end_logit": 3.6046764850616455
        },
        {
            "text": "nuclear speckle localization",
            "probability": 0.0012151578118212878,
            "start_logit": -1.8026657104492188,
            "end_logit": 3.621291160583496
        },
        {
            "text": "trafficked through nuclear speckles.",
            "probability": 0.001103095937296616,
            "start_logit": 3.3868985176086426,
            "end_logit": -1.665026307106018
        },
        {
            "text": "mRNA nuclear export (ALREX) pathway. Here we demonstrate that mRNAs containing ALREX-promoting elements are trafficked",
            "probability": 0.0010812873527186852,
            "start_logit": -1.9027726650238037,
            "end_logit": 3.6046764850616455
        },
        {
            "text": "mRNAs",
            "probability": 0.0010767550078228652,
            "start_logit": 1.4382556676864624,
            "end_logit": 0.25944772362709045
        },
        {
            "text": "trafficked through nuclear speckles. Although ALREX-promoting elements enhance nuclear speckle localization, additional features within the mRNA",
            "probability": 0.0010739124974111832,
            "start_logit": 3.3868985176086426,
            "end_logit": -1.6918385028839111
        },
        {
            "text": "ALREX-promoting elements",
            "probability": 0.0008555249541166806,
            "start_logit": 0.3122459948062897,
            "end_logit": 1.1554654836654663
        }
    ],
    "5c74266a7c78d694710000a2_003": [
        {
            "text": "pre-spliceosomal assembly",
            "probability": 0.5585476829894586,
            "start_logit": 5.334221839904785,
            "end_logit": 6.065611362457275
        },
        {
            "text": "the pre-spliceosomal assembly",
            "probability": 0.2157339739241562,
            "start_logit": 4.382927894592285,
            "end_logit": 6.065611362457275
        },
        {
            "text": "pre-spliceosomal",
            "probability": 0.08006733840656267,
            "start_logit": 5.334221839904785,
            "end_logit": 4.123139381408691
        },
        {
            "text": "the pre-spliceosomal",
            "probability": 0.030925282875632266,
            "start_logit": 4.382927894592285,
            "end_logit": 4.123139381408691
        },
        {
            "text": "assembly",
            "probability": 0.02315123390791129,
            "start_logit": 2.1509299278259277,
            "end_logit": 6.065611362457275
        },
        {
            "text": "pre-spliceosomal assembly on microinjected splicing",
            "probability": 0.021939559250785758,
            "start_logit": 5.334221839904785,
            "end_logit": 2.8285627365112305
        },
        {
            "text": "pre-spliceosomal assembly on microinjected splicing-competent precursor mRNA",
            "probability": 0.017739539864518306,
            "start_logit": 5.334221839904785,
            "end_logit": 2.616067409515381
        },
        {
            "text": "spliceosomal assembly",
            "probability": 0.01181433588879933,
            "start_logit": 1.4781955480575562,
            "end_logit": 6.065611362457275
        },
        {
            "text": "the pre-spliceosomal assembly on microinjected splicing",
            "probability": 0.008473955666567187,
            "start_logit": 4.382927894592285,
            "end_logit": 2.8285627365112305
        },
        {
            "text": "pre-spliceosomal assembly on microinjected splicing-competent precursor mRNA takes place",
            "probability": 0.006870873418056944,
            "start_logit": 5.334221839904785,
            "end_logit": 1.6675626039505005
        },
        {
            "text": "the pre-spliceosomal assembly on microinjected splicing-competent precursor mRNA",
            "probability": 0.00685173629237085,
            "start_logit": 4.382927894592285,
            "end_logit": 2.616067409515381
        },
        {
            "text": "that the pre-spliceosomal assembly",
            "probability": 0.0031969483512914467,
            "start_logit": 0.17107856273651123,
            "end_logit": 6.065611362457275
        },
        {
            "text": "the pre-spliceosomal assembly on microinjected splicing-competent precursor mRNA takes place",
            "probability": 0.0026538125068817976,
            "start_logit": 4.382927894592285,
            "end_logit": 1.6675626039505005
        },
        {
            "text": "pre-spliceosomal assembly on microinjected",
            "probability": 0.002173536800127757,
            "start_logit": 5.334221839904785,
            "end_logit": 0.5166270732879639
        },
        {
            "text": "pre-spliceosomal assembly on microinjected splicing-competent precursor",
            "probability": 0.001896141970420018,
            "start_logit": 5.334221839904785,
            "end_logit": 0.38009265065193176
        },
        {
            "text": "spliceosomal",
            "probability": 0.0016935750670281574,
            "start_logit": 1.4781955480575562,
            "end_logit": 4.123139381408691
        },
        {
            "text": "pre",
            "probability": 0.0015978391142778914,
            "start_logit": 5.334221839904785,
            "end_logit": 0.20892353355884552
        },
        {
            "text": "pre-splice",
            "probability": 0.0015813646106648024,
            "start_logit": 5.334221839904785,
            "end_logit": 0.19855952262878418
        },
        {
            "text": "pre-spliceosomal assembly on microinjected splicing-competent precursor mRNA takes place in the speckles",
            "probability": 0.0012183696971277073,
            "start_logit": 5.334221839904785,
            "end_logit": -0.06221497803926468
        },
        {
            "text": "pre-spliceosomal assembly on microinjected splicing-competent",
            "probability": 0.0010342973427107814,
            "start_logit": 5.334221839904785,
            "end_logit": -0.22600632905960083
        },
        {
            "text": "",
            "probability": 0.0008386020546505028,
            "start_logit": 2.2430567741394043,
            "end_logit": 2.6554174423217773
        }
    ],
    "5c74266a7c78d694710000a2_004": [
        {
            "text": "",
            "probability": 0.6028960310328876,
            "start_logit": 4.51168966293335,
            "end_logit": 5.453592300415039
        },
        {
            "text": "regulation of pre-mRNA splicing",
            "probability": 0.2104457341953251,
            "start_logit": 3.8130764961242676,
            "end_logit": 5.099688529968262
        },
        {
            "text": "pre-mRNA splicing",
            "probability": 0.1258608115520438,
            "start_logit": 3.299025297164917,
            "end_logit": 5.099688529968262
        },
        {
            "text": "regulation of pre-mRNA splicing. Currently, little is known about the link between inflammatory stimulation and the pre-mRNA splicing",
            "probability": 0.015836144081008925,
            "start_logit": 3.8130764961242676,
            "end_logit": 2.5127556324005127
        },
        {
            "text": "pre-mRNA splicing. Currently, little is known about the link between inflammatory stimulation and the pre-mRNA splicing",
            "probability": 0.00947108742076443,
            "start_logit": 3.299025297164917,
            "end_logit": 2.5127556324005127
        },
        {
            "text": "They play important roles in regulation of pre-mRNA splicing",
            "probability": 0.005309388018844206,
            "start_logit": 0.1333252489566803,
            "end_logit": 5.099688529968262
        },
        {
            "text": "pre-mRNA splicing. Currently, little is known about the link between inflammatory stimulation and the pre-mRNA splicing process",
            "probability": 0.0046754238122320374,
            "start_logit": 3.299025297164917,
            "end_logit": 1.80683171749115
        },
        {
            "text": "serine- and arginine-rich (SR) proteins. They play important roles in regulation of pre-mRNA splicing",
            "probability": 0.004360465695682347,
            "start_logit": -0.0635724663734436,
            "end_logit": 5.099688529968262
        },
        {
            "text": "regulation",
            "probability": 0.003970614356839744,
            "start_logit": 3.8130764961242676,
            "end_logit": 1.129381537437439
        },
        {
            "text": "accumulate a family of proteins, namely, serine- and arginine-rich (SR) proteins",
            "probability": 0.003306077478627478,
            "start_logit": 1.8742882013320923,
            "end_logit": 2.8850114345550537
        },
        {
            "text": "accumulate a family of proteins",
            "probability": 0.003090809492078145,
            "start_logit": 1.8742882013320923,
            "end_logit": 2.8176820278167725
        },
        {
            "text": "important roles in regulation of pre-mRNA splicing",
            "probability": 0.0027120518771061907,
            "start_logit": -0.5384458303451538,
            "end_logit": 5.099688529968262
        },
        {
            "text": "splicing.",
            "probability": 0.0015337881845113501,
            "start_logit": -1.1084107160568237,
            "end_logit": 5.099688529968262
        },
        {
            "text": "play important roles in regulation of pre-mRNA splicing",
            "probability": 0.0014638646384841436,
            "start_logit": -1.1550713777542114,
            "end_logit": 5.099688529968262
        },
        {
            "text": "regulation of pre-mRNA splicing.",
            "probability": 0.001276030407221911,
            "start_logit": 3.8130764961242676,
            "end_logit": -0.0057852803729474545
        },
        {
            "text": "in regulation of pre-mRNA splicing",
            "probability": 0.0009468885742741081,
            "start_logit": -1.5907251834869385,
            "end_logit": 5.099688529968262
        },
        {
            "text": "pre-mRNA splicing.",
            "probability": 0.0007631526637122128,
            "start_logit": 3.299025297164917,
            "end_logit": -0.0057852803729474545
        },
        {
            "text": "SR) proteins. They play important roles in regulation of pre-mRNA splicing",
            "probability": 0.0007265848332001388,
            "start_logit": -1.8555513620376587,
            "end_logit": 5.099688529968262
        },
        {
            "text": "regulation of pre-mRNA",
            "probability": 0.0007072202765329623,
            "start_logit": 3.8130764961242676,
            "end_logit": -0.5959523916244507
        },
        {
            "text": "splicing",
            "probability": 0.0006478314086233348,
            "start_logit": -1.970276117324829,
            "end_logit": 5.099688529968262
        }
    ],
    "5c74266a7c78d694710000a2_005": [
        {
            "text": "splicing activity",
            "probability": 0.3245648238929212,
            "start_logit": 3.3034164905548096,
            "end_logit": 4.647318363189697
        },
        {
            "text": "regulates splicing activity",
            "probability": 0.24590471440349673,
            "start_logit": 3.0258753299713135,
            "end_logit": 4.647318363189697
        },
        {
            "text": "splicing",
            "probability": 0.19422207758355303,
            "start_logit": 3.3034164905548096,
            "end_logit": 4.133835315704346
        },
        {
            "text": "regulates splicing",
            "probability": 0.1471512653348848,
            "start_logit": 3.0258753299713135,
            "end_logit": 4.133835315704346
        },
        {
            "text": "",
            "probability": 0.06680124400792412,
            "start_logit": 2.735401153564453,
            "end_logit": 3.6345701217651367
        },
        {
            "text": "SC35-positive nuclear speckles and regulates splicing activity",
            "probability": 0.0045778018198345425,
            "start_logit": -0.9578498601913452,
            "end_logit": 4.647318363189697
        },
        {
            "text": "C3G localizes to SC35-positive nuclear speckles and regulates splicing activity",
            "probability": 0.0032152074941714445,
            "start_logit": -1.3111768960952759,
            "end_logit": 4.647318363189697
        },
        {
            "text": "splicing activity.",
            "probability": 0.0027397473341716117,
            "start_logit": -1.471203088760376,
            "end_logit": 4.647318363189697
        },
        {
            "text": "SC35-positive nuclear speckles and regulates splicing",
            "probability": 0.0027393916862271115,
            "start_logit": -0.9578498601913452,
            "end_logit": 4.133835315704346
        },
        {
            "text": "C3G localizes to SC35-positive nuclear speckles and regulates splicing",
            "probability": 0.0019240048009213952,
            "start_logit": -1.3111768960952759,
            "end_logit": 4.133835315704346
        },
        {
            "text": "activity",
            "probability": 0.0014443961045095554,
            "start_logit": -2.111377477645874,
            "end_logit": 4.647318363189697
        },
        {
            "text": "splicing activity. Reversible association of C3G with speckles was seen on inhibition of transcription and splicing",
            "probability": 0.0009939281410905505,
            "start_logit": 3.3034164905548096,
            "end_logit": -1.1412572860717773
        },
        {
            "text": "regulates splicing activity. Reversible association of C3G with speckles was seen on inhibition of transcription and splicing",
            "probability": 0.0007530440691043752,
            "start_logit": 3.0258753299713135,
            "end_logit": -1.1412572860717773
        },
        {
            "text": "regulates splicing activity.",
            "probability": 0.000633078762105754,
            "start_logit": 3.0258753299713135,
            "end_logit": -1.3147861957550049
        },
        {
            "text": "regulating cellular RNA splicing activity",
            "probability": 0.0004707501193447546,
            "start_logit": -0.25571635365486145,
            "end_logit": 1.670538067817688
        },
        {
            "text": "splicing activity. Reversible association of C3G with speckles was seen on inhibition of transcription",
            "probability": 0.0004583644019063249,
            "start_logit": 3.3034164905548096,
            "end_logit": -1.9152576923370361
        },
        {
            "text": "regulating cellular RNA splicing",
            "probability": 0.0004008760402747617,
            "start_logit": -0.25571635365486145,
            "end_logit": 1.5098628997802734
        },
        {
            "text": "RNA splicing activity",
            "probability": 0.00035537801609478983,
            "start_logit": -0.5368617177009583,
            "end_logit": 1.670538067817688
        },
        {
            "text": "regulates splicing activity. Reversible association of C3G with speckles was seen on inhibition of transcription",
            "probability": 0.0003472772125813932,
            "start_logit": 3.0258753299713135,
            "end_logit": -1.9152576923370361
        },
        {
            "text": "RNA splicing",
            "probability": 0.0003026287748818332,
            "start_logit": -0.5368617177009583,
            "end_logit": 1.5098628997802734
        }
    ],
    "5c74266a7c78d694710000a2_006": [
        {
            "text": "splicing activity",
            "probability": 0.3245648238929212,
            "start_logit": 3.3034164905548096,
            "end_logit": 4.647318363189697
        },
        {
            "text": "regulates splicing activity",
            "probability": 0.24590471440349673,
            "start_logit": 3.0258753299713135,
            "end_logit": 4.647318363189697
        },
        {
            "text": "splicing",
            "probability": 0.19422207758355303,
            "start_logit": 3.3034164905548096,
            "end_logit": 4.133835315704346
        },
        {
            "text": "regulates splicing",
            "probability": 0.1471512653348848,
            "start_logit": 3.0258753299713135,
            "end_logit": 4.133835315704346
        },
        {
            "text": "",
            "probability": 0.06680124400792412,
            "start_logit": 2.735401153564453,
            "end_logit": 3.6345701217651367
        },
        {
            "text": "SC35-positive nuclear speckles and regulates splicing activity",
            "probability": 0.0045778018198345425,
            "start_logit": -0.9578498601913452,
            "end_logit": 4.647318363189697
        },
        {
            "text": "C3G localizes to SC35-positive nuclear speckles and regulates splicing activity",
            "probability": 0.0032152074941714445,
            "start_logit": -1.3111768960952759,
            "end_logit": 4.647318363189697
        },
        {
            "text": "splicing activity.",
            "probability": 0.0027397473341716117,
            "start_logit": -1.471203088760376,
            "end_logit": 4.647318363189697
        },
        {
            "text": "SC35-positive nuclear speckles and regulates splicing",
            "probability": 0.0027393916862271115,
            "start_logit": -0.9578498601913452,
            "end_logit": 4.133835315704346
        },
        {
            "text": "C3G localizes to SC35-positive nuclear speckles and regulates splicing",
            "probability": 0.0019240048009213952,
            "start_logit": -1.3111768960952759,
            "end_logit": 4.133835315704346
        },
        {
            "text": "activity",
            "probability": 0.0014443961045095554,
            "start_logit": -2.111377477645874,
            "end_logit": 4.647318363189697
        },
        {
            "text": "splicing activity. Reversible association of C3G with speckles was seen on inhibition of transcription and splicing",
            "probability": 0.0009939281410905505,
            "start_logit": 3.3034164905548096,
            "end_logit": -1.1412572860717773
        },
        {
            "text": "regulates splicing activity. Reversible association of C3G with speckles was seen on inhibition of transcription and splicing",
            "probability": 0.0007530440691043752,
            "start_logit": 3.0258753299713135,
            "end_logit": -1.1412572860717773
        },
        {
            "text": "regulates splicing activity.",
            "probability": 0.000633078762105754,
            "start_logit": 3.0258753299713135,
            "end_logit": -1.3147861957550049
        },
        {
            "text": "regulating cellular RNA splicing activity",
            "probability": 0.0004707501193447546,
            "start_logit": -0.25571635365486145,
            "end_logit": 1.670538067817688
        },
        {
            "text": "splicing activity. Reversible association of C3G with speckles was seen on inhibition of transcription",
            "probability": 0.0004583644019063249,
            "start_logit": 3.3034164905548096,
            "end_logit": -1.9152576923370361
        },
        {
            "text": "regulating cellular RNA splicing",
            "probability": 0.0004008760402747617,
            "start_logit": -0.25571635365486145,
            "end_logit": 1.5098628997802734
        },
        {
            "text": "RNA splicing activity",
            "probability": 0.00035537801609478983,
            "start_logit": -0.5368617177009583,
            "end_logit": 1.670538067817688
        },
        {
            "text": "regulates splicing activity. Reversible association of C3G with speckles was seen on inhibition of transcription",
            "probability": 0.0003472772125813932,
            "start_logit": 3.0258753299713135,
            "end_logit": -1.9152576923370361
        },
        {
            "text": "RNA splicing",
            "probability": 0.0003026287748818332,
            "start_logit": -0.5368617177009583,
            "end_logit": 1.5098628997802734
        }
    ],
    "5c74266a7c78d694710000a2_008": [
        {
            "text": "",
            "probability": 0.999993928975122,
            "start_logit": 6.714231491088867,
            "end_logit": 7.119388580322266
        },
        {
            "text": "polyA RNAs",
            "probability": 2.2258993515881174e-06,
            "start_logit": 0.6998401880264282,
            "end_logit": 0.11843643337488174
        },
        {
            "text": "exosomal mRNA degradation",
            "probability": 4.905338185062807e-07,
            "start_logit": -0.8543435335159302,
            "end_logit": 0.16019806265830994
        },
        {
            "text": "polyA RNAs are apparently accumulated in nuclear foci",
            "probability": 4.3675196630665015e-07,
            "start_logit": 0.6998401880264282,
            "end_logit": -1.5101144313812256
        },
        {
            "text": "polyA RNAs are apparently accumulated in nuclear foci that are distinct from nuclear speckles (NSs",
            "probability": 3.360595838814494e-07,
            "start_logit": 0.6998401880264282,
            "end_logit": -1.7721914052963257
        },
        {
            "text": "polyA RNAs are apparently accumulated",
            "probability": 2.941372765376826e-07,
            "start_logit": 0.6998401880264282,
            "end_logit": -1.9054332971572876
        },
        {
            "text": "polyA RNAs are apparently accumulated in nuclear foci that are distinct",
            "probability": 2.8745669231107743e-07,
            "start_logit": 0.6998401880264282,
            "end_logit": -1.9284076690673828
        },
        {
            "text": "polyA RNAs are apparently accumulated in nuclear foci that are distinct from nuclear speckles",
            "probability": 2.8664487844478435e-07,
            "start_logit": 0.6998401880264282,
            "end_logit": -1.9312357902526855
        },
        {
            "text": "exosome target mRNAs. These results suggest that exosomal mRNA degradation",
            "probability": 2.582189590095769e-07,
            "start_logit": -1.4960298538208008,
            "end_logit": 0.16019806265830994
        },
        {
            "text": "polyA RNAs mainly correspond to accumulating exosome target mRNAs. These results suggest that exosomal mRNA degradation",
            "probability": 2.0797105998998914e-07,
            "start_logit": -1.7124388217926025,
            "end_logit": 0.16019806265830994
        },
        {
            "text": "exosome inactivation, polyA RNAs",
            "probability": 1.820381531800297e-07,
            "start_logit": -1.803859829902649,
            "end_logit": 0.11843643337488174
        },
        {
            "text": "accumulating exosome target mRNAs. These results suggest that exosomal mRNA degradation",
            "probability": 1.8184858701097732e-07,
            "start_logit": -1.8466633558273315,
            "end_logit": 0.16019806265830994
        },
        {
            "text": "upon exosome inactivation, polyA RNAs",
            "probability": 1.518166320614167e-07,
            "start_logit": -1.9854027032852173,
            "end_logit": 0.11843643337488174
        },
        {
            "text": "degraded",
            "probability": 1.4729164672170021e-07,
            "start_logit": -1.1518200635910034,
            "end_logit": -0.7454050183296204
        },
        {
            "text": "exosome target mRNAs",
            "probability": 1.1642188412151325e-07,
            "start_logit": -1.4960298538208008,
            "end_logit": -0.6363893151283264
        },
        {
            "text": "polyA RNAs are apparently accumulated in nuclear foci that are distinct from nuclear speckles (NSs),",
            "probability": 1.1301097080308063e-07,
            "start_logit": 0.6998401880264282,
            "end_logit": -2.861994981765747
        },
        {
            "text": "polyA RNAs are apparently accumulated in nuclear foci that are distinct from nuclear speckles (NSs)",
            "probability": 1.0113791476595214e-07,
            "start_logit": 0.6998401880264282,
            "end_logit": -2.972994804382324
        },
        {
            "text": "polyA RNAs mainly correspond to accumulating exosome target mRNAs",
            "probability": 9.376686645958014e-08,
            "start_logit": -1.7124388217926025,
            "end_logit": -0.6363893151283264
        },
        {
            "text": "accumulating exosome target mRNAs",
            "probability": 8.198915837108505e-08,
            "start_logit": -1.8466633558273315,
            "end_logit": -0.6363893151283264
        },
        {
            "text": "mRNAs are degraded",
            "probability": 7.802947792048489e-08,
            "start_logit": -1.7871479988098145,
            "end_logit": -0.7454050183296204
        }
    ],
    "5c74266a7c78d694710000a2_009": [
        {
            "text": "",
            "probability": 0.4149154275294914,
            "start_logit": 2.182605028152466,
            "end_logit": 2.950444459915161
        },
        {
            "text": "endogenous intronless mRNAs, which do not undergo splicing",
            "probability": 0.19937901049671952,
            "start_logit": 1.2636638879776,
            "end_logit": 3.1365184783935547
        },
        {
            "text": "splicing",
            "probability": 0.13841083047549532,
            "start_logit": 0.8986825942993164,
            "end_logit": 3.1365184783935547
        },
        {
            "text": "intronless mRNAs, which do not undergo splicing",
            "probability": 0.08072011112236564,
            "start_logit": 0.3594440519809723,
            "end_logit": 3.1365184783935547
        },
        {
            "text": "undergo splicing",
            "probability": 0.044727918877046705,
            "start_logit": -0.23094581067562103,
            "end_logit": 3.1365184783935547
        },
        {
            "text": "endogenous intronless mRNAs",
            "probability": 0.035948795977840994,
            "start_logit": 1.2636638879776,
            "end_logit": 1.4234064817428589
        },
        {
            "text": "do not undergo splicing",
            "probability": 0.0198643561156366,
            "start_logit": -1.0426167249679565,
            "end_logit": 3.1365184783935547
        },
        {
            "text": "intronless mRNAs",
            "probability": 0.014554143883136186,
            "start_logit": 0.3594440519809723,
            "end_logit": 1.4234064817428589
        },
        {
            "text": "not undergo splicing",
            "probability": 0.009336054266099297,
            "start_logit": -1.797659993171692,
            "end_logit": 3.1365184783935547
        },
        {
            "text": "mRNAs, which do not undergo splicing",
            "probability": 0.008371726507413656,
            "start_logit": -1.9066835641860962,
            "end_logit": 3.1365184783935547
        },
        {
            "text": "splicing factor storage sites. In this study, we unexpectedly found that many endogenous intronless mRNAs",
            "probability": 0.007365591404112564,
            "start_logit": -0.3216123580932617,
            "end_logit": 1.4234064817428589
        },
        {
            "text": "the export-competent messenger RNP assembly",
            "probability": 0.005015456223379098,
            "start_logit": -0.2787780463695526,
            "end_logit": 0.9962772130966187
        },
        {
            "text": "many endogenous intronless mRNAs, which do not undergo splicing",
            "probability": 0.004333669570742487,
            "start_logit": -2.565129041671753,
            "end_logit": 3.1365184783935547
        },
        {
            "text": "endogenous intronless mRNAs, which do not undergo splicing, associate",
            "probability": 0.003931797596506606,
            "start_logit": 1.2636638879776,
            "end_logit": -0.7895923852920532
        },
        {
            "text": "endogenous",
            "probability": 0.003176053470467594,
            "start_logit": 1.2636638879776,
            "end_logit": -1.0030497312545776
        },
        {
            "text": "splicing, associate",
            "probability": 0.0027294917816988056,
            "start_logit": 0.8986825942993164,
            "end_logit": -0.7895923852920532
        },
        {
            "text": "export-competent messenger RNP assembly",
            "probability": 0.002592173096309616,
            "start_logit": -0.938805878162384,
            "end_logit": 0.9962772130966187
        },
        {
            "text": "intronless mRNAs, which do not undergo splicing, associate",
            "probability": 0.0015918182064901228,
            "start_logit": 0.3594440519809723,
            "end_logit": -0.7895923852920532
        },
        {
            "text": "splicing, associate with NSs. These associations do not require transcription, polyadenylation, or the polyA tail",
            "probability": 0.0015261191819387102,
            "start_logit": 0.8986825942993164,
            "end_logit": -1.3709797859191895
        },
        {
            "text": "mRNAs",
            "probability": 0.0015094542171090201,
            "start_logit": -1.9066835641860962,
            "end_logit": 1.4234064817428589
        }
    ],
    "5c74266a7c78d694710000a2_010": [
        {
            "text": "",
            "probability": 0.8280681007923195,
            "start_logit": 3.9436473846435547,
            "end_logit": 4.319874286651611
        },
        {
            "text": "active transcription",
            "probability": 0.057283775391613924,
            "start_logit": 2.9169912338256836,
            "end_logit": 2.675452470779419
        },
        {
            "text": "active transcription sites",
            "probability": 0.04457693548363275,
            "start_logit": 2.9169912338256836,
            "end_logit": 2.424651622772217
        },
        {
            "text": "transcription",
            "probability": 0.013375379510118707,
            "start_logit": 1.4623894691467285,
            "end_logit": 2.675452470779419
        },
        {
            "text": "transcription sites",
            "probability": 0.010408417137585363,
            "start_logit": 1.4623894691467285,
            "end_logit": 2.424651622772217
        },
        {
            "text": "cycle continuously between speckles and other nuclear locations, including active transcription",
            "probability": 0.0069245974584017335,
            "start_logit": 0.8040537238121033,
            "end_logit": 2.675452470779419
        },
        {
            "text": "gene-expression machinery",
            "probability": 0.006634832598204822,
            "start_logit": 1.4087038040161133,
            "end_logit": 2.0280559062957764
        },
        {
            "text": "active transcription sites. Studies on the composition, structure and behaviour of speckles have provided a model for understanding the functional compartmentalization",
            "probability": 0.006033914457078142,
            "start_logit": 2.9169912338256836,
            "end_logit": 0.42483100295066833
        },
        {
            "text": "cycle continuously between speckles and other nuclear locations, including active transcription sites",
            "probability": 0.005388564773237524,
            "start_logit": 0.8040537238121033,
            "end_logit": 2.424651622772217
        },
        {
            "text": "gene-expression",
            "probability": 0.004685427344498306,
            "start_logit": 1.4087038040161133,
            "end_logit": 1.6801795959472656
        },
        {
            "text": "both their protein and RNA-protein components can cycle continuously between speckles and other nuclear locations, including active transcription",
            "probability": 0.0032765538605125494,
            "start_logit": 0.055766019970178604,
            "end_logit": 2.675452470779419
        },
        {
            "text": "both their protein and RNA-protein components can cycle continuously between speckles and other nuclear locations, including active transcription sites",
            "probability": 0.0025497399403269436,
            "start_logit": 0.055766019970178604,
            "end_logit": 2.424651622772217
        },
        {
            "text": "protein and RNA-protein components can cycle continuously between speckles and other nuclear locations, including active transcription",
            "probability": 0.0018023480320957038,
            "start_logit": -0.541935920715332,
            "end_logit": 2.675452470779419
        },
        {
            "text": "functional compartmentalization of the nucleus and the organization of the gene-expression machinery",
            "probability": 0.00154161644268399,
            "start_logit": -0.05079812929034233,
            "end_logit": 2.0280559062957764
        },
        {
            "text": "transcription sites. Studies on the composition, structure and behaviour of speckles have provided a model for understanding the functional compartmentalization",
            "probability": 0.0014088787836219851,
            "start_logit": 1.4623894691467285,
            "end_logit": 0.42483100295066833
        },
        {
            "text": "protein and RNA-protein components can cycle continuously between speckles and other nuclear locations, including active transcription sites",
            "probability": 0.0014025463824010537,
            "start_logit": -0.541935920715332,
            "end_logit": 2.424651622772217
        },
        {
            "text": "continuously between speckles and other nuclear locations, including active transcription",
            "probability": 0.001254977503696707,
            "start_logit": -0.9039085507392883,
            "end_logit": 2.675452470779419
        },
        {
            "text": "the gene-expression machinery",
            "probability": 0.001194785395758049,
            "start_logit": -0.3056630492210388,
            "end_logit": 2.0280559062957764
        },
        {
            "text": "active transcription sites.",
            "probability": 0.0010999404258064318,
            "start_logit": 2.9169912338256836,
            "end_logit": -1.2773089408874512
        },
        {
            "text": "functional compartmentalization of the nucleus and the organization of the gene-expression",
            "probability": 0.0010886682864062198,
            "start_logit": -0.05079812929034233,
            "end_logit": 1.6801795959472656
        }
    ],
    "5e2e11a1fbd6abf43b000021_001": [
        {
            "text": "",
            "probability": 0.9910251535793932,
            "start_logit": 2.86326265335083,
            "end_logit": 3.4043962955474854
        },
        {
            "text": "G380R",
            "probability": 0.002953340741161919,
            "start_logit": -0.3756680488586426,
            "end_logit": 0.8275240659713745
        },
        {
            "text": "glycine substituted with arginine at residue 380, G380R",
            "probability": 0.002726333872780524,
            "start_logit": -0.45564723014831543,
            "end_logit": 0.8275240659713745
        },
        {
            "text": "glycine substituted with arginine at residue 380",
            "probability": 0.0010823587814685646,
            "start_logit": -0.45564723014831543,
            "end_logit": -0.09629102051258087
        },
        {
            "text": "(glycine substituted with arginine at residue 380, G380R",
            "probability": 0.0003058513979155454,
            "start_logit": -2.643260955810547,
            "end_logit": 0.8275240659713745
        },
        {
            "text": "recurrent mutations of a single amino acid in the transmembrane domain",
            "probability": 0.0002732446239744458,
            "start_logit": -0.28093764185905457,
            "end_logit": -1.6475311517715454
        },
        {
            "text": "glycine substituted with arginine",
            "probability": 0.00023659590890384702,
            "start_logit": -0.45564723014831543,
            "end_logit": -1.616835355758667
        },
        {
            "text": "recurrent mutations of a single amino acid",
            "probability": 0.000224247643952309,
            "start_logit": -0.28093764185905457,
            "end_logit": -1.8451476097106934
        },
        {
            "text": "recurrent mutations",
            "probability": 0.0002165694163824892,
            "start_logit": -0.28093764185905457,
            "end_logit": -1.8799874782562256
        },
        {
            "text": "recurrent mutations of a single amino acid in the transmembrane domain of the FGFR3 protein",
            "probability": 0.00019383529751181613,
            "start_logit": -0.28093764185905457,
            "end_logit": -1.9908897876739502
        },
        {
            "text": "recurrent",
            "probability": 0.00015594782269078987,
            "start_logit": -0.28093764185905457,
            "end_logit": -2.2083771228790283
        },
        {
            "text": "(glycine substituted with arginine at residue 380",
            "probability": 0.00012142347995724598,
            "start_logit": -2.643260955810547,
            "end_logit": -0.09629102051258087
        },
        {
            "text": "G380R)",
            "probability": 8.413883072013977e-05,
            "start_logit": -0.3756680488586426,
            "end_logit": -2.7307000160217285
        },
        {
            "text": "G380R) in 17 sporadic cases and 6 unrelated familial forms of achondroplasia",
            "probability": 8.410694095085346e-05,
            "start_logit": -0.3756680488586426,
            "end_logit": -2.7310791015625
        },
        {
            "text": "glycine substituted with arginine at residue 380, G380R)",
            "probability": 7.767154700822484e-05,
            "start_logit": -0.45564723014831543,
            "end_logit": -2.7307000160217285
        },
        {
            "text": "mutations of a single amino acid in the transmembrane domain",
            "probability": 5.9988067111816235e-05,
            "start_logit": -1.7971594333648682,
            "end_logit": -1.6475311517715454
        },
        {
            "text": "mutations of a single amino acid",
            "probability": 4.92312804526974e-05,
            "start_logit": -1.7971594333648682,
            "end_logit": -1.8451476097106934
        },
        {
            "text": "mutations",
            "probability": 4.754560399158897e-05,
            "start_logit": -1.7971594333648682,
            "end_logit": -1.8799874782562256
        },
        {
            "text": "mutations of a single amino acid in the transmembrane domain of the FGFR3 protein",
            "probability": 4.255456033003285e-05,
            "start_logit": -1.7971594333648682,
            "end_logit": -1.9908897876739502
        },
        {
            "text": "a single amino acid in the transmembrane domain",
            "probability": 3.98606033418827e-05,
            "start_logit": -2.2059166431427,
            "end_logit": -1.6475311517715454
        }
    ],
    "5e2a04feaa19d74431000009_002": [
        {
            "text": "",
            "probability": 0.9999999552873031,
            "start_logit": 6.191790580749512,
            "end_logit": 6.570744037628174
        },
        {
            "text": "We demonstrate that LB100 decreases cell viability",
            "probability": 5.949158380923478e-09,
            "start_logit": -3.1491010189056396,
            "end_logit": -3.0283803939819336
        },
        {
            "text": "We demonstrate that LB100 decreases cell viability through caspase activation and G2/M cell-cycle arrest",
            "probability": 5.223402627511485e-09,
            "start_logit": -3.1491010189056396,
            "end_logit": -3.1584811210632324
        },
        {
            "text": "Our research highlights the therapeutic potential of LB100, and provides new insights into the mechanism of LB100 chemosensitization",
            "probability": 3.401781744208541e-09,
            "start_logit": -3.6643097400665283,
            "end_logit": -3.072122097015381
        },
        {
            "text": "decreases cell viability",
            "probability": 3.0089710266768073e-09,
            "start_logit": -3.8307526111602783,
            "end_logit": -3.0283803939819336
        },
        {
            "text": "provides new insights into the mechanism of LB100 chemosensitization",
            "probability": 2.8995237257649728e-09,
            "start_logit": -3.8240625858306885,
            "end_logit": -3.072122097015381
        },
        {
            "text": "decreases cell viability through caspase activation and G2/M cell-cycle arrest",
            "probability": 2.641897586261577e-09,
            "start_logit": -3.8307526111602783,
            "end_logit": -3.1584811210632324
        },
        {
            "text": "LB100 decreases cell viability",
            "probability": 2.4238323296164266e-09,
            "start_logit": -4.047000885009766,
            "end_logit": -3.0283803939819336
        },
        {
            "text": "Our research highlights the therapeutic potential of LB100, and provides new insights into the mechanism of LB100 chemosensitization.",
            "probability": 2.2451310345919037e-09,
            "start_logit": -3.6643097400665283,
            "end_logit": -3.4876575469970703
        },
        {
            "text": "LB100 decreases cell viability through caspase activation and G2/M cell-cycle arrest",
            "probability": 2.128141721653145e-09,
            "start_logit": -4.047000885009766,
            "end_logit": -3.1584811210632324
        },
        {
            "text": "in-vitro and in-vivo approach. We demonstrate that LB100 decreases cell viability",
            "probability": 1.9565006686420183e-09,
            "start_logit": -4.26119327545166,
            "end_logit": -3.0283803939819336
        },
        {
            "text": "provides new insights into the mechanism of LB100 chemosensitization.",
            "probability": 1.9136473741542338e-09,
            "start_logit": -3.8240625858306885,
            "end_logit": -3.4876575469970703
        },
        {
            "text": "We demonstrate that LB100 decreases cell viability through caspase activation and G2/M cell-cycle arrest.",
            "probability": 1.8238482948395563e-09,
            "start_logit": -3.1491010189056396,
            "end_logit": -4.210681438446045
        },
        {
            "text": "MiR-181b-1 ectopic overexpression",
            "probability": 1.612334633671937e-09,
            "start_logit": -4.505532264709473,
            "end_logit": -2.977515697479248
        },
        {
            "text": "in-vivo approach. We demonstrate that LB100 decreases cell viability",
            "probability": 1.3889083212357364e-09,
            "start_logit": -4.603832721710205,
            "end_logit": -3.0283803939819336
        },
        {
            "text": "ectopic overexpression",
            "probability": 1.2909844844282462e-09,
            "start_logit": -4.727810382843018,
            "end_logit": -2.977515697479248
        },
        {
            "text": "demonstrate that LB100 decreases cell viability",
            "probability": 1.237434171596154e-09,
            "start_logit": -4.719310760498047,
            "end_logit": -3.0283803939819336
        },
        {
            "text": "Here",
            "probability": 1.2352240330033534e-09,
            "start_logit": -3.680215835571289,
            "end_logit": -4.069262981414795
        },
        {
            "text": "in-vivo approach. We demonstrate that LB100 decreases cell viability through caspase activation and G2/M cell-cycle arrest",
            "probability": 1.2194712108822956e-09,
            "start_logit": -4.603832721710205,
            "end_logit": -3.1584811210632324
        },
        {
            "text": "Our research",
            "probability": 1.1125031742020125e-09,
            "start_logit": -3.6643097400665283,
            "end_logit": -4.1898088455200195
        }
    ],
    "5e482160d14c9f295d00000c_001": [
        {
            "text": "",
            "probability": 0.9602266979729924,
            "start_logit": 2.3727855682373047,
            "end_logit": 3.1081180572509766
        },
        {
            "text": "phosphatase and tensin homolog (PTEN)",
            "probability": 0.02103350558323416,
            "start_logit": -0.3105270266532898,
            "end_logit": 1.9703779220581055
        },
        {
            "text": "phosphatase and tensin homolog",
            "probability": 0.00598532508556671,
            "start_logit": -0.3105270266532898,
            "end_logit": 0.7135719060897827
        },
        {
            "text": "phosphatase and tensin homolog (PTEN",
            "probability": 0.002936149895121279,
            "start_logit": -0.3105270266532898,
            "end_logit": 0.001360415481030941
        },
        {
            "text": "GSR), and phosphatase and tensin homolog (PTEN)",
            "probability": 0.00223605472814116,
            "start_logit": -2.5519306659698486,
            "end_logit": 1.9703779220581055
        },
        {
            "text": "PTEN)",
            "probability": 0.0019411697575600995,
            "start_logit": -2.6933529376983643,
            "end_logit": 1.9703779220581055
        },
        {
            "text": "thioredoxin 1 (Trx1), peroxiredoxin 1",
            "probability": 0.0008436313545924538,
            "start_logit": -0.3097204267978668,
            "end_logit": -1.2465850114822388
        },
        {
            "text": "thioredoxin 1",
            "probability": 0.0006900143687602318,
            "start_logit": -0.3097204267978668,
            "end_logit": -1.4475882053375244
        },
        {
            "text": "GSR), and phosphatase and tensin homolog",
            "probability": 0.0006362950010440177,
            "start_logit": -2.5519306659698486,
            "end_logit": 0.7135719060897827
        },
        {
            "text": "thioredoxin 1 (Trx1), peroxiredoxin 1 (Prx1)",
            "probability": 0.0005967678299375426,
            "start_logit": -0.3097204267978668,
            "end_logit": -1.5927724838256836
        },
        {
            "text": "GSH reductase (GSR), and phosphatase and tensin homolog (PTEN)",
            "probability": 0.00044915414153174596,
            "start_logit": -2.6151795387268066,
            "end_logit": 0.42852461338043213
        },
        {
            "text": "GSR)",
            "probability": 0.0003928155281654534,
            "start_logit": -2.5519306659698486,
            "end_logit": 0.23124971985816956
        },
        {
            "text": "phosphatase and tensin homolog (PTEN).",
            "probability": 0.0003642177095352074,
            "start_logit": -0.3105270266532898,
            "end_logit": -2.085742235183716
        },
        {
            "text": "GSH reductase (GSR), and phosphatase and tensin homolog",
            "probability": 0.000326776643186591,
            "start_logit": -2.6151795387268066,
            "end_logit": 0.1104353740811348
        },
        {
            "text": "GSR), and phosphatase and tensin homolog (PTEN",
            "probability": 0.00031213968729731814,
            "start_logit": -2.5519306659698486,
            "end_logit": 0.001360415481030941
        },
        {
            "text": "inhibit oxidative stress\u2011induced cardiomyocyte apoptosis",
            "probability": 0.0003103412108543378,
            "start_logit": -1.833962082862854,
            "end_logit": -0.7223865985870361
        },
        {
            "text": "PTEN",
            "probability": 0.00027097553270510536,
            "start_logit": -2.6933529376983643,
            "end_logit": 0.001360415481030941
        },
        {
            "text": "thioredoxin 1 (Trx1), peroxiredoxin 1 (Prx1",
            "probability": 0.00019223493922417188,
            "start_logit": -0.3097204267978668,
            "end_logit": -2.7255823612213135
        },
        {
            "text": "GSH reductase (GSR), and phosphatase and tensin homolog (PTEN",
            "probability": 0.0001416253491258273,
            "start_logit": -2.6151795387268066,
            "end_logit": -0.7256563305854797
        },
        {
            "text": "thioredoxin",
            "probability": 0.0001141076814245767,
            "start_logit": -0.3097204267978668,
            "end_logit": -3.2471580505371094
        }
    ],
    "5e482160d14c9f295d00000c_002": [
        {
            "text": "Vitamin C, vitamin E, and alpha-lipoic acid",
            "probability": 0.4797654144284916,
            "start_logit": 3.462908983230591,
            "end_logit": 3.7321271896362305
        },
        {
            "text": "Vitamin C, vitamin E, and alpha-lipoic acid (ALA)",
            "probability": 0.19119632208659582,
            "start_logit": 3.462908983230591,
            "end_logit": 2.8121306896209717
        },
        {
            "text": "Vitamin C, vitamin E, and alpha-lipoic acid (ALA",
            "probability": 0.11475510470785746,
            "start_logit": 3.462908983230591,
            "end_logit": 2.3016302585601807
        },
        {
            "text": "",
            "probability": 0.06588751961323329,
            "start_logit": 2.4008610248565674,
            "end_logit": 2.8088269233703613
        },
        {
            "text": "Vitamin C",
            "probability": 0.04746271998410469,
            "start_logit": 3.462908983230591,
            "end_logit": 1.4187744855880737
        },
        {
            "text": "Vitamin C, vitamin E",
            "probability": 0.030258384760283707,
            "start_logit": 3.462908983230591,
            "end_logit": 0.968603253364563
        },
        {
            "text": "alpha-lipoic acid",
            "probability": 0.01897255347691814,
            "start_logit": 0.23260509967803955,
            "end_logit": 3.7321271896362305
        },
        {
            "text": "vitamin E, and alpha-lipoic acid",
            "probability": 0.01609450593697891,
            "start_logit": 0.06808968633413315,
            "end_logit": 3.7321271896362305
        },
        {
            "text": "alpha-lipoic acid (ALA)",
            "probability": 0.007560950281710387,
            "start_logit": 0.23260509967803955,
            "end_logit": 2.8121306896209717
        },
        {
            "text": "vitamin E, and alpha-lipoic acid (ALA)",
            "probability": 0.006413989521560026,
            "start_logit": 0.06808968633413315,
            "end_logit": 2.8121306896209717
        },
        {
            "text": "Vitamin C, vitamin E, and alpha-lipoic acid (ALA) are potent nutritional antioxidants",
            "probability": 0.005267363101626481,
            "start_logit": 3.462908983230591,
            "end_logit": -0.7796401977539062
        },
        {
            "text": "alpha-lipoic acid (ALA",
            "probability": 0.004538045668449647,
            "start_logit": 0.23260509967803955,
            "end_logit": 2.3016302585601807
        },
        {
            "text": "vitamin E, and alpha-lipoic acid (ALA",
            "probability": 0.0038496453860046437,
            "start_logit": 0.06808968633413315,
            "end_logit": 2.3016302585601807
        },
        {
            "text": "ALA)",
            "probability": 0.00207366588764902,
            "start_logit": -1.0610737800598145,
            "end_logit": 2.8121306896209717
        },
        {
            "text": "and alpha-lipoic acid",
            "probability": 0.0013593993323811281,
            "start_logit": -2.4033453464508057,
            "end_logit": 3.7321271896362305
        },
        {
            "text": "ALA",
            "probability": 0.0012446042029955887,
            "start_logit": -1.0610737800598145,
            "end_logit": 2.3016302585601807
        },
        {
            "text": "vitamin E",
            "probability": 0.0010150664022914144,
            "start_logit": 0.06808968633413315,
            "end_logit": 0.968603253364563
        },
        {
            "text": "acid",
            "probability": 0.0009230234143967585,
            "start_logit": -2.7904889583587646,
            "end_logit": 3.7321271896362305
        },
        {
            "text": "C, vitamin E, and alpha-lipoic acid",
            "probability": 0.0007223765022956839,
            "start_logit": -3.035597085952759,
            "end_logit": 3.7321271896362305
        },
        {
            "text": ", vitamin E, and alpha-lipoic acid",
            "probability": 0.0006393453041755948,
            "start_logit": -3.1576988697052,
            "end_logit": 3.7321271896362305
        }
    ],
    "5e482160d14c9f295d00000c_003": [
        {
            "text": "",
            "probability": 0.8969488514267255,
            "start_logit": 4.517541408538818,
            "end_logit": 4.6692376136779785
        },
        {
            "text": "GPx, CAT, SOD, NQO1, HO-1",
            "probability": 0.01742867349372839,
            "start_logit": 1.3831182718276978,
            "end_logit": 3.862778663635254
        },
        {
            "text": "NQO1, HO-1",
            "probability": 0.010808023615367483,
            "start_logit": 0.9052903056144714,
            "end_logit": 3.862778663635254
        },
        {
            "text": "GCLC, GCLM, GS, GR, GST, GPx",
            "probability": 0.00988177328249198,
            "start_logit": 3.2370824813842773,
            "end_logit": 1.4413896799087524
        },
        {
            "text": "GCLC, GCLM, GS, GR, GST, GPx, CAT",
            "probability": 0.007683310168093226,
            "start_logit": 3.2370824813842773,
            "end_logit": 1.1897481679916382
        },
        {
            "text": "GCLM, GS, GR, GST, GPx, CAT, SOD, NQO1, HO-1",
            "probability": 0.007282360411990235,
            "start_logit": 0.5104565620422363,
            "end_logit": 3.862778663635254
        },
        {
            "text": "HO-1",
            "probability": 0.007267134246980539,
            "start_logit": 0.5083635449409485,
            "end_logit": 3.862778663635254
        },
        {
            "text": "CAT, SOD, NQO1, HO-1",
            "probability": 0.00687488836428814,
            "start_logit": 0.4528769254684448,
            "end_logit": 3.862778663635254
        },
        {
            "text": "GST, GPx, CAT, SOD, NQO1, HO-1",
            "probability": 0.006790163270286622,
            "start_logit": 0.44047650694847107,
            "end_logit": 3.862778663635254
        },
        {
            "text": "GCLC, GCLM, GS, GR, GST, GPx, CAT, SOD",
            "probability": 0.006391198590762163,
            "start_logit": 3.2370824813842773,
            "end_logit": 1.0056195259094238
        },
        {
            "text": "SOD, NQO1, HO-1",
            "probability": 0.00484611677243008,
            "start_logit": 0.10317923873662949,
            "end_logit": 3.862778663635254
        },
        {
            "text": "GCLC, GCLM, GS, GR, GST",
            "probability": 0.004333313798421698,
            "start_logit": 3.2370824813842773,
            "end_logit": 0.6170302629470825
        },
        {
            "text": "GR, GST, GPx, CAT, SOD, NQO1, HO-1",
            "probability": 0.0029108652314940014,
            "start_logit": -0.4065481126308441,
            "end_logit": 3.862778663635254
        },
        {
            "text": "GCLC, GCLM, GS, GR",
            "probability": 0.0027007217680132655,
            "start_logit": 3.2370824813842773,
            "end_logit": 0.14421676099300385
        },
        {
            "text": "GPx",
            "probability": 0.0015476347042166032,
            "start_logit": 1.3831182718276978,
            "end_logit": 1.4413896799087524
        },
        {
            "text": "GCLC, GCLM, GS, GR, GST,",
            "probability": 0.0014706096103295893,
            "start_logit": 3.2370824813842773,
            "end_logit": -0.4636252820491791
        },
        {
            "text": "GCLC, GCLM, GS, GR, GST, GPx,",
            "probability": 0.001285611496228972,
            "start_logit": 3.2370824813842773,
            "end_logit": -0.5980678200721741
        },
        {
            "text": "GCLC, GCLM, GS, GR, GST, GPx, CAT, SOD,",
            "probability": 0.0012064378408343792,
            "start_logit": 3.2370824813842773,
            "end_logit": -0.6616302132606506
        },
        {
            "text": "GPx, CAT",
            "probability": 0.0012033222296719932,
            "start_logit": 1.3831182718276978,
            "end_logit": 1.1897481679916382
        },
        {
            "text": "GS, GR, GST, GPx, CAT, SOD, NQO1, HO-1",
            "probability": 0.0011389896776452613,
            "start_logit": -1.344856858253479,
            "end_logit": 3.862778663635254
        }
    ],
    "5e2b07537d50947c2f000001_002": [
        {
            "text": "rare lesions that are congenital, traumatic, or postinfectious in nature",
            "probability": 0.338462652333229,
            "start_logit": 6.3227009773254395,
            "end_logit": 6.590408802032471
        },
        {
            "text": "Scalp arteriovenous malformations",
            "probability": 0.28060529545047047,
            "start_logit": 5.169168472290039,
            "end_logit": 7.556476593017578
        },
        {
            "text": "congenital, traumatic, or postinfectious in nature",
            "probability": 0.16059765848214974,
            "start_logit": 5.5771894454956055,
            "end_logit": 6.590408802032471
        },
        {
            "text": "rare lesions that are congenital, traumatic, or postinfectious",
            "probability": 0.060681013193322496,
            "start_logit": 6.3227009773254395,
            "end_logit": 4.871625900268555
        },
        {
            "text": "arteriovenous malformations",
            "probability": 0.04747416176491224,
            "start_logit": 3.3924050331115723,
            "end_logit": 7.556476593017578
        },
        {
            "text": "congenital, traumatic, or postinfectious",
            "probability": 0.028792626205556913,
            "start_logit": 5.5771894454956055,
            "end_logit": 4.871625900268555
        },
        {
            "text": "are rare lesions that are congenital, traumatic, or postinfectious in nature",
            "probability": 0.026073651151883856,
            "start_logit": 3.7592124938964844,
            "end_logit": 6.590408802032471
        },
        {
            "text": "rare lesions",
            "probability": 0.014767784956689994,
            "start_logit": 6.3227009773254395,
            "end_logit": 3.4584431648254395
        },
        {
            "text": "rare",
            "probability": 0.013421267787206771,
            "start_logit": 6.3227009773254395,
            "end_logit": 3.362835645675659
        },
        {
            "text": "are congenital, traumatic, or postinfectious in nature",
            "probability": 0.006255607048832064,
            "start_logit": 2.3317654132843018,
            "end_logit": 6.590408802032471
        },
        {
            "text": "are rare lesions that are congenital, traumatic, or postinfectious",
            "probability": 0.004674594253276259,
            "start_logit": 3.7592124938964844,
            "end_logit": 4.871625900268555
        },
        {
            "text": "Scalp arteriovenous malformations, also known as cirsoid aneurysms, are rare lesions",
            "probability": 0.004659534783008138,
            "start_logit": 5.169168472290039,
            "end_logit": 3.4584431648254395
        },
        {
            "text": "Scalp arteriovenous malformations, also known as cirsoid aneurysms, are rare",
            "probability": 0.004234681387219594,
            "start_logit": 5.169168472290039,
            "end_logit": 3.362835645675659
        },
        {
            "text": "rare lesions that are congenital",
            "probability": 0.0016526522489625718,
            "start_logit": 6.3227009773254395,
            "end_logit": 1.2683764696121216
        },
        {
            "text": "rare lesions that are congenital, traumatic, or postinfectious in nature.",
            "probability": 0.001548875129995654,
            "start_logit": 6.3227009773254395,
            "end_logit": 1.2035239934921265
        },
        {
            "text": "traumatic, or postinfectious in nature",
            "probability": 0.0013214283870631597,
            "start_logit": 0.7770004868507385,
            "end_logit": 6.590408802032471
        },
        {
            "text": "postinfectious in nature",
            "probability": 0.0011583480158343256,
            "start_logit": 0.6452820897102356,
            "end_logit": 6.590408802032471
        },
        {
            "text": "lesions that are congenital, traumatic, or postinfectious in nature",
            "probability": 0.0011391234619710362,
            "start_logit": 0.6285462975502014,
            "end_logit": 6.590408802032471
        },
        {
            "text": "are rare lesions",
            "probability": 0.0011376441997141744,
            "start_logit": 3.7592124938964844,
            "end_logit": 3.4584431648254395
        },
        {
            "text": "are congenital, traumatic, or postinfectious",
            "probability": 0.0011215316409229482,
            "start_logit": 2.3317654132843018,
            "end_logit": 4.871625900268555
        },
        {
            "text": "",
            "probability": 0.0002198681177785614,
            "start_logit": 2.3297224044799805,
            "end_logit": 3.244246244430542
        }
    ],
    "5e2b07537d50947c2f000001_003": [
        {
            "text": "rare congenital extracranial vascular anomalies that often present as an enlarging pulsatile scalp mass",
            "probability": 0.32250168206961133,
            "start_logit": 6.227881908416748,
            "end_logit": 7.376380920410156
        },
        {
            "text": "rare congenital extracranial vascular anomalies",
            "probability": 0.14655190088245112,
            "start_logit": 6.227881908416748,
            "end_logit": 6.587652206420898
        },
        {
            "text": "congenital extracranial vascular anomalies that often present as an enlarging pulsatile scalp mass",
            "probability": 0.12256021007971486,
            "start_logit": 5.2603759765625,
            "end_logit": 7.376380920410156
        },
        {
            "text": "extracranial vascular anomalies that often present as an enlarging pulsatile scalp mass",
            "probability": 0.07869200367764853,
            "start_logit": 4.817315101623535,
            "end_logit": 7.376380920410156
        },
        {
            "text": "congenital extracranial vascular anomalies",
            "probability": 0.05569407156102158,
            "start_logit": 5.2603759765625,
            "end_logit": 6.587652206420898
        },
        {
            "text": "enlarging pulsatile scalp mass",
            "probability": 0.05414927611961801,
            "start_logit": 4.443518161773682,
            "end_logit": 7.376380920410156
        },
        {
            "text": "an enlarging pulsatile scalp mass",
            "probability": 0.04612581745952505,
            "start_logit": 4.283146381378174,
            "end_logit": 7.376380920410156
        },
        {
            "text": "extracranial vascular anomalies",
            "probability": 0.03575938782458496,
            "start_logit": 4.817315101623535,
            "end_logit": 6.587652206420898
        },
        {
            "text": "pulsatile scalp mass",
            "probability": 0.029949485313474997,
            "start_logit": 3.851285696029663,
            "end_logit": 7.376380920410156
        },
        {
            "text": "often present as an enlarging pulsatile scalp mass",
            "probability": 0.02875840175569332,
            "start_logit": 3.8107035160064697,
            "end_logit": 7.376380920410156
        },
        {
            "text": "are rare congenital extracranial vascular anomalies that often present as an enlarging pulsatile scalp mass",
            "probability": 0.017400729954019905,
            "start_logit": 3.308285713195801,
            "end_logit": 7.376380920410156
        },
        {
            "text": "scalp arteriovenous malformations (AVM), are rare congenital extracranial vascular anomalies",
            "probability": 0.015964267243682863,
            "start_logit": 4.010855197906494,
            "end_logit": 6.587652206420898
        },
        {
            "text": "vascular anomalies that often present as an enlarging pulsatile scalp mass",
            "probability": 0.012798426264933285,
            "start_logit": 3.001095771789551,
            "end_logit": 7.376380920410156
        },
        {
            "text": "are rare congenital extracranial vascular anomalies",
            "probability": 0.007907276747019843,
            "start_logit": 3.308285713195801,
            "end_logit": 6.587652206420898
        },
        {
            "text": "vascular anomalies",
            "probability": 0.005815888107600662,
            "start_logit": 3.001095771789551,
            "end_logit": 6.587652206420898
        },
        {
            "text": "as an enlarging pulsatile scalp mass",
            "probability": 0.0053128298291538305,
            "start_logit": 2.1218981742858887,
            "end_logit": 7.376380920410156
        },
        {
            "text": "present as an enlarging pulsatile scalp mass",
            "probability": 0.005085180180961891,
            "start_logit": 2.078104019165039,
            "end_logit": 7.376380920410156
        },
        {
            "text": "scalp arteriovenous malformations",
            "probability": 0.0035929502670952957,
            "start_logit": 4.010855197906494,
            "end_logit": 5.096272945404053
        },
        {
            "text": "rare",
            "probability": 0.0027160380116756956,
            "start_logit": 6.227881908416748,
            "end_logit": 2.5994467735290527
        },
        {
            "text": "arteriovenous malformations (AVM), are rare congenital extracranial vascular anomalies",
            "probability": 0.0026100179801519757,
            "start_logit": 2.199859380722046,
            "end_logit": 6.587652206420898
        },
        {
            "text": "",
            "probability": 5.4158670360924356e-05,
            "start_logit": 2.203766345977783,
            "end_logit": 2.7085509300231934
        }
    ],
    "5e2b07537d50947c2f000001_004": [
        {
            "text": "",
            "probability": 0.5320031155795063,
            "start_logit": 4.120166778564453,
            "end_logit": 4.938169002532959
        },
        {
            "text": "a right temporal pre-auricular arteriovenous fistula",
            "probability": 0.14437507526019605,
            "start_logit": 2.347025156021118,
            "end_logit": 5.407075881958008
        },
        {
            "text": "right temporal pre-auricular arteriovenous fistula",
            "probability": 0.13869629434721512,
            "start_logit": 2.3068971633911133,
            "end_logit": 5.407075881958008
        },
        {
            "text": "high-flow scalp arteriovenous fistula",
            "probability": 0.07917401742610365,
            "start_logit": 3.3172028064727783,
            "end_logit": 3.8361318111419678
        },
        {
            "text": "arteriovenous fistula",
            "probability": 0.02696045539683665,
            "start_logit": 0.6689817309379578,
            "end_logit": 5.407075881958008
        },
        {
            "text": "pre-auricular arteriovenous fistula",
            "probability": 0.02048525654272011,
            "start_logit": 0.3943159878253937,
            "end_logit": 5.407075881958008
        },
        {
            "text": "a high-flow scalp arteriovenous fistula",
            "probability": 0.0186727255370612,
            "start_logit": 1.872618556022644,
            "end_logit": 3.8361318111419678
        },
        {
            "text": "high-flow",
            "probability": 0.010574949541853637,
            "start_logit": 3.3172028064727783,
            "end_logit": 1.8229715824127197
        },
        {
            "text": "fistula",
            "probability": 0.010184651512709303,
            "start_logit": -0.30450761318206787,
            "end_logit": 5.407075881958008
        },
        {
            "text": "temporal pre-auricular arteriovenous fistula",
            "probability": 0.0036559760587892617,
            "start_logit": -1.3290263414382935,
            "end_logit": 5.407075881958008
        },
        {
            "text": "high-flow scalp arteriovenous fistula with a feeder vessel from the distal superficial temporal artery",
            "probability": 0.0035672167371161986,
            "start_logit": 3.3172028064727783,
            "end_logit": 0.7362692952156067
        },
        {
            "text": "uncommon cause of tinnitus",
            "probability": 0.00333311559124292,
            "start_logit": 1.8712562322616577,
            "end_logit": 2.114337682723999
        },
        {
            "text": "a high-flow",
            "probability": 0.002494039544571608,
            "start_logit": 1.872618556022644,
            "end_logit": 1.8229715824127197
        },
        {
            "text": "an uncommon cause of tinnitus",
            "probability": 0.0012985994117323725,
            "start_logit": 0.9286350607872009,
            "end_logit": 2.114337682723999
        },
        {
            "text": "scalp arteriovenous fistula",
            "probability": 0.0009989201794236595,
            "start_logit": -1.055525779724121,
            "end_logit": 3.8361318111419678
        },
        {
            "text": "uncommon",
            "probability": 0.0009214609602649751,
            "start_logit": 1.8712562322616577,
            "end_logit": 0.8286353349685669
        },
        {
            "text": "a high-flow scalp arteriovenous fistula with a feeder vessel from the distal superficial temporal artery",
            "probability": 0.0008413070503281115,
            "start_logit": 1.872618556022644,
            "end_logit": 0.7362692952156067
        },
        {
            "text": "Cirsoid aneurysms of the facial region",
            "probability": 0.0007728352284002259,
            "start_logit": -0.17386488616466522,
            "end_logit": 2.697861909866333
        },
        {
            "text": "uncommon cause",
            "probability": 0.0005214126702522562,
            "start_logit": 1.8712562322616577,
            "end_logit": 0.2592167258262634
        },
        {
            "text": "high-flow scalp arteriovenous",
            "probability": 0.0004685754236762924,
            "start_logit": 3.3172028064727783,
            "end_logit": -1.293574571609497
        }
    ],
    "5e2b07537d50947c2f000001_005": [
        {
            "text": "rare arteriovenous malformations",
            "probability": 0.4390168491527554,
            "start_logit": 6.223038196563721,
            "end_logit": 5.998290538787842
        },
        {
            "text": "arteriovenous malformations",
            "probability": 0.18705366075346647,
            "start_logit": 5.369895935058594,
            "end_logit": 5.998290538787842
        },
        {
            "text": "rare arteriovenous malformations of the scalp, which are usually of congenital etiology",
            "probability": 0.12375524438187069,
            "start_logit": 6.223038196563721,
            "end_logit": 4.732058525085449
        },
        {
            "text": "rare",
            "probability": 0.0597504018107566,
            "start_logit": 6.223038196563721,
            "end_logit": 4.0039286613464355
        },
        {
            "text": "arteriovenous malformations of the scalp, which are usually of congenital etiology",
            "probability": 0.05272889080166979,
            "start_logit": 5.369895935058594,
            "end_logit": 4.732058525085449
        },
        {
            "text": "rare arteriovenous malformations of the scalp",
            "probability": 0.04113793450183345,
            "start_logit": 6.223038196563721,
            "end_logit": 3.630683422088623
        },
        {
            "text": "rare arteriovenous malformations of the scalp, which are usually of congenital",
            "probability": 0.022095393527883225,
            "start_logit": 6.223038196563721,
            "end_logit": 3.009121894836426
        },
        {
            "text": "arteriovenous malformations of the scalp",
            "probability": 0.0175278039083343,
            "start_logit": 5.369895935058594,
            "end_logit": 3.630683422088623
        },
        {
            "text": "congenital etiology",
            "probability": 0.01667152865417832,
            "start_logit": 4.218434810638428,
            "end_logit": 4.732058525085449
        },
        {
            "text": "arteriovenous malformations of the scalp, which are usually of congenital",
            "probability": 0.009414272488983508,
            "start_logit": 5.369895935058594,
            "end_logit": 3.009121894836426
        },
        {
            "text": "usually of congenital etiology",
            "probability": 0.008729316384323895,
            "start_logit": 3.5714194774627686,
            "end_logit": 4.732058525085449
        },
        {
            "text": "are rare arteriovenous malformations",
            "probability": 0.0038285675355986194,
            "start_logit": 1.4809911251068115,
            "end_logit": 5.998290538787842
        },
        {
            "text": "Cirsoid aneurysms are rare arteriovenous malformations",
            "probability": 0.0037710043307275375,
            "start_logit": 1.4658417701721191,
            "end_logit": 5.998290538787842
        },
        {
            "text": "rare arteriovenous malformations of the scalp,",
            "probability": 0.0034590295218194767,
            "start_logit": 6.223038196563721,
            "end_logit": 1.154740810394287
        },
        {
            "text": "congenital",
            "probability": 0.0029765525345236544,
            "start_logit": 4.218434810638428,
            "end_logit": 3.009121894836426
        },
        {
            "text": "malformations",
            "probability": 0.0018114281082509374,
            "start_logit": 0.7326159477233887,
            "end_logit": 5.998290538787842
        },
        {
            "text": "rare arteriovenous",
            "probability": 0.0016382967919693389,
            "start_logit": 6.223038196563721,
            "end_logit": 0.4074099063873291
        },
        {
            "text": "usually of congenital",
            "probability": 0.0015585414719547067,
            "start_logit": 3.5714194774627686,
            "end_logit": 3.009121894836426
        },
        {
            "text": "arteriovenous malformations of the scalp,",
            "probability": 0.0014738025111321283,
            "start_logit": 5.369895935058594,
            "end_logit": 1.154740810394287
        },
        {
            "text": "of congenital etiology",
            "probability": 0.0014044219080690877,
            "start_logit": 1.7443581819534302,
            "end_logit": 4.732058525085449
        },
        {
            "text": "",
            "probability": 0.00019705891989893725,
            "start_logit": 2.150209426879883,
            "end_logit": 2.3623290061950684
        }
    ],
    "5e2b07537d50947c2f000001_006": [
        {
            "text": "arteriovenous fistulas",
            "probability": 0.9063768594991066,
            "start_logit": 6.432332992553711,
            "end_logit": 7.3763909339904785
        },
        {
            "text": "(arteriovenous fistulas",
            "probability": 0.02876372793555438,
            "start_logit": 2.9819929599761963,
            "end_logit": 7.3763909339904785
        },
        {
            "text": "arteriovenous fistulas) of the scalp are rare lesions",
            "probability": 0.020882816094602165,
            "start_logit": 6.432332992553711,
            "end_logit": 3.6058623790740967
        },
        {
            "text": "arteriovenous fistulas)",
            "probability": 0.015373724327533526,
            "start_logit": 6.432332992553711,
            "end_logit": 3.299595594406128
        },
        {
            "text": "arteriovenous fistulas) of the scalp are rare",
            "probability": 0.01294110416674769,
            "start_logit": 6.432332992553711,
            "end_logit": 3.1273443698883057
        },
        {
            "text": "rare lesions",
            "probability": 0.0043417354413225456,
            "start_logit": 4.861680507659912,
            "end_logit": 3.6058623790740967
        },
        {
            "text": "Cirsoid aneurysms (arteriovenous fistulas",
            "probability": 0.0038862140360511003,
            "start_logit": 0.980313241481781,
            "end_logit": 7.3763909339904785
        },
        {
            "text": "rare",
            "probability": 0.0026905782417505756,
            "start_logit": 4.861680507659912,
            "end_logit": 3.1273443698883057
        },
        {
            "text": "fistulas",
            "probability": 0.0007528530988908492,
            "start_logit": -0.6610073447227478,
            "end_logit": 7.3763909339904785
        },
        {
            "text": "(arteriovenous fistulas) of the scalp are rare lesions",
            "probability": 0.0006627129039959179,
            "start_logit": 2.9819929599761963,
            "end_logit": 3.6058623790740967
        },
        {
            "text": "arteriovenous fistulas) of the scalp are rare lesions. They are infrequently encountered in neurosurgical practice",
            "probability": 0.0005189952334750424,
            "start_logit": 6.432332992553711,
            "end_logit": -0.0889248251914978
        },
        {
            "text": "arteriovenous fistulas) of the scalp",
            "probability": 0.0005052401187005389,
            "start_logit": 6.432332992553711,
            "end_logit": -0.11578572541475296
        },
        {
            "text": "(arteriovenous fistulas)",
            "probability": 0.00048788273804537034,
            "start_logit": 2.9819929599761963,
            "end_logit": 3.299595594406128
        },
        {
            "text": "arteriovenous fistulas) of the scalp are rare lesions.",
            "probability": 0.0004822348611276666,
            "start_logit": 6.432332992553711,
            "end_logit": -0.16238826513290405
        },
        {
            "text": "(arteriovenous fistulas) of the scalp are rare",
            "probability": 0.00041068391755247216,
            "start_logit": 2.9819929599761963,
            "end_logit": 3.1273443698883057
        },
        {
            "text": "rare lesions. They are infrequently encountered in neurosurgical practice. These lesions are difficult to manage",
            "probability": 0.00024479240954896123,
            "start_logit": 4.861680507659912,
            "end_logit": 0.7302435040473938
        },
        {
            "text": "fistulas)",
            "probability": 0.00022372961037661317,
            "start_logit": -1.8744392395019531,
            "end_logit": 7.3763909339904785
        },
        {
            "text": "arteriovenous fistula",
            "probability": 0.0001688025196434328,
            "start_logit": 6.432332992553711,
            "end_logit": -1.212090015411377
        },
        {
            "text": "rare lesions. They are infrequently encountered in neurosurgical practice",
            "probability": 0.00010790402926732226,
            "start_logit": 4.861680507659912,
            "end_logit": -0.0889248251914978
        },
        {
            "text": "rare lesions.",
            "probability": 0.00010026119935713264,
            "start_logit": 4.861680507659912,
            "end_logit": -0.16238826513290405
        },
        {
            "text": "",
            "probability": 7.714761735014455e-05,
            "start_logit": 2.0612568855285645,
            "end_logit": 2.3759772777557373
        }
    ],
    "5c74285c7c78d694710000a3_001": [
        {
            "text": "cytoplasm",
            "probability": 0.7170805769886999,
            "start_logit": 7.4000163078308105,
            "end_logit": 7.719725131988525
        },
        {
            "text": "the cytoplasm",
            "probability": 0.24985214181228507,
            "start_logit": 6.345697402954102,
            "end_logit": 7.719725131988525
        },
        {
            "text": "in the cytoplasm",
            "probability": 0.021444743821582787,
            "start_logit": 3.890307664871216,
            "end_logit": 7.719725131988525
        },
        {
            "text": "non-membranous structures that transiently form in the cytoplasm",
            "probability": 0.005825666227289106,
            "start_logit": 2.587101459503174,
            "end_logit": 7.719725131988525
        },
        {
            "text": "c",
            "probability": 0.0018234848599973249,
            "start_logit": 7.4000163078308105,
            "end_logit": 1.7452863454818726
        },
        {
            "text": "cytoplas",
            "probability": 0.000861941719438767,
            "start_logit": 7.4000163078308105,
            "end_logit": 0.995969295501709
        },
        {
            "text": "the c",
            "probability": 0.000635356210240493,
            "start_logit": 6.345697402954102,
            "end_logit": 1.7452863454818726
        },
        {
            "text": "membranous structures that transiently form in the cytoplasm",
            "probability": 0.00045409535573103735,
            "start_logit": 0.03538002446293831,
            "end_logit": 7.719725131988525
        },
        {
            "text": "cytoplasm during cellular stress,",
            "probability": 0.00035527282691178856,
            "start_logit": 7.4000163078308105,
            "end_logit": 0.10966765880584717
        },
        {
            "text": "the cytoplas",
            "probability": 0.000300326060459637,
            "start_logit": 6.345697402954102,
            "end_logit": 0.995969295501709
        },
        {
            "text": "cytoplasm during cellular stress",
            "probability": 0.000289095066332902,
            "start_logit": 7.4000163078308105,
            "end_logit": -0.09646277874708176
        },
        {
            "text": "the",
            "probability": 0.0002024374284552676,
            "start_logit": 6.345697402954102,
            "end_logit": 0.6015313863754272
        },
        {
            "text": "",
            "probability": 0.00019162719162666128,
            "start_logit": 3.3429009914398193,
            "end_logit": 3.5494487285614014
        },
        {
            "text": "cytop",
            "probability": 0.0001654449751297131,
            "start_logit": 7.4000163078308105,
            "end_logit": -0.6545796990394592
        },
        {
            "text": "transiently form in the cytoplasm",
            "probability": 0.00012955332177847902,
            "start_logit": -1.218834638595581,
            "end_logit": 7.719725131988525
        },
        {
            "text": "the cytoplasm during cellular stress,",
            "probability": 0.00012378759037704967,
            "start_logit": 6.345697402954102,
            "end_logit": 0.10966765880584717
        },
        {
            "text": "the cytoplasm during cellular stress",
            "probability": 0.00010072929574242038,
            "start_logit": 6.345697402954102,
            "end_logit": -0.09646277874708176
        },
        {
            "text": "the cytop",
            "probability": 5.7645936474570654e-05,
            "start_logit": 6.345697402954102,
            "end_logit": -0.6545796990394592
        },
        {
            "text": "in the c",
            "probability": 5.453245693725381e-05,
            "start_logit": 3.890307664871216,
            "end_logit": 1.7452863454818726
        },
        {
            "text": "cyt",
            "probability": 5.1540854509730706e-05,
            "start_logit": 7.4000163078308105,
            "end_logit": -1.8208435773849487
        }
    ],
    "5c74285c7c78d694710000a3_002": [
        {
            "text": "cytoplasmic",
            "probability": 0.9389467598583034,
            "start_logit": 8.259337425231934,
            "end_logit": 7.893230438232422
        },
        {
            "text": "cytoplasmic stress granules",
            "probability": 0.05545632113596569,
            "start_logit": 8.259337425231934,
            "end_logit": 5.064067363739014
        },
        {
            "text": "c",
            "probability": 0.0018663597022114855,
            "start_logit": 8.259337425231934,
            "end_logit": 1.6724615097045898
        },
        {
            "text": "cytoplasmic stress granules, the translational silencing machinery assembled in response to cellular stress",
            "probability": 0.0011256058776400665,
            "start_logit": 8.259337425231934,
            "end_logit": 1.1667931079864502
        },
        {
            "text": "cytoplasmic stress",
            "probability": 0.0007009987769559205,
            "start_logit": 8.259337425231934,
            "end_logit": 0.6932225227355957
        },
        {
            "text": "cytoplasmic stress granules,",
            "probability": 0.0005024610470206963,
            "start_logit": 3.555504560470581,
            "end_logit": 5.064067363739014
        },
        {
            "text": "cytoplasmic stress granules, the translational silencing machinery",
            "probability": 0.0004270422697818368,
            "start_logit": 8.259337425231934,
            "end_logit": 0.1975993812084198
        },
        {
            "text": "cytoplas",
            "probability": 0.0003053087313408384,
            "start_logit": 8.259337425231934,
            "end_logit": -0.13796012103557587
        },
        {
            "text": "cytoplasmic stress granules, the translational silencing",
            "probability": 0.00015872360480146452,
            "start_logit": 8.259337425231934,
            "end_logit": -0.7921192646026611
        },
        {
            "text": "cytop",
            "probability": 0.00015714818593553278,
            "start_logit": 8.259337425231934,
            "end_logit": -0.8020943999290466
        },
        {
            "text": "cyt",
            "probability": 0.00013954615881361373,
            "start_logit": 8.259337425231934,
            "end_logit": -0.9208881855010986
        },
        {
            "text": "Rbfox2 is a novel constituent of cytoplasmic",
            "probability": 8.785541435106478e-05,
            "start_logit": -1.017484188079834,
            "end_logit": 7.893230438232422
        },
        {
            "text": "",
            "probability": 8.406301104642592e-05,
            "start_logit": 3.4168851375579834,
            "end_logit": 3.4147353172302246
        },
        {
            "text": "we show that Rbfox2 is a novel constituent of cytoplasmic",
            "probability": 1.4481800784768903e-05,
            "start_logit": -2.820283889770508,
            "end_logit": 7.893230438232422
        },
        {
            "text": "cytoplasmic stress granules, the translational silencing machinery assembled in response to cellular stress.",
            "probability": 1.019853275923275e-05,
            "start_logit": 3.555504560470581,
            "end_logit": 1.1667931079864502
        },
        {
            "text": "cytoplasmic stress granules.",
            "probability": 5.321926788223794e-06,
            "start_logit": 4.323117256164551,
            "end_logit": -0.2512280344963074
        },
        {
            "text": "Rbfox2 is a novel constituent of cytoplasmic stress granules",
            "probability": 5.188939650338888e-06,
            "start_logit": -1.017484188079834,
            "end_logit": 5.064067363739014
        },
        {
            "text": "stress granules",
            "probability": 5.134181623843532e-06,
            "start_logit": -1.0280930995941162,
            "end_logit": 5.064067363739014
        },
        {
            "text": "we show that Rbfox2 is a novel constituent of cytoplasmic stress granules",
            "probability": 8.553279368772955e-07,
            "start_logit": -2.820283889770508,
            "end_logit": 5.064067363739014
        },
        {
            "text": "translational silencing machinery assembled in response to cellular stress",
            "probability": 6.255162887542915e-07,
            "start_logit": 0.7640827894210815,
            "end_logit": 1.1667931079864502
        }
    ],
    "5c74285c7c78d694710000a3_003": [
        {
            "text": "",
            "probability": 0.6485124487901405,
            "start_logit": 5.953800678253174,
            "end_logit": 6.368011951446533
        },
        {
            "text": "cytoplasm",
            "probability": 0.11369813901708395,
            "start_logit": 4.9365997314453125,
            "end_logit": 5.644078731536865
        },
        {
            "text": "the cytoplasm",
            "probability": 0.04297613551397582,
            "start_logit": 3.963697671890259,
            "end_logit": 5.644078731536865
        },
        {
            "text": "nucleus and cytoplasm, or exclusively in the cytoplasm",
            "probability": 0.036896666844765884,
            "start_logit": 3.811173915863037,
            "end_logit": 5.644078731536865
        },
        {
            "text": "cytoplasm. Stress prompted the formation of cytoplasmic",
            "probability": 0.03410596083367462,
            "start_logit": 4.9365997314453125,
            "end_logit": 4.440003871917725
        },
        {
            "text": "both nucleus and cytoplasm, or exclusively in the cytoplasm",
            "probability": 0.021173252856346813,
            "start_logit": 3.255791425704956,
            "end_logit": 5.644078731536865
        },
        {
            "text": "nucleus and cytoplasm",
            "probability": 0.0163492048313108,
            "start_logit": 3.811173915863037,
            "end_logit": 4.830136775970459
        },
        {
            "text": "the cytoplasm. Stress prompted the formation of cytoplasmic",
            "probability": 0.01289152493869855,
            "start_logit": 3.963697671890259,
            "end_logit": 4.440003871917725
        },
        {
            "text": "cytoplasmic",
            "probability": 0.011844931411965728,
            "start_logit": 3.8790276050567627,
            "end_logit": 4.440003871917725
        },
        {
            "text": "nucleus and cytoplasm, or exclusively in the cytoplasm. Stress prompted the formation of cytoplasmic",
            "probability": 0.011067870461025253,
            "start_logit": 3.811173915863037,
            "end_logit": 4.440003871917725
        },
        {
            "text": "both nucleus and cytoplasm",
            "probability": 0.009382035763554541,
            "start_logit": 3.255791425704956,
            "end_logit": 4.830136775970459
        },
        {
            "text": "cytoplasm, or exclusively in the cytoplasm",
            "probability": 0.009067323853181875,
            "start_logit": 2.4077298641204834,
            "end_logit": 5.644078731536865
        },
        {
            "text": "both nucleus and cytoplasm, or exclusively in the cytoplasm. Stress prompted the formation of cytoplasmic",
            "probability": 0.006351327637223226,
            "start_logit": 3.255791425704956,
            "end_logit": 4.440003871917725
        },
        {
            "text": "in the cytoplasm",
            "probability": 0.006021032891812456,
            "start_logit": 1.9983115196228027,
            "end_logit": 5.644078731536865
        },
        {
            "text": "in both nucleus and cytoplasm, or exclusively in the cytoplasm",
            "probability": 0.005412346519355702,
            "start_logit": 1.8917354345321655,
            "end_logit": 5.644078731536865
        },
        {
            "text": "exclusively in the cytoplasm",
            "probability": 0.004221701721249732,
            "start_logit": 1.6432909965515137,
            "end_logit": 5.644078731536865
        },
        {
            "text": "nucleus",
            "probability": 0.003103797481882573,
            "start_logit": 3.811173915863037,
            "end_logit": 3.168583869934082
        },
        {
            "text": "cytoplasm, or exclusively in the cytoplasm. Stress prompted the formation of cytoplasmic",
            "probability": 0.0027199195596015664,
            "start_logit": 2.4077298641204834,
            "end_logit": 4.440003871917725
        },
        {
            "text": "in both nucleus and cytoplasm",
            "probability": 0.0023982535396833873,
            "start_logit": 1.8917354345321655,
            "end_logit": 4.830136775970459
        },
        {
            "text": "in the cytoplasm. Stress prompted the formation of cytoplasmic",
            "probability": 0.0018061255334668805,
            "start_logit": 1.9983115196228027,
            "end_logit": 4.440003871917725
        }
    ],
    "5c74285c7c78d694710000a3_004": [
        {
            "text": "cytoplasm",
            "probability": 0.7929812020794578,
            "start_logit": 6.941737174987793,
            "end_logit": 7.231184959411621
        },
        {
            "text": "the cytoplasm",
            "probability": 0.17219596332893386,
            "start_logit": 5.475682735443115,
            "end_logit": 7.17007303237915
        },
        {
            "text": "c",
            "probability": 0.007460694226833522,
            "start_logit": 6.937683582305908,
            "end_logit": 2.569087505340576
        },
        {
            "text": "throughout the cytoplasm",
            "probability": 0.006442716276894542,
            "start_logit": 2.18999981880188,
            "end_logit": 7.17007303237915
        },
        {
            "text": "in cytoplasm",
            "probability": 0.005947633821322797,
            "start_logit": 2.048931121826172,
            "end_logit": 7.231184959411621
        },
        {
            "text": "cytoplasm,",
            "probability": 0.0032167168078564776,
            "start_logit": 1.6746925115585327,
            "end_logit": 6.990791320800781
        },
        {
            "text": "in the cytoplasm",
            "probability": 0.0024181739274803057,
            "start_logit": 1.3893439769744873,
            "end_logit": 6.990791320800781
        },
        {
            "text": "cytoplas",
            "probability": 0.0018446029750240627,
            "start_logit": 6.937683582305908,
            "end_logit": 1.1717031002044678
        },
        {
            "text": "the c",
            "probability": 0.001729180545068705,
            "start_logit": 5.475682735443115,
            "end_logit": 2.569087505340576
        },
        {
            "text": "",
            "probability": 0.0015753901685982273,
            "start_logit": 3.8813555240631104,
            "end_logit": 4.07027006149292
        },
        {
            "text": "cytop",
            "probability": 0.0009671129111719389,
            "start_logit": 6.937683582305908,
            "end_logit": 0.5259990096092224
        },
        {
            "text": "cytoplasm during EV71 infection",
            "probability": 0.0009076592738377907,
            "start_logit": 6.941737174987793,
            "end_logit": 0.4584992229938507
        },
        {
            "text": "the cytoplas",
            "probability": 0.00042752744996777867,
            "start_logit": 5.475682735443115,
            "end_logit": 1.1717031002044678
        },
        {
            "text": "cytoplasm in a microtubule-dependent manner",
            "probability": 0.00041889841039862883,
            "start_logit": 6.937683582305908,
            "end_logit": -0.3106878101825714
        },
        {
            "text": "punctate pattern in cytoplasm",
            "probability": 0.0004033589657318511,
            "start_logit": -0.6419907212257385,
            "end_logit": 7.231184959411621
        },
        {
            "text": "move throughout the cytoplasm",
            "probability": 0.0002846704147370312,
            "start_logit": -0.9293736219406128,
            "end_logit": 7.17007303237915
        },
        {
            "text": "the cytop",
            "probability": 0.00022414976140806684,
            "start_logit": 5.475682735443115,
            "end_logit": 0.5259990096092224
        },
        {
            "text": "punctate pattern of Sam68 re-localization in the cytoplasm",
            "probability": 0.00021086950735914854,
            "start_logit": -1.0501844882965088,
            "end_logit": 6.990791320800781
        },
        {
            "text": "cytoplasm during EV71",
            "probability": 0.0001836174351142596,
            "start_logit": 6.941737174987793,
            "end_logit": -1.1395153999328613
        },
        {
            "text": "the",
            "probability": 0.00015986171280359595,
            "start_logit": 5.475682735443115,
            "end_logit": 0.18799374997615814
        }
    ],
    "5c74285c7c78d694710000a3_005": [
        {
            "text": "cytoplasmic",
            "probability": 0.9698448027142652,
            "start_logit": 8.0012788772583,
            "end_logit": 7.948686599731445
        },
        {
            "text": "cytoplasmic granules",
            "probability": 0.01969291197300474,
            "start_logit": 8.0012788772583,
            "end_logit": 4.051809310913086
        },
        {
            "text": "c",
            "probability": 0.003978925444073814,
            "start_logit": 8.0012788772583,
            "end_logit": 2.4525623321533203
        },
        {
            "text": "cytoplasmic granules that are formed in cells",
            "probability": 0.0029028927882830255,
            "start_logit": 8.0012788772583,
            "end_logit": 2.137258291244507
        },
        {
            "text": "cytoplas",
            "probability": 0.0019508913934887023,
            "start_logit": 8.0012788772583,
            "end_logit": 1.7398369312286377
        },
        {
            "text": "cytoplasmic granules that are formed in cells when stress occurs",
            "probability": 0.00040777843751756935,
            "start_logit": 8.0012788772583,
            "end_logit": 0.17451924085617065
        },
        {
            "text": "cytop",
            "probability": 0.00027181481437475995,
            "start_logit": 8.0012788772583,
            "end_logit": -0.2310837358236313
        },
        {
            "text": "Stress granules (SGs) are cytoplasmic",
            "probability": 0.00022835230633927312,
            "start_logit": -0.35272282361984253,
            "end_logit": 7.948686599731445
        },
        {
            "text": "cytoplasmic granules that are formed in cells when stress occurs.",
            "probability": 0.00017339617478366953,
            "start_logit": 8.0012788772583,
            "end_logit": -0.6806257367134094
        },
        {
            "text": "cyt",
            "probability": 0.00011982166552957419,
            "start_logit": 8.0012788772583,
            "end_logit": -1.0502002239227295
        },
        {
            "text": "cytoplasmic granules that are formed",
            "probability": 9.021085773676575e-05,
            "start_logit": 8.0012788772583,
            "end_logit": -1.334054946899414
        },
        {
            "text": "cytoplasmic granules that are formed in cells when stress",
            "probability": 7.863305839376192e-05,
            "start_logit": 8.0012788772583,
            "end_logit": -1.4714125394821167
        },
        {
            "text": "SGs) are cytoplasmic",
            "probability": 7.602062707368766e-05,
            "start_logit": -1.4526077508926392,
            "end_logit": 7.948686599731445
        },
        {
            "text": "cytoplasmic gran",
            "probability": 7.475966166105496e-05,
            "start_logit": 8.0012788772583,
            "end_logit": -1.5219262838363647
        },
        {
            "text": "cytoplasmic g",
            "probability": 6.621784468657219e-05,
            "start_logit": 8.0012788772583,
            "end_logit": -1.6432547569274902
        },
        {
            "text": "granules",
            "probability": 1.483975909294759e-05,
            "start_logit": 0.8105748295783997,
            "end_logit": 4.051809310913086
        },
        {
            "text": "",
            "probability": 1.471730401064722e-05,
            "start_logit": 2.258415937423706,
            "end_logit": 2.595682144165039
        },
        {
            "text": "cells",
            "probability": 6.08832337079151e-06,
            "start_logit": 1.8341885805130005,
            "end_logit": 2.137258291244507
        },
        {
            "text": "Stress granules (SGs) are cytoplasmic granules",
            "probability": 4.636743791363902e-06,
            "start_logit": -0.35272282361984253,
            "end_logit": 4.051809310913086
        },
        {
            "text": "in the viral infection-induced granules",
            "probability": 2.288108521661728e-06,
            "start_logit": -0.2535001039505005,
            "end_logit": 3.2462997436523438
        }
    ],
    "5c74285c7c78d694710000a3_007": [
        {
            "text": "cytoplasmic",
            "probability": 0.8604040696464851,
            "start_logit": 8.212959289550781,
            "end_logit": 7.8355183601379395
        },
        {
            "text": "cytoplasmic stress granules",
            "probability": 0.09984231615980374,
            "start_logit": 8.212959289550781,
            "end_logit": 5.681708335876465
        },
        {
            "text": "cytoplasmic stress granules in HeLa cells",
            "probability": 0.01701820300201545,
            "start_logit": 8.212959289550781,
            "end_logit": 3.9123997688293457
        },
        {
            "text": "c",
            "probability": 0.0109002194685525,
            "start_logit": 8.212959289550781,
            "end_logit": 3.4668991565704346
        },
        {
            "text": "cytoplasmic stress",
            "probability": 0.0049110339120866,
            "start_logit": 8.212959289550781,
            "end_logit": 2.66960072517395
        },
        {
            "text": "cytoplas",
            "probability": 0.00415147431880382,
            "start_logit": 8.212959289550781,
            "end_logit": 2.501579761505127
        },
        {
            "text": "cytop",
            "probability": 0.0007904962995107561,
            "start_logit": 8.212959289550781,
            "end_logit": 0.8430219292640686
        },
        {
            "text": "stress granules",
            "probability": 0.0005214928673433328,
            "start_logit": 2.9583075046539307,
            "end_logit": 5.681708335876465
        },
        {
            "text": "cytoplasmic stress g",
            "probability": 0.00024502271929537593,
            "start_logit": 8.212959289550781,
            "end_logit": -0.32828810811042786
        },
        {
            "text": "cytoplasmic stress gran",
            "probability": 0.00022847852644082927,
            "start_logit": 8.212959289550781,
            "end_logit": -0.398196816444397
        },
        {
            "text": "",
            "probability": 0.00022293403866523057,
            "start_logit": 3.8720057010650635,
            "end_logit": 3.9181904792785645
        },
        {
            "text": "cyt",
            "probability": 0.0001894095144403766,
            "start_logit": 8.212959289550781,
            "end_logit": -0.5857276320457458
        },
        {
            "text": "cytoplasmic stress granules in HeLa",
            "probability": 0.0001582262305573157,
            "start_logit": 8.212959289550781,
            "end_logit": -0.7656131982803345
        },
        {
            "text": "cytoplasmic stress granules in HeLa cells following either oxidative or interferon-induced stress",
            "probability": 0.00012407965944499454,
            "start_logit": 8.212959289550781,
            "end_logit": -1.008715271949768
        },
        {
            "text": "stress granules in HeLa cells",
            "probability": 8.88888782021761e-05,
            "start_logit": 2.9583075046539307,
            "end_logit": 3.9123997688293457
        },
        {
            "text": "cytoplasmic stress granules in HeLa cells following either oxidative or interferon-induced stress.",
            "probability": 6.701721101098192e-05,
            "start_logit": 8.212959289550781,
            "end_logit": -1.6246895790100098
        },
        {
            "text": "ADAR1(p150) localized to cytoplasmic",
            "probability": 6.444349916184351e-05,
            "start_logit": -1.2864092588424683,
            "end_logit": 7.8355183601379395
        },
        {
            "text": "to cytoplasmic",
            "probability": 3.9064808281086157e-05,
            "start_logit": -1.7869760990142822,
            "end_logit": 7.8355183601379395
        },
        {
            "text": "stress",
            "probability": 2.5651139265792263e-05,
            "start_logit": 2.9583075046539307,
            "end_logit": 2.66960072517395
        },
        {
            "text": "ADAR1(p150) localized to cytoplasmic stress granules",
            "probability": 7.478100632885718e-06,
            "start_logit": -1.2864092588424683,
            "end_logit": 5.681708335876465
        }
    ],
    "5c74285c7c78d694710000a3_008": [
        {
            "text": "",
            "probability": 0.6675414320005632,
            "start_logit": 6.25325870513916,
            "end_logit": 6.769362449645996
        },
        {
            "text": "cytoplasmic",
            "probability": 0.3204577693555882,
            "start_logit": 5.840809345245361,
            "end_logit": 6.44796085357666
        },
        {
            "text": "cytoplasmic stress granules",
            "probability": 0.009801161411082704,
            "start_logit": 5.840809345245361,
            "end_logit": 2.9607112407684326
        },
        {
            "text": "cytoplasmic stress",
            "probability": 0.0006591971773308907,
            "start_logit": 5.840809345245361,
            "end_logit": 0.2614777684211731
        },
        {
            "text": "cytoplas",
            "probability": 0.0006000275122204274,
            "start_logit": 5.840809345245361,
            "end_logit": 0.167430579662323
        },
        {
            "text": "c",
            "probability": 0.0003038412614903112,
            "start_logit": 5.840809345245361,
            "end_logit": -0.5130395293235779
        },
        {
            "text": "oxidative stress recruits mutant FUS to cytoplasmic",
            "probability": 0.0002811916840484485,
            "start_logit": -1.1976598501205444,
            "end_logit": 6.44796085357666
        },
        {
            "text": "cytop",
            "probability": 9.865554531842287e-05,
            "start_logit": 5.840809345245361,
            "end_logit": -1.6379104852676392
        },
        {
            "text": "cyt",
            "probability": 8.721492675159193e-05,
            "start_logit": 5.840809345245361,
            "end_logit": -1.76116943359375
        },
        {
            "text": "cytoplasmic accumulation",
            "probability": 5.7298578704505824e-05,
            "start_logit": 3.7975656986236572,
            "end_logit": -0.1380254626274109
        },
        {
            "text": "stress granules",
            "probability": 4.089327499523406e-05,
            "start_logit": 0.3615188002586365,
            "end_logit": 2.9607112407684326
        },
        {
            "text": "nuclear localizing signal (NLS) of FUS resulting in cytoplasmic",
            "probability": 2.736108581371658e-05,
            "start_logit": -1.1456629037857056,
            "end_logit": 4.066049098968506
        },
        {
            "text": "cytoplasmic accumulation in transfected cells and patient fibroblasts",
            "probability": 2.4350989008574424e-05,
            "start_logit": 3.7975656986236572,
            "end_logit": -0.9937288165092468
        },
        {
            "text": "oxidative stress recruits mutant FUS to cytoplasmic stress granules",
            "probability": 8.600213027616998e-06,
            "start_logit": -1.1976598501205444,
            "end_logit": 2.9607112407684326
        },
        {
            "text": "cytoplasmic accumulation in transfected cells and patient fibroblasts.",
            "probability": 6.371452294008735e-06,
            "start_logit": 3.7975656986236572,
            "end_logit": -2.3344738483428955
        },
        {
            "text": "stress",
            "probability": 2.750360933571888e-06,
            "start_logit": 0.3615188002586365,
            "end_logit": 0.2614777684211731
        },
        {
            "text": "oxidative stress recruits mutant FUS to cytoplasmic stress",
            "probability": 5.784249350121881e-07,
            "start_logit": -1.1976598501205444,
            "end_logit": 0.2614777684211731
        },
        {
            "text": "oxidative stress recruits mutant FUS to cytoplas",
            "probability": 5.265054018691738e-07,
            "start_logit": -1.1976598501205444,
            "end_logit": 0.167430579662323
        },
        {
            "text": "nuclear localizing signal (NLS) of FUS resulting in cytoplasmic accumulation",
            "probability": 4.086268921353216e-07,
            "start_logit": -1.1456629037857056,
            "end_logit": -0.1380254626274109
        },
        {
            "text": "cytoplasmic aggregates",
            "probability": 3.6961360000919276e-07,
            "start_logit": 0.6968052387237549,
            "end_logit": -2.0808379650115967
        }
    ],
    "5e2e136bfbd6abf43b000023_002": [
        {
            "text": "OncoPPi Portal",
            "probability": 0.6553503700687598,
            "start_logit": 5.556613445281982,
            "end_logit": 5.928996562957764
        },
        {
            "text": "OncoPPi",
            "probability": 0.169787691886438,
            "start_logit": 5.556613445281982,
            "end_logit": 4.578375339508057
        },
        {
            "text": "the OncoPPi Portal",
            "probability": 0.13050004038217936,
            "start_logit": 3.942816972732544,
            "end_logit": 5.928996562957764
        },
        {
            "text": "the OncoPPi",
            "probability": 0.033809854483262784,
            "start_logit": 3.942816972732544,
            "end_logit": 4.578375339508057
        },
        {
            "text": "OncoPPi Portal,",
            "probability": 0.00673290047186859,
            "start_logit": 5.556613445281982,
            "end_logit": 1.3508325815200806
        },
        {
            "text": "the OncoPPi Portal,",
            "probability": 0.0013407237160419356,
            "start_logit": 3.942816972732544,
            "end_logit": 1.3508325815200806
        },
        {
            "text": "OncoPPi Portal, an interactive web resource",
            "probability": 0.0005500823732562342,
            "start_logit": 5.556613445281982,
            "end_logit": -1.1538606882095337
        },
        {
            "text": "",
            "probability": 0.0003795815324712751,
            "start_logit": 1.9170714616775513,
            "end_logit": 2.114682674407959
        },
        {
            "text": "Portal",
            "probability": 0.00030255862293267037,
            "start_logit": -2.1240367889404297,
            "end_logit": 5.928996562957764
        },
        {
            "text": "Here, we present the OncoPPi Portal",
            "probability": 0.00024645273375725356,
            "start_logit": -2.329141616821289,
            "end_logit": 5.928996562957764
        },
        {
            "text": "OncoPPi Portal, an interactive web resource that allows investigators to access, manipulate and interpret a high-quality cancer-focused network of PPIs",
            "probability": 0.00021164819090319388,
            "start_logit": 5.556613445281982,
            "end_logit": -2.1090033054351807
        },
        {
            "text": "OncoPPi Portal is available at http://oncoppi",
            "probability": 0.0002070312501386305,
            "start_logit": 3.563192129135132,
            "end_logit": -0.137637659907341
        },
        {
            "text": "OncoPP",
            "probability": 0.00012570787928000847,
            "start_logit": 5.556613445281982,
            "end_logit": -2.6299679279327393
        },
        {
            "text": "the OncoPPi Portal, an interactive web resource",
            "probability": 0.0001095380047102618,
            "start_logit": 3.942816972732544,
            "end_logit": -1.1538606882095337
        },
        {
            "text": "On",
            "probability": 0.00010161263863922438,
            "start_logit": 5.556613445281982,
            "end_logit": -2.8427608013153076
        },
        {
            "text": "The OncoPPi Portal",
            "probability": 7.269432978971395e-05,
            "start_logit": -0.24510155618190765,
            "end_logit": 2.624049663543701
        },
        {
            "text": "Here, we present the OncoPPi",
            "probability": 6.385079300307184e-05,
            "start_logit": -2.329141616821289,
            "end_logit": 4.578375339508057
        },
        {
            "text": "The OncoPPi",
            "probability": 6.239426579755401e-05,
            "start_logit": 0.05500955879688263,
            "end_logit": 2.1711485385894775
        },
        {
            "text": "the OncoPP",
            "probability": 2.503223324750396e-05,
            "start_logit": 3.942816972732544,
            "end_logit": -2.6299679279327393
        },
        {
            "text": "the On",
            "probability": 2.023414352290254e-05,
            "start_logit": 3.942816972732544,
            "end_logit": -2.8427608013153076
        }
    ],
    "5e2a080caa19d7443100000a_001": [
        {
            "text": "AMPK/Sirt1 pathway",
            "probability": 0.350622193044889,
            "start_logit": 6.974071025848389,
            "end_logit": 6.828742027282715
        },
        {
            "text": "AMPK/Sirt1",
            "probability": 0.27494549134368196,
            "start_logit": 6.974071025848389,
            "end_logit": 6.585605621337891
        },
        {
            "text": "AMPK/Sirt1 signaling pathway",
            "probability": 0.11841407270240867,
            "start_logit": 6.9584431648254395,
            "end_logit": 5.758848190307617
        },
        {
            "text": "the AMPK/Sirt1 pathway",
            "probability": 0.08985292782006975,
            "start_logit": 5.6125359535217285,
            "end_logit": 6.828742027282715
        },
        {
            "text": "the AMPK/Sirt1",
            "probability": 0.07045947997078042,
            "start_logit": 5.6125359535217285,
            "end_logit": 6.585605621337891
        },
        {
            "text": "AMPK/Sirt1 signaling",
            "probability": 0.033900940353049094,
            "start_logit": 6.9584431648254395,
            "end_logit": 4.508103370666504
        },
        {
            "text": "AMPK",
            "probability": 0.026602314886287504,
            "start_logit": 6.9584431648254395,
            "end_logit": 4.265658855438232
        },
        {
            "text": "the AMPK/Sirt1 signaling pathway",
            "probability": 0.014504756517962082,
            "start_logit": 4.858732223510742,
            "end_logit": 5.758848190307617
        },
        {
            "text": "the AMPK",
            "probability": 0.005429558497394889,
            "start_logit": 5.6125359535217285,
            "end_logit": 4.022425651550293
        },
        {
            "text": "the AMPK/Sirt1 signaling",
            "probability": 0.004152588238280654,
            "start_logit": 4.858732223510742,
            "end_logit": 4.508103370666504
        },
        {
            "text": "via the AMPK/Sirt1 pathway",
            "probability": 0.002446828177993962,
            "start_logit": 2.0091543197631836,
            "end_logit": 6.828742027282715
        },
        {
            "text": "via the AMPK/Sirt1",
            "probability": 0.001918715896988262,
            "start_logit": 2.0091543197631836,
            "end_logit": 6.585605621337891
        },
        {
            "text": "AMPK/Sirt1 pathway.",
            "probability": 0.001612863256874711,
            "start_logit": 6.974071025848389,
            "end_logit": 1.447043776512146
        },
        {
            "text": "Sirt1 pathway",
            "probability": 0.001543958640381294,
            "start_logit": 1.5487114191055298,
            "end_logit": 6.828742027282715
        },
        {
            "text": "Sirt1",
            "probability": 0.0012196876683249799,
            "start_logit": 1.7546885013580322,
            "end_logit": 6.387010097503662
        },
        {
            "text": "Sirt1 signaling pathway",
            "probability": 0.0006507907670621847,
            "start_logit": 1.7546885013580322,
            "end_logit": 5.758848190307617
        },
        {
            "text": "through the AMPK/Sirt1",
            "probability": 0.0004605846067727989,
            "start_logit": 0.780834972858429,
            "end_logit": 6.387010097503662
        },
        {
            "text": "",
            "probability": 0.00045767369800104365,
            "start_logit": 3.7080159187316895,
            "end_logit": 3.453489065170288
        },
        {
            "text": "the AMPK/Sirt1 pathway.",
            "probability": 0.0004133237675147743,
            "start_logit": 5.6125359535217285,
            "end_logit": 1.447043776512146
        },
        {
            "text": "AMPK/Sirt",
            "probability": 0.0003912501452821128,
            "start_logit": 6.974071025848389,
            "end_logit": 0.030624590814113617
        }
    ],
    "5e482f08d14c9f295d00000d_001": [
        {
            "text": "chemical decomposition of the water molecule into free radicals",
            "probability": 0.49147903485661004,
            "start_logit": 6.660926342010498,
            "end_logit": 7.171084880828857
        },
        {
            "text": "chemical decomposition of the water molecule into free radicals after exposure to ionizing radiation",
            "probability": 0.298202876976937,
            "start_logit": 6.660926342010498,
            "end_logit": 6.6714396476745605
        },
        {
            "text": "involves chemical decomposition of the water molecule into free radicals",
            "probability": 0.0709254764360278,
            "start_logit": 4.725136756896973,
            "end_logit": 7.171084880828857
        },
        {
            "text": "involves chemical decomposition of the water molecule into free radicals after exposure to ionizing radiation",
            "probability": 0.04303374024968135,
            "start_logit": 4.725136756896973,
            "end_logit": 6.6714396476745605
        },
        {
            "text": "decomposition of the water molecule into free radicals",
            "probability": 0.037529720068663834,
            "start_logit": 4.088640213012695,
            "end_logit": 7.171084880828857
        },
        {
            "text": "decomposition of the water molecule into free radicals after exposure to ionizing radiation",
            "probability": 0.022771002836122555,
            "start_logit": 4.088640213012695,
            "end_logit": 6.6714396476745605
        },
        {
            "text": "chemical decomposition of the water molecule",
            "probability": 0.015654964546302517,
            "start_logit": 6.660926342010498,
            "end_logit": 3.7244536876678467
        },
        {
            "text": "water molecule into free radicals",
            "probability": 0.003109095783554111,
            "start_logit": 1.5978389978408813,
            "end_logit": 7.171084880828857
        },
        {
            "text": "chemical decomposition",
            "probability": 0.002993482935673133,
            "start_logit": 6.660926342010498,
            "end_logit": 2.070103168487549
        },
        {
            "text": "free radicals",
            "probability": 0.0028372021966014617,
            "start_logit": 1.5063254833221436,
            "end_logit": 7.171084880828857
        },
        {
            "text": "involves chemical decomposition of the water molecule",
            "probability": 0.002259172294825501,
            "start_logit": 4.725136756896973,
            "end_logit": 3.7244536876678467
        },
        {
            "text": "water molecule into free radicals after exposure to ionizing radiation",
            "probability": 0.0018864310412003544,
            "start_logit": 1.5978389978408813,
            "end_logit": 6.6714396476745605
        },
        {
            "text": "free radicals after exposure to ionizing radiation",
            "probability": 0.0017214607289173203,
            "start_logit": 1.5063254833221436,
            "end_logit": 6.6714396476745605
        },
        {
            "text": "chemical decomposition of the water molecule into free radical",
            "probability": 0.0013317274941187177,
            "start_logit": 6.660926342010498,
            "end_logit": 1.2601425647735596
        },
        {
            "text": "decomposition of the water molecule",
            "probability": 0.0011954252276071193,
            "start_logit": 4.088640213012695,
            "end_logit": 3.7244536876678467
        },
        {
            "text": "chemical decomposition of the water molecule into free radicals after exposure to ionizing radiation.",
            "probability": 0.0010769951322740048,
            "start_logit": 6.660926342010498,
            "end_logit": 1.0478404760360718
        },
        {
            "text": "Water radiolysis involves chemical decomposition of the water molecule into free radicals",
            "probability": 0.0007050259639419749,
            "start_logit": 0.11398641020059586,
            "end_logit": 7.171084880828857
        },
        {
            "text": "involves chemical decomposition",
            "probability": 0.00043199035636927875,
            "start_logit": 4.725136756896973,
            "end_logit": 2.070103168487549
        },
        {
            "text": "Water radiolysis involves chemical decomposition of the water molecule into free radicals after exposure to ionizing radiation",
            "probability": 0.00042777159528742327,
            "start_logit": 0.11398641020059586,
            "end_logit": 6.6714396476745605
        },
        {
            "text": "chemical decomposition of the water",
            "probability": 0.00039998446995542607,
            "start_logit": 6.660926342010498,
            "end_logit": 0.05733603984117508
        },
        {
            "text": "",
            "probability": 2.741880932870412e-05,
            "start_logit": 1.7943551540374756,
            "end_logit": 2.24371075630188
        }
    ],
    "5e482f08d14c9f295d00000d_003": [
        {
            "text": "the PCT processes that generate the DNA-damaging species against cancerous cells",
            "probability": 0.5019462573185125,
            "start_logit": 5.6197710037231445,
            "end_logit": 8.198952674865723
        },
        {
            "text": "generate the DNA-damaging species against cancerous cells",
            "probability": 0.16342568668242452,
            "start_logit": 4.497636318206787,
            "end_logit": 8.198952674865723
        },
        {
            "text": "PCT processes that generate the DNA-damaging species against cancerous cells",
            "probability": 0.14800355946078145,
            "start_logit": 4.398514270782471,
            "end_logit": 8.198952674865723
        },
        {
            "text": "i.e. the PCT processes that generate the DNA-damaging species against cancerous cells",
            "probability": 0.07044515653444043,
            "start_logit": 3.6561124324798584,
            "end_logit": 8.198952674865723
        },
        {
            "text": "DNA-damaging species against cancerous cells",
            "probability": 0.04273045815203154,
            "start_logit": 3.1561899185180664,
            "end_logit": 8.198952674865723
        },
        {
            "text": "processes that generate the DNA-damaging species against cancerous cells",
            "probability": 0.021484692062838436,
            "start_logit": 2.468618631362915,
            "end_logit": 8.198952674865723
        },
        {
            "text": "that generate the DNA-damaging species against cancerous cells",
            "probability": 0.01751921867244618,
            "start_logit": 2.2645764350891113,
            "end_logit": 8.198952674865723
        },
        {
            "text": "the PCT processes that generate the DNA-damaging species",
            "probability": 0.009557372504988495,
            "start_logit": 5.6197710037231445,
            "end_logit": 4.237772464752197
        },
        {
            "text": "reactions-i.e. the PCT processes that generate the DNA-damaging species against cancerous cells",
            "probability": 0.007539316596381752,
            "start_logit": 1.4214094877243042,
            "end_logit": 8.198952674865723
        },
        {
            "text": "generate the DNA-damaging species",
            "probability": 0.0031117278826851462,
            "start_logit": 4.497636318206787,
            "end_logit": 4.237772464752197
        },
        {
            "text": "PCT processes that generate the DNA-damaging species",
            "probability": 0.002818080878593559,
            "start_logit": 4.398514270782471,
            "end_logit": 4.237772464752197
        },
        {
            "text": "water radiolysis reactions-i.e. the PCT processes that generate the DNA-damaging species against cancerous cells",
            "probability": 0.0017950286269318824,
            "start_logit": -0.01370108313858509,
            "end_logit": 8.198952674865723
        },
        {
            "text": "-i.e. the PCT processes that generate the DNA-damaging species against cancerous cells",
            "probability": 0.0015322429038624546,
            "start_logit": -0.17198944091796875,
            "end_logit": 8.198952674865723
        },
        {
            "text": "i.e. the PCT processes that generate the DNA-damaging species",
            "probability": 0.001341320096236208,
            "start_logit": 3.6561124324798584,
            "end_logit": 4.237772464752197
        },
        {
            "text": "cancerous cells",
            "probability": 0.0012188321246010816,
            "start_logit": -0.40082892775535583,
            "end_logit": 8.198952674865723
        },
        {
            "text": "cells",
            "probability": 0.0012066094005545964,
            "start_logit": -0.4109077751636505,
            "end_logit": 8.198952674865723
        },
        {
            "text": "the DNA-damaging species against cancerous cells",
            "probability": 0.001149315155897292,
            "start_logit": -0.45955580472946167,
            "end_logit": 8.198952674865723
        },
        {
            "text": "the PCT processes",
            "probability": 0.001122705151018396,
            "start_logit": 5.6197710037231445,
            "end_logit": 2.096200704574585
        },
        {
            "text": "against cancerous cells",
            "probability": 0.0010248766518363604,
            "start_logit": -0.5741497874259949,
            "end_logit": 8.198952674865723
        },
        {
            "text": "DNA-damaging species",
            "probability": 0.0008136148042013216,
            "start_logit": 3.1561899185180664,
            "end_logit": 4.237772464752197
        },
        {
            "text": "",
            "probability": 0.00021392833873642707,
            "start_logit": 2.5768725872039795,
            "end_logit": 3.481243848800659
        }
    ],
    "5e2b0d71fbd6abf43b000001_001": [
        {
            "text": "These tools may identify patients who may benefit from expedited discharge to subacute care facilities",
            "probability": 0.30541875873683283,
            "start_logit": 0.8822778463363647,
            "end_logit": 1.7309004068374634
        },
        {
            "text": "subacute care facilities",
            "probability": 0.10816002938651728,
            "start_logit": -0.15579408407211304,
            "end_logit": 1.7309004068374634
        },
        {
            "text": "may identify patients who may benefit from expedited discharge to subacute care facilities",
            "probability": 0.09239185907264458,
            "start_logit": -0.31336709856987,
            "end_logit": 1.7309004068374634
        },
        {
            "text": "identify patients who may benefit from expedited discharge to subacute care facilities",
            "probability": 0.08871298437937525,
            "start_logit": -0.35399970412254333,
            "end_logit": 1.7309004068374634
        },
        {
            "text": "SNF",
            "probability": 0.07258697683392526,
            "start_logit": -0.3313782811164856,
            "end_logit": 1.5076582431793213
        },
        {
            "text": "",
            "probability": 0.03592638081003913,
            "start_logit": 0.10764732211828232,
            "end_logit": 0.36531898379325867
        },
        {
            "text": "discharge to SNF",
            "probability": 0.03246438430321036,
            "start_logit": -1.1360201835632324,
            "end_logit": 1.5076582431793213
        },
        {
            "text": "independent predictors of discharge to SNF",
            "probability": 0.029084360463155424,
            "start_logit": -1.245963215827942,
            "end_logit": 1.5076582431793213
        },
        {
            "text": "capability of the Risk Assessment and Prediction Tool (RAPT) and other preoperative variables to determine expected disposition prior to surgery",
            "probability": 0.026543767077839602,
            "start_logit": -0.5161134600639343,
            "end_logit": 0.6864028573036194
        },
        {
            "text": "SNF, and demonstrated superior predictive power compared with the total RAPT Score when combined in a novel grading scale",
            "probability": 0.02517402071481901,
            "start_logit": -0.3313782811164856,
            "end_logit": 0.44868525862693787
        },
        {
            "text": "determine expected disposition prior to surgery",
            "probability": 0.02317409105072105,
            "start_logit": -0.6518735289573669,
            "end_logit": 0.6864028573036194
        },
        {
            "text": "to determine expected disposition prior to surgery",
            "probability": 0.020992927452062108,
            "start_logit": -0.7507228255271912,
            "end_logit": 0.6864028573036194
        },
        {
            "text": "determine expected disposition prior to surgery in a heterogeneous neurosurgical cohort",
            "probability": 0.020315416493085506,
            "start_logit": -0.6518735289573669,
            "end_logit": 0.554747998714447
        },
        {
            "text": "SNF, and demonstrated superior predictive power",
            "probability": 0.020066120075392494,
            "start_logit": -0.3313782811164856,
            "end_logit": 0.22190554440021515
        },
        {
            "text": "These tools may identify patients who may benefit from expedited discharge to subacute care facilities and decrease inpatient hospital resource utilization following surgery",
            "probability": 0.018559642549200766,
            "start_logit": 0.8822778463363647,
            "end_logit": -1.069793939590454
        },
        {
            "text": "to determine expected disposition prior to surgery in a heterogeneous neurosurgical cohort",
            "probability": 0.01840331358258387,
            "start_logit": -0.7507228255271912,
            "end_logit": 0.554747998714447
        },
        {
            "text": "assess the capability of the Risk Assessment and Prediction Tool (RAPT) and other preoperative variables to determine expected disposition prior to surgery",
            "probability": 0.0180272245348013,
            "start_logit": -0.9030253291130066,
            "end_logit": 0.6864028573036194
        },
        {
            "text": "superior predictive power compared with the total RAPT Score when combined in a novel grading scale",
            "probability": 0.015643024173943927,
            "start_logit": -0.8071657419204712,
            "end_logit": 0.44868525862693787
        },
        {
            "text": "determine expected disposition prior to surgery in a heterogeneous neurosurgical cohort, through observational study",
            "probability": 0.014799987197035111,
            "start_logit": -0.6518735289573669,
            "end_logit": 0.23799428343772888
        },
        {
            "text": "SNF, and demonstrated superior predictive power compared with the total RAPT Score",
            "probability": 0.013554731112814964,
            "start_logit": -0.3313782811164856,
            "end_logit": -0.17039163410663605
        }
    ],
    "5e2b0d71fbd6abf43b000001_002": [
        {
            "text": "",
            "probability": 0.2929656329629631,
            "start_logit": 1.30464768409729,
            "end_logit": 1.631643295288086
        },
        {
            "text": "Those high risk patients need an accurate discharge plan",
            "probability": 0.10560623036850254,
            "start_logit": 0.30034351348876953,
            "end_logit": 1.6156095266342163
        },
        {
            "text": "high risk patients need an accurate discharge plan",
            "probability": 0.08693925389594588,
            "start_logit": 0.10583578795194626,
            "end_logit": 1.6156095266342163
        },
        {
            "text": "accurate discharge plan",
            "probability": 0.08597568799894457,
            "start_logit": 0.094690702855587,
            "end_logit": 1.6156095266342163
        },
        {
            "text": "need an accurate discharge plan",
            "probability": 0.06690643757234674,
            "start_logit": -0.15607866644859314,
            "end_logit": 1.6156095266342163
        },
        {
            "text": "Those high risk patients need an accurate discharge plan and could benefit from targeted pre- and postoperative therapeutic exercise programs.",
            "probability": 0.05552453574440797,
            "start_logit": 0.30034351348876953,
            "end_logit": 0.9727171659469604
        },
        {
            "text": "high risk patients need an accurate discharge plan and could benefit from targeted pre- and postoperative therapeutic exercise programs.",
            "probability": 0.04571000871533197,
            "start_logit": 0.10583578795194626,
            "end_logit": 0.9727171659469604
        },
        {
            "text": "accurate discharge plan and could benefit from targeted pre- and postoperative therapeutic exercise programs.",
            "probability": 0.04520339514808832,
            "start_logit": 0.094690702855587,
            "end_logit": 0.9727171659469604
        },
        {
            "text": "need an accurate discharge plan and could benefit from targeted pre- and postoperative therapeutic exercise programs.",
            "probability": 0.03517736474026029,
            "start_logit": -0.15607866644859314,
            "end_logit": 0.9727171659469604
        },
        {
            "text": "discharge plan",
            "probability": 0.025561038165608188,
            "start_logit": -1.1183046102523804,
            "end_logit": 1.6156095266342163
        },
        {
            "text": "Those high risk patients",
            "probability": 0.025397893723886608,
            "start_logit": 0.30034351348876953,
            "end_logit": 0.19055840373039246
        },
        {
            "text": "Those high risk",
            "probability": 0.023629752232238073,
            "start_logit": 0.30034351348876953,
            "end_logit": 0.1183987632393837
        },
        {
            "text": "high risk patients",
            "probability": 0.02090855741350081,
            "start_logit": 0.10583578795194626,
            "end_logit": 0.19055840373039246
        },
        {
            "text": "high risk",
            "probability": 0.019452952933253817,
            "start_logit": 0.10583578795194626,
            "end_logit": 0.1183987632393837
        },
        {
            "text": "discharge plan and could benefit from targeted pre- and postoperative therapeutic exercise programs.",
            "probability": 0.0134392144510613,
            "start_logit": -1.1183046102523804,
            "end_logit": 0.9727171659469604
        },
        {
            "text": "Those high risk patients need an accurate",
            "probability": 0.012744085715902895,
            "start_logit": 0.30034351348876953,
            "end_logit": -0.49904054403305054
        },
        {
            "text": "high risk patients need an accurate",
            "probability": 0.010491438808680673,
            "start_logit": 0.10583578795194626,
            "end_logit": -0.49904054403305054
        },
        {
            "text": "accurate",
            "probability": 0.010375160002577506,
            "start_logit": 0.094690702855587,
            "end_logit": -0.49904054403305054
        },
        {
            "text": "an accurate discharge plan",
            "probability": 0.009917390925733677,
            "start_logit": -2.0650839805603027,
            "end_logit": 1.6156095266342163
        },
        {
            "text": "need an accurate",
            "probability": 0.00807396848076496,
            "start_logit": -0.15607866644859314,
            "end_logit": -0.49904054403305054
        }
    ],
    "5e2b0d71fbd6abf43b000001_003": [
        {
            "text": "RAPT scores<6 and >10 (of 12) predicted with >90% accuracy discharge to inpatient rehabilitation and home",
            "probability": 0.22049886293796056,
            "start_logit": 0.6642279028892517,
            "end_logit": 2.7481160163879395
        },
        {
            "text": "home",
            "probability": 0.15377087936395475,
            "start_logit": 0.3037990629673004,
            "end_logit": 2.7481160163879395
        },
        {
            "text": ">90% accuracy discharge to inpatient rehabilitation and home",
            "probability": 0.14524789905741584,
            "start_logit": 0.24677729606628418,
            "end_logit": 2.7481160163879395
        },
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.07242180276598965,
            "start_logit": 1.280859351158142,
            "end_logit": 1.0180994272232056
        },
        {
            "text": "discharge to inpatient rehabilitation and home",
            "probability": 0.049148996563663984,
            "start_logit": -0.8368082046508789,
            "end_logit": 2.7481160163879395
        },
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.03795233382946567,
            "start_logit": 1.280859351158142,
            "end_logit": 0.37192302942276
        },
        {
            "text": "inpatient rehabilitation and home",
            "probability": 0.03682183896719169,
            "start_logit": -1.1255735158920288,
            "end_logit": 2.7481160163879395
        },
        {
            "text": "<6 and >10 (of 12) predicted with >90% accuracy discharge to inpatient rehabilitation and home",
            "probability": 0.03594841917231436,
            "start_logit": -1.1495795249938965,
            "end_logit": 2.7481160163879395
        },
        {
            "text": "RAPT scores<6 and >10 (of 12) predicted with >90% accuracy discharge to inpatient rehabilitation and home, respectively.",
            "probability": 0.033083892805371884,
            "start_logit": 0.6642279028892517,
            "end_logit": 0.8512700200080872
        },
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients",
            "probability": 0.028602508623787142,
            "start_logit": 1.280859351158142,
            "end_logit": 0.08908645808696747
        },
        {
            "text": "home, respectively.",
            "probability": 0.02307195248846349,
            "start_logit": 0.3037990629673004,
            "end_logit": 0.8512700200080872
        },
        {
            "text": "with >90% accuracy discharge to inpatient rehabilitation and home",
            "probability": 0.022026211118121378,
            "start_logit": -1.6394314765930176,
            "end_logit": 2.7481160163879395
        },
        {
            "text": ">90% accuracy discharge to inpatient rehabilitation and home, respectively.",
            "probability": 0.021793155114695786,
            "start_logit": 0.24677729606628418,
            "end_logit": 0.8512700200080872
        },
        {
            "text": "RAPT scores<6 and >10 (of 12) predicted with >90% accuracy discharge to inpatient rehabilitation and home, respectively",
            "probability": 0.021707347395584126,
            "start_logit": 0.6642279028892517,
            "end_logit": 0.4298742711544037
        },
        {
            "text": "RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.021122525422455695,
            "start_logit": 0.04869198054075241,
            "end_logit": 1.0180994272232056
        },
        {
            "text": "CONCLUSIONS: The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.016671703109202223,
            "start_logit": -0.18793518841266632,
            "end_logit": 1.0180994272232056
        },
        {
            "text": "home, respectively",
            "probability": 0.015138209119096408,
            "start_logit": 0.3037990629673004,
            "end_logit": 0.4298742711544037
        },
        {
            "text": "high- and low-risk patients in our cohort",
            "probability": 0.01476492185988407,
            "start_logit": -0.30939382314682007,
            "end_logit": 1.0180994272232056
        },
        {
            "text": "RAPT scores<6 and >10 (of 12) predicted with >90% accuracy",
            "probability": 0.014590287051391194,
            "start_logit": 0.6642279028892517,
            "end_logit": 0.032579515129327774
        },
        {
            "text": ">90% accuracy discharge to inpatient rehabilitation and home, respectively",
            "probability": 0.014299151303130177,
            "start_logit": 0.24677729606628418,
            "end_logit": 0.4298742711544037
        },
        {
            "text": "",
            "probability": 0.001317101930859788,
            "start_logit": -1.0394556522369385,
            "end_logit": -0.6686591506004333
        }
    ],
    "5e2b0d71fbd6abf43b000001_004": [
        {
            "text": "RAPT scores<6 and >10 (of 12) predicted with >90% accuracy discharge to inpatient rehabilitation and home",
            "probability": 0.22049886293796056,
            "start_logit": 0.6642279028892517,
            "end_logit": 2.7481160163879395
        },
        {
            "text": "home",
            "probability": 0.15377087936395475,
            "start_logit": 0.3037990629673004,
            "end_logit": 2.7481160163879395
        },
        {
            "text": ">90% accuracy discharge to inpatient rehabilitation and home",
            "probability": 0.14524789905741584,
            "start_logit": 0.24677729606628418,
            "end_logit": 2.7481160163879395
        },
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.07242180276598965,
            "start_logit": 1.280859351158142,
            "end_logit": 1.0180994272232056
        },
        {
            "text": "discharge to inpatient rehabilitation and home",
            "probability": 0.049148996563663984,
            "start_logit": -0.8368082046508789,
            "end_logit": 2.7481160163879395
        },
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.03795233382946567,
            "start_logit": 1.280859351158142,
            "end_logit": 0.37192302942276
        },
        {
            "text": "inpatient rehabilitation and home",
            "probability": 0.03682183896719169,
            "start_logit": -1.1255735158920288,
            "end_logit": 2.7481160163879395
        },
        {
            "text": "<6 and >10 (of 12) predicted with >90% accuracy discharge to inpatient rehabilitation and home",
            "probability": 0.03594841917231436,
            "start_logit": -1.1495795249938965,
            "end_logit": 2.7481160163879395
        },
        {
            "text": "RAPT scores<6 and >10 (of 12) predicted with >90% accuracy discharge to inpatient rehabilitation and home, respectively.",
            "probability": 0.033083892805371884,
            "start_logit": 0.6642279028892517,
            "end_logit": 0.8512700200080872
        },
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients",
            "probability": 0.028602508623787142,
            "start_logit": 1.280859351158142,
            "end_logit": 0.08908645808696747
        },
        {
            "text": "home, respectively.",
            "probability": 0.02307195248846349,
            "start_logit": 0.3037990629673004,
            "end_logit": 0.8512700200080872
        },
        {
            "text": "with >90% accuracy discharge to inpatient rehabilitation and home",
            "probability": 0.022026211118121378,
            "start_logit": -1.6394314765930176,
            "end_logit": 2.7481160163879395
        },
        {
            "text": ">90% accuracy discharge to inpatient rehabilitation and home, respectively.",
            "probability": 0.021793155114695786,
            "start_logit": 0.24677729606628418,
            "end_logit": 0.8512700200080872
        },
        {
            "text": "RAPT scores<6 and >10 (of 12) predicted with >90% accuracy discharge to inpatient rehabilitation and home, respectively",
            "probability": 0.021707347395584126,
            "start_logit": 0.6642279028892517,
            "end_logit": 0.4298742711544037
        },
        {
            "text": "RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.021122525422455695,
            "start_logit": 0.04869198054075241,
            "end_logit": 1.0180994272232056
        },
        {
            "text": "CONCLUSIONS: The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.016671703109202223,
            "start_logit": -0.18793518841266632,
            "end_logit": 1.0180994272232056
        },
        {
            "text": "home, respectively",
            "probability": 0.015138209119096408,
            "start_logit": 0.3037990629673004,
            "end_logit": 0.4298742711544037
        },
        {
            "text": "high- and low-risk patients in our cohort",
            "probability": 0.01476492185988407,
            "start_logit": -0.30939382314682007,
            "end_logit": 1.0180994272232056
        },
        {
            "text": "RAPT scores<6 and >10 (of 12) predicted with >90% accuracy",
            "probability": 0.014590287051391194,
            "start_logit": 0.6642279028892517,
            "end_logit": 0.032579515129327774
        },
        {
            "text": ">90% accuracy discharge to inpatient rehabilitation and home, respectively",
            "probability": 0.014299151303130177,
            "start_logit": 0.24677729606628418,
            "end_logit": 0.4298742711544037
        },
        {
            "text": "",
            "probability": 0.001317101930859788,
            "start_logit": -1.0394556522369385,
            "end_logit": -0.6686591506004333
        }
    ],
    "5e2b0d71fbd6abf43b000001_005": [
        {
            "text": "RAPT scores<6 and >10 (of 12) predicted with >90% accuracy discharge to inpatient rehabilitation and home",
            "probability": 0.22049886293796056,
            "start_logit": 0.6642279028892517,
            "end_logit": 2.7481160163879395
        },
        {
            "text": "home",
            "probability": 0.15377087936395475,
            "start_logit": 0.3037990629673004,
            "end_logit": 2.7481160163879395
        },
        {
            "text": ">90% accuracy discharge to inpatient rehabilitation and home",
            "probability": 0.14524789905741584,
            "start_logit": 0.24677729606628418,
            "end_logit": 2.7481160163879395
        },
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.07242180276598965,
            "start_logit": 1.280859351158142,
            "end_logit": 1.0180994272232056
        },
        {
            "text": "discharge to inpatient rehabilitation and home",
            "probability": 0.049148996563663984,
            "start_logit": -0.8368082046508789,
            "end_logit": 2.7481160163879395
        },
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.03795233382946567,
            "start_logit": 1.280859351158142,
            "end_logit": 0.37192302942276
        },
        {
            "text": "inpatient rehabilitation and home",
            "probability": 0.03682183896719169,
            "start_logit": -1.1255735158920288,
            "end_logit": 2.7481160163879395
        },
        {
            "text": "<6 and >10 (of 12) predicted with >90% accuracy discharge to inpatient rehabilitation and home",
            "probability": 0.03594841917231436,
            "start_logit": -1.1495795249938965,
            "end_logit": 2.7481160163879395
        },
        {
            "text": "RAPT scores<6 and >10 (of 12) predicted with >90% accuracy discharge to inpatient rehabilitation and home, respectively.",
            "probability": 0.033083892805371884,
            "start_logit": 0.6642279028892517,
            "end_logit": 0.8512700200080872
        },
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients",
            "probability": 0.028602508623787142,
            "start_logit": 1.280859351158142,
            "end_logit": 0.08908645808696747
        },
        {
            "text": "home, respectively.",
            "probability": 0.02307195248846349,
            "start_logit": 0.3037990629673004,
            "end_logit": 0.8512700200080872
        },
        {
            "text": "with >90% accuracy discharge to inpatient rehabilitation and home",
            "probability": 0.022026211118121378,
            "start_logit": -1.6394314765930176,
            "end_logit": 2.7481160163879395
        },
        {
            "text": ">90% accuracy discharge to inpatient rehabilitation and home, respectively.",
            "probability": 0.021793155114695786,
            "start_logit": 0.24677729606628418,
            "end_logit": 0.8512700200080872
        },
        {
            "text": "RAPT scores<6 and >10 (of 12) predicted with >90% accuracy discharge to inpatient rehabilitation and home, respectively",
            "probability": 0.021707347395584126,
            "start_logit": 0.6642279028892517,
            "end_logit": 0.4298742711544037
        },
        {
            "text": "RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.021122525422455695,
            "start_logit": 0.04869198054075241,
            "end_logit": 1.0180994272232056
        },
        {
            "text": "CONCLUSIONS: The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.016671703109202223,
            "start_logit": -0.18793518841266632,
            "end_logit": 1.0180994272232056
        },
        {
            "text": "home, respectively",
            "probability": 0.015138209119096408,
            "start_logit": 0.3037990629673004,
            "end_logit": 0.4298742711544037
        },
        {
            "text": "high- and low-risk patients in our cohort",
            "probability": 0.01476492185988407,
            "start_logit": -0.30939382314682007,
            "end_logit": 1.0180994272232056
        },
        {
            "text": "RAPT scores<6 and >10 (of 12) predicted with >90% accuracy",
            "probability": 0.014590287051391194,
            "start_logit": 0.6642279028892517,
            "end_logit": 0.032579515129327774
        },
        {
            "text": ">90% accuracy discharge to inpatient rehabilitation and home, respectively",
            "probability": 0.014299151303130177,
            "start_logit": 0.24677729606628418,
            "end_logit": 0.4298742711544037
        },
        {
            "text": "",
            "probability": 0.001317101930859788,
            "start_logit": -1.0394556522369385,
            "end_logit": -0.6686591506004333
        }
    ],
    "5e2b0d71fbd6abf43b000001_006": [
        {
            "text": "",
            "probability": 0.3806420858385142,
            "start_logit": 0.5276038646697998,
            "end_logit": 0.6713507771492004
        },
        {
            "text": "The difference between the postoperative orientation predicted by the RAPT and the real one is assessed",
            "probability": 0.1353982387182745,
            "start_logit": 0.0248270221054554,
            "end_logit": 0.14048844575881958
        },
        {
            "text": "The difference between the postoperative orientation predicted by the RAPT and the real one",
            "probability": 0.06832591888835052,
            "start_logit": 0.0248270221054554,
            "end_logit": -0.5434427261352539
        },
        {
            "text": "The difference between the postoperative orientation predicted by the RAPT and the real one is assessed.",
            "probability": 0.06161354532094536,
            "start_logit": 0.0248270221054554,
            "end_logit": -0.6468501687049866
        },
        {
            "text": "assessed",
            "probability": 0.05744705070557402,
            "start_logit": -0.8325296640396118,
            "end_logit": 0.14048844575881958
        },
        {
            "text": "By the way, the patient preference must not be integrated into the RAPT, but need to be collected and be discussed with the patient.",
            "probability": 0.04974535874162114,
            "start_logit": -0.6775360107421875,
            "end_logit": -0.15845170617103577
        },
        {
            "text": "By the way, the patient preference must not be integrated into the RAPT, but need to be collected and be discussed with the patient",
            "probability": 0.029646319895525495,
            "start_logit": -0.6775360107421875,
            "end_logit": -0.6760308742523193
        },
        {
            "text": "The validity of the RAPT as a help decision tool has been confirmed.",
            "probability": 0.027692886858214732,
            "start_logit": -1.0896672010421753,
            "end_logit": -0.33206209540367126
        },
        {
            "text": "assessed.",
            "probability": 0.026141525146182037,
            "start_logit": -0.8325296640396118,
            "end_logit": -0.6468501687049866
        },
        {
            "text": "By the way, the patient preference must not be integrated into the RAPT",
            "probability": 0.0250129952881399,
            "start_logit": -0.6775360107421875,
            "end_logit": -0.8459733724594116
        },
        {
            "text": "difference between the postoperative orientation predicted by the RAPT and the real one is assessed",
            "probability": 0.024399914883896028,
            "start_logit": -1.6888136863708496,
            "end_logit": 0.14048844575881958
        },
        {
            "text": "The validity of the RAPT as a help decision tool",
            "probability": 0.018368471561491916,
            "start_logit": -1.0896672010421753,
            "end_logit": -0.7426019906997681
        },
        {
            "text": "the RAPT as a help decision tool has been confirmed.",
            "probability": 0.015279910240352797,
            "start_logit": -1.684303879737854,
            "end_logit": -0.33206209540367126
        },
        {
            "text": "validity of the RAPT as a help decision tool has been confirmed.",
            "probability": 0.013605856819488367,
            "start_logit": -1.8003424406051636,
            "end_logit": -0.33206209540367126
        },
        {
            "text": "low RAPT score was significantly associated with more frequent referral to a rehabilitation ward",
            "probability": 0.01272874931050183,
            "start_logit": -0.9667953252792358,
            "end_logit": -1.2322463989257812
        },
        {
            "text": "difference between the postoperative orientation predicted by the RAPT and the real one",
            "probability": 0.012312912051305172,
            "start_logit": -1.6888136863708496,
            "end_logit": -0.5434427261352539
        },
        {
            "text": "difference between the postoperative orientation predicted by the RAPT and the real one is assessed.",
            "probability": 0.011103285210778965,
            "start_logit": -1.6888136863708496,
            "end_logit": -0.6468501687049866
        },
        {
            "text": "must not be integrated into the RAPT, but need to be collected and be discussed with the patient.",
            "probability": 0.010206021137634117,
            "start_logit": -2.2614753246307373,
            "end_logit": -0.15845170617103577
        },
        {
            "text": "the patient preference must not be integrated into the RAPT, but need to be collected and be discussed with the patient.",
            "probability": 0.01019391046951507,
            "start_logit": -2.262662649154663,
            "end_logit": -0.15845170617103577
        },
        {
            "text": "the RAPT as a help decision tool",
            "probability": 0.01013504291369366,
            "start_logit": -1.684303879737854,
            "end_logit": -0.7426019906997681
        }
    ],
    "5e2b0d71fbd6abf43b000001_007": [
        {
            "text": "",
            "probability": 0.3806420858385142,
            "start_logit": 0.5276038646697998,
            "end_logit": 0.6713507771492004
        },
        {
            "text": "The difference between the postoperative orientation predicted by the RAPT and the real one is assessed",
            "probability": 0.1353982387182745,
            "start_logit": 0.0248270221054554,
            "end_logit": 0.14048844575881958
        },
        {
            "text": "The difference between the postoperative orientation predicted by the RAPT and the real one",
            "probability": 0.06832591888835052,
            "start_logit": 0.0248270221054554,
            "end_logit": -0.5434427261352539
        },
        {
            "text": "The difference between the postoperative orientation predicted by the RAPT and the real one is assessed.",
            "probability": 0.06161354532094536,
            "start_logit": 0.0248270221054554,
            "end_logit": -0.6468501687049866
        },
        {
            "text": "assessed",
            "probability": 0.05744705070557402,
            "start_logit": -0.8325296640396118,
            "end_logit": 0.14048844575881958
        },
        {
            "text": "By the way, the patient preference must not be integrated into the RAPT, but need to be collected and be discussed with the patient.",
            "probability": 0.04974535874162114,
            "start_logit": -0.6775360107421875,
            "end_logit": -0.15845170617103577
        },
        {
            "text": "By the way, the patient preference must not be integrated into the RAPT, but need to be collected and be discussed with the patient",
            "probability": 0.029646319895525495,
            "start_logit": -0.6775360107421875,
            "end_logit": -0.6760308742523193
        },
        {
            "text": "The validity of the RAPT as a help decision tool has been confirmed.",
            "probability": 0.027692886858214732,
            "start_logit": -1.0896672010421753,
            "end_logit": -0.33206209540367126
        },
        {
            "text": "assessed.",
            "probability": 0.026141525146182037,
            "start_logit": -0.8325296640396118,
            "end_logit": -0.6468501687049866
        },
        {
            "text": "By the way, the patient preference must not be integrated into the RAPT",
            "probability": 0.0250129952881399,
            "start_logit": -0.6775360107421875,
            "end_logit": -0.8459733724594116
        },
        {
            "text": "difference between the postoperative orientation predicted by the RAPT and the real one is assessed",
            "probability": 0.024399914883896028,
            "start_logit": -1.6888136863708496,
            "end_logit": 0.14048844575881958
        },
        {
            "text": "The validity of the RAPT as a help decision tool",
            "probability": 0.018368471561491916,
            "start_logit": -1.0896672010421753,
            "end_logit": -0.7426019906997681
        },
        {
            "text": "the RAPT as a help decision tool has been confirmed.",
            "probability": 0.015279910240352797,
            "start_logit": -1.684303879737854,
            "end_logit": -0.33206209540367126
        },
        {
            "text": "validity of the RAPT as a help decision tool has been confirmed.",
            "probability": 0.013605856819488367,
            "start_logit": -1.8003424406051636,
            "end_logit": -0.33206209540367126
        },
        {
            "text": "low RAPT score was significantly associated with more frequent referral to a rehabilitation ward",
            "probability": 0.01272874931050183,
            "start_logit": -0.9667953252792358,
            "end_logit": -1.2322463989257812
        },
        {
            "text": "difference between the postoperative orientation predicted by the RAPT and the real one",
            "probability": 0.012312912051305172,
            "start_logit": -1.6888136863708496,
            "end_logit": -0.5434427261352539
        },
        {
            "text": "difference between the postoperative orientation predicted by the RAPT and the real one is assessed.",
            "probability": 0.011103285210778965,
            "start_logit": -1.6888136863708496,
            "end_logit": -0.6468501687049866
        },
        {
            "text": "must not be integrated into the RAPT, but need to be collected and be discussed with the patient.",
            "probability": 0.010206021137634117,
            "start_logit": -2.2614753246307373,
            "end_logit": -0.15845170617103577
        },
        {
            "text": "the patient preference must not be integrated into the RAPT, but need to be collected and be discussed with the patient.",
            "probability": 0.01019391046951507,
            "start_logit": -2.262662649154663,
            "end_logit": -0.15845170617103577
        },
        {
            "text": "the RAPT as a help decision tool",
            "probability": 0.01013504291369366,
            "start_logit": -1.684303879737854,
            "end_logit": -0.7426019906997681
        }
    ],
    "5c74305d7c78d694710000a4_001": [
        {
            "text": "",
            "probability": 0.39888090044395097,
            "start_logit": 3.5121724605560303,
            "end_logit": 3.8656363487243652
        },
        {
            "text": "FUS variants",
            "probability": 0.28428631866369514,
            "start_logit": 3.9577012062072754,
            "end_logit": 3.0814266204833984
        },
        {
            "text": "FUS",
            "probability": 0.24272294010167286,
            "start_logit": 3.9577012062072754,
            "end_logit": 2.923365354537964
        },
        {
            "text": "Fused in sarcoma",
            "probability": 0.03634965193688198,
            "start_logit": 2.392063856124878,
            "end_logit": 2.590266704559326
        },
        {
            "text": "FUS variants with disease-associated amino acid substitutions or short deletions affecting nuclear localization signal (NLS)",
            "probability": 0.013751151244888148,
            "start_logit": 3.9577012062072754,
            "end_logit": 0.05256727337837219
        },
        {
            "text": "Fused in sarcoma (FUS",
            "probability": 0.005389318264411637,
            "start_logit": 2.392063856124878,
            "end_logit": 0.6815009713172913
        },
        {
            "text": "Fused in sarcoma (FUS)",
            "probability": 0.004266362136643112,
            "start_logit": 2.392063856124878,
            "end_logit": 0.4478435814380646
        },
        {
            "text": "FUS variants with disease-associated amino acid substitutions",
            "probability": 0.0021949930177735328,
            "start_logit": 3.9577012062072754,
            "end_logit": -1.7823764085769653
        },
        {
            "text": "FUS protein is believed to play an important role in pathogenesis of these diseases. In cultured cells, FUS variants",
            "probability": 0.0019368796550000155,
            "start_logit": -1.0312024354934692,
            "end_logit": 3.0814266204833984
        },
        {
            "text": "Fused",
            "probability": 0.001905972069964491,
            "start_logit": 2.392063856124878,
            "end_logit": -0.35792577266693115
        },
        {
            "text": "FUS)",
            "probability": 0.0016932278345735982,
            "start_logit": 1.467939019203186,
            "end_logit": 0.4478435814380646
        },
        {
            "text": "variants",
            "probability": 0.001659267409761734,
            "start_logit": -1.1859045028686523,
            "end_logit": 3.0814266204833984
        },
        {
            "text": "FUS protein is believed to play an important role in pathogenesis of these diseases. In cultured cells, FUS",
            "probability": 0.0016537029523424442,
            "start_logit": -1.0312024354934692,
            "end_logit": 2.923365354537964
        },
        {
            "text": "FUS variants with disease-associated amino acid substitutions or short deletions",
            "probability": 0.0012576388633473996,
            "start_logit": 3.9577012062072754,
            "end_logit": -2.3393192291259766
        },
        {
            "text": "Fused in sarcoma (FUS) belongs to the group of RNA-binding proteins",
            "probability": 0.0005873626787573486,
            "start_logit": 2.392063856124878,
            "end_logit": -1.535030722618103
        },
        {
            "text": "sarcoma",
            "probability": 0.0005524102970427572,
            "start_logit": -1.7945849895477295,
            "end_logit": 2.590266704559326
        },
        {
            "text": "In cultured cells, FUS variants",
            "probability": 0.00027048069140917663,
            "start_logit": -2.999835252761841,
            "end_logit": 3.0814266204833984
        },
        {
            "text": "FUS) belongs to the group of RNA-binding proteins",
            "probability": 0.00023311167800776122,
            "start_logit": 1.467939019203186,
            "end_logit": -1.535030722618103
        },
        {
            "text": "In cultured cells, FUS",
            "probability": 0.00023093573045712926,
            "start_logit": -2.999835252761841,
            "end_logit": 2.923365354537964
        },
        {
            "text": "disease-associated amino acid substitutions or short deletions affecting nuclear localization signal (NLS)",
            "probability": 0.00017737432941895303,
            "start_logit": -0.3929142653942108,
            "end_logit": 0.05256727337837219
        }
    ],
    "5c74305d7c78d694710000a4_002": [
        {
            "text": "cytosol",
            "probability": 0.6014927033168624,
            "start_logit": 5.587861061096191,
            "end_logit": 7.290094375610352
        },
        {
            "text": "endoplasmic-reticulum-bound transcripts resume translation faster than those at the cytosol",
            "probability": 0.3004399030789645,
            "start_logit": 4.8936944007873535,
            "end_logit": 7.290094375610352
        },
        {
            "text": "the cytosol",
            "probability": 0.03430587323642743,
            "start_logit": 2.7237632274627686,
            "end_logit": 7.290094375610352
        },
        {
            "text": "endoplasmic-reticulum-bound transcripts",
            "probability": 0.02560537998644859,
            "start_logit": 4.8936944007873535,
            "end_logit": 4.827649116516113
        },
        {
            "text": "those at the cytosol",
            "probability": 0.00882450313857059,
            "start_logit": 1.3659789562225342,
            "end_logit": 7.290094375610352
        },
        {
            "text": "transcripts resume translation faster than those at the cytosol",
            "probability": 0.007898272438863188,
            "start_logit": 1.2550907135009766,
            "end_logit": 7.290094375610352
        },
        {
            "text": "",
            "probability": 0.007346259509029534,
            "start_logit": 3.7660982608795166,
            "end_logit": 4.706634044647217
        },
        {
            "text": "endoplasmic-reticulum-bound transcripts resume translation",
            "probability": 0.002299987041464575,
            "start_logit": 4.8936944007873535,
            "end_logit": 2.417750120162964
        },
        {
            "text": "cytosol,",
            "probability": 0.002061769130534466,
            "start_logit": -0.08798892796039581,
            "end_logit": 7.290094375610352
        },
        {
            "text": "at the cytosol",
            "probability": 0.0018849509587598365,
            "start_logit": -0.1776515394449234,
            "end_logit": 7.290094375610352
        },
        {
            "text": "upon stress withdrawal, endoplasmic-reticulum-bound transcripts resume translation faster than those at the cytosol",
            "probability": 0.0018525716936331474,
            "start_logit": -0.19497856497764587,
            "end_logit": 7.290094375610352
        },
        {
            "text": "reticulum-bound transcripts resume translation faster than those at the cytosol",
            "probability": 0.0012305007101696206,
            "start_logit": -0.6041321754455566,
            "end_logit": 7.290094375610352
        },
        {
            "text": "cytosol, which have been sequestered into stress granules",
            "probability": 0.0011764413159893001,
            "start_logit": 5.587861061096191,
            "end_logit": 1.0531740188598633
        },
        {
            "text": "stress withdrawal, endoplasmic-reticulum-bound transcripts resume translation faster than those at the cytosol",
            "probability": 0.001161927135081391,
            "start_logit": -0.6614733934402466,
            "end_logit": 7.290094375610352
        },
        {
            "text": "transcripts",
            "probability": 0.0006731405015146465,
            "start_logit": 1.2550907135009766,
            "end_logit": 4.827649116516113
        },
        {
            "text": "endoplasmic-reticulum-bound transcripts resume translation faster than those at the cytosol,",
            "probability": 0.000660617128547033,
            "start_logit": 4.8936944007873535,
            "end_logit": 1.170265793800354
        },
        {
            "text": "transcripts resume translation faster than those at the cytosol,",
            "probability": 0.0003323123111667439,
            "start_logit": -1.9132333993911743,
            "end_logit": 7.290094375610352
        },
        {
            "text": "-bound transcripts resume translation faster than those at the cytosol",
            "probability": 0.0002841073954785254,
            "start_logit": -2.0699563026428223,
            "end_logit": 7.290094375610352
        },
        {
            "text": "endoplasmic-reticulum-bound transcripts resume translation faster",
            "probability": 0.00024729171107175835,
            "start_logit": 4.8936944007873535,
            "end_logit": 0.18766000866889954
        },
        {
            "text": "cytosol, which have been sequestered into stress granules.",
            "probability": 0.0002214882614223846,
            "start_logit": 5.587861061096191,
            "end_logit": -0.6167057156562805
        }
    ],
    "5c74305d7c78d694710000a4_003": [
        {
            "text": "",
            "probability": 0.9743226280284973,
            "start_logit": 4.479650974273682,
            "end_logit": 4.997166156768799
        },
        {
            "text": "nontranslating",
            "probability": 0.011393182153261941,
            "start_logit": 2.8940248489379883,
            "end_logit": 2.1340649127960205
        },
        {
            "text": "nontranslating mRNAs",
            "probability": 0.009601105649670285,
            "start_logit": 2.8940248489379883,
            "end_logit": 1.962928056716919
        },
        {
            "text": "nontranslating mRNAs and proteins",
            "probability": 0.0016170074413009604,
            "start_logit": 2.8940248489379883,
            "end_logit": 0.18162697553634644
        },
        {
            "text": "mRNAs",
            "probability": 0.0011495427495341595,
            "start_logit": 0.7715108394622803,
            "end_logit": 1.962928056716919
        },
        {
            "text": "nontranslating mRNAs and proteins that form when translation initiation is inhibited",
            "probability": 0.0009871427070071031,
            "start_logit": 2.8940248489379883,
            "end_logit": -0.3118908703327179
        },
        {
            "text": "mRNAs and proteins",
            "probability": 0.00019360470011640132,
            "start_logit": 0.7715108394622803,
            "end_logit": 0.18162697553634644
        },
        {
            "text": "proteins",
            "probability": 0.00017817068137004107,
            "start_logit": 0.688434362411499,
            "end_logit": 0.18162697553634644
        },
        {
            "text": "mRNAs and proteins that form when translation initiation is inhibited",
            "probability": 0.00011819083999294474,
            "start_logit": 0.7715108394622803,
            "end_logit": -0.3118908703327179
        },
        {
            "text": "proteins that form when translation initiation is inhibited",
            "probability": 0.0001087687565466109,
            "start_logit": 0.688434362411499,
            "end_logit": -0.3118908703327179
        },
        {
            "text": "nontranslating mRNAs and proteins that form when translation initiation is inhibited.",
            "probability": 7.466084355553529e-05,
            "start_logit": 2.8940248489379883,
            "end_logit": -2.893749713897705
        },
        {
            "text": "non",
            "probability": 3.576619438324569e-05,
            "start_logit": 2.8940248489379883,
            "end_logit": -3.62970232963562
        },
        {
            "text": "nontranslating m",
            "probability": 3.558697417175531e-05,
            "start_logit": 2.8940248489379883,
            "end_logit": -3.63472580909729
        },
        {
            "text": "yeast RNA",
            "probability": 3.2456160698202347e-05,
            "start_logit": -0.8874011039733887,
            "end_logit": 0.05461074411869049
        },
        {
            "text": "RNA",
            "probability": 3.239725771862434e-05,
            "start_logit": -1.100320816040039,
            "end_logit": 0.26571395993232727
        },
        {
            "text": "RNA-binding proteins. We demonstrate RNA homopolymers or purified cellular RNA",
            "probability": 3.0236002896641057e-05,
            "start_logit": -1.1693612337112427,
            "end_logit": 0.26571395993232727
        },
        {
            "text": "total yeast RNA",
            "probability": 3.001864661832199e-05,
            "start_logit": -0.9654726386070251,
            "end_logit": 0.05461074411869049
        },
        {
            "text": "RNA homopolymers or purified cellular RNA",
            "probability": 2.6182066075355837e-05,
            "start_logit": -1.3133199214935303,
            "end_logit": 0.26571395993232727
        },
        {
            "text": "proteins that form when translation initiation is inhibited. Stress granules are thought to form by protein-protein interactions of RNA-binding proteins",
            "probability": 2.3706433935263776e-05,
            "start_logit": 0.688434362411499,
            "end_logit": -1.8353685140609741
        },
        {
            "text": "cellular RNA",
            "probability": 9.64571264923406e-06,
            "start_logit": -2.3118810653686523,
            "end_logit": 0.26571395993232727
        }
    ],
    "5c74305d7c78d694710000a4_004": [
        {
            "text": "cytoplasmic",
            "probability": 0.9054120113615898,
            "start_logit": 6.760411739349365,
            "end_logit": 6.571925640106201
        },
        {
            "text": "cytoplasmic mRNA",
            "probability": 0.0850529075867947,
            "start_logit": 6.760411739349365,
            "end_logit": 4.206809043884277
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein",
            "probability": 0.006636605522590448,
            "start_logit": 6.760411739349365,
            "end_logit": 1.656136155128479
        },
        {
            "text": "c",
            "probability": 0.0006407648632704722,
            "start_logit": 6.760411739349365,
            "end_logit": -0.6815571784973145
        },
        {
            "text": "",
            "probability": 0.0006369200652659367,
            "start_logit": 3.058077335357666,
            "end_logit": 3.014758825302124
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein (RNP",
            "probability": 0.0005029872821838289,
            "start_logit": 6.760411739349365,
            "end_logit": -0.9236548542976379
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein (RNP)",
            "probability": 0.000253817734470725,
            "start_logit": 6.760411739349365,
            "end_logit": -1.6076033115386963
        },
        {
            "text": "Upon stress, cytoplasmic",
            "probability": 0.00020930572848468085,
            "start_logit": -1.6119376420974731,
            "end_logit": 6.571925640106201
        },
        {
            "text": "stress, cytoplasmic",
            "probability": 0.00018930932524544535,
            "start_logit": -1.7123513221740723,
            "end_logit": 6.571925640106201
        },
        {
            "text": "cytoplas",
            "probability": 0.00017840355727587922,
            "start_logit": 6.760411739349365,
            "end_logit": -1.9601715803146362
        },
        {
            "text": "cytoplasmic m",
            "probability": 0.0001407713890939401,
            "start_logit": 6.760411739349365,
            "end_logit": -2.19708251953125
        },
        {
            "text": "mRNA",
            "probability": 8.965032052009133e-05,
            "start_logit": -0.09470026940107346,
            "end_logit": 4.206809043884277
        },
        {
            "text": "Upon stress, cytoplasmic mRNA",
            "probability": 1.966183412502221e-05,
            "start_logit": -1.6119376420974731,
            "end_logit": 4.206809043884277
        },
        {
            "text": "stress, cytoplasmic mRNA",
            "probability": 1.7783405061310837e-05,
            "start_logit": -1.7123513221740723,
            "end_logit": 4.206809043884277
        },
        {
            "text": "mRNA is sequestered to insoluble ribonucleoprotein",
            "probability": 6.99533771562699e-06,
            "start_logit": -0.09470026940107346,
            "end_logit": 1.656136155128479
        },
        {
            "text": "translationally suppressed",
            "probability": 4.683950685276355e-06,
            "start_logit": -0.1881147176027298,
            "end_logit": 1.348448634147644
        },
        {
            "text": "insoluble ribonucleoprotein",
            "probability": 2.7425875017996792e-06,
            "start_logit": -1.0310423374176025,
            "end_logit": 1.656136155128479
        },
        {
            "text": "ribonucleoprotein",
            "probability": 1.7563281872674105e-06,
            "start_logit": -1.476718783378601,
            "end_logit": 1.656136155128479
        },
        {
            "text": "Upon stress, cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein",
            "probability": 1.5341960744283744e-06,
            "start_logit": -1.6119376420974731,
            "end_logit": 1.656136155128479
        },
        {
            "text": "stress, cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein",
            "probability": 1.3876238636512226e-06,
            "start_logit": -1.7123513221740723,
            "end_logit": 1.656136155128479
        }
    ],
    "5c74305d7c78d694710000a4_005": [
        {
            "text": "cytoplasmic",
            "probability": 0.9054120113615898,
            "start_logit": 6.760411739349365,
            "end_logit": 6.571925640106201
        },
        {
            "text": "cytoplasmic mRNA",
            "probability": 0.0850529075867947,
            "start_logit": 6.760411739349365,
            "end_logit": 4.206809043884277
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein",
            "probability": 0.006636605522590448,
            "start_logit": 6.760411739349365,
            "end_logit": 1.656136155128479
        },
        {
            "text": "c",
            "probability": 0.0006407648632704722,
            "start_logit": 6.760411739349365,
            "end_logit": -0.6815571784973145
        },
        {
            "text": "",
            "probability": 0.0006369200652659367,
            "start_logit": 3.058077335357666,
            "end_logit": 3.014758825302124
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein (RNP",
            "probability": 0.0005029872821838289,
            "start_logit": 6.760411739349365,
            "end_logit": -0.9236548542976379
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein (RNP)",
            "probability": 0.000253817734470725,
            "start_logit": 6.760411739349365,
            "end_logit": -1.6076033115386963
        },
        {
            "text": "Upon stress, cytoplasmic",
            "probability": 0.00020930572848468085,
            "start_logit": -1.6119376420974731,
            "end_logit": 6.571925640106201
        },
        {
            "text": "stress, cytoplasmic",
            "probability": 0.00018930932524544535,
            "start_logit": -1.7123513221740723,
            "end_logit": 6.571925640106201
        },
        {
            "text": "cytoplas",
            "probability": 0.00017840355727587922,
            "start_logit": 6.760411739349365,
            "end_logit": -1.9601715803146362
        },
        {
            "text": "cytoplasmic m",
            "probability": 0.0001407713890939401,
            "start_logit": 6.760411739349365,
            "end_logit": -2.19708251953125
        },
        {
            "text": "mRNA",
            "probability": 8.965032052009133e-05,
            "start_logit": -0.09470026940107346,
            "end_logit": 4.206809043884277
        },
        {
            "text": "Upon stress, cytoplasmic mRNA",
            "probability": 1.966183412502221e-05,
            "start_logit": -1.6119376420974731,
            "end_logit": 4.206809043884277
        },
        {
            "text": "stress, cytoplasmic mRNA",
            "probability": 1.7783405061310837e-05,
            "start_logit": -1.7123513221740723,
            "end_logit": 4.206809043884277
        },
        {
            "text": "mRNA is sequestered to insoluble ribonucleoprotein",
            "probability": 6.99533771562699e-06,
            "start_logit": -0.09470026940107346,
            "end_logit": 1.656136155128479
        },
        {
            "text": "translationally suppressed",
            "probability": 4.683950685276355e-06,
            "start_logit": -0.1881147176027298,
            "end_logit": 1.348448634147644
        },
        {
            "text": "insoluble ribonucleoprotein",
            "probability": 2.7425875017996792e-06,
            "start_logit": -1.0310423374176025,
            "end_logit": 1.656136155128479
        },
        {
            "text": "ribonucleoprotein",
            "probability": 1.7563281872674105e-06,
            "start_logit": -1.476718783378601,
            "end_logit": 1.656136155128479
        },
        {
            "text": "Upon stress, cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein",
            "probability": 1.5341960744283744e-06,
            "start_logit": -1.6119376420974731,
            "end_logit": 1.656136155128479
        },
        {
            "text": "stress, cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein",
            "probability": 1.3876238636512226e-06,
            "start_logit": -1.7123513221740723,
            "end_logit": 1.656136155128479
        }
    ],
    "5c74305d7c78d694710000a4_006": [
        {
            "text": "nontranslating mRNAs",
            "probability": 0.610458869015103,
            "start_logit": 4.571275234222412,
            "end_logit": 3.8200058937072754
        },
        {
            "text": "nontranslating",
            "probability": 0.1564152294760626,
            "start_logit": 4.571275234222412,
            "end_logit": 2.4583091735839844
        },
        {
            "text": "",
            "probability": 0.08379059490818788,
            "start_logit": 2.9698688983917236,
            "end_logit": 3.4355220794677734
        },
        {
            "text": "mRNAs",
            "probability": 0.024938021159753673,
            "start_logit": 1.373457908630371,
            "end_logit": 3.8200058937072754
        },
        {
            "text": "every mRNA, and some noncoding RNAs (ncRNAs)",
            "probability": 0.02172217739785035,
            "start_logit": 2.4915952682495117,
            "end_logit": 2.5638086795806885
        },
        {
            "text": "every mRNA",
            "probability": 0.017176414873026628,
            "start_logit": 2.4915952682495117,
            "end_logit": 2.329012155532837
        },
        {
            "text": "every mRNA, and some noncoding RNAs",
            "probability": 0.016716800640881786,
            "start_logit": 2.4915952682495117,
            "end_logit": 2.301889181137085
        },
        {
            "text": "essentially every mRNA, and some noncoding RNAs (ncRNAs)",
            "probability": 0.008944410718549865,
            "start_logit": 1.6042903661727905,
            "end_logit": 2.5638086795806885
        },
        {
            "text": "RNAs (ncRNAs)",
            "probability": 0.007324200478811441,
            "start_logit": 1.4044455289840698,
            "end_logit": 2.5638086795806885
        },
        {
            "text": "essentially every mRNA",
            "probability": 0.00707262934478025,
            "start_logit": 1.6042903661727905,
            "end_logit": 2.329012155532837
        },
        {
            "text": "essentially every mRNA, and some noncoding RNAs",
            "probability": 0.0068833767487305915,
            "start_logit": 1.6042903661727905,
            "end_logit": 2.301889181137085
        },
        {
            "text": "every",
            "probability": 0.0060821473545041825,
            "start_logit": 2.4915952682495117,
            "end_logit": 1.290832757949829
        },
        {
            "text": "every mRNA, and some noncoding RNAs (ncRNAs),",
            "probability": 0.00586717035890063,
            "start_logit": 2.4915952682495117,
            "end_logit": 1.2548474073410034
        },
        {
            "text": "RNAs",
            "probability": 0.005636506737591523,
            "start_logit": 1.4044455289840698,
            "end_logit": 2.301889181137085
        },
        {
            "text": "every mRNA, and some noncoding RNAs (ncRNAs",
            "probability": 0.004263788407782683,
            "start_logit": 2.4915952682495117,
            "end_logit": 0.9356330037117004
        },
        {
            "text": "from nontranslating mRNAs",
            "probability": 0.0038588098892751582,
            "start_logit": -0.49257686734199524,
            "end_logit": 3.8200058937072754
        },
        {
            "text": "noncoding RNAs (ncRNAs)",
            "probability": 0.0036228951438149306,
            "start_logit": 0.700534999370575,
            "end_logit": 2.5638086795806885
        },
        {
            "text": "mRNA, and some noncoding RNAs (ncRNAs)",
            "probability": 0.0035951086689085666,
            "start_logit": 0.6928357481956482,
            "end_logit": 2.5638086795806885
        },
        {
            "text": "mRNA",
            "probability": 0.0028427664906603245,
            "start_logit": 0.6928357481956482,
            "end_logit": 2.329012155532837
        },
        {
            "text": "noncoding RNAs",
            "probability": 0.002788082186823791,
            "start_logit": 0.700534999370575,
            "end_logit": 2.301889181137085
        }
    ],
    "5c74305d7c78d694710000a4_007": [
        {
            "text": "nontranslating mRNAs",
            "probability": 0.610458869015103,
            "start_logit": 4.571275234222412,
            "end_logit": 3.8200058937072754
        },
        {
            "text": "nontranslating",
            "probability": 0.1564152294760626,
            "start_logit": 4.571275234222412,
            "end_logit": 2.4583091735839844
        },
        {
            "text": "",
            "probability": 0.08379059490818788,
            "start_logit": 2.9698688983917236,
            "end_logit": 3.4355220794677734
        },
        {
            "text": "mRNAs",
            "probability": 0.024938021159753673,
            "start_logit": 1.373457908630371,
            "end_logit": 3.8200058937072754
        },
        {
            "text": "every mRNA, and some noncoding RNAs (ncRNAs)",
            "probability": 0.02172217739785035,
            "start_logit": 2.4915952682495117,
            "end_logit": 2.5638086795806885
        },
        {
            "text": "every mRNA",
            "probability": 0.017176414873026628,
            "start_logit": 2.4915952682495117,
            "end_logit": 2.329012155532837
        },
        {
            "text": "every mRNA, and some noncoding RNAs",
            "probability": 0.016716800640881786,
            "start_logit": 2.4915952682495117,
            "end_logit": 2.301889181137085
        },
        {
            "text": "essentially every mRNA, and some noncoding RNAs (ncRNAs)",
            "probability": 0.008944410718549865,
            "start_logit": 1.6042903661727905,
            "end_logit": 2.5638086795806885
        },
        {
            "text": "RNAs (ncRNAs)",
            "probability": 0.007324200478811441,
            "start_logit": 1.4044455289840698,
            "end_logit": 2.5638086795806885
        },
        {
            "text": "essentially every mRNA",
            "probability": 0.00707262934478025,
            "start_logit": 1.6042903661727905,
            "end_logit": 2.329012155532837
        },
        {
            "text": "essentially every mRNA, and some noncoding RNAs",
            "probability": 0.0068833767487305915,
            "start_logit": 1.6042903661727905,
            "end_logit": 2.301889181137085
        },
        {
            "text": "every",
            "probability": 0.0060821473545041825,
            "start_logit": 2.4915952682495117,
            "end_logit": 1.290832757949829
        },
        {
            "text": "every mRNA, and some noncoding RNAs (ncRNAs),",
            "probability": 0.00586717035890063,
            "start_logit": 2.4915952682495117,
            "end_logit": 1.2548474073410034
        },
        {
            "text": "RNAs",
            "probability": 0.005636506737591523,
            "start_logit": 1.4044455289840698,
            "end_logit": 2.301889181137085
        },
        {
            "text": "every mRNA, and some noncoding RNAs (ncRNAs",
            "probability": 0.004263788407782683,
            "start_logit": 2.4915952682495117,
            "end_logit": 0.9356330037117004
        },
        {
            "text": "from nontranslating mRNAs",
            "probability": 0.0038588098892751582,
            "start_logit": -0.49257686734199524,
            "end_logit": 3.8200058937072754
        },
        {
            "text": "noncoding RNAs (ncRNAs)",
            "probability": 0.0036228951438149306,
            "start_logit": 0.700534999370575,
            "end_logit": 2.5638086795806885
        },
        {
            "text": "mRNA, and some noncoding RNAs (ncRNAs)",
            "probability": 0.0035951086689085666,
            "start_logit": 0.6928357481956482,
            "end_logit": 2.5638086795806885
        },
        {
            "text": "mRNA",
            "probability": 0.0028427664906603245,
            "start_logit": 0.6928357481956482,
            "end_logit": 2.329012155532837
        },
        {
            "text": "noncoding RNAs",
            "probability": 0.002788082186823791,
            "start_logit": 0.700534999370575,
            "end_logit": 2.301889181137085
        }
    ],
    "5e2e1792fbd6abf43b000024_001": [
        {
            "text": "TBC1D24",
            "probability": 0.6723967087863871,
            "start_logit": 4.125612258911133,
            "end_logit": 5.220841884613037
        },
        {
            "text": "TBC1D24 by Sanger sequencing in subsequent families. We identified TBC1D24",
            "probability": 0.27605818321317066,
            "start_logit": 4.265893459320068,
            "end_logit": 4.190323829650879
        },
        {
            "text": "mutations in TBC1D24",
            "probability": 0.015901481839927102,
            "start_logit": 0.38117605447769165,
            "end_logit": 5.220841884613037
        },
        {
            "text": "TBC1D24 in skeletogenesis.INTERPRETATION: Our findings suggest that mutations in TBC1D24",
            "probability": 0.005512607772348965,
            "start_logit": -0.6781984567642212,
            "end_logit": 5.220841884613037
        },
        {
            "text": "TBC1D24 mutations",
            "probability": 0.004845681606829185,
            "start_logit": 4.293172359466553,
            "end_logit": 0.1205211952328682
        },
        {
            "text": "TBC1D24 by Sanger sequencing in subsequent families. We identified TBC1D24 mutations",
            "probability": 0.004715283388220312,
            "start_logit": 4.265893459320068,
            "end_logit": 0.1205211952328682
        },
        {
            "text": "TBC1D24 mutations were identified in half of these families. The seizure types in individuals with TBC1D24",
            "probability": 0.003644818079189537,
            "start_logit": 1.9122287034988403,
            "end_logit": 2.2166833877563477
        },
        {
            "text": "",
            "probability": 0.0035599925334502645,
            "start_logit": 1.9031333923339844,
            "end_logit": 2.20223069190979
        },
        {
            "text": "TBC1D24 mutations. More information is needed to understand the cellular roles of TBC1D24",
            "probability": 0.00355078344571515,
            "start_logit": 2.1255149841308594,
            "end_logit": 1.9772589206695557
        },
        {
            "text": "Our findings suggest that mutations in TBC1D24",
            "probability": 0.002833904733313825,
            "start_logit": -1.343580722808838,
            "end_logit": 5.220841884613037
        },
        {
            "text": "INTERPRETATION: Our findings suggest that mutations in TBC1D24",
            "probability": 0.0012322359211374085,
            "start_logit": -2.176405906677246,
            "end_logit": 5.220841884613037
        },
        {
            "text": "TBC1D",
            "probability": 0.0011000932551246112,
            "start_logit": 4.293172359466553,
            "end_logit": -1.3621717691421509
        },
        {
            "text": "TBC1D24 by Sanger sequencing in subsequent families. We identified TBC1D",
            "probability": 0.0010704895352744014,
            "start_logit": 4.265893459320068,
            "end_logit": -1.3621717691421509
        },
        {
            "text": "TBC1D24 seem to be an important cause of DOORS syndrome and can cause diverse phenotypes.",
            "probability": 0.0010252540907997973,
            "start_logit": 4.125612258911133,
            "end_logit": -1.265066146850586
        },
        {
            "text": "TBC1D24 seem to be an important cause of DOORS syndrome",
            "probability": 0.0007032957064466371,
            "start_logit": 4.125612258911133,
            "end_logit": -1.641984462738037
        },
        {
            "text": "TBC",
            "probability": 0.0005693877746019347,
            "start_logit": 4.265893459320068,
            "end_logit": -1.9934813976287842
        },
        {
            "text": "TBC1D24 seem to be an important cause of DOORS syndrome and can cause diverse phenotypes",
            "probability": 0.0005527790982633879,
            "start_logit": 4.125612258911133,
            "end_logit": -1.8828034400939941
        },
        {
            "text": "TBC1D24 by Sanger sequencing in subsequent families. We identified TBC",
            "probability": 0.00047517631552894597,
            "start_logit": 4.265893459320068,
            "end_logit": -2.1743571758270264
        },
        {
            "text": "TBC1D24 mutations were identified in half of these families. The seizure types in individuals with TBC1D24 mutations",
            "probability": 0.00018564277647848963,
            "start_logit": 1.9122287034988403,
            "end_logit": -0.7605540752410889
        },
        {
            "text": "18 families had individuals with all five main features of DOORS syndrome, and TBC1D24",
            "probability": 6.62001277922778e-05,
            "start_logit": -2.4977946281433105,
            "end_logit": 2.6183273792266846
        }
    ],
    "5e2a0a02aa19d7443100000b_002": [
        {
            "text": "first-in-class humanized antibody",
            "probability": 0.35101388434817726,
            "start_logit": 6.658398628234863,
            "end_logit": 5.805452823638916
        },
        {
            "text": "humanized antibody",
            "probability": 0.17439707773253454,
            "start_logit": 5.958907604217529,
            "end_logit": 5.805452823638916
        },
        {
            "text": "first-in-class humanized",
            "probability": 0.1379612198129932,
            "start_logit": 6.658398628234863,
            "end_logit": 4.8715996742248535
        },
        {
            "text": "a first-in-class humanized antibody",
            "probability": 0.09103187578292603,
            "start_logit": 5.308782577514648,
            "end_logit": 5.805452823638916
        },
        {
            "text": "first-in-class",
            "probability": 0.08335903310229577,
            "start_logit": 6.658398628234863,
            "end_logit": 4.367784023284912
        },
        {
            "text": "humanized",
            "probability": 0.06854439282503214,
            "start_logit": 5.958907604217529,
            "end_logit": 4.8715996742248535
        },
        {
            "text": "a first-in-class humanized",
            "probability": 0.035778837205254176,
            "start_logit": 5.308782577514648,
            "end_logit": 4.8715996742248535
        },
        {
            "text": "a first-in-class",
            "probability": 0.021618316212318262,
            "start_logit": 5.308782577514648,
            "end_logit": 4.367784023284912
        },
        {
            "text": "antibody",
            "probability": 0.012817589989417693,
            "start_logit": 3.34839129447937,
            "end_logit": 5.805452823638916
        },
        {
            "text": "first-in-class humanized antibody (PRL3-zumab) against PRL-3",
            "probability": 0.0061935740927585425,
            "start_logit": 6.658398628234863,
            "end_logit": 1.768139362335205
        },
        {
            "text": "first-in-class human",
            "probability": 0.0038351748907123947,
            "start_logit": 6.658398628234863,
            "end_logit": 1.2888420820236206
        },
        {
            "text": "humanized antibody (PRL3-zumab) against PRL-3",
            "probability": 0.003077203696665205,
            "start_logit": 5.958907604217529,
            "end_logit": 1.768139362335205
        },
        {
            "text": "generated a first-in-class humanized antibody",
            "probability": 0.002423381853182482,
            "start_logit": 1.682736873626709,
            "end_logit": 5.805452823638916
        },
        {
            "text": "human",
            "probability": 0.0019054610753516407,
            "start_logit": 5.958907604217529,
            "end_logit": 1.2888420820236206
        },
        {
            "text": "a first-in-class humanized antibody (PRL3-zumab) against PRL-3",
            "probability": 0.0016062403585867507,
            "start_logit": 5.308782577514648,
            "end_logit": 1.768139362335205
        },
        {
            "text": "a first-in-class human",
            "probability": 0.0009946135461434507,
            "start_logit": 5.308782577514648,
            "end_logit": 1.2888420820236206
        },
        {
            "text": "humanized antibody (PRL3-zumab) against PRL-3, an intracellular tumor-associated phosphatase",
            "probability": 0.0009648920951094287,
            "start_logit": 5.958907604217529,
            "end_logit": 0.608379065990448
        },
        {
            "text": "generated a first-in-class humanized",
            "probability": 0.0009524771852218141,
            "start_logit": 1.682736873626709,
            "end_logit": 4.8715996742248535
        },
        {
            "text": "first",
            "probability": 0.0007901417956755898,
            "start_logit": 6.658398628234863,
            "end_logit": -0.2909158170223236
        },
        {
            "text": "class humanized antibody",
            "probability": 0.0007267761872696036,
            "start_logit": 0.478436142206192,
            "end_logit": 5.805452823638916
        },
        {
            "text": "",
            "probability": 7.836212374059415e-06,
            "start_logit": 0.8731483817100525,
            "end_logit": 0.8808776140213013
        }
    ],
    "5e2a0a02aa19d7443100000b_003": [
        {
            "text": "first-in-class humanized antibody",
            "probability": 0.35101388434817726,
            "start_logit": 6.658398628234863,
            "end_logit": 5.805452823638916
        },
        {
            "text": "humanized antibody",
            "probability": 0.17439707773253454,
            "start_logit": 5.958907604217529,
            "end_logit": 5.805452823638916
        },
        {
            "text": "first-in-class humanized",
            "probability": 0.1379612198129932,
            "start_logit": 6.658398628234863,
            "end_logit": 4.8715996742248535
        },
        {
            "text": "a first-in-class humanized antibody",
            "probability": 0.09103187578292603,
            "start_logit": 5.308782577514648,
            "end_logit": 5.805452823638916
        },
        {
            "text": "first-in-class",
            "probability": 0.08335903310229577,
            "start_logit": 6.658398628234863,
            "end_logit": 4.367784023284912
        },
        {
            "text": "humanized",
            "probability": 0.06854439282503214,
            "start_logit": 5.958907604217529,
            "end_logit": 4.8715996742248535
        },
        {
            "text": "a first-in-class humanized",
            "probability": 0.035778837205254176,
            "start_logit": 5.308782577514648,
            "end_logit": 4.8715996742248535
        },
        {
            "text": "a first-in-class",
            "probability": 0.021618316212318262,
            "start_logit": 5.308782577514648,
            "end_logit": 4.367784023284912
        },
        {
            "text": "antibody",
            "probability": 0.012817589989417693,
            "start_logit": 3.34839129447937,
            "end_logit": 5.805452823638916
        },
        {
            "text": "first-in-class humanized antibody (PRL3-zumab) against PRL-3",
            "probability": 0.0061935740927585425,
            "start_logit": 6.658398628234863,
            "end_logit": 1.768139362335205
        },
        {
            "text": "first-in-class human",
            "probability": 0.0038351748907123947,
            "start_logit": 6.658398628234863,
            "end_logit": 1.2888420820236206
        },
        {
            "text": "humanized antibody (PRL3-zumab) against PRL-3",
            "probability": 0.003077203696665205,
            "start_logit": 5.958907604217529,
            "end_logit": 1.768139362335205
        },
        {
            "text": "generated a first-in-class humanized antibody",
            "probability": 0.002423381853182482,
            "start_logit": 1.682736873626709,
            "end_logit": 5.805452823638916
        },
        {
            "text": "human",
            "probability": 0.0019054610753516407,
            "start_logit": 5.958907604217529,
            "end_logit": 1.2888420820236206
        },
        {
            "text": "a first-in-class humanized antibody (PRL3-zumab) against PRL-3",
            "probability": 0.0016062403585867507,
            "start_logit": 5.308782577514648,
            "end_logit": 1.768139362335205
        },
        {
            "text": "a first-in-class human",
            "probability": 0.0009946135461434507,
            "start_logit": 5.308782577514648,
            "end_logit": 1.2888420820236206
        },
        {
            "text": "humanized antibody (PRL3-zumab) against PRL-3, an intracellular tumor-associated phosphatase",
            "probability": 0.0009648920951094287,
            "start_logit": 5.958907604217529,
            "end_logit": 0.608379065990448
        },
        {
            "text": "generated a first-in-class humanized",
            "probability": 0.0009524771852218141,
            "start_logit": 1.682736873626709,
            "end_logit": 4.8715996742248535
        },
        {
            "text": "first",
            "probability": 0.0007901417956755898,
            "start_logit": 6.658398628234863,
            "end_logit": -0.2909158170223236
        },
        {
            "text": "class humanized antibody",
            "probability": 0.0007267761872696036,
            "start_logit": 0.478436142206192,
            "end_logit": 5.805452823638916
        },
        {
            "text": "",
            "probability": 7.836212374059415e-06,
            "start_logit": 0.8731483817100525,
            "end_logit": 0.8808776140213013
        }
    ],
    "5e48339fd14c9f295d00000e_001": [
        {
            "text": "",
            "probability": 0.8566298464459113,
            "start_logit": 2.1169052124023438,
            "end_logit": 2.959887742996216
        },
        {
            "text": "reduce the risk of adverse health outcomes",
            "probability": 0.056728039448034666,
            "start_logit": 0.8105469942092896,
            "end_logit": 1.5515086650848389
        },
        {
            "text": "thyroid cancer, hypothyroidism and benign thyroid nodules",
            "probability": 0.028542406920728493,
            "start_logit": -0.9691353440284729,
            "end_logit": 2.644313335418701
        },
        {
            "text": "radiation protection method to reduce the risk of adverse health outcomes",
            "probability": 0.010040893073361578,
            "start_logit": -0.9210555553436279,
            "end_logit": 1.5515086650848389
        },
        {
            "text": "to reduce the risk of adverse health outcomes",
            "probability": 0.008814827770436521,
            "start_logit": -1.0512863397598267,
            "end_logit": 1.5515086650848389
        },
        {
            "text": "potential radiation protection method to reduce the risk of adverse health outcomes",
            "probability": 0.008173376457869079,
            "start_logit": -1.126839518547058,
            "end_logit": 1.5515086650848389
        },
        {
            "text": "risk of adverse health outcomes",
            "probability": 0.00583714739357383,
            "start_logit": -1.4634793996810913,
            "end_logit": 1.5515086650848389
        },
        {
            "text": "reduce the risk of adverse health outcomes in the case of accidental radioactive iodine release",
            "probability": 0.0054150459877643315,
            "start_logit": 0.8105469942092896,
            "end_logit": -0.7975785732269287
        },
        {
            "text": "A potential radiation protection method to reduce the risk of adverse health outcomes",
            "probability": 0.005036262984293849,
            "start_logit": -1.6110572814941406,
            "end_logit": 1.5515086650848389
        },
        {
            "text": "reduce the risk",
            "probability": 0.002655073409462703,
            "start_logit": 0.8105469942092896,
            "end_logit": -1.5102876424789429
        },
        {
            "text": "reduce the risk of adverse health outcomes in the case of accidental radioactive iodine release is the administration of potassium iodide",
            "probability": 0.0023329216361668782,
            "start_logit": 0.8105469942092896,
            "end_logit": -1.6396385431289673
        },
        {
            "text": "following Nuclear Accidents",
            "probability": 0.001355469333026016,
            "start_logit": -1.7328652143478394,
            "end_logit": 0.36080002784729004
        },
        {
            "text": "reduce the risk of adverse health outcomes in the case of accidental radioactive iodine release is the administration of potassium iodide (KI)",
            "probability": 0.0013534784591966163,
            "start_logit": 0.8105469942092896,
            "end_logit": -2.18408203125
        },
        {
            "text": "prevention of hypothyroidism and benign thyroid nodules",
            "probability": 0.0012642151792927154,
            "start_logit": -1.5232610702514648,
            "end_logit": 0.08149963617324829
        },
        {
            "text": "thyroid cancer",
            "probability": 0.0012591817304695647,
            "start_logit": -0.9691353440284729,
            "end_logit": -0.4766155183315277
        },
        {
            "text": "reduce the risk of adverse health",
            "probability": 0.0011005071505986398,
            "start_logit": 0.8105469942092896,
            "end_logit": -2.390988826751709
        },
        {
            "text": "radiation protection method to reduce the risk of adverse health outcomes in the case of accidental radioactive iodine release",
            "probability": 0.0009584660122140178,
            "start_logit": -0.9210555553436279,
            "end_logit": -0.7975785732269287
        },
        {
            "text": "Nuclear Accidents",
            "probability": 0.000881210316108521,
            "start_logit": -2.1634719371795654,
            "end_logit": 0.36080002784729004
        },
        {
            "text": "to reduce the risk of adverse health outcomes in the case of accidental radioactive iodine release",
            "probability": 0.0008414304145811545,
            "start_logit": -1.0512863397598267,
            "end_logit": -0.7975785732269287
        },
        {
            "text": "potential radiation protection method to reduce the risk of adverse health outcomes in the case of accidental radioactive iodine release",
            "probability": 0.0007801998769094559,
            "start_logit": -1.126839518547058,
            "end_logit": -0.7975785732269287
        }
    ],
    "5e48339fd14c9f295d00000e_002": [
        {
            "text": "protect not only from intake of radioactive iodine, but also against other radionuclides that may be released",
            "probability": 0.29183882212519624,
            "start_logit": 4.545243740081787,
            "end_logit": 4.363811492919922
        },
        {
            "text": "protect not only from intake of radioactive iodine",
            "probability": 0.217694817276691,
            "start_logit": 4.545243740081787,
            "end_logit": 4.070703983306885
        },
        {
            "text": "one of several emergency countermeasures",
            "probability": 0.07147590449067988,
            "start_logit": 2.7347025871276855,
            "end_logit": 4.767511367797852
        },
        {
            "text": "emergency countermeasures",
            "probability": 0.06548381919589989,
            "start_logit": 2.6471452713012695,
            "end_logit": 4.767511367797852
        },
        {
            "text": "will protect not only from intake of radioactive iodine, but also against other radionuclides that may be released",
            "probability": 0.052543136844222134,
            "start_logit": 2.830676555633545,
            "end_logit": 4.363811492919922
        },
        {
            "text": "protect not only from intake of radioactive iodine, but also against other radionuclides",
            "probability": 0.04729357034066662,
            "start_logit": 4.545243740081787,
            "end_logit": 2.5439841747283936
        },
        {
            "text": "will protect not only from intake of radioactive iodine",
            "probability": 0.03919412945526538,
            "start_logit": 2.830676555633545,
            "end_logit": 4.070703983306885
        },
        {
            "text": "iodine prophylaxis is one of several emergency countermeasures",
            "probability": 0.03483500564523295,
            "start_logit": 2.015964984893799,
            "end_logit": 4.767511367797852
        },
        {
            "text": "emergency countermeasures; other measures are sheltering and evacuation. The latter two countermeasures will protect not only from intake of radioactive iodine",
            "probability": 0.032622286587586785,
            "start_logit": 2.6471452713012695,
            "end_logit": 4.070703983306885
        },
        {
            "text": "not only from intake of radioactive iodine, but also against other radionuclides that may be released",
            "probability": 0.02690958290504982,
            "start_logit": 2.161524534225464,
            "end_logit": 4.363811492919922
        },
        {
            "text": "protect not only from intake",
            "probability": 0.02126662133942291,
            "start_logit": 4.545243740081787,
            "end_logit": 1.744748592376709
        },
        {
            "text": "not only from intake of radioactive iodine",
            "probability": 0.02007298648907556,
            "start_logit": 2.161524534225464,
            "end_logit": 4.070703983306885
        },
        {
            "text": "several emergency countermeasures",
            "probability": 0.01707549962971599,
            "start_logit": 1.3029868602752686,
            "end_logit": 4.767511367797852
        },
        {
            "text": "protect",
            "probability": 0.013957326071486168,
            "start_logit": 4.545243740081787,
            "end_logit": 1.3236143589019775
        },
        {
            "text": "intake of radioactive iodine, but also against other radionuclides that may be released",
            "probability": 0.009985994397436644,
            "start_logit": 1.1702256202697754,
            "end_logit": 4.363811492919922
        },
        {
            "text": "will protect not only from intake of radioactive iodine, but also against other radionuclides",
            "probability": 0.008514811429698921,
            "start_logit": 2.830676555633545,
            "end_logit": 2.5439841747283936
        },
        {
            "text": "intake of radioactive iodine",
            "probability": 0.00744897203821446,
            "start_logit": 1.1702256202697754,
            "end_logit": 4.070703983306885
        },
        {
            "text": "protect not only from intake of radioactive iodine,",
            "probability": 0.006904174670293998,
            "start_logit": 4.545243740081787,
            "end_logit": 0.6197360754013062
        },
        {
            "text": "protect not only from",
            "probability": 0.006409329970111526,
            "start_logit": 4.545243740081787,
            "end_logit": 0.5453645586967468
        },
        {
            "text": "protect not only from intake of radioactive iodine, but also against other radionuclides that may be released.",
            "probability": 0.005712884488629648,
            "start_logit": 4.545243740081787,
            "end_logit": 0.4303338825702667
        },
        {
            "text": "",
            "probability": 0.002760324609423291,
            "start_logit": 1.7549529075622559,
            "end_logit": 2.49324893951416
        }
    ],
    "5e48339fd14c9f295d00000e_003": [
        {
            "text": "when an avertable thyroid dose by protective action exceeds 100 mGy",
            "probability": 0.23503166138350273,
            "start_logit": 3.2120206356048584,
            "end_logit": 5.82940149307251
        },
        {
            "text": "an avertable thyroid dose by protective action exceeds 100 mGy",
            "probability": 0.2239488824193019,
            "start_logit": 3.1637182235717773,
            "end_logit": 5.82940149307251
        },
        {
            "text": "in cases when an avertable thyroid dose by protective action exceeds 100 mGy",
            "probability": 0.1739420611508497,
            "start_logit": 2.911022663116455,
            "end_logit": 5.82940149307251
        },
        {
            "text": "cases when an avertable thyroid dose by protective action exceeds 100 mGy",
            "probability": 0.09062355835409776,
            "start_logit": 2.25901460647583,
            "end_logit": 5.82940149307251
        },
        {
            "text": "avertable thyroid dose by protective action exceeds 100 mGy",
            "probability": 0.08734798711689265,
            "start_logit": 2.222200393676758,
            "end_logit": 5.82940149307251
        },
        {
            "text": "thyroid dose by protective action exceeds 100 mGy",
            "probability": 0.03576150697523091,
            "start_logit": 1.3291724920272827,
            "end_logit": 5.82940149307251
        },
        {
            "text": "when an avertable thyroid dose",
            "probability": 0.016073017093674705,
            "start_logit": 3.2120206356048584,
            "end_logit": 3.1468231678009033
        },
        {
            "text": "when an avertable thyroid dose by protective action",
            "probability": 0.01541929495933385,
            "start_logit": 3.2120206356048584,
            "end_logit": 3.1053009033203125
        },
        {
            "text": "an avertable thyroid dose",
            "probability": 0.01531510348029835,
            "start_logit": 3.1637182235717773,
            "end_logit": 3.1468231678009033
        },
        {
            "text": "an avertable thyroid dose by protective action",
            "probability": 0.014692207226505917,
            "start_logit": 3.1637182235717773,
            "end_logit": 3.1053009033203125
        },
        {
            "text": "protective action exceeds 100 mGy",
            "probability": 0.01459343028700203,
            "start_logit": 0.43287184834480286,
            "end_logit": 5.82940149307251
        },
        {
            "text": "exceeds 100 mGy",
            "probability": 0.013027150962363992,
            "start_logit": 0.3193361163139343,
            "end_logit": 5.82940149307251
        },
        {
            "text": "in cases when an avertable thyroid dose",
            "probability": 0.01189530680985459,
            "start_logit": 2.911022663116455,
            "end_logit": 3.1468231678009033
        },
        {
            "text": "in cases when an avertable thyroid dose by protective action",
            "probability": 0.011411500607754694,
            "start_logit": 2.911022663116455,
            "end_logit": 3.1053009033203125
        },
        {
            "text": "potassium iodide prophylaxis in cases when an avertable thyroid dose by protective action exceeds 100 mGy",
            "probability": 0.007303501266186123,
            "start_logit": -0.25934574007987976,
            "end_logit": 5.82940149307251
        },
        {
            "text": "cases when an avertable thyroid dose",
            "probability": 0.006197437374781204,
            "start_logit": 2.25901460647583,
            "end_logit": 3.1468231678009033
        },
        {
            "text": "avertable thyroid dose",
            "probability": 0.005973432182556315,
            "start_logit": 2.222200393676758,
            "end_logit": 3.1468231678009033
        },
        {
            "text": "cases when an avertable thyroid dose by protective action",
            "probability": 0.005945375054155657,
            "start_logit": 2.25901460647583,
            "end_logit": 3.1053009033203125
        },
        {
            "text": "dose by protective action exceeds 100 mGy",
            "probability": 0.005918465418072103,
            "start_logit": -0.469622403383255,
            "end_logit": 5.82940149307251
        },
        {
            "text": "avertable thyroid dose by protective action",
            "probability": 0.0057304806064481925,
            "start_logit": 2.222200393676758,
            "end_logit": 3.1053009033203125
        },
        {
            "text": "",
            "probability": 0.00384863927113698,
            "start_logit": 1.9592832326889038,
            "end_logit": 2.9701383113861084
        }
    ],
    "5e2b109cfbd6abf43b000002_001": [
        {
            "text": "Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.5236388399227334,
            "start_logit": 6.841720104217529,
            "end_logit": 7.817306995391846
        },
        {
            "text": "4 parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.27523339736021574,
            "start_logit": 6.198537349700928,
            "end_logit": 7.817306995391846
        },
        {
            "text": "Length of stay, Acuity of admission, Comorbidity, and Emergency visits",
            "probability": 0.07989466760724111,
            "start_logit": 6.841720104217529,
            "end_logit": 5.937213897705078
        },
        {
            "text": "4 parameters",
            "probability": 0.05104598029509973,
            "start_logit": 6.198537349700928,
            "end_logit": 6.1324143409729
        },
        {
            "text": "4 parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency visits",
            "probability": 0.041993983486310685,
            "start_logit": 6.198537349700928,
            "end_logit": 5.937213897705078
        },
        {
            "text": "Length of stay, Acuity of admission, Comorbidity",
            "probability": 0.004918453510809201,
            "start_logit": 6.841720104217529,
            "end_logit": 3.14949893951416
        },
        {
            "text": "with 4 parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.003412476084763469,
            "start_logit": 1.8083560466766357,
            "end_logit": 7.817306995391846
        },
        {
            "text": "Length of stay, Acuity of admission",
            "probability": 0.0030849578030847577,
            "start_logit": 6.841720104217529,
            "end_logit": 2.6830427646636963
        },
        {
            "text": "4 parameters: Length of stay, Acuity of admission, Comorbidity",
            "probability": 0.0025852220391788514,
            "start_logit": 6.198537349700928,
            "end_logit": 3.14949893951416
        },
        {
            "text": "4",
            "probability": 0.0019468301505322372,
            "start_logit": 6.198537349700928,
            "end_logit": 2.8658900260925293
        },
        {
            "text": "a simple tool with 4 parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.001716556037425962,
            "start_logit": 1.121237874031067,
            "end_logit": 7.817306995391846
        },
        {
            "text": "parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.0016498719401814859,
            "start_logit": 1.0816155672073364,
            "end_logit": 7.817306995391846
        },
        {
            "text": "4 parameters: Length of stay, Acuity of admission",
            "probability": 0.001621505801558214,
            "start_logit": 6.198537349700928,
            "end_logit": 2.6830427646636963
        },
        {
            "text": "Length of stay",
            "probability": 0.0015383224345126506,
            "start_logit": 6.841720104217529,
            "end_logit": 1.9871972799301147
        },
        {
            "text": "simple tool with 4 parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.0014734558428456605,
            "start_logit": 0.9685284495353699,
            "end_logit": 7.817306995391846
        },
        {
            "text": "Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.00108223244279274,
            "start_logit": 0.6599438786506653,
            "end_logit": 7.817306995391846
        },
        {
            "text": "The LACE index is a simple tool with 4 parameters",
            "probability": 0.0008310226482248317,
            "start_logit": 2.08071231842041,
            "end_logit": 6.1324143409729
        },
        {
            "text": "4 parameters: Length of stay",
            "probability": 0.0008085681916735398,
            "start_logit": 6.198537349700928,
            "end_logit": 1.9871972799301147
        },
        {
            "text": "Emergency visits in the previous 6 months",
            "probability": 0.0006914301586340469,
            "start_logit": 0.21192476153373718,
            "end_logit": 7.817306995391846
        },
        {
            "text": "Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.0006879710804155677,
            "start_logit": 0.2069094181060791,
            "end_logit": 7.817306995391846
        },
        {
            "text": "",
            "probability": 0.00014425516176619013,
            "start_logit": 2.912348985671997,
            "end_logit": 3.5497043132781982
        }
    ],
    "5e2b109cfbd6abf43b000002_002": [
        {
            "text": "length of stay, acuity of admission, co-morbidities, and emergency department visits within the last 6 months",
            "probability": 0.7141760490059793,
            "start_logit": 7.27635383605957,
            "end_logit": 6.936374187469482
        },
        {
            "text": "length of stay, acuity of admission, co-morbidities, and emergency department visits",
            "probability": 0.19743711292738383,
            "start_logit": 7.27635383605957,
            "end_logit": 5.650664806365967
        },
        {
            "text": "length of stay, acuity of admission",
            "probability": 0.021703045543351594,
            "start_logit": 7.27635383605957,
            "end_logit": 3.442697286605835
        },
        {
            "text": "length of stay, acuity of admission, co-morbidities",
            "probability": 0.01682441478705077,
            "start_logit": 7.27635383605957,
            "end_logit": 3.1880757808685303
        },
        {
            "text": "length of stay, acuity of admission, co-morbidities, and emergency department visits within the last 6 months)",
            "probability": 0.009428546300294736,
            "start_logit": 7.27635383605957,
            "end_logit": 2.6089866161346436
        },
        {
            "text": "length of stay",
            "probability": 0.008058556708193334,
            "start_logit": 7.27635383605957,
            "end_logit": 2.451979160308838
        },
        {
            "text": "(length of stay, acuity of admission, co-morbidities, and emergency department visits within the last 6 months",
            "probability": 0.007520121954966362,
            "start_logit": 2.722806692123413,
            "end_logit": 6.936374187469482
        },
        {
            "text": "acuity of admission, co-morbidities, and emergency department visits within the last 6 months",
            "probability": 0.005898386767306233,
            "start_logit": 2.479903221130371,
            "end_logit": 6.936374187469482
        },
        {
            "text": "emergency department visits within the last 6 months",
            "probability": 0.005132699496445527,
            "start_logit": 2.3408560752868652,
            "end_logit": 6.936374187469482
        },
        {
            "text": "",
            "probability": 0.003677909423570585,
            "start_logit": 4.368690490722656,
            "end_logit": 4.575252532958984
        },
        {
            "text": "co-morbidities, and emergency department visits within the last 6 months",
            "probability": 0.0021202402206595364,
            "start_logit": 1.4567537307739258,
            "end_logit": 6.936374187469482
        },
        {
            "text": "(length of stay, acuity of admission, co-morbidities, and emergency department visits",
            "probability": 0.0020789708219940057,
            "start_logit": 2.722806692123413,
            "end_logit": 5.650664806365967
        },
        {
            "text": "acuity of admission, co-morbidities, and emergency department visits",
            "probability": 0.001630634989631635,
            "start_logit": 2.479903221130371,
            "end_logit": 5.650664806365967
        },
        {
            "text": "emergency department visits",
            "probability": 0.0014189573726429423,
            "start_logit": 2.3408560752868652,
            "end_logit": 5.650664806365967
        },
        {
            "text": "length of stay, acuity of admission, co-morbidities, and emergency department",
            "probability": 0.0007673034372969926,
            "start_logit": 7.27635383605957,
            "end_logit": 0.10037174820899963
        },
        {
            "text": "co-morbidities, and emergency department visits",
            "probability": 0.0005861497434171632,
            "start_logit": 1.4567537307739258,
            "end_logit": 5.650664806365967
        },
        {
            "text": "length of stay, acuity",
            "probability": 0.0005582314165658601,
            "start_logit": 7.27635383605957,
            "end_logit": -0.21773698925971985
        },
        {
            "text": "length",
            "probability": 0.00045234672939612754,
            "start_logit": 7.27635383605957,
            "end_logit": -0.4280616044998169
        },
        {
            "text": "length of stay, acuity of admission,",
            "probability": 0.00027607257490120226,
            "start_logit": 7.27635383605957,
            "end_logit": -0.9218468070030212
        },
        {
            "text": "visits within the last 6 months",
            "probability": 0.0002542497789519939,
            "start_logit": -0.6642137765884399,
            "end_logit": 6.936374187469482
        }
    ],
    "5e2b109cfbd6abf43b000002_003": [
        {
            "text": "length of stay, acuity of admission, Charlson Comorbidity Index, emergency department visits in the past 6 months",
            "probability": 0.7097987723508078,
            "start_logit": 6.5971174240112305,
            "end_logit": 6.214908123016357
        },
        {
            "text": "length of stay, acuity of admission, Charlson Comorbidity Index",
            "probability": 0.09312478475260422,
            "start_logit": 6.5971174240112305,
            "end_logit": 4.18386697769165
        },
        {
            "text": "length of stay, acuity of admission",
            "probability": 0.07930805526245699,
            "start_logit": 6.5971174240112305,
            "end_logit": 4.023266315460205
        },
        {
            "text": "emergency department visits in the past 6 months",
            "probability": 0.049230167590369946,
            "start_logit": 3.928642511367798,
            "end_logit": 6.214908123016357
        },
        {
            "text": "length of stay, acuity of admission, Charlson Comorbidity Index, emergency department visits",
            "probability": 0.0265275735245677,
            "start_logit": 6.5971174240112305,
            "end_logit": 2.9281113147735596
        },
        {
            "text": "length of stay",
            "probability": 0.023346452246157154,
            "start_logit": 6.5971174240112305,
            "end_logit": 2.8003716468811035
        },
        {
            "text": "acuity of admission, Charlson Comorbidity Index, emergency department visits in the past 6 months",
            "probability": 0.0038602024148517585,
            "start_logit": 1.3828555345535278,
            "end_logit": 6.214908123016357
        },
        {
            "text": "length of stay, acuity of admission, Charlson Comorbidity",
            "probability": 0.0037477410566548143,
            "start_logit": 6.5971174240112305,
            "end_logit": 0.9710798859596252
        },
        {
            "text": "emergency department visits",
            "probability": 0.0018398973642277281,
            "start_logit": 3.928642511367798,
            "end_logit": 2.9281113147735596
        },
        {
            "text": "length of stay, acuity of admission,",
            "probability": 0.001551666643591705,
            "start_logit": 6.5971174240112305,
            "end_logit": 0.08925621956586838
        },
        {
            "text": "",
            "probability": 0.0014058897793958907,
            "start_logit": 3.338632345199585,
            "end_logit": 3.249082088470459
        },
        {
            "text": "length of stay, acuity of admission, Charlson Comorbidity Index,",
            "probability": 0.0013953026115713528,
            "start_logit": 6.5971174240112305,
            "end_logit": -0.016962070018053055
        },
        {
            "text": "Charlson Comorbidity Index, emergency department visits in the past 6 months",
            "probability": 0.0009937224051346006,
            "start_logit": 0.02583853155374527,
            "end_logit": 6.214908123016357
        },
        {
            "text": "length",
            "probability": 0.000987423561196371,
            "start_logit": 6.5971174240112305,
            "end_logit": -0.36272957921028137
        },
        {
            "text": "length of stay, acuity of admission, Charlson",
            "probability": 0.000675907755911757,
            "start_logit": 6.5971174240112305,
            "end_logit": -0.7417720556259155
        },
        {
            "text": "acuity of admission, Charlson Comorbidity Index",
            "probability": 0.0005064541289554175,
            "start_logit": 1.3828555345535278,
            "end_logit": 4.18386697769165
        },
        {
            "text": "length of stay, acuity",
            "probability": 0.00045614371928423363,
            "start_logit": 6.5971174240112305,
            "end_logit": -1.1350207328796387
        },
        {
            "text": "acuity of admission",
            "probability": 0.00043131258937994523,
            "start_logit": 1.3828555345535278,
            "end_logit": 4.023266315460205
        },
        {
            "text": "length of stay,",
            "probability": 0.0004130698164236916,
            "start_logit": 6.5971174240112305,
            "end_logit": -1.234212040901184
        },
        {
            "text": "(length of stay, acuity of admission, Charlson Comorbidity Index, emergency department visits in the past 6 months",
            "probability": 0.000399460426457188,
            "start_logit": -0.8855046629905701,
            "end_logit": 6.214908123016357
        }
    ],
    "5e2b109cfbd6abf43b000002_004": [
        {
            "text": "number of ED visits within six months",
            "probability": 0.5048258432825008,
            "start_logit": 4.692132949829102,
            "end_logit": 5.8333892822265625
        },
        {
            "text": "number of ED visits within six months (LACE) and Patients At Risk of Hospital Readmission",
            "probability": 0.1557891951999886,
            "start_logit": 4.692132949829102,
            "end_logit": 4.657679557800293
        },
        {
            "text": "Length of stay (days), Acute (emergent) admission, Charlson Comorbidity Index and number of ED visits within six months",
            "probability": 0.10401091742791813,
            "start_logit": 3.112415313720703,
            "end_logit": 5.8333892822265625
        },
        {
            "text": "Patients At Risk of Hospital Readmission",
            "probability": 0.08523568379583144,
            "start_logit": 4.089049339294434,
            "end_logit": 4.657679557800293
        },
        {
            "text": "number of ED visits",
            "probability": 0.060400181361421,
            "start_logit": 4.692132949829102,
            "end_logit": 3.71016788482666
        },
        {
            "text": "Charlson Comorbidity Index and number of ED visits within six months",
            "probability": 0.015874034137306016,
            "start_logit": 1.2326041460037231,
            "end_logit": 5.8333892822265625
        },
        {
            "text": "",
            "probability": 0.013975960989439526,
            "start_logit": 3.201838493347168,
            "end_logit": 3.736809015274048
        },
        {
            "text": "Length of stay (days), Acute (emergent) admission, Charlson Comorbidity Index and number of ED visits",
            "probability": 0.012444446653850232,
            "start_logit": 3.112415313720703,
            "end_logit": 3.71016788482666
        },
        {
            "text": "Length of stay (days), Acute (emergent) admission, Charlson Comorbidity Index",
            "probability": 0.009508729614854395,
            "start_logit": 3.112415313720703,
            "end_logit": 3.44110369682312
        },
        {
            "text": "Length of stay (days), Acute (emergent) admission",
            "probability": 0.007000894401851039,
            "start_logit": 3.112415313720703,
            "end_logit": 3.1349313259124756
        },
        {
            "text": "Acute (emergent) admission, Charlson Comorbidity Index and number of ED visits within six months",
            "probability": 0.005614126279606137,
            "start_logit": 0.19320541620254517,
            "end_logit": 5.8333892822265625
        },
        {
            "text": "Charlson Comorbidity Index and number of ED visits within six months (LACE) and Patients At Risk of Hospital Readmission",
            "probability": 0.00489872504693496,
            "start_logit": 1.2326041460037231,
            "end_logit": 4.657679557800293
        },
        {
            "text": "Readmission - Length of stay (days), Acute (emergent) admission, Charlson Comorbidity Index and number of ED visits",
            "probability": 0.0037348995131177855,
            "start_logit": 1.908861756324768,
            "end_logit": 3.71016788482666
        },
        {
            "text": "number of ED visits within six months (LACE",
            "probability": 0.002971113416225297,
            "start_logit": 4.692132949829102,
            "end_logit": 0.6981125473976135
        },
        {
            "text": "Readmission - Length of stay (days), Acute (emergent) admission, Charlson Comorbidity Index",
            "probability": 0.00285381508690067,
            "start_logit": 1.908861756324768,
            "end_logit": 3.44110369682312
        },
        {
            "text": "Length of stay (days)",
            "probability": 0.0027771928441453052,
            "start_logit": 3.112415313720703,
            "end_logit": 2.210334062576294
        },
        {
            "text": "number of ED visits within six months (LACE) and Patients At Risk of Hospital Readmission (PARR) using New Zealand hospital admissions",
            "probability": 0.0023571595277813292,
            "start_logit": 4.692132949829102,
            "end_logit": 0.4666330814361572
        },
        {
            "text": "Readmission - Length of stay (days), Acute (emergent) admission",
            "probability": 0.0021011490362066493,
            "start_logit": 1.908861756324768,
            "end_logit": 3.1349313259124756
        },
        {
            "text": "Charlson Comorbidity Index and number of ED visits",
            "probability": 0.0018992580383689458,
            "start_logit": 1.2326041460037231,
            "end_logit": 3.71016788482666
        },
        {
            "text": "number of ED visits within six months (LACE) and Patients At Risk of Hospital Readmission (PARR",
            "probability": 0.0017266743457519302,
            "start_logit": 4.692132949829102,
            "end_logit": 0.1553729921579361
        }
    ],
    "5e2b109cfbd6abf43b000002_005": [
        {
            "text": "",
            "probability": 0.6443792241866753,
            "start_logit": 6.293302059173584,
            "end_logit": 6.153716087341309
        },
        {
            "text": "Length of stay, Acute/emergent admission, Charlson comorbidity index score, Emergency department visits in previous 6 months",
            "probability": 0.19413877267742008,
            "start_logit": 6.272367477416992,
            "end_logit": 4.974936485290527
        },
        {
            "text": "Length of stay, Acute/emergent admission, Charlson comorbidity index score",
            "probability": 0.0630748037989137,
            "start_logit": 6.272367477416992,
            "end_logit": 3.850684642791748
        },
        {
            "text": "Length of stay, Acute/emergent admission",
            "probability": 0.03322372966168569,
            "start_logit": 6.272367477416992,
            "end_logit": 3.209627628326416
        },
        {
            "text": "Length of stay, Acute/emergent admission, Charlson comorbidity index score, Emergency department visits",
            "probability": 0.023933817911623603,
            "start_logit": 6.272367477416992,
            "end_logit": 2.881655693054199
        },
        {
            "text": "Length of stay",
            "probability": 0.02256220064163098,
            "start_logit": 6.272367477416992,
            "end_logit": 2.822639226913452
        },
        {
            "text": "Emergency department visits in previous 6 months",
            "probability": 0.006023648274196641,
            "start_logit": 2.799487352371216,
            "end_logit": 4.974936485290527
        },
        {
            "text": "Length of stay, Acute/emergent admission, Charlson comorbidity index score, Emergency department visits in previous 6 months)",
            "probability": 0.002821453365431031,
            "start_logit": 6.272367477416992,
            "end_logit": 0.7436153888702393
        },
        {
            "text": "(Length of stay, Acute/emergent admission, Charlson comorbidity index score, Emergency department visits in previous 6 months",
            "probability": 0.0020119348286344384,
            "start_logit": 1.7028911113739014,
            "end_logit": 4.974936485290527
        },
        {
            "text": "Length of stay, Acute/emergent admission,",
            "probability": 0.001203158383424351,
            "start_logit": 6.272367477416992,
            "end_logit": -0.1086866557598114
        },
        {
            "text": "Length of stay, Acute/emergent admission, Charlson comorbidity index score,",
            "probability": 0.0009601833490592116,
            "start_logit": 6.272367477416992,
            "end_logit": -0.3342677652835846
        },
        {
            "text": "Acute/emergent admission, Charlson comorbidity index score, Emergency department visits in previous 6 months",
            "probability": 0.0008651348726117864,
            "start_logit": 0.858924388885498,
            "end_logit": 4.974936485290527
        },
        {
            "text": "Emergency department visits",
            "probability": 0.0007426074604779666,
            "start_logit": 2.799487352371216,
            "end_logit": 2.881655693054199
        },
        {
            "text": "Length of stay, Acute/emergent admission, Charlson",
            "probability": 0.0007302304367990688,
            "start_logit": 6.272367477416992,
            "end_logit": -0.6080318689346313
        },
        {
            "text": "Length",
            "probability": 0.0006836575560416287,
            "start_logit": 6.272367477416992,
            "end_logit": -0.6739348769187927
        },
        {
            "text": "(Length of stay, Acute/emergent admission, Charlson comorbidity index score",
            "probability": 0.0006536684703533106,
            "start_logit": 1.7028911113739014,
            "end_logit": 3.850684642791748
        },
        {
            "text": "Length of stay,",
            "probability": 0.0006292470186766959,
            "start_logit": 6.272367477416992,
            "end_logit": -0.7568681240081787
        },
        {
            "text": "Length of stay, Acute/emergent admission, Charlson comorbidity index",
            "probability": 0.00046901868089850124,
            "start_logit": 6.272367477416992,
            "end_logit": -1.05074942111969
        },
        {
            "text": "Emergency department visits in previous 6 months), which have higher predictability for readmission",
            "probability": 0.00045135255110693876,
            "start_logit": 2.799487352371216,
            "end_logit": 2.3837368488311768
        },
        {
            "text": "Charlson comorbidity index score, Emergency department visits in previous 6 months",
            "probability": 0.00044215587433903613,
            "start_logit": 0.18770144879817963,
            "end_logit": 4.974936485290527
        }
    ],
    "5c7a4a31d774d04240000006_001": [
        {
            "text": "there are conflicting data on the prognostic role",
            "probability": 0.15679278862965193,
            "start_logit": 4.059596061706543,
            "end_logit": 2.588308811187744
        },
        {
            "text": "",
            "probability": 0.125235152976229,
            "start_logit": 3.062690019607544,
            "end_logit": 3.360482931137085
        },
        {
            "text": "there are conflicting data on the prognostic role and so far no data on the predictive role of PD-L1 gene and protein expression",
            "probability": 0.11147840115585607,
            "start_logit": 4.059596061706543,
            "end_logit": 2.2472145557403564
        },
        {
            "text": "conflicting data on the prognostic role",
            "probability": 0.10652621875834646,
            "start_logit": 3.6730620861053467,
            "end_logit": 2.588308811187744
        },
        {
            "text": "there are conflicting data on the prognostic role and so far no data",
            "probability": 0.07944801508543853,
            "start_logit": 4.059596061706543,
            "end_logit": 1.9084866046905518
        },
        {
            "text": "conflicting data on the prognostic role and so far no data on the predictive role of PD-L1 gene and protein expression",
            "probability": 0.07573927762972138,
            "start_logit": 3.6730620861053467,
            "end_logit": 2.2472145557403564
        },
        {
            "text": "there are conflicting data",
            "probability": 0.06848849446232912,
            "start_logit": 4.059596061706543,
            "end_logit": 1.7600494623184204
        },
        {
            "text": "conflicting data on the prognostic role and so far no data",
            "probability": 0.05397758856689724,
            "start_logit": 3.6730620861053467,
            "end_logit": 1.9084866046905518
        },
        {
            "text": "conflicting data",
            "probability": 0.04653160650619439,
            "start_logit": 3.6730620861053467,
            "end_logit": 1.7600494623184204
        },
        {
            "text": "no data on the predictive role of PD-L1 gene and protein expression in glioblastoma",
            "probability": 0.03581239102096036,
            "start_logit": 2.35591983795166,
            "end_logit": 2.8153538703918457
        },
        {
            "text": "(d) there are conflicting data on the prognostic role",
            "probability": 0.025501736699790414,
            "start_logit": 2.243417501449585,
            "end_logit": 2.588308811187744
        },
        {
            "text": "no data on the predictive role of PD-L1 gene and protein expression",
            "probability": 0.020290537345894342,
            "start_logit": 2.35591983795166,
            "end_logit": 2.2472145557403564
        },
        {
            "text": "there are conflicting data on the prognostic role and so far no data on the predictive role",
            "probability": 0.014558882089339427,
            "start_logit": 4.059596061706543,
            "end_logit": 0.21158495545387268
        },
        {
            "text": "no data",
            "probability": 0.014460585193489611,
            "start_logit": 2.35591983795166,
            "end_logit": 1.9084866046905518
        },
        {
            "text": "(d) there are conflicting data on the prognostic role and so far no data",
            "probability": 0.012921910374433321,
            "start_logit": 2.243417501449585,
            "end_logit": 1.9084866046905518
        },
        {
            "text": "there is considerable variability",
            "probability": 0.012640291696700907,
            "start_logit": 2.971212387084961,
            "end_logit": 1.1586568355560303
        },
        {
            "text": "(d) there are conflicting data",
            "probability": 0.011139387008855502,
            "start_logit": 2.243417501449585,
            "end_logit": 1.7600494623184204
        },
        {
            "text": "conflicting data on the prognostic role and so far no data on the predictive role",
            "probability": 0.009891415746097934,
            "start_logit": 3.6730620861053467,
            "end_logit": 0.21158495545387268
        },
        {
            "text": "prognostic role and so far no data on the predictive role of PD-L1 gene and protein expression in glioblastoma",
            "probability": 0.009337324808858674,
            "start_logit": 1.0116456747055054,
            "end_logit": 2.8153538703918457
        },
        {
            "text": "there are conflicting",
            "probability": 0.009227994244915452,
            "start_logit": 4.059596061706543,
            "end_logit": -0.2443745881319046
        }
    ],
    "5c7a4a31d774d04240000006_002": [
        {
            "text": "there are conflicting data on the prognostic role",
            "probability": 0.15679278862965193,
            "start_logit": 4.059596061706543,
            "end_logit": 2.588308811187744
        },
        {
            "text": "",
            "probability": 0.125235152976229,
            "start_logit": 3.062690019607544,
            "end_logit": 3.360482931137085
        },
        {
            "text": "there are conflicting data on the prognostic role and so far no data on the predictive role of PD-L1 gene and protein expression",
            "probability": 0.11147840115585607,
            "start_logit": 4.059596061706543,
            "end_logit": 2.2472145557403564
        },
        {
            "text": "conflicting data on the prognostic role",
            "probability": 0.10652621875834646,
            "start_logit": 3.6730620861053467,
            "end_logit": 2.588308811187744
        },
        {
            "text": "there are conflicting data on the prognostic role and so far no data",
            "probability": 0.07944801508543853,
            "start_logit": 4.059596061706543,
            "end_logit": 1.9084866046905518
        },
        {
            "text": "conflicting data on the prognostic role and so far no data on the predictive role of PD-L1 gene and protein expression",
            "probability": 0.07573927762972138,
            "start_logit": 3.6730620861053467,
            "end_logit": 2.2472145557403564
        },
        {
            "text": "there are conflicting data",
            "probability": 0.06848849446232912,
            "start_logit": 4.059596061706543,
            "end_logit": 1.7600494623184204
        },
        {
            "text": "conflicting data on the prognostic role and so far no data",
            "probability": 0.05397758856689724,
            "start_logit": 3.6730620861053467,
            "end_logit": 1.9084866046905518
        },
        {
            "text": "conflicting data",
            "probability": 0.04653160650619439,
            "start_logit": 3.6730620861053467,
            "end_logit": 1.7600494623184204
        },
        {
            "text": "no data on the predictive role of PD-L1 gene and protein expression in glioblastoma",
            "probability": 0.03581239102096036,
            "start_logit": 2.35591983795166,
            "end_logit": 2.8153538703918457
        },
        {
            "text": "(d) there are conflicting data on the prognostic role",
            "probability": 0.025501736699790414,
            "start_logit": 2.243417501449585,
            "end_logit": 2.588308811187744
        },
        {
            "text": "no data on the predictive role of PD-L1 gene and protein expression",
            "probability": 0.020290537345894342,
            "start_logit": 2.35591983795166,
            "end_logit": 2.2472145557403564
        },
        {
            "text": "there are conflicting data on the prognostic role and so far no data on the predictive role",
            "probability": 0.014558882089339427,
            "start_logit": 4.059596061706543,
            "end_logit": 0.21158495545387268
        },
        {
            "text": "no data",
            "probability": 0.014460585193489611,
            "start_logit": 2.35591983795166,
            "end_logit": 1.9084866046905518
        },
        {
            "text": "(d) there are conflicting data on the prognostic role and so far no data",
            "probability": 0.012921910374433321,
            "start_logit": 2.243417501449585,
            "end_logit": 1.9084866046905518
        },
        {
            "text": "there is considerable variability",
            "probability": 0.012640291696700907,
            "start_logit": 2.971212387084961,
            "end_logit": 1.1586568355560303
        },
        {
            "text": "(d) there are conflicting data",
            "probability": 0.011139387008855502,
            "start_logit": 2.243417501449585,
            "end_logit": 1.7600494623184204
        },
        {
            "text": "conflicting data on the prognostic role and so far no data on the predictive role",
            "probability": 0.009891415746097934,
            "start_logit": 3.6730620861053467,
            "end_logit": 0.21158495545387268
        },
        {
            "text": "prognostic role and so far no data on the predictive role of PD-L1 gene and protein expression in glioblastoma",
            "probability": 0.009337324808858674,
            "start_logit": 1.0116456747055054,
            "end_logit": 2.8153538703918457
        },
        {
            "text": "there are conflicting",
            "probability": 0.009227994244915452,
            "start_logit": 4.059596061706543,
            "end_logit": -0.2443745881319046
        }
    ],
    "5c7a4a31d774d04240000006_003": [
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability, primary versus metastatic biopsies",
            "probability": 0.4639910086144698,
            "start_logit": 5.5106892585754395,
            "end_logit": 3.4804534912109375
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability",
            "probability": 0.27945855498440436,
            "start_logit": 5.5106892585754395,
            "end_logit": 2.973442316055298
        },
        {
            "text": "variable detection antibodies",
            "probability": 0.06306806405230125,
            "start_logit": 5.5106892585754395,
            "end_logit": 1.4848028421401978
        },
        {
            "text": "multiple unresolved issues",
            "probability": 0.030105400818166372,
            "start_logit": 2.8520147800445557,
            "end_logit": 3.4039673805236816
        },
        {
            "text": "primary versus metastatic biopsies, oncogenic versus induced PD-L1 expression, and staining of tumor versus immune cells",
            "probability": 0.028052542782946322,
            "start_logit": 1.4135539531707764,
            "end_logit": 4.77180290222168
        },
        {
            "text": "multiple unresolved issues: variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability",
            "probability": 0.019573556954615608,
            "start_logit": 2.8520147800445557,
            "end_logit": 2.973442316055298
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs",
            "probability": 0.015421382119002576,
            "start_logit": 5.5106892585754395,
            "end_logit": 0.07634331285953522
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability,",
            "probability": 0.013972889224971152,
            "start_logit": 5.5106892585754395,
            "end_logit": -0.022292714565992355
        },
        {
            "text": "oncogenic versus induced PD-L1 expression, and staining of tumor versus immune cells",
            "probability": 0.01364461477521809,
            "start_logit": 0.6928195953369141,
            "end_logit": 4.77180290222168
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation",
            "probability": 0.010387995293781229,
            "start_logit": 5.5106892585754395,
            "end_logit": -0.31876084208488464
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability, primary versus metastatic biopsies,",
            "probability": 0.009710067880810061,
            "start_logit": 5.5106892585754395,
            "end_logit": -0.3862484097480774
        },
        {
            "text": "primary versus metastatic biopsies",
            "probability": 0.007711632233819707,
            "start_logit": 1.4135539531707764,
            "end_logit": 3.4804534912109375
        },
        {
            "text": "the presence of robust responses in some patients with low levels of expression of these markers",
            "probability": 0.006930101615265091,
            "start_logit": 2.1055948734283447,
            "end_logit": 2.6815571784973145
        },
        {
            "text": "staining of tumor versus immune cells",
            "probability": 0.00625091031528747,
            "start_logit": -0.08779822289943695,
            "end_logit": 4.77180290222168
        },
        {
            "text": "confounded by multiple unresolved issues",
            "probability": 0.0055400200457173185,
            "start_logit": 1.1593083143234253,
            "end_logit": 3.4039673805236816
        },
        {
            "text": "tissue preparation, processing variability, primary versus metastatic biopsies",
            "probability": 0.005480792639419693,
            "start_logit": 1.0720738172531128,
            "end_logit": 3.4804534912109375
        },
        {
            "text": "differing IHC cutoffs, tissue preparation, processing variability, primary versus metastatic biopsies",
            "probability": 0.005114582778342643,
            "start_logit": 1.0029199123382568,
            "end_logit": 3.4804534912109375
        },
        {
            "text": "multiple unresolved",
            "probability": 0.004766606727322921,
            "start_logit": 2.8520147800445557,
            "end_logit": 1.5608974695205688
        },
        {
            "text": "multiple unresolved issues: variable detection antibodies",
            "probability": 0.004417350343108856,
            "start_logit": 2.8520147800445557,
            "end_logit": 1.4848028421401978
        },
        {
            "text": "confounded by multiple unresolved issues: variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability",
            "probability": 0.0036019416764956637,
            "start_logit": 1.1593083143234253,
            "end_logit": 2.973442316055298
        },
        {
            "text": "",
            "probability": 0.0027999841245336266,
            "start_logit": 1.9676827192306519,
            "end_logit": 1.9132086038589478
        }
    ],
    "5c7a4a31d774d04240000006_004": [
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability, primary versus metastatic biopsies",
            "probability": 0.4639910086144698,
            "start_logit": 5.5106892585754395,
            "end_logit": 3.4804534912109375
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability",
            "probability": 0.27945855498440436,
            "start_logit": 5.5106892585754395,
            "end_logit": 2.973442316055298
        },
        {
            "text": "variable detection antibodies",
            "probability": 0.06306806405230125,
            "start_logit": 5.5106892585754395,
            "end_logit": 1.4848028421401978
        },
        {
            "text": "multiple unresolved issues",
            "probability": 0.030105400818166372,
            "start_logit": 2.8520147800445557,
            "end_logit": 3.4039673805236816
        },
        {
            "text": "primary versus metastatic biopsies, oncogenic versus induced PD-L1 expression, and staining of tumor versus immune cells",
            "probability": 0.028052542782946322,
            "start_logit": 1.4135539531707764,
            "end_logit": 4.77180290222168
        },
        {
            "text": "multiple unresolved issues: variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability",
            "probability": 0.019573556954615608,
            "start_logit": 2.8520147800445557,
            "end_logit": 2.973442316055298
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs",
            "probability": 0.015421382119002576,
            "start_logit": 5.5106892585754395,
            "end_logit": 0.07634331285953522
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability,",
            "probability": 0.013972889224971152,
            "start_logit": 5.5106892585754395,
            "end_logit": -0.022292714565992355
        },
        {
            "text": "oncogenic versus induced PD-L1 expression, and staining of tumor versus immune cells",
            "probability": 0.01364461477521809,
            "start_logit": 0.6928195953369141,
            "end_logit": 4.77180290222168
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation",
            "probability": 0.010387995293781229,
            "start_logit": 5.5106892585754395,
            "end_logit": -0.31876084208488464
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability, primary versus metastatic biopsies,",
            "probability": 0.009710067880810061,
            "start_logit": 5.5106892585754395,
            "end_logit": -0.3862484097480774
        },
        {
            "text": "primary versus metastatic biopsies",
            "probability": 0.007711632233819707,
            "start_logit": 1.4135539531707764,
            "end_logit": 3.4804534912109375
        },
        {
            "text": "the presence of robust responses in some patients with low levels of expression of these markers",
            "probability": 0.006930101615265091,
            "start_logit": 2.1055948734283447,
            "end_logit": 2.6815571784973145
        },
        {
            "text": "staining of tumor versus immune cells",
            "probability": 0.00625091031528747,
            "start_logit": -0.08779822289943695,
            "end_logit": 4.77180290222168
        },
        {
            "text": "confounded by multiple unresolved issues",
            "probability": 0.0055400200457173185,
            "start_logit": 1.1593083143234253,
            "end_logit": 3.4039673805236816
        },
        {
            "text": "tissue preparation, processing variability, primary versus metastatic biopsies",
            "probability": 0.005480792639419693,
            "start_logit": 1.0720738172531128,
            "end_logit": 3.4804534912109375
        },
        {
            "text": "differing IHC cutoffs, tissue preparation, processing variability, primary versus metastatic biopsies",
            "probability": 0.005114582778342643,
            "start_logit": 1.0029199123382568,
            "end_logit": 3.4804534912109375
        },
        {
            "text": "multiple unresolved",
            "probability": 0.004766606727322921,
            "start_logit": 2.8520147800445557,
            "end_logit": 1.5608974695205688
        },
        {
            "text": "multiple unresolved issues: variable detection antibodies",
            "probability": 0.004417350343108856,
            "start_logit": 2.8520147800445557,
            "end_logit": 1.4848028421401978
        },
        {
            "text": "confounded by multiple unresolved issues: variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability",
            "probability": 0.0036019416764956637,
            "start_logit": 1.1593083143234253,
            "end_logit": 2.973442316055298
        },
        {
            "text": "",
            "probability": 0.0027999841245336266,
            "start_logit": 1.9676827192306519,
            "end_logit": 1.9132086038589478
        }
    ],
    "5c7a4a31d774d04240000006_005": [
        {
            "text": "",
            "probability": 0.2447133496967741,
            "start_logit": 1.7822920083999634,
            "end_logit": 2.1734654903411865
        },
        {
            "text": "Increasingly, researchers say that PD-L1 expression is just one of many variables that may affect response to PD-1 blockade.",
            "probability": 0.15782263585076628,
            "start_logit": 1.1694765090942383,
            "end_logit": 2.347665309906006
        },
        {
            "text": "one of many variables that may affect response to PD-1 blockade.",
            "probability": 0.06922814918335486,
            "start_logit": 0.3454122245311737,
            "end_logit": 2.347665309906006
        },
        {
            "text": "just one of many variables that may affect response to PD-1 blockade.",
            "probability": 0.06065762577357634,
            "start_logit": 0.2132500261068344,
            "end_logit": 2.347665309906006
        },
        {
            "text": "not clear",
            "probability": 0.04695861458188394,
            "start_logit": 1.2119510173797607,
            "end_logit": 1.0929856300354004
        },
        {
            "text": "not clear whether expression of the ligand PD-L1 is a biomarker for response",
            "probability": 0.04694672614087981,
            "start_logit": 1.2119510173797607,
            "end_logit": 1.0927324295043945
        },
        {
            "text": "not clear whether expression of the ligand PD-L1 is a biomarker for response.",
            "probability": 0.041248675402845256,
            "start_logit": 1.2119510173797607,
            "end_logit": 0.9633379578590393
        },
        {
            "text": "it is not clear",
            "probability": 0.033423354678615395,
            "start_logit": 0.8719392418861389,
            "end_logit": 1.0929856300354004
        },
        {
            "text": "it is not clear whether expression of the ligand PD-L1 is a biomarker for response",
            "probability": 0.0334148929387665,
            "start_logit": 0.8719392418861389,
            "end_logit": 1.0927324295043945
        },
        {
            "text": "Increasingly, researchers say that PD-L1 expression is just one of many variables",
            "probability": 0.03273091998851243,
            "start_logit": 1.1694765090942383,
            "end_logit": 0.7745136618614197
        },
        {
            "text": "PD-L1 expression is just one of many variables that may affect response to PD-1 blockade.",
            "probability": 0.03165426426120006,
            "start_logit": -0.4371224641799927,
            "end_logit": 2.347665309906006
        },
        {
            "text": "response. Increasingly, researchers say that PD-L1 expression is just one of many variables that may affect response to PD-1 blockade.",
            "probability": 0.03163643486335333,
            "start_logit": -0.43768587708473206,
            "end_logit": 2.347665309906006
        },
        {
            "text": "many variables that may affect response to PD-1 blockade.",
            "probability": 0.031238465583242114,
            "start_logit": -0.45034512877464294,
            "end_logit": 2.347665309906006
        },
        {
            "text": "researchers say that PD-L1 expression is just one of many variables that may affect response to PD-1 blockade.",
            "probability": 0.03104716781213917,
            "start_logit": -0.4564877450466156,
            "end_logit": 2.347665309906006
        },
        {
            "text": "it is not clear whether expression of the ligand PD-L1 is a biomarker for response.",
            "probability": 0.029359237283466396,
            "start_logit": 0.8719392418861389,
            "end_logit": 0.9633379578590393
        },
        {
            "text": "variables that may affect response to PD-1 blockade.",
            "probability": 0.017861278211488998,
            "start_logit": -1.0093601942062378,
            "end_logit": 2.347665309906006
        },
        {
            "text": "Increasingly, researchers say that PD-L1 expression is just one of many variables that may affect response to PD-1 blockade",
            "probability": 0.01701174787651468,
            "start_logit": 1.1694765090942383,
            "end_logit": 0.12009762227535248
        },
        {
            "text": "not clear whether expression of the ligand PD-L1 is a biomarker for response. Increasingly",
            "probability": 0.014534068678573646,
            "start_logit": 1.2119510173797607,
            "end_logit": -0.07978558540344238
        },
        {
            "text": "one of many variables",
            "probability": 0.014357262503306416,
            "start_logit": 0.3454122245311737,
            "end_logit": 0.7745136618614197
        },
        {
            "text": "may affect response to PD-1 blockade.",
            "probability": 0.014155128690740308,
            "start_logit": -1.2419183254241943,
            "end_logit": 2.347665309906006
        }
    ],
    "5c7a4a31d774d04240000006_006": [
        {
            "text": "many patients considered PD-L1-negative experience a benefit from treatment",
            "probability": 0.34676633095437026,
            "start_logit": 2.5970919132232666,
            "end_logit": 3.683434009552002
        },
        {
            "text": "many patients considered PD-L1-negative experience a benefit from treatment.",
            "probability": 0.16678926867859262,
            "start_logit": 2.5970919132232666,
            "end_logit": 2.9515140056610107
        },
        {
            "text": "Importantly, there is not yet a definitive test for determination of PD-L1",
            "probability": 0.06677877986563072,
            "start_logit": 3.3758819103240967,
            "end_logit": 1.2573782205581665
        },
        {
            "text": "there is not yet a definitive test for determination of PD-L1",
            "probability": 0.06417076701772319,
            "start_logit": 3.3360443115234375,
            "end_logit": 1.2573782205581665
        },
        {
            "text": "especially since many patients considered PD-L1-negative experience a benefit from treatment",
            "probability": 0.04756012632336482,
            "start_logit": 0.6104354858398438,
            "end_logit": 3.683434009552002
        },
        {
            "text": "the type of cells on which PD-L1 expression is most relevant is not yet clear",
            "probability": 0.038962872444852255,
            "start_logit": 1.5314632654190063,
            "end_logit": 2.563020706176758
        },
        {
            "text": "Importantly, there is not yet a definitive test",
            "probability": 0.03675541794847604,
            "start_logit": 3.3758819103240967,
            "end_logit": 0.6602784991264343
        },
        {
            "text": "there is not yet a definitive test",
            "probability": 0.03531995293350094,
            "start_logit": 3.3360443115234375,
            "end_logit": 0.6602784991264343
        },
        {
            "text": "since many patients considered PD-L1-negative experience a benefit from treatment",
            "probability": 0.02769986868473242,
            "start_logit": 0.06986843049526215,
            "end_logit": 3.683434009552002
        },
        {
            "text": "patients considered PD-L1-negative experience a benefit from treatment",
            "probability": 0.026456650741369804,
            "start_logit": 0.02394833043217659,
            "end_logit": 3.683434009552002
        },
        {
            "text": "especially since many patients considered PD-L1-negative experience a benefit from treatment.",
            "probability": 0.02287568884183082,
            "start_logit": 0.6104354858398438,
            "end_logit": 2.9515140056610107
        },
        {
            "text": "Importantly",
            "probability": 0.019703268850803972,
            "start_logit": 3.3758819103240967,
            "end_logit": 0.03677741065621376
        },
        {
            "text": "",
            "probability": 0.01811932122074051,
            "start_logit": 1.4695632457733154,
            "end_logit": 1.859290361404419
        },
        {
            "text": "many patients considered PD-L1-negative experience a benefit from treatment. Importantly, there is not yet a definitive test",
            "probability": 0.01686930409822928,
            "start_logit": 2.5970919132232666,
            "end_logit": 0.6602784991264343
        },
        {
            "text": "since many patients considered PD-L1-negative experience a benefit from treatment.",
            "probability": 0.013323210554220456,
            "start_logit": 0.06986843049526215,
            "end_logit": 2.9515140056610107
        },
        {
            "text": "patients considered PD-L1-negative experience a benefit from treatment.",
            "probability": 0.012725241855786351,
            "start_logit": 0.02394833043217659,
            "end_logit": 2.9515140056610107
        },
        {
            "text": "a cut-off reference for PD-L1-positive status has not been established",
            "probability": 0.012385838998154326,
            "start_logit": 0.2920004725456238,
            "end_logit": 2.656428098678589
        },
        {
            "text": "many patients considered PD-L1-negative",
            "probability": 0.011995479818427255,
            "start_logit": 2.5970919132232666,
            "end_logit": 0.3193127512931824
        },
        {
            "text": "many patients considered PD-L1-negative experience a benefit from treatment. Importantly",
            "probability": 0.009043032361632062,
            "start_logit": 2.5970919132232666,
            "end_logit": 0.03677741065621376
        },
        {
            "text": "many patients considered PD-L1-negative experience a benefit",
            "probability": 0.00569957780756194,
            "start_logit": 2.5970919132232666,
            "end_logit": -0.4248250424861908
        }
    ],
    "5c7a4a31d774d04240000006_007": [
        {
            "text": "heterogeneity",
            "probability": 0.2287019825960938,
            "start_logit": 5.092513561248779,
            "end_logit": 3.6661722660064697
        },
        {
            "text": "heterogeneity in methodologies of PD-L1 assays in terms of primary antibodies and scoring algorithms, and tumor heterogenity",
            "probability": 0.20525744002207877,
            "start_logit": 5.092513561248779,
            "end_logit": 3.5580174922943115
        },
        {
            "text": "heterogeneity in methodologies",
            "probability": 0.2017360377292517,
            "start_logit": 5.092513561248779,
            "end_logit": 3.540712594985962
        },
        {
            "text": "heterogeneity in methodologies of PD-L1 assays in terms of primary antibodies and scoring algorithms",
            "probability": 0.12406327458896288,
            "start_logit": 5.092513561248779,
            "end_logit": 3.05454421043396
        },
        {
            "text": "heterogeneity in methodologies of PD-L1 assays",
            "probability": 0.07373455409771816,
            "start_logit": 5.092513561248779,
            "end_logit": 2.534224033355713
        },
        {
            "text": "tumor heterogenity for PD-L1 expression",
            "probability": 0.07199231274828057,
            "start_logit": 2.8705031871795654,
            "end_logit": 4.7323222160339355
        },
        {
            "text": "tumor heterogenity for PD-L1 expression are important issues to be considered",
            "probability": 0.030328183234827322,
            "start_logit": 2.8705031871795654,
            "end_logit": 3.86784029006958
        },
        {
            "text": "tumor heterogenity",
            "probability": 0.022248055737088348,
            "start_logit": 2.8705031871795654,
            "end_logit": 3.5580174922943115
        },
        {
            "text": "heterogeneity in methodologies of PD-L1 assays in terms of primary antibodies and scoring algorithms,",
            "probability": 0.014211863110214116,
            "start_logit": 5.092513561248779,
            "end_logit": 0.8878295421600342
        },
        {
            "text": "tumor heterogenity for PD-L1 expression are important issues",
            "probability": 0.007866154952705188,
            "start_logit": 2.8705031871795654,
            "end_logit": 2.5183322429656982
        },
        {
            "text": "heterogeneity in",
            "probability": 0.003700841460104196,
            "start_logit": 5.092513561248779,
            "end_logit": -0.45768728852272034
        },
        {
            "text": "tumor heterogenity for PD-L1 expression are important issues to be considered.",
            "probability": 0.0035806792042365333,
            "start_logit": 2.8705031871795654,
            "end_logit": 1.7313153743743896
        },
        {
            "text": "heterogeneity in methodologies of PD-L1",
            "probability": 0.0035079539583161273,
            "start_logit": 5.092513561248779,
            "end_logit": -0.511214554309845
        },
        {
            "text": ", heterogeneity",
            "probability": 0.0013861913509744203,
            "start_logit": -0.013346257619559765,
            "end_logit": 3.6661722660064697
        },
        {
            "text": "important issues to be considered",
            "probability": 0.0013081325763116577,
            "start_logit": -0.2729736268520355,
            "end_logit": 3.86784029006958
        },
        {
            "text": ", heterogeneity in methodologies",
            "probability": 0.001222747382885671,
            "start_logit": -0.013346257619559765,
            "end_logit": 3.540712594985962
        },
        {
            "text": "PD-L1 assays in terms of primary antibodies and scoring algorithms, and tumor heterogenity for PD-L1 expression",
            "probability": 0.0011504158429467783,
            "start_logit": -1.2659326791763306,
            "end_logit": 4.7323222160339355
        },
        {
            "text": "primary antibodies and scoring algorithms, and tumor heterogenity for PD-L1 expression",
            "probability": 0.001130239685805656,
            "start_logit": -1.2836264371871948,
            "end_logit": 4.7323222160339355
        },
        {
            "text": "and tumor heterogenity for PD-L1 expression",
            "probability": 0.0011244650569126947,
            "start_logit": -1.2887487411499023,
            "end_logit": 4.7323222160339355
        },
        {
            "text": "heterogenity for PD-L1 expression",
            "probability": 0.0010075383303109673,
            "start_logit": -1.3985460996627808,
            "end_logit": 4.7323222160339355
        },
        {
            "text": "",
            "probability": 0.0007409363339746237,
            "start_logit": 1.3021188974380493,
            "end_logit": 1.724306583404541
        }
    ],
    "5c7a4a31d774d04240000006_008": [
        {
            "text": "not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors treatment.",
            "probability": 0.32532634436142854,
            "start_logit": 2.76640248298645,
            "end_logit": 4.212489604949951
        },
        {
            "text": "could not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors treatment.",
            "probability": 0.21277425970131458,
            "start_logit": 2.3418054580688477,
            "end_logit": 4.212489604949951
        },
        {
            "text": "PD-L1 overexpression could not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors treatment.",
            "probability": 0.09596531376177063,
            "start_logit": 1.5455604791641235,
            "end_logit": 4.212489604949951
        },
        {
            "text": "not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors treatment",
            "probability": 0.058922543771748284,
            "start_logit": 2.76640248298645,
            "end_logit": 2.5038845539093018
        },
        {
            "text": "overexpression could not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors treatment.",
            "probability": 0.04346712630629419,
            "start_logit": 0.7535786032676697,
            "end_logit": 4.212489604949951
        },
        {
            "text": "could not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors treatment",
            "probability": 0.0385373052261134,
            "start_logit": 2.3418054580688477,
            "end_logit": 2.5038845539093018
        },
        {
            "text": "CONCLUSION: Taking this data in account, PD-L1 overexpression",
            "probability": 0.028843481729886173,
            "start_logit": 2.1095781326293945,
            "end_logit": 2.446369171142578
        },
        {
            "text": "not be currently considered a robust biomarker",
            "probability": 0.026102472415151158,
            "start_logit": 2.76640248298645,
            "end_logit": 1.6896908283233643
        },
        {
            "text": "",
            "probability": 0.02409279163647761,
            "start_logit": 1.9453505277633667,
            "end_logit": 2.4306254386901855
        },
        {
            "text": "Taking this data in account, PD-L1 overexpression",
            "probability": 0.023938579581751267,
            "start_logit": 1.9231854677200317,
            "end_logit": 2.446369171142578
        },
        {
            "text": "PD-L1 overexpression could not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors treatment",
            "probability": 0.017381071341752367,
            "start_logit": 1.5455604791641235,
            "end_logit": 2.5038845539093018
        },
        {
            "text": "could not be currently considered a robust biomarker",
            "probability": 0.017071885940898493,
            "start_logit": 2.3418054580688477,
            "end_logit": 1.6896908283233643
        },
        {
            "text": "PD-L1 overexpression",
            "probability": 0.016409597505164557,
            "start_logit": 1.5455604791641235,
            "end_logit": 2.446369171142578
        },
        {
            "text": "CONCLUSION: Taking this data in account, PD-L1 overexpression could not be currently considered a robust biomarker",
            "probability": 0.01353400880014727,
            "start_logit": 2.1095781326293945,
            "end_logit": 1.6896908283233643
        },
        {
            "text": "CONCLUSION",
            "probability": 0.011421990295789665,
            "start_logit": 2.1095781326293945,
            "end_logit": 1.520025610923767
        },
        {
            "text": "Taking this data in account, PD-L1 overexpression could not be currently considered a robust biomarker",
            "probability": 0.01123251865903382,
            "start_logit": 1.9231854677200317,
            "end_logit": 1.6896908283233643
        },
        {
            "text": "not",
            "probability": 0.009937625419356519,
            "start_logit": 2.76640248298645,
            "end_logit": 0.7239888906478882
        },
        {
            "text": "immune checkpoint inhibitors treatment.",
            "probability": 0.009468641610310982,
            "start_logit": -0.7704408764839172,
            "end_logit": 4.212489604949951
        },
        {
            "text": "overexpression could not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors treatment",
            "probability": 0.007872690597627458,
            "start_logit": 0.7535786032676697,
            "end_logit": 2.5038845539093018
        },
        {
            "text": "PD-L1 overexpression could not be currently considered a robust biomarker",
            "probability": 0.007699751337982742,
            "start_logit": 1.5455604791641235,
            "end_logit": 1.6896908283233643
        }
    ],
    "5c7a4a31d774d04240000006_009": [
        {
            "text": "",
            "probability": 0.8314684324111832,
            "start_logit": 2.7187414169311523,
            "end_logit": 3.1697025299072266
        },
        {
            "text": "the significance of companion diagnostic testing for tumor PD-L1 expression.",
            "probability": 0.07462773379283891,
            "start_logit": 1.766345500946045,
            "end_logit": 1.711417317390442
        },
        {
            "text": "the significance of companion diagnostic testing for tumor PD-L1 expression",
            "probability": 0.02358186212442448,
            "start_logit": 1.766345500946045,
            "end_logit": 0.559382975101471
        },
        {
            "text": "the significance of companion diagnostic testing",
            "probability": 0.019440836550635054,
            "start_logit": 1.766345500946045,
            "end_logit": 0.3662809431552887
        },
        {
            "text": "significance of companion diagnostic testing for tumor PD-L1 expression.",
            "probability": 0.01703419097263131,
            "start_logit": 0.28905585408210754,
            "end_logit": 1.711417317390442
        },
        {
            "text": "significance of companion diagnostic testing for tumor PD-L1 expression",
            "probability": 0.005382689819213745,
            "start_logit": 0.28905585408210754,
            "end_logit": 0.559382975101471
        },
        {
            "text": "companion diagnostic testing for tumor PD-L1 expression.",
            "probability": 0.005254149809876094,
            "start_logit": -0.8871484994888306,
            "end_logit": 1.711417317390442
        },
        {
            "text": "significance of companion diagnostic testing",
            "probability": 0.004437477940714388,
            "start_logit": 0.28905585408210754,
            "end_logit": 0.3662809431552887
        },
        {
            "text": "many patients with NSCLC fail to respond to anti-PD-1/PD-L1",
            "probability": 0.003656737076244242,
            "start_logit": 0.9686633944511414,
            "end_logit": -0.5068415403366089
        },
        {
            "text": "many patients with NSCLC fail to respond",
            "probability": 0.0033442125975278367,
            "start_logit": 0.9686633944511414,
            "end_logit": -0.5961815118789673
        },
        {
            "text": "the significance",
            "probability": 0.0032468554533239837,
            "start_logit": 1.766345500946045,
            "end_logit": -1.4234079122543335
        },
        {
            "text": "many patients with NSCLC",
            "probability": 0.0016802644024230308,
            "start_logit": 0.9686633944511414,
            "end_logit": -1.2844616174697876
        },
        {
            "text": "companion diagnostic testing for tumor PD-L1 expression",
            "probability": 0.0016602760140286947,
            "start_logit": -0.8871484994888306,
            "end_logit": 0.559382975101471
        },
        {
            "text": "companion diagnostic testing",
            "probability": 0.0013687279845573034,
            "start_logit": -0.8871484994888306,
            "end_logit": 0.3662809431552887
        },
        {
            "text": "and the significance of companion diagnostic testing for tumor PD-L1 expression.",
            "probability": 0.0009166547245226122,
            "start_logit": -2.6331911087036133,
            "end_logit": 1.711417317390442
        },
        {
            "text": "significance",
            "probability": 0.0007411126271900448,
            "start_logit": 0.28905585408210754,
            "end_logit": -1.4234079122543335
        },
        {
            "text": "we discuss",
            "probability": 0.0006685987076973425,
            "start_logit": 0.09570435434579849,
            "end_logit": -1.3330249786376953
        },
        {
            "text": "discuss",
            "probability": 0.0005611965691965104,
            "start_logit": -0.07940845191478729,
            "end_logit": -1.3330249786376953
        },
        {
            "text": "the identification of a biomarker to select these patients remains highly sought after. In this review",
            "probability": 0.0004641933818742931,
            "start_logit": -0.6783490180969238,
            "end_logit": -0.923854410648346
        },
        {
            "text": "In this review",
            "probability": 0.0004637970398970018,
            "start_logit": -0.6792032122612,
            "end_logit": -0.923854410648346
        }
    ],
    "5c7a4a31d774d04240000006_010": [
        {
            "text": "",
            "probability": 0.999810730245479,
            "start_logit": 4.520236968994141,
            "end_logit": 5.006879806518555
        },
        {
            "text": "only PD-L1 expression on tumor cells",
            "probability": 3.301205806583912e-05,
            "start_logit": -0.5753321051597595,
            "end_logit": -0.21599949896335602
        },
        {
            "text": "need to be confirmed by larger studies.",
            "probability": 2.652212889526903e-05,
            "start_logit": -0.4865812063217163,
            "end_logit": -0.5236438512802124
        },
        {
            "text": "These data need to be confirmed by larger studies.",
            "probability": 2.1613729485365846e-05,
            "start_logit": -0.691231906414032,
            "end_logit": -0.5236438512802124
        },
        {
            "text": "a significantly higher frequency of pCR in cases showing \u226550% stromal TILs (p < 0.001)",
            "probability": 1.672218007704137e-05,
            "start_logit": -1.254573106765747,
            "end_logit": -0.21689540147781372
        },
        {
            "text": "(ii) a significantly higher frequency of pCR in cases showing \u226550% stromal TILs (p < 0.001)",
            "probability": 1.4787064366605271e-05,
            "start_logit": -1.377556324005127,
            "end_logit": -0.21689540147781372
        },
        {
            "text": "(i) a significant association between PD-L1 expression in \u226525% of neoplastic cells",
            "probability": 9.9606109199567e-06,
            "start_logit": -0.7242878675460815,
            "end_logit": -1.2652782201766968
        },
        {
            "text": "a significantly higher frequency of pCR in cases showing \u226550% stromal TILs",
            "probability": 8.541641435771345e-06,
            "start_logit": -1.254573106765747,
            "end_logit": -0.8886781930923462
        },
        {
            "text": "(ii) a significantly higher frequency of pCR in cases showing \u226550% stromal TILs",
            "probability": 7.5531899025907775e-06,
            "start_logit": -1.377556324005127,
            "end_logit": -0.8886781930923462
        },
        {
            "text": "Univariate analysis showed (i) a significant association between PD-L1 expression in \u226525% of neoplastic cells",
            "probability": 7.237023211034413e-06,
            "start_logit": -1.043716311454773,
            "end_logit": -1.2652782201766968
        },
        {
            "text": "need to be confirmed by larger studies",
            "probability": 7.109073755925196e-06,
            "start_logit": -0.4865812063217163,
            "end_logit": -1.8402513265609741
        },
        {
            "text": "These data need to be confirmed by larger studies",
            "probability": 5.793411142025231e-06,
            "start_logit": -0.691231906414032,
            "end_logit": -1.8402513265609741
        },
        {
            "text": "data need to be confirmed by larger studies.",
            "probability": 4.763765553404032e-06,
            "start_logit": -2.203522205352783,
            "end_logit": -0.5236438512802124
        },
        {
            "text": "significantly higher frequency of pCR in cases showing \u226550% stromal TILs (p < 0.001)",
            "probability": 4.569135725615854e-06,
            "start_logit": -2.551985025405884,
            "end_logit": -0.21689540147781372
        },
        {
            "text": "\u226550% stromal TILs (p < 0.001)",
            "probability": 4.444490008057067e-06,
            "start_logit": -2.579643964767456,
            "end_logit": -0.21689540147781372
        },
        {
            "text": "only PD-L1 expression on tumor cells remained significantly associated with pCR",
            "probability": 3.599721544714243e-06,
            "start_logit": -0.5753321051597595,
            "end_logit": -2.432015895843506
        },
        {
            "text": "confirmed by larger studies.",
            "probability": 3.4676025946783658e-06,
            "start_logit": -2.521097183227539,
            "end_logit": -0.5236438512802124
        },
        {
            "text": "Univariate analysis",
            "probability": 3.3910645715262014e-06,
            "start_logit": -1.043716311454773,
            "end_logit": -2.0233442783355713
        },
        {
            "text": "to be confirmed by larger studies.",
            "probability": 3.205899651040499e-06,
            "start_logit": -2.5995678901672363,
            "end_logit": -0.5236438512802124
        },
        {
            "text": "a significantly higher frequency of pCR in cases showing \u226550% stromal TILs (p < 0.001).",
            "probability": 2.9759636141684057e-06,
            "start_logit": -1.254573106765747,
            "end_logit": -1.943063497543335
        }
    ],
    "5c7a4a31d774d04240000006_011": [
        {
            "text": "its clinical significance is still debatable",
            "probability": 0.6251730124303904,
            "start_logit": 3.2057478427886963,
            "end_logit": 4.649145603179932
        },
        {
            "text": "clinical significance is still debatable",
            "probability": 0.12510465828422115,
            "start_logit": 1.5968700647354126,
            "end_logit": 4.649145603179932
        },
        {
            "text": "its clinical significance",
            "probability": 0.09590834284153935,
            "start_logit": 3.2057478427886963,
            "end_logit": 2.774510145187378
        },
        {
            "text": "Although the most studied biomarker is PD-L1 expression, its clinical significance is still debatable",
            "probability": 0.035946131880638756,
            "start_logit": 0.3497408926486969,
            "end_logit": 4.649145603179932
        },
        {
            "text": "still debatable",
            "probability": 0.027744070065951074,
            "start_logit": 0.09074153751134872,
            "end_logit": 4.649145603179932
        },
        {
            "text": "debatable",
            "probability": 0.020989780564301737,
            "start_logit": -0.18824490904808044,
            "end_logit": 4.649145603179932
        },
        {
            "text": "clinical significance",
            "probability": 0.019192415890045614,
            "start_logit": 1.5968700647354126,
            "end_logit": 2.774510145187378
        },
        {
            "text": "",
            "probability": 0.012705143938513125,
            "start_logit": 1.680489420890808,
            "end_logit": 2.2783825397491455
        },
        {
            "text": "the most studied biomarker is PD-L1 expression, its clinical significance is still debatable",
            "probability": 0.008520955738859378,
            "start_logit": -1.0897520780563354,
            "end_logit": 4.649145603179932
        },
        {
            "text": "significance is still debatable",
            "probability": 0.006375764411266335,
            "start_logit": -1.3797765970230103,
            "end_logit": 4.649145603179932
        },
        {
            "text": "Although the most studied biomarker is PD-L1 expression, its clinical significance",
            "probability": 0.00551452777341273,
            "start_logit": 0.3497408926486969,
            "end_logit": 2.774510145187378
        },
        {
            "text": "is still debatable",
            "probability": 0.005400227917516829,
            "start_logit": -1.5458394289016724,
            "end_logit": 4.649145603179932
        },
        {
            "text": "PD-L1 expression, its clinical significance is still debatable",
            "probability": 0.0033264600288691157,
            "start_logit": -2.030371904373169,
            "end_logit": 4.649145603179932
        },
        {
            "text": "its clinical significance is still debatable.",
            "probability": 0.0026330828883722557,
            "start_logit": 3.2057478427886963,
            "end_logit": -0.8207274675369263
        },
        {
            "text": "its clinical",
            "probability": 0.0013873701257830422,
            "start_logit": 3.2057478427886963,
            "end_logit": -1.4614728689193726
        },
        {
            "text": "the most studied biomarker is PD-L1 expression, its clinical significance",
            "probability": 0.0013072073299566843,
            "start_logit": -1.0897520780563354,
            "end_logit": 2.774510145187378
        },
        {
            "text": "significance",
            "probability": 0.0009781116376975773,
            "start_logit": -1.3797765970230103,
            "end_logit": 2.774510145187378
        },
        {
            "text": "its clinical significance is still debatable. In this article, we show the updated survival analysis of all published data",
            "probability": 0.0007555094514621693,
            "start_logit": 3.2057478427886963,
            "end_logit": -2.0692458152770996
        },
        {
            "text": "clinical significance is still debatable.",
            "probability": 0.0005269116363536553,
            "start_logit": 1.5968700647354126,
            "end_logit": -0.8207274675369263
        },
        {
            "text": "PD-L1 expression, its clinical significance",
            "probability": 0.0005103151648488327,
            "start_logit": -2.030371904373169,
            "end_logit": 2.774510145187378
        }
    ],
    "5c7a4a31d774d04240000006_013": [
        {
            "text": "lacking",
            "probability": 0.5507685655349275,
            "start_logit": 1.9677200317382812,
            "end_logit": 4.527141094207764
        },
        {
            "text": "",
            "probability": 0.26362040519991436,
            "start_logit": 2.4371745586395264,
            "end_logit": 3.3208820819854736
        },
        {
            "text": "a rational basis for anti PD-L1/PD-1 therapy in HNSCC is lacking",
            "probability": 0.09734192038991699,
            "start_logit": 0.23463506996631622,
            "end_logit": 4.527141094207764
        },
        {
            "text": "therefore a rational basis for anti PD-L1/PD-1 therapy in HNSCC is lacking",
            "probability": 0.022187784621683564,
            "start_logit": -1.244052767753601,
            "end_logit": 4.527141094207764
        },
        {
            "text": "rational basis for anti PD-L1/PD-1 therapy in HNSCC is lacking",
            "probability": 0.0201752649604257,
            "start_logit": -1.339137315750122,
            "end_logit": 4.527141094207764
        },
        {
            "text": "comprehensive data",
            "probability": 0.012321033323017167,
            "start_logit": 1.6257047653198242,
            "end_logit": 1.0691494941711426
        },
        {
            "text": "is lacking",
            "probability": 0.008177306495166231,
            "start_logit": -2.242231845855713,
            "end_logit": 4.527141094207764
        },
        {
            "text": "comprehensive data about PD-L1 expression in HNSCC",
            "probability": 0.008117254550753572,
            "start_logit": 1.6257047653198242,
            "end_logit": 0.6518336534500122
        },
        {
            "text": "a rational basis for anti PD-L1/PD-1 therapy in HNSCC",
            "probability": 0.002795577954763834,
            "start_logit": 0.23463506996631622,
            "end_logit": 0.9769502282142639
        },
        {
            "text": "disruption of antitumoral immune response",
            "probability": 0.002165271461762745,
            "start_logit": -0.05190891772508621,
            "end_logit": 1.0080010890960693
        },
        {
            "text": "tumor stage and distant metastasis behind",
            "probability": 0.001987534480508421,
            "start_logit": -0.3529147803783417,
            "end_logit": 1.2233561277389526
        },
        {
            "text": "However, comprehensive data",
            "probability": 0.0018873057372948135,
            "start_logit": -0.25045278668403625,
            "end_logit": 1.0691494941711426
        },
        {
            "text": "comprehensive",
            "probability": 0.00136605327549569,
            "start_logit": 1.6257047653198242,
            "end_logit": -1.130232572555542
        },
        {
            "text": "However, comprehensive data about PD-L1 expression in HNSCC",
            "probability": 0.001243381190772412,
            "start_logit": -0.25045278668403625,
            "end_logit": 0.6518336534500122
        },
        {
            "text": "comprehensive data about PD-L1 expression in HNSCC and therefore a rational basis",
            "probability": 0.0011825904354705013,
            "start_logit": 1.6257047653198242,
            "end_logit": -1.2744510173797607
        },
        {
            "text": "comprehensive data about PD-L1 expression",
            "probability": 0.001064009558813231,
            "start_logit": 1.6257047653198242,
            "end_logit": -1.380113959312439
        },
        {
            "text": "tumor stage and distant metastasis",
            "probability": 0.0010158699756162499,
            "start_logit": -0.3529147803783417,
            "end_logit": 0.5522065758705139
        },
        {
            "text": "immunosuppressive microenvironment and disruption of antitumoral immune response",
            "probability": 0.0009802489310462626,
            "start_logit": -0.8444033861160278,
            "end_logit": 1.0080010890960693
        },
        {
            "text": "leaving even tumor stage and distant metastasis behind",
            "probability": 0.000850902350635602,
            "start_logit": -1.2012676000595093,
            "end_logit": 1.2233561277389526
        },
        {
            "text": "We observed a strong correlation between expression of PD-L1 and reduced overall survival time",
            "probability": 0.0007517195720151639,
            "start_logit": -0.6478284001350403,
            "end_logit": 0.5459828972816467
        }
    ],
    "5c7a4a31d774d04240000006_014": [
        {
            "text": "",
            "probability": 0.9160670820630242,
            "start_logit": 2.5791544914245605,
            "end_logit": 3.1218228340148926
        },
        {
            "text": "we observed a dichotomy between the morphology (WD- and PD-NENs) and Ki67",
            "probability": 0.013732623359588365,
            "start_logit": 0.4415992796421051,
            "end_logit": 1.0590627193450928
        },
        {
            "text": "reflecting an unfavorable environment for T-cell-mediated tumor aggression",
            "probability": 0.008744120478706869,
            "start_logit": -0.7514469027519226,
            "end_logit": 1.8007161617279053
        },
        {
            "text": "unfavorable environment for T-cell-mediated tumor aggression",
            "probability": 0.007915525597931627,
            "start_logit": -0.8510023355484009,
            "end_logit": 1.8007161617279053
        },
        {
            "text": "a dichotomy between the morphology (WD- and PD-NENs) and Ki67",
            "probability": 0.006910570832272789,
            "start_logit": -0.2451227456331253,
            "end_logit": 1.0590627193450928
        },
        {
            "text": "G3 tumors are characterized by strong PD-L1 expression in both the tumor and infiltrating immune cells",
            "probability": 0.004738193493384688,
            "start_logit": -0.10682341456413269,
            "end_logit": 0.5433670878410339
        },
        {
            "text": "In particular, G3 tumors are characterized by strong PD-L1 expression in both the tumor and infiltrating immune cells",
            "probability": 0.0047125112436561855,
            "start_logit": -0.1122584193944931,
            "end_logit": 0.5433670878410339
        },
        {
            "text": "not with gender, primary site, or lymph node status",
            "probability": 0.0044394931898099595,
            "start_logit": -0.7511247992515564,
            "end_logit": 1.122552752494812
        },
        {
            "text": "dichotomy between the morphology (WD- and PD-NENs) and Ki67",
            "probability": 0.004396402439170553,
            "start_logit": -0.6973884105682373,
            "end_logit": 1.0590627193450928
        },
        {
            "text": "we observed a dichotomy",
            "probability": 0.0038675231940627003,
            "start_logit": 0.4415992796421051,
            "end_logit": -0.20809724926948547
        },
        {
            "text": "T-cell-mediated tumor aggression",
            "probability": 0.0034709974531953896,
            "start_logit": -1.6753864288330078,
            "end_logit": 1.8007161617279053
        },
        {
            "text": "These findings suggest that NENs might acquire resistance to immune surveillance",
            "probability": 0.003338922868398694,
            "start_logit": 0.6579812169075012,
            "end_logit": -0.5714452266693115
        },
        {
            "text": "we observed a dichotomy between the morphology (WD- and PD-NENs) and Ki67.",
            "probability": 0.0030746546795267556,
            "start_logit": 0.4415992796421051,
            "end_logit": -0.4375189542770386
        },
        {
            "text": "There are no available data",
            "probability": 0.002512097141555031,
            "start_logit": 0.488040030002594,
            "end_logit": -0.6860343813896179
        },
        {
            "text": "fails to provide reliable prognostic and therapeutic indications",
            "probability": 0.002474454955440977,
            "start_logit": -0.6266363263130188,
            "end_logit": 0.4135442078113556
        },
        {
            "text": "These findings suggest that NENs",
            "probability": 0.0023257847696485368,
            "start_logit": 0.6579812169075012,
            "end_logit": -0.9330359697341919
        },
        {
            "text": "Ki67",
            "probability": 0.0021679681154087357,
            "start_logit": -1.4043846130371094,
            "end_logit": 1.0590627193450928
        },
        {
            "text": "a dichotomy",
            "probability": 0.0019462263165738874,
            "start_logit": -0.2451227456331253,
            "end_logit": -0.20809724926948547
        },
        {
            "text": "In particular in G3 cases, we observed a dichotomy",
            "probability": 0.0016176111014776738,
            "start_logit": -0.4300645887851715,
            "end_logit": -0.20809724926948547
        },
        {
            "text": "a dichotomy between the morphology (WD- and PD-NENs) and Ki67.",
            "probability": 0.0015472367071666002,
            "start_logit": -0.2451227456331253,
            "end_logit": -0.4375189542770386
        }
    ],
    "5c7a4a31d774d04240000006_016": [
        {
            "text": "there are fundamental differences in PD-L1 expression between NSCLC and gastroesophageal cancers",
            "probability": 0.5262109802742271,
            "start_logit": 3.7488291263580322,
            "end_logit": 5.814259052276611
        },
        {
            "text": "fundamental differences in PD-L1 expression between NSCLC and gastroesophageal cancers",
            "probability": 0.3963504675389621,
            "start_logit": 3.465425729751587,
            "end_logit": 5.814259052276611
        },
        {
            "text": "as there are fundamental differences in PD-L1 expression between NSCLC and gastroesophageal cancers",
            "probability": 0.019524804745587734,
            "start_logit": 0.45481258630752563,
            "end_logit": 5.814259052276611
        },
        {
            "text": "differences in PD-L1 expression between NSCLC and gastroesophageal cancers",
            "probability": 0.015552576394870642,
            "start_logit": 0.22735320031642914,
            "end_logit": 5.814259052276611
        },
        {
            "text": "",
            "probability": 0.01009953615417256,
            "start_logit": 2.4352588653564453,
            "end_logit": 3.174616575241089
        },
        {
            "text": "there are fundamental differences in PD-L1 expression",
            "probability": 0.0052551160442836226,
            "start_logit": 3.7488291263580322,
            "end_logit": 1.207758903503418
        },
        {
            "text": "there are fundamental differences",
            "probability": 0.004040690683912129,
            "start_logit": 3.7488291263580322,
            "end_logit": 0.9449724555015564
        },
        {
            "text": "fundamental differences in PD-L1 expression",
            "probability": 0.003958236865444844,
            "start_logit": 3.465425729751587,
            "end_logit": 1.207758903503418
        },
        {
            "text": "We question the use of PD-L1 as a biomarker in gastroesophageal cancers",
            "probability": 0.00361005018276169,
            "start_logit": 2.1432888507843018,
            "end_logit": 2.437818765640259
        },
        {
            "text": "fundamental differences",
            "probability": 0.0030435123967088016,
            "start_logit": 3.465425729751587,
            "end_logit": 0.9449724555015564
        },
        {
            "text": "PD-L1 expression between NSCLC and gastroesophageal cancers",
            "probability": 0.0025263849081478447,
            "start_logit": -1.5900837182998657,
            "end_logit": 5.814259052276611
        },
        {
            "text": "Potential alternatives, especially microsatellite instability and Epstein-Barr virus positivity, are discussed.",
            "probability": 0.002320085093041817,
            "start_logit": 2.2353477478027344,
            "end_logit": 1.9036420583724976
        },
        {
            "text": "NSCLC and gastroesophageal cancers",
            "probability": 0.0014007449084795119,
            "start_logit": -2.1798689365386963,
            "end_logit": 5.814259052276611
        },
        {
            "text": "Potential alternatives, especially microsatellite instability and Epstein-Barr virus positivity",
            "probability": 0.0011549569874768982,
            "start_logit": 2.2353477478027344,
            "end_logit": 1.2061012983322144
        },
        {
            "text": "there are fundamental differences in PD-L1 expression between NSCLC and gastroesophageal cancer",
            "probability": 0.0010838132719569375,
            "start_logit": 3.7488291263580322,
            "end_logit": -0.37095755338668823
        },
        {
            "text": "expression between NSCLC and gastroesophageal cancers",
            "probability": 0.0010390454025213573,
            "start_logit": -2.4785706996917725,
            "end_logit": 5.814259052276611
        },
        {
            "text": "fundamental differences in PD-L1 expression between NSCLC and gastroesophageal cancer",
            "probability": 0.000816345369382449,
            "start_logit": 3.465425729751587,
            "end_logit": -0.37095755338668823
        },
        {
            "text": "We question the use of PD-L1 as a biomarker in gastroesophageal cancers, as there are fundamental differences",
            "probability": 0.0008112941122003276,
            "start_logit": 2.1432888507843018,
            "end_logit": 0.9449724555015564
        },
        {
            "text": "Potential alternatives",
            "probability": 0.0006063991454841143,
            "start_logit": 2.2353477478027344,
            "end_logit": 0.5618213415145874
        },
        {
            "text": "We question the use of PD-L1 as a biomarker in gastroesophageal cancers,",
            "probability": 0.0005949595203776377,
            "start_logit": 2.1432888507843018,
            "end_logit": 0.6348351836204529
        }
    ],
    "5c7a4a31d774d04240000006_017": [
        {
            "text": "its use has been complicated by a number of factors",
            "probability": 0.48734039997394996,
            "start_logit": 2.7589056491851807,
            "end_logit": 4.34057092666626
        },
        {
            "text": "complicated by a number of factors",
            "probability": 0.19832531401300238,
            "start_logit": 1.8598514795303345,
            "end_logit": 4.34057092666626
        },
        {
            "text": "a number of factors",
            "probability": 0.13717657642440892,
            "start_logit": 1.4912117719650269,
            "end_logit": 4.34057092666626
        },
        {
            "text": "use has been complicated by a number of factors",
            "probability": 0.04616125906426026,
            "start_logit": 0.40208369493484497,
            "end_logit": 4.34057092666626
        },
        {
            "text": "number of factors",
            "probability": 0.026602960964454494,
            "start_logit": -0.14903467893600464,
            "end_logit": 4.34057092666626
        },
        {
            "text": "a number of factors which has prompted many researchers to establish better predictive biomarkers for immunotherapy of NSCLC",
            "probability": 0.021551410805246078,
            "start_logit": 1.4912117719650269,
            "end_logit": 2.489743232727051
        },
        {
            "text": "has been complicated by a number of factors",
            "probability": 0.019944963211675992,
            "start_logit": -0.4370805621147156,
            "end_logit": 4.34057092666626
        },
        {
            "text": "has prompted many researchers to establish better predictive biomarkers for immunotherapy of NSCLC",
            "probability": 0.009086024771592028,
            "start_logit": 0.6275079846382141,
            "end_logit": 2.489743232727051
        },
        {
            "text": "factors",
            "probability": 0.008634877772883999,
            "start_logit": -1.274247646331787,
            "end_logit": 4.34057092666626
        },
        {
            "text": "its use has been complicated by a number of factors which has prompted many researchers to establish better predictive biomarkers",
            "probability": 0.007770640384627547,
            "start_logit": 2.7589056491851807,
            "end_logit": 0.20196065306663513
        },
        {
            "text": "its use has been complicated by a number of",
            "probability": 0.005400243683294646,
            "start_logit": 2.7589056491851807,
            "end_logit": -0.1619478464126587
        },
        {
            "text": "its use has been complicated",
            "probability": 0.004996287738583648,
            "start_logit": 2.7589056491851807,
            "end_logit": -0.23969674110412598
        },
        {
            "text": "prompted many researchers to establish better predictive biomarkers for immunotherapy of NSCLC",
            "probability": 0.004725103185059865,
            "start_logit": -0.02634011022746563,
            "end_logit": 2.489743232727051
        },
        {
            "text": "number of factors which has prompted many researchers to establish better predictive biomarkers for immunotherapy of NSCLC",
            "probability": 0.004179513407646663,
            "start_logit": -0.14903467893600464,
            "end_logit": 2.489743232727051
        },
        {
            "text": "by a number of factors",
            "probability": 0.0040737290675556545,
            "start_logit": -2.025498390197754,
            "end_logit": 4.34057092666626
        },
        {
            "text": "complicated by a number of factors which has prompted many researchers to establish better predictive biomarkers",
            "probability": 0.003162296198808377,
            "start_logit": 1.8598514795303345,
            "end_logit": 0.20196065306663513
        },
        {
            "text": "been complicated by a number of factors",
            "probability": 0.002983435323270356,
            "start_logit": -2.336981773376465,
            "end_logit": 4.34057092666626
        },
        {
            "text": "and its use has been complicated by a number of factors",
            "probability": 0.002366779616970272,
            "start_logit": -2.5685269832611084,
            "end_logit": 4.34057092666626
        },
        {
            "text": "complicated by a number of",
            "probability": 0.0021976528609025485,
            "start_logit": 1.8598514795303345,
            "end_logit": -0.1619478464126587
        },
        {
            "text": "a number of factors which has prompted many researchers to establish better predictive biomarkers",
            "probability": 0.002187279865665637,
            "start_logit": 1.4912117719650269,
            "end_logit": 0.20196065306663513
        },
        {
            "text": "",
            "probability": 0.001133251666140524,
            "start_logit": 0.24106666445732117,
            "end_logit": 0.794538140296936
        }
    ],
    "5c7a4a31d774d04240000006_020": [
        {
            "text": "most locoregional recurrences and distant metastases are of epithelial origin",
            "probability": 0.24457595550824546,
            "start_logit": 1.6929559707641602,
            "end_logit": 3.114842414855957
        },
        {
            "text": "",
            "probability": 0.20947614553756416,
            "start_logit": 2.158367395401001,
            "end_logit": 2.4945149421691895
        },
        {
            "text": "the search for targetable biomarkers has not been successful so far",
            "probability": 0.07880012967051561,
            "start_logit": 1.0090560913085938,
            "end_logit": 2.666131019592285
        },
        {
            "text": "there are currently no consensus guidelines for the treatment of these neoplasms and the search for targetable biomarkers has not been successful so far",
            "probability": 0.07501591859392431,
            "start_logit": 0.959841787815094,
            "end_logit": 2.666131019592285
        },
        {
            "text": "This is particularly important as most locoregional recurrences and distant metastases are of epithelial origin",
            "probability": 0.054727275275319016,
            "start_logit": 0.1957922726869583,
            "end_logit": 3.114842414855957
        },
        {
            "text": "search for targetable biomarkers has not been successful so far",
            "probability": 0.054705028881923065,
            "start_logit": 0.644097089767456,
            "end_logit": 2.666131019592285
        },
        {
            "text": "not been successful so far",
            "probability": 0.03698427447818323,
            "start_logit": 0.2526342570781708,
            "end_logit": 2.666131019592285
        },
        {
            "text": "locoregional recurrences and distant metastases are of epithelial origin",
            "probability": 0.02742265812132387,
            "start_logit": -0.49520033597946167,
            "end_logit": 3.114842414855957
        },
        {
            "text": "has not been successful so far",
            "probability": 0.02652397917486561,
            "start_logit": -0.07980935275554657,
            "end_logit": 2.666131019592285
        },
        {
            "text": "the search for targetable biomarkers has not been successful",
            "probability": 0.025985503061528088,
            "start_logit": 1.0090560913085938,
            "end_logit": 1.5567551851272583
        },
        {
            "text": "there are currently no consensus guidelines for the treatment of these neoplasms and the search for targetable biomarkers has not been successful",
            "probability": 0.024737603737917904,
            "start_logit": 0.959841787815094,
            "end_logit": 1.5567551851272583
        },
        {
            "text": "no consensus guidelines for the treatment of these neoplasms and the search for targetable biomarkers has not been successful so far",
            "probability": 0.02390908893329536,
            "start_logit": -0.18359987437725067,
            "end_logit": 2.666131019592285
        },
        {
            "text": "search for targetable biomarkers has not been successful",
            "probability": 0.01803978878506956,
            "start_logit": 0.644097089767456,
            "end_logit": 1.5567551851272583
        },
        {
            "text": "the search for targetable biomarkers",
            "probability": 0.018026832313864056,
            "start_logit": 1.0090560913085938,
            "end_logit": 1.191077709197998
        },
        {
            "text": "there are currently no consensus guidelines for the treatment of these neoplasms and the search for targetable biomarkers",
            "probability": 0.01716113147297442,
            "start_logit": 0.959841787815094,
            "end_logit": 1.191077709197998
        },
        {
            "text": "there are currently no consensus guidelines for the treatment of these neoplasms",
            "probability": 0.014933657015618612,
            "start_logit": 0.959841787815094,
            "end_logit": 1.0520482063293457
        },
        {
            "text": "targetable biomarkers has not been successful so far",
            "probability": 0.013063244654594443,
            "start_logit": -0.7880560159683228,
            "end_logit": 2.666131019592285
        },
        {
            "text": "search for targetable biomarkers",
            "probability": 0.012514679690286157,
            "start_logit": 0.644097089767456,
            "end_logit": 1.191077709197998
        },
        {
            "text": "not been successful",
            "probability": 0.012196109088901926,
            "start_logit": 0.2526342570781708,
            "end_logit": 1.5567551851272583
        },
        {
            "text": "the search for targetable biomarkers has not been successful so far.",
            "probability": 0.011200996004084973,
            "start_logit": 1.0090560913085938,
            "end_logit": 0.7152190804481506
        }
    ],
    "5c7a4a31d774d04240000006_021": [
        {
            "text": "the selection performance of the PD-L1 biomarker test is not perfect, and the existence of 4 drug/test combinations",
            "probability": 0.30081169566874877,
            "start_logit": 3.6714088916778564,
            "end_logit": 4.583906650543213
        },
        {
            "text": "the existence of 4 drug/test combinations",
            "probability": 0.2179100739284244,
            "start_logit": 3.3490068912506104,
            "end_logit": 4.583906650543213
        },
        {
            "text": "the selection performance of the PD-L1 biomarker test is not perfect",
            "probability": 0.16896704182986846,
            "start_logit": 3.6714088916778564,
            "end_logit": 4.0071258544921875
        },
        {
            "text": "existence of 4 drug/test combinations",
            "probability": 0.05132888619034117,
            "start_logit": 1.903178095817566,
            "end_logit": 4.583906650543213
        },
        {
            "text": "the selection performance of the PD-L1 biomarker test is not perfect,",
            "probability": 0.04635078838470706,
            "start_logit": 3.6714088916778564,
            "end_logit": 2.713660478591919
        },
        {
            "text": "4 drug/test combinations",
            "probability": 0.03848831848240339,
            "start_logit": 1.615279197692871,
            "end_logit": 4.583906650543213
        },
        {
            "text": "the selection performance of the PD-L1 biomarker test is not perfect, and the existence of 4 drug/test combinations adds significantly",
            "probability": 0.028843358041716494,
            "start_logit": 3.6714088916778564,
            "end_logit": 2.239301919937134
        },
        {
            "text": "the clinical data for these drugs show considerable variation, the selection performance of the PD-L1 biomarker test is not perfect",
            "probability": 0.02693181480494902,
            "start_logit": 1.835013508796692,
            "end_logit": 4.0071258544921875
        },
        {
            "text": "the existence of 4 drug/test combinations adds significantly",
            "probability": 0.020894328158489316,
            "start_logit": 3.3490068912506104,
            "end_logit": 2.239301919937134
        },
        {
            "text": "the existence of 4 drug/test combinations adds significantly to the problems faced",
            "probability": 0.01802363536370598,
            "start_logit": 3.3490068912506104,
            "end_logit": 2.091508150100708
        },
        {
            "text": "not perfect, and the existence of 4 drug/test combinations",
            "probability": 0.012416899933374125,
            "start_logit": 0.4839828610420227,
            "end_logit": 4.583906650543213
        },
        {
            "text": "both oncologists and pathologists face some significant challenges",
            "probability": 0.011824842338605621,
            "start_logit": 2.4032063484191895,
            "end_logit": 2.6158273220062256
        },
        {
            "text": "selection performance of the PD-L1 biomarker test is not perfect, and the existence of 4 drug/test combinations",
            "probability": 0.009462960372095883,
            "start_logit": 0.21230968832969666,
            "end_logit": 4.583906650543213
        },
        {
            "text": "complex, the clinical data for these drugs show considerable variation, the selection performance of the PD-L1 biomarker test is not perfect",
            "probability": 0.008612743102702174,
            "start_logit": 0.6949480772018433,
            "end_logit": 4.0071258544921875
        },
        {
            "text": "the existence of 4 drug/test combinations adds significantly to the problems",
            "probability": 0.008599744392123429,
            "start_logit": 3.3490068912506104,
            "end_logit": 1.351556658744812
        },
        {
            "text": "the clinical data for these drugs show considerable variation, the selection performance of the PD-L1 biomarker test is not perfect,",
            "probability": 0.00738789550507268,
            "start_logit": 1.835013508796692,
            "end_logit": 2.713660478591919
        },
        {
            "text": "not perfect",
            "probability": 0.00697461860907851,
            "start_logit": 0.4839828610420227,
            "end_logit": 4.0071258544921875
        },
        {
            "text": "selection performance of the PD-L1 biomarker test is not perfect",
            "probability": 0.005315379834123999,
            "start_logit": 0.21230968832969666,
            "end_logit": 4.0071258544921875
        },
        {
            "text": "existence of 4 drug/test combinations adds significantly",
            "probability": 0.004921675132940439,
            "start_logit": 1.903178095817566,
            "end_logit": 2.239301919937134
        },
        {
            "text": "considerable variation, the selection performance of the PD-L1 biomarker test is not perfect, and the existence of 4 drug/test combinations",
            "probability": 0.004470015410516524,
            "start_logit": -0.5376837253570557,
            "end_logit": 4.583906650543213
        },
        {
            "text": "",
            "probability": 0.0014632845160122024,
            "start_logit": 1.15934419631958,
            "end_logit": 1.7701704502105713
        }
    ],
    "5c7a4a31d774d04240000006_022": [
        {
            "text": "the selection performance of the PD-L1 biomarker test is not perfect, and the existence of 4 drug/test combinations",
            "probability": 0.30081169566874877,
            "start_logit": 3.6714088916778564,
            "end_logit": 4.583906650543213
        },
        {
            "text": "the existence of 4 drug/test combinations",
            "probability": 0.2179100739284244,
            "start_logit": 3.3490068912506104,
            "end_logit": 4.583906650543213
        },
        {
            "text": "the selection performance of the PD-L1 biomarker test is not perfect",
            "probability": 0.16896704182986846,
            "start_logit": 3.6714088916778564,
            "end_logit": 4.0071258544921875
        },
        {
            "text": "existence of 4 drug/test combinations",
            "probability": 0.05132888619034117,
            "start_logit": 1.903178095817566,
            "end_logit": 4.583906650543213
        },
        {
            "text": "the selection performance of the PD-L1 biomarker test is not perfect,",
            "probability": 0.04635078838470706,
            "start_logit": 3.6714088916778564,
            "end_logit": 2.713660478591919
        },
        {
            "text": "4 drug/test combinations",
            "probability": 0.03848831848240339,
            "start_logit": 1.615279197692871,
            "end_logit": 4.583906650543213
        },
        {
            "text": "the selection performance of the PD-L1 biomarker test is not perfect, and the existence of 4 drug/test combinations adds significantly",
            "probability": 0.028843358041716494,
            "start_logit": 3.6714088916778564,
            "end_logit": 2.239301919937134
        },
        {
            "text": "the clinical data for these drugs show considerable variation, the selection performance of the PD-L1 biomarker test is not perfect",
            "probability": 0.02693181480494902,
            "start_logit": 1.835013508796692,
            "end_logit": 4.0071258544921875
        },
        {
            "text": "the existence of 4 drug/test combinations adds significantly",
            "probability": 0.020894328158489316,
            "start_logit": 3.3490068912506104,
            "end_logit": 2.239301919937134
        },
        {
            "text": "the existence of 4 drug/test combinations adds significantly to the problems faced",
            "probability": 0.01802363536370598,
            "start_logit": 3.3490068912506104,
            "end_logit": 2.091508150100708
        },
        {
            "text": "not perfect, and the existence of 4 drug/test combinations",
            "probability": 0.012416899933374125,
            "start_logit": 0.4839828610420227,
            "end_logit": 4.583906650543213
        },
        {
            "text": "both oncologists and pathologists face some significant challenges",
            "probability": 0.011824842338605621,
            "start_logit": 2.4032063484191895,
            "end_logit": 2.6158273220062256
        },
        {
            "text": "selection performance of the PD-L1 biomarker test is not perfect, and the existence of 4 drug/test combinations",
            "probability": 0.009462960372095883,
            "start_logit": 0.21230968832969666,
            "end_logit": 4.583906650543213
        },
        {
            "text": "complex, the clinical data for these drugs show considerable variation, the selection performance of the PD-L1 biomarker test is not perfect",
            "probability": 0.008612743102702174,
            "start_logit": 0.6949480772018433,
            "end_logit": 4.0071258544921875
        },
        {
            "text": "the existence of 4 drug/test combinations adds significantly to the problems",
            "probability": 0.008599744392123429,
            "start_logit": 3.3490068912506104,
            "end_logit": 1.351556658744812
        },
        {
            "text": "the clinical data for these drugs show considerable variation, the selection performance of the PD-L1 biomarker test is not perfect,",
            "probability": 0.00738789550507268,
            "start_logit": 1.835013508796692,
            "end_logit": 2.713660478591919
        },
        {
            "text": "not perfect",
            "probability": 0.00697461860907851,
            "start_logit": 0.4839828610420227,
            "end_logit": 4.0071258544921875
        },
        {
            "text": "selection performance of the PD-L1 biomarker test is not perfect",
            "probability": 0.005315379834123999,
            "start_logit": 0.21230968832969666,
            "end_logit": 4.0071258544921875
        },
        {
            "text": "existence of 4 drug/test combinations adds significantly",
            "probability": 0.004921675132940439,
            "start_logit": 1.903178095817566,
            "end_logit": 2.239301919937134
        },
        {
            "text": "considerable variation, the selection performance of the PD-L1 biomarker test is not perfect, and the existence of 4 drug/test combinations",
            "probability": 0.004470015410516524,
            "start_logit": -0.5376837253570557,
            "end_logit": 4.583906650543213
        },
        {
            "text": "",
            "probability": 0.0014632845160122024,
            "start_logit": 1.15934419631958,
            "end_logit": 1.7701704502105713
        }
    ],
    "5e307a05fbd6abf43b000036_002": [
        {
            "text": "",
            "probability": 0.9712353770934156,
            "start_logit": 4.29473876953125,
            "end_logit": 5.129998683929443
        },
        {
            "text": "HiTSelect",
            "probability": 0.022795236443404577,
            "start_logit": 2.801372766494751,
            "end_logit": 2.871347427368164
        },
        {
            "text": "HiTSelect,",
            "probability": 0.0016061878234610084,
            "start_logit": 2.801372766494751,
            "end_logit": 0.2186594009399414
        },
        {
            "text": "HiTSelect using data from both genome-wide RNAi and CRISPR/Cas9 screens. HiTSelect",
            "probability": 0.0011334340383099143,
            "start_logit": 2.316572666168213,
            "end_logit": 0.3548479378223419
        },
        {
            "text": "superior performance of HiTSelect",
            "probability": 0.0005377519347618192,
            "start_logit": -1.4021307229995728,
            "end_logit": 3.327941417694092
        },
        {
            "text": "We developed HiTSelect",
            "probability": 0.00047655137391023017,
            "start_logit": -1.0663585662841797,
            "end_logit": 2.871347427368164
        },
        {
            "text": "HiTSelect, a comprehensive analysis pipeline",
            "probability": 0.0004722761069753947,
            "start_logit": 2.801372766494751,
            "end_logit": -1.0053956508636475
        },
        {
            "text": "We document the superior performance of HiTSelect",
            "probability": 0.00046680831279703657,
            "start_logit": -1.543609380722046,
            "end_logit": 3.327941417694092
        },
        {
            "text": "HiTSelect, a comprehensive analysis pipeline for rigorously selecting screen hits and identifying functionally relevant genes and pathways",
            "probability": 0.00036618231842945126,
            "start_logit": 2.801372766494751,
            "end_logit": -1.2598280906677246
        },
        {
            "text": "document the superior performance of HiTSelect",
            "probability": 0.0002987142494941587,
            "start_logit": -1.99004065990448,
            "end_logit": 3.327941417694092
        },
        {
            "text": "the superior performance of HiTSelect",
            "probability": 0.00022396426051282488,
            "start_logit": -2.2780416011810303,
            "end_logit": 3.327941417694092
        },
        {
            "text": "HiTSelect, a comprehensive analysis pipeline for rigorously selecting screen hits",
            "probability": 6.132512205366645e-05,
            "start_logit": 2.801372766494751,
            "end_logit": -3.046769857406616
        },
        {
            "text": "HiTS",
            "probability": 5.819164481491506e-05,
            "start_logit": 2.801372766494751,
            "end_logit": -3.099217653274536
        },
        {
            "text": "HiTSelect, a comprehensive analysis pipeline for rigorously selecting screen hits and identifying functionally relevant genes and pathways by addressing off-target effects",
            "probability": 5.543727569273537e-05,
            "start_logit": 2.801372766494751,
            "end_logit": -3.147707223892212
        },
        {
            "text": "performance of HiTSelect",
            "probability": 5.021911669201448e-05,
            "start_logit": -3.77313232421875,
            "end_logit": 3.327941417694092
        },
        {
            "text": "HiTSelect using data from both genome-wide RNAi and CRISPR/Cas9 screens.",
            "probability": 3.957694837863469e-05,
            "start_logit": 2.316572666168213,
            "end_logit": -2.9999125003814697
        },
        {
            "text": "We developed HiTSelect,",
            "probability": 3.3578551199879775e-05,
            "start_logit": -1.0663585662841797,
            "end_logit": 0.2186594009399414
        },
        {
            "text": "developed HiTSelect",
            "probability": 3.212097441570298e-05,
            "start_logit": -3.763424873352051,
            "end_logit": 2.871347427368164
        },
        {
            "text": "HiTSelect, a comprehensive analysis",
            "probability": 2.9563169348931618e-05,
            "start_logit": 2.801372766494751,
            "end_logit": -3.776430130004883
        },
        {
            "text": "superior performance of HiTSelect using data from both genome-wide RNAi and CRISPR/Cas9 screens. HiTSelect",
            "probability": 2.7503241931792688e-05,
            "start_logit": -1.4021307229995728,
            "end_logit": 0.3548479378223419
        }
    ],
    "5e307a05fbd6abf43b000036_004": [
        {
            "text": "Model-based",
            "probability": 0.5692225048170211,
            "start_logit": 2.9627909660339355,
            "end_logit": 3.3280723094940186
        },
        {
            "text": "Model-based Analysis",
            "probability": 0.1484165533223967,
            "start_logit": 2.9627909660339355,
            "end_logit": 1.9838237762451172
        },
        {
            "text": "Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK) method",
            "probability": 0.07999715010996013,
            "start_logit": 2.9627909660339355,
            "end_logit": 1.365791916847229
        },
        {
            "text": "Model",
            "probability": 0.0419184365001525,
            "start_logit": 2.9627909660339355,
            "end_logit": 0.7195266485214233
        },
        {
            "text": "Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK",
            "probability": 0.03949688818854638,
            "start_logit": 2.9627909660339355,
            "end_logit": 0.6600227952003479
        },
        {
            "text": "the Model-based",
            "probability": 0.024881726202503236,
            "start_logit": -0.16734679043293,
            "end_logit": 3.3280723094940186
        },
        {
            "text": "We propose the Model-based",
            "probability": 0.023560128646356766,
            "start_logit": -0.22192461788654327,
            "end_logit": 3.3280723094940186
        },
        {
            "text": "MAGeCK) method",
            "probability": 0.012566173774355295,
            "start_logit": 1.1118085384368896,
            "end_logit": 1.365791916847229
        },
        {
            "text": "propose the Model-based",
            "probability": 0.010822158790139423,
            "start_logit": -0.9998846650123596,
            "end_logit": 3.3280723094940186
        },
        {
            "text": "the Model-based Analysis",
            "probability": 0.006487551023433591,
            "start_logit": -0.16734679043293,
            "end_logit": 1.9838237762451172
        },
        {
            "text": "Model-",
            "probability": 0.006205327528789049,
            "start_logit": 2.9627909660339355,
            "end_logit": -1.1907908916473389
        },
        {
            "text": "MAGeCK",
            "probability": 0.006204280525510366,
            "start_logit": 1.1118085384368896,
            "end_logit": 0.6600227952003479
        },
        {
            "text": "We propose the Model-based Analysis",
            "probability": 0.006142963533475486,
            "start_logit": -0.22192461788654327,
            "end_logit": 1.9838237762451172
        },
        {
            "text": "Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK)",
            "probability": 0.005160580169233906,
            "start_logit": 2.9627909660339355,
            "end_logit": -1.3751500844955444
        },
        {
            "text": "",
            "probability": 0.0036350996370858846,
            "start_logit": 0.5469545125961304,
            "end_logit": 0.6902738809585571
        },
        {
            "text": "the Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK) method",
            "probability": 0.003496817446907556,
            "start_logit": -0.16734679043293,
            "end_logit": 1.365791916847229
        },
        {
            "text": "We propose the Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK) method",
            "probability": 0.003311083332059108,
            "start_logit": -0.22192461788654327,
            "end_logit": 1.365791916847229
        },
        {
            "text": "based",
            "probability": 0.0028937897557578507,
            "start_logit": -2.318913459777832,
            "end_logit": 3.3280723094940186
        },
        {
            "text": "propose the Model-based Analysis",
            "probability": 0.0028217217231361704,
            "start_logit": -0.9998846650123596,
            "end_logit": 1.9838237762451172
        },
        {
            "text": "Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout",
            "probability": 0.002759064973179593,
            "start_logit": 2.9627909660339355,
            "end_logit": -2.001307249069214
        }
    ],
    "5e2a0eb1aa19d7443100000c_001": [
        {
            "text": "but not in vitro",
            "probability": 0.15678502498394675,
            "start_logit": 3.5075855255126953,
            "end_logit": 4.233981132507324
        },
        {
            "text": "but not",
            "probability": 0.14554400959643457,
            "start_logit": 3.5075855255126953,
            "end_logit": 4.159584045410156
        },
        {
            "text": "not in vitro",
            "probability": 0.10266364183443433,
            "start_logit": 3.084167957305908,
            "end_logit": 4.233981132507324
        },
        {
            "text": "not",
            "probability": 0.09530296706516297,
            "start_logit": 3.084167957305908,
            "end_logit": 4.159584045410156
        },
        {
            "text": "specifically inhibits PRL3+ cancer cells in vivo",
            "probability": 0.09004471272718657,
            "start_logit": 2.9417877197265625,
            "end_logit": 4.245209693908691
        },
        {
            "text": "specifically inhibits PRL3+ cancer cells in vivo, but not in vitro",
            "probability": 0.08903929540016814,
            "start_logit": 2.9417877197265625,
            "end_logit": 4.233981132507324
        },
        {
            "text": "specifically inhibits PRL3+ cancer cells in vivo, but not",
            "probability": 0.08265544534950792,
            "start_logit": 2.9417877197265625,
            "end_logit": 4.159584045410156
        },
        {
            "text": "in vivo",
            "probability": 0.036351171070043986,
            "start_logit": 2.03470778465271,
            "end_logit": 4.245209693908691
        },
        {
            "text": "in vivo, but not in vitro",
            "probability": 0.03594528274918316,
            "start_logit": 2.03470778465271,
            "end_logit": 4.233981132507324
        },
        {
            "text": "in vivo, but not",
            "probability": 0.033368113937726734,
            "start_logit": 2.03470778465271,
            "end_logit": 4.159584045410156
        },
        {
            "text": "PRL3-zumab specifically inhibits PRL3+ cancer cells in vivo",
            "probability": 0.020427395633101548,
            "start_logit": 1.4583582878112793,
            "end_logit": 4.245209693908691
        },
        {
            "text": "PRL3-zumab specifically inhibits PRL3+ cancer cells in vivo, but not in vitro",
            "probability": 0.020199308309666954,
            "start_logit": 1.4583582878112793,
            "end_logit": 4.233981132507324
        },
        {
            "text": "PRL3-zumab specifically inhibits PRL3+ cancer cells in vivo, but not",
            "probability": 0.01875107857248818,
            "start_logit": 1.4583582878112793,
            "end_logit": 4.159584045410156
        },
        {
            "text": "inhibits PRL3+ cancer cells in vivo",
            "probability": 0.013791446454106454,
            "start_logit": 1.0655299425125122,
            "end_logit": 4.245209693908691
        },
        {
            "text": "inhibits PRL3+ cancer cells in vivo, but not in vitro",
            "probability": 0.013637454522657725,
            "start_logit": 1.0655299425125122,
            "end_logit": 4.233981132507324
        },
        {
            "text": "specifically inhibits PRL3+ cancer cells",
            "probability": 0.013341718807904426,
            "start_logit": 2.9417877197265625,
            "end_logit": 2.335799217224121
        },
        {
            "text": "inhibits PRL3+ cancer cells in vivo, but not",
            "probability": 0.012659689993479065,
            "start_logit": 1.0655299425125122,
            "end_logit": 4.159584045410156
        },
        {
            "text": "specifically",
            "probability": 0.008228215848439543,
            "start_logit": 2.9417877197265625,
            "end_logit": 1.8524725437164307
        },
        {
            "text": "but not in vitro.",
            "probability": 0.005749043869729443,
            "start_logit": 3.5075855255126953,
            "end_logit": 0.9281390905380249
        },
        {
            "text": "specifically inhibits PRL3+ cancer cells in vivo,",
            "probability": 0.005499463315328368,
            "start_logit": 2.9417877197265625,
            "end_logit": 1.4495538473129272
        },
        {
            "text": "",
            "probability": 1.55199593030727e-05,
            "start_logit": -0.873699963092804,
            "end_logit": -0.6052373647689819
        }
    ],
    "5e48e0e0f8b2df0d49000001_002": [
        {
            "text": "profoundly impacted gut microbiota profiles in both animals",
            "probability": 0.20739126953122133,
            "start_logit": 2.29948353767395,
            "end_logit": 2.3007636070251465
        },
        {
            "text": "profoundly impacted",
            "probability": 0.12236702280941464,
            "start_logit": 2.29948353767395,
            "end_logit": 1.7731813192367554
        },
        {
            "text": "Irradiation profoundly impacted gut microbiota profiles in both animals",
            "probability": 0.0865103898066952,
            "start_logit": 1.4251408576965332,
            "end_logit": 2.3007636070251465
        },
        {
            "text": "profoundly",
            "probability": 0.0854372743198619,
            "start_logit": 2.29948353767395,
            "end_logit": 1.4139388799667358
        },
        {
            "text": "profoundly impacted gut microbiota profiles",
            "probability": 0.06467601336504634,
            "start_logit": 2.29948353767395,
            "end_logit": 1.1355468034744263
        },
        {
            "text": "dissimilar between minipigs and rhesus macaques. Irradiation profoundly impacted gut microbiota profiles in both animals",
            "probability": 0.058772547918857526,
            "start_logit": 1.0385512113571167,
            "end_logit": 2.3007636070251465
        },
        {
            "text": "impacted gut microbiota profiles in both animals",
            "probability": 0.057600383120611935,
            "start_logit": 1.018405556678772,
            "end_logit": 2.3007636070251465
        },
        {
            "text": "Irradiation profoundly impacted",
            "probability": 0.051043705295094756,
            "start_logit": 1.4251408576965332,
            "end_logit": 1.7731813192367554
        },
        {
            "text": "Irradiation profoundly",
            "probability": 0.03563897324192862,
            "start_logit": 1.4251408576965332,
            "end_logit": 1.4139388799667358
        },
        {
            "text": "dissimilar between minipigs and rhesus macaques. Irradiation profoundly impacted",
            "probability": 0.03467755285943498,
            "start_logit": 1.0385512113571167,
            "end_logit": 1.7731813192367554
        },
        {
            "text": "impacted",
            "probability": 0.03398594073454889,
            "start_logit": 1.018405556678772,
            "end_logit": 1.7731813192367554
        },
        {
            "text": "Irradiation profoundly impacted gut microbiota profiles",
            "probability": 0.026978701369639268,
            "start_logit": 1.4251408576965332,
            "end_logit": 1.1355468034744263
        },
        {
            "text": "dissimilar between minipigs and rhesus macaques. Irradiation profoundly",
            "probability": 0.0242120428230694,
            "start_logit": 1.0385512113571167,
            "end_logit": 1.4139388799667358
        },
        {
            "text": "dissimilar",
            "probability": 0.01879667764618739,
            "start_logit": 1.0385512113571167,
            "end_logit": 1.1607688665390015
        },
        {
            "text": "dissimilar between minipigs and rhesus macaques. Irradiation profoundly impacted gut microbiota profiles",
            "probability": 0.018328515483269248,
            "start_logit": 1.0385512113571167,
            "end_logit": 1.1355468034744263
        },
        {
            "text": "profoundly impacted gut microbiota profiles in both animals.",
            "probability": 0.01825440896899831,
            "start_logit": 2.29948353767395,
            "end_logit": -0.12943695485591888
        },
        {
            "text": "impacted gut microbiota profiles",
            "probability": 0.017962969979214382,
            "start_logit": 1.018405556678772,
            "end_logit": 1.1355468034744263
        },
        {
            "text": "dissimilar between minipigs and rhesus macaques",
            "probability": 0.016223616439158973,
            "start_logit": 1.0385512113571167,
            "end_logit": 1.013556718826294
        },
        {
            "text": "Irradiation",
            "probability": 0.011431598580806055,
            "start_logit": 1.4251408576965332,
            "end_logit": 0.2768804132938385
        },
        {
            "text": "gut microbiota profiles were dissimilar between minipigs and rhesus macaques. Irradiation profoundly impacted",
            "probability": 0.009329570440434582,
            "start_logit": -0.27435240149497986,
            "end_logit": 1.7731813192367554
        },
        {
            "text": "",
            "probability": 0.0003808252665063301,
            "start_logit": -1.0288279056549072,
            "end_logit": -0.6709467768669128
        }
    ],
    "5e48e0e0f8b2df0d49000001_003": [
        {
            "text": "decrease in the major gut microbiota community Enterobacteriaceae",
            "probability": 0.4906519007626575,
            "start_logit": 3.5909767150878906,
            "end_logit": 3.3217456340789795
        },
        {
            "text": "characterized by a decrease in the major gut microbiota community Enterobacteriaceae",
            "probability": 0.09795823944031729,
            "start_logit": 1.979783058166504,
            "end_logit": 3.3217456340789795
        },
        {
            "text": "Enterobacteriaceae",
            "probability": 0.0966857959645638,
            "start_logit": 1.9667083024978638,
            "end_logit": 3.3217456340789795
        },
        {
            "text": "decrease",
            "probability": 0.06472985800658132,
            "start_logit": 3.5909767150878906,
            "end_logit": 1.2962332963943481
        },
        {
            "text": "a decrease in the major gut microbiota community Enterobacteriaceae",
            "probability": 0.05875444556237007,
            "start_logit": 1.4686086177825928,
            "end_logit": 3.3217456340789795
        },
        {
            "text": "Enterobacteriaceae, an expansion of the minor members (e.g., Bacillaceae) and a higher richness and diversity",
            "probability": 0.04128782908873106,
            "start_logit": 1.9667083024978638,
            "end_logit": 2.4708468914031982
        },
        {
            "text": "decrease in the major gut microbiota community Enterobacteriaceae, an expansion of the minor members",
            "probability": 0.03237759789178006,
            "start_logit": 3.5909767150878906,
            "end_logit": 0.6034774780273438
        },
        {
            "text": "decrease in the major gut microbiota community",
            "probability": 0.018192050183278224,
            "start_logit": 3.5909767150878906,
            "end_logit": 0.02699541300535202
        },
        {
            "text": "major gut microbiota community Enterobacteriaceae",
            "probability": 0.015378616868936636,
            "start_logit": 0.1282198280096054,
            "end_logit": 3.3217456340789795
        },
        {
            "text": "characterized by a decrease",
            "probability": 0.012923261725248408,
            "start_logit": 1.979783058166504,
            "end_logit": 1.2962332963943481
        },
        {
            "text": "shift in the gut bacterial composition and structure by sterilizing irradiation, characterized by a decrease",
            "probability": 0.009433503189610263,
            "start_logit": 1.6650216579437256,
            "end_logit": 1.2962332963943481
        },
        {
            "text": "decrease in the major gut microbiota",
            "probability": 0.009261386794496883,
            "start_logit": 3.5909767150878906,
            "end_logit": -0.6481354832649231
        },
        {
            "text": "changes in microbiome taxonomy tend to drive microbiome functional shifts",
            "probability": 0.008853642772550172,
            "start_logit": 1.4494211673736572,
            "end_logit": 1.4483952522277832
        },
        {
            "text": "decrease in the major gut microbiota community Enterobacteriaceae,",
            "probability": 0.00858341275606536,
            "start_logit": 3.5909767150878906,
            "end_logit": -0.7241576910018921
        },
        {
            "text": "a decrease",
            "probability": 0.007751252797749435,
            "start_logit": 1.4686086177825928,
            "end_logit": 1.2962332963943481
        },
        {
            "text": "characterized by a decrease in the major gut microbiota community Enterobacteriaceae, an expansion of the minor members",
            "probability": 0.006464160195558933,
            "start_logit": 1.979783058166504,
            "end_logit": 0.6034774780273438
        },
        {
            "text": "Enterobacteriaceae, an expansion of the minor members",
            "probability": 0.006380193001843945,
            "start_logit": 1.9667083024978638,
            "end_logit": 0.6034774780273438
        },
        {
            "text": "shift in the gut bacterial composition and structure",
            "probability": 0.0051838711180158745,
            "start_logit": 1.6650216579437256,
            "end_logit": 0.6975178718566895
        },
        {
            "text": "a shift in the gut bacterial composition and structure by sterilizing irradiation, characterized by a decrease",
            "probability": 0.00448022302969064,
            "start_logit": 0.9204269647598267,
            "end_logit": 1.2962332963943481
        },
        {
            "text": "shift in the gut bacterial composition and structure by sterilizing irradiation",
            "probability": 0.004423328733959802,
            "start_logit": 1.6650216579437256,
            "end_logit": 0.5388582944869995
        },
        {
            "text": "",
            "probability": 0.0002454301159944466,
            "start_logit": -0.5137938261032104,
            "end_logit": -0.17396177351474762
        }
    ],
    "5e2b1ed9fbd6abf43b000005_001": [
        {
            "text": "Parkinson's Disease",
            "probability": 0.7042785653590931,
            "start_logit": 4.207810401916504,
            "end_logit": 3.988539695739746
        },
        {
            "text": "Parkinson's",
            "probability": 0.16987339022394607,
            "start_logit": 4.207810401916504,
            "end_logit": 2.5664191246032715
        },
        {
            "text": "",
            "probability": 0.0909371232082511,
            "start_logit": 2.976058006286621,
            "end_logit": 3.1732864379882812
        },
        {
            "text": "Parkinson's Disease (PD)",
            "probability": 0.00923776561387401,
            "start_logit": 4.207810401916504,
            "end_logit": -0.3453342318534851
        },
        {
            "text": "Parkinson",
            "probability": 0.007850204195262807,
            "start_logit": 4.207810401916504,
            "end_logit": -0.5080947279930115
        },
        {
            "text": "Parkinson's Disease (PD",
            "probability": 0.005990711863198346,
            "start_logit": 4.207810401916504,
            "end_logit": -0.7784240245819092
        },
        {
            "text": "Park",
            "probability": 0.0025776381801290607,
            "start_logit": 4.207810401916504,
            "end_logit": -1.6217607259750366
        },
        {
            "text": "QL with PD Questionnaire",
            "probability": 0.0018462439515599817,
            "start_logit": 0.6698877215385437,
            "end_logit": 1.5824416875839233
        },
        {
            "text": "Patients with Parkinson's Disease",
            "probability": 0.0015851846033264631,
            "start_logit": -1.8886626958847046,
            "end_logit": 3.988539695739746
        },
        {
            "text": "PD Questionnaire",
            "probability": 0.0013860922611428977,
            "start_logit": 0.38322290778160095,
            "end_logit": 1.5824416875839233
        },
        {
            "text": "Parkins",
            "probability": 0.0007583481039840123,
            "start_logit": 4.207810401916504,
            "end_logit": -2.8452470302581787
        },
        {
            "text": "Disease",
            "probability": 0.0007040236518663549,
            "start_logit": -2.7003068923950195,
            "end_logit": 3.988539695739746
        },
        {
            "text": "Parkinson'",
            "probability": 0.000578152086355008,
            "start_logit": 4.207810401916504,
            "end_logit": -3.1165525913238525
        },
        {
            "text": "QL",
            "probability": 0.0005693909735389894,
            "start_logit": 0.6698877215385437,
            "end_logit": 0.40610045194625854
        },
        {
            "text": "QL with PD",
            "probability": 0.00041963304449148616,
            "start_logit": 0.6698877215385437,
            "end_logit": 0.10091375559568405
        },
        {
            "text": "Parkinson's Disease (PD) undergo motor injuries, which decrease their quality of life (QL",
            "probability": 0.00038777583456439045,
            "start_logit": 4.207810401916504,
            "end_logit": -3.5159621238708496
        },
        {
            "text": "Patients with Parkinson's",
            "probability": 0.00038234967801493194,
            "start_logit": -1.8886626958847046,
            "end_logit": 2.5664191246032715
        },
        {
            "text": "PD",
            "probability": 0.00031504510278721165,
            "start_logit": 0.38322290778160095,
            "end_logit": 0.10091375559568405
        },
        {
            "text": "s Disease",
            "probability": 0.00021076744244743475,
            "start_logit": -3.9063634872436523,
            "end_logit": 3.988539695739746
        },
        {
            "text": "walking velocity with GAITRite and QL with PD Questionnaire",
            "probability": 0.00011159462216632673,
            "start_logit": -2.136147975921631,
            "end_logit": 1.5824416875839233
        }
    ],
    "5e2b1ed9fbd6abf43b000005_002": [
        {
            "text": "Parkinson's Disease Questionnaire",
            "probability": 0.3892972840967977,
            "start_logit": 6.468596935272217,
            "end_logit": 6.031848907470703
        },
        {
            "text": "Parkinson's Disease",
            "probability": 0.3036818893800645,
            "start_logit": 6.468596935272217,
            "end_logit": 5.783486366271973
        },
        {
            "text": "Parkinson's",
            "probability": 0.24195981189844362,
            "start_logit": 6.468596935272217,
            "end_logit": 5.556277275085449
        },
        {
            "text": "Parkinson's disease",
            "probability": 0.02123635003401058,
            "start_logit": 4.922853946685791,
            "end_logit": 4.6689629554748535
        },
        {
            "text": "39-item Parkinson's Disease Questionnaire",
            "probability": 0.013271788775072376,
            "start_logit": 3.0898942947387695,
            "end_logit": 6.031848907470703
        },
        {
            "text": "39-item Parkinson's Disease",
            "probability": 0.01035301825960071,
            "start_logit": 3.0898942947387695,
            "end_logit": 5.783486366271973
        },
        {
            "text": "39-item Parkinson's",
            "probability": 0.008248810476607181,
            "start_logit": 3.0898942947387695,
            "end_logit": 5.556277275085449
        },
        {
            "text": "Parkinson",
            "probability": 0.006031527992032383,
            "start_logit": 6.468596935272217,
            "end_logit": 1.8645060062408447
        },
        {
            "text": "Parkinson's Disease Questionnaire (PDQ39",
            "probability": 0.00268343345084552,
            "start_logit": 6.468596935272217,
            "end_logit": 1.0546027421951294
        },
        {
            "text": "Parkinson's Disease Question",
            "probability": 0.0010661279460771112,
            "start_logit": 6.468596935272217,
            "end_logit": 0.1315389722585678
        },
        {
            "text": "Park",
            "probability": 0.000780062260318094,
            "start_logit": 6.468596935272217,
            "end_logit": -0.18087591230869293
        },
        {
            "text": "Parkinson's disease (PD",
            "probability": 0.0002249915567915078,
            "start_logit": 4.922853946685791,
            "end_logit": 0.12155621498823166
        },
        {
            "text": "Parkinson's disease (PD)",
            "probability": 0.00022354285336934415,
            "start_logit": 4.922853946685791,
            "end_logit": 0.11509647220373154
        },
        {
            "text": "39-item Parkinson",
            "probability": 0.00020562477256143972,
            "start_logit": 3.0898942947387695,
            "end_logit": 1.8645060062408447
        },
        {
            "text": "",
            "probability": 0.0001853532469694834,
            "start_logit": 2.1964821815490723,
            "end_logit": 2.6541285514831543
        },
        {
            "text": "39-item",
            "probability": 0.0001769455887731123,
            "start_logit": 3.0898942947387695,
            "end_logit": 1.7142952680587769
        },
        {
            "text": "39",
            "probability": 0.00013335168226814818,
            "start_logit": 3.0898942947387695,
            "end_logit": 1.4314428567886353
        },
        {
            "text": "39-item Parkinson's Disease Questionnaire (PDQ39",
            "probability": 9.148268792630464e-05,
            "start_logit": 3.0898942947387695,
            "end_logit": 1.0546027421951294
        },
        {
            "text": "Disease Questionnaire",
            "probability": 8.348123964935774e-05,
            "start_logit": -1.978879690170288,
            "end_logit": 6.031848907470703
        },
        {
            "text": "Disease",
            "probability": 6.512180182126129e-05,
            "start_logit": -1.978879690170288,
            "end_logit": 5.783486366271973
        }
    ],
    "5e2b1ed9fbd6abf43b000005_003": [
        {
            "text": "Parkinson's disease",
            "probability": 0.6414476509327782,
            "start_logit": 2.681736707687378,
            "end_logit": 3.2763733863830566
        },
        {
            "text": "",
            "probability": 0.1489267107432791,
            "start_logit": 2.1047298908233643,
            "end_logit": 2.3931069374084473
        },
        {
            "text": "Parkinson's",
            "probability": 0.1200343990771095,
            "start_logit": 2.681736707687378,
            "end_logit": 1.6004241704940796
        },
        {
            "text": "Parkinson's disease (PD)",
            "probability": 0.038017265299951974,
            "start_logit": 2.681736707687378,
            "end_logit": 0.4506862163543701
        },
        {
            "text": "Parkinson's disease (PD",
            "probability": 0.012654480665129267,
            "start_logit": 2.681736707687378,
            "end_logit": -0.6493428349494934
        },
        {
            "text": "Parkinson",
            "probability": 0.007894076125566741,
            "start_logit": 2.681736707687378,
            "end_logit": -1.121241569519043
        },
        {
            "text": "Moroccan patients",
            "probability": 0.005921176195217642,
            "start_logit": 0.4829566478729248,
            "end_logit": 0.7899609804153442
        },
        {
            "text": "Parkinson's disease (PD).",
            "probability": 0.003075757562331565,
            "start_logit": 2.681736707687378,
            "end_logit": -2.06380295753479
        },
        {
            "text": "Moroccan",
            "probability": 0.0029751217543131352,
            "start_logit": 0.4829566478729248,
            "end_logit": 0.10171083360910416
        },
        {
            "text": "PDQ39-SI) was 23.22%",
            "probability": 0.002784263461865336,
            "start_logit": -0.3994937837123871,
            "end_logit": 0.917859673500061
        },
        {
            "text": "Non-motor symptoms (NMSs) are a real burden in Parkinson's disease",
            "probability": 0.0027759078250896617,
            "start_logit": -2.7610130310058594,
            "end_logit": 3.2763733863830566
        },
        {
            "text": "disease",
            "probability": 0.002182556071139786,
            "start_logit": -3.0014941692352295,
            "end_logit": 3.2763733863830566
        },
        {
            "text": "SI) was 23.22%",
            "probability": 0.0020887261183095206,
            "start_logit": -0.6869227886199951,
            "end_logit": 0.917859673500061
        },
        {
            "text": "Park",
            "probability": 0.0017722484267777903,
            "start_logit": 2.681736707687378,
            "end_logit": -2.615105152130127
        },
        {
            "text": "PD questionnaire 39-score index (PDQ39-SI) was 23.22%",
            "probability": 0.0017567911652141609,
            "start_logit": -0.8599882125854492,
            "end_logit": 0.917859673500061
        },
        {
            "text": "NMSs) are a real burden in Parkinson's disease",
            "probability": 0.0015724061390035798,
            "start_logit": -3.3293838500976562,
            "end_logit": 3.2763733863830566
        },
        {
            "text": "PD)",
            "probability": 0.0013105200604212061,
            "start_logit": -0.685879647731781,
            "end_logit": 0.4506862163543701
        },
        {
            "text": "23.22%",
            "probability": 0.001094595298894066,
            "start_logit": -1.333092451095581,
            "end_logit": 0.917859673500061
        },
        {
            "text": "39-score index (PDQ39-SI) was 23.22%",
            "probability": 0.0008970708611993084,
            "start_logit": -1.532097578048706,
            "end_logit": 0.917859673500061
        },
        {
            "text": "PD questionnaire 39-score index",
            "probability": 0.0008182762164084177,
            "start_logit": -0.8599882125854492,
            "end_logit": 0.1538154035806656
        }
    ],
    "5e2b1ed9fbd6abf43b000005_004": [
        {
            "text": "",
            "probability": 0.7006133093358486,
            "start_logit": 3.5433526039123535,
            "end_logit": 4.0456671714782715
        },
        {
            "text": "Parkinson's Disease",
            "probability": 0.24207572509411956,
            "start_logit": 3.151780128479004,
            "end_logit": 3.3745341300964355
        },
        {
            "text": "Parkinson's",
            "probability": 0.04204534672247918,
            "start_logit": 3.151780128479004,
            "end_logit": 1.6240322589874268
        },
        {
            "text": "Parkinson's Disease (PD)",
            "probability": 0.005714725043972408,
            "start_logit": 3.151780128479004,
            "end_logit": -0.37167027592658997
        },
        {
            "text": "Parkinson's Disease (PD",
            "probability": 0.004253969480392983,
            "start_logit": 3.151780128479004,
            "end_logit": -0.6668639183044434
        },
        {
            "text": "Parkinson",
            "probability": 0.002527545734338446,
            "start_logit": 3.151780128479004,
            "end_logit": -1.1874676942825317
        },
        {
            "text": "Parkinson's Disease (PD),",
            "probability": 0.0013215875162311608,
            "start_logit": 3.151780128479004,
            "end_logit": -1.8358827829360962
        },
        {
            "text": "Park",
            "probability": 0.0004986500759344766,
            "start_logit": 3.151780128479004,
            "end_logit": -2.8105671405792236
        },
        {
            "text": "Objective measurement of motor function is available for Parkinson's Disease",
            "probability": 0.00033915762330021535,
            "start_logit": -3.4187607765197754,
            "end_logit": 3.3745341300964355
        },
        {
            "text": "Disease",
            "probability": 0.00031537527288226513,
            "start_logit": -3.491462469100952,
            "end_logit": 3.3745341300964355
        },
        {
            "text": "PD)",
            "probability": 9.58203999735874e-05,
            "start_logit": -0.936545729637146,
            "end_logit": -0.37167027592658997
        },
        {
            "text": "PD",
            "probability": 7.13275011396432e-05,
            "start_logit": -0.936545729637146,
            "end_logit": -0.6668639183044434
        },
        {
            "text": "Objective measurement of motor function is available for Parkinson's",
            "probability": 5.8907186417329615e-05,
            "start_logit": -3.4187607765197754,
            "end_logit": 1.6240322589874268
        },
        {
            "text": "PD),",
            "probability": 2.2159429094307482e-05,
            "start_logit": -0.936545729637146,
            "end_logit": -1.8358827829360962
        },
        {
            "text": "total UPDRS improved significantly (effect size\u2009=\u20098) as did the PDQ39 in cases reaching target.",
            "probability": 1.1446478246412406e-05,
            "start_logit": -2.7787036895751953,
            "end_logit": -0.6543058156967163
        },
        {
            "text": "Objective measurement of motor function is available for Parkinson's Disease (PD)",
            "probability": 8.006554820704666e-06,
            "start_logit": -3.4187607765197754,
            "end_logit": -0.37167027592658997
        },
        {
            "text": "cases reaching target",
            "probability": 7.993397256954723e-06,
            "start_logit": -3.137769937515259,
            "end_logit": -0.6543058156967163
        },
        {
            "text": "Disease (PD)",
            "probability": 7.445120610458489e-06,
            "start_logit": -3.491462469100952,
            "end_logit": -0.37167027592658997
        },
        {
            "text": "Objective measurement of motor function is available for Parkinson's Disease (PD",
            "probability": 5.959978754585103e-06,
            "start_logit": -3.4187607765197754,
            "end_logit": -0.6668639183044434
        },
        {
            "text": "Disease (PD",
            "probability": 5.542054186516014e-06,
            "start_logit": -3.491462469100952,
            "end_logit": -0.6668639183044434
        }
    ],
    "5e2b1ed9fbd6abf43b000005_005": [
        {
            "text": "Parkinson's disease",
            "probability": 0.5064994255526956,
            "start_logit": 4.968925476074219,
            "end_logit": 5.512247562408447
        },
        {
            "text": "Parkinson's Disease",
            "probability": 0.2970193983596462,
            "start_logit": 5.287034511566162,
            "end_logit": 4.660412788391113
        },
        {
            "text": "Parkinson's",
            "probability": 0.14297192100732545,
            "start_logit": 5.287034511566162,
            "end_logit": 3.9292635917663574
        },
        {
            "text": "Parkinson's Disease Questionnaire",
            "probability": 0.03356524029235919,
            "start_logit": 5.287034511566162,
            "end_logit": 2.4801063537597656
        },
        {
            "text": "Parkinson",
            "probability": 0.005051142542812273,
            "start_logit": 5.287034511566162,
            "end_logit": 0.5862298011779785
        },
        {
            "text": "Parkinson's Disease Questionnaire (PDQ39",
            "probability": 0.004083444446379081,
            "start_logit": 5.287034511566162,
            "end_logit": 0.3735561966896057
        },
        {
            "text": "Parkinson's disease (PD",
            "probability": 0.002335959024866886,
            "start_logit": 4.968925476074219,
            "end_logit": 0.13314689695835114
        },
        {
            "text": "Parkinson's disease (PD)",
            "probability": 0.0018853910032129901,
            "start_logit": 4.968925476074219,
            "end_logit": -0.08114039897918701
        },
        {
            "text": "Parkinson's Disease Questionnaire (PDQ39) with the white matter structural connectivity in 27 non-demented PD",
            "probability": 0.0012883368042615811,
            "start_logit": 5.287034511566162,
            "end_logit": -0.7800325751304626
        },
        {
            "text": "",
            "probability": 0.0010195799044945616,
            "start_logit": 2.056459665298462,
            "end_logit": 2.216580867767334
        },
        {
            "text": "Parkinson's Disease Questionnaire (PDQ39) with the white matter structural connectivity in 27 non-demented",
            "probability": 0.0008205193212759473,
            "start_logit": 5.287034511566162,
            "end_logit": -1.231202483177185
        },
        {
            "text": "Parkinson's Disease Questionnaire (PDQ39) with the white matter structural connectivity in 27 non-demented PD patients",
            "probability": 0.0007952669166140117,
            "start_logit": 5.287034511566162,
            "end_logit": -1.2624621391296387
        },
        {
            "text": "Parkinson's Disease Question",
            "probability": 0.0005929517359317847,
            "start_logit": 5.287034511566162,
            "end_logit": -1.5560269355773926
        },
        {
            "text": "Park",
            "probability": 0.0005845610928700494,
            "start_logit": 5.287034511566162,
            "end_logit": -1.5702786445617676
        },
        {
            "text": "disease",
            "probability": 0.0004575497995089132,
            "start_logit": -2.0404672622680664,
            "end_logit": 5.512247562408447
        },
        {
            "text": "patients with Parkinson's disease",
            "probability": 0.00037789363085435456,
            "start_logit": -2.2317402362823486,
            "end_logit": 5.512247562408447
        },
        {
            "text": "quality of life, evaluated by Parkinson's Disease",
            "probability": 0.0002299232268929171,
            "start_logit": -1.8767727613449097,
            "end_logit": 4.660412788391113
        },
        {
            "text": "evaluated by Parkinson's Disease",
            "probability": 0.0001634362352580188,
            "start_logit": -2.218095302581787,
            "end_logit": 4.660412788391113
        },
        {
            "text": "s disease",
            "probability": 0.00013783999879732987,
            "start_logit": -3.2402594089508057,
            "end_logit": 5.512247562408447
        },
        {
            "text": "diffusion MRI connectometry, to investigate the correlation of quality of life, evaluated by Parkinson's Disease",
            "probability": 0.00012021910394290854,
            "start_logit": -2.5252022743225098,
            "end_logit": 4.660412788391113
        }
    ],
    "5e2b1ed9fbd6abf43b000005_006": [
        {
            "text": "quality of life",
            "probability": 0.9100034045233869,
            "start_logit": 5.833675384521484,
            "end_logit": 7.353326320648193
        },
        {
            "text": "quality of life (QOL)",
            "probability": 0.053478357832962814,
            "start_logit": 5.833675384521484,
            "end_logit": 4.519155025482178
        },
        {
            "text": "PDQ39 scale for quality of life",
            "probability": 0.01654408695930972,
            "start_logit": 1.8262557983398438,
            "end_logit": 7.353326320648193
        },
        {
            "text": "quality of life (QOL",
            "probability": 0.006567773461764989,
            "start_logit": 5.833675384521484,
            "end_logit": 2.4220528602600098
        },
        {
            "text": "scale for quality of life",
            "probability": 0.0051780230706251025,
            "start_logit": 0.6646503806114197,
            "end_logit": 7.353326320648193
        },
        {
            "text": "life",
            "probability": 0.002454901317228758,
            "start_logit": -0.08168639242649078,
            "end_logit": 7.353326320648193
        },
        {
            "text": "",
            "probability": 0.0017682558158837228,
            "start_logit": 3.1510069370269775,
            "end_logit": 3.7925400733947754
        },
        {
            "text": "PDQ39 scale for quality of life (QOL)",
            "probability": 0.0009722497718489371,
            "start_logit": 1.8262557983398438,
            "end_logit": 4.519155025482178
        },
        {
            "text": "for quality of life",
            "probability": 0.0009526288060007664,
            "start_logit": -1.0283029079437256,
            "end_logit": 7.353326320648193
        },
        {
            "text": "quality of life (QOL).",
            "probability": 0.0005855945683708647,
            "start_logit": 5.833675384521484,
            "end_logit": 0.004750388208776712
        },
        {
            "text": "QOL)",
            "probability": 0.00039958939290796896,
            "start_logit": 0.9370805621147156,
            "end_logit": 4.519155025482178
        },
        {
            "text": "scale for quality of life (QOL)",
            "probability": 0.0003042979501634486,
            "start_logit": 0.6646503806114197,
            "end_logit": 4.519155025482178
        },
        {
            "text": "quality",
            "probability": 0.00018722912200349007,
            "start_logit": 5.833675384521484,
            "end_logit": -1.1355441808700562
        },
        {
            "text": "life (QOL)",
            "probability": 0.00014426769222487817,
            "start_logit": -0.08168639242649078,
            "end_logit": 4.519155025482178
        },
        {
            "text": "PDQ39 scale for quality of life (QOL",
            "probability": 0.00011940374589850684,
            "start_logit": 1.8262557983398438,
            "end_logit": 2.4220528602600098
        },
        {
            "text": "Moroccan Parkinsonian patients",
            "probability": 0.00011096968553984298,
            "start_logit": 1.9493480920791626,
            "end_logit": 2.2257070541381836
        },
        {
            "text": "Moroccan Parkinsonian",
            "probability": 8.653727769305493e-05,
            "start_logit": 1.9493480920791626,
            "end_logit": 1.9770252704620361
        },
        {
            "text": "for quality of life (QOL)",
            "probability": 5.598333359640505e-05,
            "start_logit": -1.0283029079437256,
            "end_logit": 4.519155025482178
        },
        {
            "text": "QOL",
            "probability": 4.907429316623696e-05,
            "start_logit": 0.9370805621147156,
            "end_logit": 2.4220528602600098
        },
        {
            "text": "scale for quality of life (QOL",
            "probability": 3.737137942409138e-05,
            "start_logit": 0.6646503806114197,
            "end_logit": 2.4220528602600098
        }
    ],
    "5e2b1ed9fbd6abf43b000005_007": [
        {
            "text": "Parkinson's",
            "probability": 0.568645561864098,
            "start_logit": 6.037385940551758,
            "end_logit": 4.938902378082275
        },
        {
            "text": "Parkinson's Disease Quality of Life 39",
            "probability": 0.12842004901748733,
            "start_logit": 6.037385940551758,
            "end_logit": 3.45095157623291
        },
        {
            "text": "Parkinson's Disease",
            "probability": 0.11617329314988638,
            "start_logit": 6.037385940551758,
            "end_logit": 3.3507280349731445
        },
        {
            "text": "Parkinson's Disease Quality of Life",
            "probability": 0.08380516081908562,
            "start_logit": 6.037385940551758,
            "end_logit": 3.024139642715454
        },
        {
            "text": "Parkinson",
            "probability": 0.028122683134674396,
            "start_logit": 6.037385940551758,
            "end_logit": 1.932221531867981
        },
        {
            "text": "Korean version of Parkinson's",
            "probability": 0.027831611776989437,
            "start_logit": 3.020301103591919,
            "end_logit": 4.938902378082275
        },
        {
            "text": "Parkinson's disease",
            "probability": 0.008275142277289678,
            "start_logit": 2.967211961746216,
            "end_logit": 3.7790751457214355
        },
        {
            "text": "Korean version of Parkinson's Disease Quality of Life 39",
            "probability": 0.00628535099600558,
            "start_logit": 3.020301103591919,
            "end_logit": 3.45095157623291
        },
        {
            "text": "Korean version of Parkinson's Disease",
            "probability": 0.005685949580267287,
            "start_logit": 3.020301103591919,
            "end_logit": 3.3507280349731445
        },
        {
            "text": "Parkinson's Disease Rating Scale part II) and quality of life [the Korean version of Parkinson's",
            "probability": 0.0049082471882283185,
            "start_logit": 1.2850455045700073,
            "end_logit": 4.938902378082275
        },
        {
            "text": "Parkinson's Disease Quality of Life 39 (K-PDQ39",
            "probability": 0.004410718640730401,
            "start_logit": 6.037385940551758,
            "end_logit": 0.07968268543481827
        },
        {
            "text": "Korean version of Parkinson's Disease Quality of Life",
            "probability": 0.004101733763961725,
            "start_logit": 3.020301103591919,
            "end_logit": 3.024139642715454
        },
        {
            "text": "the Korean version of Parkinson's",
            "probability": 0.00409067706386649,
            "start_logit": 1.1028391122817993,
            "end_logit": 4.938902378082275
        },
        {
            "text": "",
            "probability": 0.002090862918046688,
            "start_logit": 2.5430896282196045,
            "end_logit": 2.8275182247161865
        },
        {
            "text": "Parkinson's Disease Quality of Life 39 (K-PDQ39)",
            "probability": 0.0019802541058942962,
            "start_logit": 6.037385940551758,
            "end_logit": -0.7211297750473022
        },
        {
            "text": "Korean version of Parkinson",
            "probability": 0.001376427869349318,
            "start_logit": 3.020301103591919,
            "end_logit": 1.932221531867981
        },
        {
            "text": "Korean",
            "probability": 0.0010339934572581035,
            "start_logit": 3.020301103591919,
            "end_logit": 1.6461583375930786
        },
        {
            "text": "Parkinson's Disease Rating Scale part II) and quality of life [the Korean version of Parkinson's Disease",
            "probability": 0.001002746311042922,
            "start_logit": 1.2850455045700073,
            "end_logit": 3.3507280349731445
        },
        {
            "text": "the Korean version of Parkinson's Disease Quality of Life 39",
            "probability": 0.0009238179004411091,
            "start_logit": 1.1028391122817993,
            "end_logit": 3.45095157623291
        },
        {
            "text": "the Korean version of Parkinson's Disease",
            "probability": 0.0008357181653967678,
            "start_logit": 1.1028391122817993,
            "end_logit": 3.3507280349731445
        }
    ],
    "5e2b1ed9fbd6abf43b000005_008": [
        {
            "text": "patient-perceived quality of life",
            "probability": 0.26081829660729783,
            "start_logit": 4.368727207183838,
            "end_logit": 5.5639328956604
        },
        {
            "text": "Parkinson's",
            "probability": 0.2538237107132088,
            "start_logit": 5.4471540451049805,
            "end_logit": 4.458322048187256
        },
        {
            "text": "Parkinson's disease",
            "probability": 0.10867431686150554,
            "start_logit": 5.4471540451049805,
            "end_logit": 3.6100375652313232
        },
        {
            "text": "Parkinson's Disease Rating Scale (MDS-UPDRS) and patient-perceived quality of life",
            "probability": 0.10105296024750983,
            "start_logit": 3.4205479621887207,
            "end_logit": 5.5639328956604
        },
        {
            "text": "patient-perceived quality of life (the 39-item Parkinson's",
            "probability": 0.08633310565449995,
            "start_logit": 4.368727207183838,
            "end_logit": 4.458322048187256
        },
        {
            "text": "Parkinson's disease Questionnaire",
            "probability": 0.07317753301736943,
            "start_logit": 5.4471540451049805,
            "end_logit": 3.2145705223083496
        },
        {
            "text": "patient-perceived quality of life (the 39-item Parkinson's disease",
            "probability": 0.036963415486962685,
            "start_logit": 4.368727207183838,
            "end_logit": 3.6100375652313232
        },
        {
            "text": "patient-perceived quality of life (the 39-item Parkinson's disease Questionnaire",
            "probability": 0.024889887835035287,
            "start_logit": 4.368727207183838,
            "end_logit": 3.2145705223083496
        },
        {
            "text": "quality of life",
            "probability": 0.00998966113514794,
            "start_logit": 1.1064538955688477,
            "end_logit": 5.5639328956604
        },
        {
            "text": "39-item Parkinson's",
            "probability": 0.009147902563030977,
            "start_logit": 2.1240386962890625,
            "end_logit": 4.458322048187256
        },
        {
            "text": "Parkinson",
            "probability": 0.008207421508964826,
            "start_logit": 5.4471540451049805,
            "end_logit": 1.0267208814620972
        },
        {
            "text": "perceived quality of life",
            "probability": 0.004651506602662939,
            "start_logit": 0.34209439158439636,
            "end_logit": 5.5639328956604
        },
        {
            "text": "39-item Parkinson's disease",
            "probability": 0.00391666349435838,
            "start_logit": 2.1240386962890625,
            "end_logit": 3.6100375652313232
        },
        {
            "text": "quality of life (the 39-item Parkinson's",
            "probability": 0.0033066639934847555,
            "start_logit": 1.1064538955688477,
            "end_logit": 4.458322048187256
        },
        {
            "text": "patient-perceived quality of life (the 39",
            "probability": 0.002792264432148912,
            "start_logit": 4.368727207183838,
            "end_logit": 1.0269618034362793
        },
        {
            "text": "patient-perceived quality of life (the 39-item Parkinson",
            "probability": 0.0027915917953192306,
            "start_logit": 4.368727207183838,
            "end_logit": 1.0267208814620972
        },
        {
            "text": "39-item Parkinson's disease Questionnaire",
            "probability": 0.002637345975145109,
            "start_logit": 2.1240386962890625,
            "end_logit": 3.2145705223083496
        },
        {
            "text": "patient-perceived quality of life (the 39-item",
            "probability": 0.002196097923094913,
            "start_logit": 4.368727207183838,
            "end_logit": 0.7867910265922546
        },
        {
            "text": "the 39-item Parkinson's",
            "probability": 0.0017940855340569971,
            "start_logit": 0.49500951170921326,
            "end_logit": 4.458322048187256
        },
        {
            "text": "Parkinson's Disease",
            "probability": 0.0016592622780135088,
            "start_logit": 3.4205479621887207,
            "end_logit": 1.454661250114441
        },
        {
            "text": "",
            "probability": 0.0011763063411822708,
            "start_logit": 2.097947835922241,
            "end_logit": 2.433267593383789
        }
    ],
    "5e2b1ed9fbd6abf43b000005_009": [
        {
            "text": "",
            "probability": 0.944963804678542,
            "start_logit": 4.459853649139404,
            "end_logit": 4.626274585723877
        },
        {
            "text": "Parkinson disease",
            "probability": 0.03179468108629471,
            "start_logit": 2.8148574829101562,
            "end_logit": 2.879423141479492
        },
        {
            "text": "Parkinson",
            "probability": 0.015479217281629692,
            "start_logit": 2.8148574829101562,
            "end_logit": 2.1596224308013916
        },
        {
            "text": "yoga",
            "probability": 0.0032273951942722243,
            "start_logit": 1.40472412109375,
            "end_logit": 2.0019328594207764
        },
        {
            "text": "Parkinson disease (PD)",
            "probability": 0.0017425940753672032,
            "start_logit": 2.8148574829101562,
            "end_logit": -0.024501021951436996
        },
        {
            "text": "Parkinson disease (PD",
            "probability": 0.0009347618657729927,
            "start_logit": 2.8148574829101562,
            "end_logit": -0.6473393440246582
        },
        {
            "text": "nonmotor symptoms (NMS) for Parkinson disease",
            "probability": 0.0003255846687458463,
            "start_logit": -1.7665742635726929,
            "end_logit": 2.879423141479492
        },
        {
            "text": "yoga in PDQ39",
            "probability": 0.00024150978630281384,
            "start_logit": 1.40472412109375,
            "end_logit": -0.5905877947807312
        },
        {
            "text": "Taichi in sleep and PDQ39; dance in cognition, apathy, and a mild trend to improved fatigue; yoga",
            "probability": 0.0002256899924379635,
            "start_logit": -1.2555441856384277,
            "end_logit": 2.0019328594207764
        },
        {
            "text": "sleep and PDQ39; dance in cognition, apathy, and a mild trend to improved fatigue; yoga",
            "probability": 0.0001684068098378875,
            "start_logit": -1.5483239889144897,
            "end_logit": 2.0019328594207764
        },
        {
            "text": "nonmotor symptoms (NMS) for Parkinson",
            "probability": 0.00015851065835212352,
            "start_logit": -1.7665742635726929,
            "end_logit": 2.1596224308013916
        },
        {
            "text": "Parkins",
            "probability": 0.00011947744581844776,
            "start_logit": 2.8148574829101562,
            "end_logit": -2.7045035362243652
        },
        {
            "text": "Park",
            "probability": 0.00011776253144782711,
            "start_logit": 2.8148574829101562,
            "end_logit": -2.718961000442505
        },
        {
            "text": "NMS) for Parkinson disease",
            "probability": 0.00010637973997529876,
            "start_logit": -2.8851816654205322,
            "end_logit": 2.879423141479492
        },
        {
            "text": "yoga in PDQ39;",
            "probability": 8.21089113599757e-05,
            "start_logit": 1.40472412109375,
            "end_logit": -1.6694512367248535
        },
        {
            "text": "disease",
            "probability": 7.894303853962493e-05,
            "start_logit": -3.1834702491760254,
            "end_logit": 2.879423141479492
        },
        {
            "text": "dance in cognition, apathy, and a mild trend to improved fatigue; yoga",
            "probability": 7.499972509590471e-05,
            "start_logit": -2.357222080230713,
            "end_logit": 2.0019328594207764
        },
        {
            "text": "PD)",
            "probability": 5.944386470682064e-05,
            "start_logit": -0.5632402300834656,
            "end_logit": -0.024501021951436996
        },
        {
            "text": "NMS) for Parkinson",
            "probability": 5.179089876610611e-05,
            "start_logit": -2.8851816654205322,
            "end_logit": 2.1596224308013916
        },
        {
            "text": "PDQ39; dance in cognition, apathy, and a mild trend to improved fatigue; yoga",
            "probability": 4.693774673486494e-05,
            "start_logit": -2.8258843421936035,
            "end_logit": 2.0019328594207764
        }
    ],
    "5c7a4c35d774d04240000007_001": [
        {
            "text": "",
            "probability": 0.9792935936954794,
            "start_logit": 2.4316837787628174,
            "end_logit": 2.949784994125366
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1",
            "probability": 0.006744085991448245,
            "start_logit": 0.3920900225639343,
            "end_logit": 0.011213232763111591
        },
        {
            "text": "antibodies",
            "probability": 0.005279451688125347,
            "start_logit": 0.3920900225639343,
            "end_logit": -0.2336304932832718
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1 might improve the efficiency",
            "probability": 0.0007779767254723793,
            "start_logit": 0.3920900225639343,
            "end_logit": -2.1485114097595215
        },
        {
            "text": "PD-L1, LAG-3, TIM-3, and CEACAM-1",
            "probability": 0.0007589169591202442,
            "start_logit": -1.7924388647079468,
            "end_logit": 0.011213232763111591
        },
        {
            "text": "improve the efficiency of CIK therapy for NSCLC patients.",
            "probability": 0.0007021073955507225,
            "start_logit": -0.5891584753990173,
            "end_logit": -1.2698731422424316
        },
        {
            "text": "Our results imply that implementing combined treatment on CIK cells before transfusion via antibodies",
            "probability": 0.0006672003773441353,
            "start_logit": -1.6763970851898193,
            "end_logit": -0.2336304932832718
        },
        {
            "text": "targeting PD-L1, LAG-3, TIM-3, and CEACAM-1",
            "probability": 0.0006345844817097631,
            "start_logit": -1.9713608026504517,
            "end_logit": 0.011213232763111591
        },
        {
            "text": "improve the efficiency of CIK therapy for NSCLC patients",
            "probability": 0.0005817104452791533,
            "start_logit": -0.5891584753990173,
            "end_logit": -1.4579867124557495
        },
        {
            "text": "via antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1",
            "probability": 0.0005745292159656176,
            "start_logit": -2.0707802772521973,
            "end_logit": 0.011213232763111591
        },
        {
            "text": "combined treatment on CIK cells before transfusion via antibodies",
            "probability": 0.0005484189022321208,
            "start_logit": -1.8724480867385864,
            "end_logit": -0.2336304932832718
        },
        {
            "text": "implementing combined treatment on CIK cells before transfusion via antibodies",
            "probability": 0.000493512473681094,
            "start_logit": -1.9779393672943115,
            "end_logit": -0.2336304932832718
        },
        {
            "text": "via antibodies",
            "probability": 0.00044975690448686783,
            "start_logit": -2.0707802772521973,
            "end_logit": -0.2336304932832718
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1 might improve",
            "probability": 0.00042634455484597504,
            "start_logit": 0.3920900225639343,
            "end_logit": -2.74996018409729
        },
        {
            "text": "might improve the efficiency of CIK therapy for NSCLC patients.",
            "probability": 0.0004137212713359988,
            "start_logit": -1.118052363395691,
            "end_logit": -1.2698731422424316
        },
        {
            "text": "antibodies targeting",
            "probability": 0.000398894742458742,
            "start_logit": 0.3920900225639343,
            "end_logit": -2.8165104389190674
        },
        {
            "text": "might improve the efficiency of CIK therapy for NSCLC patients",
            "probability": 0.000342776598701893,
            "start_logit": -1.118052363395691,
            "end_logit": -1.4579867124557495
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3",
            "probability": 0.00031755996247726756,
            "start_logit": 0.3920900225639343,
            "end_logit": -3.044541358947754
        },
        {
            "text": "checkpoint molecules",
            "probability": 0.00029984385101877416,
            "start_logit": -1.3942360877990723,
            "end_logit": -1.3156200647354126
        },
        {
            "text": "CEACAM-1",
            "probability": 0.0002950137632662487,
            "start_logit": -2.737309217453003,
            "end_logit": 0.011213232763111591
        }
    ],
    "5c7a4c35d774d04240000007_002": [
        {
            "text": "",
            "probability": 0.9792935936954794,
            "start_logit": 2.4316837787628174,
            "end_logit": 2.949784994125366
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1",
            "probability": 0.006744085991448245,
            "start_logit": 0.3920900225639343,
            "end_logit": 0.011213232763111591
        },
        {
            "text": "antibodies",
            "probability": 0.005279451688125347,
            "start_logit": 0.3920900225639343,
            "end_logit": -0.2336304932832718
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1 might improve the efficiency",
            "probability": 0.0007779767254723793,
            "start_logit": 0.3920900225639343,
            "end_logit": -2.1485114097595215
        },
        {
            "text": "PD-L1, LAG-3, TIM-3, and CEACAM-1",
            "probability": 0.0007589169591202442,
            "start_logit": -1.7924388647079468,
            "end_logit": 0.011213232763111591
        },
        {
            "text": "improve the efficiency of CIK therapy for NSCLC patients.",
            "probability": 0.0007021073955507225,
            "start_logit": -0.5891584753990173,
            "end_logit": -1.2698731422424316
        },
        {
            "text": "Our results imply that implementing combined treatment on CIK cells before transfusion via antibodies",
            "probability": 0.0006672003773441353,
            "start_logit": -1.6763970851898193,
            "end_logit": -0.2336304932832718
        },
        {
            "text": "targeting PD-L1, LAG-3, TIM-3, and CEACAM-1",
            "probability": 0.0006345844817097631,
            "start_logit": -1.9713608026504517,
            "end_logit": 0.011213232763111591
        },
        {
            "text": "improve the efficiency of CIK therapy for NSCLC patients",
            "probability": 0.0005817104452791533,
            "start_logit": -0.5891584753990173,
            "end_logit": -1.4579867124557495
        },
        {
            "text": "via antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1",
            "probability": 0.0005745292159656176,
            "start_logit": -2.0707802772521973,
            "end_logit": 0.011213232763111591
        },
        {
            "text": "combined treatment on CIK cells before transfusion via antibodies",
            "probability": 0.0005484189022321208,
            "start_logit": -1.8724480867385864,
            "end_logit": -0.2336304932832718
        },
        {
            "text": "implementing combined treatment on CIK cells before transfusion via antibodies",
            "probability": 0.000493512473681094,
            "start_logit": -1.9779393672943115,
            "end_logit": -0.2336304932832718
        },
        {
            "text": "via antibodies",
            "probability": 0.00044975690448686783,
            "start_logit": -2.0707802772521973,
            "end_logit": -0.2336304932832718
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1 might improve",
            "probability": 0.00042634455484597504,
            "start_logit": 0.3920900225639343,
            "end_logit": -2.74996018409729
        },
        {
            "text": "might improve the efficiency of CIK therapy for NSCLC patients.",
            "probability": 0.0004137212713359988,
            "start_logit": -1.118052363395691,
            "end_logit": -1.2698731422424316
        },
        {
            "text": "antibodies targeting",
            "probability": 0.000398894742458742,
            "start_logit": 0.3920900225639343,
            "end_logit": -2.8165104389190674
        },
        {
            "text": "might improve the efficiency of CIK therapy for NSCLC patients",
            "probability": 0.000342776598701893,
            "start_logit": -1.118052363395691,
            "end_logit": -1.4579867124557495
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3",
            "probability": 0.00031755996247726756,
            "start_logit": 0.3920900225639343,
            "end_logit": -3.044541358947754
        },
        {
            "text": "checkpoint molecules",
            "probability": 0.00029984385101877416,
            "start_logit": -1.3942360877990723,
            "end_logit": -1.3156200647354126
        },
        {
            "text": "CEACAM-1",
            "probability": 0.0002950137632662487,
            "start_logit": -2.737309217453003,
            "end_logit": 0.011213232763111591
        }
    ],
    "5c7a4c35d774d04240000007_003": [
        {
            "text": "",
            "probability": 0.9792935936954794,
            "start_logit": 2.4316837787628174,
            "end_logit": 2.949784994125366
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1",
            "probability": 0.006744085991448245,
            "start_logit": 0.3920900225639343,
            "end_logit": 0.011213232763111591
        },
        {
            "text": "antibodies",
            "probability": 0.005279451688125347,
            "start_logit": 0.3920900225639343,
            "end_logit": -0.2336304932832718
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1 might improve the efficiency",
            "probability": 0.0007779767254723793,
            "start_logit": 0.3920900225639343,
            "end_logit": -2.1485114097595215
        },
        {
            "text": "PD-L1, LAG-3, TIM-3, and CEACAM-1",
            "probability": 0.0007589169591202442,
            "start_logit": -1.7924388647079468,
            "end_logit": 0.011213232763111591
        },
        {
            "text": "improve the efficiency of CIK therapy for NSCLC patients.",
            "probability": 0.0007021073955507225,
            "start_logit": -0.5891584753990173,
            "end_logit": -1.2698731422424316
        },
        {
            "text": "Our results imply that implementing combined treatment on CIK cells before transfusion via antibodies",
            "probability": 0.0006672003773441353,
            "start_logit": -1.6763970851898193,
            "end_logit": -0.2336304932832718
        },
        {
            "text": "targeting PD-L1, LAG-3, TIM-3, and CEACAM-1",
            "probability": 0.0006345844817097631,
            "start_logit": -1.9713608026504517,
            "end_logit": 0.011213232763111591
        },
        {
            "text": "improve the efficiency of CIK therapy for NSCLC patients",
            "probability": 0.0005817104452791533,
            "start_logit": -0.5891584753990173,
            "end_logit": -1.4579867124557495
        },
        {
            "text": "via antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1",
            "probability": 0.0005745292159656176,
            "start_logit": -2.0707802772521973,
            "end_logit": 0.011213232763111591
        },
        {
            "text": "combined treatment on CIK cells before transfusion via antibodies",
            "probability": 0.0005484189022321208,
            "start_logit": -1.8724480867385864,
            "end_logit": -0.2336304932832718
        },
        {
            "text": "implementing combined treatment on CIK cells before transfusion via antibodies",
            "probability": 0.000493512473681094,
            "start_logit": -1.9779393672943115,
            "end_logit": -0.2336304932832718
        },
        {
            "text": "via antibodies",
            "probability": 0.00044975690448686783,
            "start_logit": -2.0707802772521973,
            "end_logit": -0.2336304932832718
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1 might improve",
            "probability": 0.00042634455484597504,
            "start_logit": 0.3920900225639343,
            "end_logit": -2.74996018409729
        },
        {
            "text": "might improve the efficiency of CIK therapy for NSCLC patients.",
            "probability": 0.0004137212713359988,
            "start_logit": -1.118052363395691,
            "end_logit": -1.2698731422424316
        },
        {
            "text": "antibodies targeting",
            "probability": 0.000398894742458742,
            "start_logit": 0.3920900225639343,
            "end_logit": -2.8165104389190674
        },
        {
            "text": "might improve the efficiency of CIK therapy for NSCLC patients",
            "probability": 0.000342776598701893,
            "start_logit": -1.118052363395691,
            "end_logit": -1.4579867124557495
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3",
            "probability": 0.00031755996247726756,
            "start_logit": 0.3920900225639343,
            "end_logit": -3.044541358947754
        },
        {
            "text": "checkpoint molecules",
            "probability": 0.00029984385101877416,
            "start_logit": -1.3942360877990723,
            "end_logit": -1.3156200647354126
        },
        {
            "text": "CEACAM-1",
            "probability": 0.0002950137632662487,
            "start_logit": -2.737309217453003,
            "end_logit": 0.011213232763111591
        }
    ],
    "5c7a4c35d774d04240000007_004": [
        {
            "text": "",
            "probability": 0.8076985759447525,
            "start_logit": 2.5642125606536865,
            "end_logit": 3.108546495437622
        },
        {
            "text": "immune inhibitory",
            "probability": 0.0757411432142714,
            "start_logit": 1.3064632415771484,
            "end_logit": 1.999428391456604
        },
        {
            "text": "Agents targeting other immune inhibitory",
            "probability": 0.03894329989022144,
            "start_logit": 0.6412484645843506,
            "end_logit": 1.999428391456604
        },
        {
            "text": "immune inhibitory (",
            "probability": 0.009061644648691176,
            "start_logit": 1.3064632415771484,
            "end_logit": -0.12384249269962311
        },
        {
            "text": "biomarkers for cancer immunotherapy",
            "probability": 0.008344712895487163,
            "start_logit": 0.25583285093307495,
            "end_logit": 0.8443654179573059
        },
        {
            "text": "other immune inhibitory",
            "probability": 0.007984749983501141,
            "start_logit": -0.9433248043060303,
            "end_logit": 1.999428391456604
        },
        {
            "text": "biomarkers",
            "probability": 0.006913048762254176,
            "start_logit": 0.25583285093307495,
            "end_logit": 0.6561480164527893
        },
        {
            "text": "immunotherapies that target activating and inhibitory T cell receptors",
            "probability": 0.005129853523110236,
            "start_logit": -0.6829332113265991,
            "end_logit": 1.29658043384552
        },
        {
            "text": "activating and inhibitory T cell receptors",
            "probability": 0.005126027408230911,
            "start_logit": -0.6836793422698975,
            "end_logit": 1.29658043384552
        },
        {
            "text": "targeting other immune inhibitory",
            "probability": 0.004661292079758148,
            "start_logit": -1.4815655946731567,
            "end_logit": 1.999428391456604
        },
        {
            "text": "Agents targeting other immune inhibitory (",
            "probability": 0.0046591631717820174,
            "start_logit": 0.6412484645843506,
            "end_logit": -0.12384249269962311
        },
        {
            "text": "immunotherapy agents with different mechanisms of action including immunotherapies that target activating and inhibitory T cell receptors",
            "probability": 0.004658424597097864,
            "start_logit": -0.7793329954147339,
            "end_logit": 1.29658043384552
        },
        {
            "text": "immune inhibitory (e.g., Tim-3",
            "probability": 0.004147900664945158,
            "start_logit": 1.3064632415771484,
            "end_logit": -0.9052907824516296
        },
        {
            "text": "T cell receptors",
            "probability": 0.0034394853969611674,
            "start_logit": -1.0826884508132935,
            "end_logit": 1.29658043384552
        },
        {
            "text": "inhibitory",
            "probability": 0.0030569481570347974,
            "start_logit": -1.9034411907196045,
            "end_logit": 1.999428391456604
        },
        {
            "text": "multiplicity of immunotherapy agents with different mechanisms of action",
            "probability": 0.0022908367584582976,
            "start_logit": -0.08196177333593369,
            "end_logit": -0.11055096238851547
        },
        {
            "text": "biomarkers for cancer immunotherapy.",
            "probability": 0.0021488334406931002,
            "start_logit": 0.25583285093307495,
            "end_logit": -0.5123376250267029
        },
        {
            "text": "Agents targeting other immune inhibitory (e.g., Tim-3",
            "probability": 0.0021326974040097616,
            "start_logit": 0.6412484645843506,
            "end_logit": -0.9052907824516296
        },
        {
            "text": "target activating and inhibitory T cell receptors",
            "probability": 0.0020095925535180237,
            "start_logit": -1.6200783252716064,
            "end_logit": 1.29658043384552
        },
        {
            "text": "(i) multiplicity of immunotherapy agents with different mechanisms of action",
            "probability": 0.0018517695052216892,
            "start_logit": -0.2947372496128082,
            "end_logit": -0.11055096238851547
        }
    ],
    "5c7a4c35d774d04240000007_005": [
        {
            "text": "",
            "probability": 0.9959118489493889,
            "start_logit": 2.241361141204834,
            "end_logit": 2.665299415588379
        },
        {
            "text": "immune checkpoints",
            "probability": 0.0011601156122986718,
            "start_logit": -1.9678268432617188,
            "end_logit": 0.11934831738471985
        },
        {
            "text": "Promising results in the treatment of non-small cell lung cancer (NSCLC) have been seen with agents targeting immune checkpoints",
            "probability": 0.0007929034281159632,
            "start_logit": -2.348400354385376,
            "end_logit": 0.11934831738471985
        },
        {
            "text": "agents targeting immune checkpoints",
            "probability": 0.00041866588418990974,
            "start_logit": -2.9870285987854004,
            "end_logit": 0.11934831738471985
        },
        {
            "text": "targeting immune checkpoints",
            "probability": 0.00038675480197543973,
            "start_logit": -3.0663108825683594,
            "end_logit": 0.11934831738471985
        },
        {
            "text": "However, only a select group of patients respond to these interventions.",
            "probability": 0.0001817453376967822,
            "start_logit": -1.8942240476608276,
            "end_logit": -1.8079229593276978
        },
        {
            "text": "However, only a select group of patients respond to these interventions. The identification of biomarkers that predict clinical benefit to immune checkpoint blockade",
            "probability": 0.00015200900354545835,
            "start_logit": -1.8942240476608276,
            "end_logit": -1.9865896701812744
        },
        {
            "text": "BATTLE-1",
            "probability": 0.0001202222734776806,
            "start_logit": -1.8105615377426147,
            "end_logit": -2.304849624633789
        },
        {
            "text": "only a select group of patients respond to these interventions.",
            "probability": 0.000114676805719933,
            "start_logit": -2.354712724685669,
            "end_logit": -1.8079229593276978
        },
        {
            "text": "Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination",
            "probability": 0.0001091915517379357,
            "start_logit": -2.631402015686035,
            "end_logit": -1.5802477598190308
        },
        {
            "text": "a select group of patients respond to these interventions.",
            "probability": 9.635263716356758e-05,
            "start_logit": -2.528815746307373,
            "end_logit": -1.8079229593276978
        },
        {
            "text": "only a select group of patients respond to these interventions. The identification of biomarkers that predict clinical benefit to immune checkpoint blockade",
            "probability": 9.591391552693332e-05,
            "start_logit": -2.354712724685669,
            "end_logit": -1.9865896701812744
        },
        {
            "text": "a select group of patients respond to these interventions. The identification of biomarkers that predict clinical benefit to immune checkpoint blockade",
            "probability": 8.058786293955273e-05,
            "start_logit": -2.528815746307373,
            "end_logit": -1.9865896701812744
        },
        {
            "text": "immune checkpoint blockade",
            "probability": 7.895109098483537e-05,
            "start_logit": -2.549335241317749,
            "end_logit": -1.9865896701812744
        },
        {
            "text": "immune checkpoints,",
            "probability": 6.468173880145068e-05,
            "start_logit": -1.9678268432617188,
            "end_logit": -2.7674477100372314
        },
        {
            "text": "Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination (named BATTLE-1",
            "probability": 5.290521046232149e-05,
            "start_logit": -2.631402015686035,
            "end_logit": -2.304849624633789
        },
        {
            "text": "biomarkers that predict clinical benefit to immune checkpoint blockade",
            "probability": 4.9758380565263277e-05,
            "start_logit": -3.0109848976135254,
            "end_logit": -1.9865896701812744
        },
        {
            "text": "Promising results in the treatment of non-small cell lung cancer",
            "probability": 4.8602797116634736e-05,
            "start_logit": -2.348400354385376,
            "end_logit": -2.6726720333099365
        },
        {
            "text": "Promising results in the treatment of non-small cell lung cancer (NSCLC) have been seen with agents targeting immune checkpoints,",
            "probability": 4.420798400475959e-05,
            "start_logit": -2.348400354385376,
            "end_logit": -2.7674477100372314
        },
        {
            "text": "However, only a select group",
            "probability": 3.990473428780231e-05,
            "start_logit": -1.8942240476608276,
            "end_logit": -3.3240344524383545
        }
    ],
    "5c7a4c35d774d04240000007_006": [
        {
            "text": "",
            "probability": 0.9416633781294036,
            "start_logit": 2.0912811756134033,
            "end_logit": 2.5763356685638428
        },
        {
            "text": "response and resistance to immunotherapy",
            "probability": 0.007445171444982087,
            "start_logit": -0.6632563471794128,
            "end_logit": 0.4907910227775574
        },
        {
            "text": "response and resistance",
            "probability": 0.00634762187412769,
            "start_logit": -0.6632563471794128,
            "end_logit": 0.3313055634498596
        },
        {
            "text": "Our results support the use of immune-based metrics to study response and resistance to immunotherapy",
            "probability": 0.0048866510797575795,
            "start_logit": -1.0843148231506348,
            "end_logit": 0.4907910227775574
        },
        {
            "text": "resistance to immunotherapy",
            "probability": 0.004526328282826215,
            "start_logit": -1.160910964012146,
            "end_logit": 0.4907910227775574
        },
        {
            "text": "response and resistance to immunotherapy in lung cancer.",
            "probability": 0.004349582468056055,
            "start_logit": -0.6632563471794128,
            "end_logit": -0.046694815158843994
        },
        {
            "text": "Our results support the use of immune-based metrics to study response and resistance",
            "probability": 0.004166272531709784,
            "start_logit": -1.0843148231506348,
            "end_logit": 0.3313055634498596
        },
        {
            "text": "resistance",
            "probability": 0.003859067669545069,
            "start_logit": -1.160910964012146,
            "end_logit": 0.3313055634498596
        },
        {
            "text": "Our results support the use of immune-based metrics to study response and resistance to immunotherapy in lung cancer.",
            "probability": 0.00285485593194045,
            "start_logit": -1.0843148231506348,
            "end_logit": -0.046694815158843994
        },
        {
            "text": "response and resistance to immunotherapy in lung cancer",
            "probability": 0.002773414857372933,
            "start_logit": -0.6632563471794128,
            "end_logit": -0.49669530987739563
        },
        {
            "text": "resistance to immunotherapy in lung cancer.",
            "probability": 0.002644349870131775,
            "start_logit": -1.160910964012146,
            "end_logit": -0.046694815158843994
        },
        {
            "text": "immune-based metrics to study response and resistance to immunotherapy",
            "probability": 0.002243474932682777,
            "start_logit": -1.8627960681915283,
            "end_logit": 0.4907910227775574
        },
        {
            "text": "immune-based metrics to study response and resistance",
            "probability": 0.0019127471626395308,
            "start_logit": -1.8627960681915283,
            "end_logit": 0.3313055634498596
        },
        {
            "text": "Our results support the use of immune-based metrics to study response and resistance to immunotherapy in lung cancer",
            "probability": 0.0018203356104756249,
            "start_logit": -1.0843148231506348,
            "end_logit": -0.49669530987739563
        },
        {
            "text": "resistance to immunotherapy in lung cancer",
            "probability": 0.0016861110857827595,
            "start_logit": -1.160910964012146,
            "end_logit": -0.49669530987739563
        },
        {
            "text": "hot\" cluster with abundant CD8+ T cells expressing high levels",
            "probability": 0.0014523249468574478,
            "start_logit": -1.1118873357772827,
            "end_logit": -0.6949779987335205
        },
        {
            "text": "hot\" cluster with abundant CD8+ T cells expressing high levels of PD-1 and TIM-3",
            "probability": 0.0014190993254090932,
            "start_logit": -1.1118873357772827,
            "end_logit": -0.7181212902069092
        },
        {
            "text": "use of immune-based metrics to study response and resistance to immunotherapy",
            "probability": 0.0014122547797805634,
            "start_logit": -2.325634479522705,
            "end_logit": 0.4907910227775574
        },
        {
            "text": "immune-based metrics to study response and resistance to immunotherapy in lung cancer.",
            "probability": 0.0013106721996707124,
            "start_logit": -1.8627960681915283,
            "end_logit": -0.046694815158843994
        },
        {
            "text": "Our results support the use of immune-based metrics",
            "probability": 0.0012262858168480102,
            "start_logit": -1.0843148231506348,
            "end_logit": -0.8917262554168701
        }
    ],
    "5c7a4c35d774d04240000007_007": [
        {
            "text": "",
            "probability": 0.9761809999865766,
            "start_logit": 2.802171468734741,
            "end_logit": 3.4361319541931152
        },
        {
            "text": "negative",
            "probability": 0.0068053854718584566,
            "start_logit": 0.5579593777656555,
            "end_logit": 0.7144103050231934
        },
        {
            "text": "Tim-3-negative",
            "probability": 0.0038269327312487043,
            "start_logit": -0.017691273242235184,
            "end_logit": 0.7144103050231934
        },
        {
            "text": "negative phenotype",
            "probability": 0.0038160597258248908,
            "start_logit": 0.5579593777656555,
            "end_logit": 0.13591443002223969
        },
        {
            "text": "Tim-3-negative phenotype",
            "probability": 0.0021459186888896586,
            "start_logit": -0.017691273242235184,
            "end_logit": 0.13591443002223969
        },
        {
            "text": "negative phenotype.",
            "probability": 0.0010022421364792077,
            "start_logit": 0.5579593777656555,
            "end_logit": -1.2010643482208252
        },
        {
            "text": "Their expression and regulation are still not fully characterized",
            "probability": 0.0009748841302570168,
            "start_logit": -0.6758846640586853,
            "end_logit": 0.00510341115295887
        },
        {
            "text": "anti-tumor recall responses.",
            "probability": 0.0006374662051504663,
            "start_logit": -1.0474352836608887,
            "end_logit": -0.04816332831978798
        },
        {
            "text": "PD-1-positive Tim-3-negative",
            "probability": 0.0006122442536359884,
            "start_logit": -1.8503788709640503,
            "end_logit": 0.7144103050231934
        },
        {
            "text": "anti-tumor recall responses",
            "probability": 0.0006011238024811102,
            "start_logit": -1.0474352836608887,
            "end_logit": -0.10686368495225906
        },
        {
            "text": "Tim-3-negative phenotype.",
            "probability": 0.0005635997038800338,
            "start_logit": -0.017691273242235184,
            "end_logit": -1.2010643482208252
        },
        {
            "text": "-negative",
            "probability": 0.00040105360330449985,
            "start_logit": -2.2734150886535645,
            "end_logit": 0.7144103050231934
        },
        {
            "text": "efficient anti-tumor recall responses.",
            "probability": 0.0003755063710240339,
            "start_logit": -1.5766611099243164,
            "end_logit": -0.04816332831978798
        },
        {
            "text": "Their expression and regulation are still not fully characterized and a better understanding of these mechanisms is needed to improve current immunotherapies",
            "probability": 0.00036177447435342105,
            "start_logit": -0.6758846640586853,
            "end_logit": -0.9861941933631897
        },
        {
            "text": "efficient anti-tumor recall responses",
            "probability": 0.00035409848519353266,
            "start_logit": -1.5766611099243164,
            "end_logit": -0.10686368495225906
        },
        {
            "text": "3-negative",
            "probability": 0.00034534459588053,
            "start_logit": -2.4229674339294434,
            "end_logit": 0.7144103050231934
        },
        {
            "text": "PD-1-positive Tim-3-negative phenotype",
            "probability": 0.00034331055137571607,
            "start_logit": -1.8503788709640503,
            "end_logit": 0.13591443002223969
        },
        {
            "text": "Tim-3",
            "probability": 0.0002334526315550095,
            "start_logit": -0.017691273242235184,
            "end_logit": -2.0824294090270996
        },
        {
            "text": "-negative phenotype",
            "probability": 0.00022488726168354883,
            "start_logit": -2.2734150886535645,
            "end_logit": 0.13591443002223969
        },
        {
            "text": "make CD161-expressing CD4+ T cells ideal candidates for efficient anti-tumor recall responses.",
            "probability": 0.00019371518934738273,
            "start_logit": -2.2385475635528564,
            "end_logit": -0.04816332831978798
        }
    ],
    "5c7a4c35d774d04240000007_008": [
        {
            "text": "",
            "probability": 0.8834809343269068,
            "start_logit": 1.716657042503357,
            "end_logit": 2.216080904006958
        },
        {
            "text": "targetable immune checkpoints",
            "probability": 0.04391479707512382,
            "start_logit": -0.3567676544189453,
            "end_logit": 1.2878872156143188
        },
        {
            "text": "immune checkpoints",
            "probability": 0.03210723806165195,
            "start_logit": -0.6699374914169312,
            "end_logit": 1.2878872156143188
        },
        {
            "text": "overexpression of targetable immune checkpoints",
            "probability": 0.014657191867905652,
            "start_logit": -1.4540878534317017,
            "end_logit": 1.2878872156143188
        },
        {
            "text": "its mechanism is not completely understood",
            "probability": 0.004707199898355839,
            "start_logit": -1.411828875541687,
            "end_logit": 0.10979034006595612
        },
        {
            "text": "checkpoints",
            "probability": 0.0035824945433719827,
            "start_logit": -2.862959623336792,
            "end_logit": 1.2878872156143188
        },
        {
            "text": "Furthermore, overexpression of targetable immune checkpoints",
            "probability": 0.002892059882367169,
            "start_logit": -3.077049970626831,
            "end_logit": 1.2878872156143188
        },
        {
            "text": "biomarkers that could accurately predict response to immunotherapy",
            "probability": 0.0016984001461389827,
            "start_logit": -1.4150077104568481,
            "end_logit": -0.906437337398529
        },
        {
            "text": "biomarkers that could accurately predict response to immunotherapy.",
            "probability": 0.0015185244721536548,
            "start_logit": -1.4150077104568481,
            "end_logit": -1.0183849334716797
        },
        {
            "text": "targetable immune checkpoints, such as CTLA-4 and TIM-3 were associated with EMT in both NSCLCs",
            "probability": 0.0014229837118098104,
            "start_logit": -0.3567676544189453,
            "end_logit": -2.141608238220215
        },
        {
            "text": "An association may exist between immune exclusion and EMT in NSCLC. Further investigation is merited as its mechanism is not completely understood",
            "probability": 0.0012423427580681116,
            "start_logit": -2.7439231872558594,
            "end_logit": 0.10979034006595612
        },
        {
            "text": "targetable immune checkpoints, such as CTLA-4 and TIM-3 were associated with EMT",
            "probability": 0.0011640065241063761,
            "start_logit": -0.3567676544189453,
            "end_logit": -2.342496156692505
        },
        {
            "text": "immune checkpoints, such as CTLA-4 and TIM-3 were associated with EMT in both NSCLCs",
            "probability": 0.001040380004825558,
            "start_logit": -0.6699374914169312,
            "end_logit": -2.141608238220215
        },
        {
            "text": "targetable immune checkpoints,",
            "probability": 0.0010245221167786299,
            "start_logit": -0.3567676544189453,
            "end_logit": -2.47013783454895
        },
        {
            "text": "its mechanism is not completely understood and a better understanding of this association could lead to the development of biomarkers that could accurately predict response",
            "probability": 0.0010144924219428625,
            "start_logit": -1.411828875541687,
            "end_logit": -1.4249144792556763
        },
        {
            "text": "biomarkers that could accurately predict response",
            "probability": 0.0010112726383024752,
            "start_logit": -1.4150077104568481,
            "end_logit": -1.4249144792556763
        },
        {
            "text": "not completely understood",
            "probability": 0.000966037648837961,
            "start_logit": -2.9954745769500732,
            "end_logit": 0.10979034006595612
        },
        {
            "text": "its mechanism is not completely understood and a better understanding of this association could lead to the development of biomarkers",
            "probability": 0.0008533976424470792,
            "start_logit": -1.411828875541687,
            "end_logit": -1.5978325605392456
        },
        {
            "text": "immune checkpoints, such as CTLA-4 and TIM-3 were associated with EMT",
            "probability": 0.0008510351194579454,
            "start_logit": -0.6699374914169312,
            "end_logit": -2.342496156692505
        },
        {
            "text": "biomarkers",
            "probability": 0.0008506891394474866,
            "start_logit": -1.4150077104568481,
            "end_logit": -1.5978325605392456
        }
    ],
    "5e30b56efbd6abf43b000037_002": [
        {
            "text": "Bayesian Analysis of Gene EssentiaLity), a supervised learning method for analyzing gene knockout screens",
            "probability": 0.1435807923029875,
            "start_logit": 1.406813144683838,
            "end_logit": 2.786472797393799
        },
        {
            "text": "",
            "probability": 0.11781736113703059,
            "start_logit": 1.8539025783538818,
            "end_logit": 2.1416211128234863
        },
        {
            "text": "BAGEL (Bayesian Analysis of Gene EssentiaLity), a supervised learning method for analyzing gene knockout screens",
            "probability": 0.08352730836783563,
            "start_logit": 0.8650888800621033,
            "end_logit": 2.786472797393799
        },
        {
            "text": "Bayesian Analysis of Gene EssentiaLity), a supervised learning method for analyzing gene knockout screens.",
            "probability": 0.07867360666442166,
            "start_logit": 1.406813144683838,
            "end_logit": 2.184882640838623
        },
        {
            "text": "We offer BAGEL (Bayesian Analysis of Gene EssentiaLity), a supervised learning method for analyzing gene knockout screens",
            "probability": 0.07329334531743326,
            "start_logit": 0.734385073184967,
            "end_logit": 2.786472797393799
        },
        {
            "text": "a supervised learning method for analyzing gene knockout screens",
            "probability": 0.07096772915200068,
            "start_logit": 0.7021405100822449,
            "end_logit": 2.786472797393799
        },
        {
            "text": "BAGEL (Bayesian Analysis of Gene EssentiaLity), a supervised learning method for analyzing gene knockout screens.",
            "probability": 0.045767922706554276,
            "start_logit": 0.8650888800621033,
            "end_logit": 2.184882640838623
        },
        {
            "text": "We offer BAGEL (Bayesian Analysis of Gene EssentiaLity), a supervised learning method for analyzing gene knockout screens.",
            "probability": 0.04016032874686536,
            "start_logit": 0.734385073184967,
            "end_logit": 2.184882640838623
        },
        {
            "text": "a supervised learning method for analyzing gene knockout screens.",
            "probability": 0.03888603147828946,
            "start_logit": 0.7021405100822449,
            "end_logit": 2.184882640838623
        },
        {
            "text": "Bayesian Analysis of Gene EssentiaLity), a supervised learning method",
            "probability": 0.03808983991494771,
            "start_logit": 1.406813144683838,
            "end_logit": 1.4595224857330322
        },
        {
            "text": "supervised learning method for analyzing gene knockout screens",
            "probability": 0.034740789214049314,
            "start_logit": -0.01217026636004448,
            "end_logit": 2.786472797393799
        },
        {
            "text": "analyzing gene knockout screens",
            "probability": 0.032550769116738765,
            "start_logit": -0.07728374749422073,
            "end_logit": 2.786472797393799
        },
        {
            "text": "BAGEL shows high sensitivity and specificity even across screens performed by different labs using different libraries and reagents",
            "probability": 0.03138187370202543,
            "start_logit": 1.4667892456054688,
            "end_logit": 1.2058292627334595
        },
        {
            "text": "Bayesian Analysis of Gene EssentiaLity",
            "probability": 0.029274271616466438,
            "start_logit": 1.406813144683838,
            "end_logit": 1.1962839365005493
        },
        {
            "text": "offer BAGEL (Bayesian Analysis of Gene EssentiaLity), a supervised learning method for analyzing gene knockout screens",
            "probability": 0.0289467418417657,
            "start_logit": -0.1946270912885666,
            "end_logit": 2.786472797393799
        },
        {
            "text": "BAGEL offers significantly greater sensitivity than current methods",
            "probability": 0.0282637402460254,
            "start_logit": 1.1020565032958984,
            "end_logit": 1.4659112691879272
        },
        {
            "text": "BAGEL (Bayesian Analysis of Gene EssentiaLity), a supervised learning method",
            "probability": 0.02215854748554088,
            "start_logit": 0.8650888800621033,
            "end_logit": 1.4595224857330322
        },
        {
            "text": "BAGEL shows high sensitivity and specificity even across screens performed by different labs using different libraries and reagents.",
            "probability": 0.021708592918201236,
            "start_logit": 1.4667892456054688,
            "end_logit": 0.8373069763183594
        },
        {
            "text": "Using BAGEL",
            "probability": 0.02076677814516286,
            "start_logit": 1.419933795928955,
            "end_logit": 0.8398087620735168
        },
        {
            "text": "We offer BAGEL (Bayesian Analysis of Gene EssentiaLity), a supervised learning method",
            "probability": 0.019443629925657728,
            "start_logit": 0.734385073184967,
            "end_logit": 1.4595224857330322
        }
    ],
    "5e2a1096aa19d7443100000e_001": [
        {
            "text": "a modified mRNA",
            "probability": 0.16443308486571911,
            "start_logit": 4.072715759277344,
            "end_logit": 4.4463090896606445
        },
        {
            "text": "vascular endothelial growth factor A (VEGF-A)",
            "probability": 0.1425387271151371,
            "start_logit": 4.348443031311035,
            "end_logit": 4.027691841125488
        },
        {
            "text": "vascular endothelial growth factor A",
            "probability": 0.1310832019820932,
            "start_logit": 4.348443031311035,
            "end_logit": 3.9439103603363037
        },
        {
            "text": "a modified mRNA encoding vascular endothelial growth factor A (VEGF-A)",
            "probability": 0.10818973161145211,
            "start_logit": 4.072715759277344,
            "end_logit": 4.027691841125488
        },
        {
            "text": "a modified mRNA encoding vascular endothelial growth factor A",
            "probability": 0.09949475997324497,
            "start_logit": 4.072715759277344,
            "end_logit": 3.9439103603363037
        },
        {
            "text": "mRNA",
            "probability": 0.07375436456201542,
            "start_logit": 3.2709522247314453,
            "end_logit": 4.4463090896606445
        },
        {
            "text": "modified mRNA",
            "probability": 0.06233350922371985,
            "start_logit": 3.1027112007141113,
            "end_logit": 4.4463090896606445
        },
        {
            "text": "mRNA encoding vascular endothelial growth factor A (VEGF-A)",
            "probability": 0.0485271252659032,
            "start_logit": 3.2709522247314453,
            "end_logit": 4.027691841125488
        },
        {
            "text": "mRNA encoding vascular endothelial growth factor A",
            "probability": 0.04462710655261073,
            "start_logit": 3.2709522247314453,
            "end_logit": 3.9439103603363037
        },
        {
            "text": "modified mRNA encoding vascular endothelial growth factor A (VEGF-A)",
            "probability": 0.04101270519142451,
            "start_logit": 3.1027112007141113,
            "end_logit": 4.027691841125488
        },
        {
            "text": "modified mRNA encoding vascular endothelial growth factor A",
            "probability": 0.037716603952110225,
            "start_logit": 3.1027112007141113,
            "end_logit": 3.9439103603363037
        },
        {
            "text": "vascular endothelial growth factor A (VEGF-A",
            "probability": 0.00857749028230419,
            "start_logit": 4.348443031311035,
            "end_logit": 1.2172194719314575
        },
        {
            "text": "vascular endothelial growth factor A (VEGF-A),",
            "probability": 0.007693835249981832,
            "start_logit": 4.348443031311035,
            "end_logit": 1.1084975004196167
        },
        {
            "text": "a modified mRNA encoding vascular endothelial growth factor A (VEGF-A",
            "probability": 0.006510485889162813,
            "start_logit": 4.072715759277344,
            "end_logit": 1.2172194719314575
        },
        {
            "text": "a modified mRNA encoding vascular endothelial growth factor A (VEGF-A),",
            "probability": 0.005839774127391282,
            "start_logit": 4.072715759277344,
            "end_logit": 1.1084975004196167
        },
        {
            "text": "VEGF-A)",
            "probability": 0.003548486403672523,
            "start_logit": 0.6553504467010498,
            "end_logit": 4.027691841125488
        },
        {
            "text": "vascular endothelial growth factor",
            "probability": 0.0035251560379438943,
            "start_logit": 4.348443031311035,
            "end_logit": 0.32800281047821045
        },
        {
            "text": "mRNA encoding vascular endothelial growth factor A (VEGF-A",
            "probability": 0.0029201954712295137,
            "start_logit": 3.2709522247314453,
            "end_logit": 1.2172194719314575
        },
        {
            "text": "a modified mRNA encoding vascular endothelial growth factor",
            "probability": 0.002675663613339073,
            "start_logit": 4.072715759277344,
            "end_logit": 0.32800281047821045
        },
        {
            "text": "mRNA encoding vascular endothelial growth factor A (VEGF-A),",
            "probability": 0.0026193562585240778,
            "start_logit": 3.2709522247314453,
            "end_logit": 1.1084975004196167
        },
        {
            "text": "",
            "probability": 0.002378636371020361,
            "start_logit": 1.9899708032608032,
            "end_logit": 2.2930777072906494
        }
    ],
    "5e48edb1f8b2df0d49000002_001": [
        {
            "text": "proton beams",
            "probability": 0.8255449671228324,
            "start_logit": 6.8285980224609375,
            "end_logit": 6.609147548675537
        },
        {
            "text": "",
            "probability": 0.09635733506175291,
            "start_logit": 5.4956889152526855,
            "end_logit": 5.794076442718506
        },
        {
            "text": "proton",
            "probability": 0.07256839317453471,
            "start_logit": 6.8285980224609375,
            "end_logit": 4.177633285522461
        },
        {
            "text": "proton beams,",
            "probability": 0.003356636500586581,
            "start_logit": 6.8285980224609375,
            "end_logit": 1.1040432453155518
        },
        {
            "text": "pro",
            "probability": 0.0011536418691064359,
            "start_logit": 6.8285980224609375,
            "end_logit": 0.03602759540081024
        },
        {
            "text": "beams",
            "probability": 0.0005679596067897805,
            "start_logit": -0.4531506896018982,
            "end_logit": 6.609147548675537
        },
        {
            "text": "hadron beams, especially proton beams",
            "probability": 0.0003387880161545131,
            "start_logit": -0.9698264002799988,
            "end_logit": 6.609147548675537
        },
        {
            "text": "especially proton beams",
            "probability": 6.758054752353905e-05,
            "start_logit": -2.581880807876587,
            "end_logit": 6.609147548675537
        },
        {
            "text": "hadron beams, especially proton",
            "probability": 2.978069389097649e-05,
            "start_logit": -0.9698264002799988,
            "end_logit": 4.177633285522461
        },
        {
            "text": "especially proton",
            "probability": 5.94057494012778e-06,
            "start_logit": -2.581880807876587,
            "end_logit": 4.177633285522461
        },
        {
            "text": "beams,",
            "probability": 2.3093035787664387e-06,
            "start_logit": -0.4531506896018982,
            "end_logit": 1.1040432453155518
        },
        {
            "text": "hadron beams, especially proton beams,",
            "probability": 1.377500034854374e-06,
            "start_logit": -0.9698264002799988,
            "end_logit": 1.1040432453155518
        },
        {
            "text": "proton radiography",
            "probability": 1.3114618817640686e-06,
            "start_logit": 0.12057095021009445,
            "end_logit": -0.03548193722963333
        },
        {
            "text": "protons",
            "probability": 1.2322885229636416e-06,
            "start_logit": -0.06280956417322159,
            "end_logit": 0.08562915027141571
        },
        {
            "text": "pCT and proton radiography",
            "probability": 7.340387547712411e-07,
            "start_logit": -0.4597649574279785,
            "end_logit": -0.03548193722963333
        },
        {
            "text": "Bragg peak throughout the tumor being treated. A half century ago, suggestions had already been made to use protons",
            "probability": 5.801924186065311e-07,
            "start_logit": -0.8160780668258667,
            "end_logit": 0.08562915027141571
        },
        {
            "text": "hadron beams, especially pro",
            "probability": 4.734327695673552e-07,
            "start_logit": -0.9698264002799988,
            "end_logit": 0.03602759540081024
        },
        {
            "text": "pCT and proton",
            "probability": 4.466818456312797e-07,
            "start_logit": -0.4597649574279785,
            "end_logit": -0.5321971774101257
        },
        {
            "text": "especially proton beams,",
            "probability": 2.747801047564079e-07,
            "start_logit": -2.581880807876587,
            "end_logit": 1.1040432453155518
        },
        {
            "text": "pCT scanners will be introduced into clinics. This review introduces hadron therapy and the perceived advantages of pCT and proton radiography",
            "probability": 2.3715197659201814e-07,
            "start_logit": -1.589625597000122,
            "end_logit": -0.03548193722963333
        }
    ],
    "5e2b2c85fbd6abf43b000007_001": [
        {
            "text": "Grade IV vestibular schwannoma",
            "probability": 0.8567083854102441,
            "start_logit": 6.143318176269531,
            "end_logit": 8.628064155578613
        },
        {
            "text": "vestibular schwannoma",
            "probability": 0.08912398000509299,
            "start_logit": 3.8802490234375,
            "end_logit": 8.628064155578613
        },
        {
            "text": "Grade IV",
            "probability": 0.031881295705025965,
            "start_logit": 6.143318176269531,
            "end_logit": 5.336986064910889
        },
        {
            "text": "IV vestibular schwannoma",
            "probability": 0.01386179005872537,
            "start_logit": 2.0193567276000977,
            "end_logit": 8.628064155578613
        },
        {
            "text": "schwannoma",
            "probability": 0.0036759509720184695,
            "start_logit": 0.6920324563980103,
            "end_logit": 8.628064155578613
        },
        {
            "text": "Grade IV vestibular",
            "probability": 0.0028389863528377863,
            "start_logit": 6.143318176269531,
            "end_logit": 2.9184136390686035
        },
        {
            "text": "IV",
            "probability": 0.0005158486077518535,
            "start_logit": 2.0193567276000977,
            "end_logit": 5.336986064910889
        },
        {
            "text": "Grade IV vestibular schwanno",
            "probability": 0.0004426334155618906,
            "start_logit": 6.143318176269531,
            "end_logit": 1.059953212738037
        },
        {
            "text": "vestibular",
            "probability": 0.0002953417606901145,
            "start_logit": 3.8802490234375,
            "end_logit": 2.9184136390686035
        },
        {
            "text": "Grade",
            "probability": 0.00013389510373557675,
            "start_logit": 6.143318176269531,
            "end_logit": -0.1357320249080658
        },
        {
            "text": "Grade IV vestibular schwannoma (Koos classification",
            "probability": 9.051181236154009e-05,
            "start_logit": 6.143318176269531,
            "end_logit": -0.5273083448410034
        },
        {
            "text": "INTRODUCTION: Grade IV vestibular schwannoma",
            "probability": 8.447194301074508e-05,
            "start_logit": -3.081115245819092,
            "end_logit": 8.628064155578613
        },
        {
            "text": "grade IV vestibular schwannoma",
            "probability": 7.832172465888694e-05,
            "start_logit": 2.6301305294036865,
            "end_logit": 2.841223955154419
        },
        {
            "text": "vestibular schwanno",
            "probability": 4.604746766804815e-05,
            "start_logit": 3.8802490234375,
            "end_logit": 1.059953212738037
        },
        {
            "text": "IV vestibular",
            "probability": 4.593562228736562e-05,
            "start_logit": 2.0193567276000977,
            "end_logit": 2.9184136390686035
        },
        {
            "text": "grade 4 vestibular schwannoma",
            "probability": 4.4875568846959276e-05,
            "start_logit": 1.5412840843200684,
            "end_logit": 3.373138904571533
        },
        {
            "text": "Grade IV vestibular schwan",
            "probability": 3.82785903834972e-05,
            "start_logit": 6.143318176269531,
            "end_logit": -1.3878979682922363
        },
        {
            "text": "Grade IV vestib",
            "probability": 3.637135620129076e-05,
            "start_logit": 6.143318176269531,
            "end_logit": -1.4390071630477905
        },
        {
            "text": "Grade IV vestibular s",
            "probability": 3.4959041098665854e-05,
            "start_logit": 6.143318176269531,
            "end_logit": -1.4786115884780884
        },
        {
            "text": "",
            "probability": 2.2119481798268432e-05,
            "start_logit": 1.60810387134552,
            "end_logit": 2.598884344100952
        }
    ],
    "5e2b2c85fbd6abf43b000007_002": [
        {
            "text": "stage 1 or 2",
            "probability": 0.8760063005595856,
            "start_logit": 4.331684589385986,
            "end_logit": 5.70225715637207
        },
        {
            "text": "",
            "probability": 0.052627335947600364,
            "start_logit": 3.4096009731292725,
            "end_logit": 3.8122031688690186
        },
        {
            "text": "small unilateral vestibular schwannoma",
            "probability": 0.020124345473157577,
            "start_logit": 2.4764580726623535,
            "end_logit": 3.784040689468384
        },
        {
            "text": "2",
            "probability": 0.014592674752566962,
            "start_logit": 0.23683097958564758,
            "end_logit": 5.70225715637207
        },
        {
            "text": "1 or 2",
            "probability": 0.009001352723873209,
            "start_logit": -0.24631382524967194,
            "end_logit": 5.70225715637207
        },
        {
            "text": "vestibular schwannoma",
            "probability": 0.004597840183734531,
            "start_logit": 1.0001144409179688,
            "end_logit": 3.784040689468384
        },
        {
            "text": "stage",
            "probability": 0.003851789118161852,
            "start_logit": 4.331684589385986,
            "end_logit": 0.2754216194152832
        },
        {
            "text": "142 patients with VS stage 1 or 2",
            "probability": 0.0038028811901444737,
            "start_logit": -1.1079297065734863,
            "end_logit": 5.70225715637207
        },
        {
            "text": "VS stage 1 or 2",
            "probability": 0.003565267992946146,
            "start_logit": -1.1724494695663452,
            "end_logit": 5.70225715637207
        },
        {
            "text": "stage 1",
            "probability": 0.0027744312598765248,
            "start_logit": 4.331684589385986,
            "end_logit": -0.052670352160930634
        },
        {
            "text": "unilateral vestibular schwannoma",
            "probability": 0.0027449872949706793,
            "start_logit": 0.4843042194843292,
            "end_logit": 3.784040689468384
        },
        {
            "text": "with VS stage 1 or 2",
            "probability": 0.0019223589888776478,
            "start_logit": -1.7901356220245361,
            "end_logit": 5.70225715637207
        },
        {
            "text": "patients with VS stage 1 or 2",
            "probability": 0.0016154458437846134,
            "start_logit": -1.9640777111053467,
            "end_logit": 5.70225715637207
        },
        {
            "text": "small",
            "probability": 0.00107918155273407,
            "start_logit": 2.4764580726623535,
            "end_logit": 0.8583133220672607
        },
        {
            "text": "stage 1 or 2 according",
            "probability": 0.0004153615147309535,
            "start_logit": 4.331684589385986,
            "end_logit": -1.9517221450805664
        },
        {
            "text": "schwannoma",
            "probability": 0.0003380358761267702,
            "start_logit": -1.6100754737854004,
            "end_logit": 3.784040689468384
        },
        {
            "text": "The study included a total of 142 patients with VS stage 1 or 2",
            "probability": 0.00032735170464568087,
            "start_logit": -3.5604088306427,
            "end_logit": 5.70225715637207
        },
        {
            "text": "stage 1 or 2 according to the Koos classification",
            "probability": 0.00026913802374988225,
            "start_logit": 4.331684589385986,
            "end_logit": -2.3856470584869385
        },
        {
            "text": "small unilateral",
            "probability": 0.00017945111105220133,
            "start_logit": 2.4764580726623535,
            "end_logit": -0.9357420802116394
        },
        {
            "text": "quality of life (QOL) in small unilateral vestibular schwannoma",
            "probability": 0.0001644688876799845,
            "start_logit": -2.3305060863494873,
            "end_logit": 3.784040689468384
        }
    ],
    "5e2b2c85fbd6abf43b000007_004": [
        {
            "text": "vestibular schwannomas",
            "probability": 0.585518385827461,
            "start_logit": 1.3195961713790894,
            "end_logit": 2.799842119216919
        },
        {
            "text": "",
            "probability": 0.19767609787967547,
            "start_logit": 1.3446834087371826,
            "end_logit": 1.688887119293213
        },
        {
            "text": "vestibular schwannomas is designed to stratify tumors",
            "probability": 0.04328282507692216,
            "start_logit": 1.3195961713790894,
            "end_logit": 0.19510044157505035
        },
        {
            "text": "tumor",
            "probability": 0.037579516115259615,
            "start_logit": 1.098990797996521,
            "end_logit": 0.2744090259075165
        },
        {
            "text": "vestibular schwannomas is designed to stratify tumors based on extrameatal extension and compression of the brainstem",
            "probability": 0.029362712918203998,
            "start_logit": 1.3195961713790894,
            "end_logit": -0.19292986392974854
        },
        {
            "text": "tumor classification",
            "probability": 0.025947586627198364,
            "start_logit": 1.098990797996521,
            "end_logit": -0.0959714874625206
        },
        {
            "text": "The Koos classification of vestibular schwannomas",
            "probability": 0.013233947051443243,
            "start_logit": -2.470116138458252,
            "end_logit": 2.799842119216919
        },
        {
            "text": "tumors",
            "probability": 0.010456673161627567,
            "start_logit": -0.10091938078403473,
            "end_logit": 0.19510044157505035
        },
        {
            "text": "Koos classification of vestibular schwannomas",
            "probability": 0.008163801203796459,
            "start_logit": -2.9531915187835693,
            "end_logit": 2.799842119216919
        },
        {
            "text": "tumors based on extrameatal extension and compression of the brainstem",
            "probability": 0.007093721160268408,
            "start_logit": -0.10091938078403473,
            "end_logit": -0.19292986392974854
        },
        {
            "text": "vestibular schwannomas is designed to stratify tumors based on extrameatal extension and compression of the brainstem.",
            "probability": 0.0064983795826836594,
            "start_logit": 1.3195961713790894,
            "end_logit": -1.701102614402771
        },
        {
            "text": "schwannomas",
            "probability": 0.006104359937880019,
            "start_logit": -3.2438981533050537,
            "end_logit": 2.799842119216919
        },
        {
            "text": "vestibular schwannoma",
            "probability": 0.005644321042116677,
            "start_logit": -1.3431615829467773,
            "end_logit": 0.8207522034645081
        },
        {
            "text": "We have demonstrated that the Koos classification system for vestibular schwannoma",
            "probability": 0.005298956316315013,
            "start_logit": -1.4063016176223755,
            "end_logit": 0.8207522034645081
        },
        {
            "text": "reliable method for tumor",
            "probability": 0.0034682915186947613,
            "start_logit": -1.2838062047958374,
            "end_logit": 0.2744090259075165
        },
        {
            "text": "vestibular schwannoma is a reliable method for tumor",
            "probability": 0.003268420160555781,
            "start_logit": -1.3431615829467773,
            "end_logit": 0.2744090259075165
        },
        {
            "text": "tumor classification.",
            "probability": 0.003121170765354091,
            "start_logit": 1.098990797996521,
            "end_logit": -2.2138419151306152
        },
        {
            "text": "We have demonstrated that the Koos classification system for vestibular schwannoma is a reliable method for tumor",
            "probability": 0.0030684320620524993,
            "start_logit": -1.4063016176223755,
            "end_logit": 0.2744090259075165
        },
        {
            "text": "a reliable method for tumor",
            "probability": 0.002817644982169486,
            "start_logit": -1.4915668964385986,
            "end_logit": 0.2744090259075165
        },
        {
            "text": "reliable method for tumor classification",
            "probability": 0.002394756610321723,
            "start_logit": -1.2838062047958374,
            "end_logit": -0.0959714874625206
        }
    ],
    "5e2b2c85fbd6abf43b000007_006": [
        {
            "text": "stage I or II",
            "probability": 0.40089645917310185,
            "start_logit": 3.4507036209106445,
            "end_logit": 3.900132179260254
        },
        {
            "text": "",
            "probability": 0.3830134514308143,
            "start_logit": 3.279315233230591,
            "end_logit": 4.025887489318848
        },
        {
            "text": "vestibular schwannoma (stage I or II",
            "probability": 0.09528034562982045,
            "start_logit": 2.013823986053467,
            "end_logit": 3.900132179260254
        },
        {
            "text": "vestibular schwannoma",
            "probability": 0.0509212716024858,
            "start_logit": 2.013823986053467,
            "end_logit": 3.2735893726348877
        },
        {
            "text": "I or II",
            "probability": 0.029165538026127542,
            "start_logit": 0.8299882411956787,
            "end_logit": 3.900132179260254
        },
        {
            "text": "II",
            "probability": 0.014260677691760546,
            "start_logit": 0.11450637131929398,
            "end_logit": 3.900132179260254
        },
        {
            "text": "stage",
            "probability": 0.007331186019885124,
            "start_logit": 3.4507036209106445,
            "end_logit": -0.10143370181322098
        },
        {
            "text": "stage I",
            "probability": 0.00473099595053521,
            "start_logit": 3.4507036209106445,
            "end_logit": -0.5394352674484253
        },
        {
            "text": "schwannoma (stage I or II",
            "probability": 0.0031253121815616887,
            "start_logit": -1.4034653902053833,
            "end_logit": 3.900132179260254
        },
        {
            "text": "Eighteen patients who underwent a middle fossa craniotomy for vestibular schwannoma (stage I or II",
            "probability": 0.0017451851036981638,
            "start_logit": -1.986138939857483,
            "end_logit": 3.900132179260254
        },
        {
            "text": "vestibular schwannoma (stage",
            "probability": 0.0017423898911253575,
            "start_logit": 2.013823986053467,
            "end_logit": -0.10143370181322098
        },
        {
            "text": "schwannoma",
            "probability": 0.0016702801547148428,
            "start_logit": -1.4034653902053833,
            "end_logit": 3.2735893726348877
        },
        {
            "text": "vestibular schwannoma (stage I",
            "probability": 0.0011244073601199825,
            "start_logit": 2.013823986053467,
            "end_logit": -0.5394352674484253
        },
        {
            "text": "AAO-HNS hearing classes",
            "probability": 0.0010991362512516058,
            "start_logit": -0.06321839243173599,
            "end_logit": 1.5148756504058838
        },
        {
            "text": "Eighteen patients who underwent a middle fossa craniotomy for vestibular schwannoma",
            "probability": 0.0009326902004248535,
            "start_logit": -1.986138939857483,
            "end_logit": 3.2735893726348877
        },
        {
            "text": "stage I or II of Koos classification",
            "probability": 0.0007987709233748414,
            "start_logit": 3.4507036209106445,
            "end_logit": -2.3182520866394043
        },
        {
            "text": "Hearing data were classified according to the AAO-HNS hearing classes",
            "probability": 0.0006545873247650081,
            "start_logit": -0.5814933180809021,
            "end_logit": 1.5148756504058838
        },
        {
            "text": "stage I or II of Koos classification) with attempted hearing preservation from January 2008 to February 2016",
            "probability": 0.0005980879146139916,
            "start_logit": 3.4507036209106445,
            "end_logit": -2.607588529586792
        },
        {
            "text": "patients who underwent a middle fossa craniotomy for vestibular schwannoma (stage I or II",
            "probability": 0.0004553162116665204,
            "start_logit": -3.3297626972198486,
            "end_logit": 3.900132179260254
        },
        {
            "text": "middle fossa craniotomy for vestibular schwannoma (stage I or II",
            "probability": 0.00045391095815240575,
            "start_logit": -3.3328537940979004,
            "end_logit": 3.900132179260254
        }
    ],
    "5c7a4ed5d774d04240000008_002": [
        {
            "text": "",
            "probability": 0.906492001017589,
            "start_logit": 4.157379627227783,
            "end_logit": 4.879118919372559
        },
        {
            "text": "sensitive and specific",
            "probability": 0.026447003979551627,
            "start_logit": 3.3182194232940674,
            "end_logit": 2.183839797973633
        },
        {
            "text": "sensitive and specific diagnostic tool",
            "probability": 0.010719105687418504,
            "start_logit": 3.3182194232940674,
            "end_logit": 1.2807246446609497
        },
        {
            "text": "sensitive and specific diagnostic tool for EGFR mutation analysis in CTC preparations with potential clinical impact",
            "probability": 0.008029672985218759,
            "start_logit": 3.3182194232940674,
            "end_logit": 0.9918407201766968
        },
        {
            "text": "they may provide real-time information on patient's disease status",
            "probability": 0.007886873732284255,
            "start_logit": 1.5596776008605957,
            "end_logit": 2.732438564300537
        },
        {
            "text": "sensitive and specific diagnostic tool for EGFR mutation analysis",
            "probability": 0.005616585376228825,
            "start_logit": 3.3182194232940674,
            "end_logit": 0.6344208121299744
        },
        {
            "text": "may provide real-time information on patient's disease status",
            "probability": 0.005553075204286955,
            "start_logit": 1.208829641342163,
            "end_logit": 2.732438564300537
        },
        {
            "text": "sensitive and specific diagnostic",
            "probability": 0.00533579512397247,
            "start_logit": 3.3182194232940674,
            "end_logit": 0.5831348299980164
        },
        {
            "text": "sensitive and specific diagnostic tool for EGFR mutation analysis in CTC preparations with potential clinical impact.",
            "probability": 0.004924623624565131,
            "start_logit": 3.3182194232940674,
            "end_logit": 0.5029447674751282
        },
        {
            "text": "sensitive",
            "probability": 0.003912453896480594,
            "start_logit": 3.3182194232940674,
            "end_logit": 0.27286168932914734
        },
        {
            "text": "very sensitive and specific",
            "probability": 0.003795352911650465,
            "start_logit": 1.3768539428710938,
            "end_logit": 2.183839797973633
        },
        {
            "text": "provide real-time information on patient's disease status",
            "probability": 0.002609980345436826,
            "start_logit": 0.45382046699523926,
            "end_logit": 2.732438564300537
        },
        {
            "text": "very sensitive and specific diagnostic tool",
            "probability": 0.0015382759049943093,
            "start_logit": 1.3768539428710938,
            "end_logit": 1.2807246446609497
        },
        {
            "text": "real-time information on patient's disease status",
            "probability": 0.0014942374385161722,
            "start_logit": -0.10390622168779373,
            "end_logit": 2.732438564300537
        },
        {
            "text": "since they may provide real-time information on patient's disease status",
            "probability": 0.0011548774615543938,
            "start_logit": -0.3615279793739319,
            "end_logit": 2.732438564300537
        },
        {
            "text": "very sensitive and specific diagnostic tool for EGFR mutation analysis in CTC preparations with potential clinical impact",
            "probability": 0.0011523211766298442,
            "start_logit": 1.3768539428710938,
            "end_logit": 0.9918407201766968
        },
        {
            "text": "mutation analysis of circulating tumor cells (CTCs) may be desirable since they may provide real-time information on patient's disease status",
            "probability": 0.0008882153188675974,
            "start_logit": -0.6240633130073547,
            "end_logit": 2.732438564300537
        },
        {
            "text": "sensitive and specific diagnostic tool for EGFR mutation analysis in CTC preparations with potential",
            "probability": 0.0008359090316146726,
            "start_logit": 3.3182194232940674,
            "end_logit": -1.270538568496704
        },
        {
            "text": "sensitive and specific diagnostic tool for EGFR mutation",
            "probability": 0.0008072781191155266,
            "start_logit": 3.3182194232940674,
            "end_logit": -1.3053901195526123
        },
        {
            "text": "diagnostic tool",
            "probability": 0.0008063616640242605,
            "start_logit": 0.7309687733650208,
            "end_logit": 1.2807246446609497
        }
    ],
    "5c7a4ed5d774d04240000008_003": [
        {
            "text": "",
            "probability": 0.906492001017589,
            "start_logit": 4.157379627227783,
            "end_logit": 4.879118919372559
        },
        {
            "text": "sensitive and specific",
            "probability": 0.026447003979551627,
            "start_logit": 3.3182194232940674,
            "end_logit": 2.183839797973633
        },
        {
            "text": "sensitive and specific diagnostic tool",
            "probability": 0.010719105687418504,
            "start_logit": 3.3182194232940674,
            "end_logit": 1.2807246446609497
        },
        {
            "text": "sensitive and specific diagnostic tool for EGFR mutation analysis in CTC preparations with potential clinical impact",
            "probability": 0.008029672985218759,
            "start_logit": 3.3182194232940674,
            "end_logit": 0.9918407201766968
        },
        {
            "text": "they may provide real-time information on patient's disease status",
            "probability": 0.007886873732284255,
            "start_logit": 1.5596776008605957,
            "end_logit": 2.732438564300537
        },
        {
            "text": "sensitive and specific diagnostic tool for EGFR mutation analysis",
            "probability": 0.005616585376228825,
            "start_logit": 3.3182194232940674,
            "end_logit": 0.6344208121299744
        },
        {
            "text": "may provide real-time information on patient's disease status",
            "probability": 0.005553075204286955,
            "start_logit": 1.208829641342163,
            "end_logit": 2.732438564300537
        },
        {
            "text": "sensitive and specific diagnostic",
            "probability": 0.00533579512397247,
            "start_logit": 3.3182194232940674,
            "end_logit": 0.5831348299980164
        },
        {
            "text": "sensitive and specific diagnostic tool for EGFR mutation analysis in CTC preparations with potential clinical impact.",
            "probability": 0.004924623624565131,
            "start_logit": 3.3182194232940674,
            "end_logit": 0.5029447674751282
        },
        {
            "text": "sensitive",
            "probability": 0.003912453896480594,
            "start_logit": 3.3182194232940674,
            "end_logit": 0.27286168932914734
        },
        {
            "text": "very sensitive and specific",
            "probability": 0.003795352911650465,
            "start_logit": 1.3768539428710938,
            "end_logit": 2.183839797973633
        },
        {
            "text": "provide real-time information on patient's disease status",
            "probability": 0.002609980345436826,
            "start_logit": 0.45382046699523926,
            "end_logit": 2.732438564300537
        },
        {
            "text": "very sensitive and specific diagnostic tool",
            "probability": 0.0015382759049943093,
            "start_logit": 1.3768539428710938,
            "end_logit": 1.2807246446609497
        },
        {
            "text": "real-time information on patient's disease status",
            "probability": 0.0014942374385161722,
            "start_logit": -0.10390622168779373,
            "end_logit": 2.732438564300537
        },
        {
            "text": "since they may provide real-time information on patient's disease status",
            "probability": 0.0011548774615543938,
            "start_logit": -0.3615279793739319,
            "end_logit": 2.732438564300537
        },
        {
            "text": "very sensitive and specific diagnostic tool for EGFR mutation analysis in CTC preparations with potential clinical impact",
            "probability": 0.0011523211766298442,
            "start_logit": 1.3768539428710938,
            "end_logit": 0.9918407201766968
        },
        {
            "text": "mutation analysis of circulating tumor cells (CTCs) may be desirable since they may provide real-time information on patient's disease status",
            "probability": 0.0008882153188675974,
            "start_logit": -0.6240633130073547,
            "end_logit": 2.732438564300537
        },
        {
            "text": "sensitive and specific diagnostic tool for EGFR mutation analysis in CTC preparations with potential",
            "probability": 0.0008359090316146726,
            "start_logit": 3.3182194232940674,
            "end_logit": -1.270538568496704
        },
        {
            "text": "sensitive and specific diagnostic tool for EGFR mutation",
            "probability": 0.0008072781191155266,
            "start_logit": 3.3182194232940674,
            "end_logit": -1.3053901195526123
        },
        {
            "text": "diagnostic tool",
            "probability": 0.0008063616640242605,
            "start_logit": 0.7309687733650208,
            "end_logit": 1.2807246446609497
        }
    ],
    "5c7a4ed5d774d04240000008_005": [
        {
            "text": "",
            "probability": 0.9994965073593843,
            "start_logit": 6.510676383972168,
            "end_logit": 6.936050891876221
        },
        {
            "text": "sensitivity and specificity of Real-Time PCR analysis",
            "probability": 0.0001710720893049769,
            "start_logit": 2.34157395362854,
            "end_logit": 2.4322314262390137
        },
        {
            "text": "remarkable sensitivity and specificity of Real-Time PCR analysis",
            "probability": 8.077487966024335e-05,
            "start_logit": 1.591154932975769,
            "end_logit": 2.4322314262390137
        },
        {
            "text": "sensitivity and specificity",
            "probability": 7.158854146561808e-05,
            "start_logit": 2.34157395362854,
            "end_logit": 1.5610814094543457
        },
        {
            "text": "Real-Time PCR analysis",
            "probability": 5.110088707198278e-05,
            "start_logit": 1.1332907676696777,
            "end_logit": 2.4322314262390137
        },
        {
            "text": "remarkable sensitivity and specificity",
            "probability": 3.380186590010514e-05,
            "start_logit": 1.591154932975769,
            "end_logit": 1.5610814094543457
        },
        {
            "text": "sensitivity and specificity of Real-Time PCR analysis;",
            "probability": 1.624417904758483e-05,
            "start_logit": 2.34157395362854,
            "end_logit": 0.07788101583719254
        },
        {
            "text": "sensitivity and specificity of Real-Time PCR",
            "probability": 1.3896339540146904e-05,
            "start_logit": 2.34157395362854,
            "end_logit": -0.07822815328836441
        },
        {
            "text": "taking advantage of the remarkable sensitivity and specificity of Real-Time PCR analysis",
            "probability": 1.2937269439989863e-05,
            "start_logit": -0.2403988391160965,
            "end_logit": 2.4322314262390137
        },
        {
            "text": "remarkable sensitivity and specificity of Real-Time PCR analysis;",
            "probability": 7.669992300198896e-06,
            "start_logit": 1.591154932975769,
            "end_logit": 0.07788101583719254
        },
        {
            "text": "the remarkable sensitivity and specificity of Real-Time PCR analysis",
            "probability": 7.471917787957586e-06,
            "start_logit": -0.7893593907356262,
            "end_logit": 2.4322314262390137
        },
        {
            "text": "remarkable sensitivity and specificity of Real-Time PCR",
            "probability": 6.561416059355932e-06,
            "start_logit": 1.591154932975769,
            "end_logit": -0.07822815328836441
        },
        {
            "text": "sensitivity and specificity of Real-Time",
            "probability": 6.310691057008391e-06,
            "start_logit": 2.34157395362854,
            "end_logit": -0.8676084280014038
        },
        {
            "text": "taking advantage of the remarkable sensitivity and specificity",
            "probability": 5.413859464272314e-06,
            "start_logit": -0.2403988391160965,
            "end_logit": 1.5610814094543457
        },
        {
            "text": "Real-Time PCR analysis;",
            "probability": 4.852293337037953e-06,
            "start_logit": 1.1332907676696777,
            "end_logit": 0.07788101583719254
        },
        {
            "text": "Real-Time PCR",
            "probability": 4.150970976270862e-06,
            "start_logit": 1.1332907676696777,
            "end_logit": -0.07822815328836441
        },
        {
            "text": "the remarkable sensitivity and specificity",
            "probability": 3.126773622535802e-06,
            "start_logit": -0.7893593907356262,
            "end_logit": 1.5610814094543457
        },
        {
            "text": "remarkable sensitivity and specificity of Real-Time",
            "probability": 2.9797105581266607e-06,
            "start_logit": 1.591154932975769,
            "end_logit": -0.8676084280014038
        },
        {
            "text": "Real-Time",
            "probability": 1.885064433131791e-06,
            "start_logit": 1.1332907676696777,
            "end_logit": -0.8676084280014038
        },
        {
            "text": "advantage of the remarkable sensitivity and specificity of Real-Time PCR analysis",
            "probability": 1.6538995889376548e-06,
            "start_logit": -2.297375202178955,
            "end_logit": 2.4322314262390137
        }
    ],
    "5c7a4ed5d774d04240000008_006": [
        {
            "text": "to detect \"druggable\" mutations and, in particular, to monitor tyrosine kinase inhibitor (TKI) treatments",
            "probability": 0.5200961259992047,
            "start_logit": 5.041791915893555,
            "end_logit": 6.369149208068848
        },
        {
            "text": "detect \"druggable\" mutations and, in particular, to monitor tyrosine kinase inhibitor (TKI) treatments",
            "probability": 0.11720158336948526,
            "start_logit": 3.551673650741577,
            "end_logit": 6.369149208068848
        },
        {
            "text": "to detect \"druggable\" mutations",
            "probability": 0.10270422111063729,
            "start_logit": 5.041791915893555,
            "end_logit": 4.746988773345947
        },
        {
            "text": "to monitor tyrosine kinase inhibitor (TKI) treatments",
            "probability": 0.09320164365803399,
            "start_logit": 3.3225436210632324,
            "end_logit": 6.369149208068848
        },
        {
            "text": "\"druggable\" mutations and, in particular, to monitor tyrosine kinase inhibitor (TKI) treatments",
            "probability": 0.02992030991595543,
            "start_logit": 2.1863157749176025,
            "end_logit": 6.369149208068848
        },
        {
            "text": "generally, to detect \"druggable\" mutations and, in particular, to monitor tyrosine kinase inhibitor (TKI) treatments",
            "probability": 0.028620936290621228,
            "start_logit": 2.1419167518615723,
            "end_logit": 6.369149208068848
        },
        {
            "text": "detect \"druggable\" mutations",
            "probability": 0.023143985757961227,
            "start_logit": 3.551673650741577,
            "end_logit": 4.746988773345947
        },
        {
            "text": "tyrosine kinase inhibitor (TKI) treatments",
            "probability": 0.018895833978329217,
            "start_logit": 1.7267197370529175,
            "end_logit": 6.369149208068848
        },
        {
            "text": "druggable\" mutations and, in particular, to monitor tyrosine kinase inhibitor (TKI) treatments",
            "probability": 0.012942092708484594,
            "start_logit": 1.3482632637023926,
            "end_logit": 6.369149208068848
        },
        {
            "text": "to detect \"druggable\" mutations and, in particular, to monitor tyrosine kinase inhibitor (TKI)",
            "probability": 0.009756430039081993,
            "start_logit": 5.041791915893555,
            "end_logit": 2.393062114715576
        },
        {
            "text": "monitor tyrosine kinase inhibitor (TKI) treatments",
            "probability": 0.008156924775365138,
            "start_logit": 0.886645495891571,
            "end_logit": 6.369149208068848
        },
        {
            "text": "to detect \"druggable\" mutations and, in particular, to monitor tyrosine kinase inhibitor",
            "probability": 0.006020764055529295,
            "start_logit": 5.041791915893555,
            "end_logit": 1.910349726676941
        },
        {
            "text": "\"druggable\" mutations",
            "probability": 0.00590841187175422,
            "start_logit": 2.1863157749176025,
            "end_logit": 4.746988773345947
        },
        {
            "text": "generally, to detect \"druggable\" mutations",
            "probability": 0.0056518224655838336,
            "start_logit": 2.1419167518615723,
            "end_logit": 4.746988773345947
        },
        {
            "text": "to detect \"druggable\" mutations and, in particular, to monitor tyrosine kinase inhibitor (TKI",
            "probability": 0.004269979430761561,
            "start_logit": 5.041791915893555,
            "end_logit": 1.5667445659637451
        },
        {
            "text": "to detect \"druggable\" mutations and, in particular, to monitor tyrosine kinase inhibitor (TKI) treatments.",
            "probability": 0.003629348647724707,
            "start_logit": 5.041791915893555,
            "end_logit": 1.4041887521743774
        },
        {
            "text": "druggable\" mutations",
            "probability": 0.0025556959275805117,
            "start_logit": 1.3482632637023926,
            "end_logit": 4.746988773345947
        },
        {
            "text": "detect \"druggable\" mutations and, in particular, to monitor tyrosine kinase inhibitor (TKI)",
            "probability": 0.0021985725166039152,
            "start_logit": 3.551673650741577,
            "end_logit": 2.393062114715576
        },
        {
            "text": "TKI) treatments",
            "probability": 0.0021371459952944662,
            "start_logit": -0.45275044441223145,
            "end_logit": 6.369149208068848
        },
        {
            "text": "to monitor tyrosine kinase inhibitor (TKI)",
            "probability": 0.0017483601019524782,
            "start_logit": 3.3225436210632324,
            "end_logit": 2.393062114715576
        },
        {
            "text": "",
            "probability": 0.0012398113840547842,
            "start_logit": 2.3547987937927246,
            "end_logit": 3.017087936401367
        }
    ],
    "5c7a4ed5d774d04240000008_007": [
        {
            "text": "improve not only the fidelity of the molecular analysis but also the number of tests performed on a single specimen",
            "probability": 0.24480262296447505,
            "start_logit": 2.0368452072143555,
            "end_logit": 3.4075253009796143
        },
        {
            "text": "not only the fidelity of the molecular analysis but also the number of tests performed on a single specimen",
            "probability": 0.21257160633122973,
            "start_logit": 1.8956718444824219,
            "end_logit": 3.4075253009796143
        },
        {
            "text": "improve not only the fidelity of the molecular analysis",
            "probability": 0.08251735832438295,
            "start_logit": 2.0368452072143555,
            "end_logit": 2.3200817108154297
        },
        {
            "text": "significant potential to improve patient care",
            "probability": 0.07879188967412082,
            "start_logit": 1.5547456741333008,
            "end_logit": 2.7559826374053955
        },
        {
            "text": "not only the fidelity of the molecular analysis",
            "probability": 0.07165302069401938,
            "start_logit": 1.8956718444824219,
            "end_logit": 2.3200817108154297
        },
        {
            "text": "",
            "probability": 0.06014660831842887,
            "start_logit": 1.651735782623291,
            "end_logit": 2.388967514038086
        },
        {
            "text": "fidelity of the molecular analysis but also the number of tests performed on a single specimen",
            "probability": 0.037886797325282114,
            "start_logit": 0.17099563777446747,
            "end_logit": 3.4075253009796143
        },
        {
            "text": "number of tests performed on a single specimen",
            "probability": 0.033518735042276475,
            "start_logit": 0.048497479408979416,
            "end_logit": 3.4075253009796143
        },
        {
            "text": "improve not only the fidelity of the molecular analysis but also the number of tests performed on a single specimen.",
            "probability": 0.02493287822562807,
            "start_logit": 2.0368452072143555,
            "end_logit": 1.1232603788375854
        },
        {
            "text": "not only the fidelity of the molecular analysis but also the number of tests performed on a single specimen.",
            "probability": 0.02165018458830738,
            "start_logit": 1.8956718444824219,
            "end_logit": 1.1232603788375854
        },
        {
            "text": "An increasing number of innovative platforms have been recently developed that improve not only the fidelity of the molecular analysis",
            "probability": 0.01944104801518001,
            "start_logit": 0.5912232398986816,
            "end_logit": 2.3200817108154297
        },
        {
            "text": "innovative platforms have been recently developed that improve not only the fidelity of the molecular analysis but also the number of tests performed on a single specimen",
            "probability": 0.018614725889935086,
            "start_logit": -0.5396540760993958,
            "end_logit": 3.4075253009796143
        },
        {
            "text": "have significant potential to improve patient care",
            "probability": 0.016207810516287568,
            "start_logit": -0.026571137830615044,
            "end_logit": 2.7559826374053955
        },
        {
            "text": "liquid biopsy approaches have significant potential to improve patient care",
            "probability": 0.014836952070774454,
            "start_logit": -0.11494356393814087,
            "end_logit": 2.7559826374053955
        },
        {
            "text": "fidelity of the molecular analysis",
            "probability": 0.01277077178665385,
            "start_logit": 0.17099563777446747,
            "end_logit": 2.3200817108154297
        },
        {
            "text": "potential to improve patient care",
            "probability": 0.011794880343823453,
            "start_logit": -0.3443988263607025,
            "end_logit": 2.7559826374053955
        },
        {
            "text": "improve patient care",
            "probability": 0.010440603269316388,
            "start_logit": -0.46636202931404114,
            "end_logit": 2.7559826374053955
        },
        {
            "text": "the number of tests performed on a single specimen",
            "probability": 0.009692219281704936,
            "start_logit": -1.1922836303710938,
            "end_logit": 3.4075253009796143
        },
        {
            "text": "the fidelity of the molecular analysis but also the number of tests performed on a single specimen",
            "probability": 0.009665794340129688,
            "start_logit": -1.1950137615203857,
            "end_logit": 3.4075253009796143
        },
        {
            "text": "to improve patient care",
            "probability": 0.008063492998043919,
            "start_logit": -0.7247175574302673,
            "end_logit": 2.7559826374053955
        }
    ],
    "5c7a4ed5d774d04240000008_008": [
        {
            "text": "improve not only the fidelity of the molecular analysis but also the number of tests performed on a single specimen",
            "probability": 0.24480262296447505,
            "start_logit": 2.0368452072143555,
            "end_logit": 3.4075253009796143
        },
        {
            "text": "not only the fidelity of the molecular analysis but also the number of tests performed on a single specimen",
            "probability": 0.21257160633122973,
            "start_logit": 1.8956718444824219,
            "end_logit": 3.4075253009796143
        },
        {
            "text": "improve not only the fidelity of the molecular analysis",
            "probability": 0.08251735832438295,
            "start_logit": 2.0368452072143555,
            "end_logit": 2.3200817108154297
        },
        {
            "text": "significant potential to improve patient care",
            "probability": 0.07879188967412082,
            "start_logit": 1.5547456741333008,
            "end_logit": 2.7559826374053955
        },
        {
            "text": "not only the fidelity of the molecular analysis",
            "probability": 0.07165302069401938,
            "start_logit": 1.8956718444824219,
            "end_logit": 2.3200817108154297
        },
        {
            "text": "",
            "probability": 0.06014660831842887,
            "start_logit": 1.651735782623291,
            "end_logit": 2.388967514038086
        },
        {
            "text": "fidelity of the molecular analysis but also the number of tests performed on a single specimen",
            "probability": 0.037886797325282114,
            "start_logit": 0.17099563777446747,
            "end_logit": 3.4075253009796143
        },
        {
            "text": "number of tests performed on a single specimen",
            "probability": 0.033518735042276475,
            "start_logit": 0.048497479408979416,
            "end_logit": 3.4075253009796143
        },
        {
            "text": "improve not only the fidelity of the molecular analysis but also the number of tests performed on a single specimen.",
            "probability": 0.02493287822562807,
            "start_logit": 2.0368452072143555,
            "end_logit": 1.1232603788375854
        },
        {
            "text": "not only the fidelity of the molecular analysis but also the number of tests performed on a single specimen.",
            "probability": 0.02165018458830738,
            "start_logit": 1.8956718444824219,
            "end_logit": 1.1232603788375854
        },
        {
            "text": "An increasing number of innovative platforms have been recently developed that improve not only the fidelity of the molecular analysis",
            "probability": 0.01944104801518001,
            "start_logit": 0.5912232398986816,
            "end_logit": 2.3200817108154297
        },
        {
            "text": "innovative platforms have been recently developed that improve not only the fidelity of the molecular analysis but also the number of tests performed on a single specimen",
            "probability": 0.018614725889935086,
            "start_logit": -0.5396540760993958,
            "end_logit": 3.4075253009796143
        },
        {
            "text": "have significant potential to improve patient care",
            "probability": 0.016207810516287568,
            "start_logit": -0.026571137830615044,
            "end_logit": 2.7559826374053955
        },
        {
            "text": "liquid biopsy approaches have significant potential to improve patient care",
            "probability": 0.014836952070774454,
            "start_logit": -0.11494356393814087,
            "end_logit": 2.7559826374053955
        },
        {
            "text": "fidelity of the molecular analysis",
            "probability": 0.01277077178665385,
            "start_logit": 0.17099563777446747,
            "end_logit": 2.3200817108154297
        },
        {
            "text": "potential to improve patient care",
            "probability": 0.011794880343823453,
            "start_logit": -0.3443988263607025,
            "end_logit": 2.7559826374053955
        },
        {
            "text": "improve patient care",
            "probability": 0.010440603269316388,
            "start_logit": -0.46636202931404114,
            "end_logit": 2.7559826374053955
        },
        {
            "text": "the number of tests performed on a single specimen",
            "probability": 0.009692219281704936,
            "start_logit": -1.1922836303710938,
            "end_logit": 3.4075253009796143
        },
        {
            "text": "the fidelity of the molecular analysis but also the number of tests performed on a single specimen",
            "probability": 0.009665794340129688,
            "start_logit": -1.1950137615203857,
            "end_logit": 3.4075253009796143
        },
        {
            "text": "to improve patient care",
            "probability": 0.008063492998043919,
            "start_logit": -0.7247175574302673,
            "end_logit": 2.7559826374053955
        }
    ],
    "5e355e20fbd6abf43b000065_002": [
        {
            "text": "lamin B1",
            "probability": 0.6280130070583854,
            "start_logit": 6.890236854553223,
            "end_logit": 7.247550010681152
        },
        {
            "text": "lamin B1 (LMNB1)",
            "probability": 0.16937821382965657,
            "start_logit": 6.890236854553223,
            "end_logit": 5.9371232986450195
        },
        {
            "text": "lamin B1 (LMNB1) gene",
            "probability": 0.07629470318691613,
            "start_logit": 6.890236854553223,
            "end_logit": 5.13959264755249
        },
        {
            "text": "LMNB1)",
            "probability": 0.03838075006325699,
            "start_logit": 5.405658721923828,
            "end_logit": 5.9371232986450195
        },
        {
            "text": "lamin B1 (LMNB1",
            "probability": 0.03748036412035804,
            "start_logit": 6.890236854553223,
            "end_logit": 4.428806304931641
        },
        {
            "text": "LMNB1) gene",
            "probability": 0.01728822065104748,
            "start_logit": 5.405658721923828,
            "end_logit": 5.13959264755249
        },
        {
            "text": "the lamin B1",
            "probability": 0.010485833376719609,
            "start_logit": 2.797701120376587,
            "end_logit": 7.247550010681152
        },
        {
            "text": "LMNB1",
            "probability": 0.008492972354933728,
            "start_logit": 5.405658721923828,
            "end_logit": 4.428806304931641
        },
        {
            "text": "Duplication or over expression of the lamin B1",
            "probability": 0.0031255812661489042,
            "start_logit": 1.5872962474822998,
            "end_logit": 7.247550010681152
        },
        {
            "text": "the lamin B1 (LMNB1)",
            "probability": 0.002828081119184598,
            "start_logit": 2.797701120376587,
            "end_logit": 5.9371232986450195
        },
        {
            "text": "lamin B",
            "probability": 0.0018046485318713669,
            "start_logit": 6.890236854553223,
            "end_logit": 1.395354986190796
        },
        {
            "text": "lamin",
            "probability": 0.0017423707358227554,
            "start_logit": 6.890236854553223,
            "end_logit": 1.3602358102798462
        },
        {
            "text": "the lamin B1 (LMNB1) gene",
            "probability": 0.0012738805345633628,
            "start_logit": 2.797701120376587,
            "end_logit": 5.13959264755249
        },
        {
            "text": "Duplication or over expression of the lamin B1 (LMNB1)",
            "probability": 0.0008429847249812133,
            "start_logit": 1.5872962474822998,
            "end_logit": 5.9371232986450195
        },
        {
            "text": "the lamin B1 (LMNB1",
            "probability": 0.0006258036834391816,
            "start_logit": 2.797701120376587,
            "end_logit": 4.428806304931641
        },
        {
            "text": "lamin B1 (",
            "probability": 0.00047021328328726304,
            "start_logit": 6.890236854553223,
            "end_logit": 0.05042023956775665
        },
        {
            "text": "la",
            "probability": 0.0004256263041723939,
            "start_logit": 6.890236854553223,
            "end_logit": -0.04920440539717674
        },
        {
            "text": "B1",
            "probability": 0.00041759117919296297,
            "start_logit": -0.425576388835907,
            "end_logit": 7.247550010681152
        },
        {
            "text": "Duplication or over expression of the lamin B1 (LMNB1) gene",
            "probability": 0.00037971394271655006,
            "start_logit": 1.5872962474822998,
            "end_logit": 5.13959264755249
        },
        {
            "text": "Duplication or over expression of the lamin B1 (LMNB1",
            "probability": 0.00018653741662414257,
            "start_logit": 1.5872962474822998,
            "end_logit": 4.428806304931641
        },
        {
            "text": "",
            "probability": 6.290263672126432e-05,
            "start_logit": 2.495626926422119,
            "end_logit": 2.43343186378479
        }
    ],
    "5e355e20fbd6abf43b000065_003": [
        {
            "text": "lamin B1",
            "probability": 0.7077447007641805,
            "start_logit": 7.235122203826904,
            "end_logit": 7.381819725036621
        },
        {
            "text": "lamin B1 (LMNB1)",
            "probability": 0.08970905692511474,
            "start_logit": 7.235122203826904,
            "end_logit": 5.31630802154541
        },
        {
            "text": "lamin B1 (LMNB1) gene",
            "probability": 0.08859291573825737,
            "start_logit": 7.235122203826904,
            "end_logit": 5.303788185119629
        },
        {
            "text": "lamin B1 (LMNB1",
            "probability": 0.03479217188204927,
            "start_logit": 7.235122203826904,
            "end_logit": 4.369128704071045
        },
        {
            "text": "the lamin B1",
            "probability": 0.030851859583379885,
            "start_logit": 4.102235794067383,
            "end_logit": 7.381819725036621
        },
        {
            "text": "LMNB1)",
            "probability": 0.012169827509987676,
            "start_logit": 5.2375102043151855,
            "end_logit": 5.31630802154541
        },
        {
            "text": "LMNB1) gene",
            "probability": 0.01201841307997995,
            "start_logit": 5.2375102043151855,
            "end_logit": 5.303788185119629
        },
        {
            "text": "lamin",
            "probability": 0.004839627388282233,
            "start_logit": 7.235122203826904,
            "end_logit": 2.396574020385742
        },
        {
            "text": "LMNB1",
            "probability": 0.004719866031540509,
            "start_logit": 5.2375102043151855,
            "end_logit": 4.369128704071045
        },
        {
            "text": "the lamin B1 (LMNB1)",
            "probability": 0.0039105785244632485,
            "start_logit": 4.102235794067383,
            "end_logit": 5.31630802154541
        },
        {
            "text": "the lamin B1 (LMNB1) gene",
            "probability": 0.0038619239303207993,
            "start_logit": 4.102235794067383,
            "end_logit": 5.303788185119629
        },
        {
            "text": "lamin B",
            "probability": 0.002482907121330007,
            "start_logit": 7.235122203826904,
            "end_logit": 1.7291663885116577
        },
        {
            "text": "the lamin B1 (LMNB1",
            "probability": 0.0015166531100081783,
            "start_logit": 4.102235794067383,
            "end_logit": 4.369128704071045
        },
        {
            "text": "Chromosomal rearrangements with duplication of the lamin B1",
            "probability": 0.0010665598932390456,
            "start_logit": 0.73747718334198,
            "end_logit": 7.381819725036621
        },
        {
            "text": "B1",
            "probability": 0.0005585099036389494,
            "start_logit": 0.090555839240551,
            "end_logit": 7.381819725036621
        },
        {
            "text": "la",
            "probability": 0.0003657207008836234,
            "start_logit": 7.235122203826904,
            "end_logit": -0.18614906072616577
        },
        {
            "text": "",
            "probability": 0.0002481685809864297,
            "start_logit": 3.465304136276245,
            "end_logit": 3.1959073543548584
        },
        {
            "text": "the lamin",
            "probability": 0.00021096802909007344,
            "start_logit": 4.102235794067383,
            "end_logit": 2.396574020385742
        },
        {
            "text": "duplication of the lamin B1",
            "probability": 0.0002043811957707804,
            "start_logit": -0.914729654788971,
            "end_logit": 7.381819725036621
        },
        {
            "text": "Chromosomal rearrangements with duplication of the lamin B1 (LMNB1)",
            "probability": 0.00013519010749683637,
            "start_logit": 0.73747718334198,
            "end_logit": 5.31630802154541
        }
    ],
    "5e355e20fbd6abf43b000065_004": [
        {
            "text": "lamin B1",
            "probability": 0.5588656893142578,
            "start_logit": 7.666000843048096,
            "end_logit": 7.747010231018066
        },
        {
            "text": "lamin B1 (LMNB1) gene",
            "probability": 0.15847745653339476,
            "start_logit": 7.666000843048096,
            "end_logit": 6.486713409423828
        },
        {
            "text": "lamin B1 (LMNB1)",
            "probability": 0.14179183697042208,
            "start_logit": 7.666000843048096,
            "end_logit": 6.375461101531982
        },
        {
            "text": "lamin B1 (LMNB1",
            "probability": 0.04001534093532412,
            "start_logit": 7.666000843048096,
            "end_logit": 5.110363960266113
        },
        {
            "text": "LMNB1) gene",
            "probability": 0.029732963036623396,
            "start_logit": 5.992644786834717,
            "end_logit": 6.486713409423828
        },
        {
            "text": "LMNB1)",
            "probability": 0.026602467882541437,
            "start_logit": 5.992644786834717,
            "end_logit": 6.375461101531982
        },
        {
            "text": "the lamin B1",
            "probability": 0.017165405008436406,
            "start_logit": 4.182987689971924,
            "end_logit": 7.747010231018066
        },
        {
            "text": "LMNB1",
            "probability": 0.007507532484137028,
            "start_logit": 5.992644786834717,
            "end_logit": 5.110363960266113
        },
        {
            "text": "the lamin B1 (LMNB1) gene",
            "probability": 0.004867591226508304,
            "start_logit": 4.182987689971924,
            "end_logit": 6.486713409423828
        },
        {
            "text": "the lamin B1 (LMNB1)",
            "probability": 0.004355097038563873,
            "start_logit": 4.182987689971924,
            "end_logit": 6.375461101531982
        },
        {
            "text": "lamin",
            "probability": 0.002595059651773496,
            "start_logit": 7.666000843048096,
            "end_logit": 2.3747105598449707
        },
        {
            "text": "lamin B",
            "probability": 0.0024412779612241905,
            "start_logit": 7.666000843048096,
            "end_logit": 2.3136227130889893
        },
        {
            "text": "lamin B1 (LMNB1) gene.",
            "probability": 0.0018781857435863536,
            "start_logit": 7.666000843048096,
            "end_logit": 2.0514073371887207
        },
        {
            "text": "the lamin B1 (LMNB1",
            "probability": 0.0012290601245324637,
            "start_logit": 4.182987689971924,
            "end_logit": 5.110363960266113
        },
        {
            "text": "duplications of the lamin B1",
            "probability": 0.0008213002898649711,
            "start_logit": 1.1432251930236816,
            "end_logit": 7.747010231018066
        },
        {
            "text": "B1",
            "probability": 0.0003988516074221353,
            "start_logit": 0.4209258258342743,
            "end_logit": 7.747010231018066
        },
        {
            "text": "la",
            "probability": 0.00039291443471172166,
            "start_logit": 7.666000843048096,
            "end_logit": 0.48693764209747314
        },
        {
            "text": "LMNB1) gene.",
            "probability": 0.00035237836668711614,
            "start_logit": 5.992644786834717,
            "end_logit": 2.0514073371887207
        },
        {
            "text": "LMNB1) gene. However, as only a few cases have been analyzed in detail, the mechanisms underlying LMNB1",
            "probability": 0.00025780253930536654,
            "start_logit": 5.992644786834717,
            "end_logit": 1.7388957738876343
        },
        {
            "text": "duplications of the lamin B1 (LMNB1) gene",
            "probability": 0.00023289599536455182,
            "start_logit": 1.1432251930236816,
            "end_logit": 6.486713409423828
        },
        {
            "text": "",
            "probability": 1.8892855318485947e-05,
            "start_logit": 2.5813403129577637,
            "end_logit": 2.536790132522583
        }
    ],
    "5e355e20fbd6abf43b000065_005": [
        {
            "text": "LMNB1",
            "probability": 0.8925278051098013,
            "start_logit": 6.800668239593506,
            "end_logit": 7.587745666503906
        },
        {
            "text": "LMNB1 gene",
            "probability": 0.08093123215294917,
            "start_logit": 6.800668239593506,
            "end_logit": 5.1872878074646
        },
        {
            "text": "the LMNB1",
            "probability": 0.016787417650182646,
            "start_logit": 2.827240228652954,
            "end_logit": 7.587745666503906
        },
        {
            "text": "Duplication of the LMNB1",
            "probability": 0.0037517724145252175,
            "start_logit": 1.3288389444351196,
            "end_logit": 7.587745666503906
        },
        {
            "text": "LMNB",
            "probability": 0.0035264565036077083,
            "start_logit": 6.800668239593506,
            "end_logit": 2.0539815425872803
        },
        {
            "text": "the LMNB1 gene",
            "probability": 0.001522223047077291,
            "start_logit": 2.827240228652954,
            "end_logit": 5.1872878074646
        },
        {
            "text": "Duplication of the LMNB1 gene",
            "probability": 0.00034019731657280625,
            "start_logit": 1.3288389444351196,
            "end_logit": 5.1872878074646
        },
        {
            "text": "LMNB1 gene. Lamin B1",
            "probability": 0.00025822293879002793,
            "start_logit": 4.414521217346191,
            "end_logit": 1.825903058052063
        },
        {
            "text": "L",
            "probability": 0.0001409108235951415,
            "start_logit": 6.800668239593506,
            "end_logit": -1.1659400463104248
        },
        {
            "text": "the LMNB",
            "probability": 6.632857577359448e-05,
            "start_logit": 2.827240228652954,
            "end_logit": 2.0539815425872803
        },
        {
            "text": "",
            "probability": 5.525310119284497e-05,
            "start_logit": 2.399543285369873,
            "end_logit": 2.2989821434020996
        },
        {
            "text": "LMNB1 gene.",
            "probability": 2.3560281645278136e-05,
            "start_logit": 4.414521217346191,
            "end_logit": -0.5683579444885254
        },
        {
            "text": "Duplication of the LMNB",
            "probability": 1.4823585501216736e-05,
            "start_logit": 1.3288389444351196,
            "end_logit": 2.0539815425872803
        },
        {
            "text": "extra copy of the LMNB1",
            "probability": 1.3284245839158697e-05,
            "start_logit": -2.0028135776519775,
            "end_logit": 5.275993347167969
        },
        {
            "text": "Lamin B1",
            "probability": 1.1021002469364624e-05,
            "start_logit": 1.2605006694793701,
            "end_logit": 1.825903058052063
        },
        {
            "text": "an extra copy of the LMNB1",
            "probability": 1.1018809945479907e-05,
            "start_logit": -2.189788579940796,
            "end_logit": 5.275993347167969
        },
        {
            "text": "gene",
            "probability": 8.304716754160796e-06,
            "start_logit": -2.3838632106781006,
            "end_logit": 5.1872878074646
        },
        {
            "text": "the LMNB1 gene. Lamin B1",
            "probability": 4.283148090566072e-06,
            "start_logit": 0.31538617610931396,
            "end_logit": 1.825903058052063
        },
        {
            "text": "the",
            "probability": 3.234205767006804e-06,
            "start_logit": 2.827240228652954,
            "end_logit": -0.9668558835983276
        },
        {
            "text": "the L",
            "probability": 2.650369919659632e-06,
            "start_logit": 2.827240228652954,
            "end_logit": -1.1659400463104248
        }
    ],
    "5e355e20fbd6abf43b000065_006": [
        {
            "text": "LMNB1",
            "probability": 0.8223089502254073,
            "start_logit": 6.81737756729126,
            "end_logit": 7.148377418518066
        },
        {
            "text": "LMNB1 gene",
            "probability": 0.11686017758166983,
            "start_logit": 6.81737756729126,
            "end_logit": 5.197239398956299
        },
        {
            "text": "LMNB1 gene, which results in increased lamin B1",
            "probability": 0.01592258078880426,
            "start_logit": 6.81737756729126,
            "end_logit": 3.2039995193481445
        },
        {
            "text": "the LMNB1",
            "probability": 0.015731045025518357,
            "start_logit": 2.8608975410461426,
            "end_logit": 7.148377418518066
        },
        {
            "text": "LMNB1 gene, which results in increased lamin B1 transcripts and protein expression. How duplication of LMNB1",
            "probability": 0.01243513713788351,
            "start_logit": 6.81737756729126,
            "end_logit": 2.956787347793579
        },
        {
            "text": "duplication of the LMNB1",
            "probability": 0.005930941043987344,
            "start_logit": 1.8854442834854126,
            "end_logit": 7.148377418518066
        },
        {
            "text": "LMNB1 gene,",
            "probability": 0.002703854406408841,
            "start_logit": 6.81737756729126,
            "end_logit": 1.4309395551681519
        },
        {
            "text": "LMNB",
            "probability": 0.0023875236913935196,
            "start_logit": 6.81737756729126,
            "end_logit": 1.3065179586410522
        },
        {
            "text": "the LMNB1 gene",
            "probability": 0.0022355742506796313,
            "start_logit": 2.8608975410461426,
            "end_logit": 5.197239398956299
        },
        {
            "text": "duplication of the LMNB1 gene",
            "probability": 0.0008428593941933729,
            "start_logit": 1.8854442834854126,
            "end_logit": 5.197239398956299
        },
        {
            "text": "lamin B1",
            "probability": 0.00047309201961824365,
            "start_logit": 3.3011739253997803,
            "end_logit": 3.2039995193481445
        },
        {
            "text": "ADLD is caused by duplication of the LMNB1",
            "probability": 0.0003847532292460332,
            "start_logit": -0.849891722202301,
            "end_logit": 7.148377418518066
        },
        {
            "text": "lamin B1 transcripts and protein expression. How duplication of LMNB1",
            "probability": 0.0003694730283251356,
            "start_logit": 3.3011739253997803,
            "end_logit": 2.956787347793579
        },
        {
            "text": "the LMNB1 gene, which results in increased lamin B1",
            "probability": 0.000304604291662487,
            "start_logit": 2.8608975410461426,
            "end_logit": 3.2039995193481445
        },
        {
            "text": "LMNB1 gene, which results in increased lamin",
            "probability": 0.0002693378329067703,
            "start_logit": 6.81737756729126,
            "end_logit": -0.875527560710907
        },
        {
            "text": "",
            "probability": 0.000238665541260037,
            "start_logit": 3.0395946502685547,
            "end_logit": 2.7813520431518555
        },
        {
            "text": "L",
            "probability": 0.00020883201273324162,
            "start_logit": 6.81737756729126,
            "end_logit": -1.1299638748168945
        },
        {
            "text": "LMNB1 gene, which results in increased lamin B1 transcripts and protein expression",
            "probability": 0.00017609933543507344,
            "start_logit": 6.81737756729126,
            "end_logit": -1.300445795059204
        },
        {
            "text": "duplication of the LMNB1 gene, which results in increased lamin B1",
            "probability": 0.00011484234471804942,
            "start_logit": 1.8854442834854126,
            "end_logit": 3.2039995193481445
        },
        {
            "text": "LMNB1 gene, which results in increased lamin B",
            "probability": 0.00010165681814908359,
            "start_logit": 6.81737756729126,
            "end_logit": -1.8498914241790771
        }
    ],
    "5e355e20fbd6abf43b000065_008": [
        {
            "text": "lamin B1",
            "probability": 0.5878168373944885,
            "start_logit": 6.283787250518799,
            "end_logit": 6.080355644226074
        },
        {
            "text": "lamin B1 (LMNB1)",
            "probability": 0.1521250943429273,
            "start_logit": 6.283787250518799,
            "end_logit": 4.728643417358398
        },
        {
            "text": "lamin B1 (LMNB1) gene",
            "probability": 0.12424723361381193,
            "start_logit": 6.283787250518799,
            "end_logit": 4.526213645935059
        },
        {
            "text": "lamin B1 (LMNB1",
            "probability": 0.043237752034035105,
            "start_logit": 6.283787250518799,
            "end_logit": 3.470654249191284
        },
        {
            "text": "the lamin B1",
            "probability": 0.025112828318209855,
            "start_logit": 3.1307506561279297,
            "end_logit": 6.080355644226074
        },
        {
            "text": "LMNB1)",
            "probability": 0.019663285870325394,
            "start_logit": 4.237837314605713,
            "end_logit": 4.728643417358398
        },
        {
            "text": "LMNB1) gene",
            "probability": 0.01605986759579665,
            "start_logit": 4.237837314605713,
            "end_logit": 4.526213645935059
        },
        {
            "text": "the lamin B1 (LMNB1)",
            "probability": 0.006499118660940266,
            "start_logit": 3.1307506561279297,
            "end_logit": 4.728643417358398
        },
        {
            "text": "LMNB1",
            "probability": 0.005588797050925237,
            "start_logit": 4.237837314605713,
            "end_logit": 3.470654249191284
        },
        {
            "text": "the lamin B1 (LMNB1) gene",
            "probability": 0.0053081151274715545,
            "start_logit": 3.1307506561279297,
            "end_logit": 4.526213645935059
        },
        {
            "text": "duplications of the lamin B1",
            "probability": 0.0034914887096163857,
            "start_logit": 1.1577000617980957,
            "end_logit": 6.080355644226074
        },
        {
            "text": "lamin B",
            "probability": 0.0025403420728941717,
            "start_logit": 6.283787250518799,
            "end_logit": 0.6362389922142029
        },
        {
            "text": "lamin",
            "probability": 0.0023317321584493456,
            "start_logit": 6.283787250518799,
            "end_logit": 0.5505516529083252
        },
        {
            "text": "the lamin B1 (LMNB1",
            "probability": 0.0018472118772728324,
            "start_logit": 3.1307506561279297,
            "end_logit": 3.470654249191284
        },
        {
            "text": "duplications of the lamin B1 (LMNB1)",
            "probability": 0.0009035859736545857,
            "start_logit": 1.1577000617980957,
            "end_logit": 4.728643417358398
        },
        {
            "text": "",
            "probability": 0.0008620655191581633,
            "start_logit": 3.0709140300750732,
            "end_logit": 2.7683894634246826
        },
        {
            "text": "duplications of the lamin B1 (LMNB1) gene",
            "probability": 0.0007379982772976644,
            "start_logit": 1.1577000617980957,
            "end_logit": 4.526213645935059
        },
        {
            "text": "B1",
            "probability": 0.0007110976722064401,
            "start_logit": -0.4335736334323883,
            "end_logit": 6.080355644226074
        },
        {
            "text": "la",
            "probability": 0.0006050210405723009,
            "start_logit": 6.283787250518799,
            "end_logit": -0.7985517978668213
        },
        {
            "text": "lamin B1 (",
            "probability": 0.00031052668994636527,
            "start_logit": 6.283787250518799,
            "end_logit": -1.4655451774597168
        }
    ],
    "5e2a120c76af173751000001_002": [
        {
            "text": "pronounced, sustained and dose-dependent vasodilation, blood flow upregulation, and neovessel formation",
            "probability": 0.5090768830159217,
            "start_logit": 5.438999652862549,
            "end_logit": 6.354940891265869
        },
        {
            "text": "vasodilation, blood flow upregulation, and neovessel formation",
            "probability": 0.25953079203586354,
            "start_logit": 4.765275955200195,
            "end_logit": 6.354940891265869
        },
        {
            "text": "pronounced, sustained and dose-dependent vasodilation",
            "probability": 0.0624065726519072,
            "start_logit": 5.438999652862549,
            "end_logit": 4.256012439727783
        },
        {
            "text": "vasodilation",
            "probability": 0.031815287177529496,
            "start_logit": 4.765275955200195,
            "end_logit": 4.256012439727783
        },
        {
            "text": "pronounced, sustained and dose-dependent vasodilation, blood flow upregulation",
            "probability": 0.023213199561764975,
            "start_logit": 5.438999652862549,
            "end_logit": 3.2670629024505615
        },
        {
            "text": "pronounced, sustained and dose-dependent vasodilation, blood flow upregulation, and neovessel formation,",
            "probability": 0.02302490477545658,
            "start_logit": 5.438999652862549,
            "end_logit": 3.258918285369873
        },
        {
            "text": "sustained and dose-dependent vasodilation, blood flow upregulation, and neovessel formation",
            "probability": 0.020843326574292866,
            "start_logit": 2.243434429168701,
            "end_logit": 6.354940891265869
        },
        {
            "text": "vasodilation, blood flow upregulation",
            "probability": 0.01183424403846482,
            "start_logit": 4.765275955200195,
            "end_logit": 3.2670629024505615
        },
        {
            "text": "vasodilation, blood flow upregulation, and neovessel formation,",
            "probability": 0.0117382500999121,
            "start_logit": 4.765275955200195,
            "end_logit": 3.258918285369873
        },
        {
            "text": "pronounced, sustained and dose-dependent",
            "probability": 0.009525381059913145,
            "start_logit": 5.438999652862549,
            "end_logit": 2.3763017654418945
        },
        {
            "text": "blood flow upregulation, and neovessel formation",
            "probability": 0.007592646606814814,
            "start_logit": 1.2335808277130127,
            "end_logit": 6.354940891265869
        },
        {
            "text": "dose-dependent vasodilation, blood flow upregulation, and neovessel formation",
            "probability": 0.005917863051755837,
            "start_logit": 0.9843760132789612,
            "end_logit": 6.354940891265869
        },
        {
            "text": "results in pronounced, sustained and dose-dependent vasodilation, blood flow upregulation, and neovessel formation",
            "probability": 0.005753146320871439,
            "start_logit": 0.9561474919319153,
            "end_logit": 6.354940891265869
        },
        {
            "text": "pronounced, sustained and dose-dependent vasodilation, blood flow upregulation, and neovessel formation, in striking contrast",
            "probability": 0.0056097039518539235,
            "start_logit": 5.438999652862549,
            "end_logit": 1.8468397855758667
        },
        {
            "text": "neovessel formation",
            "probability": 0.0028857480237532416,
            "start_logit": 0.2661847472190857,
            "end_logit": 6.354940891265869
        },
        {
            "text": "vasodilation, blood flow upregulation, and neovessel formation, in striking contrast",
            "probability": 0.002859864508257054,
            "start_logit": 4.765275955200195,
            "end_logit": 1.8468397855758667
        },
        {
            "text": "sustained and dose-dependent vasodilation",
            "probability": 0.002555135810646019,
            "start_logit": 2.243434429168701,
            "end_logit": 4.256012439727783
        },
        {
            "text": "pronounced",
            "probability": 0.001283020081993292,
            "start_logit": 5.438999652862549,
            "end_logit": 0.3715585768222809
        },
        {
            "text": "pronounced, sustained and dose-dependent vasodilation,",
            "probability": 0.0012776757343972553,
            "start_logit": 5.438999652862549,
            "end_logit": 0.3673844337463379
        },
        {
            "text": "pronounced, sustained and dose-dependent vasodilation, blood flow",
            "probability": 0.001240068402589076,
            "start_logit": 5.438999652862549,
            "end_logit": 0.3375083804130554
        },
        {
            "text": "",
            "probability": 1.6286516041720877e-05,
            "start_logit": 0.4833812415599823,
            "end_logit": 0.9605425000190735
        }
    ],
    "5e48efd9f8b2df0d49000004_001": [
        {
            "text": "to enable the creation of the large radiotherapy cohorts required to exploit advances in genomics",
            "probability": 0.4268920275862813,
            "start_logit": 6.79585075378418,
            "end_logit": 6.651301383972168
        },
        {
            "text": "to enable the creation of the large radiotherapy cohorts",
            "probability": 0.16164378001304236,
            "start_logit": 6.79585075378418,
            "end_logit": 5.6801652908325195
        },
        {
            "text": "enable the creation of the large radiotherapy cohorts required to exploit advances in genomics",
            "probability": 0.11164227342207746,
            "start_logit": 5.454619407653809,
            "end_logit": 6.651301383972168
        },
        {
            "text": "creation of the large radiotherapy cohorts required to exploit advances in genomics",
            "probability": 0.1008858819157755,
            "start_logit": 5.353309631347656,
            "end_logit": 6.651301383972168
        },
        {
            "text": "enable the creation of the large radiotherapy cohorts",
            "probability": 0.04227363810758163,
            "start_logit": 5.454619407653809,
            "end_logit": 5.6801652908325195
        },
        {
            "text": "creation of the large radiotherapy cohorts",
            "probability": 0.038200702400138814,
            "start_logit": 5.353309631347656,
            "end_logit": 5.6801652908325195
        },
        {
            "text": "the creation of the large radiotherapy cohorts required to exploit advances in genomics",
            "probability": 0.02984132615686957,
            "start_logit": 4.135213851928711,
            "end_logit": 6.651301383972168
        },
        {
            "text": "large radiotherapy cohorts required to exploit advances in genomics",
            "probability": 0.027099800889394253,
            "start_logit": 4.038846015930176,
            "end_logit": 6.651301383972168
        },
        {
            "text": "the creation of the large radiotherapy cohorts",
            "probability": 0.011299496005751797,
            "start_logit": 4.135213851928711,
            "end_logit": 5.6801652908325195
        },
        {
            "text": "to enable the creation of the large radiotherapy",
            "probability": 0.010343230510358818,
            "start_logit": 6.79585075378418,
            "end_logit": 2.9311025142669678
        },
        {
            "text": "large radiotherapy cohorts",
            "probability": 0.010261410310543048,
            "start_logit": 4.038846015930176,
            "end_logit": 5.6801652908325195
        },
        {
            "text": "to enable the creation of the large radiotherapy cohorts required to exploit advances in genomics.",
            "probability": 0.009539657346713427,
            "start_logit": 6.79585075378418,
            "end_logit": 2.8502278327941895
        },
        {
            "text": "radiotherapy cohorts required to exploit advances in genomics",
            "probability": 0.004022319570175708,
            "start_logit": 2.131178379058838,
            "end_logit": 6.651301383972168
        },
        {
            "text": "enable the creation of the large radiotherapy",
            "probability": 0.0027049972688273317,
            "start_logit": 5.454619407653809,
            "end_logit": 2.9311025142669678
        },
        {
            "text": "enable the creation of the large radiotherapy cohorts required to exploit advances in genomics.",
            "probability": 0.0024948440472795006,
            "start_logit": 5.454619407653809,
            "end_logit": 2.8502278327941895
        },
        {
            "text": "creation of the large radiotherapy",
            "probability": 0.002444379057148828,
            "start_logit": 5.353309631347656,
            "end_logit": 2.9311025142669678
        },
        {
            "text": "the large radiotherapy cohorts required to exploit advances in genomics",
            "probability": 0.002438834033909413,
            "start_logit": 1.6308397054672241,
            "end_logit": 6.651301383972168
        },
        {
            "text": "creation of the large radiotherapy cohorts required to exploit advances in genomics.",
            "probability": 0.0022544734555928715,
            "start_logit": 5.353309631347656,
            "end_logit": 2.8502278327941895
        },
        {
            "text": "establishment of the Radiogenomics Consortium to enable the creation of the large radiotherapy cohorts",
            "probability": 0.0021723472433801986,
            "start_logit": 2.4862639904022217,
            "end_logit": 5.6801652908325195
        },
        {
            "text": "radiotherapy cohorts",
            "probability": 0.0015230617995371802,
            "start_logit": 2.131178379058838,
            "end_logit": 5.6801652908325195
        },
        {
            "text": "",
            "probability": 2.151885962140607e-05,
            "start_logit": 1.667272925376892,
            "end_logit": 1.884522557258606
        }
    ],
    "5e48efd9f8b2df0d49000004_002": [
        {
            "text": "identification of genomic markers that are predictive for the development of adverse effects resulting from cancer treatment with radiation",
            "probability": 0.25631453253208814,
            "start_logit": 3.7332944869995117,
            "end_logit": 4.397487163543701
        },
        {
            "text": "to share biospecimens and data so as to achieve large-scale studies with increased statistical power to enable identification of relevant genomic markers",
            "probability": 0.14751626836014192,
            "start_logit": 3.649873733520508,
            "end_logit": 3.928441047668457
        },
        {
            "text": "the identification of genomic markers that are predictive for the development of adverse effects resulting from cancer treatment with radiation",
            "probability": 0.1252699858446063,
            "start_logit": 3.0173604488372803,
            "end_logit": 4.397487163543701
        },
        {
            "text": "identification of genomic markers",
            "probability": 0.12323820618858829,
            "start_logit": 3.7332944869995117,
            "end_logit": 3.66520094871521
        },
        {
            "text": "share biospecimens and data so as to achieve large-scale studies with increased statistical power to enable identification of relevant genomic markers",
            "probability": 0.11594892187490226,
            "start_logit": 3.4090850353240967,
            "end_logit": 3.928441047668457
        },
        {
            "text": "the identification of genomic markers",
            "probability": 0.06023087412270091,
            "start_logit": 3.0173604488372803,
            "end_logit": 3.66520094871521
        },
        {
            "text": "to share biospecimens and data",
            "probability": 0.04129171589560612,
            "start_logit": 3.649873733520508,
            "end_logit": 2.6551644802093506
        },
        {
            "text": "share biospecimens and data",
            "probability": 0.03245560637943789,
            "start_logit": 3.4090850353240967,
            "end_logit": 2.6551644802093506
        },
        {
            "text": "genomic markers that are predictive for the development of adverse effects resulting from cancer treatment with radiation",
            "probability": 0.020712019250038276,
            "start_logit": 1.217603325843811,
            "end_logit": 4.397487163543701
        },
        {
            "text": "achieve large-scale studies with increased statistical power to enable identification of relevant genomic markers",
            "probability": 0.010447094123040368,
            "start_logit": 1.0022591352462769,
            "end_logit": 3.928441047668457
        },
        {
            "text": "genomic markers",
            "probability": 0.009958514929693567,
            "start_logit": 1.217603325843811,
            "end_logit": 3.66520094871521
        },
        {
            "text": "to achieve large-scale studies with increased statistical power to enable identification of relevant genomic markers",
            "probability": 0.009124894168057073,
            "start_logit": 0.8669415712356567,
            "end_logit": 3.928441047668457
        },
        {
            "text": "development of a predictive instrument to enable identification of people who are at greatest risk for adverse effects resulting from cancer treatment using radiation",
            "probability": 0.009032823946206794,
            "start_logit": 2.0174319744110107,
            "end_logit": 2.7678093910217285
        },
        {
            "text": "to share biospecimens and data so as to achieve large-scale studies with increased statistical power",
            "probability": 0.007466364796201177,
            "start_logit": 3.649873733520508,
            "end_logit": 0.9449108242988586
        },
        {
            "text": "share biospecimens and data so as to achieve large-scale studies with increased statistical power",
            "probability": 0.00586862017367952,
            "start_logit": 3.4090850353240967,
            "end_logit": 0.9449108242988586
        },
        {
            "text": "the development of a predictive instrument to enable identification of people who are at greatest risk for adverse effects resulting from cancer treatment using radiation",
            "probability": 0.005547537459693704,
            "start_logit": 1.529921054840088,
            "end_logit": 2.7678093910217285
        },
        {
            "text": "identification of genomic markers that are predictive for the development of adverse effects",
            "probability": 0.005519107093324179,
            "start_logit": 3.7332944869995117,
            "end_logit": 0.5592979192733765
        },
        {
            "text": "The overall goal of radiogenomics is the identification of genomic markers",
            "probability": 0.004910343786264391,
            "start_logit": 0.5105193257331848,
            "end_logit": 3.66520094871521
        },
        {
            "text": "to share biospecimens",
            "probability": 0.004728824646197744,
            "start_logit": 3.649873733520508,
            "end_logit": 0.4881792664527893
        },
        {
            "text": "share biospecimens",
            "probability": 0.0037168925540028287,
            "start_logit": 3.4090850353240967,
            "end_logit": 0.4881792664527893
        },
        {
            "text": "",
            "probability": 0.0007008518755286057,
            "start_logit": 1.2054201364517212,
            "end_logit": 1.023497462272644
        }
    ],
    "5e48efd9f8b2df0d49000004_004": [
        {
            "text": "",
            "probability": 0.26772318022968966,
            "start_logit": 4.145119667053223,
            "end_logit": 5.442129135131836
        },
        {
            "text": "polygenic risk profiling",
            "probability": 0.2249871203532686,
            "start_logit": 3.7026584148406982,
            "end_logit": 5.71068000793457
        },
        {
            "text": "to identify enough variants for a future test involving polygenic risk profiling",
            "probability": 0.18645146916929303,
            "start_logit": 3.5147862434387207,
            "end_logit": 5.71068000793457
        },
        {
            "text": "identify enough variants for a future test involving polygenic risk profiling",
            "probability": 0.0542441601955538,
            "start_logit": 2.2801105976104736,
            "end_logit": 5.71068000793457
        },
        {
            "text": "a future test involving polygenic risk profiling",
            "probability": 0.05259384794236588,
            "start_logit": 2.2492144107818604,
            "end_logit": 5.71068000793457
        },
        {
            "text": "polygenic risk profiling.",
            "probability": 0.037721601918068635,
            "start_logit": 3.7026584148406982,
            "end_logit": 3.9248697757720947
        },
        {
            "text": "to identify enough variants for a future test involving polygenic risk profiling.",
            "probability": 0.03126066988190127,
            "start_logit": 3.5147862434387207,
            "end_logit": 3.9248697757720947
        },
        {
            "text": "larger collaborative efforts to identify enough variants for a future test involving polygenic risk profiling",
            "probability": 0.021483957931301506,
            "start_logit": 1.3539217710494995,
            "end_logit": 5.71068000793457
        },
        {
            "text": "future test involving polygenic risk profiling",
            "probability": 0.019711824635636935,
            "start_logit": 1.267833948135376,
            "end_logit": 5.71068000793457
        },
        {
            "text": "provides a basis for larger collaborative efforts to identify enough variants for a future test involving polygenic risk profiling",
            "probability": 0.017606262399439198,
            "start_logit": 1.1548699140548706,
            "end_logit": 5.71068000793457
        },
        {
            "text": "involving polygenic risk profiling",
            "probability": 0.015134409344461378,
            "start_logit": 1.0035861730575562,
            "end_logit": 5.71068000793457
        },
        {
            "text": "for a future test involving polygenic risk profiling",
            "probability": 0.009362305642380539,
            "start_logit": 0.5233068466186523,
            "end_logit": 5.71068000793457
        },
        {
            "text": "identify enough variants for a future test involving polygenic risk profiling.",
            "probability": 0.009094638902279269,
            "start_logit": 2.2801105976104736,
            "end_logit": 3.9248697757720947
        },
        {
            "text": "a basis for larger collaborative efforts to identify enough variants for a future test involving polygenic risk profiling",
            "probability": 0.008897407896679022,
            "start_logit": 0.4723752439022064,
            "end_logit": 5.71068000793457
        },
        {
            "text": "a future test involving polygenic risk profiling.",
            "probability": 0.008817945633093377,
            "start_logit": 2.2492144107818604,
            "end_logit": 3.9248697757720947
        },
        {
            "text": "test involving polygenic risk profiling",
            "probability": 0.00873229258754473,
            "start_logit": 0.45364320278167725,
            "end_logit": 5.71068000793457
        },
        {
            "text": "The work provides a basis for larger collaborative efforts to identify enough variants for a future test involving polygenic risk profiling",
            "probability": 0.007592821241354919,
            "start_logit": 0.31381848454475403,
            "end_logit": 5.71068000793457
        },
        {
            "text": "enough variants for a future test involving polygenic risk profiling",
            "probability": 0.007174691336180991,
            "start_logit": 0.2571749985218048,
            "end_logit": 5.71068000793457
        },
        {
            "text": "collaborative efforts to identify enough variants for a future test involving polygenic risk profiling",
            "probability": 0.005948270668135235,
            "start_logit": 0.06971579045057297,
            "end_logit": 5.71068000793457
        },
        {
            "text": "risk profiling",
            "probability": 0.005461122091372055,
            "start_logit": -0.015730462968349457,
            "end_logit": 5.71068000793457
        }
    ],
    "5e2f0afcfbd6abf43b000028_001": [
        {
            "text": "VEGF-R",
            "probability": 0.8791139278196715,
            "start_logit": 7.478536128997803,
            "end_logit": 7.780575752258301
        },
        {
            "text": "VEGF",
            "probability": 0.08670082742742848,
            "start_logit": 7.478536128997803,
            "end_logit": 5.46412467956543
        },
        {
            "text": "",
            "probability": 0.015238818288285771,
            "start_logit": 5.5264387130737305,
            "end_logit": 5.677604675292969
        },
        {
            "text": "R",
            "probability": 0.013986669894006355,
            "start_logit": 3.337726354598999,
            "end_logit": 7.780575752258301
        },
        {
            "text": "VEGF-R inhibitor",
            "probability": 0.0019175809011254211,
            "start_logit": 7.478536128997803,
            "end_logit": 1.6527256965637207
        },
        {
            "text": "VEGF-",
            "probability": 0.0008218199561171037,
            "start_logit": 7.478536128997803,
            "end_logit": 0.8054273128509521
        },
        {
            "text": "VEGF-R inhibitor Tivozanib to these systems abrogated the tension-induced paracrine effects on VECs",
            "probability": 0.0006584745902013547,
            "start_logit": 7.478536128997803,
            "end_logit": 0.5838319063186646
        },
        {
            "text": "VEG",
            "probability": 0.0006010773773879142,
            "start_logit": 7.478536128997803,
            "end_logit": 0.49262964725494385
        },
        {
            "text": "VE",
            "probability": 0.000467658607333879,
            "start_logit": 7.478536128997803,
            "end_logit": 0.24164453148841858
        },
        {
            "text": "-R",
            "probability": 0.0003160533801713572,
            "start_logit": -0.4522225260734558,
            "end_logit": 7.780575752258301
        },
        {
            "text": "VEGF-R inhibitor Tivozanib to these systems abrogated the tension-induced paracrine",
            "probability": 4.781169064342677e-05,
            "start_logit": 7.478536128997803,
            "end_logit": -2.0388238430023193
        },
        {
            "text": "The addition of VEGF-R",
            "probability": 4.7008184375150504e-05,
            "start_logit": -2.35781192779541,
            "end_logit": 7.780575752258301
        },
        {
            "text": "VEGF-R inhibitor Tivozanib to these systems abrogated the tension-induced paracrine effects",
            "probability": 3.3811203036057075e-05,
            "start_logit": 7.478536128997803,
            "end_logit": -2.3853018283843994
        },
        {
            "text": "R inhibitor",
            "probability": 3.050864081474783e-05,
            "start_logit": 3.337726354598999,
            "end_logit": 1.6527256965637207
        },
        {
            "text": "R inhibitor Tivozanib to these systems abrogated the tension-induced paracrine effects on VECs",
            "probability": 1.0476306238918602e-05,
            "start_logit": 3.337726354598999,
            "end_logit": 0.5838319063186646
        },
        {
            "text": "The addition of VEGF",
            "probability": 4.636086805375562e-06,
            "start_logit": -2.35781192779541,
            "end_logit": 5.46412467956543
        },
        {
            "text": "VEGF release",
            "probability": 8.516328130172212e-07,
            "start_logit": 0.9276434779167175,
            "end_logit": 0.48419880867004395
        },
        {
            "text": "R inhibitor Tivozanib to these systems abrogated the tension-induced paracrine",
            "probability": 7.606822198375354e-07,
            "start_logit": 3.337726354598999,
            "end_logit": -2.0388238430023193
        },
        {
            "text": "-R inhibitor",
            "probability": 6.8939634144557e-07,
            "start_logit": -0.4522225260734558,
            "end_logit": 1.6527256965637207
        },
        {
            "text": "R inhibitor Tivozanib to these systems abrogated the tension-induced paracrine effects",
            "probability": 5.379349827358905e-07,
            "start_logit": 3.337726354598999,
            "end_logit": -2.3853018283843994
        }
    ],
    "5e2f0afcfbd6abf43b000028_002": [
        {
            "text": "vascular endothelial growth factor receptors 1, 2\u00a0and 3 tyrosine kinases.",
            "probability": 0.6269795121333505,
            "start_logit": 6.718541622161865,
            "end_logit": 6.842409610748291
        },
        {
            "text": "vascular endothelial growth factor",
            "probability": 0.11221639781503998,
            "start_logit": 6.718541622161865,
            "end_logit": 5.121924877166748
        },
        {
            "text": "1, 2\u00a0and 3 tyrosine kinases.",
            "probability": 0.09678613529514804,
            "start_logit": 4.850131511688232,
            "end_logit": 6.842409610748291
        },
        {
            "text": "vascular endothelial growth factor receptors 1, 2\u00a0and 3",
            "probability": 0.07599914133688933,
            "start_logit": 6.718541622161865,
            "end_logit": 4.732217788696289
        },
        {
            "text": "vascular endothelial growth factor receptors",
            "probability": 0.04617401519175461,
            "start_logit": 6.718541622161865,
            "end_logit": 4.233912944793701
        },
        {
            "text": "1, 2\u00a0and 3",
            "probability": 0.011731903568457904,
            "start_logit": 4.850131511688232,
            "end_logit": 4.732217788696289
        },
        {
            "text": "vascular endothelial growth factor receptors 1",
            "probability": 0.007995882727405196,
            "start_logit": 6.718541622161865,
            "end_logit": 2.4804224967956543
        },
        {
            "text": "tyrosine kinases",
            "probability": 0.003981582068398522,
            "start_logit": 1.6593070030212402,
            "end_logit": 6.842409610748291
        },
        {
            "text": "vascular endothelial growth factor receptors 1, 2\u00a0and",
            "probability": 0.0038601403600014724,
            "start_logit": 6.718541622161865,
            "end_logit": 1.7521992921829224
        },
        {
            "text": "3 tyrosine kinases",
            "probability": 0.0036567818392543123,
            "start_logit": 1.5742112398147583,
            "end_logit": 6.842409610748291
        },
        {
            "text": "receptors 1, 2\u00a0and 3 tyrosine kinases.",
            "probability": 0.003231913679778918,
            "start_logit": 1.45070219039917,
            "end_logit": 6.842409610748291
        },
        {
            "text": "vascular endothelial growth",
            "probability": 0.0012696801385551123,
            "start_logit": 6.718541622161865,
            "end_logit": 0.6402607560157776
        },
        {
            "text": "1",
            "probability": 0.0012343155916300181,
            "start_logit": 4.850131511688232,
            "end_logit": 2.4804224967956543
        },
        {
            "text": "vascular",
            "probability": 0.001053821643382765,
            "start_logit": 6.718541622161865,
            "end_logit": 0.4539189636707306
        },
        {
            "text": "2\u00a0and 3 tyrosine kinases.",
            "probability": 0.0010261654544619896,
            "start_logit": 0.30345675349235535,
            "end_logit": 6.842409610748291
        },
        {
            "text": "Tivozanib is a selective inhibitor of vascular endothelial growth factor receptors 1, 2\u00a0and 3 tyrosine kinases.",
            "probability": 0.0009286901055315871,
            "start_logit": 0.20364758372306824,
            "end_logit": 6.842409610748291
        },
        {
            "text": "1, 2\u00a0and",
            "probability": 0.0005958856069636648,
            "start_logit": 4.850131511688232,
            "end_logit": 1.7521992921829224
        },
        {
            "text": "3",
            "probability": 0.00044325575949689125,
            "start_logit": 1.5742112398147583,
            "end_logit": 4.732217788696289
        },
        {
            "text": "receptors 1, 2\u00a0and 3",
            "probability": 0.00039175548767517507,
            "start_logit": 1.45070219039917,
            "end_logit": 4.732217788696289
        },
        {
            "text": "endothelial growth factor receptors 1, 2\u00a0and 3 tyrosine kinases.",
            "probability": 0.0003620485509941094,
            "start_logit": -0.738349199295044,
            "end_logit": 6.842409610748291
        },
        {
            "text": "",
            "probability": 8.09756458298922e-05,
            "start_logit": 2.018425464630127,
            "end_logit": 2.5880050659179688
        }
    ],
    "5e2f0afcfbd6abf43b000028_004": [
        {
            "text": "VEGFR1-3",
            "probability": 0.964486797468382,
            "start_logit": 7.15010404586792,
            "end_logit": 7.7459211349487305
        },
        {
            "text": "VEGFR1-3, with activity against PDGFR\u03b1/\u03b2 and cKIT",
            "probability": 0.014830658608033885,
            "start_logit": 7.15010404586792,
            "end_logit": 3.571021556854248
        },
        {
            "text": "VEGFR",
            "probability": 0.011534813995781329,
            "start_logit": 7.15010404586792,
            "end_logit": 3.319694757461548
        },
        {
            "text": "VEGFR1",
            "probability": 0.002865233312383578,
            "start_logit": 7.15010404586792,
            "end_logit": 1.9269747734069824
        },
        {
            "text": "VEGFR1-3, with activity against PDGFR\u03b1/\u03b2",
            "probability": 0.0018093172342278042,
            "start_logit": 7.15010404586792,
            "end_logit": 1.46727454662323
        },
        {
            "text": "VEGFR1-3,",
            "probability": 0.0017152139641460464,
            "start_logit": 7.15010404586792,
            "end_logit": 1.4138628244400024
        },
        {
            "text": "3",
            "probability": 0.0008872654551650148,
            "start_logit": 0.15889683365821838,
            "end_logit": 7.7459211349487305
        },
        {
            "text": "against VEGFR1-3",
            "probability": 0.00033058279299476935,
            "start_logit": -0.8283902406692505,
            "end_logit": 7.7459211349487305
        },
        {
            "text": "",
            "probability": 0.00027870645338784765,
            "start_logit": 3.1888442039489746,
            "end_logit": 3.5579886436462402
        },
        {
            "text": "tyrosine kinase inhibitor against VEGFR1-3",
            "probability": 0.0001797753753794198,
            "start_logit": -1.4375392198562622,
            "end_logit": 7.7459211349487305
        },
        {
            "text": "Tivozanib is a potent small molecule tyrosine kinase inhibitor against VEGFR1-3",
            "probability": 0.00017648684368631412,
            "start_logit": -1.4560010433197021,
            "end_logit": 7.7459211349487305
        },
        {
            "text": "-3",
            "probability": 0.00016797893976581865,
            "start_logit": -1.505408763885498,
            "end_logit": 7.7459211349487305
        },
        {
            "text": "VE",
            "probability": 0.0001417764607157303,
            "start_logit": 7.15010404586792,
            "end_logit": -1.0791786909103394
        },
        {
            "text": "VEGFR1-3, with activity against PDGFR\u03b1/\u03b2 and cKIT.",
            "probability": 0.00013979181273373193,
            "start_logit": 7.15010404586792,
            "end_logit": -1.093276023864746
        },
        {
            "text": "PDGFR\u03b1/\u03b2 and cKIT",
            "probability": 0.00011294629591827315,
            "start_logit": 2.272564649581909,
            "end_logit": 3.571021556854248
        },
        {
            "text": "VEGF",
            "probability": 0.00010614580914281164,
            "start_logit": 7.15010404586792,
            "end_logit": -1.3686165809631348
        },
        {
            "text": "cKIT",
            "probability": 7.819527697551425e-05,
            "start_logit": 1.9048614501953125,
            "end_logit": 3.571021556854248
        },
        {
            "text": "potent small molecule tyrosine kinase inhibitor against VEGFR1-3",
            "probability": 6.521655476043813e-05,
            "start_logit": -2.4515340328216553,
            "end_logit": 7.7459211349487305
        },
        {
            "text": "VEGF-receptors (VEGFR",
            "probability": 4.800187578098224e-05,
            "start_logit": 1.8764369487762451,
            "end_logit": 3.1114768981933594
        },
        {
            "text": "VEGFR1-3, with activity against PDGFR",
            "probability": 4.509547063860919e-05,
            "start_logit": 7.15010404586792,
            "end_logit": -2.2246484756469727
        }
    ],
    "5e2f0afcfbd6abf43b000028_005": [
        {
            "text": "VEGF",
            "probability": 0.4325417071002257,
            "start_logit": 5.064609050750732,
            "end_logit": 6.748293876647949
        },
        {
            "text": "pan-VEGF",
            "probability": 0.34981992009010704,
            "start_logit": 4.852348804473877,
            "end_logit": 6.748293876647949
        },
        {
            "text": "VEGF receptor",
            "probability": 0.10604667903559903,
            "start_logit": 5.064609050750732,
            "end_logit": 5.342494487762451
        },
        {
            "text": "pan-VEGF receptor",
            "probability": 0.08576569652613535,
            "start_logit": 4.852348804473877,
            "end_logit": 5.342494487762451
        },
        {
            "text": "",
            "probability": 0.006721866808340083,
            "start_logit": 3.527522087097168,
            "end_logit": 4.121068000793457
        },
        {
            "text": "VEGF receptor tyrosine kinase",
            "probability": 0.006107973684247974,
            "start_logit": 5.064609050750732,
            "end_logit": 2.4882102012634277
        },
        {
            "text": "pan-VEGF receptor tyrosine kinase",
            "probability": 0.004939849339525086,
            "start_logit": 4.852348804473877,
            "end_logit": 2.4882102012634277
        },
        {
            "text": "oral pan-VEGF",
            "probability": 0.002378464422531466,
            "start_logit": -0.13861462473869324,
            "end_logit": 6.748293876647949
        },
        {
            "text": "VEGF monotherapy. Future studies in glioblastoma should leverage the anti-vascular activity of agents targeting VEGF",
            "probability": 0.001444548576277237,
            "start_logit": 2.952636957168579,
            "end_logit": 3.158384084701538
        },
        {
            "text": "receptor",
            "probability": 0.0012301191462056433,
            "start_logit": 0.6078407168388367,
            "end_logit": 5.342494487762451
        },
        {
            "text": "oral pan-VEGF receptor",
            "probability": 0.0005831304798437415,
            "start_logit": -0.13861462473869324,
            "end_logit": 5.342494487762451
        },
        {
            "text": "Tivozanib is an oral pan-VEGF",
            "probability": 0.0004942107447844845,
            "start_logit": -1.7098629474639893,
            "end_logit": 6.748293876647949
        },
        {
            "text": "VEGF receptor tyrosine kinase inhibitor that hits a central pathway in glioblastoma angiogenesis",
            "probability": 0.0003603737970704625,
            "start_logit": 5.064609050750732,
            "end_logit": -0.3419983386993408
        },
        {
            "text": "pan-VEGF receptor tyrosine kinase inhibitor that hits a central pathway in glioblastoma angiogenesis",
            "probability": 0.00029145382011577087,
            "start_logit": 4.852348804473877,
            "end_logit": -0.3419983386993408
        },
        {
            "text": "VEGF receptor tyrosine kinase inhibitor",
            "probability": 0.000279821708507369,
            "start_logit": 5.064609050750732,
            "end_logit": -0.5949875116348267
        },
        {
            "text": "tyrosine kinase",
            "probability": 0.00026067523740571974,
            "start_logit": 1.9105340242385864,
            "end_logit": 2.4882102012634277
        },
        {
            "text": "pan-VEGF receptor tyrosine kinase inhibitor",
            "probability": 0.00022630698058174366,
            "start_logit": 4.852348804473877,
            "end_logit": -0.5949875116348267
        },
        {
            "text": "-VEGF",
            "probability": 0.00019936703688956206,
            "start_logit": -2.6176774501800537,
            "end_logit": 6.748293876647949
        },
        {
            "text": "anti-VEGF",
            "probability": 0.00016770600041971686,
            "start_logit": 0.17329899966716766,
            "end_logit": 3.7843823432922363
        },
        {
            "text": "VEGF receptor tyrosine",
            "probability": 0.00014012946518677177,
            "start_logit": 5.064609050750732,
            "end_logit": -1.2865734100341797
        }
    ],
    "5e2f0afcfbd6abf43b000028_006": [
        {
            "text": "VEGFR",
            "probability": 0.754599471939666,
            "start_logit": 6.578524589538574,
            "end_logit": 6.237227916717529
        },
        {
            "text": "VEGF pathway has potential as a therapeutic target in therapy-resistant EOC and VEGFR",
            "probability": 0.12568060808436018,
            "start_logit": 4.786081314086914,
            "end_logit": 6.237227916717529
        },
        {
            "text": "VEGF pathway",
            "probability": 0.034470756433039755,
            "start_logit": 4.786081314086914,
            "end_logit": 4.9435954093933105
        },
        {
            "text": "the VEGF pathway has potential as a therapeutic target in therapy-resistant EOC and VEGFR",
            "probability": 0.02453052576882274,
            "start_logit": 3.1522557735443115,
            "end_logit": 6.237227916717529
        },
        {
            "text": "VEGF receptors",
            "probability": 0.017684314550410436,
            "start_logit": 4.595317840576172,
            "end_logit": 4.466925621032715
        },
        {
            "text": "VEGF",
            "probability": 0.017177617167856263,
            "start_logit": 4.786081314086914,
            "end_logit": 4.247091293334961
        },
        {
            "text": "VEGFR blockade by tivozanib may yield stronger anti-tumour efficacy and circumvent resistance to EGFR",
            "probability": 0.008661943714484874,
            "start_logit": 6.578524589538574,
            "end_logit": 1.7699799537658691
        },
        {
            "text": "the VEGF pathway",
            "probability": 0.006728052894078249,
            "start_logit": 3.1522557735443115,
            "end_logit": 4.9435954093933105
        },
        {
            "text": "the VEGF",
            "probability": 0.003352752560683277,
            "start_logit": 3.1522557735443115,
            "end_logit": 4.247091293334961
        },
        {
            "text": "",
            "probability": 0.0030991647023500043,
            "start_logit": 3.4771485328674316,
            "end_logit": 3.8435494899749756
        },
        {
            "text": "VEGFR blockade",
            "probability": 0.001976437678834757,
            "start_logit": 6.578524589538574,
            "end_logit": 0.2923368811607361
        },
        {
            "text": "VE",
            "probability": 0.00036911858325835,
            "start_logit": 6.578524589538574,
            "end_logit": -1.385596513748169
        },
        {
            "text": "VEGF pathway has potential as a therapeutic target in therapy-resistant EOC and VEGFR blockade",
            "probability": 0.0003291811067377137,
            "start_logit": 4.786081314086914,
            "end_logit": 0.2923368811607361
        },
        {
            "text": "VEGF pathway has potential as a therapeutic target in therapy-resistant EOC and VEGF",
            "probability": 0.00031027149640852375,
            "start_logit": 4.786081314086914,
            "end_logit": 0.23317651450634003
        },
        {
            "text": "EGFR-directed therapies including erlotinib. These findings suggest that the VEGF pathway",
            "probability": 0.00030441715608688275,
            "start_logit": 0.05661369487643242,
            "end_logit": 4.9435954093933105
        },
        {
            "text": "pathway has potential as a therapeutic target in therapy-resistant EOC and VEGFR",
            "probability": 0.0002156049292147568,
            "start_logit": -1.5819700956344604,
            "end_logit": 6.237227916717529
        },
        {
            "text": "VEGF pathway has potential as a therapeutic target in therapy-resistant EOC",
            "probability": 0.00019128093602351285,
            "start_logit": 4.786081314086914,
            "end_logit": -0.2505279779434204
        },
        {
            "text": "EGFR-directed therapies including erlotinib. These findings suggest that the VEGF",
            "probability": 0.00015169848032623785,
            "start_logit": 0.05661369487643242,
            "end_logit": 4.247091293334961
        },
        {
            "text": "pan-inhibitor of VEGF receptors",
            "probability": 0.00010253176522499991,
            "start_logit": -0.5549428462982178,
            "end_logit": 4.466925621032715
        },
        {
            "text": "the VEGF pathway has potential as a therapeutic target in therapy-resistant EOC and VEGFR blockade",
            "probability": 6.425005213229816e-05,
            "start_logit": 3.1522557735443115,
            "end_logit": 0.2923368811607361
        }
    ],
    "5c7a4fddd774d04240000009_001": [
        {
            "text": "",
            "probability": 0.5734179179717022,
            "start_logit": 2.458845615386963,
            "end_logit": 2.810281753540039
        },
        {
            "text": "Circulating tumor cells",
            "probability": 0.13629588534092008,
            "start_logit": 2.343973398208618,
            "end_logit": 1.4883673191070557
        },
        {
            "text": "Circulating tumor cells are rare",
            "probability": 0.09430516286515601,
            "start_logit": 2.343973398208618,
            "end_logit": 1.1200751066207886
        },
        {
            "text": "Circulating tumor cells are rare events",
            "probability": 0.07934780446519703,
            "start_logit": 2.343973398208618,
            "end_logit": 0.9473799467086792
        },
        {
            "text": "rare",
            "probability": 0.04170164606169283,
            "start_logit": 1.5279780626296997,
            "end_logit": 1.1200751066207886
        },
        {
            "text": "rare events",
            "probability": 0.035087517555230756,
            "start_logit": 1.5279780626296997,
            "end_logit": 0.9473799467086792
        },
        {
            "text": "Circulating tumor cells are rare events which can be detected specifically only by using a combination of surface and intracellular markers,",
            "probability": 0.01384757681747643,
            "start_logit": 2.343973398208618,
            "end_logit": -0.7983505725860596
        },
        {
            "text": "Circulating tumor cells are rare events which can be detected specifically only by using a combination of surface and intracellular markers",
            "probability": 0.007240885093491989,
            "start_logit": 2.343973398208618,
            "end_logit": -1.446717381477356
        },
        {
            "text": "rare events which can be detected specifically only by using a combination of surface and intracellular markers,",
            "probability": 0.006123384231679942,
            "start_logit": 1.5279780626296997,
            "end_logit": -0.7983505725860596
        },
        {
            "text": "rare events which can be detected specifically only by using a combination of surface and intracellular markers",
            "probability": 0.0032019119438237878,
            "start_logit": 1.5279780626296997,
            "end_logit": -1.446717381477356
        },
        {
            "text": "are rare",
            "probability": 0.0021774928162043533,
            "start_logit": -1.4243884086608887,
            "end_logit": 1.1200751066207886
        },
        {
            "text": "events",
            "probability": 0.001882464679487776,
            "start_logit": -1.3972854614257812,
            "end_logit": 0.9473799467086792
        },
        {
            "text": "are rare events",
            "probability": 0.00183212953517302,
            "start_logit": -1.4243884086608887,
            "end_logit": 0.9473799467086792
        },
        {
            "text": "Circulating tumor cells are",
            "probability": 0.0007193060143445359,
            "start_logit": 2.343973398208618,
            "end_logit": -3.7559292316436768
        },
        {
            "text": "Circulating tumor cells are rare events which can be detected",
            "probability": 0.0006804466467390643,
            "start_logit": 2.343973398208618,
            "end_logit": -3.811466693878174
        },
        {
            "text": "Circulating",
            "probability": 0.000584450017669456,
            "start_logit": 2.343973398208618,
            "end_logit": -3.9635448455810547
        },
        {
            "text": "Circulating tumor cells are rare events which can be detected specifically only by using a combination of surface and intracellular markers, and",
            "probability": 0.0005733393948022384,
            "start_logit": 2.343973398208618,
            "end_logit": -3.9827382564544678
        },
        {
            "text": "tumor cells",
            "probability": 0.00033241702414212634,
            "start_logit": -3.672219753265381,
            "end_logit": 1.4883673191070557
        },
        {
            "text": "events which can be detected specifically only by using a combination of surface and intracellular markers,",
            "probability": 0.0003285229431499482,
            "start_logit": -1.3972854614257812,
            "end_logit": -0.7983505725860596
        },
        {
            "text": "are rare events which can be detected specifically only by using a combination of surface and intracellular markers,",
            "probability": 0.00031973858191632304,
            "start_logit": -1.4243884086608887,
            "end_logit": -0.7983505725860596
        }
    ],
    "5c7a4fddd774d04240000009_002": [
        {
            "text": "1 in 10(9) hematologic cells",
            "probability": 0.3694201014707936,
            "start_logit": 6.666227340698242,
            "end_logit": 6.890969276428223
        },
        {
            "text": "extremely low number of CTCs (as low as 1 in 10(9) hematologic cells",
            "probability": 0.17751114336802792,
            "start_logit": 5.933326244354248,
            "end_logit": 6.890969276428223
        },
        {
            "text": "as low as 1 in 10(9) hematologic cells",
            "probability": 0.13923810691637709,
            "start_logit": 5.690478324890137,
            "end_logit": 6.890969276428223
        },
        {
            "text": "1 in 10(9) hematologic cells)",
            "probability": 0.048800391477575804,
            "start_logit": 6.666227340698242,
            "end_logit": 4.8667731285095215
        },
        {
            "text": "extremely low number of CTCs",
            "probability": 0.04306299089539618,
            "start_logit": 5.933326244354248,
            "end_logit": 5.474599838256836
        },
        {
            "text": "extremely low number",
            "probability": 0.037236631260626235,
            "start_logit": 5.933326244354248,
            "end_logit": 5.32922887802124
        },
        {
            "text": "low as 1 in 10(9) hematologic cells",
            "probability": 0.029764669355119528,
            "start_logit": 4.1476149559021,
            "end_logit": 6.890969276428223
        },
        {
            "text": "extremely low number of CTCs (as low as 1 in 10(9) hematologic cells)",
            "probability": 0.023449220152078575,
            "start_logit": 5.933326244354248,
            "end_logit": 4.8667731285095215
        },
        {
            "text": "1 in 10(9) hematologic cells) in the blood of patients",
            "probability": 0.02148555850958855,
            "start_logit": 6.666227340698242,
            "end_logit": 4.04641580581665
        },
        {
            "text": "low number of CTCs (as low as 1 in 10(9) hematologic cells",
            "probability": 0.01872953147980752,
            "start_logit": 3.684394359588623,
            "end_logit": 6.890969276428223
        },
        {
            "text": "as low as 1 in 10(9) hematologic cells)",
            "probability": 0.018393352443635123,
            "start_logit": 5.690478324890137,
            "end_logit": 4.8667731285095215
        },
        {
            "text": "1 in 10(9)",
            "probability": 0.01756561923338373,
            "start_logit": 6.666227340698242,
            "end_logit": 3.8449783325195312
        },
        {
            "text": "extremely low number of CTCs (as low as 1 in 10(9) hematologic cells) in the blood of patients",
            "probability": 0.010324089137957357,
            "start_logit": 5.933326244354248,
            "end_logit": 4.04641580581665
        },
        {
            "text": "",
            "probability": 0.008557056628773995,
            "start_logit": 4.814265251159668,
            "end_logit": 4.977753162384033
        },
        {
            "text": "extremely low number of CTCs (as low as 1 in 10(9)",
            "probability": 0.008440507545937871,
            "start_logit": 5.933326244354248,
            "end_logit": 3.8449783325195312
        },
        {
            "text": "as low as 1 in 10(9) hematologic cells) in the blood of patients",
            "probability": 0.008098120489398118,
            "start_logit": 5.690478324890137,
            "end_logit": 4.04641580581665
        },
        {
            "text": "as low as 1 in 10(9)",
            "probability": 0.006620656426471202,
            "start_logit": 5.690478324890137,
            "end_logit": 3.8449783325195312
        },
        {
            "text": "(as low as 1 in 10(9) hematologic cells",
            "probability": 0.004689980305174186,
            "start_logit": 2.2997212409973145,
            "end_logit": 6.890969276428223
        },
        {
            "text": "low number of CTCs",
            "probability": 0.004543656405377295,
            "start_logit": 3.684394359588623,
            "end_logit": 5.474599838256836
        },
        {
            "text": "CTCs (as low as 1 in 10(9) hematologic cells",
            "probability": 0.004068616498500079,
            "start_logit": 2.1575958728790283,
            "end_logit": 6.890969276428223
        }
    ],
    "5c7a4fddd774d04240000009_003": [
        {
            "text": "",
            "probability": 0.9680049749915772,
            "start_logit": 4.932656764984131,
            "end_logit": 5.466851234436035
        },
        {
            "text": "one CTC",
            "probability": 0.01505275759379621,
            "start_logit": 2.437305212020874,
            "end_logit": 3.7985267639160156
        },
        {
            "text": "extremely scare number of CTCs",
            "probability": 0.00901183130628,
            "start_logit": 2.5545997619628906,
            "end_logit": 3.1682093143463135
        },
        {
            "text": "extremely scare number",
            "probability": 0.002608539642839524,
            "start_logit": 2.5545997619628906,
            "end_logit": 1.9284615516662598
        },
        {
            "text": "scare number of CTCs",
            "probability": 0.001238814309982686,
            "start_logit": 0.570216178894043,
            "end_logit": 3.1682093143463135
        },
        {
            "text": "extremely scare",
            "probability": 0.0008980777923799024,
            "start_logit": 2.5545997619628906,
            "end_logit": 0.8621724247932434
        },
        {
            "text": "CTCs in whole blood down to one CTC",
            "probability": 0.000586658791524786,
            "start_logit": -0.8075678944587708,
            "end_logit": 3.7985267639160156
        },
        {
            "text": "down to one CTC",
            "probability": 0.00046995150953586627,
            "start_logit": -1.0293817520141602,
            "end_logit": 3.7985267639160156
        },
        {
            "text": "CTCs",
            "probability": 0.0004608544352842274,
            "start_logit": -0.4186115860939026,
            "end_logit": 3.1682093143463135
        },
        {
            "text": "scare number",
            "probability": 0.00035858374706313254,
            "start_logit": 0.570216178894043,
            "end_logit": 1.9284615516662598
        },
        {
            "text": "the extremely scare number of CTCs",
            "probability": 0.00034249359311522737,
            "start_logit": -0.7154408693313599,
            "end_logit": 3.1682093143463135
        },
        {
            "text": "one",
            "probability": 0.0002158827247544652,
            "start_logit": 2.437305212020874,
            "end_logit": -0.4460543990135193
        },
        {
            "text": "number of CTCs",
            "probability": 0.0001485507834297935,
            "start_logit": -1.550766944885254,
            "end_logit": 3.1682093143463135
        },
        {
            "text": "scare",
            "probability": 0.00012345455466999125,
            "start_logit": 0.570216178894043,
            "end_logit": 0.8621724247932434
        },
        {
            "text": "one CTC. Furthermore, it was demonstrated that the designed probe allowed capturing living CTCs with minimal cell damage",
            "probability": 0.00011691818240242226,
            "start_logit": 2.437305212020874,
            "end_logit": -1.0593153238296509
        },
        {
            "text": "the extremely scare number",
            "probability": 9.913724355193364e-05,
            "start_logit": -0.7154408693313599,
            "end_logit": 1.9284615516662598
        },
        {
            "text": "CTCs from whole blood was still full of challenge due to the extremely scare number of CTCs",
            "probability": 8.16769712502784e-05,
            "start_logit": -2.1489217281341553,
            "end_logit": 3.1682093143463135
        },
        {
            "text": "CTC",
            "probability": 7.808824150960336e-05,
            "start_logit": -2.824171781539917,
            "end_logit": 3.7985267639160156
        },
        {
            "text": "in whole blood down to one CTC",
            "probability": 5.141817025377952e-05,
            "start_logit": -3.2420196533203125,
            "end_logit": 3.7985267639160156
        },
        {
            "text": "whole blood down to one CTC",
            "probability": 5.133541479893866e-05,
            "start_logit": -3.2436304092407227,
            "end_logit": 3.7985267639160156
        }
    ],
    "5c7a4fddd774d04240000009_004": [
        {
            "text": "",
            "probability": 0.7076786468673901,
            "start_logit": 3.68440842628479,
            "end_logit": 3.8641250133514404
        },
        {
            "text": "one",
            "probability": 0.08341496481936654,
            "start_logit": 2.905001401901245,
            "end_logit": 2.5053696632385254
        },
        {
            "text": "as low as one",
            "probability": 0.06154057396305556,
            "start_logit": 2.600870370864868,
            "end_logit": 2.5053696632385254
        },
        {
            "text": "one CTC",
            "probability": 0.040964567252884464,
            "start_logit": 2.905001401901245,
            "end_logit": 1.794249415397644
        },
        {
            "text": "as low as one CTC",
            "probability": 0.03022219078255129,
            "start_logit": 2.600870370864868,
            "end_logit": 1.794249415397644
        },
        {
            "text": "one CTC in the whole blood",
            "probability": 0.016689910830303103,
            "start_logit": 2.905001401901245,
            "end_logit": 0.8963463306427002
        },
        {
            "text": "low as one",
            "probability": 0.012883123214594096,
            "start_logit": 1.037091851234436,
            "end_logit": 2.5053696632385254
        },
        {
            "text": "as low as one CTC in the whole blood",
            "probability": 0.012313218546734983,
            "start_logit": 2.600870370864868,
            "end_logit": 0.8963463306427002
        },
        {
            "text": "one CTC in the whole blood was captured and identified by the ICC method",
            "probability": 0.006524393063260619,
            "start_logit": 2.905001401901245,
            "end_logit": -0.0429101325571537
        },
        {
            "text": "low as one CTC",
            "probability": 0.006326821194425634,
            "start_logit": 1.037091851234436,
            "end_logit": 1.794249415397644
        },
        {
            "text": "one CTC in the whole blood was captured and identified",
            "probability": 0.005746341285614057,
            "start_logit": 2.905001401901245,
            "end_logit": -0.16989471018314362
        },
        {
            "text": "as low as one CTC in the whole blood was captured and identified by the ICC method",
            "probability": 0.004813463564279015,
            "start_logit": 2.600870370864868,
            "end_logit": -0.0429101325571537
        },
        {
            "text": "as low as one CTC in the whole blood was captured and identified",
            "probability": 0.004239444824679566,
            "start_logit": 2.600870370864868,
            "end_logit": -0.16989471018314362
        },
        {
            "text": "low as one CTC in the whole blood",
            "probability": 0.002577693081007718,
            "start_logit": 1.037091851234436,
            "end_logit": 0.8963463306427002
        },
        {
            "text": "low as one CTC in the whole blood was captured and identified by the ICC method",
            "probability": 0.001007667627942397,
            "start_logit": 1.037091851234436,
            "end_logit": -0.0429101325571537
        },
        {
            "text": "low as one CTC in the whole blood was captured and identified",
            "probability": 0.0008875004979740413,
            "start_logit": 1.037091851234436,
            "end_logit": -0.16989471018314362
        },
        {
            "text": "as low",
            "probability": 0.0007309257899462611,
            "start_logit": 2.600870370864868,
            "end_logit": -1.9277703762054443
        },
        {
            "text": "one CTC in the whole blood was captured and identified by the ICC",
            "probability": 0.0006161087635394878,
            "start_logit": 2.905001401901245,
            "end_logit": -2.402789831161499
        },
        {
            "text": "as low as one CTC in the whole blood was captured and identified by the ICC",
            "probability": 0.00045454298295268995,
            "start_logit": 2.600870370864868,
            "end_logit": -2.402789831161499
        },
        {
            "text": "CTC",
            "probability": 0.0003679010474982512,
            "start_logit": -1.8076473474502563,
            "end_logit": 1.794249415397644
        }
    ],
    "5c7a4fddd774d04240000009_005": [
        {
            "text": "rare cell species in blood circulation",
            "probability": 0.25056320158353695,
            "start_logit": 2.6239254474639893,
            "end_logit": 2.506314992904663
        },
        {
            "text": "",
            "probability": 0.18096996957206207,
            "start_logit": 2.188014268875122,
            "end_logit": 2.6168460845947266
        },
        {
            "text": "rare",
            "probability": 0.13201761896432826,
            "start_logit": 2.6239254474639893,
            "end_logit": 1.8655391931533813
        },
        {
            "text": "rare cell species",
            "probability": 0.09006007451550688,
            "start_logit": 2.6239254474639893,
            "end_logit": 1.4830807447433472
        },
        {
            "text": "a rare cell species in blood circulation",
            "probability": 0.06969194202928533,
            "start_logit": 1.3442989587783813,
            "end_logit": 2.506314992904663
        },
        {
            "text": "a rare",
            "probability": 0.036719534989812966,
            "start_logit": 1.3442989587783813,
            "end_logit": 1.8655391931533813
        },
        {
            "text": "cell species in blood circulation",
            "probability": 0.028061340089501778,
            "start_logit": 0.4346070885658264,
            "end_logit": 2.506314992904663
        },
        {
            "text": "circulating tumor cells (CTCs), a rare cell species in blood circulation",
            "probability": 0.025916227781043594,
            "start_logit": 0.3550835847854614,
            "end_logit": 2.506314992904663
        },
        {
            "text": "a rare cell species",
            "probability": 0.025049414489522602,
            "start_logit": 1.3442989587783813,
            "end_logit": 1.4830807447433472
        },
        {
            "text": "rare cell species in blood circulation.",
            "probability": 0.024705374720738894,
            "start_logit": 2.6239254474639893,
            "end_logit": 0.18962462246418
        },
        {
            "text": "rare cell species in blood",
            "probability": 0.022513538366117265,
            "start_logit": 2.6239254474639893,
            "end_logit": 0.0967206358909607
        },
        {
            "text": "blood circulation",
            "probability": 0.02197722904269083,
            "start_logit": 0.1902211308479309,
            "end_logit": 2.506314992904663
        },
        {
            "text": "rare cell",
            "probability": 0.017615014692681577,
            "start_logit": 2.6239254474639893,
            "end_logit": -0.1486445516347885
        },
        {
            "text": "circulating tumor cells",
            "probability": 0.014743707599476396,
            "start_logit": 0.3550835847854614,
            "end_logit": 1.942262053489685
        },
        {
            "text": "circulating tumor cells (CTCs), a rare",
            "probability": 0.013654833042392572,
            "start_logit": 0.3550835847854614,
            "end_logit": 1.8655391931533813
        },
        {
            "text": "in blood circulation",
            "probability": 0.01320626677351837,
            "start_logit": -0.3190942704677582,
            "end_logit": 2.506314992904663
        },
        {
            "text": "cell species",
            "probability": 0.010086103480055304,
            "start_logit": 0.4346070885658264,
            "end_logit": 1.4830807447433472
        },
        {
            "text": "circulating tumor cells (CTCs), a rare cell species",
            "probability": 0.009315084539033886,
            "start_logit": 0.3550835847854614,
            "end_logit": 1.4830807447433472
        },
        {
            "text": "a rare cell species in blood circulation.",
            "probability": 0.00687158182832955,
            "start_logit": 1.3442989587783813,
            "end_logit": 0.18962462246418
        },
        {
            "text": "a rare cell species in blood",
            "probability": 0.0062619419003649346,
            "start_logit": 1.3442989587783813,
            "end_logit": 0.0967206358909607
        }
    ],
    "5e35c4ea9be68b5512000002_002": [
        {
            "text": "combining single-cell RNA sequencing",
            "probability": 0.5543993106749876,
            "start_logit": 5.055117607116699,
            "end_logit": 3.4333384037017822
        },
        {
            "text": "perform many such assays in a pool",
            "probability": 0.08932322862392725,
            "start_logit": 1.803510308265686,
            "end_logit": 4.8593220710754395
        },
        {
            "text": "in a pool",
            "probability": 0.07526941030206544,
            "start_logit": 1.6323225498199463,
            "end_logit": 4.8593220710754395
        },
        {
            "text": "pool",
            "probability": 0.06625139063872351,
            "start_logit": 1.5047051906585693,
            "end_logit": 4.8593220710754395
        },
        {
            "text": "single-cell RNA sequencing",
            "probability": 0.04713172426161693,
            "start_logit": 2.5901787281036377,
            "end_logit": 3.4333384037017822
        },
        {
            "text": "combining single-cell RNA sequencing (RNA-seq) and clustered regularly interspaced short palindromic repeats",
            "probability": 0.03806824156716946,
            "start_logit": 5.055117607116699,
            "end_logit": 0.7548335790634155
        },
        {
            "text": "a pool",
            "probability": 0.025939832655352314,
            "start_logit": 0.5670284628868103,
            "end_logit": 4.8593220710754395
        },
        {
            "text": "accurately identifies individual gene targets, gene signatures, and cell states affected by individual perturbations and\u00a0their genetic interactions.",
            "probability": 0.02188370985199548,
            "start_logit": 2.3643832206726074,
            "end_logit": 2.891930103302002
        },
        {
            "text": "to perform many such assays in a pool",
            "probability": 0.015352304322532808,
            "start_logit": 0.042514316737651825,
            "end_logit": 4.8593220710754395
        },
        {
            "text": "assays in a pool",
            "probability": 0.012534175296161371,
            "start_logit": -0.16029232740402222,
            "end_logit": 4.8593220710754395
        },
        {
            "text": "combining",
            "probability": 0.010734487699912733,
            "start_logit": 5.055117607116699,
            "end_logit": -0.5110850930213928
        },
        {
            "text": "identifies individual gene targets, gene signatures, and cell states affected by individual perturbations and\u00a0their genetic interactions.",
            "probability": 0.008254745690589045,
            "start_logit": 1.389428973197937,
            "end_logit": 2.891930103302002
        },
        {
            "text": "perform many such assays",
            "probability": 0.007793096804179808,
            "start_logit": 1.803510308265686,
            "end_logit": 2.4202988147735596
        },
        {
            "text": "Perturb-seq accurately identifies individual gene targets, gene signatures, and cell states affected by individual perturbations and\u00a0their genetic interactions.",
            "probability": 0.0067450634596592715,
            "start_logit": 1.1874516010284424,
            "end_logit": 2.891930103302002
        },
        {
            "text": "accurately identifies individual gene targets",
            "probability": 0.005070352130668556,
            "start_logit": 2.3643832206726074,
            "end_logit": 1.4295978546142578
        },
        {
            "text": "individual gene targets, gene signatures, and cell states affected by individual perturbations and\u00a0their genetic interactions.",
            "probability": 0.003882555522765508,
            "start_logit": 0.6351342797279358,
            "end_logit": 2.891930103302002
        },
        {
            "text": "Perturb-seq, combining single-cell RNA sequencing",
            "probability": 0.0033873102907487503,
            "start_logit": -0.04273141548037529,
            "end_logit": 3.4333384037017822
        },
        {
            "text": "single-cell RNA sequencing (RNA-seq) and clustered regularly interspaced short palindromic repeats",
            "probability": 0.0032363349486924297,
            "start_logit": 2.5901787281036377,
            "end_logit": 0.7548335790634155
        },
        {
            "text": "RNA sequencing",
            "probability": 0.0022950582587167637,
            "start_logit": -0.43200936913490295,
            "end_logit": 3.4333384037017822
        },
        {
            "text": "accurately identifies individual gene targets, gene signatures, and cell states",
            "probability": 0.002201146809315859,
            "start_logit": 2.3643832206726074,
            "end_logit": 0.5951660871505737
        },
        {
            "text": "",
            "probability": 0.0002465201902191847,
            "start_logit": 0.14809291064739227,
            "end_logit": 0.6221665143966675
        }
    ],
    "5e2daaa2fbd6abf43b00000e_001": [
        {
            "text": "adenosine A2A receptor",
            "probability": 0.31037404031520105,
            "start_logit": 6.93516206741333,
            "end_logit": 7.630543231964111
        },
        {
            "text": "adenosine A2A",
            "probability": 0.25541558003544756,
            "start_logit": 6.93516206741333,
            "end_logit": 7.435657024383545
        },
        {
            "text": "adenosine A2A receptor antagonist",
            "probability": 0.13297282579164563,
            "start_logit": 6.93516206741333,
            "end_logit": 6.782909870147705
        },
        {
            "text": "selective adenosine A2A receptor",
            "probability": 0.11033137253036594,
            "start_logit": 5.900872230529785,
            "end_logit": 7.630543231964111
        },
        {
            "text": "selective adenosine A2A",
            "probability": 0.09079480836197462,
            "start_logit": 5.900872230529785,
            "end_logit": 7.435657024383545
        },
        {
            "text": "selective adenosine A2A receptor antagonist",
            "probability": 0.04726901245972203,
            "start_logit": 5.900872230529785,
            "end_logit": 6.782909870147705
        },
        {
            "text": "A2A receptor",
            "probability": 0.013528541242132357,
            "start_logit": 3.802185535430908,
            "end_logit": 7.630543231964111
        },
        {
            "text": "A2A",
            "probability": 0.011133019388102081,
            "start_logit": 3.802185535430908,
            "end_logit": 7.435657024383545
        },
        {
            "text": "A2A receptor antagonist",
            "probability": 0.005796001353651399,
            "start_logit": 3.802185535430908,
            "end_logit": 6.782909870147705
        },
        {
            "text": "a selective adenosine A2A receptor",
            "probability": 0.005746117402696954,
            "start_logit": 2.945908308029175,
            "end_logit": 7.630543231964111
        },
        {
            "text": "a selective adenosine A2A",
            "probability": 0.004728642601266359,
            "start_logit": 2.945908308029175,
            "end_logit": 7.435657024383545
        },
        {
            "text": "selective",
            "probability": 0.0033293064175473628,
            "start_logit": 5.900872230529785,
            "end_logit": 4.129818916320801
        },
        {
            "text": "a selective adenosine A2A receptor antagonist",
            "probability": 0.00246179566948062,
            "start_logit": 2.945908308029175,
            "end_logit": 6.782909870147705
        },
        {
            "text": "adenosine",
            "probability": 0.002124432015239193,
            "start_logit": 6.93516206741333,
            "end_logit": 2.6462695598602295
        },
        {
            "text": "receptor",
            "probability": 0.0013422648015772264,
            "start_logit": 1.4917422533035278,
            "end_logit": 7.630543231964111
        },
        {
            "text": "selective adenosine",
            "probability": 0.0007551904142845022,
            "start_logit": 5.900872230529785,
            "end_logit": 2.6462695598602295
        },
        {
            "text": "A2A receptor antagonist,",
            "probability": 0.0006574196846156361,
            "start_logit": 1.625584602355957,
            "end_logit": 6.782909870147705
        },
        {
            "text": "receptor antagonist",
            "probability": 0.0005750633765798381,
            "start_logit": 1.4917422533035278,
            "end_logit": 6.782909870147705
        },
        {
            "text": "adenosine A",
            "probability": 0.00033867935332183776,
            "start_logit": 6.93516206741333,
            "end_logit": 0.8100636005401611
        },
        {
            "text": "antagonist",
            "probability": 0.00031630681098475134,
            "start_logit": 0.8939746618270874,
            "end_logit": 6.782909870147705
        },
        {
            "text": "",
            "probability": 9.579974163150796e-06,
            "start_logit": 1.8557884693145752,
            "end_logit": 2.3240582942962646
        }
    ],
    "5e48f2b6f8b2df0d49000005_001": [
        {
            "text": "adverse late reactions after radiotherapy",
            "probability": 0.3239096223885915,
            "start_logit": 2.8359670639038086,
            "end_logit": 4.312033653259277
        },
        {
            "text": "predictive assay for adverse late reactions after radiotherapy",
            "probability": 0.24011325207083864,
            "start_logit": 2.5366132259368896,
            "end_logit": 4.312033653259277
        },
        {
            "text": "adverse late reactions",
            "probability": 0.09041443667933596,
            "start_logit": 2.8359670639038086,
            "end_logit": 3.035973072052002
        },
        {
            "text": "a predictive assay for adverse late reactions after radiotherapy",
            "probability": 0.0680269337387288,
            "start_logit": 1.2754062414169312,
            "end_logit": 4.312033653259277
        },
        {
            "text": "predictive assay for adverse late reactions",
            "probability": 0.06702395645160344,
            "start_logit": 2.5366132259368896,
            "end_logit": 3.035973072052002
        },
        {
            "text": "",
            "probability": 0.04298495090792661,
            "start_logit": 2.3836026191711426,
            "end_logit": 2.744783639907837
        },
        {
            "text": "as a predictive assay for adverse late reactions after radiotherapy",
            "probability": 0.028475195903723667,
            "start_logit": 0.4045359194278717,
            "end_logit": 4.312033653259277
        },
        {
            "text": "for adverse late reactions after radiotherapy",
            "probability": 0.020560968001110437,
            "start_logit": 0.07889705151319504,
            "end_logit": 4.312033653259277
        },
        {
            "text": "predictive",
            "probability": 0.019097021744462324,
            "start_logit": 2.5366132259368896,
            "end_logit": 1.7804553508758545
        },
        {
            "text": "a predictive assay for adverse late reactions",
            "probability": 0.01898868223689519,
            "start_logit": 1.2754062414169312,
            "end_logit": 3.035973072052002
        },
        {
            "text": "assay for adverse late reactions after radiotherapy",
            "probability": 0.013999253762656096,
            "start_logit": -0.30549344420433044,
            "end_logit": 4.312033653259277
        },
        {
            "text": "radiotherapy",
            "probability": 0.011365479185061672,
            "start_logit": -0.5139168500900269,
            "end_logit": 4.312033653259277
        },
        {
            "text": "has been suggested as a predictive assay for adverse late reactions after radiotherapy",
            "probability": 0.010744393770827428,
            "start_logit": -0.5701133608818054,
            "end_logit": 4.312033653259277
        },
        {
            "text": "suggested as a predictive assay for adverse late reactions after radiotherapy",
            "probability": 0.009676583890122336,
            "start_logit": -0.6747885346412659,
            "end_logit": 4.312033653259277
        },
        {
            "text": "as a predictive assay for adverse late reactions",
            "probability": 0.007948417147917337,
            "start_logit": 0.4045359194278717,
            "end_logit": 3.035973072052002
        },
        {
            "text": "predictive assay for adverse late reactions after radiotherapy.",
            "probability": 0.006099625063487155,
            "start_logit": -1.1362701654434204,
            "end_logit": 4.312033653259277
        },
        {
            "text": "for adverse late reactions",
            "probability": 0.005739280993548307,
            "start_logit": 0.07889705151319504,
            "end_logit": 3.035973072052002
        },
        {
            "text": "a predictive",
            "probability": 0.005410412884809602,
            "start_logit": 1.2754062414169312,
            "end_logit": 1.7804553508758545
        },
        {
            "text": "adverse late reactions after radiotherapy.",
            "probability": 0.004817793517136204,
            "start_logit": 2.8359670639038086,
            "end_logit": 0.10388516634702682
        },
        {
            "text": "predicting individual clinical risk",
            "probability": 0.004603739661217249,
            "start_logit": 1.0708067417144775,
            "end_logit": 1.8235983848571777
        }
    ],
    "5e48f2b6f8b2df0d49000005_002": [
        {
            "text": "flow cytometry",
            "probability": 0.3663490800704158,
            "start_logit": 2.07074236869812,
            "end_logit": 2.9957387447357178
        },
        {
            "text": "RILA was assessed using flow cytometry",
            "probability": 0.20543550801258006,
            "start_logit": 1.4922878742218018,
            "end_logit": 2.9957387447357178
        },
        {
            "text": "assessed using flow cytometry",
            "probability": 0.11732290131377465,
            "start_logit": 0.9320856928825378,
            "end_logit": 2.9957387447357178
        },
        {
            "text": "severity of radiation toxicity",
            "probability": 0.0868626757302487,
            "start_logit": 0.421319842338562,
            "end_logit": 3.2059030532836914
        },
        {
            "text": "using flow cytometry",
            "probability": 0.07666650156521806,
            "start_logit": 0.5066205859184265,
            "end_logit": 2.9957387447357178
        },
        {
            "text": "correlates with the severity of radiation toxicity",
            "probability": 0.04416336168313171,
            "start_logit": -0.25511306524276733,
            "end_logit": 3.2059030532836914
        },
        {
            "text": "the severity of radiation toxicity",
            "probability": 0.03220278934685563,
            "start_logit": -0.5709555149078369,
            "end_logit": 3.2059030532836914
        },
        {
            "text": "",
            "probability": 0.030217912912565235,
            "start_logit": 1.0359758138656616,
            "end_logit": 1.5353535413742065
        },
        {
            "text": "radiation toxicity",
            "probability": 0.012149237799456397,
            "start_logit": -1.545742154121399,
            "end_logit": 3.2059030532836914
        },
        {
            "text": "with the severity of radiation toxicity",
            "probability": 0.00824641193934283,
            "start_logit": -1.9332304000854492,
            "end_logit": 3.2059030532836914
        },
        {
            "text": "toxicity",
            "probability": 0.006470163325870988,
            "start_logit": -2.175807237625122,
            "end_logit": 3.2059030532836914
        },
        {
            "text": "flow cytometry.",
            "probability": 0.002857402719610978,
            "start_logit": 2.07074236869812,
            "end_logit": -1.857934832572937
        },
        {
            "text": "flow cytometry.Results: 245 patients",
            "probability": 0.0017102204995815974,
            "start_logit": 2.07074236869812,
            "end_logit": -2.371225595474243
        },
        {
            "text": "RILA was assessed",
            "probability": 0.001695640354462868,
            "start_logit": 1.4922878742218018,
            "end_logit": -1.801332950592041
        },
        {
            "text": "15.3%",
            "probability": 0.0016321567930587513,
            "start_logit": -0.4781290888786316,
            "end_logit": 0.13092587888240814
        },
        {
            "text": "RILA was assessed using flow cytometry.",
            "probability": 0.001602329611929092,
            "start_logit": 1.4922878742218018,
            "end_logit": -1.857934832572937
        },
        {
            "text": "flow cytometry.Results: 245",
            "probability": 0.0015732261149702554,
            "start_logit": 2.07074236869812,
            "end_logit": -2.4547195434570312
        },
        {
            "text": "assessed",
            "probability": 0.0009683693334947664,
            "start_logit": 0.9320856928825378,
            "end_logit": -1.801332950592041
        },
        {
            "text": "RILA was assessed using flow cytometry.Results: 245 patients",
            "probability": 0.0009590307066624626,
            "start_logit": 1.4922878742218018,
            "end_logit": -2.371225595474243
        },
        {
            "text": "assessed using flow cytometry.",
            "probability": 0.0009150801667693392,
            "start_logit": 0.9320856928825378,
            "end_logit": -1.857934832572937
        }
    ],
    "5e2f906ffbd6abf43b00002c_001": [
        {
            "text": "oral viscous lidocaine/ antacid \u00b1 anticholinergic",
            "probability": 0.8209450351635231,
            "start_logit": 7.051507472991943,
            "end_logit": 7.555911540985107
        },
        {
            "text": "oral viscous lidocaine/ antacid",
            "probability": 0.04914270674263139,
            "start_logit": 7.051507472991943,
            "end_logit": 4.7401838302612305
        },
        {
            "text": "lidocaine/ antacid \u00b1 anticholinergic",
            "probability": 0.03727411183842196,
            "start_logit": 3.959350347518921,
            "end_logit": 7.555911540985107
        },
        {
            "text": "anticholinergic",
            "probability": 0.026777996275606005,
            "start_logit": 3.628631830215454,
            "end_logit": 7.555911540985107
        },
        {
            "text": "oral viscous lidocaine",
            "probability": 0.025459099129348874,
            "start_logit": 7.051507472991943,
            "end_logit": 4.082528591156006
        },
        {
            "text": "antacid \u00b1 anticholinergic",
            "probability": 0.010047994602496509,
            "start_logit": 2.6484243869781494,
            "end_logit": 7.555911540985107
        },
        {
            "text": "viscous lidocaine/ antacid \u00b1 anticholinergic",
            "probability": 0.009751227049526577,
            "start_logit": 2.6184444427490234,
            "end_logit": 7.555911540985107
        },
        {
            "text": "",
            "probability": 0.007556313788315228,
            "start_logit": 4.584626197814941,
            "end_logit": 5.334720134735107
        },
        {
            "text": "oral viscous lidocaine/ antacid \u00b1 anticholinergic)",
            "probability": 0.0031897860905839835,
            "start_logit": 7.051507472991943,
            "end_logit": 2.0054092407226562
        },
        {
            "text": "lidocaine/ antacid",
            "probability": 0.0022312708752818653,
            "start_logit": 3.959350347518921,
            "end_logit": 4.7401838302612305
        },
        {
            "text": "(oral viscous lidocaine/ antacid \u00b1 anticholinergic",
            "probability": 0.002167494720160296,
            "start_logit": 1.1146233081817627,
            "end_logit": 7.555911540985107
        },
        {
            "text": "lidocaine",
            "probability": 0.0011559425632725801,
            "start_logit": 3.959350347518921,
            "end_logit": 4.082528591156006
        },
        {
            "text": "oral gastrointestinal (GI) cocktail (oral viscous lidocaine/ antacid \u00b1 anticholinergic",
            "probability": 0.00097009795385187,
            "start_logit": 0.31069308519363403,
            "end_logit": 7.555911540985107
        },
        {
            "text": "antacid",
            "probability": 0.000601484424598137,
            "start_logit": 2.6484243869781494,
            "end_logit": 4.7401838302612305
        },
        {
            "text": "viscous lidocaine/ antacid",
            "probability": 0.0005837195801790162,
            "start_logit": 2.6184444427490234,
            "end_logit": 4.7401838302612305
        },
        {
            "text": "/ antacid \u00b1 anticholinergic",
            "probability": 0.0005243906762779281,
            "start_logit": -0.30446699261665344,
            "end_logit": 7.555911540985107
        },
        {
            "text": "oral",
            "probability": 0.00046514044756381853,
            "start_logit": 7.051507472991943,
            "end_logit": 0.08003950119018555
        },
        {
            "text": "\u00b1 anticholinergic",
            "probability": 0.0004597853431266095,
            "start_logit": -0.43594422936439514,
            "end_logit": 7.555911540985107
        },
        {
            "text": "lidocaine/ antacid \u00b1 anticholinergic)",
            "probability": 0.0003939982556975059,
            "start_logit": -0.5903574824333191,
            "end_logit": 7.555911540985107
        },
        {
            "text": "viscous lidocaine",
            "probability": 0.0003024044795364834,
            "start_logit": 2.6184444427490234,
            "end_logit": 4.082528591156006
        }
    ],
    "5e2f906ffbd6abf43b00002c_002": [
        {
            "text": "IV pantoprazole",
            "probability": 0.47966745752110557,
            "start_logit": 4.367315769195557,
            "end_logit": 5.730350017547607
        },
        {
            "text": "",
            "probability": 0.4362110468093599,
            "start_logit": 4.4970574378967285,
            "end_logit": 5.505641460418701
        },
        {
            "text": "pantoprazole",
            "probability": 0.055861932942622365,
            "start_logit": 2.2171058654785156,
            "end_logit": 5.730350017547607
        },
        {
            "text": "Intravenous PPI",
            "probability": 0.0050813499242876176,
            "start_logit": 2.9472708702087402,
            "end_logit": 2.6028788089752197
        },
        {
            "text": "proton pump inhibitor",
            "probability": 0.0030888431521366565,
            "start_logit": 2.7423248291015625,
            "end_logit": 2.310044527053833
        },
        {
            "text": "IV pantoprazole in addition",
            "probability": 0.002803128221741986,
            "start_logit": 4.367315769195557,
            "end_logit": 0.5879929661750793
        },
        {
            "text": "proton pump inhibitor (PPI), a novel acid-lowering drug",
            "probability": 0.0026253362779352853,
            "start_logit": 2.7423248291015625,
            "end_logit": 2.1474568843841553
        },
        {
            "text": "proton pump inhibitor (PPI)",
            "probability": 0.002432410214193867,
            "start_logit": 2.7423248291015625,
            "end_logit": 2.0711305141448975
        },
        {
            "text": "IV",
            "probability": 0.0015885983052974539,
            "start_logit": 4.367315769195557,
            "end_logit": 0.020109008997678757
        },
        {
            "text": "proton pump inhibitor (PPI), a novel acid-lowering",
            "probability": 0.001497581889973077,
            "start_logit": 2.7423248291015625,
            "end_logit": 1.586099624633789
        },
        {
            "text": "placebo, antacid, and antispasmodic",
            "probability": 0.0014958825763018257,
            "start_logit": 2.2895760536193848,
            "end_logit": 2.037713050842285
        },
        {
            "text": "pantoprazole, antacid, and antispasmodic",
            "probability": 0.0013368396292770593,
            "start_logit": 1.501641869544983,
            "end_logit": 2.7132391929626465
        },
        {
            "text": "IV pantoprazole, antacid, and antispasmodic",
            "probability": 0.0010925732053427147,
            "start_logit": 1.299869179725647,
            "end_logit": 2.7132391929626465
        },
        {
            "text": "IV pantoprazole in addition to the conventional GI cocktail",
            "probability": 0.0009520535178124133,
            "start_logit": 4.367315769195557,
            "end_logit": -0.49187707901000977
        },
        {
            "text": "an intravenous (IV) proton pump inhibitor",
            "probability": 0.0008697794094011853,
            "start_logit": 1.4750125408172607,
            "end_logit": 2.310044527053833
        },
        {
            "text": "proton pump inhibitor (PPI",
            "probability": 0.0008024980523446567,
            "start_logit": 2.7423248291015625,
            "end_logit": 0.9622220396995544
        },
        {
            "text": "an intravenous (IV) proton pump inhibitor (PPI), a novel acid-lowering drug",
            "probability": 0.0007392616992295351,
            "start_logit": 1.4750125408172607,
            "end_logit": 2.1474568843841553
        },
        {
            "text": "an intravenous (IV) proton pump inhibitor (PPI)",
            "probability": 0.0006849361444783878,
            "start_logit": 1.4750125408172607,
            "end_logit": 2.0711305141448975
        },
        {
            "text": "intravenous (IV) proton pump inhibitor",
            "probability": 0.000631636431011956,
            "start_logit": 1.155086874961853,
            "end_logit": 2.310044527053833
        },
        {
            "text": "intravenous (IV) proton pump inhibitor (PPI), a novel acid-lowering drug",
            "probability": 0.0005368540761463344,
            "start_logit": 1.155086874961853,
            "end_logit": 2.1474568843841553
        }
    ],
    "5e2f906ffbd6abf43b00002c_003": [
        {
            "text": "IV pantoprazole",
            "probability": 0.47966745752110557,
            "start_logit": 4.367315769195557,
            "end_logit": 5.730350017547607
        },
        {
            "text": "",
            "probability": 0.4362110468093599,
            "start_logit": 4.4970574378967285,
            "end_logit": 5.505641460418701
        },
        {
            "text": "pantoprazole",
            "probability": 0.055861932942622365,
            "start_logit": 2.2171058654785156,
            "end_logit": 5.730350017547607
        },
        {
            "text": "Intravenous PPI",
            "probability": 0.0050813499242876176,
            "start_logit": 2.9472708702087402,
            "end_logit": 2.6028788089752197
        },
        {
            "text": "proton pump inhibitor",
            "probability": 0.0030888431521366565,
            "start_logit": 2.7423248291015625,
            "end_logit": 2.310044527053833
        },
        {
            "text": "IV pantoprazole in addition",
            "probability": 0.002803128221741986,
            "start_logit": 4.367315769195557,
            "end_logit": 0.5879929661750793
        },
        {
            "text": "proton pump inhibitor (PPI), a novel acid-lowering drug",
            "probability": 0.0026253362779352853,
            "start_logit": 2.7423248291015625,
            "end_logit": 2.1474568843841553
        },
        {
            "text": "proton pump inhibitor (PPI)",
            "probability": 0.002432410214193867,
            "start_logit": 2.7423248291015625,
            "end_logit": 2.0711305141448975
        },
        {
            "text": "IV",
            "probability": 0.0015885983052974539,
            "start_logit": 4.367315769195557,
            "end_logit": 0.020109008997678757
        },
        {
            "text": "proton pump inhibitor (PPI), a novel acid-lowering",
            "probability": 0.001497581889973077,
            "start_logit": 2.7423248291015625,
            "end_logit": 1.586099624633789
        },
        {
            "text": "placebo, antacid, and antispasmodic",
            "probability": 0.0014958825763018257,
            "start_logit": 2.2895760536193848,
            "end_logit": 2.037713050842285
        },
        {
            "text": "pantoprazole, antacid, and antispasmodic",
            "probability": 0.0013368396292770593,
            "start_logit": 1.501641869544983,
            "end_logit": 2.7132391929626465
        },
        {
            "text": "IV pantoprazole, antacid, and antispasmodic",
            "probability": 0.0010925732053427147,
            "start_logit": 1.299869179725647,
            "end_logit": 2.7132391929626465
        },
        {
            "text": "IV pantoprazole in addition to the conventional GI cocktail",
            "probability": 0.0009520535178124133,
            "start_logit": 4.367315769195557,
            "end_logit": -0.49187707901000977
        },
        {
            "text": "an intravenous (IV) proton pump inhibitor",
            "probability": 0.0008697794094011853,
            "start_logit": 1.4750125408172607,
            "end_logit": 2.310044527053833
        },
        {
            "text": "proton pump inhibitor (PPI",
            "probability": 0.0008024980523446567,
            "start_logit": 2.7423248291015625,
            "end_logit": 0.9622220396995544
        },
        {
            "text": "an intravenous (IV) proton pump inhibitor (PPI), a novel acid-lowering drug",
            "probability": 0.0007392616992295351,
            "start_logit": 1.4750125408172607,
            "end_logit": 2.1474568843841553
        },
        {
            "text": "an intravenous (IV) proton pump inhibitor (PPI)",
            "probability": 0.0006849361444783878,
            "start_logit": 1.4750125408172607,
            "end_logit": 2.0711305141448975
        },
        {
            "text": "intravenous (IV) proton pump inhibitor",
            "probability": 0.000631636431011956,
            "start_logit": 1.155086874961853,
            "end_logit": 2.310044527053833
        },
        {
            "text": "intravenous (IV) proton pump inhibitor (PPI), a novel acid-lowering drug",
            "probability": 0.0005368540761463344,
            "start_logit": 1.155086874961853,
            "end_logit": 2.1474568843841553
        }
    ],
    "5e2f906ffbd6abf43b00002c_004": [
        {
            "text": "Benzocaine and Lidocaine",
            "probability": 0.7121465082794775,
            "start_logit": 4.633453369140625,
            "end_logit": 4.99457311630249
        },
        {
            "text": "Benzocaine",
            "probability": 0.07542660283244092,
            "start_logit": 3.427032709121704,
            "end_logit": 3.9558701515197754
        },
        {
            "text": "",
            "probability": 0.07285581067087211,
            "start_logit": 3.372918128967285,
            "end_logit": 3.975306987762451
        },
        {
            "text": "Benzocaine or viscous Lidocaine",
            "probability": 0.07266124700234926,
            "start_logit": 3.2166075706481934,
            "end_logit": 4.12894344329834
        },
        {
            "text": "Benzocaine (Hurricaine)",
            "probability": 0.018082640680177002,
            "start_logit": 3.427032709121704,
            "end_logit": 2.527662515640259
        },
        {
            "text": "Benzocaine (Hurricaine) would work as quickly and effectively as viscous Lidocaine",
            "probability": 0.013904251010173225,
            "start_logit": 3.427032709121704,
            "end_logit": 2.264904737472534
        },
        {
            "text": "Benzocaine and Lidocaine as the topical anesthetic",
            "probability": 0.008175282961022599,
            "start_logit": 4.633453369140625,
            "end_logit": 0.52740478515625
        },
        {
            "text": "Lidocaine",
            "probability": 0.007558436065870197,
            "start_logit": 0.08783400803804398,
            "end_logit": 4.99457311630249
        },
        {
            "text": "viscous Lidocaine in this preparation. This was a prospective randomized, single-blinded comparison between Benzocaine and Lidocaine",
            "probability": 0.005406682981098897,
            "start_logit": -0.24719451367855072,
            "end_logit": 4.99457311630249
        },
        {
            "text": "Benzocaine (Hurricaine",
            "probability": 0.005312063626377993,
            "start_logit": 3.427032709121704,
            "end_logit": 1.3026905059814453
        },
        {
            "text": "Benzocaine or viscous Lidocaine in addition to 30 cc of Maalox and 10 cc of Donnatal",
            "probability": 0.0033638518707632247,
            "start_logit": 3.2166075706481934,
            "end_logit": 1.0562219619750977
        },
        {
            "text": "Benzocaine and Lidocaine as the topical anesthetic in a gastrointestinal",
            "probability": 0.0011504333856927223,
            "start_logit": 4.633453369140625,
            "end_logit": -1.4335718154907227
        },
        {
            "text": "viscous Lidocaine",
            "probability": 0.0007829325935899845,
            "start_logit": -1.3139092922210693,
            "end_logit": 4.12894344329834
        },
        {
            "text": "Patients were randomized to equivalent doses of either Benzocaine or viscous Lidocaine",
            "probability": 0.0006040410650175142,
            "start_logit": -1.5733137130737305,
            "end_logit": 4.12894344329834
        },
        {
            "text": "either Benzocaine or viscous Lidocaine",
            "probability": 0.0005758982126305919,
            "start_logit": -1.6210249662399292,
            "end_logit": 4.12894344329834
        },
        {
            "text": "viscous Lidocaine in this preparation. This was a prospective randomized, single-blinded comparison between Benzocaine",
            "probability": 0.0005368632981876843,
            "start_logit": -0.24719451367855072,
            "end_logit": 2.6849255561828613
        },
        {
            "text": "equivalent doses of either Benzocaine or viscous Lidocaine",
            "probability": 0.0005228788691414442,
            "start_logit": -1.7176060676574707,
            "end_logit": 4.12894344329834
        },
        {
            "text": "Benzocaine or viscous Lidocaine in addition to 30 cc of Maalox",
            "probability": 0.00040988237159656025,
            "start_logit": 3.2166075706481934,
            "end_logit": -1.0487498044967651
        },
        {
            "text": "Benzocaine or viscous Lidocaine in addition to 30 cc of Maalox and 10 cc of Donnatal.",
            "probability": 0.0002871612320376926,
            "start_logit": 3.2166075706481934,
            "end_logit": -1.4045761823654175
        },
        {
            "text": "Benzocaine, 38 to viscous Lidocaine",
            "probability": 0.00023653099148306916,
            "start_logit": 0.30013835430145264,
            "end_logit": 1.317928433418274
        }
    ],
    "5e2f906ffbd6abf43b00002c_005": [
        {
            "text": "Benzocaine and Lidocaine",
            "probability": 0.7121465082794775,
            "start_logit": 4.633453369140625,
            "end_logit": 4.99457311630249
        },
        {
            "text": "Benzocaine",
            "probability": 0.07542660283244092,
            "start_logit": 3.427032709121704,
            "end_logit": 3.9558701515197754
        },
        {
            "text": "",
            "probability": 0.07285581067087211,
            "start_logit": 3.372918128967285,
            "end_logit": 3.975306987762451
        },
        {
            "text": "Benzocaine or viscous Lidocaine",
            "probability": 0.07266124700234926,
            "start_logit": 3.2166075706481934,
            "end_logit": 4.12894344329834
        },
        {
            "text": "Benzocaine (Hurricaine)",
            "probability": 0.018082640680177002,
            "start_logit": 3.427032709121704,
            "end_logit": 2.527662515640259
        },
        {
            "text": "Benzocaine (Hurricaine) would work as quickly and effectively as viscous Lidocaine",
            "probability": 0.013904251010173225,
            "start_logit": 3.427032709121704,
            "end_logit": 2.264904737472534
        },
        {
            "text": "Benzocaine and Lidocaine as the topical anesthetic",
            "probability": 0.008175282961022599,
            "start_logit": 4.633453369140625,
            "end_logit": 0.52740478515625
        },
        {
            "text": "Lidocaine",
            "probability": 0.007558436065870197,
            "start_logit": 0.08783400803804398,
            "end_logit": 4.99457311630249
        },
        {
            "text": "viscous Lidocaine in this preparation. This was a prospective randomized, single-blinded comparison between Benzocaine and Lidocaine",
            "probability": 0.005406682981098897,
            "start_logit": -0.24719451367855072,
            "end_logit": 4.99457311630249
        },
        {
            "text": "Benzocaine (Hurricaine",
            "probability": 0.005312063626377993,
            "start_logit": 3.427032709121704,
            "end_logit": 1.3026905059814453
        },
        {
            "text": "Benzocaine or viscous Lidocaine in addition to 30 cc of Maalox and 10 cc of Donnatal",
            "probability": 0.0033638518707632247,
            "start_logit": 3.2166075706481934,
            "end_logit": 1.0562219619750977
        },
        {
            "text": "Benzocaine and Lidocaine as the topical anesthetic in a gastrointestinal",
            "probability": 0.0011504333856927223,
            "start_logit": 4.633453369140625,
            "end_logit": -1.4335718154907227
        },
        {
            "text": "viscous Lidocaine",
            "probability": 0.0007829325935899845,
            "start_logit": -1.3139092922210693,
            "end_logit": 4.12894344329834
        },
        {
            "text": "Patients were randomized to equivalent doses of either Benzocaine or viscous Lidocaine",
            "probability": 0.0006040410650175142,
            "start_logit": -1.5733137130737305,
            "end_logit": 4.12894344329834
        },
        {
            "text": "either Benzocaine or viscous Lidocaine",
            "probability": 0.0005758982126305919,
            "start_logit": -1.6210249662399292,
            "end_logit": 4.12894344329834
        },
        {
            "text": "viscous Lidocaine in this preparation. This was a prospective randomized, single-blinded comparison between Benzocaine",
            "probability": 0.0005368632981876843,
            "start_logit": -0.24719451367855072,
            "end_logit": 2.6849255561828613
        },
        {
            "text": "equivalent doses of either Benzocaine or viscous Lidocaine",
            "probability": 0.0005228788691414442,
            "start_logit": -1.7176060676574707,
            "end_logit": 4.12894344329834
        },
        {
            "text": "Benzocaine or viscous Lidocaine in addition to 30 cc of Maalox",
            "probability": 0.00040988237159656025,
            "start_logit": 3.2166075706481934,
            "end_logit": -1.0487498044967651
        },
        {
            "text": "Benzocaine or viscous Lidocaine in addition to 30 cc of Maalox and 10 cc of Donnatal.",
            "probability": 0.0002871612320376926,
            "start_logit": 3.2166075706481934,
            "end_logit": -1.4045761823654175
        },
        {
            "text": "Benzocaine, 38 to viscous Lidocaine",
            "probability": 0.00023653099148306916,
            "start_logit": 0.30013835430145264,
            "end_logit": 1.317928433418274
        }
    ],
    "5e2f906ffbd6abf43b00002c_006": [
        {
            "text": "antacid + Donnatal + viscous lidocaine",
            "probability": 0.2465069829173338,
            "start_logit": 2.8454904556274414,
            "end_logit": 5.477353572845459
        },
        {
            "text": "antacid + Donnatal (group 2); antacid + Donnatal + viscous lidocaine",
            "probability": 0.2186013016935973,
            "start_logit": 2.7253496646881104,
            "end_logit": 5.477353572845459
        },
        {
            "text": "antacid (group 1); antacid + Donnatal",
            "probability": 0.13480540011006045,
            "start_logit": 4.5054755210876465,
            "end_logit": 3.213810443878174
        },
        {
            "text": "Donnatal or Donnatal + lidocaine",
            "probability": 0.0959114493468378,
            "start_logit": 3.5330657958984375,
            "end_logit": 3.845813274383545
        },
        {
            "text": "antacid",
            "probability": 0.08002757380578311,
            "start_logit": 4.5054755210876465,
            "end_logit": 2.692349433898926
        },
        {
            "text": "Donnatal + viscous lidocaine",
            "probability": 0.04052711892625945,
            "start_logit": 1.0400714874267578,
            "end_logit": 5.477353572845459
        },
        {
            "text": "antacid + Donnatal",
            "probability": 0.022730471960970552,
            "start_logit": 2.7253496646881104,
            "end_logit": 3.213810443878174
        },
        {
            "text": "antacid + Donnatal + viscous lidocaine (group 3)",
            "probability": 0.02087699741564179,
            "start_logit": 2.8454904556274414,
            "end_logit": 3.0086112022399902
        },
        {
            "text": "Donnatal or Donnatal + lidocaine to an antacid",
            "probability": 0.01925151820432382,
            "start_logit": 3.5330657958984375,
            "end_logit": 2.2399778366088867
        },
        {
            "text": "antacid + Donnatal (group 2); antacid + Donnatal + viscous lidocaine (group 3)",
            "probability": 0.01851362893051842,
            "start_logit": 2.7253496646881104,
            "end_logit": 3.0086112022399902
        },
        {
            "text": "Donnatal or Donnatal + lidocaine to an antacid did not relieve dyspepsia better than plain antacid",
            "probability": 0.013708715532770097,
            "start_logit": 3.5330657958984375,
            "end_logit": 1.9004197120666504
        },
        {
            "text": "antacid (group 1); antacid + Donnatal (group 2)",
            "probability": 0.013309186166005642,
            "start_logit": 4.5054755210876465,
            "end_logit": 0.8984326720237732
        },
        {
            "text": "antacid (group 1); antacid + Donnatal (group 2); antacid + Donnatal",
            "probability": 0.012012084185045494,
            "start_logit": 4.5054755210876465,
            "end_logit": 0.7958913445472717
        },
        {
            "text": "Donnatal + lidocaine",
            "probability": 0.01019712143662169,
            "start_logit": 1.291745901107788,
            "end_logit": 3.845813274383545
        },
        {
            "text": "group 2); antacid + Donnatal + viscous lidocaine",
            "probability": 0.008851495506205067,
            "start_logit": -0.48131343722343445,
            "end_logit": 5.477353572845459
        },
        {
            "text": "Donnatal (group 2); antacid + Donnatal + viscous lidocaine",
            "probability": 0.008621432709749906,
            "start_logit": -0.5076485872268677,
            "end_logit": 5.477353572845459
        },
        {
            "text": "addition of Donnatal or Donnatal + lidocaine",
            "probability": 0.008079111131946731,
            "start_logit": 1.058922290802002,
            "end_logit": 3.845813274383545
        },
        {
            "text": "viscous lidocaine",
            "probability": 0.007591103306826286,
            "start_logit": -0.6349229216575623,
            "end_logit": 5.477353572845459
        },
        {
            "text": "group 1); antacid + Donnatal (group 2); antacid + Donnatal + viscous lidocaine",
            "probability": 0.007555192661164745,
            "start_logit": -0.6396647691726685,
            "end_logit": 5.477353572845459
        },
        {
            "text": "Donnatal",
            "probability": 0.006489622678635929,
            "start_logit": 3.5330657958984375,
            "end_logit": 1.1525923013687134
        },
        {
            "text": "",
            "probability": 0.005832491373701854,
            "start_logit": 2.1036574840545654,
            "end_logit": 2.475240468978882
        }
    ],
    "5e2f906ffbd6abf43b00002c_007": [
        {
            "text": "liquid antacid, viscous lidocaine, and an anticholinergic",
            "probability": 0.5458241098751335,
            "start_logit": 5.333949565887451,
            "end_logit": 7.773487567901611
        },
        {
            "text": "a mixture of liquid antacid, viscous lidocaine, and an anticholinergic",
            "probability": 0.17943881030750644,
            "start_logit": 4.221487045288086,
            "end_logit": 7.773487567901611
        },
        {
            "text": "antacid, viscous lidocaine, and an anticholinergic",
            "probability": 0.1403639992915555,
            "start_logit": 3.9758918285369873,
            "end_logit": 7.773487567901611
        },
        {
            "text": "mixture of liquid antacid, viscous lidocaine, and an anticholinergic",
            "probability": 0.08652883689001703,
            "start_logit": 3.4921305179595947,
            "end_logit": 7.773487567901611
        },
        {
            "text": "anticholinergic",
            "probability": 0.019752071850078552,
            "start_logit": 2.01491117477417,
            "end_logit": 7.773487567901611
        },
        {
            "text": "viscous lidocaine, and an anticholinergic",
            "probability": 0.007534954924745562,
            "start_logit": 1.0512056350708008,
            "end_logit": 7.773487567901611
        },
        {
            "text": "liquid antacid, viscous lidocaine",
            "probability": 0.006683605785343245,
            "start_logit": 5.333949565887451,
            "end_logit": 3.3708484172821045
        },
        {
            "text": "morphine or nitroglycerin",
            "probability": 0.0027222196122938243,
            "start_logit": 3.591710329055786,
            "end_logit": 4.214877605438232
        },
        {
            "text": "a mixture of liquid antacid, viscous lidocaine",
            "probability": 0.002197224800056411,
            "start_logit": 4.221487045288086,
            "end_logit": 3.3708484172821045
        },
        {
            "text": "antacid, viscous lidocaine",
            "probability": 0.0017187544865571623,
            "start_logit": 3.9758918285369873,
            "end_logit": 3.3708484172821045
        },
        {
            "text": "an anticholinergic",
            "probability": 0.0014242032936775137,
            "start_logit": -0.6147346496582031,
            "end_logit": 7.773487567901611
        },
        {
            "text": "lidocaine, and an anticholinergic",
            "probability": 0.0012468804538661867,
            "start_logit": -0.747702419757843,
            "end_logit": 7.773487567901611
        },
        {
            "text": "mixture of liquid antacid, viscous lidocaine",
            "probability": 0.0010595439526653399,
            "start_logit": 3.4921305179595947,
            "end_logit": 3.3708484172821045
        },
        {
            "text": "anticholinergic)",
            "probability": 0.0009954033005404638,
            "start_logit": -0.972954511642456,
            "end_logit": 7.773487567901611
        },
        {
            "text": "liquid antacid, viscous lidocaine, and an anticholinergic)",
            "probability": 0.0009661201457362376,
            "start_logit": 5.333949565887451,
            "end_logit": 1.4367237091064453
        },
        {
            "text": "(a mixture of liquid antacid, viscous lidocaine, and an anticholinergic",
            "probability": 0.00040665329277934573,
            "start_logit": -1.868141531944275,
            "end_logit": 7.773487567901611
        },
        {
            "text": "a mixture of liquid antacid, viscous lidocaine, and an anticholinergic)",
            "probability": 0.0003176104654019114,
            "start_logit": 4.221487045288086,
            "end_logit": 1.4367237091064453
        },
        {
            "text": "liquid antacid",
            "probability": 0.0002908636986403945,
            "start_logit": 5.333949565887451,
            "end_logit": 0.23629027605056763
        },
        {
            "text": "of liquid antacid, viscous lidocaine, and an anticholinergic",
            "probability": 0.00025961514768138024,
            "start_logit": -2.3169021606445312,
            "end_logit": 7.773487567901611
        },
        {
            "text": "antacid, viscous lidocaine, and an anticholinergic)",
            "probability": 0.00024844722869186097,
            "start_logit": 3.9758918285369873,
            "end_logit": 1.4367237091064453
        },
        {
            "text": "",
            "probability": 2.0071197032134638e-05,
            "start_logit": 0.9843781590461731,
            "end_logit": 1.912292718887329
        }
    ],
    "5e2f906ffbd6abf43b00002c_008": [
        {
            "text": "",
            "probability": 0.5697151457682753,
            "start_logit": 3.511711835861206,
            "end_logit": 4.221900939941406
        },
        {
            "text": "antacid and viscous lidocaine",
            "probability": 0.20374774772148574,
            "start_logit": 2.7127232551574707,
            "end_logit": 3.992635726928711
        },
        {
            "text": "antacid plus 15 mL of 2% viscous lidocaine",
            "probability": 0.11536487037118112,
            "start_logit": 2.1029138565063477,
            "end_logit": 4.03366231918335
        },
        {
            "text": "30 mL of antacid plus 15 mL of 2% viscous lidocaine",
            "probability": 0.030048564610017783,
            "start_logit": 0.757628858089447,
            "end_logit": 4.03366231918335
        },
        {
            "text": "a single dose of antacid and viscous lidocaine",
            "probability": 0.02611969476483162,
            "start_logit": 0.6585301756858826,
            "end_logit": 3.992635726928711
        },
        {
            "text": "2% viscous lidocaine",
            "probability": 0.019285114085590974,
            "start_logit": 0.3141474723815918,
            "end_logit": 4.03366231918335
        },
        {
            "text": "viscous lidocaine",
            "probability": 0.010512448234945118,
            "start_logit": -0.25159934163093567,
            "end_logit": 3.992635726928711
        },
        {
            "text": "single dose of antacid and viscous lidocaine",
            "probability": 0.006003667462153071,
            "start_logit": -0.8117889165878296,
            "end_logit": 3.992635726928711
        },
        {
            "text": "15 mL of 2% viscous lidocaine",
            "probability": 0.00483698757731415,
            "start_logit": -1.0688939094543457,
            "end_logit": 4.03366231918335
        },
        {
            "text": "antacid",
            "probability": 0.00463399468683603,
            "start_logit": 2.1029138565063477,
            "end_logit": 0.8189817070960999
        },
        {
            "text": "Mylanta II), or 30 mL of antacid plus 15 mL of 2% viscous lidocaine",
            "probability": 0.0031818663581625007,
            "start_logit": -1.487718105316162,
            "end_logit": 4.03366231918335
        },
        {
            "text": "We conclude that a single dose of antacid and viscous lidocaine",
            "probability": 0.0018967175108225826,
            "start_logit": -1.9640346765518188,
            "end_logit": 3.992635726928711
        },
        {
            "text": "30 mL of antacid",
            "probability": 0.001206995581079904,
            "start_logit": 0.757628858089447,
            "end_logit": 0.8189817070960999
        },
        {
            "text": "antacid and viscous lidocaine provides a significantly greater degree of immediate pain relief than antacid alone",
            "probability": 0.0009960916009910694,
            "start_logit": 2.7127232551574707,
            "end_logit": -1.3281630277633667
        },
        {
            "text": "antacid plus 15 mL of 2%",
            "probability": 0.00077671557690297,
            "start_logit": 2.1029138565063477,
            "end_logit": -0.9671186208724976
        },
        {
            "text": "a single dose of antacid",
            "probability": 0.0004776334441819148,
            "start_logit": 0.6585301756858826,
            "end_logit": -0.008965585380792618
        },
        {
            "text": "antacid in combination with viscous lidocaine",
            "probability": 0.000439468274419745,
            "start_logit": -0.40508827567100525,
            "end_logit": 0.9713748097419739
        },
        {
            "text": "antacid (Mylanta II), or 30 mL of antacid",
            "probability": 0.0003125769152240654,
            "start_logit": -0.5934101343154907,
            "end_logit": 0.8189817070960999
        },
        {
            "text": "30 mL of antacid (Mylanta II), or 30 mL of antacid",
            "probability": 0.00024139187164581892,
            "start_logit": -0.8518390655517578,
            "end_logit": 0.8189817070960999
        },
        {
            "text": "30 mL of antacid plus 15 mL of 2%",
            "probability": 0.0002023075839385367,
            "start_logit": 0.757628858089447,
            "end_logit": -0.9671186208724976
        }
    ],
    "5c7f806d617e120c34000001_001": [
        {
            "text": "",
            "probability": 0.6426435500616811,
            "start_logit": 2.6724131107330322,
            "end_logit": 3.020751953125
        },
        {
            "text": "putative antigens are of unique specificity or are shared by certain groups of (histologically related) neoplasias",
            "probability": 0.06427049729310289,
            "start_logit": 1.3239774703979492,
            "end_logit": 2.0666980743408203
        },
        {
            "text": "these putative antigens are of unique specificity or are shared by certain groups of (histologically related) neoplasias",
            "probability": 0.04707167474936675,
            "start_logit": 1.0125482082366943,
            "end_logit": 2.0666980743408203
        },
        {
            "text": "unique specificity or are shared by certain groups of (histologically related) neoplasias",
            "probability": 0.02832365571742545,
            "start_logit": 0.5045741200447083,
            "end_logit": 2.0666980743408203
        },
        {
            "text": "human tumour specific antigens that can be presented by HLA molecules have not been identified on the molecular level",
            "probability": 0.027036340665030734,
            "start_logit": 0.3865238130092621,
            "end_logit": 2.138232946395874
        },
        {
            "text": "putative antigens are of unique specificity",
            "probability": 0.02659319831738431,
            "start_logit": 1.3239774703979492,
            "end_logit": 1.1842528581619263
        },
        {
            "text": "HLA molecules have not been identified on the molecular level",
            "probability": 0.023053470730425574,
            "start_logit": 0.22715823352336884,
            "end_logit": 2.138232946395874
        },
        {
            "text": "these putative antigens are of unique specificity",
            "probability": 0.019476842944478906,
            "start_logit": 1.0125482082366943,
            "end_logit": 1.1842528581619263
        },
        {
            "text": "human tumour specific antigens that can be presented by HLA molecules",
            "probability": 0.019044611592977448,
            "start_logit": 0.3865238130092621,
            "end_logit": 1.7878352403640747
        },
        {
            "text": "HLA molecules",
            "probability": 0.016239046599190718,
            "start_logit": 0.22715823352336884,
            "end_logit": 1.7878352403640747
        },
        {
            "text": "human tumour specific antigens that can be presented by HLA molecules have not been identified",
            "probability": 0.01476685503093257,
            "start_logit": 0.3865238130092621,
            "end_logit": 1.5334361791610718
        },
        {
            "text": "HLA molecules have not been identified",
            "probability": 0.012591469550328459,
            "start_logit": 0.22715823352336884,
            "end_logit": 1.5334361791610718
        },
        {
            "text": "unique specificity",
            "probability": 0.011719476669548682,
            "start_logit": 0.5045741200447083,
            "end_logit": 1.1842528581619263
        },
        {
            "text": "have not been identified on the molecular level",
            "probability": 0.00781995227355535,
            "start_logit": -0.8539796471595764,
            "end_logit": 2.138232946395874
        },
        {
            "text": "that can be presented by HLA molecules have not been identified on the molecular level",
            "probability": 0.007531311765319856,
            "start_logit": -0.8915888667106628,
            "end_logit": 2.138232946395874
        },
        {
            "text": "whether these putative antigens are of unique specificity or are shared by certain groups of (histologically related) neoplasias",
            "probability": 0.007490646460053052,
            "start_logit": -0.825468122959137,
            "end_logit": 2.0666980743408203
        },
        {
            "text": "shared by certain groups of (histologically related) neoplasias",
            "probability": 0.006975884180539396,
            "start_logit": -0.8966641426086426,
            "end_logit": 2.0666980743408203
        },
        {
            "text": "putative antigens are of unique specificity or are shared by certain groups of (histologically related) neoplasias.",
            "probability": 0.006396985202476061,
            "start_logit": 1.3239774703979492,
            "end_logit": -0.24057580530643463
        },
        {
            "text": "not been identified on the molecular level",
            "probability": 0.00563327086458461,
            "start_logit": -1.181967854499817,
            "end_logit": 2.138232946395874
        },
        {
            "text": "tumour specific antigens that can be presented by HLA molecules have not been identified on the molecular level",
            "probability": 0.00532125933159848,
            "start_logit": -1.238948106765747,
            "end_logit": 2.138232946395874
        }
    ],
    "5c7f806d617e120c34000001_002": [
        {
            "text": "",
            "probability": 0.6426435500616811,
            "start_logit": 2.6724131107330322,
            "end_logit": 3.020751953125
        },
        {
            "text": "putative antigens are of unique specificity or are shared by certain groups of (histologically related) neoplasias",
            "probability": 0.06427049729310289,
            "start_logit": 1.3239774703979492,
            "end_logit": 2.0666980743408203
        },
        {
            "text": "these putative antigens are of unique specificity or are shared by certain groups of (histologically related) neoplasias",
            "probability": 0.04707167474936675,
            "start_logit": 1.0125482082366943,
            "end_logit": 2.0666980743408203
        },
        {
            "text": "unique specificity or are shared by certain groups of (histologically related) neoplasias",
            "probability": 0.02832365571742545,
            "start_logit": 0.5045741200447083,
            "end_logit": 2.0666980743408203
        },
        {
            "text": "human tumour specific antigens that can be presented by HLA molecules have not been identified on the molecular level",
            "probability": 0.027036340665030734,
            "start_logit": 0.3865238130092621,
            "end_logit": 2.138232946395874
        },
        {
            "text": "putative antigens are of unique specificity",
            "probability": 0.02659319831738431,
            "start_logit": 1.3239774703979492,
            "end_logit": 1.1842528581619263
        },
        {
            "text": "HLA molecules have not been identified on the molecular level",
            "probability": 0.023053470730425574,
            "start_logit": 0.22715823352336884,
            "end_logit": 2.138232946395874
        },
        {
            "text": "these putative antigens are of unique specificity",
            "probability": 0.019476842944478906,
            "start_logit": 1.0125482082366943,
            "end_logit": 1.1842528581619263
        },
        {
            "text": "human tumour specific antigens that can be presented by HLA molecules",
            "probability": 0.019044611592977448,
            "start_logit": 0.3865238130092621,
            "end_logit": 1.7878352403640747
        },
        {
            "text": "HLA molecules",
            "probability": 0.016239046599190718,
            "start_logit": 0.22715823352336884,
            "end_logit": 1.7878352403640747
        },
        {
            "text": "human tumour specific antigens that can be presented by HLA molecules have not been identified",
            "probability": 0.01476685503093257,
            "start_logit": 0.3865238130092621,
            "end_logit": 1.5334361791610718
        },
        {
            "text": "HLA molecules have not been identified",
            "probability": 0.012591469550328459,
            "start_logit": 0.22715823352336884,
            "end_logit": 1.5334361791610718
        },
        {
            "text": "unique specificity",
            "probability": 0.011719476669548682,
            "start_logit": 0.5045741200447083,
            "end_logit": 1.1842528581619263
        },
        {
            "text": "have not been identified on the molecular level",
            "probability": 0.00781995227355535,
            "start_logit": -0.8539796471595764,
            "end_logit": 2.138232946395874
        },
        {
            "text": "that can be presented by HLA molecules have not been identified on the molecular level",
            "probability": 0.007531311765319856,
            "start_logit": -0.8915888667106628,
            "end_logit": 2.138232946395874
        },
        {
            "text": "whether these putative antigens are of unique specificity or are shared by certain groups of (histologically related) neoplasias",
            "probability": 0.007490646460053052,
            "start_logit": -0.825468122959137,
            "end_logit": 2.0666980743408203
        },
        {
            "text": "shared by certain groups of (histologically related) neoplasias",
            "probability": 0.006975884180539396,
            "start_logit": -0.8966641426086426,
            "end_logit": 2.0666980743408203
        },
        {
            "text": "putative antigens are of unique specificity or are shared by certain groups of (histologically related) neoplasias.",
            "probability": 0.006396985202476061,
            "start_logit": 1.3239774703979492,
            "end_logit": -0.24057580530643463
        },
        {
            "text": "not been identified on the molecular level",
            "probability": 0.00563327086458461,
            "start_logit": -1.181967854499817,
            "end_logit": 2.138232946395874
        },
        {
            "text": "tumour specific antigens that can be presented by HLA molecules have not been identified on the molecular level",
            "probability": 0.00532125933159848,
            "start_logit": -1.238948106765747,
            "end_logit": 2.138232946395874
        }
    ],
    "5c7f806d617e120c34000001_003": [
        {
            "text": "",
            "probability": 0.993395400737027,
            "start_logit": 2.2316019535064697,
            "end_logit": 2.705173969268799
        },
        {
            "text": "CTL epitope derived from EBV linked to an endoplasmic reticulum translocation signal sequence",
            "probability": 0.00109538041067947,
            "start_logit": -1.349183440208435,
            "end_logit": -0.5240676999092102
        },
        {
            "text": "tumour-associated antigens",
            "probability": 0.000857403725964396,
            "start_logit": -1.4546681642532349,
            "end_logit": -0.6635310649871826
        },
        {
            "text": "These CTLs recognize short peptides derived from tumour-associated antigens",
            "probability": 0.000592043925775194,
            "start_logit": -1.8249962329864502,
            "end_logit": -0.6635310649871826
        },
        {
            "text": "minigene expression vector encoding a CTL epitope derived from EBV linked to an endoplasmic reticulum translocation signal sequence",
            "probability": 0.0005485986804630557,
            "start_logit": -2.04067325592041,
            "end_logit": -0.5240676999092102
        },
        {
            "text": "CTL epitope derived from EBV",
            "probability": 0.0004501896228434486,
            "start_logit": -1.349183440208435,
            "end_logit": -1.4132558107376099
        },
        {
            "text": "These minigene transfected BL cells were not only susceptible to lysis by virus-specific CTL",
            "probability": 0.0003164138153255559,
            "start_logit": -2.34356427192688,
            "end_logit": -0.7714929580688477
        },
        {
            "text": "CTL",
            "probability": 0.00030825463648612,
            "start_logit": -2.3696889877319336,
            "end_logit": -0.7714929580688477
        },
        {
            "text": "minigene transfected BL cells were not only susceptible to lysis by virus-specific CTL",
            "probability": 0.0002691438471862495,
            "start_logit": -2.505369186401367,
            "end_logit": -0.7714929580688477
        },
        {
            "text": "tumour-associated antigens in conjunction with class I molecules expressed on tumour cells",
            "probability": 0.00025307103351485577,
            "start_logit": -1.4546681642532349,
            "end_logit": -1.8837697505950928
        },
        {
            "text": "tumour-associated antigens in conjunction with class I molecules",
            "probability": 0.00024852957344465015,
            "start_logit": -1.4546681642532349,
            "end_logit": -1.9018781185150146
        },
        {
            "text": "EBV linked to an endoplasmic reticulum translocation signal sequence",
            "probability": 0.00022600639781493952,
            "start_logit": -2.9274771213531494,
            "end_logit": -0.5240676999092102
        },
        {
            "text": "minigene expression vector encoding a CTL epitope derived from EBV",
            "probability": 0.00022546818497226704,
            "start_logit": -2.04067325592041,
            "end_logit": -1.4132558107376099
        },
        {
            "text": "a CTL epitope derived from EBV linked to an endoplasmic reticulum translocation signal sequence",
            "probability": 0.0002134050852531059,
            "start_logit": -2.9848482608795166,
            "end_logit": -0.5240676999092102
        },
        {
            "text": "short peptides derived from tumour-associated antigens",
            "probability": 0.00020920089394611311,
            "start_logit": -2.8652820587158203,
            "end_logit": -0.6635310649871826
        },
        {
            "text": "These CTLs recognize short peptides derived from tumour-associated antigens in conjunction with class I molecules expressed on tumour cells",
            "probability": 0.00017474751233859532,
            "start_logit": -1.8249962329864502,
            "end_logit": -1.8837697505950928
        },
        {
            "text": "These CTLs recognize short peptides derived from tumour-associated antigens in conjunction with class I molecules",
            "probability": 0.00017161159892080423,
            "start_logit": -1.8249962329864502,
            "end_logit": -1.9018781185150146
        },
        {
            "text": "endoplasmic reticulum translocation signal sequence",
            "probability": 0.00016351080801856366,
            "start_logit": -3.2511613368988037,
            "end_logit": -0.5240676999092102
        },
        {
            "text": "derived from tumour-associated antigens",
            "probability": 0.00015952926516024518,
            "start_logit": -3.136349678039551,
            "end_logit": -0.6635310649871826
        },
        {
            "text": "CTL response",
            "probability": 0.00012209024486508144,
            "start_logit": -2.324596881866455,
            "end_logit": -1.7427507638931274
        }
    ],
    "5c7f806d617e120c34000001_004": [
        {
            "text": "MART-1 and gp100",
            "probability": 0.2870313201349994,
            "start_logit": 1.6142768859863281,
            "end_logit": 1.8608144521713257
        },
        {
            "text": "",
            "probability": 0.20546609777549826,
            "start_logit": 1.3096882104873657,
            "end_logit": 1.8310928344726562
        },
        {
            "text": "MART-1 and gp100, that could be recognised by autologous TIL",
            "probability": 0.17279436640200166,
            "start_logit": 1.6142768859863281,
            "end_logit": 1.353325366973877
        },
        {
            "text": "MART-1 and gp100, that could be recognised by autologous TIL.",
            "probability": 0.10093459863877959,
            "start_logit": 1.6142768859863281,
            "end_logit": 0.8156958818435669
        },
        {
            "text": "tumour specific antigens, such as MART-1 and gp100, that could be recognised by autologous TIL",
            "probability": 0.036567068659274955,
            "start_logit": 0.17239464819431305,
            "end_logit": 1.2422534227371216
        },
        {
            "text": "MART-1 and gp100,",
            "probability": 0.034084431059814235,
            "start_logit": 1.6142768859863281,
            "end_logit": -0.2699361741542816
        },
        {
            "text": "The focus on cellular immune responses",
            "probability": 0.024184307085077888,
            "start_logit": 0.2310379147529602,
            "end_logit": 0.7701660394668579
        },
        {
            "text": "identification of tumour specific antigens, such as MART-1 and gp100, that could be recognised by autologous TIL",
            "probability": 0.023803714486587874,
            "start_logit": -0.2569117844104767,
            "end_logit": 1.2422534227371216
        },
        {
            "text": "tumour specific antigens, such as MART-1 and gp100, that could be recognised by autologous TIL.",
            "probability": 0.01675094425877007,
            "start_logit": 0.17239464819431305,
            "end_logit": 0.4615599811077118
        },
        {
            "text": "the identification of tumour specific antigens, such as MART-1 and gp100, that could be recognised by autologous TIL",
            "probability": 0.01471656349244871,
            "start_logit": -0.7377797961235046,
            "end_logit": 1.2422534227371216
        },
        {
            "text": "tumour specific antigens, such as MART-1 and gp100",
            "probability": 0.013175639596605648,
            "start_logit": 0.17239464819431305,
            "end_logit": 0.22147499024868011
        },
        {
            "text": "identification of tumour specific antigens, such as MART-1 and gp100, that could be recognised by autologous TIL.",
            "probability": 0.010904201762297267,
            "start_logit": -0.2569117844104767,
            "end_logit": 0.4615599811077118
        },
        {
            "text": "cellular immune responses",
            "probability": 0.009007232549462743,
            "start_logit": -0.7566381692886353,
            "end_logit": 0.7701660394668579
        },
        {
            "text": "autologous TIL",
            "probability": 0.008600897663016164,
            "start_logit": -1.3859587907791138,
            "end_logit": 1.353325366973877
        },
        {
            "text": "identification of tumour specific antigens, such as MART-1 and gp100",
            "probability": 0.008576819926642741,
            "start_logit": -0.2569117844104767,
            "end_logit": 0.22147499024868011
        },
        {
            "text": "focus on cellular immune responses",
            "probability": 0.007144781481542796,
            "start_logit": -0.9882838129997253,
            "end_logit": 0.7701660394668579
        },
        {
            "text": "The focus on cellular immune responses, combined with rapid biotechnological advances, resulted in the identification of tumour specific antigens",
            "probability": 0.006816491077251136,
            "start_logit": 0.2310379147529602,
            "end_logit": -0.4961930811405182
        },
        {
            "text": "the identification of tumour specific antigens, such as MART-1 and gp100, that could be recognised by autologous TIL.",
            "probability": 0.006741484723308058,
            "start_logit": -0.7377797961235046,
            "end_logit": 0.4615599811077118
        },
        {
            "text": "tumour specific antigens",
            "probability": 0.006428245041422529,
            "start_logit": 0.17239464819431305,
            "end_logit": -0.4961930811405182
        },
        {
            "text": "The focus on cellular immune responses, combined with rapid biotechnological advances",
            "probability": 0.006270794185198349,
            "start_logit": 0.2310379147529602,
            "end_logit": -0.5796349048614502
        }
    ],
    "5c7f806d617e120c34000001_005": [
        {
            "text": "point mutations",
            "probability": 0.3277834142737103,
            "start_logit": 4.940664768218994,
            "end_logit": 6.387751579284668
        },
        {
            "text": "mostly arise by point mutations",
            "probability": 0.32227841411903857,
            "start_logit": 4.923727512359619,
            "end_logit": 6.387751579284668
        },
        {
            "text": "Tumour-specific antigens, which could be a more potent target for immunotherapy, mostly arise by point mutations",
            "probability": 0.15435196884722405,
            "start_logit": 4.187547206878662,
            "end_logit": 6.387751579284668
        },
        {
            "text": "arise by point mutations",
            "probability": 0.08742541320880529,
            "start_logit": 3.6190977096557617,
            "end_logit": 6.387751579284668
        },
        {
            "text": "by point mutations",
            "probability": 0.0826003777827358,
            "start_logit": 3.562325954437256,
            "end_logit": 6.387751579284668
        },
        {
            "text": "point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific",
            "probability": 0.005174862711037907,
            "start_logit": 4.940664768218994,
            "end_logit": 2.239211320877075
        },
        {
            "text": "mostly arise by point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific",
            "probability": 0.005087952822422002,
            "start_logit": 4.923727512359619,
            "end_logit": 2.239211320877075
        },
        {
            "text": "antigens, which could be a more potent target for immunotherapy, mostly arise by point mutations",
            "probability": 0.003927813754390531,
            "start_logit": 0.5163946747779846,
            "end_logit": 6.387751579284668
        },
        {
            "text": "point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific.",
            "probability": 0.0014985060271688728,
            "start_logit": 4.940664768218994,
            "end_logit": 0.9998671412467957
        },
        {
            "text": "mostly arise by point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific.",
            "probability": 0.0014733391774988866,
            "start_logit": 4.923727512359619,
            "end_logit": 0.9998671412467957
        },
        {
            "text": "arise by point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific",
            "probability": 0.001380223925648495,
            "start_logit": 3.6190977096557617,
            "end_logit": 2.239211320877075
        },
        {
            "text": "by point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific",
            "probability": 0.0013040489429663202,
            "start_logit": 3.562325954437256,
            "end_logit": 2.239211320877075
        },
        {
            "text": "Tumour-specific antigens",
            "probability": 0.0011841562099661985,
            "start_logit": 4.187547206878662,
            "end_logit": 1.517546534538269
        },
        {
            "text": "specific antigens, which could be a more potent target for immunotherapy, mostly arise by point mutations",
            "probability": 0.001170756669961062,
            "start_logit": -0.6940380334854126,
            "end_logit": 6.387751579284668
        },
        {
            "text": "which could be a more potent target for immunotherapy, mostly arise by point mutations",
            "probability": 0.0010446085864183824,
            "start_logit": -0.8080460429191589,
            "end_logit": 6.387751579284668
        },
        {
            "text": "Tumour-specific antigens, which could be a more potent target for immunotherapy,",
            "probability": 0.0005951963415436898,
            "start_logit": 4.187547206878662,
            "end_logit": 0.8296521306037903
        },
        {
            "text": "Tumour-specific antigens, which could be a more potent target for immunotherapy",
            "probability": 0.0004132635599455807,
            "start_logit": 4.187547206878662,
            "end_logit": 0.46484634280204773
        },
        {
            "text": "arise by point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific.",
            "probability": 0.00039967705172455175,
            "start_logit": 3.6190977096557617,
            "end_logit": 0.9998671412467957
        },
        {
            "text": "by point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific.",
            "probability": 0.0003776187523951327,
            "start_logit": 3.562325954437256,
            "end_logit": 0.9998671412467957
        },
        {
            "text": "point mutations and have the disadvantage of being not only tumour-specific",
            "probability": 0.0003103256588961756,
            "start_logit": 4.940664768218994,
            "end_logit": -0.5747345089912415
        },
        {
            "text": "",
            "probability": 0.00021806157650187374,
            "start_logit": 1.7887924909591675,
            "end_logit": 2.2242929935455322
        }
    ],
    "5c7f806d617e120c34000001_006": [
        {
            "text": "point mutations",
            "probability": 0.3277834142737103,
            "start_logit": 4.940664768218994,
            "end_logit": 6.387751579284668
        },
        {
            "text": "mostly arise by point mutations",
            "probability": 0.32227841411903857,
            "start_logit": 4.923727512359619,
            "end_logit": 6.387751579284668
        },
        {
            "text": "Tumour-specific antigens, which could be a more potent target for immunotherapy, mostly arise by point mutations",
            "probability": 0.15435196884722405,
            "start_logit": 4.187547206878662,
            "end_logit": 6.387751579284668
        },
        {
            "text": "arise by point mutations",
            "probability": 0.08742541320880529,
            "start_logit": 3.6190977096557617,
            "end_logit": 6.387751579284668
        },
        {
            "text": "by point mutations",
            "probability": 0.0826003777827358,
            "start_logit": 3.562325954437256,
            "end_logit": 6.387751579284668
        },
        {
            "text": "point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific",
            "probability": 0.005174862711037907,
            "start_logit": 4.940664768218994,
            "end_logit": 2.239211320877075
        },
        {
            "text": "mostly arise by point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific",
            "probability": 0.005087952822422002,
            "start_logit": 4.923727512359619,
            "end_logit": 2.239211320877075
        },
        {
            "text": "antigens, which could be a more potent target for immunotherapy, mostly arise by point mutations",
            "probability": 0.003927813754390531,
            "start_logit": 0.5163946747779846,
            "end_logit": 6.387751579284668
        },
        {
            "text": "point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific.",
            "probability": 0.0014985060271688728,
            "start_logit": 4.940664768218994,
            "end_logit": 0.9998671412467957
        },
        {
            "text": "mostly arise by point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific.",
            "probability": 0.0014733391774988866,
            "start_logit": 4.923727512359619,
            "end_logit": 0.9998671412467957
        },
        {
            "text": "arise by point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific",
            "probability": 0.001380223925648495,
            "start_logit": 3.6190977096557617,
            "end_logit": 2.239211320877075
        },
        {
            "text": "by point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific",
            "probability": 0.0013040489429663202,
            "start_logit": 3.562325954437256,
            "end_logit": 2.239211320877075
        },
        {
            "text": "Tumour-specific antigens",
            "probability": 0.0011841562099661985,
            "start_logit": 4.187547206878662,
            "end_logit": 1.517546534538269
        },
        {
            "text": "specific antigens, which could be a more potent target for immunotherapy, mostly arise by point mutations",
            "probability": 0.001170756669961062,
            "start_logit": -0.6940380334854126,
            "end_logit": 6.387751579284668
        },
        {
            "text": "which could be a more potent target for immunotherapy, mostly arise by point mutations",
            "probability": 0.0010446085864183824,
            "start_logit": -0.8080460429191589,
            "end_logit": 6.387751579284668
        },
        {
            "text": "Tumour-specific antigens, which could be a more potent target for immunotherapy,",
            "probability": 0.0005951963415436898,
            "start_logit": 4.187547206878662,
            "end_logit": 0.8296521306037903
        },
        {
            "text": "Tumour-specific antigens, which could be a more potent target for immunotherapy",
            "probability": 0.0004132635599455807,
            "start_logit": 4.187547206878662,
            "end_logit": 0.46484634280204773
        },
        {
            "text": "arise by point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific.",
            "probability": 0.00039967705172455175,
            "start_logit": 3.6190977096557617,
            "end_logit": 0.9998671412467957
        },
        {
            "text": "by point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific.",
            "probability": 0.0003776187523951327,
            "start_logit": 3.562325954437256,
            "end_logit": 0.9998671412467957
        },
        {
            "text": "point mutations and have the disadvantage of being not only tumour-specific",
            "probability": 0.0003103256588961756,
            "start_logit": 4.940664768218994,
            "end_logit": -0.5747345089912415
        },
        {
            "text": "",
            "probability": 0.00021806157650187374,
            "start_logit": 1.7887924909591675,
            "end_logit": 2.2242929935455322
        }
    ],
    "5c7f806d617e120c34000001_007": [
        {
            "text": "unique sets of antigens",
            "probability": 0.2916912003633522,
            "start_logit": 2.7352709770202637,
            "end_logit": 2.545043468475342
        },
        {
            "text": "unique sets of antigens, which are known as tumour-specific antigens",
            "probability": 0.17992583724240277,
            "start_logit": 2.7352709770202637,
            "end_logit": 2.061892509460449
        },
        {
            "text": "unique sets",
            "probability": 0.1452009248122232,
            "start_logit": 2.7352709770202637,
            "end_logit": 1.847466230392456
        },
        {
            "text": "tumours express unique sets of antigens",
            "probability": 0.08440981277991387,
            "start_logit": 1.4952589273452759,
            "end_logit": 2.545043468475342
        },
        {
            "text": "tumours express unique sets of antigens, which are known as tumour-specific antigens",
            "probability": 0.052067070302366986,
            "start_logit": 1.4952589273452759,
            "end_logit": 2.061892509460449
        },
        {
            "text": "tumours express unique sets",
            "probability": 0.04201834976030353,
            "start_logit": 1.4952589273452759,
            "end_logit": 1.847466230392456
        },
        {
            "text": "two, tumours express unique sets of antigens",
            "probability": 0.0386925690816208,
            "start_logit": 0.7152228355407715,
            "end_logit": 2.545043468475342
        },
        {
            "text": "tumour-specific antigens",
            "probability": 0.02526036873349232,
            "start_logit": 0.7719629406929016,
            "end_logit": 2.061892509460449
        },
        {
            "text": "two, tumours express unique sets of antigens, which are known as tumour-specific antigens",
            "probability": 0.023866996599136363,
            "start_logit": 0.7152228355407715,
            "end_logit": 2.061892509460449
        },
        {
            "text": "two, tumours express unique sets",
            "probability": 0.019260768946796236,
            "start_logit": 0.7152228355407715,
            "end_logit": 1.847466230392456
        },
        {
            "text": "sets of antigens",
            "probability": 0.016142609581751944,
            "start_logit": -0.1589623987674713,
            "end_logit": 2.545043468475342
        },
        {
            "text": "unique sets of antigens, which are known as tumour-specific antigens.",
            "probability": 0.01284385437215418,
            "start_logit": 2.7352709770202637,
            "end_logit": -0.5777868032455444
        },
        {
            "text": "a population of bound peptides",
            "probability": 0.010057335719070594,
            "start_logit": -0.09816734492778778,
            "end_logit": 2.0110883712768555
        },
        {
            "text": "sets of antigens, which are known as tumour-specific antigens",
            "probability": 0.009957354012242826,
            "start_logit": -0.1589623987674713,
            "end_logit": 2.061892509460449
        },
        {
            "text": "in a population of bound peptides",
            "probability": 0.008266136517823345,
            "start_logit": -0.29430240392684937,
            "end_logit": 2.0110883712768555
        },
        {
            "text": "sets",
            "probability": 0.008035627530872629,
            "start_logit": -0.1589623987674713,
            "end_logit": 1.847466230392456
        },
        {
            "text": "bound peptides",
            "probability": 0.007959450822729811,
            "start_logit": -0.33210963010787964,
            "end_logit": 2.0110883712768555
        },
        {
            "text": "antigens",
            "probability": 0.007694190670120566,
            "start_logit": -0.899959146976471,
            "end_logit": 2.545043468475342
        },
        {
            "text": "unique sets of antigens,",
            "probability": 0.007246066633799046,
            "start_logit": 2.7352709770202637,
            "end_logit": -1.150193452835083
        },
        {
            "text": "express unique sets of antigens",
            "probability": 0.006800338910444272,
            "start_logit": -1.0234522819519043,
            "end_logit": 2.545043468475342
        },
        {
            "text": "",
            "probability": 0.002603136607382652,
            "start_logit": -0.022292813286185265,
            "end_logit": 0.5836286544799805
        }
    ],
    "5c7f806d617e120c34000001_008": [
        {
            "text": "",
            "probability": 0.9865333059043362,
            "start_logit": 2.2603085041046143,
            "end_logit": 2.5278384685516357
        },
        {
            "text": "Fifth",
            "probability": 0.002533825860408957,
            "start_logit": -0.07552234083414078,
            "end_logit": -1.100797414779663
        },
        {
            "text": "Fifth, secretion of TSA by at least some cancer cells within a tumour favours antitumour immunity",
            "probability": 0.001518181254081087,
            "start_logit": -0.07552234083414078,
            "end_logit": -1.6130146980285645
        },
        {
            "text": "These professional antigen-presenting cells endocytose and process TSA to display antigenic peptides on their MHC class II molecules",
            "probability": 0.001379176034895836,
            "start_logit": -1.3549227714538574,
            "end_logit": -0.42964109778404236
        },
        {
            "text": "MHC class II molecules",
            "probability": 0.001225338240261212,
            "start_logit": -1.4731920957565308,
            "end_logit": -0.42964109778404236
        },
        {
            "text": "endocytose and process TSA to display antigenic peptides on their MHC class II molecules",
            "probability": 0.0009455166076345307,
            "start_logit": -1.7324328422546387,
            "end_logit": -0.42964109778404236
        },
        {
            "text": "antigenic peptides on their MHC class II molecules",
            "probability": 0.0008123812923670864,
            "start_logit": -1.8841944932937622,
            "end_logit": -0.42964109778404236
        },
        {
            "text": "Third, TSA concentration within the tumour extracellular matrix must reach a certain threshold to allow successful cancer immunosurveillance.",
            "probability": 0.0005390293438110123,
            "start_logit": -1.3190088272094727,
            "end_logit": -1.4050265550613403
        },
        {
            "text": "professional antigen-presenting cells endocytose and process TSA to display antigenic peptides on their MHC class II molecules",
            "probability": 0.0005329453744143692,
            "start_logit": -2.3057453632354736,
            "end_logit": -0.42964109778404236
        },
        {
            "text": "These professional antigen-presenting cells endocytose and process TSA",
            "probability": 0.00048779106541160805,
            "start_logit": -1.3549227714538574,
            "end_logit": -1.468995451927185
        },
        {
            "text": "Fourth, treatment by local injection of purified TSA enhances immunity against cancer cells that do not secrete TSA. Fifth",
            "probability": 0.00048503383364506796,
            "start_logit": -1.7287893295288086,
            "end_logit": -1.100797414779663
        },
        {
            "text": "process TSA to display antigenic peptides on their MHC class II molecules",
            "probability": 0.0004560301768747414,
            "start_logit": -2.4616053104400635,
            "end_logit": -0.42964109778404236
        },
        {
            "text": "These professional antigen-presenting cells endocytose and process TSA to display antigenic peptides",
            "probability": 0.000429550168472028,
            "start_logit": -1.3549227714538574,
            "end_logit": -1.5961440801620483
        },
        {
            "text": "peptides on their MHC class II molecules",
            "probability": 0.0003627652987704385,
            "start_logit": -2.690408229827881,
            "end_logit": -0.42964109778404236
        },
        {
            "text": "endocytose and process TSA",
            "probability": 0.00033441311459363546,
            "start_logit": -1.7324328422546387,
            "end_logit": -1.468995451927185
        },
        {
            "text": "TSA to display antigenic peptides on their MHC class II molecules",
            "probability": 0.00031544538394809535,
            "start_logit": -2.830178737640381,
            "end_logit": -0.42964109778404236
        },
        {
            "text": "endocytose and process TSA to display antigenic peptides",
            "probability": 0.0002944851185245455,
            "start_logit": -1.7324328422546387,
            "end_logit": -1.5961440801620483
        },
        {
            "text": "secreted TSA",
            "probability": 0.0002854711952079749,
            "start_logit": -2.396437168121338,
            "end_logit": -0.9632270932197571
        },
        {
            "text": "Fourth, treatment by local injection of purified TSA enhances immunity against cancer cells that do not secrete TSA.",
            "probability": 0.00027629516691186006,
            "start_logit": -1.7287893295288086,
            "end_logit": -1.6635463237762451
        },
        {
            "text": "antigenic peptides",
            "probability": 0.0002530195654292683,
            "start_logit": -1.8841944932937622,
            "end_logit": -1.5961440801620483
        }
    ],
    "5c7f806d617e120c34000001_009": [
        {
            "text": "shared and general tumour-specific antigens",
            "probability": 0.24126729753789425,
            "start_logit": 2.984778642654419,
            "end_logit": 3.434919595718384
        },
        {
            "text": "FSPs",
            "probability": 0.21051616319908822,
            "start_logit": 2.7985594272613525,
            "end_logit": 3.4847958087921143
        },
        {
            "text": "FSPs as shared and general tumour-specific antigens",
            "probability": 0.20027395853134955,
            "start_logit": 2.7985594272613525,
            "end_logit": 3.434919595718384
        },
        {
            "text": "shared",
            "probability": 0.08180039901056578,
            "start_logit": 2.984778642654419,
            "end_logit": 2.3532962799072266
        },
        {
            "text": "FSPs as shared",
            "probability": 0.06790182460064571,
            "start_logit": 2.7985594272613525,
            "end_logit": 2.3532962799072266
        },
        {
            "text": "",
            "probability": 0.04120200063659412,
            "start_logit": 2.01827073097229,
            "end_logit": 2.6340088844299316
        },
        {
            "text": "frame-shifted peptide (FSP) sequences",
            "probability": 0.02316368850811361,
            "start_logit": 1.9725066423416138,
            "end_logit": 2.103872060775757
        },
        {
            "text": "shared and general tumour-specific antigens.",
            "probability": 0.01680125623241627,
            "start_logit": 2.984778642654419,
            "end_logit": 0.7704678177833557
        },
        {
            "text": "tumour-specific antigens",
            "probability": 0.016611694936326863,
            "start_logit": 0.30898016691207886,
            "end_logit": 3.434919595718384
        },
        {
            "text": "shared and general",
            "probability": 0.014024864596746262,
            "start_logit": 2.984778642654419,
            "end_logit": 0.5898459553718567
        },
        {
            "text": "FSPs as shared and general tumour-specific antigens.",
            "probability": 0.01394658177176714,
            "start_logit": 2.7985594272613525,
            "end_logit": 0.7704678177833557
        },
        {
            "text": "general tumour-specific antigens",
            "probability": 0.011849694395353102,
            "start_logit": -0.028824716806411743,
            "end_logit": 3.434919595718384
        },
        {
            "text": "FSPs as shared and general",
            "probability": 0.011641922379535881,
            "start_logit": 2.7985594272613525,
            "end_logit": 0.5898459553718567
        },
        {
            "text": "importance of FSPs",
            "probability": 0.008010638424822233,
            "start_logit": -0.4702325463294983,
            "end_logit": 3.4847958087921143
        },
        {
            "text": "importance of FSPs as shared and general tumour-specific antigens",
            "probability": 0.007620898287915557,
            "start_logit": -0.4702325463294983,
            "end_logit": 3.434919595718384
        },
        {
            "text": "frame-shifted peptide",
            "probability": 0.007015302678618411,
            "start_logit": 1.9725066423416138,
            "end_logit": 0.9093800187110901
        },
        {
            "text": "Data presented here expand the importance of FSPs",
            "probability": 0.0069754774845211896,
            "start_logit": -0.6086022257804871,
            "end_logit": 3.4847958087921143
        },
        {
            "text": "shared and general tumour-specific",
            "probability": 0.00696152908401799,
            "start_logit": 2.984778642654419,
            "end_logit": -0.11058669537305832
        },
        {
            "text": "Data presented here expand the importance of FSPs as shared and general tumour-specific antigens",
            "probability": 0.0066361008449037215,
            "start_logit": -0.6086022257804871,
            "end_logit": 3.434919595718384
        },
        {
            "text": "FSPs as shared and general tumour-specific",
            "probability": 0.005778706858804281,
            "start_logit": 2.7985594272613525,
            "end_logit": -0.11058669537305832
        }
    ],
    "5c7f806d617e120c34000001_010": [
        {
            "text": "shared and general tumour-specific antigens",
            "probability": 0.24126729753789425,
            "start_logit": 2.984778642654419,
            "end_logit": 3.434919595718384
        },
        {
            "text": "FSPs",
            "probability": 0.21051616319908822,
            "start_logit": 2.7985594272613525,
            "end_logit": 3.4847958087921143
        },
        {
            "text": "FSPs as shared and general tumour-specific antigens",
            "probability": 0.20027395853134955,
            "start_logit": 2.7985594272613525,
            "end_logit": 3.434919595718384
        },
        {
            "text": "shared",
            "probability": 0.08180039901056578,
            "start_logit": 2.984778642654419,
            "end_logit": 2.3532962799072266
        },
        {
            "text": "FSPs as shared",
            "probability": 0.06790182460064571,
            "start_logit": 2.7985594272613525,
            "end_logit": 2.3532962799072266
        },
        {
            "text": "",
            "probability": 0.04120200063659412,
            "start_logit": 2.01827073097229,
            "end_logit": 2.6340088844299316
        },
        {
            "text": "frame-shifted peptide (FSP) sequences",
            "probability": 0.02316368850811361,
            "start_logit": 1.9725066423416138,
            "end_logit": 2.103872060775757
        },
        {
            "text": "shared and general tumour-specific antigens.",
            "probability": 0.01680125623241627,
            "start_logit": 2.984778642654419,
            "end_logit": 0.7704678177833557
        },
        {
            "text": "tumour-specific antigens",
            "probability": 0.016611694936326863,
            "start_logit": 0.30898016691207886,
            "end_logit": 3.434919595718384
        },
        {
            "text": "shared and general",
            "probability": 0.014024864596746262,
            "start_logit": 2.984778642654419,
            "end_logit": 0.5898459553718567
        },
        {
            "text": "FSPs as shared and general tumour-specific antigens.",
            "probability": 0.01394658177176714,
            "start_logit": 2.7985594272613525,
            "end_logit": 0.7704678177833557
        },
        {
            "text": "general tumour-specific antigens",
            "probability": 0.011849694395353102,
            "start_logit": -0.028824716806411743,
            "end_logit": 3.434919595718384
        },
        {
            "text": "FSPs as shared and general",
            "probability": 0.011641922379535881,
            "start_logit": 2.7985594272613525,
            "end_logit": 0.5898459553718567
        },
        {
            "text": "importance of FSPs",
            "probability": 0.008010638424822233,
            "start_logit": -0.4702325463294983,
            "end_logit": 3.4847958087921143
        },
        {
            "text": "importance of FSPs as shared and general tumour-specific antigens",
            "probability": 0.007620898287915557,
            "start_logit": -0.4702325463294983,
            "end_logit": 3.434919595718384
        },
        {
            "text": "frame-shifted peptide",
            "probability": 0.007015302678618411,
            "start_logit": 1.9725066423416138,
            "end_logit": 0.9093800187110901
        },
        {
            "text": "Data presented here expand the importance of FSPs",
            "probability": 0.0069754774845211896,
            "start_logit": -0.6086022257804871,
            "end_logit": 3.4847958087921143
        },
        {
            "text": "shared and general tumour-specific",
            "probability": 0.00696152908401799,
            "start_logit": 2.984778642654419,
            "end_logit": -0.11058669537305832
        },
        {
            "text": "Data presented here expand the importance of FSPs as shared and general tumour-specific antigens",
            "probability": 0.0066361008449037215,
            "start_logit": -0.6086022257804871,
            "end_logit": 3.434919595718384
        },
        {
            "text": "FSPs as shared and general tumour-specific",
            "probability": 0.005778706858804281,
            "start_logit": 2.7985594272613525,
            "end_logit": -0.11058669537305832
        }
    ],
    "5e35cb27158f994d3a000002_001": [
        {
            "text": "regulatory variants",
            "probability": 0.5362263837153133,
            "start_logit": 3.067385196685791,
            "end_logit": 4.390128135681152
        },
        {
            "text": "110 regulatory variants",
            "probability": 0.1731595785045832,
            "start_logit": 1.9370423555374146,
            "end_logit": 4.390128135681152
        },
        {
            "text": "regulatory variants associated with promoter usage",
            "probability": 0.04967437700995862,
            "start_logit": 3.067385196685791,
            "end_logit": 2.011060953140259
        },
        {
            "text": "5376 and 110 regulatory variants",
            "probability": 0.04517673318102849,
            "start_logit": 0.5934109687805176,
            "end_logit": 4.390128135681152
        },
        {
            "text": "regulatory variants associated with promoter usage (puQTLs) and enhancer activity (eaQTLs)",
            "probability": 0.031998937325076846,
            "start_logit": 3.067385196685791,
            "end_logit": 1.5712743997573853
        },
        {
            "text": "regulatory variants associated with promoter usage (puQTLs) and enhancer activity",
            "probability": 0.029121693183735777,
            "start_logit": 3.067385196685791,
            "end_logit": 1.4770550727844238
        },
        {
            "text": "promoter usage",
            "probability": 0.02256914316055663,
            "start_logit": 2.27847957611084,
            "end_logit": 2.011060953140259
        },
        {
            "text": "110 regulatory variants associated with promoter usage",
            "probability": 0.016040975317038568,
            "start_logit": 1.9370423555374146,
            "end_logit": 2.011060953140259
        },
        {
            "text": "promoter usage (puQTLs) and enhancer activity (eaQTLs)",
            "probability": 0.014538453040499236,
            "start_logit": 2.27847957611084,
            "end_logit": 1.5712743997573853
        },
        {
            "text": "promoter usage (puQTLs) and enhancer activity",
            "probability": 0.013231200914905775,
            "start_logit": 2.27847957611084,
            "end_logit": 1.4770550727844238
        },
        {
            "text": "110",
            "probability": 0.011436799286907783,
            "start_logit": 1.9370423555374146,
            "end_logit": 1.67275071144104
        },
        {
            "text": "110 regulatory variants associated with promoter usage (puQTLs) and enhancer activity (eaQTLs)",
            "probability": 0.010333177680318318,
            "start_logit": 1.9370423555374146,
            "end_logit": 1.5712743997573853
        },
        {
            "text": "110 regulatory variants associated with promoter usage (puQTLs) and enhancer activity",
            "probability": 0.009404050733379596,
            "start_logit": 1.9370423555374146,
            "end_logit": 1.4770550727844238
        },
        {
            "text": "regulatory variants associated with promoter usage (puQTLs",
            "probability": 0.007246512772066234,
            "start_logit": 3.067385196685791,
            "end_logit": 0.08609206229448318
        },
        {
            "text": "regulatory variants associated with promoter usage (puQTLs) and enhancer activity (eaQTLs",
            "probability": 0.00612634283737821,
            "start_logit": 3.067385196685791,
            "end_logit": -0.08183032274246216
        },
        {
            "text": "variants",
            "probability": 0.005696298552592056,
            "start_logit": -1.477354645729065,
            "end_logit": 4.390128135681152
        },
        {
            "text": "",
            "probability": 0.00565529090620539,
            "start_logit": 1.2221170663833618,
            "end_logit": 1.6834313869476318
        },
        {
            "text": "map 5376 and 110 regulatory variants",
            "probability": 0.004886623817108799,
            "start_logit": -1.6306695938110352,
            "end_logit": 4.390128135681152
        },
        {
            "text": "5376 and 110 regulatory variants associated with promoter usage",
            "probability": 0.004185034799227896,
            "start_logit": 0.5934109687805176,
            "end_logit": 2.011060953140259
        },
        {
            "text": "promoter usage (puQTLs",
            "probability": 0.003292393262119366,
            "start_logit": 2.27847957611084,
            "end_logit": 0.08609206229448318
        }
    ],
    "5e48f90bf8b2df0d49000006_001": [
        {
            "text": "wide range of products",
            "probability": 0.8935698758691568,
            "start_logit": 6.59986686706543,
            "end_logit": 7.809351444244385
        },
        {
            "text": "for wide range of products",
            "probability": 0.044629614864213206,
            "start_logit": 3.6030399799346924,
            "end_logit": 7.809351444244385
        },
        {
            "text": "commonly employed for wide range of products",
            "probability": 0.012073076275164235,
            "start_logit": 2.2956202030181885,
            "end_logit": 7.809351444244385
        },
        {
            "text": "industrial manufacturing, research and development studies. Gamma (\u03b3)-sterilization has been commonly employed for wide range of products",
            "probability": 0.011105781231127885,
            "start_logit": 2.2121081352233887,
            "end_logit": 7.809351444244385
        },
        {
            "text": "wide range of products as indicated by the pharmacopoeias",
            "probability": 0.00887066369171828,
            "start_logit": 6.59986686706543,
            "end_logit": 3.1968765258789062
        },
        {
            "text": "wide range of products as indicated by the pharmacopoeias.",
            "probability": 0.006479392154032543,
            "start_logit": 6.59986686706543,
            "end_logit": 2.882753610610962
        },
        {
            "text": "employed for wide range of products",
            "probability": 0.005175958193270585,
            "start_logit": 1.4486668109893799,
            "end_logit": 7.809351444244385
        },
        {
            "text": "has been commonly employed for wide range of products",
            "probability": 0.004910556427306896,
            "start_logit": 1.3960295915603638,
            "end_logit": 7.809351444244385
        },
        {
            "text": "Gamma (\u03b3)-sterilization has been commonly employed for wide range of products",
            "probability": 0.004201657262355833,
            "start_logit": 1.2401213645935059,
            "end_logit": 7.809351444244385
        },
        {
            "text": "been commonly employed for wide range of products",
            "probability": 0.0024026203675980764,
            "start_logit": 0.6812022924423218,
            "end_logit": 7.809351444244385
        },
        {
            "text": "products",
            "probability": 0.002025787057894769,
            "start_logit": 0.5106006264686584,
            "end_logit": 7.809351444244385
        },
        {
            "text": "wide range of",
            "probability": 0.0011264010103738738,
            "start_logit": 6.59986686706543,
            "end_logit": 1.1331545114517212
        },
        {
            "text": "wide range",
            "probability": 0.0009345645979345419,
            "start_logit": 6.59986686706543,
            "end_logit": 0.9464523792266846
        },
        {
            "text": "research and development studies. Gamma (\u03b3)-sterilization has been commonly employed for wide range of products",
            "probability": 0.0005059829469625096,
            "start_logit": -0.8766099810600281,
            "end_logit": 7.809351444244385
        },
        {
            "text": "for wide range of products as indicated by the pharmacopoeias",
            "probability": 0.00044304795275945083,
            "start_logit": 3.6030399799346924,
            "end_logit": 3.1968765258789062
        },
        {
            "text": "for industrial manufacturing, research and development studies. Gamma (\u03b3)-sterilization has been commonly employed for wide range of products",
            "probability": 0.00042345056303616133,
            "start_logit": -1.0546761751174927,
            "end_logit": 7.809351444244385
        },
        {
            "text": "range of products",
            "probability": 0.0003799690621153364,
            "start_logit": -1.1630231142044067,
            "end_logit": 7.809351444244385
        },
        {
            "text": "for wide range of products as indicated by the pharmacopoeias.",
            "probability": 0.00032361518018655776,
            "start_logit": 3.6030399799346924,
            "end_logit": 2.882753610610962
        },
        {
            "text": "wide",
            "probability": 0.00022668193693524527,
            "start_logit": 6.59986686706543,
            "end_logit": -0.47008049488067627
        },
        {
            "text": "\u03b3)-sterilization has been commonly employed for wide range of products",
            "probability": 0.00017322780955900493,
            "start_logit": -1.9485054016113281,
            "end_logit": 7.809351444244385
        },
        {
            "text": "",
            "probability": 1.8075546297991164e-05,
            "start_logit": 1.4849082231521606,
            "end_logit": 2.1158902645111084
        }
    ],
    "5e48f90bf8b2df0d49000006_002": [
        {
            "text": "minimize the risk of infection transmission through bone allografts",
            "probability": 0.4540899025644653,
            "start_logit": 7.012941837310791,
            "end_logit": 8.450845718383789
        },
        {
            "text": "to minimize the risk of infection transmission through bone allografts",
            "probability": 0.387639715943135,
            "start_logit": 6.85472297668457,
            "end_logit": 8.450845718383789
        },
        {
            "text": "minimize the risk of infection transmission",
            "probability": 0.06628382454155352,
            "start_logit": 7.012941837310791,
            "end_logit": 6.526496410369873
        },
        {
            "text": "to minimize the risk of infection transmission",
            "probability": 0.056584043758305544,
            "start_logit": 6.85472297668457,
            "end_logit": 6.526496410369873
        },
        {
            "text": "infection transmission through bone allografts",
            "probability": 0.00750937792386152,
            "start_logit": 2.910799264907837,
            "end_logit": 8.450845718383789
        },
        {
            "text": "usually used to minimize the risk of infection transmission through bone allografts",
            "probability": 0.004990461832547059,
            "start_logit": 2.5021750926971436,
            "end_logit": 8.450845718383789
        },
        {
            "text": "bone allografts",
            "probability": 0.004862011009359958,
            "start_logit": 2.4760987758636475,
            "end_logit": 8.450845718383789
        },
        {
            "text": "used to minimize the risk of infection transmission through bone allografts",
            "probability": 0.004661745075216204,
            "start_logit": 2.4340364933013916,
            "end_logit": 8.450845718383789
        },
        {
            "text": "Gamma sterilization is usually used to minimize the risk of infection transmission through bone allografts",
            "probability": 0.001886871654494627,
            "start_logit": 1.5295668840408325,
            "end_logit": 8.450845718383789
        },
        {
            "text": "minimize the risk",
            "probability": 0.0018190992736314671,
            "start_logit": 7.012941837310791,
            "end_logit": 2.930891990661621
        },
        {
            "text": "minimize the risk of infection transmission through bone allografts.",
            "probability": 0.0016763055142128213,
            "start_logit": 7.012941837310791,
            "end_logit": 2.8491427898406982
        },
        {
            "text": "to minimize the risk",
            "probability": 0.00155289761283066,
            "start_logit": 6.85472297668457,
            "end_logit": 2.930891990661621
        },
        {
            "text": "to minimize the risk of infection transmission through bone allografts.",
            "probability": 0.0014309998740197028,
            "start_logit": 6.85472297668457,
            "end_logit": 2.8491427898406982
        },
        {
            "text": "infection transmission",
            "probability": 0.0010961492116658303,
            "start_logit": 2.910799264907837,
            "end_logit": 6.526496410369873
        },
        {
            "text": "risk of infection transmission through bone allografts",
            "probability": 0.0007851767921476731,
            "start_logit": 0.6528002619743347,
            "end_logit": 8.450845718383789
        },
        {
            "text": "usually used to minimize the risk of infection transmission",
            "probability": 0.0007284612465984275,
            "start_logit": 2.5021750926971436,
            "end_logit": 6.526496410369873
        },
        {
            "text": "used to minimize the risk of infection transmission",
            "probability": 0.0006804782288221323,
            "start_logit": 2.4340364933013916,
            "end_logit": 6.526496410369873
        },
        {
            "text": "minimize the risk of infection",
            "probability": 0.0005671382751121748,
            "start_logit": 7.012941837310791,
            "end_logit": 1.765398383140564
        },
        {
            "text": "to minimize the risk of infection",
            "probability": 0.0004841449206938762,
            "start_logit": 6.85472297668457,
            "end_logit": 1.765398383140564
        },
        {
            "text": "the risk of infection transmission through bone allografts",
            "probability": 0.0004480271835793397,
            "start_logit": 0.09174526482820511,
            "end_logit": 8.450845718383789
        },
        {
            "text": "",
            "probability": 0.00022316756374685071,
            "start_logit": 3.598933458328247,
            "end_logit": 4.2467265129089355
        }
    ],
    "5e48f90bf8b2df0d49000006_003": [
        {
            "text": "provide safety against disease transmission",
            "probability": 0.3946842089147377,
            "start_logit": 6.439701557159424,
            "end_logit": 8.130752563476562
        },
        {
            "text": "to provide safety against disease transmission",
            "probability": 0.3903124354241201,
            "start_logit": 6.428563117980957,
            "end_logit": 8.130752563476562
        },
        {
            "text": "safety against disease transmission",
            "probability": 0.09009781886192735,
            "start_logit": 4.9625115394592285,
            "end_logit": 8.130752563476562
        },
        {
            "text": "gold standard method to provide safety against disease transmission",
            "probability": 0.047396827508293674,
            "start_logit": 4.320170879364014,
            "end_logit": 8.130752563476562
        },
        {
            "text": "a gold standard method to provide safety against disease transmission",
            "probability": 0.045015068016148824,
            "start_logit": 4.268612861633301,
            "end_logit": 8.130752563476562
        },
        {
            "text": "as a gold standard method to provide safety against disease transmission",
            "probability": 0.01170709750563256,
            "start_logit": 2.9218108654022217,
            "end_logit": 8.130752563476562
        },
        {
            "text": "provide safety against disease transmission.",
            "probability": 0.0036154473475843107,
            "start_logit": 6.439701557159424,
            "end_logit": 3.4378821849823
        },
        {
            "text": "to provide safety against disease transmission.",
            "probability": 0.0035754003517484392,
            "start_logit": 6.428563117980957,
            "end_logit": 3.4378821849823
        },
        {
            "text": "used as a gold standard method to provide safety against disease transmission",
            "probability": 0.002685323095693576,
            "start_logit": 1.4494166374206543,
            "end_logit": 8.130752563476562
        },
        {
            "text": "Gamma sterilization of bone allografts is used as a gold standard method to provide safety against disease transmission",
            "probability": 0.0020993512905880182,
            "start_logit": 1.2032439708709717,
            "end_logit": 8.130752563476562
        },
        {
            "text": "bone allografts is used as a gold standard method to provide safety against disease transmission",
            "probability": 0.0017675834245388447,
            "start_logit": 1.0312288999557495,
            "end_logit": 8.130752563476562
        },
        {
            "text": "gold standard method",
            "probability": 0.0009971891673946065,
            "start_logit": 4.320170879364014,
            "end_logit": 4.269382476806641
        },
        {
            "text": "disease transmission",
            "probability": 0.0009866574079545555,
            "start_logit": 0.44818317890167236,
            "end_logit": 8.130752563476562
        },
        {
            "text": "a gold standard method",
            "probability": 0.0009470789619279953,
            "start_logit": 4.268612861633301,
            "end_logit": 4.269382476806641
        },
        {
            "text": "safety against disease transmission.",
            "probability": 0.0008253279783429498,
            "start_logit": 4.9625115394592285,
            "end_logit": 3.4378821849823
        },
        {
            "text": "provide safety",
            "probability": 0.000768166764574948,
            "start_logit": 6.439701557159424,
            "end_logit": 1.888918161392212
        },
        {
            "text": "to provide safety",
            "probability": 0.0007596580605987326,
            "start_logit": 6.428563117980957,
            "end_logit": 1.888918161392212
        },
        {
            "text": "provide safety against disease",
            "probability": 0.0006348131087467656,
            "start_logit": 6.439701557159424,
            "end_logit": 1.698241949081421
        },
        {
            "text": "to provide safety against disease",
            "probability": 0.0006277815147340567,
            "start_logit": 6.428563117980957,
            "end_logit": 1.698241949081421
        },
        {
            "text": "gold standard method to provide safety against disease transmission.",
            "probability": 0.000434171751563007,
            "start_logit": 4.320170879364014,
            "end_logit": 3.4378821849823
        },
        {
            "text": "",
            "probability": 6.25935431490065e-05,
            "start_logit": 2.6636767387390137,
            "end_logit": 3.1575982570648193
        }
    ],
    "5e48f90bf8b2df0d49000006_004": [
        {
            "text": "the preferred sterilization method of choice",
            "probability": 0.2985854071148914,
            "start_logit": 0.9783961772918701,
            "end_logit": 2.3571534156799316
        },
        {
            "text": "",
            "probability": 0.22592744803430484,
            "start_logit": 1.336958646774292,
            "end_logit": 1.719748854637146
        },
        {
            "text": "preferred sterilization method of choice",
            "probability": 0.1558877512500067,
            "start_logit": 0.3284763693809509,
            "end_logit": 2.3571534156799316
        },
        {
            "text": "the preferred sterilization method of choice for this device",
            "probability": 0.05783429878889551,
            "start_logit": 0.9783961772918701,
            "end_logit": 0.715679407119751
        },
        {
            "text": "It was determined that gamma sterilization was the preferred sterilization method of choice",
            "probability": 0.04459778154426137,
            "start_logit": -0.9229757189750671,
            "end_logit": 2.3571534156799316
        },
        {
            "text": "gamma sterilization was the preferred sterilization method of choice",
            "probability": 0.03936296186674265,
            "start_logit": -1.0478345155715942,
            "end_logit": 2.3571534156799316
        },
        {
            "text": "preferred sterilization method of choice for this device",
            "probability": 0.03019457270345704,
            "start_logit": 0.3284763693809509,
            "end_logit": 0.715679407119751
        },
        {
            "text": "sterilization method of choice",
            "probability": 0.02533594982328935,
            "start_logit": -1.4884355068206787,
            "end_logit": 2.3571534156799316
        },
        {
            "text": "method of choice",
            "probability": 0.021155703739752015,
            "start_logit": -1.668750286102295,
            "end_logit": 2.3571534156799316
        },
        {
            "text": "the preferred",
            "probability": 0.017393435825126792,
            "start_logit": 0.9783961772918701,
            "end_logit": -0.48580971360206604
        },
        {
            "text": "this device",
            "probability": 0.011620801684173104,
            "start_logit": -0.6263890862464905,
            "end_logit": 0.715679407119751
        },
        {
            "text": "the preferred sterilization method",
            "probability": 0.011278439696225767,
            "start_logit": 0.9783961772918701,
            "end_logit": -0.9190096855163574
        },
        {
            "text": "was the preferred sterilization method of choice",
            "probability": 0.009084984009606913,
            "start_logit": -2.5140368938446045,
            "end_logit": 2.3571534156799316
        },
        {
            "text": "the preferred sterilization method of choice for this device.",
            "probability": 0.009082647164932659,
            "start_logit": 0.9783961772918701,
            "end_logit": -1.1355369091033936
        },
        {
            "text": "preferred",
            "probability": 0.009080897902846951,
            "start_logit": 0.3284763693809509,
            "end_logit": -0.48580971360206604
        },
        {
            "text": "It was determined that gamma sterilization was the preferred sterilization method of choice for this device",
            "probability": 0.008638337178213907,
            "start_logit": -0.9229757189750671,
            "end_logit": 0.715679407119751
        },
        {
            "text": "gamma sterilization was the preferred sterilization method of choice for this device",
            "probability": 0.0076243823159821015,
            "start_logit": -1.0478345155715942,
            "end_logit": 0.715679407119751
        },
        {
            "text": "preferred sterilization method",
            "probability": 0.005888333990739624,
            "start_logit": 0.3284763693809509,
            "end_logit": -0.9190096855163574
        },
        {
            "text": "determined that gamma sterilization was the preferred sterilization method of choice",
            "probability": 0.005836977946327518,
            "start_logit": -2.956446647644043,
            "end_logit": 2.3571534156799316
        },
        {
            "text": "the preferred sterilization",
            "probability": 0.005588887420223344,
            "start_logit": 0.9783961772918701,
            "end_logit": -1.6211223602294922
        }
    ],
    "5e2f93bbfbd6abf43b00002e_001": [
        {
            "text": "shock, acute abdominal pain, and pulsatile abdominal mass",
            "probability": 0.935563569352412,
            "start_logit": 6.863371849060059,
            "end_logit": 6.451290130615234
        },
        {
            "text": "shock",
            "probability": 0.02921326321287867,
            "start_logit": 6.863371849060059,
            "end_logit": 2.9847638607025146
        },
        {
            "text": "shock, acute abdominal pain",
            "probability": 0.013069082458078503,
            "start_logit": 6.863371849060059,
            "end_logit": 2.1803903579711914
        },
        {
            "text": "the classic triad of shock, acute abdominal pain, and pulsatile abdominal mass",
            "probability": 0.005958997952532155,
            "start_logit": 1.8071250915527344,
            "end_logit": 6.451290130615234
        },
        {
            "text": "shock, acute abdominal pain, and pulsatile",
            "probability": 0.004314968992712468,
            "start_logit": 6.863371849060059,
            "end_logit": 1.0722311735153198
        },
        {
            "text": "shock, acute abdominal pain, and pulsatile abdominal",
            "probability": 0.001553556846677463,
            "start_logit": 6.863371849060059,
            "end_logit": 0.05068807676434517
        },
        {
            "text": "shock,",
            "probability": 0.0013343884386825637,
            "start_logit": 6.863371849060059,
            "end_logit": -0.10138587653636932
        },
        {
            "text": "shock, acute abdominal pain, and pulsatile abdominal mass was made in only one",
            "probability": 0.0011217528946204489,
            "start_logit": 6.863371849060059,
            "end_logit": -0.27496641874313354
        },
        {
            "text": "",
            "probability": 0.0010998201429156594,
            "start_logit": 3.15985107421875,
            "end_logit": 3.408808469772339
        },
        {
            "text": "classic triad of shock, acute abdominal pain, and pulsatile abdominal mass",
            "probability": 0.0010808581630737317,
            "start_logit": 0.09997807443141937,
            "end_logit": 6.451290130615234
        },
        {
            "text": "shock, acute abdominal pain, and pulsatile abdominal mass was made in only one of 19 (5.3%) patients. Shock",
            "probability": 0.0010701769196117504,
            "start_logit": 6.863371849060059,
            "end_logit": -0.3220349848270416
        },
        {
            "text": "triad of shock, acute abdominal pain, and pulsatile abdominal mass",
            "probability": 0.0009696419671472641,
            "start_logit": -0.00860562827438116,
            "end_logit": 6.451290130615234
        },
        {
            "text": "shock, acute abdominal pain, and pulsatile abdominal mass was made in only one of 19 (5.3%) patients.",
            "probability": 0.0007936608380031547,
            "start_logit": 6.863371849060059,
            "end_logit": -0.6209580302238464
        },
        {
            "text": "shock, acute abdominal pain, and pulsatile abdominal mass was made in only one of 19 (5.3%",
            "probability": 0.0007861547717943507,
            "start_logit": 6.863371849060059,
            "end_logit": -0.6304605603218079
        },
        {
            "text": "shock, acute abdominal pain, and pulsatile abdominal mass was made in only one of 19 (5.3%) patients",
            "probability": 0.0007009054640795963,
            "start_logit": 6.863371849060059,
            "end_logit": -0.7452412247657776
        },
        {
            "text": "shock, acute abdominal pain, and pulsatile abdominal mass was made in only one of 19 (5.3%)",
            "probability": 0.0005114233213653343,
            "start_logit": 6.863371849060059,
            "end_logit": -1.060416579246521
        },
        {
            "text": "pulsatile abdominal mass",
            "probability": 0.00023859384317930906,
            "start_logit": -1.4107698202133179,
            "end_logit": 6.451290130615234
        },
        {
            "text": "shock, acute abdominal pain, and pulsatile abdominal mass was made in only one of 19",
            "probability": 0.00022494116179329001,
            "start_logit": 6.863371849060059,
            "end_logit": -1.8817753791809082
        },
        {
            "text": "Shock, acute abdominal pain, and abdominal swelling",
            "probability": 0.000208171695402961,
            "start_logit": 2.9925355911254883,
            "end_logit": 1.9115852117538452
        },
        {
            "text": "the classic triad of shock",
            "probability": 0.0001860715630396175,
            "start_logit": 1.8071250915527344,
            "end_logit": 2.9847638607025146
        }
    ],
    "5e2f93bbfbd6abf43b00002e_002": [
        {
            "text": "hypotension, back pain and a pulsatile abdominal mass",
            "probability": 0.9172920666217178,
            "start_logit": 5.210023403167725,
            "end_logit": 4.809029579162598
        },
        {
            "text": "hypotension, back pain",
            "probability": 0.04162293320213207,
            "start_logit": 5.210023403167725,
            "end_logit": 1.7162549495697021
        },
        {
            "text": "hypotension",
            "probability": 0.02133122265328931,
            "start_logit": 5.210023403167725,
            "end_logit": 1.0477755069732666
        },
        {
            "text": "hypotension, back pain and a pulsatile abdominal mass.",
            "probability": 0.003899422047277973,
            "start_logit": 5.210023403167725,
            "end_logit": -0.6515679955482483
        },
        {
            "text": "",
            "probability": 0.003854385927712716,
            "start_logit": 2.02184796333313,
            "end_logit": 2.5249907970428467
        },
        {
            "text": "hypotension, back pain and a pulsatile",
            "probability": 0.0030733087861964524,
            "start_logit": 5.210023403167725,
            "end_logit": -0.8896415829658508
        },
        {
            "text": "hypotension, back pain and a pulsatile abdominal mass. This variability in symptoms can delay diagnosis and treatment. We present",
            "probability": 0.00157122178357311,
            "start_logit": 5.210023403167725,
            "end_logit": -1.5605428218841553
        },
        {
            "text": "pulsatile abdominal mass",
            "probability": 0.0012159046197923473,
            "start_logit": -1.4159141778945923,
            "end_logit": 4.809029579162598
        },
        {
            "text": "triad of hypotension, back pain and a pulsatile abdominal mass",
            "probability": 0.0011697813479681627,
            "start_logit": -1.4545856714248657,
            "end_logit": 4.809029579162598
        },
        {
            "text": "the classic triad of hypotension, back pain and a pulsatile abdominal mass",
            "probability": 0.0010819926450343343,
            "start_logit": -1.5325981378555298,
            "end_logit": 4.809029579162598
        },
        {
            "text": "hypotension, back pain and a pulsatile abdominal",
            "probability": 0.0008620364218503013,
            "start_logit": 5.210023403167725,
            "end_logit": -2.1608541011810303
        },
        {
            "text": "back pain and a pulsatile abdominal mass",
            "probability": 0.0007602804735565734,
            "start_logit": -1.8854703903198242,
            "end_logit": 4.809029579162598
        },
        {
            "text": "hypotension, back pain and a pulsatile abdominal mass. This variability in symptoms can delay diagnosis and treatment. We",
            "probability": 0.0006570190488149845,
            "start_logit": 5.210023403167725,
            "end_logit": -2.432438611984253
        },
        {
            "text": "hypotension, back pain and a pulsatile abdominal mass. This variability in symptoms can delay diagnosis and treatment.",
            "probability": 0.0005856765062382308,
            "start_logit": 5.210023403167725,
            "end_logit": -2.547384023666382
        },
        {
            "text": "classic triad of hypotension, back pain and a pulsatile abdominal mass",
            "probability": 0.0004173566708891414,
            "start_logit": -2.4852166175842285,
            "end_logit": 4.809029579162598
        },
        {
            "text": "decompression of urinary retention",
            "probability": 0.00032205525015523986,
            "start_logit": 0.28300192952156067,
            "end_logit": 1.7815929651260376
        },
        {
            "text": "present the case of a patient presenting with a unique combination of symptoms suggesting that decompression of urinary retention",
            "probability": 9.726128479188115e-05,
            "start_logit": -0.914320170879364,
            "end_logit": 1.7815929651260376
        },
        {
            "text": "We present the case of a patient presenting with a unique combination of symptoms suggesting that decompression of urinary retention",
            "probability": 7.994212897931326e-05,
            "start_logit": -1.1104182004928589,
            "end_logit": 1.7815929651260376
        },
        {
            "text": "triad of hypotension, back pain",
            "probability": 5.307985611049443e-05,
            "start_logit": -1.4545856714248657,
            "end_logit": 1.7162549495697021
        },
        {
            "text": "unique combination of symptoms suggesting that decompression of urinary retention",
            "probability": 5.305272391968083e-05,
            "start_logit": -1.5204349756240845,
            "end_logit": 1.7815929651260376
        }
    ],
    "5e2f93bbfbd6abf43b00002e_003": [
        {
            "text": "abdominal pain, pulsatile abdominal mass and shock",
            "probability": 0.962962825034217,
            "start_logit": 5.901381015777588,
            "end_logit": 6.084817886352539
        },
        {
            "text": "abdominal pain, pulsatile abdominal mass",
            "probability": 0.010876581150132972,
            "start_logit": 5.901381015777588,
            "end_logit": 1.6014150381088257
        },
        {
            "text": "shock",
            "probability": 0.007998594621589259,
            "start_logit": 1.110632061958313,
            "end_logit": 6.084817886352539
        },
        {
            "text": "pain, pulsatile abdominal mass and shock",
            "probability": 0.003978107718031626,
            "start_logit": 0.41217246651649475,
            "end_logit": 6.084817886352539
        },
        {
            "text": "pulsatile abdominal mass and shock",
            "probability": 0.002725540393379101,
            "start_logit": 0.034032925963401794,
            "end_logit": 6.084817886352539
        },
        {
            "text": "",
            "probability": 0.0026741938316704058,
            "start_logit": 2.90828537940979,
            "end_logit": 3.191546678543091
        },
        {
            "text": "abdominal pain, pulsatile abdominal mass and shock.",
            "probability": 0.0022397163402602866,
            "start_logit": 5.901381015777588,
            "end_logit": 0.021152302622795105
        },
        {
            "text": "abdominal pain",
            "probability": 0.0019720882700508396,
            "start_logit": 5.901381015777588,
            "end_logit": -0.10610390454530716
        },
        {
            "text": "abdominal pain, pulsatile abdominal mass and shock. Most symptoms are misleading",
            "probability": 0.0008550989311365188,
            "start_logit": 5.901381015777588,
            "end_logit": -0.941735029220581
        },
        {
            "text": "abdominal pain, pulsatile abdominal mass and shock. Most symptoms are misleading and will only present as vague abdominal pain",
            "probability": 0.0006849217161391035,
            "start_logit": 5.901381015777588,
            "end_logit": -1.1636476516723633
        },
        {
            "text": "classic triad of symptoms such as abdominal pain, pulsatile abdominal mass and shock",
            "probability": 0.0006245087812180734,
            "start_logit": -1.439423680305481,
            "end_logit": 6.084817886352539
        },
        {
            "text": "symptoms such as abdominal pain, pulsatile abdominal mass and shock",
            "probability": 0.000497553699647128,
            "start_logit": -1.6666855812072754,
            "end_logit": 6.084817886352539
        },
        {
            "text": "abdominal",
            "probability": 0.00036143903068326546,
            "start_logit": 5.901381015777588,
            "end_logit": -1.802858829498291
        },
        {
            "text": "triad of symptoms such as abdominal pain, pulsatile abdominal mass and shock",
            "probability": 0.00031911137102154635,
            "start_logit": -2.110848903656006,
            "end_logit": 6.084817886352539
        },
        {
            "text": "abdominal pain, pulsatile abdominal mass and shock. Most symptoms are misleading and will only present as vague abdominal pain. Here we describe",
            "probability": 0.0002598785908868211,
            "start_logit": 5.901381015777588,
            "end_logit": -2.132737636566162
        },
        {
            "text": "abdominal mass and shock",
            "probability": 0.0002363538787694099,
            "start_logit": -2.4110589027404785,
            "end_logit": 6.084817886352539
        },
        {
            "text": "abdominal pain, pulsatile",
            "probability": 0.00021058990998737038,
            "start_logit": 5.901381015777588,
            "end_logit": -2.3430395126342773
        },
        {
            "text": "Some of these patients present with the classic triad of symptoms such as abdominal pain, pulsatile abdominal mass and shock",
            "probability": 0.00019092040430523103,
            "start_logit": -2.624532461166382,
            "end_logit": 6.084817886352539
        },
        {
            "text": "abdominal pain,",
            "probability": 0.00018414518816230587,
            "start_logit": 5.901381015777588,
            "end_logit": -2.4772276878356934
        },
        {
            "text": "the classic triad of symptoms such as abdominal pain, pulsatile abdominal mass and shock",
            "probability": 0.0001478311387112483,
            "start_logit": -2.8803184032440186,
            "end_logit": 6.084817886352539
        }
    ],
    "5e2f93bbfbd6abf43b00002e_004": [
        {
            "text": "continuous abdominal bruit, abdominal and left flank pain",
            "probability": 0.4924577489731074,
            "start_logit": 4.8193488121032715,
            "end_logit": 4.237555980682373
        },
        {
            "text": "",
            "probability": 0.26574363500498044,
            "start_logit": 4.037115097045898,
            "end_logit": 4.4029130935668945
        },
        {
            "text": "continuous abdominal bruit, abdominal and left flank pain with an associated pulsatile mass",
            "probability": 0.10506849172419634,
            "start_logit": 4.8193488121032715,
            "end_logit": 2.6927597522735596
        },
        {
            "text": "continuous abdominal bruit, abdominal and left flank pain with an associated pulsatile mass (Mansour Triad",
            "probability": 0.05206042757994335,
            "start_logit": 4.8193488121032715,
            "end_logit": 1.9905524253845215
        },
        {
            "text": "abdominal and left flank pain",
            "probability": 0.018283180855970048,
            "start_logit": 1.5259217023849487,
            "end_logit": 4.237555980682373
        },
        {
            "text": "continuous abdominal bruit",
            "probability": 0.01809522263593232,
            "start_logit": 4.8193488121032715,
            "end_logit": 0.9337952733039856
        },
        {
            "text": "abdominal bruit, abdominal and left flank pain",
            "probability": 0.014057077822464495,
            "start_logit": 1.2630661725997925,
            "end_logit": 4.237555980682373
        },
        {
            "text": "continuous abdominal bruit,",
            "probability": 0.006953326290902001,
            "start_logit": 4.8193488121032715,
            "end_logit": -0.02263253927230835
        },
        {
            "text": "continuous abdominal bruit, abdominal and left flank pain with an associated pulsatile mass (Mansour Triad)",
            "probability": 0.00490454002269565,
            "start_logit": 4.8193488121032715,
            "end_logit": -0.37169137597084045
        },
        {
            "text": "abdominal and left flank pain with an associated pulsatile mass",
            "probability": 0.003900814314452746,
            "start_logit": 1.5259217023849487,
            "end_logit": 2.6927597522735596
        },
        {
            "text": "abdominal bruit, abdominal and left flank pain with an associated pulsatile mass",
            "probability": 0.0029991526540821068,
            "start_logit": 1.2630661725997925,
            "end_logit": 2.6927597522735596
        },
        {
            "text": "continuous",
            "probability": 0.0029880529081614256,
            "start_logit": 4.8193488121032715,
            "end_logit": -0.8672307133674622
        },
        {
            "text": "continuous abdominal bruit, abdominal and left flank pain with an associated pulsatile mass (Mansour Triad).",
            "probability": 0.0021903964384643844,
            "start_logit": 4.8193488121032715,
            "end_logit": -1.1777701377868652
        },
        {
            "text": "continuous abdominal bruit, abdominal and left flank pain with an associated pulsatile mass (Mansour",
            "probability": 0.002010555646091935,
            "start_logit": 4.8193488121032715,
            "end_logit": -1.263441562652588
        },
        {
            "text": "abdominal and left flank pain with an associated pulsatile mass (Mansour Triad",
            "probability": 0.0019328159925760733,
            "start_logit": 1.5259217023849487,
            "end_logit": 1.9905524253845215
        },
        {
            "text": "abdominal bruit, abdominal and left flank pain with an associated pulsatile mass (Mansour Triad",
            "probability": 0.0014860513079305903,
            "start_logit": 1.2630661725997925,
            "end_logit": 1.9905524253845215
        },
        {
            "text": "left flank pain",
            "probability": 0.0014035316392118015,
            "start_logit": -1.041068196296692,
            "end_logit": 4.237555980682373
        },
        {
            "text": "bruit, abdominal and left flank pain",
            "probability": 0.0013973081790294775,
            "start_logit": -1.0455121994018555,
            "end_logit": 4.237555980682373
        },
        {
            "text": "the unique syndrome: continuous abdominal bruit, abdominal and left flank pain",
            "probability": 0.0010344848945778322,
            "start_logit": -1.3461562395095825,
            "end_logit": 4.237555980682373
        },
        {
            "text": "Mansour Triad",
            "probability": 0.0010331851152290995,
            "start_logit": 0.8995900750160217,
            "end_logit": 1.9905524253845215
        }
    ],
    "5e2f93bbfbd6abf43b00002e_005": [
        {
            "text": "pain, hypotension, and a pulsatile mass",
            "probability": 0.9701178233996106,
            "start_logit": 5.818514823913574,
            "end_logit": 7.122358798980713
        },
        {
            "text": "triad of pain, hypotension, and a pulsatile mass",
            "probability": 0.006317346338454747,
            "start_logit": 0.7843965291976929,
            "end_logit": 7.122358798980713
        },
        {
            "text": "pain, hypotension",
            "probability": 0.005393698967390659,
            "start_logit": 5.818514823913574,
            "end_logit": 1.9301726818084717
        },
        {
            "text": "the classical triad of pain, hypotension, and a pulsatile mass",
            "probability": 0.00522762173789059,
            "start_logit": 0.5950537323951721,
            "end_logit": 7.122358798980713
        },
        {
            "text": "classical triad of pain, hypotension, and a pulsatile mass",
            "probability": 0.004633664210422377,
            "start_logit": 0.47444525361061096,
            "end_logit": 7.122358798980713
        },
        {
            "text": "pain, hypotension, and a pulsatile mass.",
            "probability": 0.003924867312209442,
            "start_logit": 5.818514823913574,
            "end_logit": 1.6122738122940063
        },
        {
            "text": "pain",
            "probability": 0.0010061670651779198,
            "start_logit": 5.818514823913574,
            "end_logit": 0.2510893940925598
        },
        {
            "text": "pain, hypotension, and a pulsatile",
            "probability": 0.000896075514971729,
            "start_logit": 5.818514823913574,
            "end_logit": 0.13521067798137665
        },
        {
            "text": "hypotension, and a pulsatile mass",
            "probability": 0.0007567830272635149,
            "start_logit": -1.3375813961029053,
            "end_logit": 7.122358798980713
        },
        {
            "text": "mass",
            "probability": 0.0004459441010346681,
            "start_logit": -1.866464376449585,
            "end_logit": 7.122358798980713
        },
        {
            "text": "",
            "probability": 0.00029015956862961915,
            "start_logit": 2.4035086631774902,
            "end_logit": 2.4226231575012207
        },
        {
            "text": "of pain, hypotension, and a pulsatile mass",
            "probability": 0.0002698717893314094,
            "start_logit": -2.368710994720459,
            "end_logit": 7.122358798980713
        },
        {
            "text": "pulsatile mass",
            "probability": 0.00023813643283798807,
            "start_logit": -2.49381422996521,
            "end_logit": 7.122358798980713
        },
        {
            "text": "pain,",
            "probability": 0.0001411672953196129,
            "start_logit": 5.818514823913574,
            "end_logit": -1.712868332862854
        },
        {
            "text": "a pulsatile mass",
            "probability": 9.183466480198292e-05,
            "start_logit": -3.4466681480407715,
            "end_logit": 7.122358798980713
        },
        {
            "text": "triad of pain, hypotension, and a pulsatile mass.",
            "probability": 6.786146660657406e-05,
            "start_logit": -3.749189615249634,
            "end_logit": 7.122358798980713
        },
        {
            "text": "results in the classical triad of pain, hypotension, and a pulsatile mass",
            "probability": 5.592503864657959e-05,
            "start_logit": -3.942645788192749,
            "end_logit": 7.122358798980713
        },
        {
            "text": "hypotension, and a pulsatile mass.",
            "probability": 4.472982272723432e-05,
            "start_logit": -4.166017532348633,
            "end_logit": 7.122358798980713
        },
        {
            "text": "pain, hypotension, and",
            "probability": 4.064896321361818e-05,
            "start_logit": 5.818514823913574,
            "end_logit": -2.95784068107605
        },
        {
            "text": "pain, hypotension,",
            "probability": 3.9673283458918716e-05,
            "start_logit": 5.818514823913574,
            "end_logit": -2.9821360111236572
        }
    ],
    "5ca61b14ecadf2e73f00004f_001": [
        {
            "text": "",
            "probability": 0.9791289281983528,
            "start_logit": 3.0970258712768555,
            "end_logit": 3.6020867824554443
        },
        {
            "text": "upstream",
            "probability": 0.0052113770866027255,
            "start_logit": 0.4889993965625763,
            "end_logit": 0.9742940664291382
        },
        {
            "text": "upstream of the \"pioneer\" factor FOXA1 in determining the genomic response to estrogen",
            "probability": 0.0028279576840296258,
            "start_logit": 0.4889993965625763,
            "end_logit": 0.3630047142505646
        },
        {
            "text": "CTCF acts upstream",
            "probability": 0.0022170296566566363,
            "start_logit": -0.3656764328479767,
            "end_logit": 0.9742940664291382
        },
        {
            "text": "upstream of the \"pioneer\" factor FOXA1 in determining the genomic response",
            "probability": 0.0021198464305739262,
            "start_logit": 0.4889993965625763,
            "end_logit": 0.07479357719421387
        },
        {
            "text": "CTCF acts upstream of the \"pioneer\" factor FOXA1 in determining the genomic response to estrogen",
            "probability": 0.001203072805723768,
            "start_logit": -0.3656764328479767,
            "end_logit": 0.3630047142505646
        },
        {
            "text": "upstream of the \"pioneer\" factor FOXA1",
            "probability": 0.00110674918738172,
            "start_logit": 0.4889993965625763,
            "end_logit": -0.5751230120658875
        },
        {
            "text": "CTCF acts upstream of the \"pioneer\" factor FOXA1 in determining the genomic response",
            "probability": 0.0009018273531236371,
            "start_logit": -0.3656764328479767,
            "end_logit": 0.07479357719421387
        },
        {
            "text": "in determining the genomic response to estrogen",
            "probability": 0.0006738330044214104,
            "start_logit": -0.9453283548355103,
            "end_logit": 0.3630047142505646
        },
        {
            "text": "showed that CTCF acts upstream",
            "probability": 0.0005778863934367854,
            "start_logit": -1.7102227210998535,
            "end_logit": 0.9742940664291382
        },
        {
            "text": "We showed that CTCF acts upstream",
            "probability": 0.0005390594330940031,
            "start_logit": -1.7797741889953613,
            "end_logit": 0.9742940664291382
        },
        {
            "text": "in determining the genomic response",
            "probability": 0.0005051074481391241,
            "start_logit": -0.9453283548355103,
            "end_logit": 0.07479357719421387
        },
        {
            "text": "determining the genomic response to estrogen",
            "probability": 0.0004947693092171113,
            "start_logit": -1.2542190551757812,
            "end_logit": 0.3630047142505646
        },
        {
            "text": "CTCF acts upstream of the \"pioneer\" factor FOXA1",
            "probability": 0.0004708344320762747,
            "start_logit": -0.3656764328479767,
            "end_logit": -0.5751230120658875
        },
        {
            "text": "upstream of the \"pioneer\" factor FOXA1 in determining the genomic response to estrogen.",
            "probability": 0.0004396982606489291,
            "start_logit": 0.4889993965625763,
            "end_logit": -1.4982166290283203
        },
        {
            "text": "determining the genomic response",
            "probability": 0.00037088071014093464,
            "start_logit": -1.2542190551757812,
            "end_logit": 0.07479357719421387
        },
        {
            "text": "acts upstream",
            "probability": 0.0003285852709155158,
            "start_logit": -2.274803638458252,
            "end_logit": 0.9742940664291382
        },
        {
            "text": "showed that CTCF acts upstream of the \"pioneer\" factor FOXA1 in determining the genomic response to estrogen",
            "probability": 0.0003135904847524817,
            "start_logit": -1.7102227210998535,
            "end_logit": 0.3630047142505646
        },
        {
            "text": "We showed that CTCF acts upstream of the \"pioneer\" factor FOXA1 in determining the genomic response to estrogen",
            "probability": 0.0002925210056063347,
            "start_logit": -1.7797741889953613,
            "end_logit": 0.3630047142505646
        },
        {
            "text": "estrogen",
            "probability": 0.00027644584510617563,
            "start_logit": -1.8362957239151,
            "end_logit": 0.3630047142505646
        }
    ],
    "5ca61b14ecadf2e73f00004f_002": [
        {
            "text": "",
            "probability": 0.9427397975261707,
            "start_logit": 1.0334378480911255,
            "end_logit": 1.5247445106506348
        },
        {
            "text": "binding of ER",
            "probability": 0.005983451390116717,
            "start_logit": -0.7963086366653442,
            "end_logit": -1.7053017616271973
        },
        {
            "text": "binding of ER to the genome",
            "probability": 0.005599123916822504,
            "start_logit": -0.7963086366653442,
            "end_logit": -1.7716891765594482
        },
        {
            "text": "estrogen-ER activity and endocrine response in breast cancer cells.",
            "probability": 0.004704689798882997,
            "start_logit": -2.429123878479004,
            "end_logit": -0.31292423605918884
        },
        {
            "text": "endocrine response in breast cancer cells.",
            "probability": 0.004582055021544658,
            "start_logit": -2.455536127090454,
            "end_logit": -0.31292423605918884
        },
        {
            "text": "binding of ER to the genome correlates with expression of the Forkhead protein FOXA1 (also called HNF3\u03b1).",
            "probability": 0.004153022475537909,
            "start_logit": -0.7963086366653442,
            "end_logit": -2.070462942123413
        },
        {
            "text": "FOXA1 is a major determinant of estrogen-ER activity and endocrine response in breast cancer cells.",
            "probability": 0.0032528987805587137,
            "start_logit": -2.7981371879577637,
            "end_logit": -0.31292423605918884
        },
        {
            "text": "estrogen-ER activity and endocrine response",
            "probability": 0.002921656973839646,
            "start_logit": -2.429123878479004,
            "end_logit": -0.789333164691925
        },
        {
            "text": "major determinant of estrogen-ER activity and endocrine response in breast cancer cells.",
            "probability": 0.002875370702396641,
            "start_logit": -2.921502113342285,
            "end_logit": -0.31292423605918884
        },
        {
            "text": "binding",
            "probability": 0.002868962468092323,
            "start_logit": -0.7963086366653442,
            "end_logit": -2.4403488636016846
        },
        {
            "text": "endocrine response",
            "probability": 0.0028454996143191737,
            "start_logit": -2.455536127090454,
            "end_logit": -0.789333164691925
        },
        {
            "text": "binding of ER to the genome correlates with expression",
            "probability": 0.002773497290253989,
            "start_logit": -0.7963086366653442,
            "end_logit": -2.4741902351379395
        },
        {
            "text": "binding of ER to the genome correlates",
            "probability": 0.002227538197342433,
            "start_logit": -0.7963086366653442,
            "end_logit": -2.6934022903442383
        },
        {
            "text": "FOXA1 is a major determinant of estrogen-ER activity and endocrine response",
            "probability": 0.0020200809859281864,
            "start_logit": -2.7981371879577637,
            "end_logit": -0.789333164691925
        },
        {
            "text": "estrogen-ER activity and endocrine response in breast cancer cells",
            "probability": 0.0019611323217689526,
            "start_logit": -2.429123878479004,
            "end_logit": -1.1879620552062988
        },
        {
            "text": "endocrine response in breast cancer cells",
            "probability": 0.0019100124741504643,
            "start_logit": -2.455536127090454,
            "end_logit": -1.1879620552062988
        },
        {
            "text": "major determinant of estrogen-ER activity and endocrine response",
            "probability": 0.0017856324697594103,
            "start_logit": -2.921502113342285,
            "end_logit": -0.789333164691925
        },
        {
            "text": "Estrogen receptor-\u03b1 (ER) is the key feature of most breast cancers and binding of ER",
            "probability": 0.0017264792023579765,
            "start_logit": -2.039222002029419,
            "end_logit": -1.7053017616271973
        },
        {
            "text": "Estrogen receptor-\u03b1 (ER) is the key feature of most breast cancers and binding of ER to the genome",
            "probability": 0.0016155844450890778,
            "start_logit": -2.039222002029419,
            "end_logit": -1.7716891765594482
        },
        {
            "text": "a major determinant of estrogen-ER activity and endocrine response in breast cancer cells.",
            "probability": 0.001453513945067619,
            "start_logit": -3.6036996841430664,
            "end_logit": -0.31292423605918884
        }
    ],
    "5ca61b14ecadf2e73f00004f_004": [
        {
            "text": "",
            "probability": 0.9427397975261707,
            "start_logit": 1.0334378480911255,
            "end_logit": 1.5247445106506348
        },
        {
            "text": "binding of ER",
            "probability": 0.005983451390116717,
            "start_logit": -0.7963086366653442,
            "end_logit": -1.7053017616271973
        },
        {
            "text": "binding of ER to the genome",
            "probability": 0.005599123916822504,
            "start_logit": -0.7963086366653442,
            "end_logit": -1.7716891765594482
        },
        {
            "text": "estrogen-ER activity and endocrine response in breast cancer cells.",
            "probability": 0.004704689798882997,
            "start_logit": -2.429123878479004,
            "end_logit": -0.31292423605918884
        },
        {
            "text": "endocrine response in breast cancer cells.",
            "probability": 0.004582055021544658,
            "start_logit": -2.455536127090454,
            "end_logit": -0.31292423605918884
        },
        {
            "text": "binding of ER to the genome correlates with expression of the Forkhead protein FOXA1 (also called HNF3\u03b1).",
            "probability": 0.004153022475537909,
            "start_logit": -0.7963086366653442,
            "end_logit": -2.070462942123413
        },
        {
            "text": "FOXA1 is a major determinant of estrogen-ER activity and endocrine response in breast cancer cells.",
            "probability": 0.0032528987805587137,
            "start_logit": -2.7981371879577637,
            "end_logit": -0.31292423605918884
        },
        {
            "text": "estrogen-ER activity and endocrine response",
            "probability": 0.002921656973839646,
            "start_logit": -2.429123878479004,
            "end_logit": -0.789333164691925
        },
        {
            "text": "major determinant of estrogen-ER activity and endocrine response in breast cancer cells.",
            "probability": 0.002875370702396641,
            "start_logit": -2.921502113342285,
            "end_logit": -0.31292423605918884
        },
        {
            "text": "binding",
            "probability": 0.002868962468092323,
            "start_logit": -0.7963086366653442,
            "end_logit": -2.4403488636016846
        },
        {
            "text": "endocrine response",
            "probability": 0.0028454996143191737,
            "start_logit": -2.455536127090454,
            "end_logit": -0.789333164691925
        },
        {
            "text": "binding of ER to the genome correlates with expression",
            "probability": 0.002773497290253989,
            "start_logit": -0.7963086366653442,
            "end_logit": -2.4741902351379395
        },
        {
            "text": "binding of ER to the genome correlates",
            "probability": 0.002227538197342433,
            "start_logit": -0.7963086366653442,
            "end_logit": -2.6934022903442383
        },
        {
            "text": "FOXA1 is a major determinant of estrogen-ER activity and endocrine response",
            "probability": 0.0020200809859281864,
            "start_logit": -2.7981371879577637,
            "end_logit": -0.789333164691925
        },
        {
            "text": "estrogen-ER activity and endocrine response in breast cancer cells",
            "probability": 0.0019611323217689526,
            "start_logit": -2.429123878479004,
            "end_logit": -1.1879620552062988
        },
        {
            "text": "endocrine response in breast cancer cells",
            "probability": 0.0019100124741504643,
            "start_logit": -2.455536127090454,
            "end_logit": -1.1879620552062988
        },
        {
            "text": "major determinant of estrogen-ER activity and endocrine response",
            "probability": 0.0017856324697594103,
            "start_logit": -2.921502113342285,
            "end_logit": -0.789333164691925
        },
        {
            "text": "Estrogen receptor-\u03b1 (ER) is the key feature of most breast cancers and binding of ER",
            "probability": 0.0017264792023579765,
            "start_logit": -2.039222002029419,
            "end_logit": -1.7053017616271973
        },
        {
            "text": "Estrogen receptor-\u03b1 (ER) is the key feature of most breast cancers and binding of ER to the genome",
            "probability": 0.0016155844450890778,
            "start_logit": -2.039222002029419,
            "end_logit": -1.7716891765594482
        },
        {
            "text": "a major determinant of estrogen-ER activity and endocrine response in breast cancer cells.",
            "probability": 0.001453513945067619,
            "start_logit": -3.6036996841430664,
            "end_logit": -0.31292423605918884
        }
    ],
    "5ca61b14ecadf2e73f00004f_006": [
        {
            "text": "",
            "probability": 0.9951598264953214,
            "start_logit": 3.0736734867095947,
            "end_logit": 3.5593278408050537
        },
        {
            "text": "knockdown of FoxA1 expression blocks the association of ER with chromatin and estrogen-induced gene expression",
            "probability": 0.0006427388344705385,
            "start_logit": -0.49226513504981995,
            "end_logit": -0.21965369582176208
        },
        {
            "text": "estrogen-induced gene expression demonstrating the necessity of FoxA1 in mediating an estrogen response in breast cancer cells",
            "probability": 0.00040279381016206014,
            "start_logit": -1.2074834108352661,
            "end_logit": 0.02825089916586876
        },
        {
            "text": "estrogen response in breast cancer cells",
            "probability": 0.00034158933770454336,
            "start_logit": -1.3722989559173584,
            "end_logit": 0.02825089916586876
        },
        {
            "text": "estrogen-induced gene expression demonstrating the necessity of FoxA1 in mediating an estrogen response in breast cancer cells.",
            "probability": 0.0003255024267018688,
            "start_logit": -1.2074834108352661,
            "end_logit": -0.18480397760868073
        },
        {
            "text": "estrogen-induced gene expression",
            "probability": 0.00031435414438124305,
            "start_logit": -1.2074834108352661,
            "end_logit": -0.21965369582176208
        },
        {
            "text": "necessity of FoxA1 in mediating an estrogen response in breast cancer cells",
            "probability": 0.00028914328355864375,
            "start_logit": -1.5389858484268188,
            "end_logit": 0.02825089916586876
        },
        {
            "text": "knockdown",
            "probability": 0.00028367185146113786,
            "start_logit": -0.49226513504981995,
            "end_logit": -1.037574052810669
        },
        {
            "text": "estrogen response in breast cancer cells.",
            "probability": 0.00027604237094303307,
            "start_logit": -1.3722989559173584,
            "end_logit": -0.18480397760868073
        },
        {
            "text": "demonstrating the necessity of FoxA1 in mediating an estrogen response in breast cancer cells",
            "probability": 0.00027137906406879295,
            "start_logit": -1.6023916006088257,
            "end_logit": 0.02825089916586876
        },
        {
            "text": "necessity of FoxA1 in mediating an estrogen response in breast cancer cells.",
            "probability": 0.0002336600962785851,
            "start_logit": -1.5389858484268188,
            "end_logit": -0.18480397760868073
        },
        {
            "text": "demonstrating the necessity of FoxA1 in mediating an estrogen response in breast cancer cells.",
            "probability": 0.0002193046210787934,
            "start_logit": -1.6023916006088257,
            "end_logit": -0.18480397760868073
        },
        {
            "text": "estrogen-induced gene expression demonstrating the necessity of FoxA1 in mediating an estrogen response",
            "probability": 0.0001841691747458254,
            "start_logit": -1.2074834108352661,
            "end_logit": -0.7543191313743591
        },
        {
            "text": "mediating an estrogen response in breast cancer cells",
            "probability": 0.00017767395253872925,
            "start_logit": -2.0259580612182617,
            "end_logit": 0.02825089916586876
        },
        {
            "text": "knockdown of FoxA1 expression blocks the association of ER with chromatin and estrogen-induced gene expression demonstrating the necessity",
            "probability": 0.0001700516118538975,
            "start_logit": -0.49226513504981995,
            "end_logit": -1.5492901802062988
        },
        {
            "text": "estrogen response",
            "probability": 0.0001561846901314285,
            "start_logit": -1.3722989559173584,
            "end_logit": -0.7543191313743591
        },
        {
            "text": "breast cancer cells",
            "probability": 0.00015204651856555248,
            "start_logit": -2.1817216873168945,
            "end_logit": 0.02825089916586876
        },
        {
            "text": "mediating an estrogen response in breast cancer cells.",
            "probability": 0.00014358041572138454,
            "start_logit": -2.0259580612182617,
            "end_logit": -0.18480397760868073
        },
        {
            "text": "necessity of FoxA1 in mediating an estrogen response",
            "probability": 0.00013220481192317347,
            "start_logit": -1.5389858484268188,
            "end_logit": -0.7543191313743591
        },
        {
            "text": "demonstrating the necessity of FoxA1 in mediating an estrogen response",
            "probability": 0.0001240824883896186,
            "start_logit": -1.6023916006088257,
            "end_logit": -0.7543191313743591
        }
    ],
    "5ca61b14ecadf2e73f00004f_008": [
        {
            "text": "",
            "probability": 0.996783505345569,
            "start_logit": 3.747490406036377,
            "end_logit": 4.187486171722412
        },
        {
            "text": "critical role in this reprogramming of ER binding.",
            "probability": 0.00048663671533922674,
            "start_logit": -0.6301332712173462,
            "end_logit": 0.9403388500213623
        },
        {
            "text": "appears to play a critical role in this reprogramming of ER binding.",
            "probability": 0.00041444265709034324,
            "start_logit": -0.7907165288925171,
            "end_logit": 0.9403388500213623
        },
        {
            "text": "Given previous findings from cell lines, FoxA1 appears to play a critical role in this reprogramming of ER binding.",
            "probability": 0.0002863299404565253,
            "start_logit": -1.1605063676834106,
            "end_logit": 0.9403388500213623
        },
        {
            "text": "play a critical role in this reprogramming of ER binding.",
            "probability": 0.00018720471809957146,
            "start_logit": -1.5854483842849731,
            "end_logit": 0.9403388500213623
        },
        {
            "text": "critical role in this reprogramming of ER binding",
            "probability": 0.0001862997597202058,
            "start_logit": -0.6301332712173462,
            "end_logit": -0.01982204243540764
        },
        {
            "text": "reprogramming of ER binding.",
            "probability": 0.00018100952011103745,
            "start_logit": -1.6191015243530273,
            "end_logit": 0.9403388500213623
        },
        {
            "text": "this reprogramming of ER binding.",
            "probability": 0.00017168879831621218,
            "start_logit": -1.671967625617981,
            "end_logit": 0.9403388500213623
        },
        {
            "text": "appears to play a critical role in this reprogramming of ER binding",
            "probability": 0.00015866161553369917,
            "start_logit": -0.7907165288925171,
            "end_logit": -0.01982204243540764
        },
        {
            "text": "critical role in this reprogramming",
            "probability": 0.00014764454902732704,
            "start_logit": -0.6301332712173462,
            "end_logit": -0.25237134099006653
        },
        {
            "text": "appears to play a critical role in this reprogramming",
            "probability": 0.00012574102461861342,
            "start_logit": -0.7907165288925171,
            "end_logit": -0.25237134099006653
        },
        {
            "text": "a critical role in this reprogramming of ER binding.",
            "probability": 0.00012306671611760555,
            "start_logit": -2.0049245357513428,
            "end_logit": 0.9403388500213623
        },
        {
            "text": "ER binding.",
            "probability": 0.00011770314171921306,
            "start_logit": -2.049485445022583,
            "end_logit": 0.9403388500213623
        },
        {
            "text": "FoxA1 appears to play a critical role in this reprogramming of ER binding.",
            "probability": 0.00011504211346084341,
            "start_logit": -2.072352886199951,
            "end_logit": 0.9403388500213623
        },
        {
            "text": "Given previous findings from cell lines, FoxA1 appears to play a critical role in this reprogramming of ER binding",
            "probability": 0.00010961605942652067,
            "start_logit": -1.1605063676834106,
            "end_logit": -0.01982204243540764
        },
        {
            "text": "Given previous findings from cell lines",
            "probability": 8.714728855430187e-05,
            "start_logit": -1.1605063676834106,
            "end_logit": -0.2492062747478485
        },
        {
            "text": "Given previous findings from cell lines, FoxA1 appears to play a critical role in this reprogramming",
            "probability": 8.687189765830927e-05,
            "start_logit": -1.1605063676834106,
            "end_logit": -0.25237134099006653
        },
        {
            "text": "in this reprogramming of ER binding.",
            "probability": 8.400945080456032e-05,
            "start_logit": -2.3867218494415283,
            "end_logit": 0.9403388500213623
        },
        {
            "text": "cell lines, FoxA1 appears to play a critical role in this reprogramming of ER binding.",
            "probability": 7.479182513964422e-05,
            "start_logit": -2.5029425621032715,
            "end_logit": 0.9403388500213623
        },
        {
            "text": "to play a critical role in this reprogramming of ER binding.",
            "probability": 7.258686323722412e-05,
            "start_logit": -2.532867193222046,
            "end_logit": 0.9403388500213623
        }
    ],
    "5ca61b14ecadf2e73f00004f_009": [
        {
            "text": "",
            "probability": 0.9996798043707809,
            "start_logit": 2.8919215202331543,
            "end_logit": 3.280717134475708
        },
        {
            "text": "We investigated FOXA1 for its role in predicting chemosensitivity of this subgroup in neoadjuvant chemotherapy settings",
            "probability": 6.883870094430273e-05,
            "start_logit": -2.6274006366729736,
            "end_logit": -0.7833849191665649
        },
        {
            "text": "role in predicting chemosensitivity of this subgroup in neoadjuvant chemotherapy settings",
            "probability": 3.981380666759191e-05,
            "start_logit": -3.174952983856201,
            "end_logit": -0.7833849191665649
        },
        {
            "text": "its role in predicting chemosensitivity of this subgroup in neoadjuvant chemotherapy settings",
            "probability": 2.855640180304209e-05,
            "start_logit": -3.5072855949401855,
            "end_logit": -0.7833849191665649
        },
        {
            "text": "neoadjuvant chemotherapy settings",
            "probability": 2.4777424077721853e-05,
            "start_logit": -3.649233818054199,
            "end_logit": -0.7833849191665649
        },
        {
            "text": "predicting chemosensitivity of this subgroup in neoadjuvant chemotherapy settings",
            "probability": 1.9842242226803398e-05,
            "start_logit": -3.8713536262512207,
            "end_logit": -0.7833849191665649
        },
        {
            "text": "estrogen receptor (ER)-positive breast cancer responds poorly to chemotherapy",
            "probability": 1.795764378857115e-05,
            "start_logit": -3.1523373126983643,
            "end_logit": -1.6021984815597534
        },
        {
            "text": "We investigated FOXA1 for its role in predicting chemosensitivity of this subgroup in neoadjuvant chemotherapy",
            "probability": 1.686107435881472e-05,
            "start_logit": -2.6274006366729736,
            "end_logit": -2.190143346786499
        },
        {
            "text": "We investigated FOXA1 for its role in predicting chemosensitivity",
            "probability": 1.5394061891175604e-05,
            "start_logit": -2.6274006366729736,
            "end_logit": -2.2811691761016846
        },
        {
            "text": "Most estrogen receptor (ER)-positive breast cancer responds poorly to chemotherapy",
            "probability": 1.4978713699657183e-05,
            "start_logit": -3.3337230682373047,
            "end_logit": -1.6021984815597534
        },
        {
            "text": "CONCLUSIONS: FOXA1 expression can independently predict chemosensitivity of ER-positive breast cancer patients.",
            "probability": 1.099144773041619e-05,
            "start_logit": -3.566970109939575,
            "end_logit": -1.6784640550613403
        },
        {
            "text": "role in predicting chemosensitivity of this subgroup in neoadjuvant chemotherapy",
            "probability": 9.751833569214083e-06,
            "start_logit": -3.174952983856201,
            "end_logit": -2.190143346786499
        },
        {
            "text": "role in predicting chemosensitivity",
            "probability": 8.903366791597403e-06,
            "start_logit": -3.174952983856201,
            "end_logit": -2.2811691761016846
        },
        {
            "text": "independently predict chemosensitivity of ER-positive breast cancer patients.",
            "probability": 7.27413776341864e-06,
            "start_logit": -3.979762315750122,
            "end_logit": -1.6784640550613403
        },
        {
            "text": "CONCLUSIONS: FOXA1 expression can independently predict chemosensitivity of ER-positive breast cancer patients",
            "probability": 7.1882268654522466e-06,
            "start_logit": -3.566970109939575,
            "end_logit": -2.1031370162963867
        },
        {
            "text": "its role in predicting chemosensitivity of this subgroup in neoadjuvant chemotherapy",
            "probability": 6.994490128610321e-06,
            "start_logit": -3.5072855949401855,
            "end_logit": -2.190143346786499
        },
        {
            "text": "its role in predicting chemosensitivity",
            "probability": 6.385928419843182e-06,
            "start_logit": -3.5072855949401855,
            "end_logit": -2.2811691761016846
        },
        {
            "text": "neoadjuvant chemotherapy",
            "probability": 6.068882533567485e-06,
            "start_logit": -3.649233818054199,
            "end_logit": -2.190143346786499
        },
        {
            "text": "predicting chemosensitivity of this subgroup in neoadjuvant chemotherapy",
            "probability": 4.860078953297486e-06,
            "start_logit": -3.8713536262512207,
            "end_logit": -2.190143346786499
        },
        {
            "text": "independently predict chemosensitivity of ER-positive breast cancer patients",
            "probability": 4.757167006245381e-06,
            "start_logit": -3.979762315750122,
            "end_logit": -2.1031370162963867
        }
    ],
    "5ca61b14ecadf2e73f00004f_010": [
        {
            "text": "",
            "probability": 0.9987569978395282,
            "start_logit": 3.001659393310547,
            "end_logit": 3.584787607192993
        },
        {
            "text": "forkhead box A1",
            "probability": 0.00040932051875418123,
            "start_logit": -0.9052038788795471,
            "end_logit": -0.3081173896789551
        },
        {
            "text": "after neoadjuvant chemotherapy",
            "probability": 0.0001246769973354538,
            "start_logit": -1.6349139213562012,
            "end_logit": -0.7671794891357422
        },
        {
            "text": "Expression of forkhead box A1",
            "probability": 0.00012039873390215858,
            "start_logit": -2.1288933753967285,
            "end_logit": -0.3081173896789551
        },
        {
            "text": "forkhead box A1 (FOXA1)",
            "probability": 7.502386667566708e-05,
            "start_logit": -0.9052038788795471,
            "end_logit": -2.004809617996216
        },
        {
            "text": "Patients with ER-positive HER2-negative breast cancer should be selected for neoadjuvant chemotherapy.",
            "probability": 5.9791040099796636e-05,
            "start_logit": -1.9124940633773804,
            "end_logit": -1.2244699001312256
        },
        {
            "text": "Patients with ER-positive HER2-negative breast cancer should be selected for neoadjuvant chemotherapy",
            "probability": 5.065000130923308e-05,
            "start_logit": -1.9124940633773804,
            "end_logit": -1.3903864622116089
        },
        {
            "text": "could be a prognostic marker in ER-positive breast cancer.",
            "probability": 4.3663511814609776e-05,
            "start_logit": -2.535822868347168,
            "end_logit": -0.9154841303825378
        },
        {
            "text": "after neoadjuvant chemotherapy were significantly associated with distant disease-free survival, both by univariate and multivariate analyses",
            "probability": 4.293374356218123e-05,
            "start_logit": -1.6349139213562012,
            "end_logit": -1.8332477807998657
        },
        {
            "text": "after neoadjuvant chemotherapy were significantly associated with distant disease-free survival",
            "probability": 3.853242013628389e-05,
            "start_logit": -1.6349139213562012,
            "end_logit": -1.9414058923721313
        },
        {
            "text": "expression of FOXA1 after neoadjuvant chemotherapy",
            "probability": 3.700905176613832e-05,
            "start_logit": -2.849477767944336,
            "end_logit": -0.7671794891357422
        },
        {
            "text": "significantly associated with distant disease-free survival, both by univariate and multivariate analyses",
            "probability": 3.586546013422851e-05,
            "start_logit": -1.814797282218933,
            "end_logit": -1.8332477807998657
        },
        {
            "text": "significantly associated with distant disease-free survival",
            "probability": 3.218873696098032e-05,
            "start_logit": -1.814797282218933,
            "end_logit": -1.9414058923721313
        },
        {
            "text": "prognostic marker in ER-positive breast cancer.",
            "probability": 3.103390915581795e-05,
            "start_logit": -2.8772552013397217,
            "end_logit": -0.9154841303825378
        },
        {
            "text": "ER-positive HER2-negative breast cancer should be selected for neoadjuvant chemotherapy.",
            "probability": 2.729037709963516e-05,
            "start_logit": -2.6968157291412354,
            "end_logit": -1.2244699001312256
        },
        {
            "text": "forkhead box A1 (FOXA1",
            "probability": 2.6126178663017307e-05,
            "start_logit": -0.9052038788795471,
            "end_logit": -3.059678077697754
        },
        {
            "text": "ER-positive breast cancer.",
            "probability": 2.4225435240696676e-05,
            "start_logit": -3.1249325275421143,
            "end_logit": -0.9154841303825378
        },
        {
            "text": "ER-positive HER2-negative breast cancer should be selected for neoadjuvant chemotherapy",
            "probability": 2.311814000089098e-05,
            "start_logit": -2.6968157291412354,
            "end_logit": -1.3903864622116089
        },
        {
            "text": "Expression of forkhead box A1 (FOXA1)",
            "probability": 2.2067739451926493e-05,
            "start_logit": -2.1288933753967285,
            "end_logit": -2.004809617996216
        },
        {
            "text": "a prognostic marker in ER-positive breast cancer.",
            "probability": 1.9086298408763933e-05,
            "start_logit": -3.3633649349212646,
            "end_logit": -0.9154841303825378
        }
    ],
    "5ca61b14ecadf2e73f00004f_011": [
        {
            "text": "phosphomimetic FoxA1 promoted the activation of estrogen signaling",
            "probability": 0.29864011354877384,
            "start_logit": 2.0121798515319824,
            "end_logit": 2.203176975250244
        },
        {
            "text": "promoted the activation of estrogen signaling",
            "probability": 0.15996500404791875,
            "start_logit": 1.3878957033157349,
            "end_logit": 2.203176975250244
        },
        {
            "text": "phosphomimetic FoxA1",
            "probability": 0.06469093417786621,
            "start_logit": 2.0121798515319824,
            "end_logit": 0.6735588312149048
        },
        {
            "text": "phosphomimetic FoxA1 promoted",
            "probability": 0.06037675243254417,
            "start_logit": 2.0121798515319824,
            "end_logit": 0.6045418977737427
        },
        {
            "text": "phosphomimetic FoxA1 promoted the activation of estrogen signaling,",
            "probability": 0.05773884083653239,
            "start_logit": 2.0121798515319824,
            "end_logit": 0.5598678588867188
        },
        {
            "text": "The phosphomimetic FoxA1 promoted the activation of estrogen signaling",
            "probability": 0.056099934643977216,
            "start_logit": 0.34007528424263,
            "end_logit": 2.203176975250244
        },
        {
            "text": "phosphomimetic FoxA1 promoted the activation",
            "probability": 0.03788807401424002,
            "start_logit": 2.0121798515319824,
            "end_logit": 0.13857415318489075
        },
        {
            "text": "phosphomimetic",
            "probability": 0.032509393107908596,
            "start_logit": 2.0121798515319824,
            "end_logit": -0.01453317329287529
        },
        {
            "text": "promoted the activation of estrogen signaling, whereas the nonphosphorylatable FoxA1 suppressed its activation",
            "probability": 0.032487502774444545,
            "start_logit": 1.3878957033157349,
            "end_logit": 0.6090773940086365
        },
        {
            "text": "promoted",
            "probability": 0.03234048946909052,
            "start_logit": 1.3878957033157349,
            "end_logit": 0.6045418977737427
        },
        {
            "text": "promoted the activation of estrogen signaling,",
            "probability": 0.03092750601512743,
            "start_logit": 1.3878957033157349,
            "end_logit": 0.5598678588867188
        },
        {
            "text": "promoted the activation of estrogen signaling, whereas the nonphosphorylatable FoxA1 suppressed its activation.",
            "probability": 0.028085972332169903,
            "start_logit": 1.3878957033157349,
            "end_logit": 0.46349215507507324
        },
        {
            "text": "promoted the activation",
            "probability": 0.020294547309920936,
            "start_logit": 1.3878957033157349,
            "end_logit": 0.13857415318489075
        },
        {
            "text": "activation of estrogen signaling",
            "probability": 0.019299219795972558,
            "start_logit": -0.7269946932792664,
            "end_logit": 2.203176975250244
        },
        {
            "text": "estrogen signaling",
            "probability": 0.012756591586584539,
            "start_logit": -1.1410112380981445,
            "end_logit": 2.203176975250244
        },
        {
            "text": "The phosphomimetic FoxA1",
            "probability": 0.012152276317841049,
            "start_logit": 0.34007528424263,
            "end_logit": 0.6735588312149048
        },
        {
            "text": "The phosphomimetic FoxA1 promoted",
            "probability": 0.01134185165291981,
            "start_logit": 0.34007528424263,
            "end_logit": 0.6045418977737427
        },
        {
            "text": "",
            "probability": 0.010868299415211977,
            "start_logit": 0.26009461283683777,
            "end_logit": 0.6418732404708862
        },
        {
            "text": "The phosphomimetic FoxA1 promoted the activation of estrogen signaling,",
            "probability": 0.010846316520769249,
            "start_logit": 0.34007528424263,
            "end_logit": 0.5598678588867188
        },
        {
            "text": "Stimulation with the epidermal growth factor, which activates c-Abl, enhanced the activation of estrogen signaling",
            "probability": 0.010690380000186598,
            "start_logit": -0.019831819459795952,
            "end_logit": 0.9052937030792236
        }
    ],
    "5ca61b14ecadf2e73f00004f_012": [
        {
            "text": "phosphomimetic FoxA1 promoted the activation of estrogen signaling",
            "probability": 0.29864011354877384,
            "start_logit": 2.0121798515319824,
            "end_logit": 2.203176975250244
        },
        {
            "text": "promoted the activation of estrogen signaling",
            "probability": 0.15996500404791875,
            "start_logit": 1.3878957033157349,
            "end_logit": 2.203176975250244
        },
        {
            "text": "phosphomimetic FoxA1",
            "probability": 0.06469093417786621,
            "start_logit": 2.0121798515319824,
            "end_logit": 0.6735588312149048
        },
        {
            "text": "phosphomimetic FoxA1 promoted",
            "probability": 0.06037675243254417,
            "start_logit": 2.0121798515319824,
            "end_logit": 0.6045418977737427
        },
        {
            "text": "phosphomimetic FoxA1 promoted the activation of estrogen signaling,",
            "probability": 0.05773884083653239,
            "start_logit": 2.0121798515319824,
            "end_logit": 0.5598678588867188
        },
        {
            "text": "The phosphomimetic FoxA1 promoted the activation of estrogen signaling",
            "probability": 0.056099934643977216,
            "start_logit": 0.34007528424263,
            "end_logit": 2.203176975250244
        },
        {
            "text": "phosphomimetic FoxA1 promoted the activation",
            "probability": 0.03788807401424002,
            "start_logit": 2.0121798515319824,
            "end_logit": 0.13857415318489075
        },
        {
            "text": "phosphomimetic",
            "probability": 0.032509393107908596,
            "start_logit": 2.0121798515319824,
            "end_logit": -0.01453317329287529
        },
        {
            "text": "promoted the activation of estrogen signaling, whereas the nonphosphorylatable FoxA1 suppressed its activation",
            "probability": 0.032487502774444545,
            "start_logit": 1.3878957033157349,
            "end_logit": 0.6090773940086365
        },
        {
            "text": "promoted",
            "probability": 0.03234048946909052,
            "start_logit": 1.3878957033157349,
            "end_logit": 0.6045418977737427
        },
        {
            "text": "promoted the activation of estrogen signaling,",
            "probability": 0.03092750601512743,
            "start_logit": 1.3878957033157349,
            "end_logit": 0.5598678588867188
        },
        {
            "text": "promoted the activation of estrogen signaling, whereas the nonphosphorylatable FoxA1 suppressed its activation.",
            "probability": 0.028085972332169903,
            "start_logit": 1.3878957033157349,
            "end_logit": 0.46349215507507324
        },
        {
            "text": "promoted the activation",
            "probability": 0.020294547309920936,
            "start_logit": 1.3878957033157349,
            "end_logit": 0.13857415318489075
        },
        {
            "text": "activation of estrogen signaling",
            "probability": 0.019299219795972558,
            "start_logit": -0.7269946932792664,
            "end_logit": 2.203176975250244
        },
        {
            "text": "estrogen signaling",
            "probability": 0.012756591586584539,
            "start_logit": -1.1410112380981445,
            "end_logit": 2.203176975250244
        },
        {
            "text": "The phosphomimetic FoxA1",
            "probability": 0.012152276317841049,
            "start_logit": 0.34007528424263,
            "end_logit": 0.6735588312149048
        },
        {
            "text": "The phosphomimetic FoxA1 promoted",
            "probability": 0.01134185165291981,
            "start_logit": 0.34007528424263,
            "end_logit": 0.6045418977737427
        },
        {
            "text": "",
            "probability": 0.010868299415211977,
            "start_logit": 0.26009461283683777,
            "end_logit": 0.6418732404708862
        },
        {
            "text": "The phosphomimetic FoxA1 promoted the activation of estrogen signaling,",
            "probability": 0.010846316520769249,
            "start_logit": 0.34007528424263,
            "end_logit": 0.5598678588867188
        },
        {
            "text": "Stimulation with the epidermal growth factor, which activates c-Abl, enhanced the activation of estrogen signaling",
            "probability": 0.010690380000186598,
            "start_logit": -0.019831819459795952,
            "end_logit": 0.9052937030792236
        }
    ],
    "5e369c30b5b409ea53000001_002": [
        {
            "text": "",
            "probability": 0.5229768229516666,
            "start_logit": 0.7596444487571716,
            "end_logit": 1.1757633686065674
        },
        {
            "text": "ChromoTrace",
            "probability": 0.23568300771920625,
            "start_logit": 0.4793732464313507,
            "end_logit": 0.6589851379394531
        },
        {
            "text": "ChromoTrace can assign the 3D positions of the majority of loci with high accuracy and reasonable sensitivity to specific genome sequences",
            "probability": 0.062337049790416314,
            "start_logit": 0.5055913329124451,
            "end_logit": -0.6971647143363953
        },
        {
            "text": "Our reconstruction method, ChromoTrace",
            "probability": 0.04181650077577073,
            "start_logit": -1.2498234510421753,
            "end_logit": 0.6589851379394531
        },
        {
            "text": "ChromoTrace can assign the 3D positions of the majority of loci",
            "probability": 0.02989504438624733,
            "start_logit": 0.5055913329124451,
            "end_logit": -1.4320279359817505
        },
        {
            "text": "We find that ChromoTrace",
            "probability": 0.02543521808153318,
            "start_logit": -1.0909862518310547,
            "end_logit": 0.0029916740022599697
        },
        {
            "text": "reconstruction method, ChromoTrace",
            "probability": 0.015538724050657269,
            "start_logit": -2.239779233932495,
            "end_logit": 0.6589851379394531
        },
        {
            "text": "We find that ChromoTrace can assign the 3D positions of the majority of loci with high accuracy and reasonable sensitivity to specific genome sequences",
            "probability": 0.012628780349599727,
            "start_logit": -1.0909862518310547,
            "end_logit": -0.6971647143363953
        },
        {
            "text": "ChromoTrace can assign the 3D positions of the majority of loci with high accuracy and reasonable sensitivity to specific genome sequences.",
            "probability": 0.011567295873624516,
            "start_logit": 0.5055913329124451,
            "end_logit": -2.3815388679504395
        },
        {
            "text": "We find that ChromoTrace can assign the 3D positions of the majority of loci",
            "probability": 0.006056397445255654,
            "start_logit": -1.0909862518310547,
            "end_logit": -1.4320279359817505
        },
        {
            "text": "can assign the 3D positions of the majority of loci with high accuracy and reasonable sensitivity to specific genome sequences",
            "probability": 0.005815566880493568,
            "start_logit": -1.8664263486862183,
            "end_logit": -0.6971647143363953
        },
        {
            "text": "ChromoTrace can assign the 3D positions of the majority of loci with high accuracy",
            "probability": 0.005491632335189652,
            "start_logit": 0.5055913329124451,
            "end_logit": -3.126495122909546
        },
        {
            "text": "ChromoTrace,",
            "probability": 0.0053181458259171956,
            "start_logit": 0.4793732464313507,
            "end_logit": -3.132377862930298
        },
        {
            "text": "ChromoTrace, uses suffix trees",
            "probability": 0.004377334466134043,
            "start_logit": 0.4793732464313507,
            "end_logit": -3.3270626068115234
        },
        {
            "text": "Our reconstruction method",
            "probability": 0.0030364086175754313,
            "start_logit": -1.2498234510421753,
            "end_logit": -1.9636304378509521
        },
        {
            "text": "can assign the 3D positions of the majority of loci",
            "probability": 0.00278897751189813,
            "start_logit": -1.8664263486862183,
            "end_logit": -1.4320279359817505
        },
        {
            "text": "high accuracy and reasonable sensitivity to specific genome sequences",
            "probability": 0.002550898779844961,
            "start_logit": -2.690518856048584,
            "end_logit": -0.6971647143363953
        },
        {
            "text": "We find that ChromoTrace can assign the 3D positions of the majority of loci with high accuracy and reasonable sensitivity to specific genome sequences.",
            "probability": 0.002343403149779695,
            "start_logit": -1.0909862518310547,
            "end_logit": -2.3815388679504395
        },
        {
            "text": "find that ChromoTrace",
            "probability": 0.0022472176352405244,
            "start_logit": -3.517428159713745,
            "end_logit": 0.0029916740022599697
        },
        {
            "text": "assign the 3D positions of the majority of loci with high accuracy and reasonable sensitivity to specific genome sequences",
            "probability": 0.0020955733739491727,
            "start_logit": -2.8871374130249023,
            "end_logit": -0.6971647143363953
        }
    ],
    "5e2dad57fbd6abf43b000010_001": [
        {
            "text": "",
            "probability": 0.9999872509077378,
            "start_logit": 4.969768047332764,
            "end_logit": 5.50261116027832
        },
        {
            "text": "This review",
            "probability": 1.6679121792110996e-06,
            "start_logit": -1.3994115591049194,
            "end_logit": -1.4321343898773193
        },
        {
            "text": "Extended-release amantadine",
            "probability": 1.2642576133145624e-06,
            "start_logit": -1.5664775371551514,
            "end_logit": -1.5421559810638428
        },
        {
            "text": "Extended-release amantadine (amantadine ER) is the first approved medication for the treatment of dyskinesia",
            "probability": 1.2231843157548882e-06,
            "start_logit": -1.5664775371551514,
            "end_logit": -1.5751835107803345
        },
        {
            "text": "This review discusses the safety and efficacy",
            "probability": 8.687374274735433e-07,
            "start_logit": -1.3994115591049194,
            "end_logit": -2.084421396255493
        },
        {
            "text": "This review discusses the safety",
            "probability": 8.380347003014933e-07,
            "start_logit": -1.3994115591049194,
            "end_logit": -2.1204028129577637
        },
        {
            "text": "safety and efficacy",
            "probability": 8.072757778963586e-07,
            "start_logit": -1.4727871417999268,
            "end_logit": -2.084421396255493
        },
        {
            "text": "safety",
            "probability": 7.787452148314778e-07,
            "start_logit": -1.4727871417999268,
            "end_logit": -2.1204028129577637
        },
        {
            "text": "Extended-release",
            "probability": 6.546216941012804e-07,
            "start_logit": -1.5664775371551514,
            "end_logit": -2.200338840484619
        },
        {
            "text": "This review discusses the safety and efficacy of amantadine ER in dyskinesia in PD patients.",
            "probability": 6.352061848405691e-07,
            "start_logit": -1.3994115591049194,
            "end_logit": -2.397512674331665
        },
        {
            "text": "This",
            "probability": 5.946702919974695e-07,
            "start_logit": -1.3994115591049194,
            "end_logit": -2.4634552001953125
        },
        {
            "text": "safety and efficacy of amantadine ER in dyskinesia in PD patients.",
            "probability": 5.902664611596525e-07,
            "start_logit": -1.4727871417999268,
            "end_logit": -2.397512674331665
        },
        {
            "text": "Extended-release amantadine (amantadine ER",
            "probability": 5.545610070322713e-07,
            "start_logit": -1.5664775371551514,
            "end_logit": -2.3662195205688477
        },
        {
            "text": "Extended-release amantadine (amantadine ER) is the first approved medication for the treatment of dyskinesia.",
            "probability": 3.9349820769358306e-07,
            "start_logit": -1.5664775371551514,
            "end_logit": -2.709319829940796
        },
        {
            "text": "dyskinesia",
            "probability": 3.328587526690878e-07,
            "start_logit": -2.8679721355438232,
            "end_logit": -1.5751835107803345
        },
        {
            "text": "This review discusses",
            "probability": 3.1875008182440737e-07,
            "start_logit": -1.3994115591049194,
            "end_logit": -3.087054967880249
        },
        {
            "text": "discusses the safety and efficacy",
            "probability": 3.180772788535029e-07,
            "start_logit": -2.404158115386963,
            "end_logit": -2.084421396255493
        },
        {
            "text": "discusses the safety",
            "probability": 3.068358615927453e-07,
            "start_logit": -2.404158115386963,
            "end_logit": -2.1204028129577637
        },
        {
            "text": "review",
            "probability": 3.031679311709641e-07,
            "start_logit": -3.104452610015869,
            "end_logit": -1.4321343898773193
        },
        {
            "text": "amantadine ER) is the first approved medication for the treatment of dyskinesia",
            "probability": 2.984312806487236e-07,
            "start_logit": -2.9771506786346436,
            "end_logit": -1.5751835107803345
        }
    ],
    "5e49032df8b2df0d49000008_001": [
        {
            "text": "A single technologist",
            "probability": 0.5462964194684921,
            "start_logit": 4.789270401000977,
            "end_logit": 5.4451799392700195
        },
        {
            "text": "single technologist",
            "probability": 0.31109270269047395,
            "start_logit": 4.226199626922607,
            "end_logit": 5.4451799392700195
        },
        {
            "text": "technologist",
            "probability": 0.08834833394268136,
            "start_logit": 2.9673960208892822,
            "end_logit": 5.4451799392700195
        },
        {
            "text": "A single technologist wore 3 electronic dosimeters for 3 mo, at the front waist, the back waist, and the front collar",
            "probability": 0.017114745633283395,
            "start_logit": 4.789270401000977,
            "end_logit": 1.9819586277008057
        },
        {
            "text": "single technologist wore 3 electronic dosimeters for 3 mo, at the front waist, the back waist, and the front collar",
            "probability": 0.009746123688854233,
            "start_logit": 4.226199626922607,
            "end_logit": 1.9819586277008057
        },
        {
            "text": "A single technologist wore 3 electronic dosimeters for 3 mo, at the front waist, the back waist, and the front collar.",
            "probability": 0.003414777749764037,
            "start_logit": 4.789270401000977,
            "end_logit": 0.37013062834739685
        },
        {
            "text": "A single",
            "probability": 0.002983610770954468,
            "start_logit": 4.789270401000977,
            "end_logit": 0.2351524531841278
        },
        {
            "text": "A single technologist wore 3 electronic dosimeters for 3 mo",
            "probability": 0.0027773991938017423,
            "start_logit": 4.789270401000977,
            "end_logit": 0.16353316605091095
        },
        {
            "text": "technologist wore 3 electronic dosimeters for 3 mo, at the front waist, the back waist, and the front collar",
            "probability": 0.0027678366701075876,
            "start_logit": 2.9673960208892822,
            "end_logit": 1.9819586277008057
        },
        {
            "text": "",
            "probability": 0.002185337610611203,
            "start_logit": 2.3199121952056885,
            "end_logit": 2.3931467533111572
        },
        {
            "text": "A single technologist wore 3 electronic dosimeters",
            "probability": 0.0021468811203825054,
            "start_logit": 4.789270401000977,
            "end_logit": -0.09396563470363617
        },
        {
            "text": "single technologist wore 3 electronic dosimeters for 3 mo, at the front waist, the back waist, and the front collar.",
            "probability": 0.0019445714842776095,
            "start_logit": 4.226199626922607,
            "end_logit": 0.37013062834739685
        },
        {
            "text": "single",
            "probability": 0.0016990401280969176,
            "start_logit": 4.226199626922607,
            "end_logit": 0.2351524531841278
        },
        {
            "text": "single technologist wore 3 electronic dosimeters for 3 mo",
            "probability": 0.0015816113576046617,
            "start_logit": 4.226199626922607,
            "end_logit": 0.16353316605091095
        },
        {
            "text": "A single technologist wore 3 electronic",
            "probability": 0.0013243500327387572,
            "start_logit": 4.789270401000977,
            "end_logit": -0.5770599842071533
        },
        {
            "text": "single technologist wore 3 electronic dosimeters",
            "probability": 0.0012225579855433535,
            "start_logit": 4.226199626922607,
            "end_logit": -0.09396563470363617
        },
        {
            "text": "A",
            "probability": 0.0009818013362981,
            "start_logit": 4.789270401000977,
            "end_logit": -0.876348078250885
        },
        {
            "text": "A single technologist wore 3 electronic dosimeters for 3 mo,",
            "probability": 0.0008177695096780116,
            "start_logit": 4.789270401000977,
            "end_logit": -1.0591565370559692
        },
        {
            "text": "A single techno",
            "probability": 0.0007999683023741511,
            "start_logit": 4.789270401000977,
            "end_logit": -1.0811649560928345
        },
        {
            "text": "single technologist wore 3 electronic",
            "probability": 0.0007541613239818784,
            "start_logit": 4.226199626922607,
            "end_logit": -0.5770599842071533
        }
    ],
    "5e49032df8b2df0d49000008_002": [
        {
            "text": "",
            "probability": 0.36639097635860174,
            "start_logit": 3.536834239959717,
            "end_logit": 4.114029884338379
        },
        {
            "text": "the collar above the apron",
            "probability": 0.20927857365566807,
            "start_logit": 2.6629085540771484,
            "end_logit": 4.427920818328857
        },
        {
            "text": "at the collar above the apron",
            "probability": 0.1702576412899472,
            "start_logit": 2.456555128097534,
            "end_logit": 4.427920818328857
        },
        {
            "text": "collar above the apron",
            "probability": 0.1373017839208124,
            "start_logit": 2.2414236068725586,
            "end_logit": 4.427920818328857
        },
        {
            "text": "dosimeters are worn at the collar above the apron",
            "probability": 0.038173614539770515,
            "start_logit": 0.9613868594169617,
            "end_logit": 4.427920818328857
        },
        {
            "text": "leaded aprons",
            "probability": 0.015953531243373658,
            "start_logit": 1.5261263847351074,
            "end_logit": 2.9907169342041016
        },
        {
            "text": "when dosimeters are worn at the collar above the apron",
            "probability": 0.015244619839769213,
            "start_logit": 0.04346894472837448,
            "end_logit": 4.427920818328857
        },
        {
            "text": "worn at the collar above the apron",
            "probability": 0.007964953191313332,
            "start_logit": -0.6057066321372986,
            "end_logit": 4.427920818328857
        },
        {
            "text": "the collar",
            "probability": 0.007614567654345324,
            "start_logit": 2.6629085540771484,
            "end_logit": 1.114317774772644
        },
        {
            "text": "at the collar",
            "probability": 0.006194797229479531,
            "start_logit": 2.456555128097534,
            "end_logit": 1.114317774772644
        },
        {
            "text": "collar",
            "probability": 0.004995703594805215,
            "start_logit": 2.2414236068725586,
            "end_logit": 1.114317774772644
        },
        {
            "text": "above the apron",
            "probability": 0.004946680733332934,
            "start_logit": -1.0820409059524536,
            "end_logit": 4.427920818328857
        },
        {
            "text": "apron",
            "probability": 0.004291705341452864,
            "start_logit": -1.2240735292434692,
            "end_logit": 4.427920818328857
        },
        {
            "text": "unshielded tissues such as the brain and lens of the eye become less challenging when dosimeters are worn at the collar above the apron",
            "probability": 0.0022024804813460417,
            "start_logit": -1.8911734819412231,
            "end_logit": 4.427920818328857
        },
        {
            "text": "dosimeters were worn over leaded aprons",
            "probability": 0.0019322129501379755,
            "start_logit": -0.5848878622055054,
            "end_logit": 2.9907169342041016
        },
        {
            "text": "the collar above the apron. The absence of leaded aprons",
            "probability": 0.0017151477874113288,
            "start_logit": 2.6629085540771484,
            "end_logit": -0.3762461841106415
        },
        {
            "text": "aprons",
            "probability": 0.001554316815965537,
            "start_logit": -0.8025177121162415,
            "end_logit": 2.9907169342041016
        },
        {
            "text": "at the collar above the apron. The absence of leaded aprons",
            "probability": 0.0013953507597427935,
            "start_logit": 2.456555128097534,
            "end_logit": -0.3762461841106415
        },
        {
            "text": "dosimeters are worn at the collar",
            "probability": 0.0013889409003820887,
            "start_logit": 0.9613868594169617,
            "end_logit": 1.114317774772644
        },
        {
            "text": "torso when dosimeters were worn over leaded aprons",
            "probability": 0.001202401712342134,
            "start_logit": -1.0592328310012817,
            "end_logit": 2.9907169342041016
        }
    ],
    "5e49032df8b2df0d49000008_004": [
        {
            "text": "",
            "probability": 0.9999833296135614,
            "start_logit": 4.679669380187988,
            "end_logit": 5.0284810066223145
        },
        {
            "text": "dosimeter return compliance",
            "probability": 3.630138580411467e-06,
            "start_logit": -2.190615177154541,
            "end_logit": -0.6274574995040894
        },
        {
            "text": "return compliance",
            "probability": 2.9220512037723865e-06,
            "start_logit": -2.407600164413452,
            "end_logit": -0.6274574995040894
        },
        {
            "text": "dose per participant, collective dose, dosimeter return compliance",
            "probability": 1.4780341422852306e-06,
            "start_logit": -3.0891730785369873,
            "end_logit": -0.6274574995040894
        },
        {
            "text": "workers exceeding ALARA levels",
            "probability": 1.2529622444797886e-06,
            "start_logit": -1.7401026487350464,
            "end_logit": -2.141730308532715
        },
        {
            "text": "workers",
            "probability": 1.1524399749318353e-06,
            "start_logit": -1.7401026487350464,
            "end_logit": -2.2253594398498535
        },
        {
            "text": "dosimeter return compliance, and number of workers exceeding ALARA levels",
            "probability": 7.985146336594028e-07,
            "start_logit": -2.190615177154541,
            "end_logit": -2.141730308532715
        },
        {
            "text": "dosimeter return compliance, and number of workers",
            "probability": 7.344516472475322e-07,
            "start_logit": -2.190615177154541,
            "end_logit": -2.2253594398498535
        },
        {
            "text": "Four indicators: dose per participant, collective dose, dosimeter return compliance",
            "probability": 6.90970734315471e-07,
            "start_logit": -3.849543809890747,
            "end_logit": -0.6274574995040894
        },
        {
            "text": "return compliance, and number of workers exceeding ALARA levels",
            "probability": 6.427580090481974e-07,
            "start_logit": -2.407600164413452,
            "end_logit": -2.141730308532715
        },
        {
            "text": "return compliance, and number of workers",
            "probability": 5.911910172060174e-07,
            "start_logit": -2.407600164413452,
            "end_logit": -2.2253594398498535
        },
        {
            "text": "workers exceeding ALARA levels were chosen as meaningful parameters in characterizing the health",
            "probability": 4.310897117695603e-07,
            "start_logit": -1.7401026487350464,
            "end_logit": -3.2086799144744873
        },
        {
            "text": "compliance",
            "probability": 3.655335173785579e-07,
            "start_logit": -4.486283302307129,
            "end_logit": -0.6274574995040894
        },
        {
            "text": "dose per participant, collective dose, dosimeter return compliance, and number of workers exceeding ALARA levels",
            "probability": 3.25120340592949e-07,
            "start_logit": -3.0891730785369873,
            "end_logit": -2.141730308532715
        },
        {
            "text": "dose per participant, collective dose, dosimeter return compliance, and number of workers",
            "probability": 2.9903668591253544e-07,
            "start_logit": -3.0891730785369873,
            "end_logit": -2.2253594398498535
        },
        {
            "text": "workers exceeding ALARA levels were chosen as meaningful parameters in characterizing the health of the program",
            "probability": 2.8513466606043675e-07,
            "start_logit": -1.7401026487350464,
            "end_logit": -3.6220345497131348
        },
        {
            "text": "dosimeter return",
            "probability": 2.79112157932471e-07,
            "start_logit": -2.190615177154541,
            "end_logit": -3.1928699016571045
        },
        {
            "text": "dosimeter return compliance, and number of workers exceeding ALARA levels were chosen as meaningful parameters in characterizing the health",
            "probability": 2.7473409097887684e-07,
            "start_logit": -2.190615177154541,
            "end_logit": -3.2086799144744873
        },
        {
            "text": "benchmarks developed based on more than 1 million monitored workers",
            "probability": 2.686571340877587e-07,
            "start_logit": -3.867543935775757,
            "end_logit": -1.5541188716888428
        },
        {
            "text": "workers exceeding ALARA levels were chosen as meaningful parameters in characterizing the health of the program.",
            "probability": 2.4845594681098095e-07,
            "start_logit": -1.7401026487350464,
            "end_logit": -3.759730577468872
        }
    ],
    "5e2f9596fbd6abf43b00002f_001": [
        {
            "text": "alacrima, achalasia and adrenal insufficiency",
            "probability": 0.6735281640795128,
            "start_logit": 3.870166063308716,
            "end_logit": 5.356211185455322
        },
        {
            "text": "a classical clinical triad: alacrima, achalasia and adrenal insufficiency",
            "probability": 0.08067255775235094,
            "start_logit": 1.7480347156524658,
            "end_logit": 5.356211185455322
        },
        {
            "text": "alacrima, achalasia and adrenal insufficiency, the canonic symptoms that are associated with progressive peripheral neuropathy",
            "probability": 0.07199948558233969,
            "start_logit": 3.870166063308716,
            "end_logit": 3.120340347290039
        },
        {
            "text": "classical clinical triad: alacrima, achalasia and adrenal insufficiency",
            "probability": 0.05059567585463023,
            "start_logit": 1.281502366065979,
            "end_logit": 5.356211185455322
        },
        {
            "text": "clinical triad: alacrima, achalasia and adrenal insufficiency",
            "probability": 0.04531067096574908,
            "start_logit": 1.1711788177490234,
            "end_logit": 5.356211185455322
        },
        {
            "text": "It is characterized by a classical clinical triad: alacrima, achalasia and adrenal insufficiency",
            "probability": 0.012010824922742684,
            "start_logit": -0.1565554291009903,
            "end_logit": 5.356211185455322
        },
        {
            "text": "alacrima, achalasia and adrenal insufficiency, the canonic symptoms",
            "probability": 0.009878539774553547,
            "start_logit": 3.870166063308716,
            "end_logit": 1.1340460777282715
        },
        {
            "text": "characterized by a classical clinical triad: alacrima, achalasia and adrenal insufficiency",
            "probability": 0.00897029272949582,
            "start_logit": -0.4484454393386841,
            "end_logit": 5.356211185455322
        },
        {
            "text": "canonic symptoms that are associated with progressive peripheral neuropathy",
            "probability": 0.006755091533448025,
            "start_logit": 1.5038036108016968,
            "end_logit": 3.120340347290039
        },
        {
            "text": "progressive peripheral neuropathy",
            "probability": 0.006624517574984572,
            "start_logit": 1.4842846393585205,
            "end_logit": 3.120340347290039
        },
        {
            "text": "the canonic symptoms that are associated with progressive peripheral neuropathy",
            "probability": 0.005676163226315487,
            "start_logit": 1.3297826051712036,
            "end_logit": 3.120340347290039
        },
        {
            "text": "adrenal insufficiency",
            "probability": 0.005416180811875157,
            "start_logit": -0.9529728293418884,
            "end_logit": 5.356211185455322
        },
        {
            "text": "alacrima, achalasia and adrenal insufficiency, the canonic",
            "probability": 0.004739605254251229,
            "start_logit": 3.870166063308716,
            "end_logit": 0.3996352255344391
        },
        {
            "text": "triad: alacrima, achalasia and adrenal insufficiency",
            "probability": 0.004471946076131397,
            "start_logit": -1.1445400714874268,
            "end_logit": 5.356211185455322
        },
        {
            "text": "alacrima, achalasia",
            "probability": 0.003423786784163788,
            "start_logit": 3.870166063308716,
            "end_logit": 0.07442855834960938
        },
        {
            "text": "achalasia and adrenal insufficiency",
            "probability": 0.0031720562773983945,
            "start_logit": -1.4879837036132812,
            "end_logit": 5.356211185455322
        },
        {
            "text": "alacrima, achalasia and adrenal insufficiency,",
            "probability": 0.0025905701936991972,
            "start_logit": 3.870166063308716,
            "end_logit": -0.2044406235218048
        },
        {
            "text": "alacrima, achalasia and adrenal insufficiency, the canonic symptoms that are associated with progressive peripheral neuropathy.",
            "probability": 0.001239346461915541,
            "start_logit": 3.870166063308716,
            "end_logit": -0.9417344331741333
        },
        {
            "text": "by a classical clinical triad: alacrima, achalasia and adrenal insufficiency",
            "probability": 0.001204101060659413,
            "start_logit": -2.4566304683685303,
            "end_logit": 5.356211185455322
        },
        {
            "text": "a classical clinical triad: alacrima, achalasia and adrenal insufficiency, the canonic symptoms",
            "probability": 0.0011832126894956187,
            "start_logit": 1.7480347156524658,
            "end_logit": 1.1340460777282715
        },
        {
            "text": "",
            "probability": 0.0005372103942878191,
            "start_logit": 0.7955719232559204,
            "end_logit": 1.296910047531128
        }
    ],
    "5e2f9596fbd6abf43b00002f_002": [
        {
            "text": "",
            "probability": 0.597980324390873,
            "start_logit": 2.289677858352661,
            "end_logit": 2.9059386253356934
        },
        {
            "text": "adrenal insufficiency and alacrima",
            "probability": 0.11638830809101057,
            "start_logit": 1.2459619045257568,
            "end_logit": 2.3130288124084473
        },
        {
            "text": "adrenocorticotropic hormone-resistant adrenal insufficiency, alacrima, achalasia",
            "probability": 0.10319938615864323,
            "start_logit": 1.982596516609192,
            "end_logit": 1.456125020980835
        },
        {
            "text": "adrenocorticotropic hormone-resistant adrenal insufficiency",
            "probability": 0.07606263149771139,
            "start_logit": 1.982596516609192,
            "end_logit": 1.1510192155838013
        },
        {
            "text": "neurological and dermatological abnormalities",
            "probability": 0.013155507139168346,
            "start_logit": -2.153390645980835,
            "end_logit": 3.532289743423462
        },
        {
            "text": "usually adrenal insufficiency and alacrima",
            "probability": 0.012039853903100577,
            "start_logit": -1.0227478742599487,
            "end_logit": 2.3130288124084473
        },
        {
            "text": "alacrima, achalasia, and neurological and dermatological abnormalities",
            "probability": 0.010788685036100809,
            "start_logit": -2.3517332077026367,
            "end_logit": 3.532289743423462
        },
        {
            "text": "adrenal insufficiency, alacrima, achalasia, and neurological and dermatological abnormalities",
            "probability": 0.010012797915803522,
            "start_logit": -2.4263670444488525,
            "end_logit": 3.532289743423462
        },
        {
            "text": "at least two symptoms, usually adrenal insufficiency and alacrima",
            "probability": 0.008164112946190826,
            "start_logit": -1.4112221002578735,
            "end_logit": 2.3130288124084473
        },
        {
            "text": "achalasia, and neurological and dermatological abnormalities",
            "probability": 0.00793007743966192,
            "start_logit": -2.6595683097839355,
            "end_logit": 3.532289743423462
        },
        {
            "text": "adrenocorticotropic hormone-resistant adrenal insufficiency, alacrima",
            "probability": 0.007741970144585581,
            "start_logit": 1.982596516609192,
            "end_logit": -1.133881688117981
        },
        {
            "text": "characterised by adrenocorticotropic hormone-resistant adrenal insufficiency, alacrima, achalasia",
            "probability": 0.006850076268804734,
            "start_logit": -0.7298066020011902,
            "end_logit": 1.456125020980835
        },
        {
            "text": "characterised by adrenocorticotropic hormone-resistant adrenal insufficiency",
            "probability": 0.005048817113740886,
            "start_logit": -0.7298066020011902,
            "end_logit": 1.1510192155838013
        },
        {
            "text": "TAS",
            "probability": 0.005044362000195805,
            "start_logit": 0.10710383206605911,
            "end_logit": 0.31322598457336426
        },
        {
            "text": "abnormalities",
            "probability": 0.0049000977732382885,
            "start_logit": -3.1409759521484375,
            "end_logit": 3.532289743423462
        },
        {
            "text": "achalasia, alacrima, adrenal insufficiency, neurological impairment, and dermatological abnormalities",
            "probability": 0.0034899641517217948,
            "start_logit": -0.7305974960327148,
            "end_logit": 0.7825475931167603
        },
        {
            "text": "two symptoms, usually adrenal insufficiency and alacrima",
            "probability": 0.0034110424336530588,
            "start_logit": -2.283952236175537,
            "end_logit": 2.3130288124084473
        },
        {
            "text": "adrenal insufficiency",
            "probability": 0.003274378904455197,
            "start_logit": 1.2459619045257568,
            "end_logit": -1.257775068283081
        },
        {
            "text": "adrenal insufficiency and alacrima.",
            "probability": 0.0023828219573548237,
            "start_logit": 1.2459619045257568,
            "end_logit": -1.575617790222168
        },
        {
            "text": "adrenal insufficiency, neurological impairment, and dermatological abnormalities",
            "probability": 0.0021347847339857045,
            "start_logit": -1.222123146057129,
            "end_logit": 0.7825475931167603
        }
    ],
    "5e2f9596fbd6abf43b00002f_003": [
        {
            "text": "alacrima, achalasia, adrenal insufficiency and autonomic/neurological abnormalities",
            "probability": 0.39896047546409097,
            "start_logit": 1.2993566989898682,
            "end_logit": 4.550837516784668
        },
        {
            "text": "characterized by alacrima, achalasia, adrenal insufficiency and autonomic/neurological abnormalities",
            "probability": 0.32882964281540894,
            "start_logit": 1.1060341596603394,
            "end_logit": 4.550837516784668
        },
        {
            "text": "autonomic/neurological abnormalities",
            "probability": 0.11539433647964575,
            "start_logit": 0.05884962156414986,
            "end_logit": 4.550837516784668
        },
        {
            "text": "",
            "probability": 0.0472506177286804,
            "start_logit": 1.404186725616455,
            "end_logit": 2.3126108646392822
        },
        {
            "text": "abnormalities",
            "probability": 0.01311734743213654,
            "start_logit": -2.115570068359375,
            "end_logit": 4.550837516784668
        },
        {
            "text": "by alacrima, achalasia, adrenal insufficiency and autonomic/neurological abnormalities",
            "probability": 0.012740441255158965,
            "start_logit": -2.1447243690490723,
            "end_logit": 4.550837516784668
        },
        {
            "text": "alacrima, achalasia, adrenal insufficiency",
            "probability": 0.011165901693626846,
            "start_logit": 1.2993566989898682,
            "end_logit": 0.9748398065567017
        },
        {
            "text": "achalasia, adrenal insufficiency and autonomic/neurological abnormalities",
            "probability": 0.009698780454891554,
            "start_logit": -2.4175055027008057,
            "end_logit": 4.550837516784668
        },
        {
            "text": "characterized by alacrima, achalasia, adrenal insufficiency",
            "probability": 0.009203115825837641,
            "start_logit": 1.1060341596603394,
            "end_logit": 0.9748398065567017
        },
        {
            "text": "alacrima, achalasia",
            "probability": 0.007898013777501293,
            "start_logit": 1.2993566989898682,
            "end_logit": 0.62858647108078
        },
        {
            "text": "alacrima, achalasia, adrenal insufficiency and autonomic/neurological",
            "probability": 0.007741734442605802,
            "start_logit": 1.2993566989898682,
            "end_logit": 0.608600914478302
        },
        {
            "text": "adrenal insufficiency and autonomic/neurological abnormalities",
            "probability": 0.007518220928687919,
            "start_logit": -2.6721761226654053,
            "end_logit": 4.550837516784668
        },
        {
            "text": "characterized by alacrima, achalasia",
            "probability": 0.006509670027803755,
            "start_logit": 1.1060341596603394,
            "end_logit": 0.62858647108078
        },
        {
            "text": "characterized by alacrima, achalasia, adrenal insufficiency and autonomic/neurological",
            "probability": 0.006380862085580067,
            "start_logit": 1.1060341596603394,
            "end_logit": 0.608600914478302
        },
        {
            "text": "abnormalities.",
            "probability": 0.004330520872626142,
            "start_logit": -3.223817825317383,
            "end_logit": 4.550837516784668
        },
        {
            "text": "alacrima, achalasia, adrenal insufficiency and autonomic/neurological abnormalities.",
            "probability": 0.003687624837045156,
            "start_logit": 1.2993566989898682,
            "end_logit": -0.13304226100444794
        },
        {
            "text": "characterized by alacrima, achalasia, adrenal insufficiency and autonomic/neurological abnormalities.",
            "probability": 0.003039399721469229,
            "start_logit": 1.1060341596603394,
            "end_logit": -0.13304226100444794
        },
        {
            "text": "alacrima",
            "probability": 0.0023539393996559964,
            "start_logit": 1.2993566989898682,
            "end_logit": -0.5819345712661743
        },
        {
            "text": "autonomic/neurological",
            "probability": 0.0022392000314490406,
            "start_logit": 0.05884962156414986,
            "end_logit": 0.608600914478302
        },
        {
            "text": "characterized by alacrima",
            "probability": 0.0019401547260980954,
            "start_logit": 1.1060341596603394,
            "end_logit": -0.5819345712661743
        }
    ],
    "5e2f9596fbd6abf43b00002f_004": [
        {
            "text": "esophageal achalasia, adrenocorticotropic hormone refractoriness, and alacrima",
            "probability": 0.5480084806459381,
            "start_logit": 4.17051887512207,
            "end_logit": 4.4819655418396
        },
        {
            "text": "esophageal achalasia",
            "probability": 0.22950671661244007,
            "start_logit": 4.17051887512207,
            "end_logit": 3.611607074737549
        },
        {
            "text": "three signs: esophageal achalasia, adrenocorticotropic hormone refractoriness, and alacrima",
            "probability": 0.06567977146520614,
            "start_logit": 2.0490190982818604,
            "end_logit": 4.4819655418396
        },
        {
            "text": "esophageal achalasia, adrenocorticotropic hormone refractoriness",
            "probability": 0.042418667306259664,
            "start_logit": 4.17051887512207,
            "end_logit": 1.9232633113861084
        },
        {
            "text": "three signs",
            "probability": 0.03295977217060324,
            "start_logit": 2.0490190982818604,
            "end_logit": 3.7924623489379883
        },
        {
            "text": "three signs: esophageal achalasia",
            "probability": 0.027506779966374267,
            "start_logit": 2.0490190982818604,
            "end_logit": 3.611607074737549
        },
        {
            "text": "adrenocorticotropic hormone refractoriness, and alacrima",
            "probability": 0.008516785297802016,
            "start_logit": 0.006267069838941097,
            "end_logit": 4.4819655418396
        },
        {
            "text": "alacrima",
            "probability": 0.008016699195774647,
            "start_logit": -0.05424512177705765,
            "end_logit": 4.4819655418396
        },
        {
            "text": "characterized by three signs",
            "probability": 0.00676424334009516,
            "start_logit": 0.4653817117214203,
            "end_logit": 3.7924623489379883
        },
        {
            "text": "characterized by three signs: esophageal achalasia",
            "probability": 0.005645140756190025,
            "start_logit": 0.4653817117214203,
            "end_logit": 3.611607074737549
        },
        {
            "text": "signs: esophageal achalasia, adrenocorticotropic hormone refractoriness, and alacrima",
            "probability": 0.005332525656398067,
            "start_logit": -0.46194690465927124,
            "end_logit": 4.4819655418396
        },
        {
            "text": "three signs: esophageal achalasia, adrenocorticotropic hormone refractoriness",
            "probability": 0.0050839512031817975,
            "start_logit": 2.0490190982818604,
            "end_logit": 1.9232633113861084
        },
        {
            "text": "signs",
            "probability": 0.002675996380740835,
            "start_logit": -0.46194690465927124,
            "end_logit": 3.7924623489379883
        },
        {
            "text": "esophageal achalasia, adrenocorticotropic hormone refractoriness, and alacrima.",
            "probability": 0.0026287976770867534,
            "start_logit": 4.17051887512207,
            "end_logit": -0.8577986359596252
        },
        {
            "text": "three",
            "probability": 0.0023522646037247045,
            "start_logit": 2.0490190982818604,
            "end_logit": 1.1525530815124512
        },
        {
            "text": "signs: esophageal achalasia",
            "probability": 0.002233269188113592,
            "start_logit": -0.46194690465927124,
            "end_logit": 3.611607074737549
        },
        {
            "text": "by three signs: esophageal achalasia, adrenocorticotropic hormone refractoriness, and alacrima",
            "probability": 0.0013171879485415774,
            "start_logit": -1.860272765159607,
            "end_logit": 4.4819655418396
        },
        {
            "text": "",
            "probability": 0.001207259265680535,
            "start_logit": 1.0979863405227661,
            "end_logit": 1.436560034751892
        },
        {
            "text": "achalasia, adrenocorticotropic hormone refractoriness, and alacrima",
            "probability": 0.0011023260050192585,
            "start_logit": -2.0383493900299072,
            "end_logit": 4.4819655418396
        },
        {
            "text": "characterized by three signs: esophageal achalasia, adrenocorticotropic hormone refractoriness",
            "probability": 0.0010433653148295367,
            "start_logit": 0.4653817117214203,
            "end_logit": 1.9232633113861084
        }
    ],
    "5e2f9596fbd6abf43b00002f_005": [
        {
            "text": "",
            "probability": 0.7358165329432154,
            "start_logit": 3.836707830429077,
            "end_logit": 4.813899040222168
        },
        {
            "text": "hypoglycemic seizures at the severe end of the spectrum to insidious hyperpigmentation and delayed development",
            "probability": 0.13433937136876253,
            "start_logit": 3.346971035003662,
            "end_logit": 3.6030242443084717
        },
        {
            "text": "hypoglycemic seizures",
            "probability": 0.060394430379091674,
            "start_logit": 3.346971035003662,
            "end_logit": 2.8035519123077393
        },
        {
            "text": "achalasia, alacrima and adrenal insufficiency",
            "probability": 0.01884897248489263,
            "start_logit": 2.0187058448791504,
            "end_logit": 2.967378616333008
        },
        {
            "text": "insidious hyperpigmentation and delayed development",
            "probability": 0.011554618819652293,
            "start_logit": 0.8936870694160461,
            "end_logit": 3.6030242443084717
        },
        {
            "text": "hypoglycemic seizures at the severe end of the spectrum to insidious hyperpigmentation",
            "probability": 0.008805846421920357,
            "start_logit": 3.346971035003662,
            "end_logit": 0.8780708909034729
        },
        {
            "text": "hypoglycemic seizures at the severe end of the spectrum to insidious hyperpigmentation and delayed development.",
            "probability": 0.004746976107925528,
            "start_logit": 3.346971035003662,
            "end_logit": 0.2601628303527832
        },
        {
            "text": "achalasia, alacrima and adrenal insufficiency with neurological manifestations",
            "probability": 0.004446427158407386,
            "start_logit": 2.0187058448791504,
            "end_logit": 1.5230211019515991
        },
        {
            "text": "hypoglycemic seizures at the severe end of the spectrum",
            "probability": 0.003914137376532098,
            "start_logit": 3.346971035003662,
            "end_logit": 0.06724999099969864
        },
        {
            "text": "seizures at the severe end of the spectrum to insidious hyperpigmentation and delayed development",
            "probability": 0.0037551773650895924,
            "start_logit": -0.2302626669406891,
            "end_logit": 3.6030242443084717
        },
        {
            "text": "hyperpigmentation and delayed development",
            "probability": 0.003317555118051354,
            "start_logit": -0.3541700839996338,
            "end_logit": 3.6030242443084717
        },
        {
            "text": "hypoglycemic",
            "probability": 0.0017269944742226825,
            "start_logit": 3.346971035003662,
            "end_logit": -0.7509623765945435
        },
        {
            "text": "seizures",
            "probability": 0.0016882005299436692,
            "start_logit": -0.2302626669406891,
            "end_logit": 2.8035519123077393
        },
        {
            "text": "from hypoglycemic seizures at the severe end of the spectrum to insidious hyperpigmentation and delayed development",
            "probability": 0.0012138260259045458,
            "start_logit": -1.3596208095550537,
            "end_logit": 3.6030242443084717
        },
        {
            "text": "achalasia, alacrima and adrenal insufficiency with neurological",
            "probability": 0.0011585333436716012,
            "start_logit": 2.0187058448791504,
            "end_logit": 0.17807506024837494
        },
        {
            "text": "adrenal insufficiency",
            "probability": 0.0009799086514214567,
            "start_logit": -0.9380484819412231,
            "end_logit": 2.967378616333008
        },
        {
            "text": "neurological manifestations",
            "probability": 0.0009577087595708416,
            "start_logit": 0.4833934009075165,
            "end_logit": 1.5230211019515991
        },
        {
            "text": "ranging from hypoglycemic seizures at the severe end of the spectrum to insidious hyperpigmentation and delayed development",
            "probability": 0.0009348708595053584,
            "start_logit": -1.620745062828064,
            "end_logit": 3.6030242443084717
        },
        {
            "text": "insidious hyperpigmentation",
            "probability": 0.0007573967166363256,
            "start_logit": 0.8936870694160461,
            "end_logit": 0.8780708909034729
        },
        {
            "text": "achalasia",
            "probability": 0.0006425150955826978,
            "start_logit": 2.0187058448791504,
            "end_logit": -0.411444753408432
        }
    ],
    "5e2f9596fbd6abf43b00002f_006": [
        {
            "text": "achalasia, alacrimia and adrenal insufficiency",
            "probability": 0.7196771097364894,
            "start_logit": 6.361187934875488,
            "end_logit": 8.072093963623047
        },
        {
            "text": "the triad of achalasia, alacrimia and adrenal insufficiency",
            "probability": 0.12375126349197273,
            "start_logit": 4.600658893585205,
            "end_logit": 8.072093963623047
        },
        {
            "text": "triad of achalasia, alacrimia and adrenal insufficiency",
            "probability": 0.09050201489992549,
            "start_logit": 4.287757396697998,
            "end_logit": 8.072093963623047
        },
        {
            "text": "characterized by the triad of achalasia, alacrimia and adrenal insufficiency",
            "probability": 0.03202410515503811,
            "start_logit": 3.2488741874694824,
            "end_logit": 8.072093963623047
        },
        {
            "text": "achalasia",
            "probability": 0.012373951726151133,
            "start_logit": 6.361187934875488,
            "end_logit": 4.008884906768799
        },
        {
            "text": "achalasia, alacrimia and adrenal insufficiency.",
            "probability": 0.004932536682702366,
            "start_logit": 6.361187934875488,
            "end_logit": 3.089144706726074
        },
        {
            "text": "alacrimia and adrenal insufficiency",
            "probability": 0.002825636050506262,
            "start_logit": 0.8211187720298767,
            "end_logit": 8.072093963623047
        },
        {
            "text": "the triad of achalasia",
            "probability": 0.002127748874853841,
            "start_logit": 4.600658893585205,
            "end_logit": 4.008884906768799
        },
        {
            "text": "adrenal insufficiency",
            "probability": 0.0019642976585145504,
            "start_logit": 0.4575200378894806,
            "end_logit": 8.072093963623047
        },
        {
            "text": "triad of achalasia",
            "probability": 0.0015560694488409247,
            "start_logit": 4.287757396697998,
            "end_logit": 4.008884906768799
        },
        {
            "text": "by the triad of achalasia, alacrimia and adrenal insufficiency",
            "probability": 0.0014614867402349032,
            "start_logit": 0.16183951497077942,
            "end_logit": 8.072093963623047
        },
        {
            "text": "achalasia, alacrimia",
            "probability": 0.0011613864656821499,
            "start_logit": 6.361187934875488,
            "end_logit": 1.642905831336975
        },
        {
            "text": "achalasia, alacrimia and adrenal",
            "probability": 0.0011595439391528413,
            "start_logit": 6.361187934875488,
            "end_logit": 1.6413180828094482
        },
        {
            "text": "insufficiency.",
            "probability": 0.0011404339245836821,
            "start_logit": -0.08620589226484299,
            "end_logit": 8.072093963623047
        },
        {
            "text": "triad of achalasia, alacrimia and adrenal insufficiency.",
            "probability": 0.0010844310804739023,
            "start_logit": -0.13655921816825867,
            "end_logit": 8.072093963623047
        },
        {
            "text": "the triad of achalasia, alacrimia and adrenal insufficiency.",
            "probability": 0.0008481687668632716,
            "start_logit": 4.600658893585205,
            "end_logit": 3.089144706726074
        },
        {
            "text": "characterized by the triad of achalasia",
            "probability": 0.0005506146102197444,
            "start_logit": 3.2488741874694824,
            "end_logit": 4.008884906768799
        },
        {
            "text": "the triad",
            "probability": 0.000360671666915887,
            "start_logit": 4.600658893585205,
            "end_logit": 2.2340331077575684
        },
        {
            "text": "triad",
            "probability": 0.0002637671054996534,
            "start_logit": 4.287757396697998,
            "end_logit": 2.2340331077575684
        },
        {
            "text": "characterized by the triad of achalasia, alacrimia and adrenal insufficiency.",
            "probability": 0.000219487421888103,
            "start_logit": 3.2488741874694824,
            "end_logit": 3.089144706726074
        },
        {
            "text": "",
            "probability": 1.5274553490436392e-05,
            "start_logit": 1.5506349802017212,
            "end_logit": 2.12227725982666
        }
    ],
    "5ca61f17ecadf2e73f000050_001": [
        {
            "text": "",
            "probability": 0.9712212624705555,
            "start_logit": 4.657156944274902,
            "end_logit": 5.414938449859619
        },
        {
            "text": "Modifications of histones",
            "probability": 0.007862978412958155,
            "start_logit": 2.8626816272735596,
            "end_logit": 2.3930249214172363
        },
        {
            "text": "Modifications of histones further lead to repressed, activated or poised gene transcription",
            "probability": 0.006378463112141112,
            "start_logit": 2.8626816272735596,
            "end_logit": 2.183786630630493
        },
        {
            "text": "Modifications of histones further lead to repressed",
            "probability": 0.0027810738522236703,
            "start_logit": 2.8626816272735596,
            "end_logit": 1.353696584701538
        },
        {
            "text": "repressed, activated or poised gene transcription",
            "probability": 0.001850039380721895,
            "start_logit": 1.6249613761901855,
            "end_logit": 2.183786630630493
        },
        {
            "text": "DNA is wrapped around histones that are subjected to chemical modifications. Modifications of histones",
            "probability": 0.0011548054568668294,
            "start_logit": 0.9444480538368225,
            "end_logit": 2.3930249214172363
        },
        {
            "text": "DNA is wrapped around histones that are subjected to chemical modifications",
            "probability": 0.0011522307193520336,
            "start_logit": 0.9444480538368225,
            "end_logit": 2.3907928466796875
        },
        {
            "text": "DNA is wrapped around histones that are subjected to chemical modifications. Modifications of histones further lead to repressed, activated or poised gene transcription",
            "probability": 0.0009367803930614117,
            "start_logit": 0.9444480538368225,
            "end_logit": 2.183786630630493
        },
        {
            "text": "Modifications of histones further lead to repressed, activated",
            "probability": 0.0008139842407003354,
            "start_logit": 2.8626816272735596,
            "end_logit": 0.12504518032073975
        },
        {
            "text": "repressed",
            "probability": 0.0008066357140980057,
            "start_logit": 1.6249613761901855,
            "end_logit": 1.353696584701538
        },
        {
            "text": "histones",
            "probability": 0.0006125753229047577,
            "start_logit": 0.3104327917098999,
            "end_logit": 2.3930249214172363
        },
        {
            "text": "Modifications of histones further lead to repressed, activated or poised",
            "probability": 0.000570408665586989,
            "start_logit": 2.8626816272735596,
            "end_logit": -0.23054276406764984
        },
        {
            "text": "DNA is wrapped around histones",
            "probability": 0.0005522119138685531,
            "start_logit": 0.9444480538368225,
            "end_logit": 1.6552696228027344
        },
        {
            "text": "histones that are subjected to chemical modifications. Modifications of histones",
            "probability": 0.0005276397894208301,
            "start_logit": 0.1611747145652771,
            "end_logit": 2.3930249214172363
        },
        {
            "text": "histones that are subjected to chemical modifications",
            "probability": 0.0005264633713912455,
            "start_logit": 0.1611747145652771,
            "end_logit": 2.3907928466796875
        },
        {
            "text": "histones further lead to repressed, activated or poised gene transcription",
            "probability": 0.0004969222723690468,
            "start_logit": 0.3104327917098999,
            "end_logit": 2.183786630630493
        },
        {
            "text": "wrapped around histones that are subjected to chemical modifications. Modifications of histones",
            "probability": 0.0004422599802741239,
            "start_logit": -0.015341219492256641,
            "end_logit": 2.3930249214172363
        },
        {
            "text": "wrapped around histones that are subjected to chemical modifications",
            "probability": 0.00044127392382995524,
            "start_logit": -0.015341219492256641,
            "end_logit": 2.3907928466796875
        },
        {
            "text": "poised gene transcription",
            "probability": 0.0004399575035803356,
            "start_logit": 0.18867731094360352,
            "end_logit": 2.183786630630493
        },
        {
            "text": "chemical modifications. Modifications of histones",
            "probability": 0.00043203350409562485,
            "start_logit": -0.03873597830533981,
            "end_logit": 2.3930249214172363
        }
    ],
    "5ca61f17ecadf2e73f000050_002": [
        {
            "text": "",
            "probability": 0.9906812679991034,
            "start_logit": 4.402896881103516,
            "end_logit": 4.907115459442139
        },
        {
            "text": "a structural backbone poised to integrate novel regulatory inputs, and a highly adaptive transcriptional readout",
            "probability": 0.0014186908148678316,
            "start_logit": 1.3919161558151245,
            "end_logit": 1.36943781375885
        },
        {
            "text": "a structural backbone poised to integrate novel regulatory inputs",
            "probability": 0.0010467829359177467,
            "start_logit": 1.3919161558151245,
            "end_logit": 1.065424919128418
        },
        {
            "text": "a structural backbone",
            "probability": 0.0009736652873937113,
            "start_logit": 1.3919161558151245,
            "end_logit": 0.9930156469345093
        },
        {
            "text": "structural backbone poised to integrate novel regulatory inputs, and a highly adaptive transcriptional readout",
            "probability": 0.0007918531158298131,
            "start_logit": 0.8088023066520691,
            "end_logit": 1.36943781375885
        },
        {
            "text": "preexistence of a structural backbone poised to integrate novel regulatory inputs, and a highly adaptive transcriptional readout",
            "probability": 0.0006371046189957546,
            "start_logit": 0.5913602709770203,
            "end_logit": 1.36943781375885
        },
        {
            "text": "structural backbone poised to integrate novel regulatory inputs",
            "probability": 0.0005842698921548804,
            "start_logit": 0.8088023066520691,
            "end_logit": 1.065424919128418
        },
        {
            "text": "topologically associating domains",
            "probability": 0.000545743757700108,
            "start_logit": 0.7441204190254211,
            "end_logit": 1.061893343925476
        },
        {
            "text": "structural backbone",
            "probability": 0.0005434587180786597,
            "start_logit": 0.8088023066520691,
            "end_logit": 0.9930156469345093
        },
        {
            "text": "preexistence of a structural backbone poised to integrate novel regulatory inputs",
            "probability": 0.0004700885045352635,
            "start_logit": 0.5913602709770203,
            "end_logit": 1.065424919128418
        },
        {
            "text": "preexistence of a structural backbone",
            "probability": 0.00043725288516240475,
            "start_logit": 0.5913602709770203,
            "end_logit": 0.9930156469345093
        },
        {
            "text": "the preexistence of a structural backbone poised to integrate novel regulatory inputs, and a highly adaptive transcriptional readout",
            "probability": 0.000381834462774847,
            "start_logit": 0.07941356301307678,
            "end_logit": 1.36943781375885
        },
        {
            "text": "the preexistence of a structural backbone poised to integrate novel regulatory inputs",
            "probability": 0.0002817370746248658,
            "start_logit": 0.07941356301307678,
            "end_logit": 1.065424919128418
        },
        {
            "text": "the preexistence of a structural backbone",
            "probability": 0.00026205777752154585,
            "start_logit": 0.07941356301307678,
            "end_logit": 0.9930156469345093
        },
        {
            "text": "poised to integrate novel regulatory inputs, and a highly adaptive transcriptional readout",
            "probability": 0.0001737104621093683,
            "start_logit": -0.7081837058067322,
            "end_logit": 1.36943781375885
        },
        {
            "text": "highly adaptive transcriptional readout",
            "probability": 0.00016294274674728446,
            "start_logit": -0.7721747159957886,
            "end_logit": 1.36943781375885
        },
        {
            "text": "a structural backbone poised to integrate novel regulatory inputs,",
            "probability": 0.00015694512872768847,
            "start_logit": 1.3919161558151245,
            "end_logit": -0.832155704498291
        },
        {
            "text": "both the preexistence of a structural backbone poised to integrate novel regulatory inputs, and a highly adaptive transcriptional readout",
            "probability": 0.0001517307222863387,
            "start_logit": -0.8434662222862244,
            "end_logit": 1.36943781375885
        },
        {
            "text": "adaptive transcriptional readout",
            "probability": 0.00014953975882922514,
            "start_logit": -0.8580113053321838,
            "end_logit": 1.36943781375885
        },
        {
            "text": "topologically associating domains (TADs)",
            "probability": 0.00014932333663927812,
            "start_logit": 0.7441204190254211,
            "end_logit": -0.2341422140598297
        }
    ],
    "5ca61f17ecadf2e73f000050_003": [
        {
            "text": "the PRC2 complex",
            "probability": 0.2244838482246978,
            "start_logit": 4.457943916320801,
            "end_logit": 5.067506790161133
        },
        {
            "text": "the PRC2 complex is sequestered",
            "probability": 0.20547154369744183,
            "start_logit": 4.457943916320801,
            "end_logit": 4.979010581970215
        },
        {
            "text": "PRC2 complex",
            "probability": 0.18741102610874658,
            "start_logit": 4.277444362640381,
            "end_logit": 5.067506790161133
        },
        {
            "text": "PRC2 complex is sequestered",
            "probability": 0.17153854562374304,
            "start_logit": 4.277444362640381,
            "end_logit": 4.979010581970215
        },
        {
            "text": "",
            "probability": 0.0895382833877671,
            "start_logit": 3.9979071617126465,
            "end_logit": 4.608406066894531
        },
        {
            "text": "the PRC2",
            "probability": 0.0325426571472189,
            "start_logit": 4.457943916320801,
            "end_logit": 3.1362547874450684
        },
        {
            "text": "PRC2",
            "probability": 0.02716833668211516,
            "start_logit": 4.277444362640381,
            "end_logit": 3.1362547874450684
        },
        {
            "text": "sequestered",
            "probability": 0.023906563214613635,
            "start_logit": 2.3067893981933594,
            "end_logit": 4.979010581970215
        },
        {
            "text": "that the PRC2 complex",
            "probability": 0.008843223345222088,
            "start_logit": 1.2237915992736816,
            "end_logit": 5.067506790161133
        },
        {
            "text": "that the PRC2 complex is sequestered",
            "probability": 0.008094260528647368,
            "start_logit": 1.2237915992736816,
            "end_logit": 4.979010581970215
        },
        {
            "text": "the PRC2 complex is sequestered at poised",
            "probability": 0.002916290532808601,
            "start_logit": 4.457943916320801,
            "end_logit": 0.724015474319458
        },
        {
            "text": "PRC2 complex is sequestered at poised",
            "probability": 0.002434674055648838,
            "start_logit": 4.277444362640381,
            "end_logit": 0.724015474319458
        },
        {
            "text": "PRC2 complex is redistributed",
            "probability": 0.002368642552675087,
            "start_logit": 1.7370340824127197,
            "end_logit": 3.2369298934936523
        },
        {
            "text": "sequestered at poised enhancers, but not at active promoters with high levels of H3.3K27M proteins",
            "probability": 0.0021655724893305845,
            "start_logit": 2.3067893981933594,
            "end_logit": 2.577542304992676
        },
        {
            "text": "redistributed",
            "probability": 0.0021468541351163358,
            "start_logit": 1.6387206315994263,
            "end_logit": 3.2369298934936523
        },
        {
            "text": "the PRC2 complex is sequestered at poised enhancers,",
            "probability": 0.0021150336797342846,
            "start_logit": 4.457943916320801,
            "end_logit": 0.40277376770973206
        },
        {
            "text": "the PRC2 complex is sequestered at poised enhancers",
            "probability": 0.0020747876034860036,
            "start_logit": 4.457943916320801,
            "end_logit": 0.3835618197917938
        },
        {
            "text": "PRC2 complex is sequestered at poised enhancers,",
            "probability": 0.0017657423253756852,
            "start_logit": 4.277444362640381,
            "end_logit": 0.40277376770973206
        },
        {
            "text": "PRC2 complex is sequestered at poised enhancers",
            "probability": 0.0017321427657361367,
            "start_logit": 4.277444362640381,
            "end_logit": 0.3835618197917938
        },
        {
            "text": "that the PRC2",
            "probability": 0.0012819718998749003,
            "start_logit": 1.2237915992736816,
            "end_logit": 3.1362547874450684
        }
    ],
    "5ca61f17ecadf2e73f000050_004": [
        {
            "text": "",
            "probability": 0.4825896703436676,
            "start_logit": 3.2462573051452637,
            "end_logit": 3.685208320617676
        },
        {
            "text": "repression by transcriptional repressors",
            "probability": 0.2298364822832632,
            "start_logit": 3.0208470821380615,
            "end_logit": 3.1688199043273926
        },
        {
            "text": "repression by transcriptional repressors.",
            "probability": 0.07448339059125843,
            "start_logit": 3.0208470821380615,
            "end_logit": 2.0420279502868652
        },
        {
            "text": "H3K4me1 and low levels of H3K27ac",
            "probability": 0.03840070327872332,
            "start_logit": 2.137423276901245,
            "end_logit": 2.262951374053955
        },
        {
            "text": "repression",
            "probability": 0.031265487435595776,
            "start_logit": 3.0208470821380615,
            "end_logit": 1.173966646194458
        },
        {
            "text": "the poised enhancer state is more generally the result of repression by transcriptional repressors",
            "probability": 0.026428605859898046,
            "start_logit": 0.8579259514808655,
            "end_logit": 3.1688199043273926
        },
        {
            "text": "the result of repression by transcriptional repressors",
            "probability": 0.017134789490614297,
            "start_logit": 0.4245898425579071,
            "end_logit": 3.1688199043273926
        },
        {
            "text": "result of repression by transcriptional repressors",
            "probability": 0.014676251078456885,
            "start_logit": 0.26970958709716797,
            "end_logit": 3.1688199043273926
        },
        {
            "text": "poised enhancer state is more generally the result of repression by transcriptional repressors",
            "probability": 0.013367474611151937,
            "start_logit": 0.1763034611940384,
            "end_logit": 3.1688199043273926
        },
        {
            "text": "involving H3K4me1 and low levels of H3K27ac",
            "probability": 0.010555727525958592,
            "start_logit": 0.8460161089897156,
            "end_logit": 2.262951374053955
        },
        {
            "text": "H3K4me1",
            "probability": 0.010537774333541533,
            "start_logit": 2.137423276901245,
            "end_logit": 0.9698419570922852
        },
        {
            "text": "transcriptional repressors",
            "probability": 0.00879176133688672,
            "start_logit": -0.24270595610141754,
            "end_logit": 3.1688199043273926
        },
        {
            "text": "the poised enhancer state is more generally the result of repression by transcriptional repressors.",
            "probability": 0.00856475070228028,
            "start_logit": 0.8579259514808655,
            "end_logit": 2.0420279502868652
        },
        {
            "text": "low levels of H3K27ac",
            "probability": 0.006719515471006407,
            "start_logit": 0.39436355233192444,
            "end_logit": 2.262951374053955
        },
        {
            "text": "the result of repression by transcriptional repressors.",
            "probability": 0.005552892237340653,
            "start_logit": 0.4245898425579071,
            "end_logit": 2.0420279502868652
        },
        {
            "text": "H3K27ac",
            "probability": 0.0049849585270857425,
            "start_logit": 0.09577258676290512,
            "end_logit": 2.262951374053955
        },
        {
            "text": "result of repression by transcriptional repressors.",
            "probability": 0.004756150679964025,
            "start_logit": 0.26970958709716797,
            "end_logit": 2.0420279502868652
        },
        {
            "text": "poised enhancer state is more generally the result of repression by transcriptional repressors.",
            "probability": 0.0043320138856548455,
            "start_logit": 0.1763034611940384,
            "end_logit": 2.0420279502868652
        },
        {
            "text": "the poised enhancer state is more generally the result of repression",
            "probability": 0.0035951787820811382,
            "start_logit": 0.8579259514808655,
            "end_logit": 1.173966646194458
        },
        {
            "text": "more generally the result of repression by transcriptional repressors",
            "probability": 0.003426421545570383,
            "start_logit": -1.1850045919418335,
            "end_logit": 3.1688199043273926
        }
    ],
    "5ca61f17ecadf2e73f000050_006": [
        {
            "text": "histone H3K27ac",
            "probability": 0.3710860794294884,
            "start_logit": 7.1738362312316895,
            "end_logit": 7.319822311401367
        },
        {
            "text": "H3K27ac",
            "probability": 0.16069031208780277,
            "start_logit": 6.336881160736084,
            "end_logit": 7.319822311401367
        },
        {
            "text": "histone H3K27ac distinguishes active enhancers from inactive/poised enhancer elements containing H3K4me1",
            "probability": 0.14425102350197225,
            "start_logit": 7.1738362312316895,
            "end_logit": 6.374943256378174
        },
        {
            "text": "histone H3K27ac distinguishes active enhancers from inactive/poised enhancer elements containing H3K4me1 alone",
            "probability": 0.12997439524471693,
            "start_logit": 7.1738362312316895,
            "end_logit": 6.270725727081299
        },
        {
            "text": "H3K27ac distinguishes active enhancers from inactive/poised enhancer elements containing H3K4me1",
            "probability": 0.062464595872617136,
            "start_logit": 6.336881160736084,
            "end_logit": 6.374943256378174
        },
        {
            "text": "H3K27ac distinguishes active enhancers from inactive/poised enhancer elements containing H3K4me1 alone",
            "probability": 0.05628242958455023,
            "start_logit": 6.336881160736084,
            "end_logit": 6.270725727081299
        },
        {
            "text": "H3K4me1",
            "probability": 0.025251436221031175,
            "start_logit": 5.431164264678955,
            "end_logit": 6.374943256378174
        },
        {
            "text": "H3K4me1 alone",
            "probability": 0.02275228329207795,
            "start_logit": 5.431164264678955,
            "end_logit": 6.270725727081299
        },
        {
            "text": "histone H3K27ac distinguishes active enhancers",
            "probability": 0.004661419419327224,
            "start_logit": 7.1738362312316895,
            "end_logit": 2.9427082538604736
        },
        {
            "text": "histone H3K27ac distinguishes active enhancers from inactive/poised enhancer elements containing H3K4me1 alone.",
            "probability": 0.00402809622536606,
            "start_logit": 7.1738362312316895,
            "end_logit": 2.796682119369507
        },
        {
            "text": "histone",
            "probability": 0.0035345445609455102,
            "start_logit": 7.1738362312316895,
            "end_logit": 2.6659727096557617
        },
        {
            "text": "that histone H3K27ac",
            "probability": 0.002845448167678248,
            "start_logit": 2.3031227588653564,
            "end_logit": 7.319822311401367
        },
        {
            "text": "H3K27ac distinguishes active enhancers",
            "probability": 0.0020185207227806164,
            "start_logit": 6.336881160736084,
            "end_logit": 2.9427082538604736
        },
        {
            "text": "H3K27ac distinguishes active enhancers from inactive/poised enhancer elements containing H3K4me1 alone.",
            "probability": 0.0017442746453030559,
            "start_logit": 6.336881160736084,
            "end_logit": 2.796682119369507
        },
        {
            "text": "",
            "probability": 0.0016419352934770575,
            "start_logit": 4.632140636444092,
            "end_logit": 4.440959453582764
        },
        {
            "text": "histone H3K27ac distinguishes",
            "probability": 0.0016228017184657991,
            "start_logit": 7.1738362312316895,
            "end_logit": 1.8875423669815063
        },
        {
            "text": "containing H3K4me1",
            "probability": 0.0013645307164639104,
            "start_logit": 2.513091802597046,
            "end_logit": 6.374943256378174
        },
        {
            "text": "histone H3K27ac distinguishes active",
            "probability": 0.001283034999112898,
            "start_logit": 7.1738362312316895,
            "end_logit": 1.6526166200637817
        },
        {
            "text": "inactive/poised enhancer elements containing H3K4me1",
            "probability": 0.0012733561735104656,
            "start_logit": 2.443937301635742,
            "end_logit": 6.374943256378174
        },
        {
            "text": "containing H3K4me1 alone",
            "probability": 0.0012294821233127143,
            "start_logit": 2.513091802597046,
            "end_logit": 6.270725727081299
        }
    ],
    "5e369ecfb5b409ea53000002_002": [
        {
            "text": "Transcribed-ultraconserved regions",
            "probability": 0.27362792519734513,
            "start_logit": -0.45864903926849365,
            "end_logit": 0.7012113332748413
        },
        {
            "text": "promoting breast cancer cells survival",
            "probability": 0.1742824677358029,
            "start_logit": -0.8354557156562805,
            "end_logit": 0.6269261240959167
        },
        {
            "text": "",
            "probability": 0.07422859528973123,
            "start_logit": -0.6644114851951599,
            "end_logit": -0.3976460099220276
        },
        {
            "text": "important role of uc.63 in promoting breast cancer cells survival",
            "probability": 0.07046918053103265,
            "start_logit": -1.7409576177597046,
            "end_logit": 0.6269261240959167
        },
        {
            "text": "uc.63 in promoting breast cancer cells survival",
            "probability": 0.06343703038604047,
            "start_logit": -1.8460853099822998,
            "end_logit": 0.6269261240959167
        },
        {
            "text": "survival",
            "probability": 0.056859211200201945,
            "start_logit": -1.9555548429489136,
            "end_logit": 0.6269261240959167
        },
        {
            "text": "uc.63",
            "probability": 0.05480772087377016,
            "start_logit": -0.7735143303871155,
            "end_logit": -0.5918615460395813
        },
        {
            "text": "an important role of uc.63 in promoting breast cancer cells survival",
            "probability": 0.03291804297761218,
            "start_logit": -2.5021121501922607,
            "end_logit": 0.6269261240959167
        },
        {
            "text": "Our results reveal an important role of uc.63 in promoting breast cancer cells survival",
            "probability": 0.03183591701386383,
            "start_logit": -2.5355379581451416,
            "end_logit": 0.6269261240959167
        },
        {
            "text": "reveal an important role of uc.63 in promoting breast cancer cells survival",
            "probability": 0.029727886347932057,
            "start_logit": -2.6040475368499756,
            "end_logit": 0.6269261240959167
        },
        {
            "text": "breast cancer cells survival",
            "probability": 0.027005673123508118,
            "start_logit": -2.7000861167907715,
            "end_logit": 0.6269261240959167
        },
        {
            "text": "oncogenesis",
            "probability": 0.02292551756557118,
            "start_logit": -1.5664018392562866,
            "end_logit": -0.670554518699646
        },
        {
            "text": "in promoting breast cancer cells survival",
            "probability": 0.019412762054428594,
            "start_logit": -3.0302023887634277,
            "end_logit": 0.6269261240959167
        },
        {
            "text": "promoting breast cancer",
            "probability": 0.012010470318955408,
            "start_logit": -0.8354557156562805,
            "end_logit": -2.0479724407196045
        },
        {
            "text": "overexpression of one specific T-UCRs named uc.63",
            "probability": 0.011422708726297925,
            "start_logit": -2.3417420387268066,
            "end_logit": -0.5918615460395813
        },
        {
            "text": "promoting breast cancer cells",
            "probability": 0.01102386325572475,
            "start_logit": -0.8354557156562805,
            "end_logit": -2.1336889266967773
        },
        {
            "text": "uc.63 is associated with bad outcome in luminal A subtype of breast cancer patients",
            "probability": 0.009926836230364588,
            "start_logit": -0.7735143303871155,
            "end_logit": -2.3004508018493652
        },
        {
            "text": "uc.63 is associated with bad outcome in luminal A subtype of breast cancer patients.",
            "probability": 0.009029705808305227,
            "start_logit": -0.7735143303871155,
            "end_logit": -2.3951728343963623
        },
        {
            "text": "We found that overexpression of one specific T-UCRs named uc.63",
            "probability": 0.008000740029957501,
            "start_logit": -2.6978113651275635,
            "end_logit": -0.5918615460395813
        },
        {
            "text": "promoting breast cancer cells survival and offer the prospect to identify a signature associated with poor prognosis.",
            "probability": 0.007047745333554131,
            "start_logit": -0.8354557156562805,
            "end_logit": -2.5810434818267822
        }
    ],
    "5e369ecfb5b409ea53000002_004": [
        {
            "text": "Transcribed ultraconserved regions",
            "probability": 0.9058621028991638,
            "start_logit": 0.9456722736358643,
            "end_logit": 2.224836826324463
        },
        {
            "text": "uc.38",
            "probability": 0.03224252319931918,
            "start_logit": -0.4476096034049988,
            "end_logit": 0.28251779079437256
        },
        {
            "text": "ultraconserved regions",
            "probability": 0.012019449119369809,
            "start_logit": -3.3766887187957764,
            "end_logit": 2.224836826324463
        },
        {
            "text": "",
            "probability": 0.008967042016191959,
            "start_logit": -0.8157893419265747,
            "end_logit": -0.6290327906608582
        },
        {
            "text": "Transcribed ultraconserved",
            "probability": 0.005123162794651949,
            "start_logit": 0.9456722736358643,
            "end_logit": -2.9502782821655273
        },
        {
            "text": "clinical significance and biological mechanism of T-UCRs in breast cancer remain largely unknown. The expression of uc.38",
            "probability": 0.005015113480580624,
            "start_logit": -2.3084397315979004,
            "end_logit": 0.28251779079437256
        },
        {
            "text": "Transcribed ultraconserved regions (T-UCRs) are a type of lncRNA",
            "probability": 0.00466204775427576,
            "start_logit": 0.9456722736358643,
            "end_logit": -3.04459547996521
        },
        {
            "text": "biological mechanism of T-UCRs in breast cancer remain largely unknown. The expression of uc.38",
            "probability": 0.0038535937022693054,
            "start_logit": -2.571889638900757,
            "end_logit": 0.28251779079437256
        },
        {
            "text": "the clinical significance and biological mechanism of T-UCRs in breast cancer remain largely unknown. The expression of uc.38",
            "probability": 0.003592816201439721,
            "start_logit": -2.6419594287872314,
            "end_logit": 0.28251779079437256
        },
        {
            "text": "breast cancer remain largely unknown. The expression of uc.38",
            "probability": 0.003284614334962219,
            "start_logit": -2.7316465377807617,
            "end_logit": 0.28251779079437256
        },
        {
            "text": "These sequences are involved in cancer biology and tumourigenesis",
            "probability": 0.002734518323303237,
            "start_logit": -1.3624868392944336,
            "end_logit": -1.2699358463287354
        },
        {
            "text": "largely unknown. The expression of uc.38",
            "probability": 0.0019405065579315242,
            "start_logit": -3.257946729660034,
            "end_logit": 0.28251779079437256
        },
        {
            "text": "uc.38, a T-UCR, was down-regulated in both breast cancer tissues and breast cancer cell lines",
            "probability": 0.0015472154403385226,
            "start_logit": -0.4476096034049988,
            "end_logit": -2.7543115615844727
        },
        {
            "text": "38",
            "probability": 0.0015292726891687524,
            "start_logit": -3.496103525161743,
            "end_logit": 0.28251779079437256
        },
        {
            "text": "remain largely unknown. The expression of uc.38",
            "probability": 0.0014781490556541527,
            "start_logit": -3.5301051139831543,
            "end_logit": 0.28251779079437256
        },
        {
            "text": "uc.38, a T-UCR, was down-regulated in both breast cancer tissues and breast cancer cell lines.",
            "probability": 0.0014500221588705613,
            "start_logit": -0.4476096034049988,
            "end_logit": -2.8191895484924316
        },
        {
            "text": "uc.38, a T-UCR, was down-regulated",
            "probability": 0.0012992944870661779,
            "start_logit": -0.4476096034049988,
            "end_logit": -2.9289469718933105
        },
        {
            "text": "uc.38, a T-UCR",
            "probability": 0.001266070124910218,
            "start_logit": -0.4476096034049988,
            "end_logit": -2.954850673675537
        },
        {
            "text": "involved in cancer biology and tumourigenesis",
            "probability": 0.001091514024522224,
            "start_logit": -2.280876398086548,
            "end_logit": -1.2699358463287354
        },
        {
            "text": "cancer biology and tumourigenesis",
            "probability": 0.0010409716360099237,
            "start_logit": -2.3282876014709473,
            "end_logit": -1.2699358463287354
        }
    ],
    "5e2dadcffbd6abf43b000011_001": [
        {
            "text": "hallucination, dizziness, orthostatic hypotension and pedal edema",
            "probability": 0.976347385803551,
            "start_logit": 7.86138391494751,
            "end_logit": 8.344422340393066
        },
        {
            "text": "The most common side effects are hallucination, dizziness, orthostatic hypotension and pedal edema",
            "probability": 0.009899231886488814,
            "start_logit": 3.2700226306915283,
            "end_logit": 8.344422340393066
        },
        {
            "text": "pedal edema",
            "probability": 0.0037375675676988773,
            "start_logit": 2.2960004806518555,
            "end_logit": 8.344422340393066
        },
        {
            "text": "hallucination, dizziness, orthostatic hypotension",
            "probability": 0.0035506178002972827,
            "start_logit": 7.86138391494751,
            "end_logit": 2.7277255058288574
        },
        {
            "text": "hallucination, dizziness",
            "probability": 0.002448643848654263,
            "start_logit": 7.86138391494751,
            "end_logit": 2.356138229370117
        },
        {
            "text": "most common side effects are hallucination, dizziness, orthostatic hypotension and pedal edema",
            "probability": 0.0017937481625148295,
            "start_logit": 1.5618728399276733,
            "end_logit": 8.344422340393066
        },
        {
            "text": "hallucination",
            "probability": 0.000474788546611596,
            "start_logit": 7.86138391494751,
            "end_logit": 0.715718150138855
        },
        {
            "text": "side effects are hallucination, dizziness, orthostatic hypotension and pedal edema",
            "probability": 0.0003109466636292339,
            "start_logit": -0.19056841731071472,
            "end_logit": 8.344422340393066
        },
        {
            "text": "dizziness, orthostatic hypotension and pedal edema",
            "probability": 0.0002897091818689545,
            "start_logit": -0.26131221652030945,
            "end_logit": 8.344422340393066
        },
        {
            "text": "hallucination, dizziness, orthostatic hypotension and pedal edema.",
            "probability": 0.00028237655791228834,
            "start_logit": -0.2869483232498169,
            "end_logit": 8.344422340393066
        },
        {
            "text": "orthostatic hypotension and pedal edema",
            "probability": 0.00024287206983371562,
            "start_logit": -0.437654972076416,
            "end_logit": 8.344422340393066
        },
        {
            "text": "edema.",
            "probability": 0.00011448888769900387,
            "start_logit": -1.1897120475769043,
            "end_logit": 8.344422340393066
        },
        {
            "text": "hall",
            "probability": 8.365057870867469e-05,
            "start_logit": 7.86138391494751,
            "end_logit": -1.020503044128418
        },
        {
            "text": "hallucination, dizziness,",
            "probability": 7.891843463277803e-05,
            "start_logit": 7.86138391494751,
            "end_logit": -1.0787365436553955
        },
        {
            "text": "common side effects are hallucination, dizziness, orthostatic hypotension and pedal edema",
            "probability": 7.841655010361272e-05,
            "start_logit": -1.5681548118591309,
            "end_logit": 8.344422340393066
        },
        {
            "text": "hallucination, dizziness, orthostatic hypotension and",
            "probability": 5.955968265261598e-05,
            "start_logit": 7.86138391494751,
            "end_logit": -1.3601725101470947
        },
        {
            "text": "hallucination,",
            "probability": 5.845723411175052e-05,
            "start_logit": 7.86138391494751,
            "end_logit": -1.3788559436798096
        },
        {
            "text": ", dizziness, orthostatic hypotension and pedal edema",
            "probability": 5.389342788652588e-05,
            "start_logit": -1.9431812763214111,
            "end_logit": 8.344422340393066
        },
        {
            "text": ", orthostatic hypotension and pedal edema",
            "probability": 5.185010466565067e-05,
            "start_logit": -1.9818328619003296,
            "end_logit": 8.344422340393066
        },
        {
            "text": "",
            "probability": 4.287701047932192e-05,
            "start_logit": 2.953789710998535,
            "end_logit": 3.218778610229492
        }
    ],
    "5e490d276d0a277941000001_001": [
        {
            "text": "collects and organizes the following types of information",
            "probability": 0.36253307081396235,
            "start_logit": 2.7802133560180664,
            "end_logit": 3.404212236404419
        },
        {
            "text": "The database collects and organizes the following types of information",
            "probability": 0.13902636542258295,
            "start_logit": 1.8217612504959106,
            "end_logit": 3.404212236404419
        },
        {
            "text": "comprehensive database resource for systems biology of DNA damage and repair. The database collects and organizes the following types of information",
            "probability": 0.10096276210876051,
            "start_logit": 1.5018494129180908,
            "end_logit": 3.404212236404419
        },
        {
            "text": "organizes the following types of information",
            "probability": 0.08461363226124059,
            "start_logit": 1.3251930475234985,
            "end_logit": 3.404212236404419
        },
        {
            "text": "information about eight main DNA damage checkpoint, repair and tolerance pathways",
            "probability": 0.06569288244977724,
            "start_logit": 2.284822702407837,
            "end_logit": 2.1914777755737305
        },
        {
            "text": "REPAIRtoire contains information about eight main DNA damage checkpoint, repair and tolerance pathways",
            "probability": 0.03575301021173253,
            "start_logit": 1.6764665842056274,
            "end_logit": 2.1914777755737305
        },
        {
            "text": "contains information about eight main DNA damage checkpoint, repair and tolerance pathways",
            "probability": 0.03404618578428916,
            "start_logit": 1.6275501251220703,
            "end_logit": 2.1914777755737305
        },
        {
            "text": "collects and organizes the following types of information: (i) DNA damage linked to environmental mutagenic and cytotoxic agents",
            "probability": 0.025752886559497,
            "start_logit": 2.7802133560180664,
            "end_logit": 0.7596432566642761
        },
        {
            "text": "information",
            "probability": 0.020655796956595904,
            "start_logit": 2.284822702407837,
            "end_logit": 1.0344831943511963
        },
        {
            "text": "REPAIRtoire is the first comprehensive database resource for systems biology of DNA damage and repair. The database collects and organizes the following types of information",
            "probability": 0.017481205530919138,
            "start_logit": -0.2517760097980499,
            "end_logit": 3.404212236404419
        },
        {
            "text": "eight main DNA damage checkpoint, repair and tolerance pathways",
            "probability": 0.016727911150221927,
            "start_logit": 0.9169107675552368,
            "end_logit": 2.1914777755737305
        },
        {
            "text": "first comprehensive database resource for systems biology of DNA damage and repair. The database collects and organizes the following types of information",
            "probability": 0.013161019104069686,
            "start_logit": -0.5356429815292358,
            "end_logit": 3.404212236404419
        },
        {
            "text": "comprehensive database resource for systems biology of DNA damage and repair",
            "probability": 0.011500166739094014,
            "start_logit": 1.5018494129180908,
            "end_logit": 1.2318220138549805
        },
        {
            "text": "REPAIRtoire contains information",
            "probability": 0.011241810253724852,
            "start_logit": 1.6764665842056274,
            "end_logit": 1.0344831943511963
        },
        {
            "text": "the first comprehensive database resource for systems biology of DNA damage and repair. The database collects and organizes the following types of information",
            "probability": 0.011185302849937517,
            "start_logit": -0.6983016729354858,
            "end_logit": 3.404212236404419
        },
        {
            "text": "contains information",
            "probability": 0.010705133866586844,
            "start_logit": 1.6275501251220703,
            "end_logit": 1.0344831943511963
        },
        {
            "text": "the following types of information",
            "probability": 0.010539079460388078,
            "start_logit": -0.7578121423721313,
            "end_logit": 3.404212236404419
        },
        {
            "text": "comprehensive",
            "probability": 0.0099803197863349,
            "start_logit": 1.5018494129180908,
            "end_logit": 1.0900756120681763
        },
        {
            "text": "The database collects and organizes the following types of information: (i) DNA damage linked to environmental mutagenic and cytotoxic agents",
            "probability": 0.009875872039669008,
            "start_logit": 1.8217612504959106,
            "end_logit": 0.7596432566642761
        },
        {
            "text": "collects and organizes the following types of information: (i) DNA damage",
            "probability": 0.007110754885595227,
            "start_logit": 2.7802133560180664,
            "end_logit": -0.5272950530052185
        },
        {
            "text": "",
            "probability": 0.001454831765020562,
            "start_logit": 0.2545330226421356,
            "end_logit": 0.411667138338089
        }
    ],
    "5e2f9ceefbd6abf43b000033_001": [
        {
            "text": "acetylsalicylic acid",
            "probability": 0.4319601965851206,
            "start_logit": 4.528669357299805,
            "end_logit": 4.816077709197998
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide (HCT), enalapril",
            "probability": 0.11509807375603233,
            "start_logit": 5.531671524047852,
            "end_logit": 2.4905266761779785
        },
        {
            "text": "acetylsalicylic acid, from 0.058 to 1.102 \u03bcg/spot for HCT",
            "probability": 0.08131246097336456,
            "start_logit": 4.528669357299805,
            "end_logit": 3.146043539047241
        },
        {
            "text": "enalapril (ENA), and atorvastatin (ATR)",
            "probability": 0.07569990619193175,
            "start_logit": 1.8401905298233032,
            "end_logit": 5.763000011444092
        },
        {
            "text": "atorvastatin (ATR)",
            "probability": 0.058878274908370325,
            "start_logit": 1.58888578414917,
            "end_logit": 5.763000011444092
        },
        {
            "text": "enalapril (ENA), and atorvastatin",
            "probability": 0.05342947180341457,
            "start_logit": 1.8401905298233032,
            "end_logit": 5.414585590362549
        },
        {
            "text": "atorvastatin",
            "probability": 0.041556658221932545,
            "start_logit": 1.58888578414917,
            "end_logit": 5.414585590362549
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide",
            "probability": 0.03370343500080758,
            "start_logit": 5.531671524047852,
            "end_logit": 1.262341856956482
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide (HCT), enalapril (ENA)",
            "probability": 0.016378346512103674,
            "start_logit": 5.531671524047852,
            "end_logit": 0.540702223777771
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide (HCT)",
            "probability": 0.01627716704339269,
            "start_logit": 5.531671524047852,
            "end_logit": 0.5345054268836975
        },
        {
            "text": "hydrochlorothiazide (HCT), enalapril (ENA), and atorvastatin",
            "probability": 0.013605323434005175,
            "start_logit": 0.47228917479515076,
            "end_logit": 5.414585590362549
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide (HCT), enalapril (ENA",
            "probability": 0.013486054322658366,
            "start_logit": 5.531671524047852,
            "end_logit": 0.3463982343673706
        },
        {
            "text": "ENA), and atorvastatin (ATR)",
            "probability": 0.011594005378925833,
            "start_logit": -0.03609820455312729,
            "end_logit": 5.763000011444092
        },
        {
            "text": "ENA), and atorvastatin",
            "probability": 0.008183122207725775,
            "start_logit": -0.03609820455312729,
            "end_logit": 5.414585590362549
        },
        {
            "text": "acetylsalicylic acid,",
            "probability": 0.006148794130034279,
            "start_logit": 4.528669357299805,
            "end_logit": 0.5640002489089966
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide (HCT),",
            "probability": 0.0060789117584086555,
            "start_logit": 5.531671524047852,
            "end_logit": -0.4504322111606598
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide (HCT",
            "probability": 0.00417423055727575,
            "start_logit": 5.531671524047852,
            "end_logit": -0.8263278603553772
        },
        {
            "text": "ATR)",
            "probability": 0.004118330613056753,
            "start_logit": -1.0711385011672974,
            "end_logit": 5.763000011444092
        },
        {
            "text": "HCT), enalapril (ENA), and atorvastatin (ATR)",
            "probability": 0.003884596069856175,
            "start_logit": -1.1295673847198486,
            "end_logit": 5.763000011444092
        },
        {
            "text": "HCT",
            "probability": 0.003705799082909818,
            "start_logit": 1.4402689933776855,
            "end_logit": 3.146043539047241
        },
        {
            "text": "",
            "probability": 0.0007268414486728022,
            "start_logit": 0.9729444980621338,
            "end_logit": 1.984422206878662
        }
    ],
    "5e2f9ceefbd6abf43b000033_002": [
        {
            "text": "hydrochlorothiazide, aspirin, atorvastatin and either enalapril or valsartan",
            "probability": 0.9413970230525135,
            "start_logit": 7.107605934143066,
            "end_logit": 6.684417724609375
        },
        {
            "text": "hydrochlorothiazide, aspirin, atorvastatin",
            "probability": 0.034547323882169245,
            "start_logit": 7.107605934143066,
            "end_logit": 3.379382848739624
        },
        {
            "text": "enalapril or valsartan",
            "probability": 0.008281704325395314,
            "start_logit": 2.3742897510528564,
            "end_logit": 6.684417724609375
        },
        {
            "text": "hydrochlorothiazide, aspirin",
            "probability": 0.004359904189085556,
            "start_logit": 7.107605934143066,
            "end_logit": 1.3095028400421143
        },
        {
            "text": "hydrochlorothiazide, aspirin, atorvastatin and either enalapril",
            "probability": 0.0035963268776235233,
            "start_logit": 7.107605934143066,
            "end_logit": 1.1169657707214355
        },
        {
            "text": "hydrochlorothiazide",
            "probability": 0.002368616014841806,
            "start_logit": 7.107605934143066,
            "end_logit": 0.6993585824966431
        },
        {
            "text": "atorvastatin and either enalapril or valsartan",
            "probability": 0.0013125015955174526,
            "start_logit": 0.5321758985519409,
            "end_logit": 6.684417724609375
        },
        {
            "text": "hydrochlorothiazide, aspirin, atorvastatin and either enalapril or valsartan.",
            "probability": 0.0012995443954377565,
            "start_logit": 0.5222547054290771,
            "end_logit": 6.684417724609375
        },
        {
            "text": "valsartan",
            "probability": 0.0008227978665860054,
            "start_logit": 0.06519625335931778,
            "end_logit": 6.684417724609375
        },
        {
            "text": "aspirin, atorvastatin and either enalapril or valsartan",
            "probability": 0.00045115711958100465,
            "start_logit": -0.535698652267456,
            "end_logit": 6.684417724609375
        },
        {
            "text": "either enalapril or valsartan",
            "probability": 0.0002517718134198907,
            "start_logit": -1.1189911365509033,
            "end_logit": 6.684417724609375
        },
        {
            "text": "h",
            "probability": 0.00024564262290936636,
            "start_logit": 7.107605934143066,
            "end_logit": -1.5668247938156128
        },
        {
            "text": "hydrochlorothiazide, aspirin,",
            "probability": 0.00019604614851163435,
            "start_logit": 7.107605934143066,
            "end_logit": -1.7923524379730225
        },
        {
            "text": "hydrochlorothiazide, aspirin, atorvastatin and",
            "probability": 0.00019558999664163657,
            "start_logit": 7.107605934143066,
            "end_logit": -1.7946819067001343
        },
        {
            "text": "hydrochlorothiazide,",
            "probability": 0.00016159789329942491,
            "start_logit": 7.107605934143066,
            "end_logit": -1.9855914115905762
        },
        {
            "text": "comprising hydrochlorothiazide, aspirin, atorvastatin and either enalapril or valsartan",
            "probability": 0.00011133733815192308,
            "start_logit": -1.9349496364593506,
            "end_logit": 6.684417724609375
        },
        {
            "text": "hydrochlorothiazide, aspirin, atorvastatin and either enalapril or",
            "probability": 9.421994163453406e-05,
            "start_logit": 7.107605934143066,
            "end_logit": -2.5250706672668457
        },
        {
            "text": "hydrochlorothiazide, aspirin, atorvastatin and either enalapril or valsart",
            "probability": 9.204021366917397e-05,
            "start_logit": 7.107605934143066,
            "end_logit": -2.5484769344329834
        },
        {
            "text": ", atorvastatin and either enalapril or valsartan",
            "probability": 8.691757927526169e-05,
            "start_logit": -2.182554006576538,
            "end_logit": 6.684417724609375
        },
        {
            "text": ", aspirin, atorvastatin and either enalapril or valsartan",
            "probability": 8.03793723545022e-05,
            "start_logit": -2.260756731033325,
            "end_logit": 6.684417724609375
        },
        {
            "text": "",
            "probability": 4.755776138135095e-05,
            "start_logit": 1.5540403127670288,
            "end_logit": 2.3448081016540527
        }
    ],
    "5e2f9ceefbd6abf43b000033_003": [
        {
            "text": "aspirin, valsartan, atorvastatin and hydrochlorthiazide",
            "probability": 0.6000536929245524,
            "start_logit": 4.656724452972412,
            "end_logit": 5.099969387054443
        },
        {
            "text": "aspirin, valsartan, atorvastatin",
            "probability": 0.09554631212187045,
            "start_logit": 4.656724452972412,
            "end_logit": 3.262561321258545
        },
        {
            "text": "aspirin, valsartan",
            "probability": 0.0718877378980625,
            "start_logit": 4.656724452972412,
            "end_logit": 2.978055953979492
        },
        {
            "text": "valsartan, atorvastatin and hydrochlorthiazide",
            "probability": 0.05454752308128997,
            "start_logit": 2.258777618408203,
            "end_logit": 5.099969387054443
        },
        {
            "text": "",
            "probability": 0.04625416426053758,
            "start_logit": 3.4484007358551025,
            "end_logit": 3.7454254627227783
        },
        {
            "text": "aspirin, valsartan, atorvastatin and hydrochlorthiazide (PolyPill)",
            "probability": 0.03611062640147435,
            "start_logit": 4.656724452972412,
            "end_logit": 2.2895374298095703
        },
        {
            "text": "aspirin",
            "probability": 0.026322321993311908,
            "start_logit": 4.656724452972412,
            "end_logit": 1.9733675718307495
        },
        {
            "text": "atorvastatin and hydrochlorthiazide",
            "probability": 0.022765837564897872,
            "start_logit": 1.3849663734436035,
            "end_logit": 5.099969387054443
        },
        {
            "text": "valsartan, atorvastatin",
            "probability": 0.00868558051930058,
            "start_logit": 2.258777618408203,
            "end_logit": 3.262561321258545
        },
        {
            "text": "hydrochlorthiazide",
            "probability": 0.008246044761159333,
            "start_logit": 0.3694389760494232,
            "end_logit": 5.099969387054443
        },
        {
            "text": "aspirin, valsartan, atorvastatin and hydrochlorthiazide (PolyPill",
            "probability": 0.006667035468222938,
            "start_logit": 4.656724452972412,
            "end_logit": 0.6001255512237549
        },
        {
            "text": "valsartan",
            "probability": 0.006534911939537603,
            "start_logit": 2.258777618408203,
            "end_logit": 2.978055953979492
        },
        {
            "text": "atorvastatin",
            "probability": 0.0036249953084865573,
            "start_logit": 1.3849663734436035,
            "end_logit": 3.262561321258545
        },
        {
            "text": "valsartan, atorvastatin and hydrochlorthiazide (PolyPill)",
            "probability": 0.0032826149565284425,
            "start_logit": 2.258777618408203,
            "end_logit": 2.2895374298095703
        },
        {
            "text": "a fixed-dose combination pill consisting of aspirin, valsartan, atorvastatin and hydrochlorthiazide",
            "probability": 0.0023611701333697637,
            "start_logit": -0.8811373710632324,
            "end_logit": 5.099969387054443
        },
        {
            "text": "fixed-dose combination pill consisting of aspirin, valsartan, atorvastatin and hydrochlorthiazide",
            "probability": 0.0020421259450183827,
            "start_logit": -1.0263032913208008,
            "end_logit": 5.099969387054443
        },
        {
            "text": "aspirin, valsartan,",
            "probability": 0.0017422366052619032,
            "start_logit": 4.656724452972412,
            "end_logit": -0.7418800592422485
        },
        {
            "text": "atorvastatin and hydrochlorthiazide (PolyPill)",
            "probability": 0.0013700251572754552,
            "start_logit": 1.3849663734436035,
            "end_logit": 2.2895374298095703
        },
        {
            "text": "aspirin,",
            "probability": 0.001043118083821218,
            "start_logit": 4.656724452972412,
            "end_logit": -1.2548353672027588
        },
        {
            "text": ", atorvastatin and hydrochlorthiazide",
            "probability": 0.0009119248760211178,
            "start_logit": -1.8324923515319824,
            "end_logit": 5.099969387054443
        }
    ],
    "5cc011e2a49efeb44c000001_001": [
        {
            "text": "",
            "probability": 0.8313008124752197,
            "start_logit": 1.6620210409164429,
            "end_logit": 2.051262140274048
        },
        {
            "text": "important",
            "probability": 0.0440811941895286,
            "start_logit": 0.3864004611968994,
            "end_logit": 0.3899242579936981
        },
        {
            "text": "important for miRNA-mediated gene silencing",
            "probability": 0.024248256431712186,
            "start_logit": 0.3864004611968994,
            "end_logit": -0.20776428282260895
        },
        {
            "text": "Nup358-AGO interaction is important",
            "probability": 0.023070875862396856,
            "start_logit": -0.26106175780296326,
            "end_logit": 0.3899242579936981
        },
        {
            "text": "Nup358-AGO interaction",
            "probability": 0.021323615795540474,
            "start_logit": -0.26106175780296326,
            "end_logit": 0.3111684024333954
        },
        {
            "text": "Nup358-AGO interaction is important for miRNA-mediated gene silencing",
            "probability": 0.012690865669616753,
            "start_logit": -0.26106175780296326,
            "end_logit": -0.20776428282260895
        },
        {
            "text": "promotes the association of target mRNA with miRISC",
            "probability": 0.005461110591296318,
            "start_logit": -0.6241658329963684,
            "end_logit": -0.6878905296325684
        },
        {
            "text": "localizes to the nuclear pore complex",
            "probability": 0.005086508011862241,
            "start_logit": -0.44593867659568787,
            "end_logit": -0.9371783137321472
        },
        {
            "text": "important for miRNA-mediated gene silencing and identifies SIM as a new interacting motif for the AGO family of proteins.",
            "probability": 0.004962994012409244,
            "start_logit": 0.3864004611968994,
            "end_logit": -1.7940998077392578
        },
        {
            "text": "Nup358-AGO",
            "probability": 0.004469576911442076,
            "start_logit": -0.26106175780296326,
            "end_logit": -1.2513530254364014
        },
        {
            "text": "localizes",
            "probability": 0.0029912025919272473,
            "start_logit": -0.44593867659568787,
            "end_logit": -1.4680943489074707
        },
        {
            "text": "interaction is important",
            "probability": 0.0029079621189275788,
            "start_logit": -2.3321802616119385,
            "end_logit": 0.3899242579936981
        },
        {
            "text": "Nup358 localizes to the nuclear pore complex",
            "probability": 0.0027050402261372137,
            "start_logit": -1.0774134397506714,
            "end_logit": -0.9371783137321472
        },
        {
            "text": "interaction",
            "probability": 0.002687729210708664,
            "start_logit": -2.3321802616119385,
            "end_logit": 0.3111684024333954
        },
        {
            "text": "localizes to the nuclear pore complex and to the cytoplasmic annulate lamellae (AL),",
            "probability": 0.0024587307267811024,
            "start_logit": -0.44593867659568787,
            "end_logit": -1.664124608039856
        },
        {
            "text": "association of target mRNA with miRISC",
            "probability": 0.0023796524766078963,
            "start_logit": -1.4548635482788086,
            "end_logit": -0.6878905296325684
        },
        {
            "text": "localizes to the nuclear pore complex and to the cytoplasmic annulate lamellae",
            "probability": 0.002217912966041003,
            "start_logit": -0.44593867659568787,
            "end_logit": -1.7672032117843628
        },
        {
            "text": "AGO interaction is important",
            "probability": 0.0017442203353835368,
            "start_logit": -2.843325138092041,
            "end_logit": 0.3899242579936981
        },
        {
            "text": "AGO interaction",
            "probability": 0.0016121227696911228,
            "start_logit": -2.843325138092041,
            "end_logit": 0.3111684024333954
        },
        {
            "text": "interaction is important for miRNA-mediated gene silencing",
            "probability": 0.0015996166267703174,
            "start_logit": -2.3321802616119385,
            "end_logit": -0.20776428282260895
        }
    ],
    "5cc011e2a49efeb44c000001_002": [
        {
            "text": "",
            "probability": 0.8313008124752197,
            "start_logit": 1.6620210409164429,
            "end_logit": 2.051262140274048
        },
        {
            "text": "important",
            "probability": 0.0440811941895286,
            "start_logit": 0.3864004611968994,
            "end_logit": 0.3899242579936981
        },
        {
            "text": "important for miRNA-mediated gene silencing",
            "probability": 0.024248256431712186,
            "start_logit": 0.3864004611968994,
            "end_logit": -0.20776428282260895
        },
        {
            "text": "Nup358-AGO interaction is important",
            "probability": 0.023070875862396856,
            "start_logit": -0.26106175780296326,
            "end_logit": 0.3899242579936981
        },
        {
            "text": "Nup358-AGO interaction",
            "probability": 0.021323615795540474,
            "start_logit": -0.26106175780296326,
            "end_logit": 0.3111684024333954
        },
        {
            "text": "Nup358-AGO interaction is important for miRNA-mediated gene silencing",
            "probability": 0.012690865669616753,
            "start_logit": -0.26106175780296326,
            "end_logit": -0.20776428282260895
        },
        {
            "text": "promotes the association of target mRNA with miRISC",
            "probability": 0.005461110591296318,
            "start_logit": -0.6241658329963684,
            "end_logit": -0.6878905296325684
        },
        {
            "text": "localizes to the nuclear pore complex",
            "probability": 0.005086508011862241,
            "start_logit": -0.44593867659568787,
            "end_logit": -0.9371783137321472
        },
        {
            "text": "important for miRNA-mediated gene silencing and identifies SIM as a new interacting motif for the AGO family of proteins.",
            "probability": 0.004962994012409244,
            "start_logit": 0.3864004611968994,
            "end_logit": -1.7940998077392578
        },
        {
            "text": "Nup358-AGO",
            "probability": 0.004469576911442076,
            "start_logit": -0.26106175780296326,
            "end_logit": -1.2513530254364014
        },
        {
            "text": "localizes",
            "probability": 0.0029912025919272473,
            "start_logit": -0.44593867659568787,
            "end_logit": -1.4680943489074707
        },
        {
            "text": "interaction is important",
            "probability": 0.0029079621189275788,
            "start_logit": -2.3321802616119385,
            "end_logit": 0.3899242579936981
        },
        {
            "text": "Nup358 localizes to the nuclear pore complex",
            "probability": 0.0027050402261372137,
            "start_logit": -1.0774134397506714,
            "end_logit": -0.9371783137321472
        },
        {
            "text": "interaction",
            "probability": 0.002687729210708664,
            "start_logit": -2.3321802616119385,
            "end_logit": 0.3111684024333954
        },
        {
            "text": "localizes to the nuclear pore complex and to the cytoplasmic annulate lamellae (AL),",
            "probability": 0.0024587307267811024,
            "start_logit": -0.44593867659568787,
            "end_logit": -1.664124608039856
        },
        {
            "text": "association of target mRNA with miRISC",
            "probability": 0.0023796524766078963,
            "start_logit": -1.4548635482788086,
            "end_logit": -0.6878905296325684
        },
        {
            "text": "localizes to the nuclear pore complex and to the cytoplasmic annulate lamellae",
            "probability": 0.002217912966041003,
            "start_logit": -0.44593867659568787,
            "end_logit": -1.7672032117843628
        },
        {
            "text": "AGO interaction is important",
            "probability": 0.0017442203353835368,
            "start_logit": -2.843325138092041,
            "end_logit": 0.3899242579936981
        },
        {
            "text": "AGO interaction",
            "probability": 0.0016121227696911228,
            "start_logit": -2.843325138092041,
            "end_logit": 0.3111684024333954
        },
        {
            "text": "interaction is important for miRNA-mediated gene silencing",
            "probability": 0.0015996166267703174,
            "start_logit": -2.3321802616119385,
            "end_logit": -0.20776428282260895
        }
    ],
    "5cc011e2a49efeb44c000001_003": [
        {
            "text": "",
            "probability": 0.6000314511998546,
            "start_logit": 1.9908738136291504,
            "end_logit": 2.5854883193969727
        },
        {
            "text": "mislocalization of Tpr to the nuclear interior",
            "probability": 0.11398751561920872,
            "start_logit": 0.9674568772315979,
            "end_logit": 1.948012113571167
        },
        {
            "text": "cellular depletion of Nup153 by RNAi is shown to result in mislocalization of Tpr to the nuclear interior",
            "probability": 0.09933082682800741,
            "start_logit": 0.829823911190033,
            "end_logit": 1.948012113571167
        },
        {
            "text": "mislocalization of Tpr to the nuclear interior.",
            "probability": 0.03419945040468979,
            "start_logit": 0.9674568772315979,
            "end_logit": 0.7441327571868896
        },
        {
            "text": "mislocalization",
            "probability": 0.03207117954622516,
            "start_logit": 0.9674568772315979,
            "end_logit": 0.6798809766769409
        },
        {
            "text": "cellular depletion of Nup153 by RNAi is shown to result in mislocalization",
            "probability": 0.02794741831481053,
            "start_logit": 0.829823911190033,
            "end_logit": 0.6798809766769409
        },
        {
            "text": "Tpr to the nuclear interior",
            "probability": 0.01823934296490516,
            "start_logit": -0.8650510907173157,
            "end_logit": 1.948012113571167
        },
        {
            "text": "peripherally attached to the NPC that does not act as an essential scaffold for other nucleoporins.",
            "probability": 0.0106836231432665,
            "start_logit": -0.0989399403333664,
            "end_logit": 0.6470320224761963
        },
        {
            "text": "peripherally attached to the NPC that does not act as an essential scaffold for other nucleoporins",
            "probability": 0.008407980707757126,
            "start_logit": -0.0989399403333664,
            "end_logit": 0.40750133991241455
        },
        {
            "text": "precede NPC association of Tpr in late telophase",
            "probability": 0.007640304735191506,
            "start_logit": -0.3213883638381958,
            "end_logit": 0.5342059135437012
        },
        {
            "text": "depletion of Nup153 by RNAi is shown to result in mislocalization of Tpr to the nuclear interior",
            "probability": 0.00643755775314094,
            "start_logit": -1.9064828157424927,
            "end_logit": 1.948012113571167
        },
        {
            "text": "result in mislocalization of Tpr to the nuclear interior",
            "probability": 0.006257179373539293,
            "start_logit": -1.934902548789978,
            "end_logit": 1.948012113571167
        },
        {
            "text": "in mislocalization of Tpr to the nuclear interior",
            "probability": 0.006230927705103975,
            "start_logit": -1.939106822013855,
            "end_logit": 1.948012113571167
        },
        {
            "text": "to result in mislocalization of Tpr to the nuclear interior",
            "probability": 0.005489686785911746,
            "start_logit": -2.065760850906372,
            "end_logit": 1.948012113571167
        },
        {
            "text": "Tpr to the nuclear interior.",
            "probability": 0.005472314242080784,
            "start_logit": -0.8650510907173157,
            "end_logit": 0.7441327571868896
        },
        {
            "text": "the nuclear interior",
            "probability": 0.0038573750355717393,
            "start_logit": -2.418645143508911,
            "end_logit": 1.948012113571167
        },
        {
            "text": "peripherally attached",
            "probability": 0.0036820795524496823,
            "start_logit": -0.0989399403333664,
            "end_logit": -0.41820231080055237
        },
        {
            "text": "only peripherally attached to the NPC that does not act as an essential scaffold for other nucleoporins.",
            "probability": 0.003534413075902968,
            "start_logit": -1.2051047086715698,
            "end_logit": 0.6470320224761963
        },
        {
            "text": "in anaphase/early telophase is shown to precede NPC association of Tpr in late telophase",
            "probability": 0.0033359053083136057,
            "start_logit": -1.150081753730774,
            "end_logit": 0.5342059135437012
        },
        {
            "text": "peripherally attached to the NPC",
            "probability": 0.003163467704068673,
            "start_logit": -0.0989399403333664,
            "end_logit": -0.5700111985206604
        }
    ],
    "5cc011e2a49efeb44c000001_004": [
        {
            "text": "",
            "probability": 0.9880487600741674,
            "start_logit": 2.8242294788360596,
            "end_logit": 3.2815892696380615
        },
        {
            "text": "enhances ulp1 mutant defects",
            "probability": 0.002326051334586447,
            "start_logit": -0.9840383529663086,
            "end_logit": 1.038297176361084
        },
        {
            "text": "Loss of Esc1 (or Nup60) alters SUMO conjugate accumulation and enhances ulp1 mutant defects",
            "probability": 0.002233940283470052,
            "start_logit": -1.024443507194519,
            "end_logit": 1.038297176361084
        },
        {
            "text": "both Esc1 and Ulp1 help retain unspliced pre-mRNAs in the nucleus",
            "probability": 0.0014459868949021108,
            "start_logit": -0.6187904477119446,
            "end_logit": 0.19766920804977417
        },
        {
            "text": "In esc1Delta cells",
            "probability": 0.0013821376055888025,
            "start_logit": -0.26760315895080566,
            "end_logit": -0.1986788511276245
        },
        {
            "text": "alters SUMO conjugate accumulation and enhances ulp1 mutant defects",
            "probability": 0.0007772840475519781,
            "start_logit": -2.080159902572632,
            "end_logit": 1.038297176361084
        },
        {
            "text": "both Esc1 and Ulp1 help retain unspliced pre-mRNAs in the nucleus.",
            "probability": 0.0004502088895128837,
            "start_logit": -0.6187904477119446,
            "end_logit": -0.9691664576530457
        },
        {
            "text": "esc1Delta cells",
            "probability": 0.00044021274765398136,
            "start_logit": -1.4117316007614136,
            "end_logit": -0.1986788511276245
        },
        {
            "text": "Therefore, these proteins are essential for proper nuclear basket function, which includes mRNA surveillance and regulation of SUMO protein dynamics.",
            "probability": 0.0003905343899988317,
            "start_logit": -0.688574492931366,
            "end_logit": -1.0415780544281006
        },
        {
            "text": "Therefore, these proteins are essential for proper nuclear basket function",
            "probability": 0.0003270837240059315,
            "start_logit": -0.688574492931366,
            "end_logit": -1.218877911567688
        },
        {
            "text": "Therefore, these proteins are essential for proper nuclear basket function, which includes mRNA surveillance and regulation of SUMO protein dynamics",
            "probability": 0.00026867378778714095,
            "start_logit": -0.688574492931366,
            "end_logit": -1.4155961275100708
        },
        {
            "text": "normal NPC localization of the Ulp1 SUMO protease. In esc1Delta cells",
            "probability": 0.00025734937984603346,
            "start_logit": -1.9485551118850708,
            "end_logit": -0.1986788511276245
        },
        {
            "text": "normal NPC localization of the Ulp1 SUMO protease",
            "probability": 0.00023834836049589086,
            "start_logit": -1.9485551118850708,
            "end_logit": -0.2753801643848419
        },
        {
            "text": "these proteins are essential for proper nuclear basket function, which includes mRNA surveillance and regulation of SUMO protein dynamics.",
            "probability": 0.0002275489385996205,
            "start_logit": -1.2287251949310303,
            "end_logit": -1.0415780544281006
        },
        {
            "text": "Loss of Esc1 (or Nup60) alters SUMO conjugate accumulation",
            "probability": 0.0002163267667638397,
            "start_logit": -1.024443507194519,
            "end_logit": -1.296434998512268
        },
        {
            "text": "enhances ulp1 mutant defects.",
            "probability": 0.0002147334877138765,
            "start_logit": -0.9840383529663086,
            "end_logit": -1.3442325592041016
        },
        {
            "text": "Loss of Esc1 (or Nup60) alters SUMO conjugate accumulation and enhances ulp1 mutant defects.",
            "probability": 0.00020623009530412506,
            "start_logit": -1.024443507194519,
            "end_logit": -1.3442325592041016
        },
        {
            "text": "esc1Delta cells, Ulp1 and nuclear basket components Nup60 and Mlp1 no longer distribute broadly around the nuclear periphery",
            "probability": 0.00019704974967215633,
            "start_logit": -1.4117316007614136,
            "end_logit": -1.0024807453155518
        },
        {
            "text": "these proteins are essential for proper nuclear basket function",
            "probability": 0.00019057874578211554,
            "start_logit": -1.2287251949310303,
            "end_logit": -1.218877911567688
        },
        {
            "text": "proper assembly of the nuclear basket",
            "probability": 0.0001609606965963219,
            "start_logit": -1.176810622215271,
            "end_logit": -1.4396977424621582
        }
    ],
    "5e36ad01b5b409ea53000006_002": [
        {
            "text": "Transcribed ultraconserved regions",
            "probability": 0.9614238396319489,
            "start_logit": 4.7013258934021,
            "end_logit": 6.138956546783447
        },
        {
            "text": "AGS",
            "probability": 0.014254614040023554,
            "start_logit": 2.5388731956481934,
            "end_logit": 4.09007453918457
        },
        {
            "text": "SGC-7901 and AGS",
            "probability": 0.009315673189723688,
            "start_logit": 2.1134908199310303,
            "end_logit": 4.09007453918457
        },
        {
            "text": "ultraconserved regions",
            "probability": 0.008522067001411384,
            "start_logit": -0.024430541321635246,
            "end_logit": 6.138956546783447
        },
        {
            "text": "regions",
            "probability": 0.002085681159714237,
            "start_logit": -1.4319939613342285,
            "end_logit": 6.138956546783447
        },
        {
            "text": "Transcribed ultraconserved regions (T-UCRs) are a subset of long noncoding RNAs",
            "probability": 0.0020297439177056524,
            "start_logit": 4.7013258934021,
            "end_logit": -0.021549168974161148
        },
        {
            "text": "Transcribed ultraconserved regions (T-UCRs) are a subset of long noncoding RNAs.",
            "probability": 0.0006101393464645563,
            "start_logit": 4.7013258934021,
            "end_logit": -1.2235267162322998
        },
        {
            "text": "Transcribed ultraconserved",
            "probability": 0.0005306126985731409,
            "start_logit": 4.7013258934021,
            "end_logit": -1.363181710243225
        },
        {
            "text": "",
            "probability": 0.0002649905517082179,
            "start_logit": 1.0864096879959106,
            "end_logit": 1.5573962926864624
        },
        {
            "text": "SGC-7901",
            "probability": 0.00015693505045299107,
            "start_logit": 2.1134908199310303,
            "end_logit": 0.006453017704188824
        },
        {
            "text": "Transcribed ultraconserved regions (",
            "probability": 0.00013209948495577337,
            "start_logit": 4.7013258934021,
            "end_logit": -2.7536587715148926
        },
        {
            "text": "T-UCRs are dysregulated in cancers and play an important role in the development and progression of malignancies",
            "probability": 0.00012562129567449468,
            "start_logit": 0.1324653923511505,
            "end_logit": 1.7649182081222534
        },
        {
            "text": "AGS gastric cancer cells",
            "probability": 0.00010179368512688663,
            "start_logit": 2.5388731956481934,
            "end_logit": -0.8518133163452148
        },
        {
            "text": "AGS gastric cancer",
            "probability": 8.779129704618949e-05,
            "start_logit": 2.5388731956481934,
            "end_logit": -0.9997990131378174
        },
        {
            "text": "dysregulated in cancers and play an important role in the development and progression of malignancies",
            "probability": 7.868866590292777e-05,
            "start_logit": -0.3353072702884674,
            "end_logit": 1.7649182081222534
        },
        {
            "text": "SGC-7901 and AGS gastric cancer cells",
            "probability": 6.652419355285087e-05,
            "start_logit": 2.1134908199310303,
            "end_logit": -0.8518133163452148
        },
        {
            "text": "SGC-7901 and AGS gastric cancer",
            "probability": 5.7373355033533e-05,
            "start_logit": 2.1134908199310303,
            "end_logit": -0.9997990131378174
        },
        {
            "text": "T-UCRs are dysregulated in cancers",
            "probability": 5.417197818477356e-05,
            "start_logit": 0.1324653923511505,
            "end_logit": 0.9238101840019226
        },
        {
            "text": "T-UCRs are dysregulated",
            "probability": 5.2344025764997e-05,
            "start_logit": 0.1324653923511505,
            "end_logit": 0.8894842267036438
        },
        {
            "text": "development and progression of malignancies",
            "probability": 4.9295431031511645e-05,
            "start_logit": -0.8029749989509583,
            "end_logit": 1.7649182081222534
        }
    ],
    "5e36ad01b5b409ea53000006_004": [
        {
            "text": "Transcribed ultraconserved regions",
            "probability": 0.9529734990363896,
            "start_logit": 3.7483408451080322,
            "end_logit": 4.529063701629639
        },
        {
            "text": "Uc.160+",
            "probability": 0.019701509745895122,
            "start_logit": 1.9401854276657104,
            "end_logit": 2.458327293395996
        },
        {
            "text": "ultraconserved regions",
            "probability": 0.009523684087276172,
            "start_logit": -0.8574644923210144,
            "end_logit": 4.529063701629639
        },
        {
            "text": "",
            "probability": 0.005474564463360525,
            "start_logit": 1.2015868425369263,
            "end_logit": 1.916343331336975
        },
        {
            "text": "Transcribed ultraconserved regions (T-UCRs) are a novel class of noncoding RNAs",
            "probability": 0.0029255316280265976,
            "start_logit": 3.7483408451080322,
            "end_logit": -1.257047176361084
        },
        {
            "text": "regions",
            "probability": 0.0015063518884135354,
            "start_logit": -2.7015554904937744,
            "end_logit": 4.529063701629639
        },
        {
            "text": "GC biology. Uc.160+",
            "probability": 0.0014635805449396988,
            "start_logit": -0.6596239805221558,
            "end_logit": 2.458327293395996
        },
        {
            "text": "Transcribed ultraconserved",
            "probability": 0.0013265998177065782,
            "start_logit": 3.7483408451080322,
            "end_logit": -2.0479042530059814
        },
        {
            "text": "Uc.160+, a T-UCR reported to be downregulated in human cancer, has not been examined in GC",
            "probability": 0.0012912403215909216,
            "start_logit": 1.9401854276657104,
            "end_logit": -0.26676473021507263
        },
        {
            "text": "GC), indicating that T-UCRs could play an important role in GC biology. Uc.160+",
            "probability": 0.0008816131434400588,
            "start_logit": -1.1665117740631104,
            "end_logit": 2.458327293395996
        },
        {
            "text": "Uc.160+,",
            "probability": 0.0008301056266422058,
            "start_logit": 1.9401854276657104,
            "end_logit": -0.7085703015327454
        },
        {
            "text": "160+",
            "probability": 0.0006896999971049073,
            "start_logit": -1.4120084047317505,
            "end_logit": 2.458327293395996
        },
        {
            "text": "T-UCRs could play an important role in GC biology. Uc.160+",
            "probability": 0.0005425790102934736,
            "start_logit": -1.6519314050674438,
            "end_logit": 2.458327293395996
        },
        {
            "text": "Uc.160+, a T-UCR reported to be downregulated in human cancer",
            "probability": 0.00035424540848772926,
            "start_logit": 1.9401854276657104,
            "end_logit": -1.5601333379745483
        },
        {
            "text": "indicating that T-UCRs could play an important role in GC biology. Uc.160+",
            "probability": 0.00019063948619314744,
            "start_logit": -2.697880983352661,
            "end_logit": 2.458327293395996
        },
        {
            "text": "GC biology",
            "probability": 8.596084900321723e-05,
            "start_logit": -0.6596239805221558,
            "end_logit": -0.37642189860343933
        },
        {
            "text": "GC",
            "probability": 6.907667433594327e-05,
            "start_logit": -1.1665117740631104,
            "end_logit": -0.08820894360542297
        },
        {
            "text": "GC biology. Uc.160+,",
            "probability": 6.166666722846679e-05,
            "start_logit": -0.6596239805221558,
            "end_logit": -0.7085703015327454
        },
        {
            "text": "distinct signatures in human cancers. We previously discovered the downregulation of T-UCR expression in gastric cancer (GC",
            "probability": 5.607159432139798e-05,
            "start_logit": -1.375099539756775,
            "end_logit": -0.08820894360542297
        },
        {
            "text": "GC), indicating that T-UCRs could play an important role in GC biology",
            "probability": 5.178000935071529e-05,
            "start_logit": -1.1665117740631104,
            "end_logit": -0.37642189860343933
        }
    ],
    "5e36ad01b5b409ea53000006_005": [
        {
            "text": "",
            "probability": 0.9734585056905517,
            "start_logit": 2.9808034896850586,
            "end_logit": 3.702552080154419
        },
        {
            "text": "Uc.416+A in GC",
            "probability": 0.008333452857606732,
            "start_logit": 0.7126058340072632,
            "end_logit": 1.210172414779663
        },
        {
            "text": "prostate cancer (PCa) and gastric cancer (GC",
            "probability": 0.0035159593362716225,
            "start_logit": 0.46712130308151245,
            "end_logit": 0.5926914811134338
        },
        {
            "text": "GC",
            "probability": 0.002116819750520986,
            "start_logit": -0.040276266634464264,
            "end_logit": 0.5926914811134338
        },
        {
            "text": "prostate cancer",
            "probability": 0.002010881629831468,
            "start_logit": 0.46712130308151245,
            "end_logit": 0.03395231440663338
        },
        {
            "text": "representative 26 T-UCRs and determined the regions that were differently expressed in prostate cancer (PCa) and gastric cancer (GC",
            "probability": 0.001618454987846059,
            "start_logit": -0.30871912837028503,
            "end_logit": 0.5926914811134338
        },
        {
            "text": "oncogenic role of Uc.416+A in GC",
            "probability": 0.0014823912444259177,
            "start_logit": -1.014015555381775,
            "end_logit": 1.210172414779663
        },
        {
            "text": "an oncogenic role of Uc.416+A in GC",
            "probability": 0.0010671814727832825,
            "start_logit": -1.3426510095596313,
            "end_logit": 1.210172414779663
        },
        {
            "text": "Uc.416+A",
            "probability": 0.0010513751279718141,
            "start_logit": 0.7126058340072632,
            "end_logit": -0.8600065112113953
        },
        {
            "text": "representative 26 T-UCRs and determined the regions that were differently expressed in prostate cancer",
            "probability": 0.0009256425039374592,
            "start_logit": -0.30871912837028503,
            "end_logit": 0.03395231440663338
        },
        {
            "text": "26 T-UCRs and determined the regions that were differently expressed in prostate cancer (PCa) and gastric cancer (GC",
            "probability": 0.0008166888773880835,
            "start_logit": -0.9926881790161133,
            "end_logit": 0.5926914811134338
        },
        {
            "text": "prostate cancer (PCa)",
            "probability": 0.0004800727425519863,
            "start_logit": 0.46712130308151245,
            "end_logit": -1.398438572883606
        },
        {
            "text": "26 T-UCRs and determined the regions that were differently expressed in prostate cancer",
            "probability": 0.00046708863890583676,
            "start_logit": -0.9926881790161133,
            "end_logit": 0.03395231440663338
        },
        {
            "text": "prostate cancer (PCa",
            "probability": 0.0004519458205332422,
            "start_logit": 0.46712130308151245,
            "end_logit": -1.4588139057159424
        },
        {
            "text": "prostate cancer (PCa) and gastric cancer (GC)",
            "probability": 0.0004208042928700558,
            "start_logit": 0.46712130308151245,
            "end_logit": -1.5302083492279053
        },
        {
            "text": "PCa) and gastric cancer (GC",
            "probability": 0.0004113771644084314,
            "start_logit": -1.6784359216690063,
            "end_logit": 0.5926914811134338
        },
        {
            "text": "representative 26",
            "probability": 0.0003727837543844398,
            "start_logit": -0.30871912837028503,
            "end_logit": -0.8755372762680054
        },
        {
            "text": "representative 26 T-UCRs",
            "probability": 0.00037082317852640606,
            "start_logit": -0.30871912837028503,
            "end_logit": -0.8808104395866394
        },
        {
            "text": "Uc.416+A was associated with cell growth through the regulation of IGFBP6",
            "probability": 0.0003476692383339171,
            "start_logit": -0.3965020775794983,
            "end_logit": -0.8575012683868408
        },
        {
            "text": "GC, which suggests that our approach would provide new insights into functional studies of T-UCRs in cancer biology",
            "probability": 0.00028008169035036574,
            "start_logit": -0.9417383074760437,
            "end_logit": -0.5284352898597717
        }
    ],
    "5e2dae57fbd6abf43b000012_001": [
        {
            "text": "approximately twice",
            "probability": 0.586485621456431,
            "start_logit": 6.693428039550781,
            "end_logit": 7.308770179748535
        },
        {
            "text": "twice",
            "probability": 0.22094961668970034,
            "start_logit": 5.717214584350586,
            "end_logit": 7.308770179748535
        },
        {
            "text": "approximately twice the level",
            "probability": 0.07114562309731423,
            "start_logit": 6.693428039550781,
            "end_logit": 5.199350833892822
        },
        {
            "text": "it reaches plasma concentration approximately twice",
            "probability": 0.027922904196112434,
            "start_logit": 3.6487271785736084,
            "end_logit": 7.308770179748535
        },
        {
            "text": "twice the level",
            "probability": 0.026803040990953354,
            "start_logit": 5.717214584350586,
            "end_logit": 5.199350833892822
        },
        {
            "text": "approximately twice the level achieved",
            "probability": 0.011636033164829421,
            "start_logit": 6.693428039550781,
            "end_logit": 3.388728618621826
        },
        {
            "text": "approximately twice the level achieved by amantadine immediate release",
            "probability": 0.008915453539964225,
            "start_logit": 6.693428039550781,
            "end_logit": 3.122408151626587
        },
        {
            "text": "reaches plasma concentration approximately twice",
            "probability": 0.00862040365127732,
            "start_logit": 2.473411798477173,
            "end_logit": 7.308770179748535
        },
        {
            "text": "When it is given at bedtime, it reaches plasma concentration approximately twice",
            "probability": 0.007591560465760167,
            "start_logit": 2.3463170528411865,
            "end_logit": 7.308770179748535
        },
        {
            "text": "plasma concentration approximately twice",
            "probability": 0.004672279639767812,
            "start_logit": 1.8609269857406616,
            "end_logit": 7.308770179748535
        },
        {
            "text": "approximately twice the",
            "probability": 0.004428000823293396,
            "start_logit": 6.693428039550781,
            "end_logit": 2.42257022857666
        },
        {
            "text": "twice the level achieved",
            "probability": 0.004383700083171937,
            "start_logit": 5.717214584350586,
            "end_logit": 3.388728618621826
        },
        {
            "text": "it reaches plasma concentration approximately twice the level",
            "probability": 0.003387282390292342,
            "start_logit": 3.6487271785736084,
            "end_logit": 5.199350833892822
        },
        {
            "text": "twice the level achieved by amantadine immediate release",
            "probability": 0.003358762721885869,
            "start_logit": 5.717214584350586,
            "end_logit": 3.122408151626587
        },
        {
            "text": "approximately twice the level achieved by amantadine immediate release.",
            "probability": 0.0028786658330792535,
            "start_logit": 6.693428039550781,
            "end_logit": 1.9919489622116089
        },
        {
            "text": "twice the",
            "probability": 0.0016681825586427178,
            "start_logit": 5.717214584350586,
            "end_logit": 2.42257022857666
        },
        {
            "text": "",
            "probability": 0.0016236134819495483,
            "start_logit": 3.991219997406006,
            "end_logit": 4.121484279632568
        },
        {
            "text": "concentration approximately twice",
            "probability": 0.0013990340203565842,
            "start_logit": 0.6550619006156921,
            "end_logit": 7.308770179748535
        },
        {
            "text": "twice the level achieved by amantadine immediate release.",
            "probability": 0.0010844939571018081,
            "start_logit": 5.717214584350586,
            "end_logit": 1.9919489622116089
        },
        {
            "text": "reaches plasma concentration approximately twice the level",
            "probability": 0.0010457272381161847,
            "start_logit": 2.473411798477173,
            "end_logit": 5.199350833892822
        }
    ],
    "5e2dae57fbd6abf43b000012_002": [
        {
            "text": "higher in PD patients versus healthy volunteers",
            "probability": 0.5088896885805895,
            "start_logit": 5.7246222496032715,
            "end_logit": 4.972379207611084
        },
        {
            "text": "higher",
            "probability": 0.23948664092311903,
            "start_logit": 5.7246222496032715,
            "end_logit": 4.2186455726623535
        },
        {
            "text": "higher in PD patients",
            "probability": 0.09201407500174248,
            "start_logit": 5.7246222496032715,
            "end_logit": 3.262089490890503
        },
        {
            "text": "Amantadine plasma concentrations were higher in PD patients versus healthy volunteers",
            "probability": 0.05659165992693165,
            "start_logit": 3.528252601623535,
            "end_logit": 4.972379207611084
        },
        {
            "text": "higher in PD patients versus healthy volunteers.",
            "probability": 0.029927701711127026,
            "start_logit": 5.7246222496032715,
            "end_logit": 2.138932466506958
        },
        {
            "text": "Amantadine plasma concentrations were higher",
            "probability": 0.026632385847641427,
            "start_logit": 3.528252601623535,
            "end_logit": 4.2186455726623535
        },
        {
            "text": "Amantadine plasma concentrations were higher in PD patients",
            "probability": 0.010232530463554792,
            "start_logit": 3.528252601623535,
            "end_logit": 3.262089490890503
        },
        {
            "text": "higher in",
            "probability": 0.005855163160086604,
            "start_logit": 5.7246222496032715,
            "end_logit": 0.5074717998504639
        },
        {
            "text": "were higher in PD patients versus healthy volunteers",
            "probability": 0.005107228301397886,
            "start_logit": 1.1230478286743164,
            "end_logit": 4.972379207611084
        },
        {
            "text": "plasma concentrations were higher in PD patients versus healthy volunteers",
            "probability": 0.0034242569671089186,
            "start_logit": 0.7232754826545715,
            "end_logit": 4.972379207611084
        },
        {
            "text": "Amantadine plasma concentrations were higher in PD patients versus healthy volunteers.",
            "probability": 0.0033281443024612153,
            "start_logit": 3.528252601623535,
            "end_logit": 2.138932466506958
        },
        {
            "text": "healthy volunteers",
            "probability": 0.003265707398377236,
            "start_logit": 0.6758673787117004,
            "end_logit": 4.972379207611084
        },
        {
            "text": "PD patients versus healthy volunteers",
            "probability": 0.0030855157738375397,
            "start_logit": 0.6191098093986511,
            "end_logit": 4.972379207611084
        },
        {
            "text": "in PD patients versus healthy volunteers",
            "probability": 0.0028668190157068118,
            "start_logit": 0.5455940365791321,
            "end_logit": 4.972379207611084
        },
        {
            "text": "were higher",
            "probability": 0.002403493287004518,
            "start_logit": 1.1230478286743164,
            "end_logit": 4.2186455726623535
        },
        {
            "text": "",
            "probability": 0.0019216259380158097,
            "start_logit": 2.3321006298065186,
            "end_logit": 2.785841226577759
        },
        {
            "text": "plasma concentrations were higher",
            "probability": 0.0016114765480861853,
            "start_logit": 0.7232754826545715,
            "end_logit": 4.2186455726623535
        },
        {
            "text": "Amantadine plasma concentrations",
            "probability": 0.0013730149070899477,
            "start_logit": 3.528252601623535,
            "end_logit": 1.2535265684127808
        },
        {
            "text": "concentrations were higher in PD patients versus healthy volunteers",
            "probability": 0.0010594166305174476,
            "start_logit": -0.4498906135559082,
            "end_logit": 4.972379207611084
        },
        {
            "text": "were higher in PD patients",
            "probability": 0.0009234553156040735,
            "start_logit": 1.1230478286743164,
            "end_logit": 3.262089490890503
        }
    ],
    "5e4981e96d0a277941000009_001": [
        {
            "text": "The reduction of the dose limit for eye lens from 150 to 20 mSv yr-1",
            "probability": 0.34019654163375124,
            "start_logit": 4.359645843505859,
            "end_logit": 5.139166831970215
        },
        {
            "text": "reduction of the dose limit for eye lens from 150 to 20 mSv yr-1",
            "probability": 0.17569738496250237,
            "start_logit": 3.698885440826416,
            "end_logit": 5.139166831970215
        },
        {
            "text": "The reduction of the dose limit",
            "probability": 0.11293697914844496,
            "start_logit": 4.359645843505859,
            "end_logit": 4.036473274230957
        },
        {
            "text": "150 to 20 mSv yr-1",
            "probability": 0.08001039480762412,
            "start_logit": 2.912278890609741,
            "end_logit": 5.139166831970215
        },
        {
            "text": "reduction of the dose limit",
            "probability": 0.0583272593150248,
            "start_logit": 3.698885440826416,
            "end_logit": 4.036473274230957
        },
        {
            "text": "dose limit for eye lens from 150 to 20 mSv yr-1",
            "probability": 0.04987252603080627,
            "start_logit": 2.4395925998687744,
            "end_logit": 5.139166831970215
        },
        {
            "text": "Eye lens dose is conventionally monitored by specific dosemeters worn near the eye",
            "probability": 0.045944570589672745,
            "start_logit": 3.706186532974243,
            "end_logit": 3.7905383110046387
        },
        {
            "text": "conventionally monitored by specific dosemeters worn near the eye",
            "probability": 0.022801764416749814,
            "start_logit": 3.0055887699127197,
            "end_logit": 3.7905383110046387
        },
        {
            "text": "dose limit",
            "probability": 0.01655646587520349,
            "start_logit": 2.4395925998687744,
            "end_logit": 4.036473274230957
        },
        {
            "text": "",
            "probability": 0.015196443481041332,
            "start_logit": 3.0180232524871826,
            "end_logit": 3.3723273277282715
        },
        {
            "text": "The reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states",
            "probability": 0.012443963616610336,
            "start_logit": 4.359645843505859,
            "end_logit": 1.8308789730072021
        },
        {
            "text": "150 to 20 mSv yr-1 must be implemented by EU member states by February 2018",
            "probability": 0.012274749055624526,
            "start_logit": 2.912278890609741,
            "end_logit": 3.264554500579834
        },
        {
            "text": "monitored by specific dosemeters worn near the eye",
            "probability": 0.011387478561295348,
            "start_logit": 2.311265230178833,
            "end_logit": 3.7905383110046387
        },
        {
            "text": "20 mSv yr-1",
            "probability": 0.008302304368673711,
            "start_logit": 0.6466554403305054,
            "end_logit": 5.139166831970215
        },
        {
            "text": "dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states by February 2018",
            "probability": 0.007651165117609386,
            "start_logit": 2.4395925998687744,
            "end_logit": 3.264554500579834
        },
        {
            "text": "20 mSv dose limit",
            "probability": 0.007409871158606078,
            "start_logit": 2.177405595779419,
            "end_logit": 3.494696617126465
        },
        {
            "text": "Eye lens dose is conventionally monitored by specific dosemeters worn near the eye.",
            "probability": 0.006684830813156793,
            "start_logit": 3.706186532974243,
            "end_logit": 1.8629435300827026
        },
        {
            "text": "reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states",
            "probability": 0.0064267903944795635,
            "start_logit": 3.698885440826416,
            "end_logit": 1.8308789730072021
        },
        {
            "text": "The reduction",
            "probability": 0.005449430204169866,
            "start_logit": 4.359645843505859,
            "end_logit": 1.0051543712615967
        },
        {
            "text": "compliance with the 20 mSv dose limit",
            "probability": 0.00442908644895338,
            "start_logit": 1.6627858877182007,
            "end_logit": 3.494696617126465
        }
    ],
    "5e4981e96d0a277941000009_002": [
        {
            "text": "lower occupational exposure limit",
            "probability": 0.6800917560194164,
            "start_logit": 6.796657085418701,
            "end_logit": 7.375543594360352
        },
        {
            "text": "updated lower occupational exposure limit",
            "probability": 0.10887976043840253,
            "start_logit": 4.9646735191345215,
            "end_logit": 7.375543594360352
        },
        {
            "text": "lower occupational exposure limit for the lens of the eye",
            "probability": 0.08261680752851341,
            "start_logit": 6.796657085418701,
            "end_logit": 5.267529010772705
        },
        {
            "text": "the updated lower occupational exposure limit",
            "probability": 0.054438140893126964,
            "start_logit": 4.271494388580322,
            "end_logit": 7.375543594360352
        },
        {
            "text": "Due to the updated lower occupational exposure limit",
            "probability": 0.01690135388870811,
            "start_logit": 3.101823091506958,
            "end_logit": 7.375543594360352
        },
        {
            "text": "updated lower occupational exposure limit for the lens of the eye",
            "probability": 0.013226594988505253,
            "start_logit": 4.9646735191345215,
            "end_logit": 5.267529010772705
        },
        {
            "text": "occupational exposure limit",
            "probability": 0.011355494973165046,
            "start_logit": 2.7041311264038086,
            "end_logit": 7.375543594360352
        },
        {
            "text": "the updated lower occupational exposure limit for the lens of the eye",
            "probability": 0.006613086202811084,
            "start_logit": 4.271494388580322,
            "end_logit": 5.267529010772705
        },
        {
            "text": "lower occupational exposure limit for the lens of the eye,",
            "probability": 0.005811275929457541,
            "start_logit": 6.796657085418701,
            "end_logit": 2.6131160259246826
        },
        {
            "text": "limit",
            "probability": 0.0050676439646741706,
            "start_logit": 1.8973053693771362,
            "end_logit": 7.375543594360352
        },
        {
            "text": "exposure limit",
            "probability": 0.0025080885631788364,
            "start_logit": 1.1939502954483032,
            "end_logit": 7.375543594360352
        },
        {
            "text": "lower",
            "probability": 0.002153552943961926,
            "start_logit": 6.796657085418701,
            "end_logit": 1.6204348802566528
        },
        {
            "text": "Due to the updated lower occupational exposure limit for the lens of the eye",
            "probability": 0.002053158105264291,
            "start_logit": 3.101823091506958,
            "end_logit": 5.267529010772705
        },
        {
            "text": "20 mSv",
            "probability": 0.0018029179768418403,
            "start_logit": 3.6378884315490723,
            "end_logit": 4.6014909744262695
        },
        {
            "text": "occupational exposure limit for the lens of the eye",
            "probability": 0.0013794531903753794,
            "start_logit": 2.7041311264038086,
            "end_logit": 5.267529010772705
        },
        {
            "text": "lower occupational exposure",
            "probability": 0.0011026316389847917,
            "start_logit": 6.796657085418701,
            "end_logit": 0.9510155916213989
        },
        {
            "text": "to the updated lower occupational exposure limit",
            "probability": 0.000935366891532249,
            "start_logit": 0.20761293172836304,
            "end_logit": 7.375543594360352
        },
        {
            "text": "updated lower occupational exposure limit for the lens of the eye,",
            "probability": 0.0009303602424828213,
            "start_logit": 4.9646735191345215,
            "end_logit": 2.6131160259246826
        },
        {
            "text": "within the new annual limit of 20 mSv",
            "probability": 0.0008605375537301463,
            "start_logit": 2.8982839584350586,
            "end_logit": 4.6014909744262695
        },
        {
            "text": "lower occupational",
            "probability": 0.0007579397018222846,
            "start_logit": 6.796657085418701,
            "end_logit": 0.5761644244194031
        },
        {
            "text": "",
            "probability": 0.0005140783650451179,
            "start_logit": 3.371650457382202,
            "end_logit": 3.612942934036255
        }
    ],
    "5e4981e96d0a277941000009_003": [
        {
            "text": "lower occupational exposure limit",
            "probability": 0.6800917560194164,
            "start_logit": 6.796657085418701,
            "end_logit": 7.375543594360352
        },
        {
            "text": "updated lower occupational exposure limit",
            "probability": 0.10887976043840253,
            "start_logit": 4.9646735191345215,
            "end_logit": 7.375543594360352
        },
        {
            "text": "lower occupational exposure limit for the lens of the eye",
            "probability": 0.08261680752851341,
            "start_logit": 6.796657085418701,
            "end_logit": 5.267529010772705
        },
        {
            "text": "the updated lower occupational exposure limit",
            "probability": 0.054438140893126964,
            "start_logit": 4.271494388580322,
            "end_logit": 7.375543594360352
        },
        {
            "text": "Due to the updated lower occupational exposure limit",
            "probability": 0.01690135388870811,
            "start_logit": 3.101823091506958,
            "end_logit": 7.375543594360352
        },
        {
            "text": "updated lower occupational exposure limit for the lens of the eye",
            "probability": 0.013226594988505253,
            "start_logit": 4.9646735191345215,
            "end_logit": 5.267529010772705
        },
        {
            "text": "occupational exposure limit",
            "probability": 0.011355494973165046,
            "start_logit": 2.7041311264038086,
            "end_logit": 7.375543594360352
        },
        {
            "text": "the updated lower occupational exposure limit for the lens of the eye",
            "probability": 0.006613086202811084,
            "start_logit": 4.271494388580322,
            "end_logit": 5.267529010772705
        },
        {
            "text": "lower occupational exposure limit for the lens of the eye,",
            "probability": 0.005811275929457541,
            "start_logit": 6.796657085418701,
            "end_logit": 2.6131160259246826
        },
        {
            "text": "limit",
            "probability": 0.0050676439646741706,
            "start_logit": 1.8973053693771362,
            "end_logit": 7.375543594360352
        },
        {
            "text": "exposure limit",
            "probability": 0.0025080885631788364,
            "start_logit": 1.1939502954483032,
            "end_logit": 7.375543594360352
        },
        {
            "text": "lower",
            "probability": 0.002153552943961926,
            "start_logit": 6.796657085418701,
            "end_logit": 1.6204348802566528
        },
        {
            "text": "Due to the updated lower occupational exposure limit for the lens of the eye",
            "probability": 0.002053158105264291,
            "start_logit": 3.101823091506958,
            "end_logit": 5.267529010772705
        },
        {
            "text": "20 mSv",
            "probability": 0.0018029179768418403,
            "start_logit": 3.6378884315490723,
            "end_logit": 4.6014909744262695
        },
        {
            "text": "occupational exposure limit for the lens of the eye",
            "probability": 0.0013794531903753794,
            "start_logit": 2.7041311264038086,
            "end_logit": 5.267529010772705
        },
        {
            "text": "lower occupational exposure",
            "probability": 0.0011026316389847917,
            "start_logit": 6.796657085418701,
            "end_logit": 0.9510155916213989
        },
        {
            "text": "to the updated lower occupational exposure limit",
            "probability": 0.000935366891532249,
            "start_logit": 0.20761293172836304,
            "end_logit": 7.375543594360352
        },
        {
            "text": "updated lower occupational exposure limit for the lens of the eye,",
            "probability": 0.0009303602424828213,
            "start_logit": 4.9646735191345215,
            "end_logit": 2.6131160259246826
        },
        {
            "text": "within the new annual limit of 20 mSv",
            "probability": 0.0008605375537301463,
            "start_logit": 2.8982839584350586,
            "end_logit": 4.6014909744262695
        },
        {
            "text": "lower occupational",
            "probability": 0.0007579397018222846,
            "start_logit": 6.796657085418701,
            "end_logit": 0.5761644244194031
        },
        {
            "text": "",
            "probability": 0.0005140783650451179,
            "start_logit": 3.371650457382202,
            "end_logit": 3.612942934036255
        }
    ],
    "5e4981e96d0a277941000009_004": [
        {
            "text": "2013/59/Euratom",
            "probability": 0.4609726125941965,
            "start_logit": 7.320706844329834,
            "end_logit": 8.360980987548828
        },
        {
            "text": "European directive 2013/59/Euratom",
            "probability": 0.2816400816411547,
            "start_logit": 6.827998161315918,
            "end_logit": 8.360980987548828
        },
        {
            "text": "2013/59",
            "probability": 0.037017994167097716,
            "start_logit": 7.320706844329834,
            "end_logit": 5.839046478271484
        },
        {
            "text": "directive 2013/59/Euratom",
            "probability": 0.032223653931455196,
            "start_logit": 4.660068988800049,
            "end_logit": 8.360980987548828
        },
        {
            "text": "European directive",
            "probability": 0.025342784605310534,
            "start_logit": 6.827998161315918,
            "end_logit": 5.952845096588135
        },
        {
            "text": "European directive 2013/59",
            "probability": 0.02261685535012725,
            "start_logit": 6.827998161315918,
            "end_logit": 5.839046478271484
        },
        {
            "text": "Euratom directive",
            "probability": 0.020587432063928997,
            "start_logit": 5.298285007476807,
            "end_logit": 7.274744987487793
        },
        {
            "text": "new Euratom directive",
            "probability": 0.01620217453688898,
            "start_logit": 5.058749675750732,
            "end_logit": 7.274744987487793
        },
        {
            "text": "current European directive 2013/59/Euratom",
            "probability": 0.015895013740087515,
            "start_logit": 3.953373670578003,
            "end_logit": 8.360980987548828
        },
        {
            "text": "permitted yearly limit set by the new Euratom directive",
            "probability": 0.015492420501516668,
            "start_logit": 5.013955116271973,
            "end_logit": 7.274744987487793
        },
        {
            "text": "the current European directive 2013/59/Euratom",
            "probability": 0.014532315938435658,
            "start_logit": 3.8637430667877197,
            "end_logit": 8.360980987548828
        },
        {
            "text": "reduced to 20 millisieverts (mSv) in the current European directive 2013/59/Euratom",
            "probability": 0.012178656979525774,
            "start_logit": 3.6870532035827637,
            "end_logit": 8.360980987548828
        },
        {
            "text": "20 millisieverts (mSv) in the current European directive 2013/59/Euratom",
            "probability": 0.0095976010433039,
            "start_logit": 3.4488813877105713,
            "end_logit": 8.360980987548828
        },
        {
            "text": "European",
            "probability": 0.00702771228297288,
            "start_logit": 6.827998161315918,
            "end_logit": 4.670212268829346
        },
        {
            "text": "the new Euratom directive",
            "probability": 0.006777942447236778,
            "start_logit": 4.187277793884277,
            "end_logit": 7.274744987487793
        },
        {
            "text": "cross the permitted yearly limit set by the new Euratom directive",
            "probability": 0.006323614217078217,
            "start_logit": 4.117895126342773,
            "end_logit": 7.274744987487793
        },
        {
            "text": "in the current European directive 2013/59/Euratom",
            "probability": 0.004865588115228694,
            "start_logit": 2.7695558071136475,
            "end_logit": 8.360980987548828
        },
        {
            "text": "could cross the permitted yearly limit set by the new Euratom directive",
            "probability": 0.003905333777568399,
            "start_logit": 3.6359474658966064,
            "end_logit": 7.274744987487793
        },
        {
            "text": "the permitted yearly limit set by the new Euratom directive",
            "probability": 0.0030486506046884967,
            "start_logit": 3.388303279876709,
            "end_logit": 7.274744987487793
        },
        {
            "text": "directive",
            "probability": 0.002899577063116452,
            "start_logit": 4.660068988800049,
            "end_logit": 5.952845096588135
        },
        {
            "text": "",
            "probability": 0.0008519843990809869,
            "start_logit": 4.318446159362793,
            "end_logit": 5.069715976715088
        }
    ],
    "5e4981e96d0a277941000009_005": [
        {
            "text": "2013/59/Euratom",
            "probability": 0.4609726125941965,
            "start_logit": 7.320706844329834,
            "end_logit": 8.360980987548828
        },
        {
            "text": "European directive 2013/59/Euratom",
            "probability": 0.2816400816411547,
            "start_logit": 6.827998161315918,
            "end_logit": 8.360980987548828
        },
        {
            "text": "2013/59",
            "probability": 0.037017994167097716,
            "start_logit": 7.320706844329834,
            "end_logit": 5.839046478271484
        },
        {
            "text": "directive 2013/59/Euratom",
            "probability": 0.032223653931455196,
            "start_logit": 4.660068988800049,
            "end_logit": 8.360980987548828
        },
        {
            "text": "European directive",
            "probability": 0.025342784605310534,
            "start_logit": 6.827998161315918,
            "end_logit": 5.952845096588135
        },
        {
            "text": "European directive 2013/59",
            "probability": 0.02261685535012725,
            "start_logit": 6.827998161315918,
            "end_logit": 5.839046478271484
        },
        {
            "text": "Euratom directive",
            "probability": 0.020587432063928997,
            "start_logit": 5.298285007476807,
            "end_logit": 7.274744987487793
        },
        {
            "text": "new Euratom directive",
            "probability": 0.01620217453688898,
            "start_logit": 5.058749675750732,
            "end_logit": 7.274744987487793
        },
        {
            "text": "current European directive 2013/59/Euratom",
            "probability": 0.015895013740087515,
            "start_logit": 3.953373670578003,
            "end_logit": 8.360980987548828
        },
        {
            "text": "permitted yearly limit set by the new Euratom directive",
            "probability": 0.015492420501516668,
            "start_logit": 5.013955116271973,
            "end_logit": 7.274744987487793
        },
        {
            "text": "the current European directive 2013/59/Euratom",
            "probability": 0.014532315938435658,
            "start_logit": 3.8637430667877197,
            "end_logit": 8.360980987548828
        },
        {
            "text": "reduced to 20 millisieverts (mSv) in the current European directive 2013/59/Euratom",
            "probability": 0.012178656979525774,
            "start_logit": 3.6870532035827637,
            "end_logit": 8.360980987548828
        },
        {
            "text": "20 millisieverts (mSv) in the current European directive 2013/59/Euratom",
            "probability": 0.0095976010433039,
            "start_logit": 3.4488813877105713,
            "end_logit": 8.360980987548828
        },
        {
            "text": "European",
            "probability": 0.00702771228297288,
            "start_logit": 6.827998161315918,
            "end_logit": 4.670212268829346
        },
        {
            "text": "the new Euratom directive",
            "probability": 0.006777942447236778,
            "start_logit": 4.187277793884277,
            "end_logit": 7.274744987487793
        },
        {
            "text": "cross the permitted yearly limit set by the new Euratom directive",
            "probability": 0.006323614217078217,
            "start_logit": 4.117895126342773,
            "end_logit": 7.274744987487793
        },
        {
            "text": "in the current European directive 2013/59/Euratom",
            "probability": 0.004865588115228694,
            "start_logit": 2.7695558071136475,
            "end_logit": 8.360980987548828
        },
        {
            "text": "could cross the permitted yearly limit set by the new Euratom directive",
            "probability": 0.003905333777568399,
            "start_logit": 3.6359474658966064,
            "end_logit": 7.274744987487793
        },
        {
            "text": "the permitted yearly limit set by the new Euratom directive",
            "probability": 0.0030486506046884967,
            "start_logit": 3.388303279876709,
            "end_logit": 7.274744987487793
        },
        {
            "text": "directive",
            "probability": 0.002899577063116452,
            "start_logit": 4.660068988800049,
            "end_logit": 5.952845096588135
        },
        {
            "text": "",
            "probability": 0.0008519843990809869,
            "start_logit": 4.318446159362793,
            "end_logit": 5.069715976715088
        }
    ],
    "5e4981e96d0a277941000009_006": [
        {
            "text": "The reduction of the dose limit for eye lens from 150 to 20 mSv yr-1",
            "probability": 0.34019654163375124,
            "start_logit": 4.359645843505859,
            "end_logit": 5.139166831970215
        },
        {
            "text": "reduction of the dose limit for eye lens from 150 to 20 mSv yr-1",
            "probability": 0.17569738496250237,
            "start_logit": 3.698885440826416,
            "end_logit": 5.139166831970215
        },
        {
            "text": "The reduction of the dose limit",
            "probability": 0.11293697914844496,
            "start_logit": 4.359645843505859,
            "end_logit": 4.036473274230957
        },
        {
            "text": "150 to 20 mSv yr-1",
            "probability": 0.08001039480762412,
            "start_logit": 2.912278890609741,
            "end_logit": 5.139166831970215
        },
        {
            "text": "reduction of the dose limit",
            "probability": 0.0583272593150248,
            "start_logit": 3.698885440826416,
            "end_logit": 4.036473274230957
        },
        {
            "text": "dose limit for eye lens from 150 to 20 mSv yr-1",
            "probability": 0.04987252603080627,
            "start_logit": 2.4395925998687744,
            "end_logit": 5.139166831970215
        },
        {
            "text": "Eye lens dose is conventionally monitored by specific dosemeters worn near the eye",
            "probability": 0.045944570589672745,
            "start_logit": 3.706186532974243,
            "end_logit": 3.7905383110046387
        },
        {
            "text": "conventionally monitored by specific dosemeters worn near the eye",
            "probability": 0.022801764416749814,
            "start_logit": 3.0055887699127197,
            "end_logit": 3.7905383110046387
        },
        {
            "text": "dose limit",
            "probability": 0.01655646587520349,
            "start_logit": 2.4395925998687744,
            "end_logit": 4.036473274230957
        },
        {
            "text": "",
            "probability": 0.015196443481041332,
            "start_logit": 3.0180232524871826,
            "end_logit": 3.3723273277282715
        },
        {
            "text": "The reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states",
            "probability": 0.012443963616610336,
            "start_logit": 4.359645843505859,
            "end_logit": 1.8308789730072021
        },
        {
            "text": "150 to 20 mSv yr-1 must be implemented by EU member states by February 2018",
            "probability": 0.012274749055624526,
            "start_logit": 2.912278890609741,
            "end_logit": 3.264554500579834
        },
        {
            "text": "monitored by specific dosemeters worn near the eye",
            "probability": 0.011387478561295348,
            "start_logit": 2.311265230178833,
            "end_logit": 3.7905383110046387
        },
        {
            "text": "20 mSv yr-1",
            "probability": 0.008302304368673711,
            "start_logit": 0.6466554403305054,
            "end_logit": 5.139166831970215
        },
        {
            "text": "dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states by February 2018",
            "probability": 0.007651165117609386,
            "start_logit": 2.4395925998687744,
            "end_logit": 3.264554500579834
        },
        {
            "text": "20 mSv dose limit",
            "probability": 0.007409871158606078,
            "start_logit": 2.177405595779419,
            "end_logit": 3.494696617126465
        },
        {
            "text": "Eye lens dose is conventionally monitored by specific dosemeters worn near the eye.",
            "probability": 0.006684830813156793,
            "start_logit": 3.706186532974243,
            "end_logit": 1.8629435300827026
        },
        {
            "text": "reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states",
            "probability": 0.0064267903944795635,
            "start_logit": 3.698885440826416,
            "end_logit": 1.8308789730072021
        },
        {
            "text": "The reduction",
            "probability": 0.005449430204169866,
            "start_logit": 4.359645843505859,
            "end_logit": 1.0051543712615967
        },
        {
            "text": "compliance with the 20 mSv dose limit",
            "probability": 0.00442908644895338,
            "start_logit": 1.6627858877182007,
            "end_logit": 3.494696617126465
        }
    ],
    "5e2f972bfbd6abf43b000030_001": [
        {
            "text": "dark urine, pigmentation of tissues, and ochronotic arthropathies",
            "probability": 0.8266715376211442,
            "start_logit": 2.94529128074646,
            "end_logit": 4.639172077178955
        },
        {
            "text": "a triad of dark urine, pigmentation of tissues, and ochronotic arthropathies",
            "probability": 0.04608744008149411,
            "start_logit": 0.05842430144548416,
            "end_logit": 4.639172077178955
        },
        {
            "text": "dark urine, pigmentation of tissues",
            "probability": 0.041186038743301165,
            "start_logit": 2.94529128074646,
            "end_logit": 1.6398639678955078
        },
        {
            "text": "triad of dark urine, pigmentation of tissues, and ochronotic arthropathies",
            "probability": 0.027178044174046755,
            "start_logit": -0.4697067141532898,
            "end_logit": 4.639172077178955
        },
        {
            "text": "dark urine",
            "probability": 0.013164503825817287,
            "start_logit": 2.94529128074646,
            "end_logit": 0.49928873777389526
        },
        {
            "text": "ochronotic arthropathies",
            "probability": 0.01125953441826662,
            "start_logit": -1.3509008884429932,
            "end_logit": 4.639172077178955
        },
        {
            "text": "characterized by a triad of dark urine, pigmentation of tissues, and ochronotic arthropathies",
            "probability": 0.011177045946128276,
            "start_logit": -1.3582539558410645,
            "end_logit": 4.639172077178955
        },
        {
            "text": "dark urine, pigmentation of tissues, and ochronotic arthropathies.",
            "probability": 0.004471279022839869,
            "start_logit": 2.94529128074646,
            "end_logit": -0.5805608630180359
        },
        {
            "text": "pigmentation of tissues, and ochronotic arthropathies",
            "probability": 0.0034561168497600383,
            "start_logit": -2.531970500946045,
            "end_logit": 4.639172077178955
        },
        {
            "text": "a triad of dark urine, pigmentation of tissues",
            "probability": 0.0022961466633267535,
            "start_logit": 0.05842430144548416,
            "end_logit": 1.6398639678955078
        },
        {
            "text": "dark urine, pigmentation of tissues,",
            "probability": 0.002286901324668445,
            "start_logit": 2.94529128074646,
            "end_logit": -1.25103759765625
        },
        {
            "text": "urine, pigmentation of tissues, and ochronotic arthropathies",
            "probability": 0.002242875050336475,
            "start_logit": -2.964357614517212,
            "end_logit": 4.639172077178955
        },
        {
            "text": "of dark urine, pigmentation of tissues, and ochronotic arthropathies",
            "probability": 0.001859320950359,
            "start_logit": -3.151904821395874,
            "end_logit": 4.639172077178955
        },
        {
            "text": "triad of dark urine, pigmentation of tissues",
            "probability": 0.0013540516751556898,
            "start_logit": -0.4697067141532898,
            "end_logit": 1.6398639678955078
        },
        {
            "text": "triad of dark urine, pigmentation of tissues, and ochronotic arthropathies.",
            "probability": 0.0012383291067298683,
            "start_logit": -3.5583531856536865,
            "end_logit": 4.639172077178955
        },
        {
            "text": "by a triad of dark urine, pigmentation of tissues, and ochronotic arthropathies",
            "probability": 0.0011848200752043105,
            "start_logit": -3.602525234222412,
            "end_logit": 4.639172077178955
        },
        {
            "text": "dark urine, pigmentation",
            "probability": 0.0007937404369973065,
            "start_logit": 2.94529128074646,
            "end_logit": -2.309234142303467
        },
        {
            "text": "a triad of dark urine",
            "probability": 0.0007339290802497757,
            "start_logit": 0.05842430144548416,
            "end_logit": 0.49928873777389526
        },
        {
            "text": "characterized by a triad of dark urine, pigmentation of tissues",
            "probability": 0.000556857501950025,
            "start_logit": -1.3582539558410645,
            "end_logit": 1.6398639678955078
        },
        {
            "text": "triad of dark urine",
            "probability": 0.00043280244961262896,
            "start_logit": -0.4697067141532898,
            "end_logit": 0.49928873777389526
        },
        {
            "text": "",
            "probability": 0.0003686850026111115,
            "start_logit": -0.45360997319221497,
            "end_logit": 0.3228532373905182
        }
    ],
    "5e2f972bfbd6abf43b000030_002": [
        {
            "text": "",
            "probability": 0.943939500582916,
            "start_logit": 0.6871063709259033,
            "end_logit": 0.8030102252960205
        },
        {
            "text": "clinical triad of symptoms",
            "probability": 0.012764737340670596,
            "start_logit": -1.1129173040390015,
            "end_logit": -1.7003417015075684
        },
        {
            "text": "clinical triad of symptoms; homogentisic aciduria",
            "probability": 0.004202792212960059,
            "start_logit": -1.1129173040390015,
            "end_logit": -2.811279058456421
        },
        {
            "text": "The condition is characterised by a clinical triad of symptoms",
            "probability": 0.0036940927236103808,
            "start_logit": -2.3528687953948975,
            "end_logit": -1.7003417015075684
        },
        {
            "text": "clinical triad of symptoms; homogentisic aciduria from birth",
            "probability": 0.0035240039937520042,
            "start_logit": -1.1129173040390015,
            "end_logit": -2.9874303340911865
        },
        {
            "text": "a clinical triad of symptoms",
            "probability": 0.0034124590092425655,
            "start_logit": -2.4321706295013428,
            "end_logit": -1.7003417015075684
        },
        {
            "text": "homogentisic aciduria",
            "probability": 0.003361100784553316,
            "start_logit": -1.3363978862762451,
            "end_logit": -2.811279058456421
        },
        {
            "text": "clinical triad of symptoms; homogentisic aciduria from birth, ochronosis (darkening) of collagenous tissues",
            "probability": 0.003147658869405053,
            "start_logit": -1.1129173040390015,
            "end_logit": -3.1003692150115967
        },
        {
            "text": "homogentisic aciduria from birth",
            "probability": 0.0028182531964450097,
            "start_logit": -1.3363978862762451,
            "end_logit": -2.9874303340911865
        },
        {
            "text": "clinical",
            "probability": 0.002789867560850827,
            "start_logit": -1.1129173040390015,
            "end_logit": -3.221034049987793
        },
        {
            "text": "homogentisic aciduria from birth, ochronosis (darkening) of collagenous tissues",
            "probability": 0.002517278551825486,
            "start_logit": -1.3363978862762451,
            "end_logit": -3.1003692150115967
        },
        {
            "text": "clinical triad of symptoms; homogentisic aciduria from birth, ochronosis",
            "probability": 0.002180031609705654,
            "start_logit": -1.1129173040390015,
            "end_logit": -3.467688798904419
        },
        {
            "text": "symptoms",
            "probability": 0.001851018358204556,
            "start_logit": -3.043867826461792,
            "end_logit": -1.7003417015075684
        },
        {
            "text": "clinical triad",
            "probability": 0.0018224789170551055,
            "start_logit": -1.1129173040390015,
            "end_logit": -3.6468305587768555
        },
        {
            "text": "homogentisic aciduria from birth, ochronosis",
            "probability": 0.0017434375963526457,
            "start_logit": -1.3363978862762451,
            "end_logit": -3.467688798904419
        },
        {
            "text": "clinical triad of symptoms;",
            "probability": 0.0014362866773886614,
            "start_logit": -1.1129173040390015,
            "end_logit": -3.884967088699341
        },
        {
            "text": "clinical triad of symptoms; homogentisic aciduria from birth,",
            "probability": 0.0012996156580604682,
            "start_logit": -1.1129173040390015,
            "end_logit": -3.984959602355957
        },
        {
            "text": "The condition is characterised by a clinical triad of symptoms; homogentisic aciduria",
            "probability": 0.0012162807364061662,
            "start_logit": -2.3528687953948975,
            "end_logit": -2.811279058456421
        },
        {
            "text": "triad of symptoms",
            "probability": 0.0011555528385578222,
            "start_logit": -3.5150249004364014,
            "end_logit": -1.7003417015075684
        },
        {
            "text": "a clinical triad of symptoms; homogentisic aciduria",
            "probability": 0.0011235527820376288,
            "start_logit": -2.4321706295013428,
            "end_logit": -2.811279058456421
        }
    ],
    "5e2f972bfbd6abf43b000030_003": [
        {
            "text": "ochronotic osteoarthropathy",
            "probability": 0.69191267975101,
            "start_logit": 2.841491222381592,
            "end_logit": 4.426652431488037
        },
        {
            "text": "The condition has a triad of clinical features, the most damaging of which is ochronotic osteoarthropathy",
            "probability": 0.10087633432605814,
            "start_logit": 0.9159268140792847,
            "end_logit": 4.426652431488037
        },
        {
            "text": "clinical features, the most damaging of which is ochronotic osteoarthropathy",
            "probability": 0.06386552137976818,
            "start_logit": 0.45881110429763794,
            "end_logit": 4.426652431488037
        },
        {
            "text": "a triad of clinical features, the most damaging of which is ochronotic osteoarthropathy",
            "probability": 0.037255164967688395,
            "start_logit": -0.08017794787883759,
            "end_logit": 4.426652431488037
        },
        {
            "text": "triad of clinical features, the most damaging of which is ochronotic osteoarthropathy",
            "probability": 0.028630849601594902,
            "start_logit": -0.34348374605178833,
            "end_logit": 4.426652431488037
        },
        {
            "text": "osteoarthropathy",
            "probability": 0.015130704079569677,
            "start_logit": -0.9812424778938293,
            "end_logit": 4.426652431488037
        },
        {
            "text": "the most damaging of which is ochronotic osteoarthropathy",
            "probability": 0.011633660451297847,
            "start_logit": -1.2440658807754517,
            "end_logit": 4.426652431488037
        },
        {
            "text": "ochronotic osteoarthropathy.",
            "probability": 0.011348994174968752,
            "start_logit": 2.841491222381592,
            "end_logit": 0.31632179021835327
        },
        {
            "text": "has a triad of clinical features, the most damaging of which is ochronotic osteoarthropathy",
            "probability": 0.009245328610759704,
            "start_logit": -1.473850131034851,
            "end_logit": 4.426652431488037
        },
        {
            "text": "",
            "probability": 0.005644165790142955,
            "start_logit": 0.8745803236961365,
            "end_logit": 1.5847259759902954
        },
        {
            "text": "The condition has a triad of clinical features",
            "probability": 0.005552353501007553,
            "start_logit": 0.9159268140792847,
            "end_logit": 1.5269789695739746
        },
        {
            "text": "clinical features",
            "probability": 0.0035152343073892615,
            "start_logit": 0.45881110429763794,
            "end_logit": 1.5269789695739746
        },
        {
            "text": "most damaging of which is ochronotic osteoarthropathy",
            "probability": 0.003240918851244239,
            "start_logit": -2.522111654281616,
            "end_logit": 4.426652431488037
        },
        {
            "text": "condition has a triad of clinical features, the most damaging of which is ochronotic osteoarthropathy",
            "probability": 0.0026779752017143917,
            "start_logit": -2.712907552719116,
            "end_logit": 4.426652431488037
        },
        {
            "text": "a triad of clinical features",
            "probability": 0.0020505686196958146,
            "start_logit": -0.08017794787883759,
            "end_logit": 1.5269789695739746
        },
        {
            "text": "The condition has a triad of clinical features, the most damaging of which is ochronotic osteoarthropathy.",
            "probability": 0.0016546089761942438,
            "start_logit": 0.9159268140792847,
            "end_logit": 0.31632179021835327
        },
        {
            "text": "triad of clinical features, the most damaging of which is ochronotic osteoarthropathy.",
            "probability": 0.0016007860728547267,
            "start_logit": -3.227473735809326,
            "end_logit": 4.426652431488037
        },
        {
            "text": "triad of clinical features",
            "probability": 0.0015758760375690192,
            "start_logit": -0.34348374605178833,
            "end_logit": 1.5269789695739746
        },
        {
            "text": "arthropathy",
            "probability": 0.0013896185972705696,
            "start_logit": 0.4851580858230591,
            "end_logit": 0.5725551247596741
        },
        {
            "text": "osteoarthropathy.",
            "probability": 0.001198656702201635,
            "start_logit": -3.5167670249938965,
            "end_logit": 4.426652431488037
        }
    ],
    "5e2f972bfbd6abf43b000030_004": [
        {
            "text": "homogentisic aciduria, ochronosis, and arthritis",
            "probability": 0.8985236710995583,
            "start_logit": 3.583045721054077,
            "end_logit": 5.90724515914917
        },
        {
            "text": "a triad of homogentisic aciduria, ochronosis, and arthritis",
            "probability": 0.03643741490235004,
            "start_logit": 0.3778887987136841,
            "end_logit": 5.90724515914917
        },
        {
            "text": "triad of homogentisic aciduria, ochronosis, and arthritis",
            "probability": 0.020212461312982755,
            "start_logit": -0.21140801906585693,
            "end_logit": 5.90724515914917
        },
        {
            "text": "characterized by a triad of homogentisic aciduria, ochronosis, and arthritis",
            "probability": 0.009421726227694178,
            "start_logit": -0.9746890068054199,
            "end_logit": 5.90724515914917
        },
        {
            "text": "arthritis",
            "probability": 0.009211726362031243,
            "start_logit": -0.997230052947998,
            "end_logit": 5.90724515914917
        },
        {
            "text": "homogentisic aciduria",
            "probability": 0.008341878846706806,
            "start_logit": 3.583045721054077,
            "end_logit": 1.2277805805206299
        },
        {
            "text": "homogentisic aciduria, ochronosis",
            "probability": 0.004638207504247611,
            "start_logit": 3.583045721054077,
            "end_logit": 0.6408200860023499
        },
        {
            "text": "ochronosis, and arthritis",
            "probability": 0.0040323958987185955,
            "start_logit": -1.8233466148376465,
            "end_logit": 5.90724515914917
        },
        {
            "text": "of homogentisic aciduria, ochronosis, and arthritis",
            "probability": 0.0027071922006009557,
            "start_logit": -2.2217953205108643,
            "end_logit": 5.90724515914917
        },
        {
            "text": "homogentisic aciduria, ochronosis, and arthritis.",
            "probability": 0.0016415331385372085,
            "start_logit": 3.583045721054077,
            "end_logit": -0.3978772461414337
        },
        {
            "text": "arthritis.",
            "probability": 0.0012377490410075214,
            "start_logit": -3.004412889480591,
            "end_logit": 5.90724515914917
        },
        {
            "text": "by a triad of homogentisic aciduria, ochronosis, and arthritis",
            "probability": 0.0007829501954876878,
            "start_logit": -3.4623935222625732,
            "end_logit": 5.90724515914917
        },
        {
            "text": "triad of homogentisic aciduria, ochronosis, and arthritis.",
            "probability": 0.000742839428208175,
            "start_logit": -3.5149827003479004,
            "end_logit": 5.90724515914917
        },
        {
            "text": "aciduria, ochronosis, and arthritis",
            "probability": 0.0005176353272450093,
            "start_logit": -3.8761916160583496,
            "end_logit": 5.90724515914917
        },
        {
            "text": ", ochronosis, and arthritis",
            "probability": 0.0004122446618842351,
            "start_logit": -4.103845596313477,
            "end_logit": 5.90724515914917
        },
        {
            "text": "a triad of homogentisic aciduria",
            "probability": 0.00033828435508062886,
            "start_logit": 0.3778887987136841,
            "end_logit": 1.2277805805206299
        },
        {
            "text": "homogentisic aciduria,",
            "probability": 0.00021312893411111228,
            "start_logit": 3.583045721054077,
            "end_logit": -2.439365863800049
        },
        {
            "text": "a triad of homogentisic aciduria, ochronosis",
            "probability": 0.00018809108393176392,
            "start_logit": 0.3778887987136841,
            "end_logit": 0.6408200860023499
        },
        {
            "text": "triad of homogentisic aciduria",
            "probability": 0.00018765215529638302,
            "start_logit": -0.21140801906585693,
            "end_logit": 1.2277805805206299
        },
        {
            "text": "homogentisic aciduria, ochronosis,",
            "probability": 0.00016886002553399132,
            "start_logit": 3.583045721054077,
            "end_logit": -2.6721930503845215
        },
        {
            "text": "",
            "probability": 4.235729878532296e-05,
            "start_logit": -0.7026740312576294,
            "end_logit": 0.2305973321199417
        }
    ],
    "5e2f972bfbd6abf43b000030_005": [
        {
            "text": "homogentisic aciduria (HGA) or alkaptonuria, ochronosis then ochronotic arthropathy",
            "probability": 0.34290295088204564,
            "start_logit": 2.298980474472046,
            "end_logit": 2.2150604724884033
        },
        {
            "text": "a triad of signs",
            "probability": 0.13955504328663831,
            "start_logit": 0.9212101697921753,
            "end_logit": 2.6938424110412598
        },
        {
            "text": "signs",
            "probability": 0.12457225455307733,
            "start_logit": 0.8076369762420654,
            "end_logit": 2.6938424110412598
        },
        {
            "text": "homogentisic aciduria",
            "probability": 0.08170441674975866,
            "start_logit": 2.298980474472046,
            "end_logit": 0.7807210683822632
        },
        {
            "text": "homogentisic aciduria (HGA) or alkaptonuria",
            "probability": 0.08023867206109696,
            "start_logit": 2.298980474472046,
            "end_logit": 0.7626186013221741
        },
        {
            "text": "characterized by a triad of signs",
            "probability": 0.048873687456550935,
            "start_logit": -0.12800976634025574,
            "end_logit": 2.6938424110412598
        },
        {
            "text": "triad of signs",
            "probability": 0.03209876234259577,
            "start_logit": -0.5484314560890198,
            "end_logit": 2.6938424110412598
        },
        {
            "text": "a triad of signs, according to chronology of appearance: homogentisic aciduria",
            "probability": 0.020600961641030945,
            "start_logit": 0.9212101697921753,
            "end_logit": 0.7807210683822632
        },
        {
            "text": "a triad of signs, according to chronology of appearance: homogentisic aciduria (HGA) or alkaptonuria",
            "probability": 0.020231388595804433,
            "start_logit": 0.9212101697921753,
            "end_logit": 0.7626186013221741
        },
        {
            "text": "signs, according to chronology of appearance: homogentisic aciduria",
            "probability": 0.018389218885580753,
            "start_logit": 0.8076369762420654,
            "end_logit": 0.7807210683822632
        },
        {
            "text": "signs, according to chronology of appearance: homogentisic aciduria (HGA) or alkaptonuria",
            "probability": 0.018059323624315612,
            "start_logit": 0.8076369762420654,
            "end_logit": 0.7626186013221741
        },
        {
            "text": "alkaptonuria, ochronosis then ochronotic arthropathy",
            "probability": 0.015000465681470936,
            "start_logit": -0.8303857445716858,
            "end_logit": 2.2150604724884033
        },
        {
            "text": "a triad of signs, according to chronology of appearance",
            "probability": 0.011047283345187267,
            "start_logit": 0.9212101697921753,
            "end_logit": 0.1575678586959839
        },
        {
            "text": "signs, according to chronology of appearance",
            "probability": 0.009861234396022739,
            "start_logit": 0.8076369762420654,
            "end_logit": 0.1575678586959839
        },
        {
            "text": "homogentisic aciduria (HGA)",
            "probability": 0.008576262405552725,
            "start_logit": 2.298980474472046,
            "end_logit": -1.4733887910842896
        },
        {
            "text": "characterized by a triad of signs, according to chronology of appearance: homogentisic aciduria",
            "probability": 0.007214679862770259,
            "start_logit": -0.12800976634025574,
            "end_logit": 0.7807210683822632
        },
        {
            "text": "",
            "probability": 0.005603524614825596,
            "start_logit": 0.06744661927223206,
            "end_logit": 0.33254265785217285
        },
        {
            "text": "homogentisic aciduria (HGA",
            "probability": 0.005475219941302208,
            "start_logit": 2.298980474472046,
            "end_logit": -1.9221545457839966
        },
        {
            "text": "according to chronology of appearance: homogentisic aciduria",
            "probability": 0.005042555556147213,
            "start_logit": -0.4862145781517029,
            "end_logit": 0.7807210683822632
        },
        {
            "text": "according to chronology of appearance: homogentisic aciduria (HGA) or alkaptonuria",
            "probability": 0.004952094118225912,
            "start_logit": -0.4862145781517029,
            "end_logit": 0.7626186013221741
        }
    ],
    "5e2f972bfbd6abf43b000030_006": [
        {
            "text": "homogentisic aciduria (dark urine), relentlessly progressive arthritis and ochronosis",
            "probability": 0.3994040281455281,
            "start_logit": 2.469191789627075,
            "end_logit": 3.1135778427124023
        },
        {
            "text": "homogentisic aciduria",
            "probability": 0.38519698902296023,
            "start_logit": 2.469191789627075,
            "end_logit": 3.077359199523926
        },
        {
            "text": "homogentisic aciduria (dark urine)",
            "probability": 0.10386981851533905,
            "start_logit": 2.469191789627075,
            "end_logit": 1.7667427062988281
        },
        {
            "text": "triad of homogentisic aciduria (dark urine), relentlessly progressive arthritis and ochronosis",
            "probability": 0.0225459132120931,
            "start_logit": -0.4052278995513916,
            "end_logit": 3.1135778427124023
        },
        {
            "text": "triad of homogentisic aciduria",
            "probability": 0.021743941653254648,
            "start_logit": -0.4052278995513916,
            "end_logit": 3.077359199523926
        },
        {
            "text": "homogentisic aciduria (dark urine), relentlessly progressive arthritis",
            "probability": 0.011415323293037183,
            "start_logit": 2.469191789627075,
            "end_logit": -0.44143906235694885
        },
        {
            "text": "homogentisic aciduria (dark urine",
            "probability": 0.007239812617403278,
            "start_logit": 2.469191789627075,
            "end_logit": -0.8968003392219543
        },
        {
            "text": "characterized by triad of homogentisic aciduria (dark urine), relentlessly progressive arthritis and ochronosis",
            "probability": 0.007155528941212051,
            "start_logit": -1.5528963804244995,
            "end_logit": 3.1135778427124023
        },
        {
            "text": "characterized by triad of homogentisic aciduria",
            "probability": 0.006901002515721356,
            "start_logit": -1.5528963804244995,
            "end_logit": 3.077359199523926
        },
        {
            "text": "dark urine), relentlessly progressive arthritis and ochronosis",
            "probability": 0.006411781845335316,
            "start_logit": -1.6626445055007935,
            "end_logit": 3.1135778427124023
        },
        {
            "text": "ochronosis",
            "probability": 0.006250391278233147,
            "start_logit": -1.6881376504898071,
            "end_logit": 3.1135778427124023
        },
        {
            "text": "triad of homogentisic aciduria (dark urine)",
            "probability": 0.005863335741695162,
            "start_logit": -0.4052278995513916,
            "end_logit": 1.7667427062988281
        },
        {
            "text": "relentlessly progressive arthritis and ochronosis",
            "probability": 0.004844395779154131,
            "start_logit": -1.942959189414978,
            "end_logit": 3.1135778427124023
        },
        {
            "text": "homogentisic aciduria (dark urine), relentlessly progressive arthritis and ochronosis.",
            "probability": 0.0023030041210810987,
            "start_logit": 2.469191789627075,
            "end_logit": -2.0421812534332275
        },
        {
            "text": "homogentisic aciduria (dark urine),",
            "probability": 0.002008794918709862,
            "start_logit": 2.469191789627075,
            "end_logit": -2.178860664367676
        },
        {
            "text": "characterized by triad of homogentisic aciduria (dark urine)",
            "probability": 0.001860881313480748,
            "start_logit": -1.5528963804244995,
            "end_logit": 1.7667427062988281
        },
        {
            "text": "dark urine)",
            "probability": 0.0016674609410605708,
            "start_logit": -1.6626445055007935,
            "end_logit": 1.7667427062988281
        },
        {
            "text": "",
            "probability": 0.0015794129154084072,
            "start_logit": -0.21444344520568848,
            "end_logit": 0.26429277658462524
        },
        {
            "text": "of homogentisic aciduria (dark urine), relentlessly progressive arthritis and ochronosis",
            "probability": 0.0008692468131279962,
            "start_logit": -3.66090989112854,
            "end_logit": 3.1135778427124023
        },
        {
            "text": "triad of homogentisic aciduria (dark urine), relentlessly progressive arthritis and ochronosis.",
            "probability": 0.0008689364161646619,
            "start_logit": -3.661267042160034,
            "end_logit": 3.1135778427124023
        }
    ],
    "5e2f972bfbd6abf43b000030_007": [
        {
            "text": "homogentisic aciduria, arthritis and ochronosis",
            "probability": 0.7716419347309137,
            "start_logit": 2.8169076442718506,
            "end_logit": 3.9402287006378174
        },
        {
            "text": "homogentisic aciduria, arthritis",
            "probability": 0.09740758390772393,
            "start_logit": 2.8169076442718506,
            "end_logit": 1.8706121444702148
        },
        {
            "text": "a triad of homogentisic aciduria, arthritis and ochronosis",
            "probability": 0.03764148443858552,
            "start_logit": -0.2035062313079834,
            "end_logit": 3.9402287006378174
        },
        {
            "text": "homogentisic aciduria",
            "probability": 0.03236862467206902,
            "start_logit": 2.8169076442718506,
            "end_logit": 0.7688976526260376
        },
        {
            "text": "triad of homogentisic aciduria, arthritis and ochronosis",
            "probability": 0.023859136372818335,
            "start_logit": -0.6594457626342773,
            "end_logit": 3.9402287006378174
        },
        {
            "text": "arthritis and ochronosis",
            "probability": 0.008199816935615835,
            "start_logit": -1.7275011539459229,
            "end_logit": 3.9402287006378174
        },
        {
            "text": "a triad of homogentisic aciduria, arthritis",
            "probability": 0.004751641776883737,
            "start_logit": -0.2035062313079834,
            "end_logit": 1.8706121444702148
        },
        {
            "text": "ochronosis",
            "probability": 0.004745574551501412,
            "start_logit": -2.274400472640991,
            "end_logit": 3.9402287006378174
        },
        {
            "text": "characterized by a triad of homogentisic aciduria, arthritis and ochronosis",
            "probability": 0.003214989808084384,
            "start_logit": -2.6637887954711914,
            "end_logit": 3.9402287006378174
        },
        {
            "text": "triad of homogentisic aciduria, arthritis",
            "probability": 0.003011838423493112,
            "start_logit": -0.6594457626342773,
            "end_logit": 1.8706121444702148
        },
        {
            "text": "of homogentisic aciduria, arthritis and ochronosis",
            "probability": 0.0027250768746284746,
            "start_logit": -2.8291163444519043,
            "end_logit": 3.9402287006378174
        },
        {
            "text": "Alkaptonuria, a metabolic disorder characterized by a triad of homogentisic aciduria, arthritis and ochronosis",
            "probability": 0.001898357397080048,
            "start_logit": -3.1906239986419678,
            "end_logit": 3.9402287006378174
        },
        {
            "text": "a triad of homogentisic aciduria",
            "probability": 0.0015789746863834992,
            "start_logit": -0.2035062313079834,
            "end_logit": 0.7688976526260376
        },
        {
            "text": "a metabolic disorder characterized by a triad of homogentisic aciduria, arthritis and ochronosis",
            "probability": 0.0011663053570517385,
            "start_logit": -3.677772045135498,
            "end_logit": 3.9402287006378174
        },
        {
            "text": "arthritis",
            "probability": 0.001035097135386383,
            "start_logit": -1.7275011539459229,
            "end_logit": 1.8706121444702148
        },
        {
            "text": "metabolic disorder characterized by a triad of homogentisic aciduria, arthritis and ochronosis",
            "probability": 0.0010297554546098411,
            "start_logit": -3.8022916316986084,
            "end_logit": 3.9402287006378174
        },
        {
            "text": "triad of homogentisic aciduria",
            "probability": 0.001000836522085568,
            "start_logit": -0.6594457626342773,
            "end_logit": 0.7688976526260376
        },
        {
            "text": "homogentisic aciduria,",
            "probability": 0.0007934253643689419,
            "start_logit": 2.8169076442718506,
            "end_logit": -2.939687728881836
        },
        {
            "text": "by a triad of homogentisic aciduria, arthritis and ochronosis",
            "probability": 0.0007679511867284718,
            "start_logit": -4.09564208984375,
            "end_logit": 3.9402287006378174
        },
        {
            "text": "aciduria, arthritis and ochronosis",
            "probability": 0.0005898742264607112,
            "start_logit": -4.359458923339844,
            "end_logit": 3.9402287006378174
        },
        {
            "text": "",
            "probability": 0.00057172017752771,
            "start_logit": -0.4322117865085602,
            "end_logit": -0.018278103321790695
        }
    ],
    "5cc0817da49efeb44c000002_001": [
        {
            "text": "",
            "probability": 0.9991586550962828,
            "start_logit": 2.6788594722747803,
            "end_logit": 2.934490203857422
        },
        {
            "text": "Cell-free DNA (cfDNA) and cell-free RNA (cfRNA)",
            "probability": 0.00013626560243454395,
            "start_logit": -0.5286535024642944,
            "end_logit": -2.7580597400665283
        },
        {
            "text": "Cell-free",
            "probability": 0.0001118443147214724,
            "start_logit": -0.5286535024642944,
            "end_logit": -2.9555578231811523
        },
        {
            "text": "Cell-free DNA",
            "probability": 0.00010330867842460287,
            "start_logit": -0.5286535024642944,
            "end_logit": -3.0349442958831787
        },
        {
            "text": "Cell-free DNA (cfDNA) and cell-free RNA",
            "probability": 7.94889158322618e-05,
            "start_logit": -0.5286535024642944,
            "end_logit": -3.2970480918884277
        },
        {
            "text": "Cell-free DNA (cfDNA) and cell-free RNA (cfRNA",
            "probability": 5.8914322135219824e-05,
            "start_logit": -0.5286535024642944,
            "end_logit": -3.59658145904541
        },
        {
            "text": "Cell-free DNA (cfDNA)",
            "probability": 5.090982553768334e-05,
            "start_logit": -0.5286535024642944,
            "end_logit": -3.742609739303589
        },
        {
            "text": "Cell-free DNA (cfDNA",
            "probability": 4.571869189729935e-05,
            "start_logit": -0.5286535024642944,
            "end_logit": -3.850158452987671
        },
        {
            "text": "cfDNA can be easily purified from serum and plasma and contains DNA fragments of tumor origin",
            "probability": 4.488858129404107e-05,
            "start_logit": -2.2607147693634033,
            "end_logit": -2.136420965194702
        },
        {
            "text": "cell-free RNA (cfRNA)",
            "probability": 3.601056761789209e-05,
            "start_logit": -1.8594470024108887,
            "end_logit": -2.7580597400665283
        },
        {
            "text": "DNA fragments of tumor origin",
            "probability": 3.045941532676784e-05,
            "start_logit": -2.648503065109253,
            "end_logit": -2.136420965194702
        },
        {
            "text": "DNA fragments of tumor origin. For this reason, it is the most widely used material for the detection of somatic mutations",
            "probability": 2.5303836958997345e-05,
            "start_logit": -2.648503065109253,
            "end_logit": -2.3218600749969482
        },
        {
            "text": "cell-free RNA",
            "probability": 2.1006335621827888e-05,
            "start_logit": -1.8594470024108887,
            "end_logit": -3.2970480918884277
        },
        {
            "text": "DNA fragments of tumor origin. For this reason, it is the most widely used material for the detection of somatic mutations in blood",
            "probability": 2.0198233949278727e-05,
            "start_logit": -2.648503065109253,
            "end_logit": -2.5472209453582764
        },
        {
            "text": "cell-free RNA (cfRNA), RNA associated to platelets and circulating tumor cells",
            "probability": 1.8227121451562806e-05,
            "start_logit": -1.8594470024108887,
            "end_logit": -3.4389615058898926
        },
        {
            "text": "cell-free RNA (cfRNA",
            "probability": 1.5569139555462685e-05,
            "start_logit": -1.8594470024108887,
            "end_logit": -3.59658145904541
        },
        {
            "text": "and cell-free RNA (cfRNA)",
            "probability": 1.5528701968659782e-05,
            "start_logit": -2.7005693912506104,
            "end_logit": -2.7580597400665283
        },
        {
            "text": "detection of somatic mutations",
            "probability": 9.637648803152021e-06,
            "start_logit": -3.6137819290161133,
            "end_logit": -2.3218600749969482
        },
        {
            "text": "and cell-free RNA",
            "probability": 9.058483298189712e-06,
            "start_logit": -2.7005693912506104,
            "end_logit": -3.2970480918884277
        },
        {
            "text": "cell-free RNA (cfRNA), RNA associated to platelets and circulating tumor cells (CTCs)",
            "probability": 9.006486888222248e-06,
            "start_logit": -1.8594470024108887,
            "end_logit": -4.143927097320557
        }
    ],
    "5cc0817da49efeb44c000002_002": [
        {
            "text": "cell",
            "probability": 0.44034081384510293,
            "start_logit": 5.463593482971191,
            "end_logit": 2.755098342895508
        },
        {
            "text": "cell-free DNA (cfDNA) is beginning to inform on tumor genetics, tumor burden, and mechanisms of progression and drug resistance",
            "probability": 0.28303472569143107,
            "start_logit": 5.463593482971191,
            "end_logit": 2.3131189346313477
        },
        {
            "text": "cell-free",
            "probability": 0.14191240531750926,
            "start_logit": 5.463593482971191,
            "end_logit": 1.6227593421936035
        },
        {
            "text": "cell-free DNA",
            "probability": 0.060346772368866174,
            "start_logit": 5.463593482971191,
            "end_logit": 0.7676568031311035
        },
        {
            "text": "",
            "probability": 0.014546592195210463,
            "start_logit": 2.5287795066833496,
            "end_logit": 2.2797200679779053
        },
        {
            "text": "cell-free DNA (cfDNA) is beginning to inform on tumor genetics, tumor burden",
            "probability": 0.013065185410499445,
            "start_logit": 5.463593482971191,
            "end_logit": -0.7624995708465576
        },
        {
            "text": "cell-free DNA (cfDNA) is beginning to inform on tumor genetics",
            "probability": 0.010913976823100384,
            "start_logit": 5.463593482971191,
            "end_logit": -0.942406415939331
        },
        {
            "text": "cell-free DNA (cfDNA) is beginning to inform on tumor genetics, tumor burden, and mechanisms of progression and drug resistance.",
            "probability": 0.007386421325722414,
            "start_logit": 5.463593482971191,
            "end_logit": -1.3328073024749756
        },
        {
            "text": "cell-free DNA (cfDNA) is beginning to inform on tumor genetics, tumor burden, and mechanisms of progression",
            "probability": 0.005364600992013262,
            "start_logit": 5.463593482971191,
            "end_logit": -1.6526286602020264
        },
        {
            "text": "cell-free DNA (cfDNA) is beginning to inform",
            "probability": 0.00432758015468387,
            "start_logit": 5.463593482971191,
            "end_logit": -1.8674421310424805
        },
        {
            "text": "cell-free DNA (cfDNA",
            "probability": 0.004068542474564699,
            "start_logit": 5.463593482971191,
            "end_logit": -1.9291658401489258
        },
        {
            "text": "Known to be present in the blood of cancer patients for decades, cell",
            "probability": 0.003695529599001661,
            "start_logit": 0.683168351650238,
            "end_logit": 2.755098342895508
        },
        {
            "text": "cell-",
            "probability": 0.0035529574344023876,
            "start_logit": 5.463593482971191,
            "end_logit": -2.0646703243255615
        },
        {
            "text": "Known to be present in the blood of cancer patients",
            "probability": 0.0019428587351684012,
            "start_logit": 0.683168351650238,
            "end_logit": 2.1121349334716797
        },
        {
            "text": "Known to be present in the blood of cancer patients for decades, cell-free",
            "probability": 0.0011909899737362457,
            "start_logit": 0.683168351650238,
            "end_logit": 1.6227593421936035
        },
        {
            "text": "tumor genetics, tumor burden, and mechanisms of progression and drug resistance",
            "probability": 0.0011304997319847758,
            "start_logit": -0.05931633710861206,
            "end_logit": 2.3131189346313477
        },
        {
            "text": "inform on tumor genetics, tumor burden, and mechanisms of progression and drug resistance",
            "probability": 0.001006163143113178,
            "start_logit": -0.1758318841457367,
            "end_logit": 2.3131189346313477
        },
        {
            "text": "present in the blood of cancer patients for decades, cell",
            "probability": 0.000859665017096055,
            "start_logit": -0.7751680016517639,
            "end_logit": 2.755098342895508
        },
        {
            "text": "cancer patients for decades, cell",
            "probability": 0.0008072636844102863,
            "start_logit": -0.8380604386329651,
            "end_logit": 2.755098342895508
        },
        {
            "text": "Known to be present in the blood of cancer patients for decades, cell-free DNA",
            "probability": 0.0005064560823830631,
            "start_logit": 0.683168351650238,
            "end_logit": 0.7676568031311035
        }
    ],
    "5cc0817da49efeb44c000002_003": [
        {
            "text": "cell",
            "probability": 0.7706273350015274,
            "start_logit": 5.436359882354736,
            "end_logit": 3.972616195678711
        },
        {
            "text": "",
            "probability": 0.10126785447076457,
            "start_logit": 3.7640438079833984,
            "end_logit": 3.6154963970184326
        },
        {
            "text": "cell-free DNA (cfDNA) to replace conventional screening",
            "probability": 0.0852450021710072,
            "start_logit": 5.436359882354736,
            "end_logit": 1.7709407806396484
        },
        {
            "text": "cell-free",
            "probability": 0.021950427820142615,
            "start_logit": 5.436359882354736,
            "end_logit": 0.4141979217529297
        },
        {
            "text": "cell-",
            "probability": 0.008116743449607555,
            "start_logit": 5.436359882354736,
            "end_logit": -0.5806596875190735
        },
        {
            "text": "cell-free DNA",
            "probability": 0.007020558630590437,
            "start_logit": 5.436359882354736,
            "end_logit": -0.7257459163665771
        },
        {
            "text": "cell-free DNA (cfDNA)",
            "probability": 0.0014784279362305768,
            "start_logit": 5.436359882354736,
            "end_logit": -2.283609390258789
        },
        {
            "text": "using cell",
            "probability": 0.0008234464534976233,
            "start_logit": -1.4051017761230469,
            "end_logit": 3.972616195678711
        },
        {
            "text": "cell-free DNA (cfDNA",
            "probability": 0.0007330945707516268,
            "start_logit": 5.436359882354736,
            "end_logit": -2.9850692749023438
        },
        {
            "text": "cell-free DNA (cfDNA) to replace conventional screening.",
            "probability": 0.0005333309087170611,
            "start_logit": 5.436359882354736,
            "end_logit": -3.303201913833618
        },
        {
            "text": "determine the principal factors contributing to the cost of avoiding a birth with Down syndrome by using cell",
            "probability": 0.0004270045100939917,
            "start_logit": -2.0618057250976562,
            "end_logit": 3.972616195678711
        },
        {
            "text": "Down syndrome by using cell",
            "probability": 0.00042362214282936164,
            "start_logit": -2.069758415222168,
            "end_logit": 3.972616195678711
        },
        {
            "text": "This study aimed to determine the principal factors contributing to the cost of avoiding a birth with Down syndrome by using cell",
            "probability": 0.0003660677309214182,
            "start_logit": -2.2157819271087646,
            "end_logit": 3.972616195678711
        },
        {
            "text": "cost of avoiding a birth with Down syndrome by using cell",
            "probability": 0.00019264326478776744,
            "start_logit": -2.857760190963745,
            "end_logit": 3.972616195678711
        },
        {
            "text": "study aimed to determine the principal factors contributing to the cost of avoiding a birth with Down syndrome by using cell",
            "probability": 0.0001705693109699553,
            "start_logit": -2.9794585704803467,
            "end_logit": 3.972616195678711
        },
        {
            "text": "the principal factors contributing to the cost of avoiding a birth with Down syndrome by using cell",
            "probability": 0.00015670601395935751,
            "start_logit": -3.0642287731170654,
            "end_logit": 3.972616195678711
        },
        {
            "text": "to determine the principal factors contributing to the cost of avoiding a birth with Down syndrome by using cell",
            "probability": 0.00013482666120485516,
            "start_logit": -3.2146103382110596,
            "end_logit": 3.972616195678711
        },
        {
            "text": "conventional screening",
            "probability": 0.00011263830254259901,
            "start_logit": -1.1927430629730225,
            "end_logit": 1.7709407806396484
        },
        {
            "text": "principal factors contributing to the cost of avoiding a birth with Down syndrome by using cell",
            "probability": 0.00011094267567318961,
            "start_logit": -3.4095866680145264,
            "end_logit": 3.972616195678711
        },
        {
            "text": "avoiding a birth with Down syndrome by using cell",
            "probability": 0.00010875797418143772,
            "start_logit": -3.4294753074645996,
            "end_logit": 3.972616195678711
        }
    ],
    "5cc0817da49efeb44c000002_004": [
        {
            "text": "",
            "probability": 0.99893264453421,
            "start_logit": 4.136370658874512,
            "end_logit": 4.506509304046631
        },
        {
            "text": "27.71 ng/ml",
            "probability": 0.00023066149894504276,
            "start_logit": -0.06404327601194382,
            "end_logit": 0.3334318697452545
        },
        {
            "text": "isolated from a serum specimen before chemotherapy",
            "probability": 0.00017369883580611154,
            "start_logit": -0.1562359780073166,
            "end_logit": 0.14199627935886383
        },
        {
            "text": "serum specimen before chemotherapy",
            "probability": 9.746114435457859e-05,
            "start_logit": -0.7341051697731018,
            "end_logit": 0.14199627935886383
        },
        {
            "text": "overall survival",
            "probability": 6.478144914873219e-05,
            "start_logit": -1.4609551429748535,
            "end_logit": 0.46041175723075867
        },
        {
            "text": "cfDNA was isolated from a serum specimen before chemotherapy",
            "probability": 6.380680466042692e-05,
            "start_logit": -1.1576991081237793,
            "end_logit": 0.14199627935886383
        },
        {
            "text": "isolated from a serum",
            "probability": 5.347744204609649e-05,
            "start_logit": -0.1562359780073166,
            "end_logit": -1.0360667705535889
        },
        {
            "text": "27.71 ng/ml (mean 32.64). A threshold of 55.03 ng/ml",
            "probability": 4.5565644818257114e-05,
            "start_logit": -0.06404327601194382,
            "end_logit": -1.288365364074707
        },
        {
            "text": "before chemotherapy",
            "probability": 3.873673450906142e-05,
            "start_logit": -1.6567705869674683,
            "end_logit": 0.14199627935886383
        },
        {
            "text": "concentration before therapy may be a useful predictive and prognostic biomarker for prostate specific antigen response and survival",
            "probability": 3.5492643333676836e-05,
            "start_logit": -0.5960990190505981,
            "end_logit": -1.0061382055282593
        },
        {
            "text": "isolated from a serum specimen before chemotherapy. Its value was correlated to recurrence-free and overall survival",
            "probability": 3.32337438722986e-05,
            "start_logit": -0.1562359780073166,
            "end_logit": -1.511760950088501
        },
        {
            "text": "concentration before therapy may be a useful predictive and prognostic biomarker",
            "probability": 3.3158691283618764e-05,
            "start_logit": -0.5960990190505981,
            "end_logit": -1.074158787727356
        },
        {
            "text": "concentration before therapy",
            "probability": 3.2229764048379116e-05,
            "start_logit": -0.5960990190505981,
            "end_logit": -1.102573275566101
        },
        {
            "text": "serum",
            "probability": 3.0005800987555266e-05,
            "start_logit": -0.7341051697731018,
            "end_logit": -1.0360667705535889
        },
        {
            "text": "the cfDNA concentration before therapy may be a useful predictive and prognostic biomarker for prostate specific antigen response and survival",
            "probability": 2.7701187028698797e-05,
            "start_logit": -0.8439491987228394,
            "end_logit": -1.0061382055282593
        },
        {
            "text": "the cfDNA concentration before therapy may be a useful predictive and prognostic biomarker",
            "probability": 2.5879591447697703e-05,
            "start_logit": -0.8439491987228394,
            "end_logit": -1.074158787727356
        },
        {
            "text": "the cfDNA concentration before therapy",
            "probability": 2.5154585230563978e-05,
            "start_logit": -0.8439491987228394,
            "end_logit": -1.102573275566101
        },
        {
            "text": "cfDNA was isolated from a serum",
            "probability": 1.9644488015932468e-05,
            "start_logit": -1.1576991081237793,
            "end_logit": -1.0360667705535889
        },
        {
            "text": "serum specimen before chemotherapy. Its value was correlated to recurrence-free and overall survival",
            "probability": 1.864721023574773e-05,
            "start_logit": -0.7341051697731018,
            "end_logit": -1.511760950088501
        },
        {
            "text": "concentration",
            "probability": 1.8018206017216886e-05,
            "start_logit": -0.5960990190505981,
            "end_logit": -1.684080958366394
        }
    ],
    "5cc0817da49efeb44c000002_005": [
        {
            "text": "",
            "probability": 0.8596080362135861,
            "start_logit": 4.24062442779541,
            "end_logit": 4.649717807769775
        },
        {
            "text": "non-invasive prenatal screening of fetal chromosomal aneuploidy",
            "probability": 0.0577614301982825,
            "start_logit": 2.7052855491638184,
            "end_logit": 3.4849014282226562
        },
        {
            "text": "Cell-free fetal DNA analysis for non-invasive prenatal screening of fetal chromosomal aneuploidy",
            "probability": 0.03714607167413284,
            "start_logit": 2.263822317123413,
            "end_logit": 3.4849014282226562
        },
        {
            "text": "for non-invasive prenatal screening of fetal chromosomal aneuploidy",
            "probability": 0.010669644894209799,
            "start_logit": 1.0163670778274536,
            "end_logit": 3.4849014282226562
        },
        {
            "text": "fetal chromosomal aneuploidy",
            "probability": 0.006479533526151879,
            "start_logit": 0.5176128149032593,
            "end_logit": 3.4849014282226562
        },
        {
            "text": "prenatal screening of fetal chromosomal aneuploidy",
            "probability": 0.005480633917394519,
            "start_logit": 0.3501850664615631,
            "end_logit": 3.4849014282226562
        },
        {
            "text": "non-invasive prenatal screening of fetal chromosomal aneuploidy has been widely adopted for clinical use",
            "probability": 0.003753872568720559,
            "start_logit": 2.7052855491638184,
            "end_logit": 0.7513681650161743
        },
        {
            "text": "non-invasive prenatal screening",
            "probability": 0.0033882355837496513,
            "start_logit": 2.7052855491638184,
            "end_logit": 0.6488894820213318
        },
        {
            "text": "Cell-free fetal DNA analysis",
            "probability": 0.0031559064851788493,
            "start_logit": 2.263822317123413,
            "end_logit": 1.0193191766738892
        },
        {
            "text": "analysis for non-invasive prenatal screening of fetal chromosomal aneuploidy",
            "probability": 0.0021861000275082,
            "start_logit": -0.5689165592193604,
            "end_logit": 3.4849014282226562
        },
        {
            "text": "screening of fetal chromosomal aneuploidy",
            "probability": 0.0021827088220650014,
            "start_logit": -0.5704690217971802,
            "end_logit": 3.4849014282226562
        },
        {
            "text": "Cell-free fetal DNA analysis for non-invasive prenatal screening",
            "probability": 0.002178956466464957,
            "start_logit": 2.263822317123413,
            "end_logit": 0.6488894820213318
        },
        {
            "text": "fetal DNA analysis for non-invasive prenatal screening of fetal chromosomal aneuploidy",
            "probability": 0.0020756517603439653,
            "start_logit": -0.6207605004310608,
            "end_logit": 3.4849014282226562
        },
        {
            "text": "Cell-free fetal DNA",
            "probability": 0.0007200004100351035,
            "start_logit": 2.263822317123413,
            "end_logit": -0.45846009254455566
        },
        {
            "text": "for non-invasive prenatal screening of fetal chromosomal aneuploidy has been widely adopted for clinical use",
            "probability": 0.000693412319412314,
            "start_logit": 1.0163670778274536,
            "end_logit": 0.7513681650161743
        },
        {
            "text": "for non-invasive prenatal screening",
            "probability": 0.0006258721498486955,
            "start_logit": 1.0163670778274536,
            "end_logit": 0.6488894820213318
        },
        {
            "text": "non-invasive prenatal screening of fetal chromosomal aneuploidy has been widely adopted for clinical use.",
            "probability": 0.0005437916179757205,
            "start_logit": 2.7052855491638184,
            "end_logit": -1.1806089878082275
        },
        {
            "text": "DNA analysis for non-invasive prenatal screening of fetal chromosomal aneuploidy",
            "probability": 0.0005328556651298357,
            "start_logit": -1.98054039478302,
            "end_logit": 3.4849014282226562
        },
        {
            "text": "fetal chromosomal aneuploidy has been widely adopted for clinical use",
            "probability": 0.00042110008492570155,
            "start_logit": 0.5176128149032593,
            "end_logit": 0.7513681650161743
        },
        {
            "text": "Cell-free",
            "probability": 0.00039618561488357295,
            "start_logit": 2.263822317123413,
            "end_logit": -1.0558290481567383
        }
    ],
    "5e36d807b5b409ea5300000a_002": [
        {
            "text": "facilitates the transfer of parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks",
            "probability": 0.4380644919242174,
            "start_logit": 3.242114543914795,
            "end_logit": 3.5337324142456055
        },
        {
            "text": "facilitates the transfer of parental (H3-H4)2 tetramers to lagging-strand DNA",
            "probability": 0.18338286698928571,
            "start_logit": 3.242114543914795,
            "end_logit": 2.662942409515381
        },
        {
            "text": "facilitates the transfer of parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks.",
            "probability": 0.11955521827973865,
            "start_logit": 3.242114543914795,
            "end_logit": 2.23514461517334
        },
        {
            "text": "facilitates",
            "probability": 0.061236899505678004,
            "start_logit": 3.242114543914795,
            "end_logit": 1.566116213798523
        },
        {
            "text": "transfer of parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks",
            "probability": 0.037573844209988695,
            "start_logit": 0.7860565781593323,
            "end_logit": 3.5337324142456055
        },
        {
            "text": "the transfer of parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks",
            "probability": 0.024760849942017417,
            "start_logit": 0.36901217699050903,
            "end_logit": 3.5337324142456055
        },
        {
            "text": "facilitates the transfer of parental (H3-H4)2 tetramers to lagging-strand",
            "probability": 0.01631460600038818,
            "start_logit": 3.242114543914795,
            "end_logit": 0.24342705309391022
        },
        {
            "text": "transfer of parental (H3-H4)2 tetramers to lagging-strand DNA",
            "probability": 0.015729189199448965,
            "start_logit": 0.7860565781593323,
            "end_logit": 2.662942409515381
        },
        {
            "text": "facilitates the transfer of parental (H3-H4)2 tetramers",
            "probability": 0.015307076029280924,
            "start_logit": 3.242114543914795,
            "end_logit": 0.17968147993087769
        },
        {
            "text": "lagging-strand DNA at replication forks",
            "probability": 0.011708819022760905,
            "start_logit": -0.3799092769622803,
            "end_logit": 3.5337324142456055
        },
        {
            "text": "parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks",
            "probability": 0.011529502188753997,
            "start_logit": -0.3953424394130707,
            "end_logit": 3.5337324142456055
        },
        {
            "text": "facilitates the transfer",
            "probability": 0.01093530097469566,
            "start_logit": 3.242114543914795,
            "end_logit": -0.1566375494003296
        },
        {
            "text": "the transfer of parental (H3-H4)2 tetramers to lagging-strand DNA",
            "probability": 0.010365404489903647,
            "start_logit": 0.36901217699050903,
            "end_logit": 2.662942409515381
        },
        {
            "text": "transfer of parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks.",
            "probability": 0.010254538381785137,
            "start_logit": 0.7860565781593323,
            "end_logit": 2.23514461517334
        },
        {
            "text": "facilitate",
            "probability": 0.007697969014149928,
            "start_logit": 3.242114543914795,
            "end_logit": -0.5076771974563599
        },
        {
            "text": "the transfer of parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks.",
            "probability": 0.006757655263512796,
            "start_logit": 0.36901217699050903,
            "end_logit": 2.23514461517334
        },
        {
            "text": "lagging-strand DNA",
            "probability": 0.004901554088579345,
            "start_logit": -0.3799092769622803,
            "end_logit": 2.662942409515381
        },
        {
            "text": "the Mcm2-Ctf4-Pol\u03b1 axis facilitates",
            "probability": 0.004873178270595098,
            "start_logit": 0.7111109495162964,
            "end_logit": 1.566116213798523
        },
        {
            "text": "parental (H3-H4)2 tetramers to lagging-strand DNA",
            "probability": 0.004826488348886119,
            "start_logit": -0.3953424394130707,
            "end_logit": 2.662942409515381
        },
        {
            "text": ".",
            "probability": 0.0034618515955699715,
            "start_logit": -0.2998602092266083,
            "end_logit": 2.23514461517334
        },
        {
            "text": "",
            "probability": 0.0007626962807636359,
            "start_logit": -0.004113432951271534,
            "end_logit": 0.42669886350631714
        }
    ],
    "5e2dafccfbd6abf43b000013_001": [
        {
            "text": "N-methyl-D-aspartic acid or N-methyl-D-aspartate",
            "probability": 0.21689871912334913,
            "start_logit": 7.145987033843994,
            "end_logit": 7.90337610244751
        },
        {
            "text": "N-methyl-D-aspartic acid",
            "probability": 0.16458625529534823,
            "start_logit": 7.145987033843994,
            "end_logit": 7.62738037109375
        },
        {
            "text": "N-methyl-D-aspartate",
            "probability": 0.1611347991938002,
            "start_logit": 6.848797798156738,
            "end_logit": 7.90337610244751
        },
        {
            "text": "N-methyl-D-aspartic acid or N-methyl-D-aspartate (NMDA)",
            "probability": 0.09043455975437435,
            "start_logit": 7.145987033843994,
            "end_logit": 7.028572082519531
        },
        {
            "text": "N-methyl-D-aspartic acid or N-methyl-D-aspartate (NMDA",
            "probability": 0.07159484076607167,
            "start_logit": 7.145987033843994,
            "end_logit": 6.794968605041504
        },
        {
            "text": "N-methyl-D-aspartate (NMDA)",
            "probability": 0.06718414329553385,
            "start_logit": 6.848797798156738,
            "end_logit": 7.028572082519531
        },
        {
            "text": "N-methyl-D-aspartic acid or N-methyl-D-aspartate (NMDA) receptor",
            "probability": 0.05643154689061322,
            "start_logit": 7.145987033843994,
            "end_logit": 6.556973934173584
        },
        {
            "text": "N-methyl-D-aspartate (NMDA",
            "probability": 0.05318805171731954,
            "start_logit": 6.848797798156738,
            "end_logit": 6.794968605041504
        },
        {
            "text": "N-methyl-D-aspartate (NMDA) receptor",
            "probability": 0.04192318891124153,
            "start_logit": 6.848797798156738,
            "end_logit": 6.556973934173584
        },
        {
            "text": "NMDA)",
            "probability": 0.03014105810733505,
            "start_logit": 6.047248840332031,
            "end_logit": 7.028572082519531
        },
        {
            "text": "NMDA",
            "probability": 0.023861942398754096,
            "start_logit": 6.047248840332031,
            "end_logit": 6.794968605041504
        },
        {
            "text": "NMDA) receptor",
            "probability": 0.018808147444257357,
            "start_logit": 6.047248840332031,
            "end_logit": 6.556973934173584
        },
        {
            "text": "N-methyl-D-aspartate (NMDA) receptor antagonist that can be effective against postoperative pain",
            "probability": 0.0016435998322137332,
            "start_logit": 6.848797798156738,
            "end_logit": 3.318023681640625
        },
        {
            "text": "NMDA) receptor antagonist that can be effective against postoperative pain",
            "probability": 0.0007373739638241913,
            "start_logit": 6.047248840332031,
            "end_logit": 3.318023681640625
        },
        {
            "text": "acid or N-methyl-D-aspartate",
            "probability": 0.00034368957409891727,
            "start_logit": 0.6985400915145874,
            "end_logit": 7.90337610244751
        },
        {
            "text": "acid",
            "probability": 0.0002607972062427201,
            "start_logit": 0.6985400915145874,
            "end_logit": 7.62738037109375
        },
        {
            "text": "methyl-D-aspartic acid or N-methyl-D-aspartate",
            "probability": 0.00023174985937138501,
            "start_logit": 0.3044598400592804,
            "end_logit": 7.90337610244751
        },
        {
            "text": "methyl-D-aspartate",
            "probability": 0.00021946244610128197,
            "start_logit": 0.24998237192630768,
            "end_logit": 7.90337610244751
        },
        {
            "text": "an N-methyl-D-aspartic acid or N-methyl-D-aspartate",
            "probability": 0.00019675524013903443,
            "start_logit": 0.14076176285743713,
            "end_logit": 7.90337610244751
        },
        {
            "text": "methyl-D-aspartic acid",
            "probability": 0.0001758555406565965,
            "start_logit": 0.3044598400592804,
            "end_logit": 7.62738037109375
        },
        {
            "text": "",
            "probability": 3.463439353949499e-06,
            "start_logit": 1.8046468496322632,
            "end_logit": 2.1997926235198975
        }
    ],
    "5e499c636d0a27794100000a_001": [
        {
            "text": "tumor-targeted radionuclides",
            "probability": 0.7763370691782753,
            "start_logit": 5.747898101806641,
            "end_logit": 7.452530384063721
        },
        {
            "text": "with tumor-targeted radionuclides",
            "probability": 0.1852608007078322,
            "start_logit": 4.315075874328613,
            "end_logit": 7.452530384063721
        },
        {
            "text": "Molecular radiotherapy with tumor-targeted radionuclides",
            "probability": 0.021883625438456112,
            "start_logit": 2.1790499687194824,
            "end_logit": 7.452530384063721
        },
        {
            "text": "radionuclides",
            "probability": 0.006668739346447101,
            "start_logit": 0.9907421469688416,
            "end_logit": 7.452530384063721
        },
        {
            "text": "targeted radionuclides",
            "probability": 0.003982362547737504,
            "start_logit": 0.4751865565776825,
            "end_logit": 7.452530384063721
        },
        {
            "text": "",
            "probability": 0.001693800664530928,
            "start_logit": 3.115020275115967,
            "end_logit": 3.957796335220337
        },
        {
            "text": "radiotherapy with tumor-targeted radionuclides",
            "probability": 0.0012259774600360614,
            "start_logit": -0.7029502391815186,
            "end_logit": 7.452530384063721
        },
        {
            "text": "tumor-targeted",
            "probability": 0.0009292064488283472,
            "start_logit": 3.1160080432891846,
            "end_logit": 3.3564093112945557
        },
        {
            "text": "tumor-targeted radionuclide",
            "probability": 0.0005705831937191704,
            "start_logit": 5.747898101806641,
            "end_logit": 0.23684729635715485
        },
        {
            "text": "tumor-targeted radionuclides may overcome some of these challenges,",
            "probability": 0.00036049607119816105,
            "start_logit": 5.747898101806641,
            "end_logit": -0.22233062982559204
        },
        {
            "text": "with tumor-targeted",
            "probability": 0.000184678902705924,
            "start_logit": 4.315075874328613,
            "end_logit": 0.5416291952133179
        },
        {
            "text": "a tumor-targeted",
            "probability": 0.00015823301098286252,
            "start_logit": 1.3457458019256592,
            "end_logit": 3.3564093112945557
        },
        {
            "text": "with tumor-targeted radionuclide",
            "probability": 0.00013616082953598024,
            "start_logit": 4.315075874328613,
            "end_logit": 0.23684729635715485
        },
        {
            "text": "tumor-targeted radiotherapeutic drug",
            "probability": 0.0001318170261897647,
            "start_logit": 3.1160080432891846,
            "end_logit": 1.4034931659698486
        },
        {
            "text": "tumor-targeted radionuclides may overcome some of these challenges, but to date there exists no single cancer-selective agent",
            "probability": 0.00011792735382745777,
            "start_logit": 5.747898101806641,
            "end_logit": -1.33974289894104
        },
        {
            "text": "with tumor-targeted radionuclides may overcome some of these challenges,",
            "probability": 8.602679616070548e-05,
            "start_logit": 4.315075874328613,
            "end_logit": -0.22233062982559204
        },
        {
            "text": "tumor-targeted radiotherapeutic",
            "probability": 8.551839565760022e-05,
            "start_logit": 3.1160080432891846,
            "end_logit": 0.9708098769187927
        },
        {
            "text": "tumor-targeted radiotherapeutic drug with broad applicability in pediatric oncology",
            "probability": 7.763137410397007e-05,
            "start_logit": 3.1160080432891846,
            "end_logit": 0.8740500211715698
        },
        {
            "text": "tumor",
            "probability": 7.72848606034913e-05,
            "start_logit": 5.747898101806641,
            "end_logit": -1.7623136043548584
        },
        {
            "text": "targeted",
            "probability": 3.206039317122452e-05,
            "start_logit": -0.2507014870643616,
            "end_logit": 3.3564093112945557
        }
    ],
    "5e499c636d0a27794100000a_002": [
        {
            "text": "directed at distinct molecular targets",
            "probability": 0.34104160146534473,
            "start_logit": 3.2876274585723877,
            "end_logit": 3.4536936283111572
        },
        {
            "text": "131I meta-Iodobenzylguanidine and 177Lu Lutetium DOTATATE, directed at distinct molecular targets",
            "probability": 0.28294839938921423,
            "start_logit": 3.1008875370025635,
            "end_logit": 3.4536936283111572
        },
        {
            "text": "131I meta-Iodobenzylguanidine and 177Lu Lutetium DOTATATE",
            "probability": 0.1680979234771947,
            "start_logit": 3.1008875370025635,
            "end_logit": 2.9329757690429688
        },
        {
            "text": "distinct molecular targets",
            "probability": 0.0492627080292412,
            "start_logit": 1.352790355682373,
            "end_logit": 3.4536936283111572
        },
        {
            "text": "",
            "probability": 0.03949997227402427,
            "start_logit": 2.1474926471710205,
            "end_logit": 2.438123941421509
        },
        {
            "text": "131I meta-Iodobenzylguanidine",
            "probability": 0.03931243561660686,
            "start_logit": 3.1008875370025635,
            "end_logit": 1.4799699783325195
        },
        {
            "text": "131I meta-Iodobenzylguanidine and 177Lu Lutetium DOTATATE,",
            "probability": 0.01572954652751004,
            "start_logit": 3.1008875370025635,
            "end_logit": 0.5639699697494507
        },
        {
            "text": "molecular targets",
            "probability": 0.015124933023599888,
            "start_logit": 0.17196756601333618,
            "end_logit": 3.4536936283111572
        },
        {
            "text": "directed at distinct molecular targets: Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor (SSTR2)",
            "probability": 0.011657480104169329,
            "start_logit": 3.2876274585723877,
            "end_logit": 0.0776372030377388
        },
        {
            "text": "treated with molecular radiotherapy, 131I meta-Iodobenzylguanidine and 177Lu Lutetium DOTATATE",
            "probability": 0.006657223506633335,
            "start_logit": -0.12795664370059967,
            "end_logit": 2.9329757690429688
        },
        {
            "text": "directed at distinct molecular targets: Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor",
            "probability": 0.006110265954826253,
            "start_logit": 3.2876274585723877,
            "end_logit": -0.568340539932251
        },
        {
            "text": "meta-Iodobenzylguanidine and 177Lu Lutetium DOTATATE, directed at distinct molecular targets",
            "probability": 0.004896901425000253,
            "start_logit": -0.9557743668556213,
            "end_logit": 3.4536936283111572
        },
        {
            "text": "177Lu Lutetium DOTATATE, directed at distinct molecular targets",
            "probability": 0.00408785855391598,
            "start_logit": -1.1363557577133179,
            "end_logit": 3.4536936283111572
        },
        {
            "text": "targets",
            "probability": 0.00350996301216603,
            "start_logit": -1.2887715101242065,
            "end_logit": 3.4536936283111572
        },
        {
            "text": "meta-Iodobenzylguanidine and 177Lu Lutetium DOTATATE",
            "probability": 0.002909219358695678,
            "start_logit": -0.9557743668556213,
            "end_logit": 2.9329757690429688
        },
        {
            "text": "177Lu Lutetium DOTATATE",
            "probability": 0.002428571908747678,
            "start_logit": -1.1363557577133179,
            "end_logit": 2.9329757690429688
        },
        {
            "text": "distinct molecular targets: Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor (SSTR2), respectively",
            "probability": 0.001943309277288889,
            "start_logit": 1.352790355682373,
            "end_logit": 0.22091859579086304
        },
        {
            "text": "distinct molecular targets: Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor (SSTR2)",
            "probability": 0.0016838973200363001,
            "start_logit": 1.352790355682373,
            "end_logit": 0.0776372030377388
        },
        {
            "text": "treated with molecular radiotherapy, 131I meta-Iodobenzylguanidine",
            "probability": 0.0015569000798834394,
            "start_logit": -0.12795664370059967,
            "end_logit": 1.4799699783325195
        },
        {
            "text": "directed",
            "probability": 0.00154088969590061,
            "start_logit": 3.2876274585723877,
            "end_logit": -1.9459508657455444
        }
    ],
    "5e2f992cfbd6abf43b000031_001": [
        {
            "text": "three antihypertensive agents, a statin and antiplatelet therapy",
            "probability": 0.3431421120711111,
            "start_logit": 5.603446960449219,
            "end_logit": 6.361854076385498
        },
        {
            "text": "antihypertensive agents, a statin and antiplatelet therapy",
            "probability": 0.15717766105242215,
            "start_logit": 4.822679042816162,
            "end_logit": 6.361854076385498
        },
        {
            "text": "three antihypertensive agents",
            "probability": 0.1337141312807051,
            "start_logit": 5.603446960449219,
            "end_logit": 5.4194135665893555
        },
        {
            "text": "fixed doses of three antihypertensive agents, a statin and antiplatelet therapy",
            "probability": 0.0734891400099005,
            "start_logit": 4.062439918518066,
            "end_logit": 6.361854076385498
        },
        {
            "text": "antihypertensive agents",
            "probability": 0.06124830985478783,
            "start_logit": 4.822679042816162,
            "end_logit": 5.4194135665893555
        },
        {
            "text": "three antihypertensive agents, a statin and antiplatelet",
            "probability": 0.035735619490555155,
            "start_logit": 5.603446960449219,
            "end_logit": 4.099857330322266
        },
        {
            "text": "three antihypertensive agents, a statin",
            "probability": 0.03160274905909616,
            "start_logit": 5.603446960449219,
            "end_logit": 3.9769535064697266
        },
        {
            "text": "fixed doses of three antihypertensive agents",
            "probability": 0.02863692962568684,
            "start_logit": 4.062439918518066,
            "end_logit": 5.4194135665893555
        },
        {
            "text": "three antihypertensive agents, a statin and antiplatelet therapy taken once daily per os",
            "probability": 0.019951439470885547,
            "start_logit": 5.603446960449219,
            "end_logit": 3.5170106887817383
        },
        {
            "text": "",
            "probability": 0.018513343519602543,
            "start_logit": 4.308716773986816,
            "end_logit": 4.736931324005127
        },
        {
            "text": "antihypertensive agents, a statin and antiplatelet",
            "probability": 0.016368848037575757,
            "start_logit": 4.822679042816162,
            "end_logit": 4.099857330322266
        },
        {
            "text": "antihypertensive agents, a statin",
            "probability": 0.014475769674419848,
            "start_logit": 4.822679042816162,
            "end_logit": 3.9769535064697266
        },
        {
            "text": "three antihypertensive agents, a statin and antiplatelet therapy taken once daily",
            "probability": 0.010520457487359804,
            "start_logit": 5.603446960449219,
            "end_logit": 2.877031087875366
        },
        {
            "text": "antihypertensive agents, a statin and antiplatelet therapy taken once daily per os",
            "probability": 0.009138839216600997,
            "start_logit": 4.822679042816162,
            "end_logit": 3.5170106887817383
        },
        {
            "text": "statin and antiplatelet therapy",
            "probability": 0.008924690914727848,
            "start_logit": 1.9541239738464355,
            "end_logit": 6.361854076385498
        },
        {
            "text": "three antihypertensive agents, a statin and antiplatelet therapy taken once daily per os for 12 months",
            "probability": 0.007965601922755873,
            "start_logit": 5.603446960449219,
            "end_logit": 2.598841905593872
        },
        {
            "text": "fixed doses of three antihypertensive agents, a statin and antiplatelet",
            "probability": 0.007653330359923006,
            "start_logit": 4.062439918518066,
            "end_logit": 4.099857330322266
        },
        {
            "text": "three",
            "probability": 0.007494301210905779,
            "start_logit": 5.603446960449219,
            "end_logit": 2.5378522872924805
        },
        {
            "text": "antiplatelet therapy",
            "probability": 0.007478512896789504,
            "start_logit": 1.7773362398147583,
            "end_logit": 6.361854076385498
        },
        {
            "text": "fixed doses of three antihypertensive agents, a statin",
            "probability": 0.006768212844188514,
            "start_logit": 4.062439918518066,
            "end_logit": 3.9769535064697266
        }
    ],
    "5e2f992cfbd6abf43b000031_002": [
        {
            "text": "atenolol, ramipril, hydrochlorothiazide, and a statin",
            "probability": 0.8868924013763062,
            "start_logit": 8.491598129272461,
            "end_logit": 8.178093910217285
        },
        {
            "text": "atenolol",
            "probability": 0.07503081364562063,
            "start_logit": 8.491598129272461,
            "end_logit": 5.708269119262695
        },
        {
            "text": "atenolol, ramipril, hydrochlorothiazide",
            "probability": 0.014516050223861005,
            "start_logit": 8.491598129272461,
            "end_logit": 4.065625190734863
        },
        {
            "text": "atenolol, ramipril",
            "probability": 0.012951590868664075,
            "start_logit": 8.491598129272461,
            "end_logit": 3.9515888690948486
        },
        {
            "text": "hydrochlorothiazide, and a statin",
            "probability": 0.004409668801837243,
            "start_logit": 3.187674045562744,
            "end_logit": 8.178093910217285
        },
        {
            "text": "ramipril, hydrochlorothiazide, and a statin",
            "probability": 0.0021429978820983945,
            "start_logit": 2.4660801887512207,
            "end_logit": 8.178093910217285
        },
        {
            "text": "ate",
            "probability": 0.0007593213708961978,
            "start_logit": 8.491598129272461,
            "end_logit": 1.1150400638580322
        },
        {
            "text": "atenolol,",
            "probability": 0.000493201293869748,
            "start_logit": 8.491598129272461,
            "end_logit": 0.6835323572158813
        },
        {
            "text": "the Polycap (comprised of atenolol, ramipril, hydrochlorothiazide, and a statin",
            "probability": 0.0004876897645807749,
            "start_logit": 0.9857986569404602,
            "end_logit": 8.178093910217285
        },
        {
            "text": "Polycap (comprised of atenolol, ramipril, hydrochlorothiazide, and a statin",
            "probability": 0.00046883410083076545,
            "start_logit": 0.9463681578636169,
            "end_logit": 8.178093910217285
        },
        {
            "text": "atenolol, ramipril, hydrochlorothiazide, and a statin)",
            "probability": 0.0004526626226887409,
            "start_logit": 8.491598129272461,
            "end_logit": 0.5977620482444763
        },
        {
            "text": "atenolol, ramipril,",
            "probability": 0.00043464884023485206,
            "start_logit": 8.491598129272461,
            "end_logit": 0.5571534037590027
        },
        {
            "text": "statin",
            "probability": 0.00020840817188971753,
            "start_logit": 0.1356177031993866,
            "end_logit": 8.178093910217285
        },
        {
            "text": "comprised of atenolol, ramipril, hydrochlorothiazide, and a statin",
            "probability": 0.00017890008368935654,
            "start_logit": -0.017053360119462013,
            "end_logit": 8.178093910217285
        },
        {
            "text": ", ramipril, hydrochlorothiazide, and a statin",
            "probability": 0.00013202476224104687,
            "start_logit": -0.3208913207054138,
            "end_logit": 8.178093910217285
        },
        {
            "text": "a statin",
            "probability": 0.00010130589502764803,
            "start_logit": -0.5857362151145935,
            "end_logit": 8.178093910217285
        },
        {
            "text": "statin)",
            "probability": 8.529846116784727e-05,
            "start_logit": -0.757724404335022,
            "end_logit": 8.178093910217285
        },
        {
            "text": "atenolol, ramipril, hydrochlorothiazide, and a stat",
            "probability": 7.823093729893523e-05,
            "start_logit": 8.491598129272461,
            "end_logit": -1.1577198505401611
        },
        {
            "text": "atenolol, ramipril, hydrochlorothiazide,",
            "probability": 7.680193444693363e-05,
            "start_logit": 8.491598129272461,
            "end_logit": -1.1761552095413208
        },
        {
            "text": "hydrochlorothiazide",
            "probability": 7.217445284087251e-05,
            "start_logit": 3.187674045562744,
            "end_logit": 4.065625190734863
        },
        {
            "text": "",
            "probability": 2.6974509908892514e-05,
            "start_logit": 2.8891565799713135,
            "end_logit": 3.379948854446411
        }
    ],
    "5e2f992cfbd6abf43b000031_003": [
        {
            "text": "K(+) supplementation",
            "probability": 0.642784085465136,
            "start_logit": 6.077114582061768,
            "end_logit": 6.330803871154785
        },
        {
            "text": "K(+)",
            "probability": 0.10768344818398505,
            "start_logit": 6.077114582061768,
            "end_logit": 4.544190883636475
        },
        {
            "text": "K(+",
            "probability": 0.04492558546948566,
            "start_logit": 6.077114582061768,
            "end_logit": 3.6700024604797363
        },
        {
            "text": "simvastatin (20 mg), and aspirin (100 mg)",
            "probability": 0.02997819439302633,
            "start_logit": 4.515779495239258,
            "end_logit": 4.826800346374512
        },
        {
            "text": "simvastatin",
            "probability": 0.02554371406250857,
            "start_logit": 4.515779495239258,
            "end_logit": 4.666721343994141
        },
        {
            "text": "simvastatin (20 mg), and aspirin",
            "probability": 0.02455349750013649,
            "start_logit": 4.515779495239258,
            "end_logit": 4.6271843910217285
        },
        {
            "text": "simvastatin (20 mg), and aspirin (100 mg",
            "probability": 0.016552981644886933,
            "start_logit": 4.515779495239258,
            "end_logit": 4.232896327972412
        },
        {
            "text": "hydrochlorthiazide, 12.5 mg; atenolol, 50 mg; ramipril, 5 mg",
            "probability": 0.014577720761022135,
            "start_logit": 4.6451497077941895,
            "end_logit": 3.976454257965088
        },
        {
            "text": "3 blood pressure (BP) lowering drugs",
            "probability": 0.013746480932543166,
            "start_logit": 3.3609609603881836,
            "end_logit": 5.201931476593018
        },
        {
            "text": "supplementation",
            "probability": 0.011969340824416258,
            "start_logit": 2.093654155731201,
            "end_logit": 6.330803871154785
        },
        {
            "text": "",
            "probability": 0.010443568906059745,
            "start_logit": 3.8365683555603027,
            "end_logit": 4.4515275955200195
        },
        {
            "text": "hydrochlorthiazide, 12.5 mg",
            "probability": 0.009053858758135504,
            "start_logit": 4.6451497077941895,
            "end_logit": 3.5001509189605713
        },
        {
            "text": "simvastatin (20 mg)",
            "probability": 0.008093740009828137,
            "start_logit": 4.515779495239258,
            "end_logit": 3.517421007156372
        },
        {
            "text": "aspirin (100 mg)",
            "probability": 0.007142809478789965,
            "start_logit": 3.0814154148101807,
            "end_logit": 4.826800346374512
        },
        {
            "text": "plus K(+) supplementation",
            "probability": 0.006672695163293779,
            "start_logit": 1.5093295574188232,
            "end_logit": 6.330803871154785
        },
        {
            "text": "blood pressure (BP) lowering drugs",
            "probability": 0.005903010033565354,
            "start_logit": 2.5156404972076416,
            "end_logit": 5.201931476593018
        },
        {
            "text": "aspirin",
            "probability": 0.005850284122589403,
            "start_logit": 3.0814154148101807,
            "end_logit": 4.6271843910217285
        },
        {
            "text": "hydrochlorthiazide, 12.5 mg; atenolol, 50 mg; ramipril, 5 mg)",
            "probability": 0.005458958401544937,
            "start_logit": 4.6451497077941895,
            "end_logit": 2.994217872619629
        },
        {
            "text": "full-dose polycap (plus K(+) supplementation",
            "probability": 0.004766603852556259,
            "start_logit": 1.1729397773742676,
            "end_logit": 6.330803871154785
        },
        {
            "text": "hydrochlorthiazide",
            "probability": 0.004299422036490501,
            "start_logit": 4.6451497077941895,
            "end_logit": 2.7554404735565186
        }
    ],
    "5e2f992cfbd6abf43b000031_004": [
        {
            "text": "simvastatin",
            "probability": 0.2686525281039508,
            "start_logit": 5.266851425170898,
            "end_logit": 5.191096305847168
        },
        {
            "text": "hydrochlorothiazide",
            "probability": 0.17789043585902564,
            "start_logit": 3.0308165550231934,
            "end_logit": 7.014880180358887
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril, simvastatin",
            "probability": 0.1446830818748681,
            "start_logit": 5.335815906524658,
            "end_logit": 4.50325870513916
        },
        {
            "text": "ramipril, simvastatin, atenolol, and hydrochlorothiazide",
            "probability": 0.09638855777862904,
            "start_logit": 2.4180362224578857,
            "end_logit": 7.014880180358887
        },
        {
            "text": "atenolol, and hydrochlorothiazide",
            "probability": 0.08838264402285063,
            "start_logit": 2.331324338912964,
            "end_logit": 7.014880180358887
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril, simvastatin, atenolol",
            "probability": 0.08072508551715193,
            "start_logit": 5.335815906524658,
            "end_logit": 3.919762372970581
        },
        {
            "text": "aspirin",
            "probability": 0.05544780478296407,
            "start_logit": 5.335815906524658,
            "end_logit": 3.5441551208496094
        },
        {
            "text": "simvastatin, atenolol, and hydrochlorothiazide",
            "probability": 0.027506202147901865,
            "start_logit": 1.1640602350234985,
            "end_logit": 7.014880180358887
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril",
            "probability": 0.016796320264899564,
            "start_logit": 5.335815906524658,
            "end_logit": 2.3498728275299072
        },
        {
            "text": "aspirin [acetylsalicylic acid]",
            "probability": 0.008058589791385884,
            "start_logit": 5.335815906524658,
            "end_logit": 1.6154515743255615
        },
        {
            "text": "ramipril, simvastatin",
            "probability": 0.007820637117851319,
            "start_logit": 2.4180362224578857,
            "end_logit": 4.50325870513916
        },
        {
            "text": "ramipril, simvastatin, atenolol",
            "probability": 0.004363479074099145,
            "start_logit": 2.4180362224578857,
            "end_logit": 3.919762372970581
        },
        {
            "text": "atenolol",
            "probability": 0.004001053927925552,
            "start_logit": 2.331324338912964,
            "end_logit": 3.919762372970581
        },
        {
            "text": "dose-normalized salicylic acid. However, for simvastatin",
            "probability": 0.003969447568762694,
            "start_logit": 1.052059531211853,
            "end_logit": 5.191096305847168
        },
        {
            "text": "aspirin [acetylsalicylic acid",
            "probability": 0.0034841108134563018,
            "start_logit": 5.335815906524658,
            "end_logit": 0.7769258618354797
        },
        {
            "text": "salicylic acid. However, for simvastatin",
            "probability": 0.0024491497345578614,
            "start_logit": 0.5691735148429871,
            "end_logit": 5.191096305847168
        },
        {
            "text": "aspirin [acetylsalicylic acid],",
            "probability": 0.0023754179249008377,
            "start_logit": 5.335815906524658,
            "end_logit": 0.39388638734817505
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril, simvastatin,",
            "probability": 0.002371546371670012,
            "start_logit": 5.335815906524658,
            "end_logit": 0.3922552168369293
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril,",
            "probability": 0.0021081779211063675,
            "start_logit": 5.335815906524658,
            "end_logit": 0.27453702688217163
        },
        {
            "text": "hydrochlorothiazide)",
            "probability": 0.0020630199701033632,
            "start_logit": -1.426180362701416,
            "end_logit": 7.014880180358887
        },
        {
            "text": "",
            "probability": 0.0004627094319391161,
            "start_logit": 1.562475562095642,
            "end_logit": 2.5313973426818848
        }
    ],
    "5e2f992cfbd6abf43b000031_005": [
        {
            "text": "ramipril, hydrochlorothiazide, atenolol, aspirin, and simvastatin",
            "probability": 0.863779541617166,
            "start_logit": 5.968785285949707,
            "end_logit": 7.555812835693359
        },
        {
            "text": "simvastatin",
            "probability": 0.06098530789432035,
            "start_logit": 3.318100690841675,
            "end_logit": 7.555812835693359
        },
        {
            "text": "hydrochlorothiazide, atenolol, aspirin, and simvastatin",
            "probability": 0.01256170731376186,
            "start_logit": 1.7381207942962646,
            "end_logit": 7.555812835693359
        },
        {
            "text": "ramipril, hydrochlorothiazide, atenolol",
            "probability": 0.008563362857054887,
            "start_logit": 5.968785285949707,
            "end_logit": 2.941988229751587
        },
        {
            "text": "ramipril, hydrochlorothiazide, atenolol, aspirin",
            "probability": 0.008428170467581262,
            "start_logit": 5.968785285949707,
            "end_logit": 2.926074981689453
        },
        {
            "text": "atenolol, aspirin, and simvastatin",
            "probability": 0.008242270914895634,
            "start_logit": 1.3167436122894287,
            "end_logit": 7.555812835693359
        },
        {
            "text": "ramipril",
            "probability": 0.00823025320829307,
            "start_logit": 5.968785285949707,
            "end_logit": 2.9023120403289795
        },
        {
            "text": "ramipril, hydrochlorothiazide",
            "probability": 0.007418592166572064,
            "start_logit": 5.968785285949707,
            "end_logit": 2.7984845638275146
        },
        {
            "text": "ramipril, hydrochlorothiazide, atenolol, aspirin, and simvastatin.",
            "probability": 0.006092470414954296,
            "start_logit": 5.968785285949707,
            "end_logit": 2.601548910140991
        },
        {
            "text": "it included ramipril, hydrochlorothiazide, atenolol, aspirin, and simvastatin",
            "probability": 0.005424695039332036,
            "start_logit": 0.8984293937683105,
            "end_logit": 7.555812835693359
        },
        {
            "text": "aspirin, and simvastatin",
            "probability": 0.005288963963065132,
            "start_logit": 0.8730900883674622,
            "end_logit": 7.555812835693359
        },
        {
            "text": "included ramipril, hydrochlorothiazide, atenolol, aspirin, and simvastatin",
            "probability": 0.0011863982138013171,
            "start_logit": -0.6216102838516235,
            "end_logit": 7.555812835693359
        },
        {
            "text": "ramipril, hydrochlorothiazide,",
            "probability": 0.0009684181666775401,
            "start_logit": 5.968785285949707,
            "end_logit": 0.7624039649963379
        },
        {
            "text": "simvastatin.",
            "probability": 0.0008540869551256337,
            "start_logit": -0.9502545595169067,
            "end_logit": 7.555812835693359
        },
        {
            "text": "ramipril,",
            "probability": 0.000679569175300583,
            "start_logit": 5.968785285949707,
            "end_logit": 0.4081990122795105
        },
        {
            "text": "ramipril, hydrochlorothiazide, atenolol,",
            "probability": 0.0004507929210932656,
            "start_logit": 5.968785285949707,
            "end_logit": -0.0022519403137266636
        },
        {
            "text": "and simvastatin",
            "probability": 0.00024689351645885873,
            "start_logit": -2.1913304328918457,
            "end_logit": 7.555812835693359
        },
        {
            "text": ", aspirin, and simvastatin",
            "probability": 0.00016079401379484948,
            "start_logit": -2.6201634407043457,
            "end_logit": 7.555812835693359
        },
        {
            "text": "ramipril, hydrochlorothiazide, atenolol, aspirin,",
            "probability": 0.00015933180984431481,
            "start_logit": 5.968785285949707,
            "end_logit": -1.0422711372375488
        },
        {
            "text": ", hydrochlorothiazide, atenolol, aspirin, and simvastatin",
            "probability": 0.00015561065262312428,
            "start_logit": -2.652930498123169,
            "end_logit": 7.555812835693359
        },
        {
            "text": "",
            "probability": 0.0001227687182838706,
            "start_logit": 1.761514663696289,
            "end_logit": 2.9043128490448
        }
    ],
    "5e2f992cfbd6abf43b000031_006": [
        {
            "text": "statin, aspirin, and folic acid",
            "probability": 0.3654510228690919,
            "start_logit": 5.3359375,
            "end_logit": 6.871220588684082
        },
        {
            "text": "aspirin",
            "probability": 0.20758629514621132,
            "start_logit": 5.5005998611450195,
            "end_logit": 6.140973091125488
        },
        {
            "text": "three blood-pressure-lowering drugs plus aspirin",
            "probability": 0.05923082164754046,
            "start_logit": 4.246494770050049,
            "end_logit": 6.140973091125488
        },
        {
            "text": "blood-pressure-lowering drugs plus aspirin",
            "probability": 0.052909569675445925,
            "start_logit": 4.133636951446533,
            "end_logit": 6.140973091125488
        },
        {
            "text": "folic acid",
            "probability": 0.04711784288625022,
            "start_logit": 3.28745698928833,
            "end_logit": 6.871220588684082
        },
        {
            "text": "thiazide",
            "probability": 0.03368849975662198,
            "start_logit": 6.167571544647217,
            "end_logit": 3.6556107997894287
        },
        {
            "text": "blood-pressure-lowering drugs at low doses, with a statin, aspirin, and folic acid",
            "probability": 0.031237612485833056,
            "start_logit": 2.8764281272888184,
            "end_logit": 6.871220588684082
        },
        {
            "text": "three blood-pressure-lowering drugs at low doses, with a statin, aspirin, and folic acid",
            "probability": 0.030701969981739224,
            "start_logit": 2.8591320514678955,
            "end_logit": 6.871220588684082
        },
        {
            "text": "thiazide (12.5 mg), atenolol",
            "probability": 0.026273261555513357,
            "start_logit": 6.167571544647217,
            "end_logit": 3.407006025314331
        },
        {
            "text": "thiazide (12.5 mg)",
            "probability": 0.022575167956320263,
            "start_logit": 6.167571544647217,
            "end_logit": 3.2553048133850098
        },
        {
            "text": "atenolol",
            "probability": 0.019967167301278094,
            "start_logit": 4.509771823883057,
            "end_logit": 4.790343284606934
        },
        {
            "text": "a statin, aspirin, and folic acid",
            "probability": 0.018514451847721047,
            "start_logit": 2.3533568382263184,
            "end_logit": 6.871220588684082
        },
        {
            "text": "aspirin, and folic acid",
            "probability": 0.014613670232611958,
            "start_logit": 2.116762638092041,
            "end_logit": 6.871220588684082
        },
        {
            "text": "thiazide (12.5 mg), atenolol (50 mg)",
            "probability": 0.013375902437282672,
            "start_logit": 6.167571544647217,
            "end_logit": 2.7319090366363525
        },
        {
            "text": "statin, aspirin",
            "probability": 0.012734283673853847,
            "start_logit": 5.3359375,
            "end_logit": 3.5143861770629883
        },
        {
            "text": "three blood-pressure-lowering drugs",
            "probability": 0.011781224510484342,
            "start_logit": 4.246494770050049,
            "end_logit": 4.52603816986084
        },
        {
            "text": "blood-pressure-lowering drugs",
            "probability": 0.010523904645604838,
            "start_logit": 4.133636951446533,
            "end_logit": 4.52603816986084
        },
        {
            "text": "statin",
            "probability": 0.00914314587363039,
            "start_logit": 5.3359375,
            "end_logit": 3.1830928325653076
        },
        {
            "text": "thiazide (12.5 mg), atenolol (50 mg), ramipril (5 mg)",
            "probability": 0.007242153761225662,
            "start_logit": 6.167571544647217,
            "end_logit": 2.118372917175293
        },
        {
            "text": "thiazide (12.5 mg), atenolol (50 mg), ramipril",
            "probability": 0.004959380000884471,
            "start_logit": 6.167571544647217,
            "end_logit": 1.7397350072860718
        },
        {
            "text": "",
            "probability": 0.00037265175485489766,
            "start_logit": 2.514223098754883,
            "end_logit": 2.804691791534424
        }
    ],
    "5cd96eb2a49efeb44c000003_001": [
        {
            "text": "gPLINK",
            "probability": 0.5873379666615076,
            "start_logit": 6.048309326171875,
            "end_logit": 5.84127140045166
        },
        {
            "text": "gPLINK software",
            "probability": 0.3262055257343849,
            "start_logit": 6.048309326171875,
            "end_logit": 5.253198623657227
        },
        {
            "text": "genetic differentiation coefficient Fst was applied to detect the selection signatures. Using gPLINK",
            "probability": 0.03822885201419584,
            "start_logit": 3.3162994384765625,
            "end_logit": 5.84127140045166
        },
        {
            "text": "genetic differentiation coefficient Fst was applied to detect the selection signatures. Using gPLINK software",
            "probability": 0.021232175471979458,
            "start_logit": 3.3162994384765625,
            "end_logit": 5.253198623657227
        },
        {
            "text": "Fst was applied to detect the selection signatures. Using gPLINK",
            "probability": 0.0064015599456587104,
            "start_logit": 1.5292506217956543,
            "end_logit": 5.84127140045166
        },
        {
            "text": "genetic differentiation coefficient Fst",
            "probability": 0.006386705418939911,
            "start_logit": 3.3162994384765625,
            "end_logit": 4.051899433135986
        },
        {
            "text": "Using gPLINK",
            "probability": 0.003591421876703991,
            "start_logit": 0.9512571096420288,
            "end_logit": 5.84127140045166
        },
        {
            "text": "Fst was applied to detect the selection signatures. Using gPLINK software",
            "probability": 0.0035554048028998905,
            "start_logit": 1.5292506217956543,
            "end_logit": 5.253198623657227
        },
        {
            "text": "",
            "probability": 0.002842859363125328,
            "start_logit": 3.1380488872528076,
            "end_logit": 3.4207417964935303
        },
        {
            "text": "Using gPLINK software",
            "probability": 0.0019946635973209187,
            "start_logit": 0.9512571096420288,
            "end_logit": 5.253198623657227
        },
        {
            "text": "Fst",
            "probability": 0.0010694769902958386,
            "start_logit": 1.5292506217956543,
            "end_logit": 4.051899433135986
        },
        {
            "text": "differentiation coefficient Fst was applied to detect the selection signatures. Using gPLINK",
            "probability": 0.00024142532164498877,
            "start_logit": -1.7484861612319946,
            "end_logit": 5.84127140045166
        },
        {
            "text": "g",
            "probability": 0.00021884815123217414,
            "start_logit": 6.048309326171875,
            "end_logit": -2.053706169128418
        },
        {
            "text": "genetic differentiation coefficient",
            "probability": 0.00020204332260492634,
            "start_logit": 3.3162994384765625,
            "end_logit": 0.5984077453613281
        },
        {
            "text": "gPLINK software to set quality control standards",
            "probability": 0.00015103654552218448,
            "start_logit": 6.048309326171875,
            "end_logit": -2.424562454223633
        },
        {
            "text": "differentiation coefficient Fst was applied to detect the selection signatures. Using gPLINK software",
            "probability": 0.00013408680937219896,
            "start_logit": -1.7484861612319946,
            "end_logit": 5.253198623657227
        },
        {
            "text": "gPLINK software to set quality control standards, a total of 34 304 SNPs were selected for statistical analysis",
            "probability": 5.733617837444766e-05,
            "start_logit": 6.048309326171875,
            "end_logit": -3.3931524753570557
        },
        {
            "text": "software",
            "probability": 5.4395885163355404e-05,
            "start_logit": -2.6506850719451904,
            "end_logit": 5.253198623657227
        },
        {
            "text": "gPLINK software to set quality control standards,",
            "probability": 5.388217345795388e-05,
            "start_logit": 6.048309326171875,
            "end_logit": -3.455284595489502
        },
        {
            "text": "differentiation coefficient Fst",
            "probability": 4.033373561536165e-05,
            "start_logit": -1.7484861612319946,
            "end_logit": 4.051899433135986
        }
    ],
    "5cd96eb2a49efeb44c000003_003": [
        {
            "text": "SweeD",
            "probability": 0.43422271380496863,
            "start_logit": 3.204841136932373,
            "end_logit": 4.222683429718018
        },
        {
            "text": "SweeD (Sweep Detector)",
            "probability": 0.25616746596269757,
            "start_logit": 3.204841136932373,
            "end_logit": 3.6949572563171387
        },
        {
            "text": "SweeD (Sweep Detector",
            "probability": 0.08772689941638603,
            "start_logit": 3.204841136932373,
            "end_logit": 2.623354434967041
        },
        {
            "text": "Sweep Detector)",
            "probability": 0.08023305363810304,
            "start_logit": 2.0439453125,
            "end_logit": 3.6949572563171387
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes",
            "probability": 0.02994017150766475,
            "start_logit": 3.204841136932373,
            "end_logit": 1.5483269691467285
        },
        {
            "text": "Sweep Detector",
            "probability": 0.02747654546969018,
            "start_logit": 2.0439453125,
            "end_logit": 2.623354434967041
        },
        {
            "text": "SweeD (Sweep Detector),",
            "probability": 0.020537598525097036,
            "start_logit": 3.204841136932373,
            "end_logit": 1.1713831424713135
        },
        {
            "text": "",
            "probability": 0.013475538050794026,
            "start_logit": 1.5766820907592773,
            "end_logit": 2.3781609535217285
        },
        {
            "text": "We present SweeD",
            "probability": 0.0111557414760696,
            "start_logit": -0.4567621350288391,
            "end_logit": 4.222683429718018
        },
        {
            "text": "Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes",
            "probability": 0.009377425730003788,
            "start_logit": 2.0439453125,
            "end_logit": 1.5483269691467285
        },
        {
            "text": "We present SweeD (Sweep Detector)",
            "probability": 0.0065812725451835025,
            "start_logit": -0.4567621350288391,
            "end_logit": 3.6949572563171387
        },
        {
            "text": "Sweep Detector),",
            "probability": 0.006432488364084001,
            "start_logit": 2.0439453125,
            "end_logit": 1.1713831424713135
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool",
            "probability": 0.003973060958025431,
            "start_logit": 3.204841136932373,
            "end_logit": -0.47133731842041016
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes.",
            "probability": 0.0029075025738816047,
            "start_logit": 3.204841136932373,
            "end_logit": -0.7835796475410461
        },
        {
            "text": "SweeD (Sweep Detector), an open-source",
            "probability": 0.002597772348202079,
            "start_logit": 3.204841136932373,
            "end_logit": -0.8962198495864868
        },
        {
            "text": "We present SweeD (Sweep Detector",
            "probability": 0.0022538171755472213,
            "start_logit": -0.4567621350288391,
            "end_logit": 2.623354434967041
        },
        {
            "text": "SweepFinder program",
            "probability": 0.0015630051459449151,
            "start_logit": 0.5943321585655212,
            "end_logit": 1.2062451839447021
        },
        {
            "text": "Sweep Detector), an open-source tool",
            "probability": 0.0012443844566863383,
            "start_logit": 2.0439453125,
            "end_logit": -0.47133731842041016
        },
        {
            "text": "SweepFinder",
            "probability": 0.0012228971173817809,
            "start_logit": 0.5943321585655212,
            "end_logit": 0.9608575701713562
        },
        {
            "text": "Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes.",
            "probability": 0.0009106457335887249,
            "start_logit": 2.0439453125,
            "end_logit": -0.7835796475410461
        }
    ],
    "5cd96eb2a49efeb44c000003_004": [
        {
            "text": "SweeD",
            "probability": 0.43422271380496863,
            "start_logit": 3.204841136932373,
            "end_logit": 4.222683429718018
        },
        {
            "text": "SweeD (Sweep Detector)",
            "probability": 0.25616746596269757,
            "start_logit": 3.204841136932373,
            "end_logit": 3.6949572563171387
        },
        {
            "text": "SweeD (Sweep Detector",
            "probability": 0.08772689941638603,
            "start_logit": 3.204841136932373,
            "end_logit": 2.623354434967041
        },
        {
            "text": "Sweep Detector)",
            "probability": 0.08023305363810304,
            "start_logit": 2.0439453125,
            "end_logit": 3.6949572563171387
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes",
            "probability": 0.02994017150766475,
            "start_logit": 3.204841136932373,
            "end_logit": 1.5483269691467285
        },
        {
            "text": "Sweep Detector",
            "probability": 0.02747654546969018,
            "start_logit": 2.0439453125,
            "end_logit": 2.623354434967041
        },
        {
            "text": "SweeD (Sweep Detector),",
            "probability": 0.020537598525097036,
            "start_logit": 3.204841136932373,
            "end_logit": 1.1713831424713135
        },
        {
            "text": "",
            "probability": 0.013475538050794026,
            "start_logit": 1.5766820907592773,
            "end_logit": 2.3781609535217285
        },
        {
            "text": "We present SweeD",
            "probability": 0.0111557414760696,
            "start_logit": -0.4567621350288391,
            "end_logit": 4.222683429718018
        },
        {
            "text": "Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes",
            "probability": 0.009377425730003788,
            "start_logit": 2.0439453125,
            "end_logit": 1.5483269691467285
        },
        {
            "text": "We present SweeD (Sweep Detector)",
            "probability": 0.0065812725451835025,
            "start_logit": -0.4567621350288391,
            "end_logit": 3.6949572563171387
        },
        {
            "text": "Sweep Detector),",
            "probability": 0.006432488364084001,
            "start_logit": 2.0439453125,
            "end_logit": 1.1713831424713135
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool",
            "probability": 0.003973060958025431,
            "start_logit": 3.204841136932373,
            "end_logit": -0.47133731842041016
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes.",
            "probability": 0.0029075025738816047,
            "start_logit": 3.204841136932373,
            "end_logit": -0.7835796475410461
        },
        {
            "text": "SweeD (Sweep Detector), an open-source",
            "probability": 0.002597772348202079,
            "start_logit": 3.204841136932373,
            "end_logit": -0.8962198495864868
        },
        {
            "text": "We present SweeD (Sweep Detector",
            "probability": 0.0022538171755472213,
            "start_logit": -0.4567621350288391,
            "end_logit": 2.623354434967041
        },
        {
            "text": "SweepFinder program",
            "probability": 0.0015630051459449151,
            "start_logit": 0.5943321585655212,
            "end_logit": 1.2062451839447021
        },
        {
            "text": "Sweep Detector), an open-source tool",
            "probability": 0.0012443844566863383,
            "start_logit": 2.0439453125,
            "end_logit": -0.47133731842041016
        },
        {
            "text": "SweepFinder",
            "probability": 0.0012228971173817809,
            "start_logit": 0.5943321585655212,
            "end_logit": 0.9608575701713562
        },
        {
            "text": "Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes.",
            "probability": 0.0009106457335887249,
            "start_logit": 2.0439453125,
            "end_logit": -0.7835796475410461
        }
    ],
    "5cd96eb2a49efeb44c000003_005": [
        {
            "text": "SweeD",
            "probability": 0.43422271380496863,
            "start_logit": 3.204841136932373,
            "end_logit": 4.222683429718018
        },
        {
            "text": "SweeD (Sweep Detector)",
            "probability": 0.25616746596269757,
            "start_logit": 3.204841136932373,
            "end_logit": 3.6949572563171387
        },
        {
            "text": "SweeD (Sweep Detector",
            "probability": 0.08772689941638603,
            "start_logit": 3.204841136932373,
            "end_logit": 2.623354434967041
        },
        {
            "text": "Sweep Detector)",
            "probability": 0.08023305363810304,
            "start_logit": 2.0439453125,
            "end_logit": 3.6949572563171387
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes",
            "probability": 0.02994017150766475,
            "start_logit": 3.204841136932373,
            "end_logit": 1.5483269691467285
        },
        {
            "text": "Sweep Detector",
            "probability": 0.02747654546969018,
            "start_logit": 2.0439453125,
            "end_logit": 2.623354434967041
        },
        {
            "text": "SweeD (Sweep Detector),",
            "probability": 0.020537598525097036,
            "start_logit": 3.204841136932373,
            "end_logit": 1.1713831424713135
        },
        {
            "text": "",
            "probability": 0.013475538050794026,
            "start_logit": 1.5766820907592773,
            "end_logit": 2.3781609535217285
        },
        {
            "text": "We present SweeD",
            "probability": 0.0111557414760696,
            "start_logit": -0.4567621350288391,
            "end_logit": 4.222683429718018
        },
        {
            "text": "Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes",
            "probability": 0.009377425730003788,
            "start_logit": 2.0439453125,
            "end_logit": 1.5483269691467285
        },
        {
            "text": "We present SweeD (Sweep Detector)",
            "probability": 0.0065812725451835025,
            "start_logit": -0.4567621350288391,
            "end_logit": 3.6949572563171387
        },
        {
            "text": "Sweep Detector),",
            "probability": 0.006432488364084001,
            "start_logit": 2.0439453125,
            "end_logit": 1.1713831424713135
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool",
            "probability": 0.003973060958025431,
            "start_logit": 3.204841136932373,
            "end_logit": -0.47133731842041016
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes.",
            "probability": 0.0029075025738816047,
            "start_logit": 3.204841136932373,
            "end_logit": -0.7835796475410461
        },
        {
            "text": "SweeD (Sweep Detector), an open-source",
            "probability": 0.002597772348202079,
            "start_logit": 3.204841136932373,
            "end_logit": -0.8962198495864868
        },
        {
            "text": "We present SweeD (Sweep Detector",
            "probability": 0.0022538171755472213,
            "start_logit": -0.4567621350288391,
            "end_logit": 2.623354434967041
        },
        {
            "text": "SweepFinder program",
            "probability": 0.0015630051459449151,
            "start_logit": 0.5943321585655212,
            "end_logit": 1.2062451839447021
        },
        {
            "text": "Sweep Detector), an open-source tool",
            "probability": 0.0012443844566863383,
            "start_logit": 2.0439453125,
            "end_logit": -0.47133731842041016
        },
        {
            "text": "SweepFinder",
            "probability": 0.0012228971173817809,
            "start_logit": 0.5943321585655212,
            "end_logit": 0.9608575701713562
        },
        {
            "text": "Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes.",
            "probability": 0.0009106457335887249,
            "start_logit": 2.0439453125,
            "end_logit": -0.7835796475410461
        }
    ],
    "5cd96eb2a49efeb44c000003_006": [
        {
            "text": "SmileFinder",
            "probability": 0.9441106264856963,
            "start_logit": 5.358553886413574,
            "end_logit": 6.081465244293213
        },
        {
            "text": "",
            "probability": 0.0300494025354996,
            "start_logit": 3.853496551513672,
            "end_logit": 4.139122009277344
        },
        {
            "text": "SmileFinder is",
            "probability": 0.017097879792032616,
            "start_logit": 5.358553886413574,
            "end_logit": 2.070176362991333
        },
        {
            "text": "SmileFinder is a simple program",
            "probability": 0.005666690217956951,
            "start_logit": 5.358553886413574,
            "end_logit": 0.9658271074295044
        },
        {
            "text": "Smile",
            "probability": 0.0008225533573052047,
            "start_logit": 5.358553886413574,
            "end_logit": -0.9641200304031372
        },
        {
            "text": "SmileFinder is a simple program that looks for diversity and divergence patterns consistent with selection sweeps by evaluating allele frequencies in windows",
            "probability": 0.000740234842678415,
            "start_logit": 5.358553886413574,
            "end_logit": -1.0695658922195435
        },
        {
            "text": "SmileFinder is a",
            "probability": 0.0006110567190158616,
            "start_logit": 5.358553886413574,
            "end_logit": -1.2613435983657837
        },
        {
            "text": "SmileFinder is a simple program that looks for diversity and divergence patterns consistent with selection sweeps",
            "probability": 0.0002918683464504322,
            "start_logit": 5.358553886413574,
            "end_logit": -2.000230550765991
        },
        {
            "text": "SmileFinder is a simple program that looks for diversity and divergence patterns",
            "probability": 0.000261341319915123,
            "start_logit": 5.358553886413574,
            "end_logit": -2.110706090927124
        },
        {
            "text": "FINDINGS: SmileFinder",
            "probability": 0.00015913654848693633,
            "start_logit": -3.3296821117401123,
            "end_logit": 6.081465244293213
        },
        {
            "text": "SmileFinder is a simple",
            "probability": 9.841024038235066e-05,
            "start_logit": 5.358553886413574,
            "end_logit": -3.087388515472412
        },
        {
            "text": "The output from SmileFinder",
            "probability": 5.095454669029896e-05,
            "start_logit": -1.2667170763015747,
            "end_logit": 2.879671573638916
        },
        {
            "text": "a simple program",
            "probability": 1.6230183647727497e-05,
            "start_logit": -0.4969339072704315,
            "end_logit": 0.9658271074295044
        },
        {
            "text": "SmileFinder can be used to plot percentile values",
            "probability": 6.076148597913643e-06,
            "start_logit": 2.3034276962280273,
            "end_logit": -2.8170361518859863
        },
        {
            "text": "output from SmileFinder",
            "probability": 5.007369938655861e-06,
            "start_logit": -3.586740255355835,
            "end_logit": 2.879671573638916
        },
        {
            "text": "simple program",
            "probability": 3.120030992403893e-06,
            "start_logit": -2.145963668823242,
            "end_logit": 0.9658271074295044
        },
        {
            "text": "FINDINGS: SmileFinder is",
            "probability": 2.8819690195382306e-06,
            "start_logit": -3.3296821117401123,
            "end_logit": 2.070176362991333
        },
        {
            "text": "evaluating allele frequencies in windows, including neighboring loci from two or more populations of a diploid species against the genome-wide neutral expectation",
            "probability": 2.659059977238873e-06,
            "start_logit": -0.9971371293067932,
            "end_logit": -0.34286969900131226
        },
        {
            "text": "a simple program that looks for diversity and divergence patterns consistent with selection sweeps by evaluating allele frequencies in windows",
            "probability": 2.120134854212815e-06,
            "start_logit": -0.4969339072704315,
            "end_logit": -1.0695658922195435
        },
        {
            "text": "a",
            "probability": 1.7501508618519287e-06,
            "start_logit": -0.4969339072704315,
            "end_logit": -1.2613435983657837
        }
    ],
    "5cd96eb2a49efeb44c000003_007": [
        {
            "text": "OmegaPlus",
            "probability": 0.9651577735583451,
            "start_logit": 6.314406871795654,
            "end_logit": 6.493633270263672
        },
        {
            "text": "OmegaPlus,",
            "probability": 0.01617514645584977,
            "start_logit": 6.314406871795654,
            "end_logit": 2.404817581176758
        },
        {
            "text": "",
            "probability": 0.008355538272928186,
            "start_logit": 3.7335073947906494,
            "end_logit": 4.325165748596191
        },
        {
            "text": "open-source sweep-detection software OmegaPlus",
            "probability": 0.005721884668540787,
            "start_logit": 1.1864135265350342,
            "end_logit": 6.493633270263672
        },
        {
            "text": "software OmegaPlus",
            "probability": 0.0019504828965637045,
            "start_logit": 0.11019226908683777,
            "end_logit": 6.493633270263672
        },
        {
            "text": "our open-source sweep-detection software OmegaPlus",
            "probability": 0.0011462511087180864,
            "start_logit": -0.42138800024986267,
            "end_logit": 6.493633270263672
        },
        {
            "text": "OmegaPlus, which implements all four parallelization strategies presented here, with a variety of neutrality tests",
            "probability": 0.0003384858348870123,
            "start_logit": 6.314406871795654,
            "end_logit": -1.4619313478469849
        },
        {
            "text": "O",
            "probability": 0.00032057518911270957,
            "start_logit": 6.314406871795654,
            "end_logit": -1.5162967443466187
        },
        {
            "text": "OmegaP",
            "probability": 0.0002318279754407575,
            "start_logit": 6.314406871795654,
            "end_logit": -1.8404179811477661
        },
        {
            "text": "Omega",
            "probability": 0.00014081466602031603,
            "start_logit": 6.314406871795654,
            "end_logit": -2.3389689922332764
        },
        {
            "text": "open-source sweep-detection software OmegaPlus,",
            "probability": 9.589346431506903e-05,
            "start_logit": 1.1864135265350342,
            "end_logit": 2.404817581176758
        },
        {
            "text": "OmegaPlus, which implements all four parallelization strategies presented here,",
            "probability": 7.071190782887342e-05,
            "start_logit": 6.314406871795654,
            "end_logit": -3.027799606323242
        },
        {
            "text": "compare the accuracy of our open-source sweep-detection software OmegaPlus",
            "probability": 6.638166597200035e-05,
            "start_logit": -3.270219087600708,
            "end_logit": 6.493633270263672
        },
        {
            "text": "we compare the accuracy of our open-source sweep-detection software OmegaPlus",
            "probability": 4.961550936889279e-05,
            "start_logit": -3.5613365173339844,
            "end_logit": 6.493633270263672
        },
        {
            "text": "the accuracy of our open-source sweep-detection software OmegaPlus",
            "probability": 3.735740843542803e-05,
            "start_logit": -3.8451087474823,
            "end_logit": 6.493633270263672
        },
        {
            "text": "software OmegaPlus,",
            "probability": 3.2688278927943374e-05,
            "start_logit": 0.11019226908683777,
            "end_logit": 2.404817581176758
        },
        {
            "text": "accuracy of our open-source sweep-detection software OmegaPlus",
            "probability": 2.9711573073085924e-05,
            "start_logit": -4.074103355407715,
            "end_logit": 6.493633270263672
        },
        {
            "text": "OmegaPlus, which implements all four parallelization strategies presented here, with a variety of neutrality tests.",
            "probability": 2.743166170413139e-05,
            "start_logit": 6.314406871795654,
            "end_logit": -3.9747157096862793
        },
        {
            "text": "sweep-detection software OmegaPlus",
            "probability": 2.613965229870074e-05,
            "start_logit": -4.202186584472656,
            "end_logit": 6.493633270263672
        },
        {
            "text": "OmegaPlus, which implements all four parallelization strategies presented here, with a variety of neutrality tests.CONCLUSIONS",
            "probability": 2.5288251669365905e-05,
            "start_logit": 6.314406871795654,
            "end_logit": -4.0560736656188965
        }
    ],
    "5cd96eb2a49efeb44c000003_008": [
        {
            "text": "SFS- and LD-based methods",
            "probability": 0.5308950963417742,
            "start_logit": 4.597448348999023,
            "end_logit": 4.79164457321167
        },
        {
            "text": "SFS- and LD-based",
            "probability": 0.19231501061382125,
            "start_logit": 4.597448348999023,
            "end_logit": 3.776214838027954
        },
        {
            "text": "both SFS- and LD-based methods",
            "probability": 0.07881704371608012,
            "start_logit": 2.6900131702423096,
            "end_logit": 4.79164457321167
        },
        {
            "text": "SFS- and LD",
            "probability": 0.06398684506643386,
            "start_logit": 4.597448348999023,
            "end_logit": 2.675757646560669
        },
        {
            "text": "both SFS- and LD-based",
            "probability": 0.0285512160561564,
            "start_logit": 2.6900131702423096,
            "end_logit": 3.776214838027954
        },
        {
            "text": "SweeD, SweepFinder, SweepFinder2, and OmegaPlus",
            "probability": 0.026100500343594915,
            "start_logit": 2.489097833633423,
            "end_logit": 3.887385129928589
        },
        {
            "text": "LD-based methods",
            "probability": 0.024130509218143355,
            "start_logit": 1.5063608884811401,
            "end_logit": 4.79164457321167
        },
        {
            "text": "both SFS- and LD",
            "probability": 0.009499530132424635,
            "start_logit": 2.6900131702423096,
            "end_logit": 2.675757646560669
        },
        {
            "text": "LD-based",
            "probability": 0.008741197966192242,
            "start_logit": 1.5063608884811401,
            "end_logit": 3.776214838027954
        },
        {
            "text": "SFS- and LD-based methods are able to detect selective sweeps accurately",
            "probability": 0.006174435134912395,
            "start_logit": 4.597448348999023,
            "end_logit": 0.3374975323677063
        },
        {
            "text": "SFS",
            "probability": 0.005170877937398588,
            "start_logit": 4.597448348999023,
            "end_logit": 0.16012261807918549
        },
        {
            "text": "equilibrium neutral models or mild bottlenecks, both SFS- and LD-based methods",
            "probability": 0.0039802017728119005,
            "start_logit": -0.2957835793495178,
            "end_logit": 4.79164457321167
        },
        {
            "text": "",
            "probability": 0.0034526473459894763,
            "start_logit": 1.971582293510437,
            "end_logit": 2.382087469100952
        },
        {
            "text": "In equilibrium neutral models or mild bottlenecks, both SFS- and LD-based methods",
            "probability": 0.0033598402806364587,
            "start_logit": -0.46522265672683716,
            "end_logit": 4.79164457321167
        },
        {
            "text": "LD",
            "probability": 0.0029083620575042755,
            "start_logit": 1.5063608884811401,
            "end_logit": 2.675757646560669
        },
        {
            "text": "SFS- and LD-based methods are able to detect selective sweeps accurately. Methods and tools that rely on LD",
            "probability": 0.002764019829030236,
            "start_logit": 4.597448348999023,
            "end_logit": -0.4662337899208069
        },
        {
            "text": "SFS- and LD-based methods are able to detect selective sweeps accurately.",
            "probability": 0.002686264850591358,
            "start_logit": 4.597448348999023,
            "end_logit": -0.4947681725025177
        },
        {
            "text": "SweeD, SweepFinder, SweepFinder2, and OmegaPlus)",
            "probability": 0.002516845855701786,
            "start_logit": 2.489097833633423,
            "end_logit": 1.5484371185302734
        },
        {
            "text": "SweepFinder, SweepFinder2, and OmegaPlus",
            "probability": 0.002187434264870659,
            "start_logit": 0.009872637689113617,
            "end_logit": 3.887385129928589
        },
        {
            "text": "SweepFinder2, and OmegaPlus",
            "probability": 0.0017621212159320435,
            "start_logit": -0.2063383311033249,
            "end_logit": 3.887385129928589
        }
    ],
    "5cd96eb2a49efeb44c000003_010": [
        {
            "text": "RAiSD",
            "probability": 0.7773267726452929,
            "start_logit": 5.485057353973389,
            "end_logit": 5.840266227722168
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep Detection)",
            "probability": 0.09567491640717313,
            "start_logit": 5.485057353973389,
            "end_logit": 3.745361566543579
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep Detection",
            "probability": 0.074330026091786,
            "start_logit": 5.485057353973389,
            "end_logit": 3.492920398712158
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep Detection),",
            "probability": 0.040622903418597325,
            "start_logit": 5.485057353973389,
            "end_logit": 2.888737440109253
        },
        {
            "text": "Raised Accuracy in Sweep Detection)",
            "probability": 0.002298016380312151,
            "start_logit": 1.7561475038528442,
            "end_logit": 3.745361566543579
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep Detection), an open-source software",
            "probability": 0.001790965469332352,
            "start_logit": 5.485057353973389,
            "end_logit": -0.23283974826335907
        },
        {
            "text": "Raised Accuracy in Sweep Detection",
            "probability": 0.0017853333341940334,
            "start_logit": 1.7561475038528442,
            "end_logit": 3.492920398712158
        },
        {
            "text": "",
            "probability": 0.0012551128137312025,
            "start_logit": 2.1317594051361084,
            "end_logit": 2.7649288177490234
        },
        {
            "text": "We present RAiSD",
            "probability": 0.001198247794067931,
            "start_logit": -0.9899431467056274,
            "end_logit": 5.840266227722168
        },
        {
            "text": "Raised Accuracy in Sweep Detection),",
            "probability": 0.0009757217563116276,
            "start_logit": 1.7561475038528442,
            "end_logit": 2.888737440109253
        },
        {
            "text": "RAiSD (",
            "probability": 0.0005837262670268153,
            "start_logit": 5.485057353973389,
            "end_logit": -1.3539177179336548
        },
        {
            "text": "present RAiSD",
            "probability": 0.0004523930969376285,
            "start_logit": -1.9640072584152222,
            "end_logit": 5.840266227722168
        },
        {
            "text": "RAiSD (Raised Accuracy",
            "probability": 0.00035971670457920514,
            "start_logit": 5.485057353973389,
            "end_logit": -1.8380330801010132
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep Detection), an open-source",
            "probability": 0.0003006747864914149,
            "start_logit": 5.485057353973389,
            "end_logit": -2.0173206329345703
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep",
            "probability": 0.0002480289157467687,
            "start_logit": 5.485057353973389,
            "end_logit": -2.2098045349121094
        },
        {
            "text": "R",
            "probability": 0.00024134445539839995,
            "start_logit": 5.485057353973389,
            "end_logit": -2.2371246814727783
        },
        {
            "text": "RAiSD achieves higher sensitivity and accuracy than the current state of the art",
            "probability": 0.00014793591958072304,
            "start_logit": 1.9095146656036377,
            "end_logit": 0.8489720225334167
        },
        {
            "text": "We present RAiSD (Raised Accuracy in Sweep Detection)",
            "probability": 0.00014748270813109128,
            "start_logit": -0.9899431467056274,
            "end_logit": 3.745361566543579
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep Detection), an",
            "probability": 0.0001461014364433638,
            "start_logit": 5.485057353973389,
            "end_logit": -2.739048719406128
        },
        {
            "text": "We present RAiSD (Raised Accuracy in Sweep Detection",
            "probability": 0.00011457959886599265,
            "start_logit": -0.9899431467056274,
            "end_logit": 3.492920398712158
        }
    ],
    "5e36d924b5b409ea5300000b_002": [
        {
            "text": "WD40 domain",
            "probability": 0.14864121154101215,
            "start_logit": 0.9998268485069275,
            "end_logit": 1.4791383743286133
        },
        {
            "text": "WD40 domain that is essential for proliferation",
            "probability": 0.12881468798055232,
            "start_logit": 0.9998268485069275,
            "end_logit": 1.3359777927398682
        },
        {
            "text": "proliferation",
            "probability": 0.08863054207901745,
            "start_logit": 0.625928521156311,
            "end_logit": 1.3359777927398682
        },
        {
            "text": "essential for proliferation",
            "probability": 0.08123131695897198,
            "start_logit": 0.5387528538703918,
            "end_logit": 1.3359777927398682
        },
        {
            "text": "WD40 domain that is essential for proliferation and averts genome instability.",
            "probability": 0.07844481751426498,
            "start_logit": 0.9998268485069275,
            "end_logit": 0.8399983644485474
        },
        {
            "text": "fork protection function of AND-1/Ctf4 manifested via the WD40 domain",
            "probability": 0.057480202730430204,
            "start_logit": 0.049732010811567307,
            "end_logit": 1.4791383743286133
        },
        {
            "text": "proliferation and averts genome instability.",
            "probability": 0.053973710673650595,
            "start_logit": 0.625928521156311,
            "end_logit": 0.8399983644485474
        },
        {
            "text": "fork protection function",
            "probability": 0.053222225976362024,
            "start_logit": 0.049732010811567307,
            "end_logit": 1.4021738767623901
        },
        {
            "text": "fork protection function of AND-1/Ctf4 manifested via the WD40 domain that is essential for proliferation",
            "probability": 0.04981319987247488,
            "start_logit": 0.049732010811567307,
            "end_logit": 1.3359777927398682
        },
        {
            "text": "essential for proliferation and averts genome instability.",
            "probability": 0.04946777370801076,
            "start_logit": 0.5387528538703918,
            "end_logit": 0.8399983644485474
        },
        {
            "text": "the WD40 domain",
            "probability": 0.03461590822204648,
            "start_logit": -0.4573952257633209,
            "end_logit": 1.4791383743286133
        },
        {
            "text": "the WD40 domain that is essential for proliferation",
            "probability": 0.02999866168041858,
            "start_logit": -0.4573952257633209,
            "end_logit": 1.3359777927398682
        },
        {
            "text": "a fork protection function of AND-1/Ctf4 manifested via the WD40 domain",
            "probability": 0.025152522547241648,
            "start_logit": -0.776750385761261,
            "end_logit": 1.4791383743286133
        },
        {
            "text": "a fork protection function",
            "probability": 0.023289292230977778,
            "start_logit": -0.776750385761261,
            "end_logit": 1.4021738767623901
        },
        {
            "text": "a fork protection function of AND-1/Ctf4 manifested via the WD40 domain that is essential for proliferation",
            "probability": 0.02179755069443023,
            "start_logit": -0.776750385761261,
            "end_logit": 1.3359777927398682
        },
        {
            "text": "the WD40 domain that is essential for proliferation and averts genome instability.",
            "probability": 0.018268410055442493,
            "start_logit": -0.4573952257633209,
            "end_logit": 0.8399983644485474
        },
        {
            "text": "fork protection",
            "probability": 0.017969304241405314,
            "start_logit": 0.049732010811567307,
            "end_logit": 0.31636276841163635
        },
        {
            "text": "",
            "probability": 0.016890471275172517,
            "start_logit": -0.10954248905181885,
            "end_logit": 0.4137219190597534
        },
        {
            "text": "via the WD40 domain",
            "probability": 0.011945790250558606,
            "start_logit": -1.521329641342163,
            "end_logit": 1.4791383743286133
        },
        {
            "text": "via the WD40 domain that is essential for proliferation",
            "probability": 0.010352399767558787,
            "start_logit": -1.521329641342163,
            "end_logit": 1.3359777927398682
        }
    ],
    "5e2db15cfbd6abf43b000014_001": [
        {
            "text": "ADS-5102",
            "probability": 0.30207664584165794,
            "start_logit": 0.6767265200614929,
            "end_logit": 0.9729702472686768
        },
        {
            "text": "ADS-5102 (amantadine) extended-release (ER) capsules",
            "probability": 0.14029539157144238,
            "start_logit": 0.6767265200614929,
            "end_logit": 0.20603960752487183
        },
        {
            "text": "",
            "probability": 0.092055055792114,
            "start_logit": -0.05884625017642975,
            "end_logit": 0.52024906873703
        },
        {
            "text": "ADS-5102 (amantadine) extended-release (ER) capsules (GOCOVRITM",
            "probability": 0.09196144737038452,
            "start_logit": 0.6767265200614929,
            "end_logit": -0.21634109318256378
        },
        {
            "text": "ADS-5102 (amantadine) extended-release (ER) capsules (GOCOVRITM)",
            "probability": 0.050288046366162596,
            "start_logit": 0.6767265200614929,
            "end_logit": -0.8199431300163269
        },
        {
            "text": "pooled ADS-5102",
            "probability": 0.04556629862110386,
            "start_logit": -0.20427305996418,
            "end_logit": -0.03754257410764694
        },
        {
            "text": "recent US FDA-approved treatment for dyskinesia in PD patients",
            "probability": 0.038441843984482416,
            "start_logit": -0.7023149728775024,
            "end_logit": 0.2904775142669678
        },
        {
            "text": "extended-release (ER) capsules",
            "probability": 0.034336720893330515,
            "start_logit": -0.7308082580566406,
            "end_logit": 0.20603960752487183
        },
        {
            "text": "recent US FDA-approved treatment for dyskinesia in PD patients.",
            "probability": 0.02588125972824774,
            "start_logit": -0.7023149728775024,
            "end_logit": -0.10514989495277405
        },
        {
            "text": "recent US FDA-approved treatment for dyskinesia in PD patients. ADS-5102",
            "probability": 0.02416304041022444,
            "start_logit": -0.7023149728775024,
            "end_logit": -0.1738448292016983
        },
        {
            "text": "extended-release (ER) capsules (GOCOVRITM",
            "probability": 0.022507186557839495,
            "start_logit": -0.7308082580566406,
            "end_logit": -0.21634109318256378
        },
        {
            "text": "approved treatment for dyskinesia in PD patients",
            "probability": 0.018703203901261338,
            "start_logit": -1.4227666854858398,
            "end_logit": 0.2904775142669678
        },
        {
            "text": "In the pooled ADS-5102",
            "probability": 0.017079535168915912,
            "start_logit": -1.1855604648590088,
            "end_logit": -0.03754257410764694
        },
        {
            "text": "GOCOVRITM) is a recent US FDA-approved treatment for dyskinesia in PD patients",
            "probability": 0.015850310244775845,
            "start_logit": -1.5882724523544312,
            "end_logit": 0.2904775142669678
        },
        {
            "text": "recent US FDA-approved treatment for dyskinesia",
            "probability": 0.014526278873578961,
            "start_logit": -0.7023149728775024,
            "end_logit": -0.6827096939086914
        },
        {
            "text": "extended-release (ER) capsules (GOCOVRITM) is a recent US FDA-approved treatment for dyskinesia",
            "probability": 0.014118218563628205,
            "start_logit": -0.7308082580566406,
            "end_logit": -0.6827096939086914
        },
        {
            "text": "ADS-5102 (amantadine) extended-release",
            "probability": 0.013925638809698875,
            "start_logit": 0.6767265200614929,
            "end_logit": -2.1039788722991943
        },
        {
            "text": "amantadine) extended-release (ER) capsules",
            "probability": 0.013324012209122556,
            "start_logit": -1.6774557828903198,
            "end_logit": 0.20603960752487183
        },
        {
            "text": "approved treatment for dyskinesia in PD patients.",
            "probability": 0.012592072277134252,
            "start_logit": -1.4227666854858398,
            "end_logit": -0.10514989495277405
        },
        {
            "text": "extended-release (ER) capsules (GOCOVRITM)",
            "probability": 0.012307792814894358,
            "start_logit": -0.7308082580566406,
            "end_logit": -0.8199431300163269
        }
    ],
    "5e4adcbe6d0a277941000017_001": [
        {
            "text": "may not",
            "probability": 0.16166586191458368,
            "start_logit": 2.465726137161255,
            "end_logit": 3.883906126022339
        },
        {
            "text": "not",
            "probability": 0.14315041763137593,
            "start_logit": 2.344090461730957,
            "end_logit": 3.883906126022339
        },
        {
            "text": "this mutation did not affect the clinical outcome of RAI therapy.CONCLUSION: The status of BRAF mutation may not",
            "probability": 0.08929883595029302,
            "start_logit": 1.8721829652786255,
            "end_logit": 3.883906126022339
        },
        {
            "text": "did not affect the clinical outcome of RAI therapy.CONCLUSION: The status of BRAF mutation may not",
            "probability": 0.07045422383353096,
            "start_logit": 1.6351577043533325,
            "end_logit": 3.883906126022339
        },
        {
            "text": "may not affect the clinical response to RAI therapy",
            "probability": 0.06033319896660128,
            "start_logit": 2.465726137161255,
            "end_logit": 2.89825701713562
        },
        {
            "text": "not affect the clinical response to RAI therapy",
            "probability": 0.05342329250481523,
            "start_logit": 2.344090461730957,
            "end_logit": 2.89825701713562
        },
        {
            "text": "The status of BRAF mutation may not",
            "probability": 0.04405492973306881,
            "start_logit": 1.1656317710876465,
            "end_logit": 3.883906126022339
        },
        {
            "text": "this mutation did not affect the clinical outcome of RAI therapy",
            "probability": 0.04141454424012403,
            "start_logit": 1.8721829652786255,
            "end_logit": 3.1155498027801514
        },
        {
            "text": "may not affect",
            "probability": 0.03981840267309246,
            "start_logit": 2.465726137161255,
            "end_logit": 2.482703685760498
        },
        {
            "text": "not affect the clinical outcome of RAI therapy.CONCLUSION: The status of BRAF mutation may not",
            "probability": 0.03970189424762197,
            "start_logit": 1.0615934133529663,
            "end_logit": 3.883906126022339
        },
        {
            "text": "may not affect the clinical response to RAI therapy for patients with PTMC with intermediate-risk to high-risk features",
            "probability": 0.0360901130820581,
            "start_logit": 2.465726137161255,
            "end_logit": 2.3843934535980225
        },
        {
            "text": "not affect",
            "probability": 0.0352580371920393,
            "start_logit": 2.344090461730957,
            "end_logit": 2.482703685760498
        },
        {
            "text": "did not affect the clinical outcome of RAI therapy",
            "probability": 0.0326748891943176,
            "start_logit": 1.6351577043533325,
            "end_logit": 3.1155498027801514
        },
        {
            "text": "not affect the clinical response to RAI therapy for patients with PTMC with intermediate-risk to high-risk features",
            "probability": 0.03195674522052051,
            "start_logit": 2.344090461730957,
            "end_logit": 2.3843934535980225
        },
        {
            "text": "did not affect the clinical outcome of RAI therapy.CONCLUSION: The status of BRAF mutation may not affect the clinical response to RAI therapy",
            "probability": 0.02629329812890097,
            "start_logit": 1.6351577043533325,
            "end_logit": 2.89825701713562
        },
        {
            "text": "this mutation did not affect the clinical outcome of RAI therapy.CONCLUSION: The status of BRAF mutation may not affect",
            "probability": 0.021994359019258312,
            "start_logit": 1.8721829652786255,
            "end_logit": 2.482703685760498
        },
        {
            "text": "",
            "probability": 0.020210138239858903,
            "start_logit": 1.8871926069259644,
            "end_logit": 2.3830924034118652
        },
        {
            "text": "not affect the clinical outcome of RAI therapy",
            "probability": 0.018412735599936687,
            "start_logit": 1.0615934133529663,
            "end_logit": 3.1155498027801514
        },
        {
            "text": "did not affect the clinical outcome of RAI therapy.CONCLUSION: The status of BRAF mutation may not affect",
            "probability": 0.017352919295391792,
            "start_logit": 1.6351577043533325,
            "end_logit": 2.482703685760498
        },
        {
            "text": "The status of BRAF mutation may not affect the clinical response to RAI therapy",
            "probability": 0.016441163332610212,
            "start_logit": 1.1656317710876465,
            "end_logit": 2.89825701713562
        }
    ],
    "5e4adcbe6d0a277941000017_002": [
        {
            "text": "may not",
            "probability": 0.16166586191458368,
            "start_logit": 2.465726137161255,
            "end_logit": 3.883906126022339
        },
        {
            "text": "not",
            "probability": 0.14315041763137593,
            "start_logit": 2.344090461730957,
            "end_logit": 3.883906126022339
        },
        {
            "text": "this mutation did not affect the clinical outcome of RAI therapy.CONCLUSION: The status of BRAF mutation may not",
            "probability": 0.08929883595029302,
            "start_logit": 1.8721829652786255,
            "end_logit": 3.883906126022339
        },
        {
            "text": "did not affect the clinical outcome of RAI therapy.CONCLUSION: The status of BRAF mutation may not",
            "probability": 0.07045422383353096,
            "start_logit": 1.6351577043533325,
            "end_logit": 3.883906126022339
        },
        {
            "text": "may not affect the clinical response to RAI therapy",
            "probability": 0.06033319896660128,
            "start_logit": 2.465726137161255,
            "end_logit": 2.89825701713562
        },
        {
            "text": "not affect the clinical response to RAI therapy",
            "probability": 0.05342329250481523,
            "start_logit": 2.344090461730957,
            "end_logit": 2.89825701713562
        },
        {
            "text": "The status of BRAF mutation may not",
            "probability": 0.04405492973306881,
            "start_logit": 1.1656317710876465,
            "end_logit": 3.883906126022339
        },
        {
            "text": "this mutation did not affect the clinical outcome of RAI therapy",
            "probability": 0.04141454424012403,
            "start_logit": 1.8721829652786255,
            "end_logit": 3.1155498027801514
        },
        {
            "text": "may not affect",
            "probability": 0.03981840267309246,
            "start_logit": 2.465726137161255,
            "end_logit": 2.482703685760498
        },
        {
            "text": "not affect the clinical outcome of RAI therapy.CONCLUSION: The status of BRAF mutation may not",
            "probability": 0.03970189424762197,
            "start_logit": 1.0615934133529663,
            "end_logit": 3.883906126022339
        },
        {
            "text": "may not affect the clinical response to RAI therapy for patients with PTMC with intermediate-risk to high-risk features",
            "probability": 0.0360901130820581,
            "start_logit": 2.465726137161255,
            "end_logit": 2.3843934535980225
        },
        {
            "text": "not affect",
            "probability": 0.0352580371920393,
            "start_logit": 2.344090461730957,
            "end_logit": 2.482703685760498
        },
        {
            "text": "did not affect the clinical outcome of RAI therapy",
            "probability": 0.0326748891943176,
            "start_logit": 1.6351577043533325,
            "end_logit": 3.1155498027801514
        },
        {
            "text": "not affect the clinical response to RAI therapy for patients with PTMC with intermediate-risk to high-risk features",
            "probability": 0.03195674522052051,
            "start_logit": 2.344090461730957,
            "end_logit": 2.3843934535980225
        },
        {
            "text": "did not affect the clinical outcome of RAI therapy.CONCLUSION: The status of BRAF mutation may not affect the clinical response to RAI therapy",
            "probability": 0.02629329812890097,
            "start_logit": 1.6351577043533325,
            "end_logit": 2.89825701713562
        },
        {
            "text": "this mutation did not affect the clinical outcome of RAI therapy.CONCLUSION: The status of BRAF mutation may not affect",
            "probability": 0.021994359019258312,
            "start_logit": 1.8721829652786255,
            "end_logit": 2.482703685760498
        },
        {
            "text": "",
            "probability": 0.020210138239858903,
            "start_logit": 1.8871926069259644,
            "end_logit": 2.3830924034118652
        },
        {
            "text": "not affect the clinical outcome of RAI therapy",
            "probability": 0.018412735599936687,
            "start_logit": 1.0615934133529663,
            "end_logit": 3.1155498027801514
        },
        {
            "text": "did not affect the clinical outcome of RAI therapy.CONCLUSION: The status of BRAF mutation may not affect",
            "probability": 0.017352919295391792,
            "start_logit": 1.6351577043533325,
            "end_logit": 2.482703685760498
        },
        {
            "text": "The status of BRAF mutation may not affect the clinical response to RAI therapy",
            "probability": 0.016441163332610212,
            "start_logit": 1.1656317710876465,
            "end_logit": 2.89825701713562
        }
    ],
    "5e4adcbe6d0a277941000017_003": [
        {
            "text": "incomplete bio-chemical response",
            "probability": 0.22900574896108908,
            "start_logit": 1.3679708242416382,
            "end_logit": 1.6639604568481445
        },
        {
            "text": "incomplete bio-chemical response to first RAIT.",
            "probability": 0.17985086825020843,
            "start_logit": 1.3679708242416382,
            "end_logit": 1.4223413467407227
        },
        {
            "text": "incomplete bio-chemical response to first RAIT",
            "probability": 0.10658787321229551,
            "start_logit": 1.3679708242416382,
            "end_logit": 0.8991830945014954
        },
        {
            "text": "negative prognostic clue",
            "probability": 0.06535563077348318,
            "start_logit": 1.4190884828567505,
            "end_logit": 0.3589392900466919
        },
        {
            "text": "negative prognostic clue, which predicts the absence of radioiodine uptake at pT-WBS in DTC patients",
            "probability": 0.04950077520086126,
            "start_logit": 1.4190884828567505,
            "end_logit": 0.08108402043581009
        },
        {
            "text": "negative",
            "probability": 0.04691316763066074,
            "start_logit": 1.4190884828567505,
            "end_logit": 0.027394086122512817
        },
        {
            "text": "negative prognostic clue, which predicts the absence of radioiodine uptake at pT-WBS",
            "probability": 0.04117961983509559,
            "start_logit": 1.4190884828567505,
            "end_logit": -0.10296083986759186
        },
        {
            "text": "negative prognostic",
            "probability": 0.04098241238856331,
            "start_logit": 1.4190884828567505,
            "end_logit": -0.10776130110025406
        },
        {
            "text": "incomplete response",
            "probability": 0.03847259876438283,
            "start_logit": 0.1559227705001831,
            "end_logit": 1.092207670211792
        },
        {
            "text": "negative prognostic clue,",
            "probability": 0.028239986858703565,
            "start_logit": 1.4190884828567505,
            "end_logit": -0.48016536235809326
        },
        {
            "text": "absence of radioiodine uptake at pT-WBS in DTC patients with incomplete bio-chemical response",
            "probability": 0.025271425597125665,
            "start_logit": -0.8361019492149353,
            "end_logit": 1.6639604568481445
        },
        {
            "text": "",
            "probability": 0.024213836216273734,
            "start_logit": 0.15568089485168457,
            "end_logit": 0.6294274926185608
        },
        {
            "text": "incomplete",
            "probability": 0.021558635546045948,
            "start_logit": 1.0879675149917603,
            "end_logit": -0.419006884098053
        },
        {
            "text": "absence of radioiodine uptake at pT-WBS in DTC patients with incomplete bio-chemical response to first RAIT.",
            "probability": 0.019847046880625954,
            "start_logit": -0.8361019492149353,
            "end_logit": 1.4223413467407227
        },
        {
            "text": "negative prognostic clue, which predicts the absence of radioiodine uptake at pT-WBS in DTC patients with incomplete",
            "probability": 0.01928666071669487,
            "start_logit": 1.4190884828567505,
            "end_logit": -0.8614906072616577
        },
        {
            "text": "which predicts the absence of radioiodine uptake at pT-WBS in DTC patients with incomplete bio-chemical response",
            "probability": 0.013634311680599354,
            "start_logit": -1.4531867504119873,
            "end_logit": 1.6639604568481445
        },
        {
            "text": "negative prognostic clue, which predicts the absence of radioiodine uptake",
            "probability": 0.013364528841735928,
            "start_logit": 1.4190884828567505,
            "end_logit": -1.2283002138137817
        },
        {
            "text": "predicts the absence of radioiodine uptake at pT-WBS in DTC patients with incomplete bio-chemical response",
            "probability": 0.01293715432670597,
            "start_logit": -1.5056729316711426,
            "end_logit": 1.6639604568481445
        },
        {
            "text": "incomplete response to first RAIT",
            "probability": 0.012035448071659337,
            "start_logit": 0.1559227705001831,
            "end_logit": -0.06988229602575302
        },
        {
            "text": "absence of radioiodine uptake at pT-WBS in DTC patients with incomplete bio-chemical response to first RAIT",
            "probability": 0.011762270247189606,
            "start_logit": -0.8361019492149353,
            "end_logit": 0.8991830945014954
        }
    ],
    "5e4adcbe6d0a277941000017_004": [
        {
            "text": "radioiodine-refractory effects",
            "probability": 0.16802747958264272,
            "start_logit": 2.1376354694366455,
            "end_logit": 2.822486162185669
        },
        {
            "text": "radioiodine-refractory",
            "probability": 0.16301654737395604,
            "start_logit": 2.1376354694366455,
            "end_logit": 2.792210340499878
        },
        {
            "text": "refractory effects",
            "probability": 0.10978663583645662,
            "start_logit": 1.71204674243927,
            "end_logit": 2.822486162185669
        },
        {
            "text": "refractory",
            "probability": 0.10651256786279713,
            "start_logit": 1.71204674243927,
            "end_logit": 2.792210340499878
        },
        {
            "text": "radioiodine-refractory effects during RIA therapy in these patients.",
            "probability": 0.05104428091302638,
            "start_logit": 2.1376354694366455,
            "end_logit": 1.6310521364212036
        },
        {
            "text": "suggesting the radioiodine-refractory effects",
            "probability": 0.05022352833498871,
            "start_logit": 0.9299915432929993,
            "end_logit": 2.822486162185669
        },
        {
            "text": "suggesting the radioiodine-refractory",
            "probability": 0.048725757277583166,
            "start_logit": 0.9299915432929993,
            "end_logit": 2.792210340499878
        },
        {
            "text": "radioiodine-refractory effects during RIA therapy",
            "probability": 0.043236174891068846,
            "start_logit": 2.1376354694366455,
            "end_logit": 1.465036153793335
        },
        {
            "text": "refractory effects during RIA therapy in these patients.",
            "probability": 0.03335156781528676,
            "start_logit": 1.71204674243927,
            "end_logit": 1.6310521364212036
        },
        {
            "text": "the radioiodine-refractory effects",
            "probability": 0.028696738563669465,
            "start_logit": 0.37029141187667847,
            "end_logit": 2.822486162185669
        },
        {
            "text": "refractory effects during RIA therapy",
            "probability": 0.02824986841150872,
            "start_logit": 1.71204674243927,
            "end_logit": 1.465036153793335
        },
        {
            "text": "the radioiodine-refractory",
            "probability": 0.027840941571950464,
            "start_logit": 0.37029141187667847,
            "end_logit": 2.792210340499878
        },
        {
            "text": "correlated with a lower expression of NIS in PTCs without HT, suggesting the radioiodine-refractory effects",
            "probability": 0.025563394703131976,
            "start_logit": 0.2546693682670593,
            "end_logit": 2.822486162185669
        },
        {
            "text": "correlated with a lower expression of NIS in PTCs without HT, suggesting the radioiodine-refractory",
            "probability": 0.02480104060367475,
            "start_logit": 0.2546693682670593,
            "end_logit": 2.792210340499878
        },
        {
            "text": "lower expression of NIS in PTCs without HT, suggesting the radioiodine-refractory effects",
            "probability": 0.018823847110638562,
            "start_logit": -0.051367536187171936,
            "end_logit": 2.822486162185669
        },
        {
            "text": "lower expression of NIS in PTCs without HT, suggesting the radioiodine-refractory",
            "probability": 0.018262480469822536,
            "start_logit": -0.051367536187171936,
            "end_logit": 2.792210340499878
        },
        {
            "text": "suggesting the radioiodine-refractory effects during RIA therapy in these patients.",
            "probability": 0.015257170405353902,
            "start_logit": 0.9299915432929993,
            "end_logit": 1.6310521364212036
        },
        {
            "text": "inhibitory effect",
            "probability": 0.013699226080885016,
            "start_logit": 0.5906732678413391,
            "end_logit": 1.8626601696014404
        },
        {
            "text": "suggesting the radioiodine-refractory effects during RIA therapy",
            "probability": 0.01292332218594105,
            "start_logit": 0.9299915432929993,
            "end_logit": 1.465036153793335
        },
        {
            "text": "the radioiodine-refractory effects during RIA therapy in these patients.",
            "probability": 0.008717647781005792,
            "start_logit": 0.37029141187667847,
            "end_logit": 1.6310521364212036
        },
        {
            "text": "",
            "probability": 0.0032397822246117676,
            "start_logit": 0.3499322831630707,
            "end_logit": 0.6615679264068604
        }
    ],
    "5e4adcbe6d0a277941000017_005": [
        {
            "text": "not",
            "probability": 0.1704178460373311,
            "start_logit": 0.5382810831069946,
            "end_logit": 1.5439666509628296
        },
        {
            "text": "The latter, but not BRAF(V600E)",
            "probability": 0.16010129126483105,
            "start_logit": 1.1286793947219849,
            "end_logit": 0.8911216855049133
        },
        {
            "text": "The latter, but not BRAF(V600E) , associates with advanced stages and shorter DFI.",
            "probability": 0.1012894094197656,
            "start_logit": 1.1286793947219849,
            "end_logit": 0.4332968592643738
        },
        {
            "text": "not.CONCLUSION: In PTC, BRAF(V600E) induces uPA and uPAR expression.",
            "probability": 0.06186452417266304,
            "start_logit": 0.5382810831069946,
            "end_logit": 0.5306602120399475
        },
        {
            "text": "but not BRAF(V600E)",
            "probability": 0.06165041164297704,
            "start_logit": 0.17435261607170105,
            "end_logit": 0.8911216855049133
        },
        {
            "text": "the BRAF(V600E) was not",
            "probability": 0.058764543363130375,
            "start_logit": -0.5264335870742798,
            "end_logit": 1.5439666509628296
        },
        {
            "text": "not BRAF(V600E)",
            "probability": 0.04691081595427579,
            "start_logit": -0.09887902438640594,
            "end_logit": 0.8911216855049133
        },
        {
            "text": "BRAF(V600E) was not",
            "probability": 0.04122344231725615,
            "start_logit": -0.8809651732444763,
            "end_logit": 1.5439666509628296
        },
        {
            "text": "but not BRAF(V600E) , associates with advanced stages and shorter DFI.",
            "probability": 0.03900364410848635,
            "start_logit": 0.17435261607170105,
            "end_logit": 0.4332968592643738
        },
        {
            "text": "",
            "probability": 0.03147694232738905,
            "start_logit": 0.10214348882436752,
            "end_logit": 0.2911061942577362
        },
        {
            "text": "not BRAF(V600E) , associates with advanced stages and shorter DFI.",
            "probability": 0.02967851668071883,
            "start_logit": -0.09887902438640594,
            "end_logit": 0.4332968592643738
        },
        {
            "text": "The latter, but not BRAF(V600E) , associates with advanced stages and shorter DFI",
            "probability": 0.0287751943295533,
            "start_logit": 1.1286793947219849,
            "end_logit": -0.8251712918281555
        },
        {
            "text": "In PTC, BRAF(V600E) induces uPA and uPAR expression.",
            "probability": 0.02854857571776275,
            "start_logit": -0.2350587695837021,
            "end_logit": 0.5306602120399475
        },
        {
            "text": "was not",
            "probability": 0.023438745936741404,
            "start_logit": -1.4455817937850952,
            "end_logit": 1.5439666509628296
        },
        {
            "text": "not.CONCLUSION: In PTC, BRAF(V600E) induces uPA and uPAR expression",
            "probability": 0.022288959662343635,
            "start_logit": 0.5382810831069946,
            "end_logit": -0.49019521474838257
        },
        {
            "text": "The latter, but not BRAF(V600E) ,",
            "probability": 0.020595411145920266,
            "start_logit": 1.1286793947219849,
            "end_logit": -1.1596167087554932
        },
        {
            "text": "The latter, but not BRAF(V600E) , associates with advanced stages and shorter DFI. If confirmed in larger case studies",
            "probability": 0.020057157379989032,
            "start_logit": 1.1286793947219849,
            "end_logit": -1.1860989332199097
        },
        {
            "text": "The latter, but not",
            "probability": 0.01971699989559944,
            "start_logit": 1.1286793947219849,
            "end_logit": -1.203203797340393
        },
        {
            "text": "not.CONCLUSION: In PTC",
            "probability": 0.01713042024731292,
            "start_logit": 0.5382810831069946,
            "end_logit": -0.7534308433532715
        },
        {
            "text": "The latter",
            "probability": 0.017067148395952938,
            "start_logit": 1.1286793947219849,
            "end_logit": -1.3475295305252075
        }
    ]
}
